chr1	1005805	1005806	rs3934834	Body mass index
chr1	1079197	1079198	rs11260603	IgG glycosylation
chr1	1247493	1247494	rs12103	Inflammatory bowel disease
chr1	2069171	2069172	rs425277	Height
chr1	2069680	2069681	rs3753242	Response to antipsychotic treatment in schizophrenia (reasoning)
chr1	2205580	2205581	rs12045693	IgG glycosylation
chr1	2392647	2392648	rs2477686	Non-obstructive azoospermia
chr1	2452978	2452979	rs12073504	Obesity-related traits
chr1	2501337	2501338	rs10797432	Ulcerative colitis
chr1	2513215	2513216	rs734999	Ulcerative colitis
chr1	2526745	2526746	rs3748816	Celiac disease
chr1	2553623	2553624	rs3890745	Rheumatoid arthritis
chr1	2709163	2709164	rs4648356	Multiple sclerosis
chr1	3083711	3083712	rs2651899	Migraine
chr1	3280252	3280253	rs6658356	Response to statin therapy
chr1	3649561	3649562	rs9662633	Visceral adipose tissue adjusted for BMI
chr1	3651030	3651031	rs12562437	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr1	3651408	3651409	rs10910018	Visceral fat
chr1	3669355	3669356	rs76597070	Obesity-related traits
chr1	3691527	3691528	rs1175550	Blood trace element (Cu levels)
chr1	4183005	4183006	rs10915437	Migraine - clinic-based
chr1	4315203	4315204	rs966321	Factor VII
chr1	4444538	4444539	rs239339	Obesity-related traits
chr1	4668669	4668670	rs3896439	Dental caries
chr1	5170711	5170712	rs7513590	Anthropometric traits
chr1	5354843	5354844	rs912988	Major depressive disorder
chr1	5661008	5661009	rs7528859	Migraine with aura
chr1	5707815	5707816	rs4845812	Metabolite levels (MHPG)
chr1	5913620	5913621	rs548726	Response to taxane treatment (placlitaxel)
chr1	6279369	6279370	rs846111	QT interval
chr1	6631430	6631431	rs11587438	White blood cell types
chr1	7113111	7113112	rs11120822	Stearic acid (18:0) plasma levels
chr1	7521584	7521585	rs1616122	Periodontal microbiota
chr1	7879062	7879063	rs2797685	Crohn's disease
chr1	8021972	8021973	rs35675666	Inflammatory bowel disease
chr1	8021972	8021973	rs35675666	Ulcerative colitis
chr1	8046671	8046672	rs12727642	Celiac disease
chr1	8338354	8338355	rs438895	Economic and political preferences
chr1	8386729	8386730	rs9628987	Breast cancer
chr1	8390887	8390888	rs2289731	Breast cancer
chr1	8394235	8394236	rs12711517	Breast cancer
chr1	8395440	8395441	rs2305016	Breast cancer
chr1	8395559	8395560	rs7535752	Breast cancer
chr1	8422675	8422676	rs2252865	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr1	8422675	8422676	rs2252865	Schizophrenia
chr1	8447721	8447722	rs2120461	Bone mineral density
chr1	8526141	8526142	rs4908760	Vitiligo
chr1	8759553	8759554	rs12025126	Vertical cup-disc ratio
chr1	9151324	9151325	rs12080794	Response to antidepressant treatment (citalopram)
chr1	9317603	9317604	rs6662509	Height
chr1	9408958	9408959	rs11121380	Response to tocilizumab in rheumatoid arthritis
chr1	9411468	9411469	rs11121382	Immune response to anthrax vaccine
chr1	9432389	9432390	rs9308447	Dental caries
chr1	10286175	10286176	rs17396340	Mean platelet volume
chr1	10353111	10353112	rs10492972	Multiple sclerosis
chr1	10385470	10385471	rs17401966	Hepatocellular carcinoma
chr1	10566214	10566215	rs616488	Breast cancer
chr1	10581657	10581658	rs2056417	Self-reported allergy
chr1	10638603	10638604	rs12741973	Optic disc size (rim)
chr1	10750431	10750432	rs516243	Migraine - clinic-based
chr1	10796865	10796866	rs880315	Blood pressure
chr1	10799576	10799577	rs12046278	Systolic blood pressure
chr1	11033081	11033082	rs12565727	Male-pattern baldness
chr1	11046854	11046855	rs9430161	Ewing sarcoma
chr1	11171225	11171226	rs17036350	Corneal curvature
chr1	11736599	11736600	rs2336030	Visceral adipose tissue adjusted for BMI
chr1	11788563	11788564	rs4846033	Schizophrenia
chr1	11838645	11838646	rs12134663	Homocysteine levels
chr1	11852515	11852516	rs17375901	Atrial fibrillation
chr1	11856377	11856378	rs1801133	Homocysteine levels
chr1	11862777	11862778	rs17367504	Blood pressure
chr1	11862777	11862778	rs17367504	Systolic blood pressure
chr1	11899032	11899033	rs1023252	Natriuretic peptide levels
chr1	11958722	11958723	rs12085006	Folate pathway vitamin levels
chr1	12046062	12046063	rs2336384	Platelet counts
chr1	12741239	12741240	rs2489260	Obesity-related traits
chr1	15339959	15339960	rs6429703	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
chr1	15347639	15347640	rs6667220	Chronic obstructive pulmonary disease-related biomarkers
chr1	15548635	15548636	rs10737909	Migraine
chr1	15792425	15792426	rs2901964	Erectile dysfunction and prostate cancer treatment
chr1	16071009	16071010	rs59905655	Obesity-related traits
chr1	16080170	16080171	rs12725198	Cardiac Troponin-T levels
chr1	16299311	16299312	rs10927875	Dilated cardiomyopathy
chr1	16393356	16393357	rs9442235	Cognitive performance
chr1	16505319	16505320	rs1497406	Gamma gluatamyl transferase levels
chr1	16505319	16505320	rs1497406	Liver enzyme levels (gamma-glutamyl transferase)
chr1	17216330	17216331	rs6586513	Allergic rhinitis
chr1	17306674	17306675	rs2284746	Height
chr1	17306674	17306675	rs2284746	Pulmonary function (interaction)
chr1	17306674	17306675	rs2284746	Pulmonary function
chr1	17331675	17331676	rs3738814	Height
chr1	17591678	17591679	rs3003429	Pulmonary function (interaction)
chr1	17674536	17674537	rs2240335	Rheumatoid arthritis
chr1	17722362	17722363	rs7538876	Basal cell carcinoma
chr1	17834741	17834742	rs2254135	Response to hepatitis C treatment
chr1	17919816	17919817	rs6693036	Obesity-related traits
chr1	18244706	18244707	rs6686929	Obesity-related traits
chr1	18294486	18294487	rs16861326	Erectile dysfunction and prostate cancer treatment
chr1	18795254	18795255	rs3007729	Diabetic retinopathy
chr1	18979873	18979874	rs742071	Orofacial clefts
chr1	18990250	18990251	rs2236835	Body mass index
chr1	19032271	19032272	rs2236824	Response to amphetamines
chr1	19139516	19139517	rs12063142	Parkinson's disease
chr1	19206333	19206334	rs28441017	Anorexia nervosa
chr1	19321494	19321495	rs16862426	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr1	19332075	19332076	rs7523455	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr1	19386584	19386585	rs12123383	Response to amphetamines
chr1	19568971	19568972	rs710865	Brain structure
chr1	19718823	19718824	rs7667	Crohn's disease and psoriasis
chr1	19765517	19765518	rs12045440	Thyroid volume
chr1	19839114	19839115	rs12138950	Thyroid volume
chr1	19841173	19841174	rs10799824	Thyroid hormone levels
chr1	19843353	19843354	rs10917468	Thyroid volume
chr1	19861105	19861106	rs10917477	Thyroid function
chr1	20140035	20140036	rs1317209	Ulcerative colitis
chr1	20142865	20142866	rs3806308	Ulcerative colitis
chr1	20171859	20171860	rs6426833	Ulcerative colitis
chr1	20200989	20200990	rs4654903	Ulcerative colitis
chr1	20227722	20227723	rs4654925	Ulcerative colitis
chr1	20455219	20455220	rs12722987	Obesity-related traits
chr1	21654734	21654735	rs213032	Obesity-related traits
chr1	21766452	21766453	rs1976403	Liver enzyme levels (alkaline phosphatase)
chr1	21786067	21786068	rs4654748	Folate pathway vitamin levels
chr1	21820989	21820990	rs10799701	Metabolic traits
chr1	21821756	21821757	rs1780324	Liver enzyme levels
chr1	21823291	21823292	rs1697421	Phosphorus levels
chr1	21837754	21837755	rs16825455	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
chr1	21875915	21875916	rs885814	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr1	21890385	21890386	rs1256335	Folate pathway vitamin levels
chr1	21904528	21904529	rs2242420	Hematological and biochemical traits
chr1	22373623	22373624	rs2501276	Immune response to smallpox vaccine (IL-6)
chr1	22422720	22422721	rs10917151	Endometriosis
chr1	22439519	22439520	rs4654783	Endometriosis
chr1	22450486	22450487	rs2235529	Endometriosis
chr1	22485870	22485871	rs16826658	Endometriosis
chr1	22490723	22490724	rs7521902	Endometriosis
chr1	22490723	22490724	rs7521902	Bone mineral density
chr1	22490723	22490724	rs7521902	Ovarian cancer
chr1	22499529	22499530	rs17360053	Obesity-related traits
chr1	22573941	22573942	rs909814	IgG glycosylation
chr1	22573941	22573942	rs909814	Testosterone levels
chr1	22698446	22698447	rs7524102	Dupuytren's disease
chr1	22698446	22698447	rs7524102	Bone mineral density
chr1	22698446	22698447	rs7524102	Ulcerative colitis
chr1	22698446	22698447	rs7524102	Bone mineral density (spine)
chr1	22698446	22698447	rs7524102	Bone mineral density (hip)
chr1	22702230	22702231	rs12568930	Inflammatory bowel disease
chr1	22702857	22702858	rs6696981	Bone mineral density (spine)
chr1	22711472	22711473	rs6426749	Bone mineral density
chr1	22711472	22711473	rs6426749	Bone mineral density (hip)
chr1	23536890	23536891	rs1738475	Height
chr1	23766232	23766233	rs1077514	Cholesterol, total
chr1	24300848	24300849	rs6667686	Obesity-related traits
chr1	24431955	24431956	rs3934861	Bipolar disorder (mood-incongruent)
chr1	24519919	24519920	rs4649203	Psoriasis
chr1	24584489	24584490	rs6670533	Fasting insulin-related traits (interaction with BMI)
chr1	24626173	24626174	rs10794657	Adiponectin levels
chr1	25044110	25044111	rs4601530	Height
chr1	25193154	25193155	rs3131513	Alcohol dependence
chr1	25273199	25273200	rs7551188	Crohn's disease
chr1	25296742	25296743	rs10751776	IgG glycosylation
chr1	25297183	25297184	rs11249215	Ankylosing spondylitis
chr1	25303575	25303576	rs10903122	Celiac disease
chr1	25402623	25402624	rs10903027	IgG glycosylation
chr1	25570080	25570081	rs1043879	Erythrocyte sedimentation rate
chr1	25674784	25674785	rs3091242	Erythrocyte sedimentation rate
chr1	25768936	25768937	rs10903129	Erythrocyte sedimentation rate
chr1	25768936	25768937	rs10903129	Cholesterol, total
chr1	25775732	25775733	rs12027135	LDL cholesterol
chr1	25775732	25775733	rs12027135	Cholesterol, total
chr1	26521139	26521140	rs11809207	Height
chr1	26568541	26568542	rs10902723	Obesity-related traits
chr1	26619648	26619649	rs6598955	Obesity-related traits
chr1	26650549	26650550	rs11247915	Obesity-related traits
chr1	26741543	26741544	rs7532866	Height
chr1	27138392	27138393	rs12748152	Triglycerides
chr1	27138392	27138393	rs12748152	LDL cholesterol
chr1	27138392	27138393	rs12748152	HDL cholesterol
chr1	27731650	27731651	rs11548323	Estradiol plasma levels (breast cancer)
chr1	28262408	28262409	rs4409675	Corneal astigmatism
chr1	30185661	30185662	rs1866967	Prostate cancer (gene x gene interaction)
chr1	30265651	30265652	rs6691847	Non-alcoholic fatty liver disease
chr1	30431559	30431560	rs1009080	Schizophrenia
chr1	30432218	30432219	rs4949526	Bipolar disorder and schizophrenia
chr1	30437267	30437268	rs6694545	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr1	30525713	30525714	rs2860031	Bipolar disorder (mood-incongruent)
chr1	30567595	30567596	rs910696	Smoking behavior
chr1	30627711	30627712	rs2180233	Attention deficit hyperactivity disorder and conduct disorder
chr1	31315592	31315593	rs4949316	Metabolite levels (5-HIAA)
chr1	31883924	31883925	rs4478858	Alcohol dependence
chr1	33928757	33928758	rs12565140	Estradiol plasma levels (breast cancer)
chr1	33983018	33983019	rs10798959	Metabolite levels (HVA/MHPG ratio)
chr1	34173819	34173820	rs564148	Response to amphetamines
chr1	34180841	34180842	rs16835742	Intelligence
chr1	34181829	34181830	rs7533254	Intelligence
chr1	34186192	34186193	rs528059	Intelligence
chr1	34189428	34189429	rs544991	Intelligence
chr1	34248063	34248064	rs476463	Brain structure
chr1	34359857	34359858	rs2281597	Attention deficit hyperactivity disorder
chr1	34750935	34750936	rs771390	Epilepsy (generalized)
chr1	34989236	34989237	rs10914967	Visceral adipose tissue adjusted for BMI
chr1	35289038	35289039	rs7526035	Formal thought disorder in schizophrenia
chr1	35687814	35687815	rs673604	Endometrial cancer
chr1	35908450	35908451	rs2275247	Systemic lupus erythematosus and Systemic sclerosis
chr1	36571919	36571920	rs96067	Corneal structure
chr1	36904719	36904720	rs6702784	Diabetic retinopathy
chr1	37162351	37162352	rs589249	Schizophrenia
chr1	37958812	37958813	rs9253	Hemostatic factors and hematological phenotypes
chr1	38092722	38092723	rs4074961	Axial length
chr1	38196840	38196841	rs731174	Prostate cancer (gene x gene interaction)
chr1	38247152	38247153	rs12117544	Cognitive performance
chr1	38279986	38279987	rs3748682	Hypothyroidism
chr1	38602072	38602073	rs7547921	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr1	38624128	38624129	rs12131057	Rheumatoid arthritis
chr1	38721662	38721663	rs11802770	Waist-to-hip circumference ratio (interaction)
chr1	39380384	39380385	rs4246511	Menopause (age at onset)
chr1	40028179	40028180	rs4660293	HDL cholesterol
chr1	40064960	40064961	rs12037222	C-reactive protein
chr1	40069938	40069939	rs3916164	Red blood cell traits
chr1	40132794	40132795	rs873917	Amyotrophic lateral sclerosis
chr1	40433770	40433771	rs3103778	PR interval
chr1	41239510	41239511	rs4660456	Platelet counts
chr1	41530870	41530871	rs6686842	Height
chr1	41688937	41688938	rs11209718	Height
chr1	41745769	41745770	rs2154319	Height
chr1	41839821	41839822	rs4660531	Bipolar disorder
chr1	42297123	42297124	rs349423	Bronchopulmonary dysplasia
chr1	43596383	43596384	rs16830359	Cardiac hypertrophy
chr1	43645410	43645411	rs621559	Telomere length
chr1	44005279	44005280	rs2819332	Amyotrophic lateral sclerosis (age of onset)
chr1	44117005	44117006	rs660899	Hypertension risk in short sleep duration
chr1	44129778	44129779	rs669446	Amyotrophic lateral sclerosis (age of onset)
chr1	44215827	44215828	rs2367725	Aging (time to event)
chr1	44319372	44319373	rs3011225	Amyotrophic lateral sclerosis (age of onset)
chr1	45978674	45978675	rs4660306	Homocysteine levels
chr1	47179309	47179310	rs10789491	Response to hepatitis C treatment
chr1	47284922	47284923	rs12059860	Testosterone levels
chr1	47404185	47404186	rs9332998	Metabolic traits
chr1	47918820	47918821	rs527430	Response to antidepressant treatment
chr1	48009996	48009997	rs11582540	Response to amphetamines
chr1	48025062	48025063	rs685001	Obesity-related traits
chr1	48098405	48098406	rs2506991	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)
chr1	48254781	48254782	rs6588505	Obesity-related traits
chr1	48321220	48321221	rs946836	White matter integrity
chr1	50607028	50607029	rs12092053	Obesity-related traits
chr1	50937847	50937848	rs3827730	Depression and alcohol dependence
chr1	51546139	51546140	rs17391905	QRS duration
chr1	51859241	51859242	rs6673480	IgE grass sensitization
chr1	53581669	53581670	rs3820201	Hippocampal atrophy
chr1	53629584	53629585	rs6695567	Systemic lupus erythematosus
chr1	53777630	53777631	rs2788032	Body mass index (interaction)
chr1	53871084	53871085	rs114216682	Chronic obstructive pulmonary disease
chr1	53958602	53958603	rs1298637	Nicotine use
chr1	53978118	53978119	rs6588480	Response to statin therapy
chr1	54320336	54320337	rs11206226	Nonalcoholic fatty liver disease
chr1	54375569	54375570	rs2235544	Multiple myeloma (hyperdiploidy)
chr1	54375569	54375570	rs2235544	Thyroid hormone levels
chr1	54668277	54668278	rs1890566	Migraine
chr1	55107018	55107019	rs1368882	Non-substance related behavioral disinhibition
chr1	55496038	55496039	rs11206510	Coronary heart disease
chr1	55496038	55496039	rs11206510	LDL cholesterol
chr1	55496038	55496039	rs11206510	Myocardial infarction (early onset)
chr1	55504649	55504650	rs2479409	LDL cholesterol
chr1	55504649	55504650	rs2479409	Cholesterol, total
chr1	55505646	55505647	rs11591147	Response to statin therapy (LDL-C)
chr1	55505646	55505647	rs11591147	LDL cholesterol
chr1	55512994	55512995	rs2495478	Wilms tumor
chr1	55625547	55625548	rs17111684	LDL cholesterol
chr1	55742836	55742837	rs12239436	Coronary heart disease
chr1	55958029	55958030	rs1998013	Metabolite levels
chr1	56060950	56060951	rs10888935	Inflammatory biomarkers
chr1	56108603	56108604	rs1165472	Paclitaxel-induced neuropathy
chr1	56112773	56112774	rs10443215	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)
chr1	56116504	56116505	rs72669744	Lipid metabolism phenotypes
chr1	56359812	56359813	rs6684428	Airflow obstruction
chr1	56850685	56850686	rs11206801	AB1-42
chr1	56962820	56962821	rs17114036	Coronary heart disease
chr1	56966349	56966350	rs17114046	Coronary heart disease
chr1	57126918	57126919	rs2746347	Lymphocyte counts
chr1	57243453	57243454	rs17372114	Resistin levels
chr1	57269520	57269521	rs6662617	Obesity-related traits
chr1	57625931	57625932	rs17541203	Pubertal anthropometrics
chr1	57805549	57805550	rs10159302	HIV-1 control
chr1	58319827	58319828	rs985795	Bulimia nervosa
chr1	58367235	58367236	rs6679454	Immune reponse to smallpox (secreted IL-10)
chr1	58757914	58757915	rs527409	Kawasaki disease
chr1	59036624	59036625	rs638065	Word reading
chr1	59162147	59162148	rs2811893	Diabetic retinopathy
chr1	59325625	59325626	rs4601609	Cognitive performance
chr1	59762467	59762468	rs835367	Obesity-related traits
chr1	59799160	59799161	rs17119280	Response to antipsychotic therapy (extrapyramidal side effects)
chr1	59853318	59853319	rs7534016	Obesity-related traits
chr1	60084515	60084516	rs12727131	Neutrophil count
chr1	60691587	60691588	rs17120400	Periodontitis (PAL4Q3)
chr1	61041874	61041875	rs12565755	Response to tocilizumab in rheumatoid arthritis
chr1	61059258	61059259	rs2989476	Bipolar disorder
chr1	61095557	61095558	rs472913	Bipolar disorder
chr1	61205468	61205469	rs1514178	Phospholipid levels (plasma)
chr1	61620495	61620496	rs334699	Thyroid hormone levels
chr1	61791862	61791863	rs6691768	Celiac disease
chr1	61815798	61815799	rs41350144	Bipolar disorder
chr1	61820071	61820072	rs17121983	Bipolar disorder
chr1	61821818	61821819	rs7556462	Bipolar disorder
chr1	61822282	61822283	rs4915737	Bipolar disorder
chr1	61824388	61824389	rs41453448	Bipolar disorder
chr1	61831889	61831890	rs1125777	Bipolar disorder
chr1	61831937	61831938	rs12568010	Bipolar disorder
chr1	61897966	61897967	rs2207790	Electrocardiographic conduction measures
chr1	62380297	62380298	rs1056513	Obesity-related traits
chr1	62931631	62931632	rs1167998	Lipid metabolism phenotypes
chr1	62931631	62931632	rs1167998	Triglycerides
chr1	62950857	62950858	rs10889332	Metabolite levels
chr1	62969401	62969402	rs1168029	Lipid metabolism phenotypes
chr1	62996837	62996838	rs1168013	Triglycerides
chr1	63025941	63025942	rs2131925	Triglycerides
chr1	63025941	63025942	rs2131925	LDL cholesterol
chr1	63025941	63025942	rs2131925	Cholesterol, total
chr1	63049592	63049593	rs1748195	Triglycerides
chr1	63118195	63118196	rs10889353	Triglycerides
chr1	63118195	63118196	rs10889353	Lipid metabolism phenotypes
chr1	63118195	63118196	rs10889353	LDL cholesterol
chr1	63118195	63118196	rs10889353	Cholesterol, total
chr1	63191776	63191777	rs12130333	Triglycerides
chr1	63480729	63480730	rs17124318	Weight
chr1	63480729	63480730	rs17124318	Body mass index
chr1	63586972	63586973	rs7526034	Brain imaging
chr1	63591128	63591129	rs10493340	Blood pressure
chr1	64108770	64108771	rs2269241	Type 1 diabetes
chr1	64127467	64127468	rs2749097	Alcohol consumption (transferrin glycosylation)
chr1	64868351	64868352	rs11208446	Bilirubin levels
chr1	65515532	65515533	rs478665	Estradiol plasma levels (breast cancer)
chr1	65815658	65815659	rs1413885	Anticoagulant levels
chr1	65979279	65979280	rs11208659	Obesity (early onset extreme)
chr1	65992624	65992625	rs1751492	Soluble leptin receptor levels
chr1	66086193	66086194	rs10889569	C-reactive protein
chr1	66089781	66089782	rs6700896	C-reactive protein
chr1	66102256	66102257	rs1805096	C-reactive protein
chr1	66105943	66105944	rs1892534	C-reactive protein
chr1	66117828	66117829	rs1938492	Fibrinogen
chr1	66161460	66161461	rs4420065	C-reactive protein
chr1	66169678	66169679	rs12753193	Metabolic traits
chr1	66279124	66279125	rs4384209	Economic and political preferences (feminism/equality)
chr1	66310864	66310865	rs10493389	Echocardiographic traits
chr1	66762465	66762466	rs546784	Acute lymphoblastic leukemia (childhood)
chr1	66769099	66769100	rs6683977	Acute lymphoblastic leukemia (childhood)
chr1	67046125	67046126	rs1867631	Menopause (age at onset)
chr1	67123056	67123057	rs6681460	Presence of antiphospholipid antibodies
chr1	67590460	67590461	rs11209002	Crohn's disease
chr1	67597118	67597119	rs3762318	Leprosy
chr1	67601131	67601132	rs11209003	Crohn's disease
chr1	67648595	67648596	rs76418789	Crohn's disease
chr1	67653009	67653010	rs2064689	Crohn's disease
chr1	67670212	67670213	rs1004819	Crohn's disease
chr1	67670915	67670916	rs2902440	Crohn's disease
chr1	67675515	67675516	rs11805303	Crohn's disease
chr1	67681668	67681669	rs7517847	Crohn's disease
chr1	67681668	67681669	rs7517847	Inflammatory bowel disease
chr1	67685597	67685598	rs11465802	Crohn's disease
chr1	67694201	67694202	rs2201841	Ulcerative colitis
chr1	67694201	67694202	rs2201841	Psoriasis
chr1	67694201	67694202	rs2201841	Crohn's disease
chr1	67702525	67702526	rs11465804	Crohn's disease
chr1	67705957	67705958	rs11209026	Inflammatory bowel disease
chr1	67705957	67705958	rs11209026	Crohn's disease
chr1	67705957	67705958	rs11209026	Ankylosing spondylitis
chr1	67705957	67705958	rs11209026	Ulcerative colitis
chr1	67705957	67705958	rs11209026	Psoriasis
chr1	67719128	67719129	rs1343151	Crohn's disease
chr1	67722566	67722567	rs10889676	Crohn's disease
chr1	67725119	67725120	rs10889677	Ulcerative colitis
chr1	67725119	67725120	rs10889677	Crohn's disease
chr1	67726103	67726104	rs9988642	Crohn's disease
chr1	67728017	67728018	rs12567232	Crohn's disease
chr1	67730054	67730055	rs6669582	Crohn's disease
chr1	67730627	67730628	rs10789230	Crohn's disease
chr1	67753507	67753508	rs1495965	Behcet's disease
chr1	67760139	67760140	rs924080	Behcet's disease
chr1	67790597	67790598	rs17129789	Primary biliary cirrhosis
chr1	67822376	67822377	rs3790567	Primary biliary cirrhosis
chr1	67954728	67954729	rs17129789	Primary biliary cirrhosis
chr1	68105452	68105453	rs344924	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
chr1	68633923	68633924	rs1367448	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
chr1	68635074	68635075	rs1430742	Bone mineral density (spine)
chr1	68635389	68635390	rs2566755	Bone mineral density (hip)
chr1	68647715	68647716	rs12407028	Bone mineral density
chr1	68785212	68785213	rs11209261	Airflow obstruction
chr1	68927512	68927513	rs435066	IgG glycosylation
chr1	69579251	69579252	rs4147141	Inattentive symptoms
chr1	69579251	69579252	rs4147141	Attention deficit hyperactivity disorder
chr1	69684996	69684997	rs4650135	Inattentive symptoms
chr1	70154440	70154441	rs1417437	Orofacial clefts
chr1	70335681	70335682	rs2226284	Hypertension risk in short sleep duration
chr1	70355980	70355981	rs12037173	Attention deficit hyperactivity disorder
chr1	70404539	70404540	rs1023008	Obesity-related traits
chr1	70887098	70887099	rs672203	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
chr1	70921172	70921173	rs10458561	Antipsychotic-induced QTc interval prolongation
chr1	70995561	70995562	rs2651244	Inflammatory bowel disease
chr1	71443149	71443150	rs909848	IgG glycosylation
chr1	72071128	72071129	rs10493485	Hemostatic factors and hematological phenotypes
chr1	72274472	72274473	rs12141391	Systemic lupus erythematosus
chr1	72751184	72751185	rs3101336	Obesity (early onset extreme)
chr1	72751184	72751185	rs3101336	Obesity
chr1	72765115	72765116	rs2568958	Obesity
chr1	72765115	72765116	rs2568958	Body mass index
chr1	72765115	72765116	rs2568958	Weight
chr1	72812439	72812440	rs2815752	Body mass index
chr1	72823712	72823713	rs990871	Subcutaneous adipose tissue
chr1	72837238	72837239	rs7531118	Obesity
chr1	72838405	72838406	rs10789336	Body mass index
chr1	72838528	72838529	rs1993709	Obesity (early onset extreme)
chr1	73824908	73824909	rs10789369	Schizophrenia
chr1	74054059	74054060	rs2341260	Cardiac Troponin-T levels
chr1	74083034	74083035	rs2341263	Metabolite levels  (X-11787)
chr1	74339166	74339167	rs11210359	Bipolar disorder and schizophrenia
chr1	74991401	74991402	rs1514177	Obesity
chr1	74991643	74991644	rs1514175	Body mass index
chr1	74993062	74993063	rs1514174	Obesity
chr1	74993062	74993063	rs1514174	Pubertal anthropometrics
chr1	75235316	75235317	rs3931020	Resistin levels
chr1	75298781	75298782	rs11161851	Visceral fat
chr1	75770624	75770625	rs1249675	Capecitabine sensitivity
chr1	75913825	75913826	rs1857353	MRI atrophy measures
chr1	76106674	76106675	rs211718	Metabolic traits
chr1	76106674	76106675	rs211718	Metabolite levels
chr1	76477206	76477207	rs12122440	Pubertal anthropometrics
chr1	76484013	76484014	rs12753569	Personality dimensions
chr1	76772327	76772328	rs10873876	Acute lymphoblastic leukemia (childhood)
chr1	76899463	76899464	rs4949718	Liver enzyme levels (aspartate transaminase)
chr1	76899463	76899464	rs4949718	Liver enzyme levels (alanine transaminase)
chr1	78048330	78048331	rs17381664	Obesity
chr1	78623625	78623626	rs17391694	Crohn's disease
chr1	78623625	78623626	rs17391694	Height
chr1	78987301	78987302	rs672561	IgG glycosylation
chr1	79176867	79176868	rs4650376	IgG glycosylation
chr1	79227955	79227956	rs1937020	Anorexia nervosa
chr1	79238014	79238015	rs4650608	Schizophrenia or bipolar disorder
chr1	79238014	79238015	rs4650608	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr1	79238014	79238015	rs4650608	Bipolar disorder
chr1	79254761	79254762	rs12730292	Bipolar disorder
chr1	79263804	79263805	rs10873998	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr1	79509108	79509109	rs6687262	IgG glycosylation
chr1	80000647	80000648	rs3000140	Obesity-related traits
chr1	80134122	80134123	rs7533906	Bipolar disorder and schizophrenia
chr1	80243000	80243001	rs12024204	Endometriosis
chr1	80477879	80477880	rs10493631	Obesity-related traits
chr1	80734580	80734581	rs11162963	Aging (time to event)
chr1	80911113	80911114	rs12118390	Estradiol plasma levels (breast cancer)
chr1	82074851	82074852	rs11809789	Bilirubin levels
chr1	82247247	82247248	rs11163372	Temperament
chr1	82398543	82398544	rs6681544	Metabolite levels  (X-11787)
chr1	82765051	82765052	rs1770678	Obesity-related traits
chr1	83054798	83054799	rs10874322	Response to taxane treatment (docetaxel)
chr1	83311834	83311835	rs11163585	Response to antipsychotic treatment
chr1	83489843	83489844	rs12742923	HIV-associated dementia
chr1	84232747	84232748	rs17129289	Obesity-related traits
chr1	84254550	84254551	rs7552393	Select biomarker traits
chr1	84254734	84254735	rs7539409	Alzheimer's disease
chr1	84387631	84387632	rs10465746	Obesity-related traits
chr1	84622512	84622513	rs903263	Breast cancer (male)
chr1	84761347	84761348	rs1085093	Metabolic syndrome
chr1	84792972	84792973	rs315553	Obesity-related traits
chr1	84865229	84865230	rs12144715	Response to hepatitis C treatment
chr1	84868960	84868961	rs604708	IgG glycosylation
chr1	85226298	85226299	rs1750491	Dental caries
chr1	85268242	85268243	rs10782529	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr1	85290408	85290409	rs9728717	Economic and political preferences (time)
chr1	85311191	85311192	rs1983853	Type 1 diabetes
chr1	85772008	85772009	rs233100	Multiple sclerosis
chr1	85797109	85797110	rs28489187	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr1	85797109	85797110	rs28489187	Serum dimethylarginine levels (asymmetric)
chr1	85845997	85845998	rs1884139	Serum dimethylarginine levels (symmetric)
chr1	87003471	87003472	rs11161841	Serum dimethylarginine levels (asymmetric)
chr1	87051200	87051201	rs1953652	IgG glycosylation
chr1	87613357	87613358	rs7553864	Smoking behavior
chr1	87705030	87705031	rs6576878	White blood cell types
chr1	88132379	88132380	rs983332	Response to TNF antagonist treatment
chr1	88625635	88625636	rs12032672	Periodontal microbiota
chr1	88651770	88651771	rs10923038	Serum protein levels (sST2)
chr1	88802011	88802012	rs2179965	Cognitive test performance
chr1	89123442	89123443	rs6699417	Height
chr1	89146233	89146234	rs12145922	Liver enzyme levels (gamma-glutamyl transferase)
chr1	89341407	89341408	rs17130643	Obesity-related traits
chr1	90022795	90022796	rs922107	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
chr1	90025518	90025519	rs922106	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
chr1	90539763	90539764	rs2813746	Brain structure (hippocampal volume)
chr1	90875887	90875888	rs2136093	Response to antidepressants
chr1	90943906	90943907	rs2390582	Coronary artery calcification
chr1	91288129	91288130	rs3843306	Pulmonary function decline
chr1	91569688	91569689	rs164898	Metabolic syndrome
chr1	92077096	92077097	rs1192415	Optic disc parameters
chr1	92077096	92077097	rs1192415	Optic disc size (disc)
chr1	92194321	92194322	rs11165354	Type 2 diabetes
chr1	92211019	92211020	rs17131547	Bone mineral density
chr1	92554282	92554283	rs34856868	Obesity-related traits
chr1	93009437	93009438	rs7515577	Cholesterol, total
chr1	93148376	93148377	rs11810217	Multiple sclerosis
chr1	93303602	93303603	rs6604026	Multiple sclerosis
chr1	93323970	93323971	rs10874746	Height
chr1	93401836	93401837	rs12745968	Bipolar disorder and schizophrenia
chr1	94462768	94462769	rs17110736	Dialysis-related mortality
chr1	94533013	94533014	rs1931575	Palmitoleic acid (16:1n-7) plasma levels
chr1	94553437	94553438	rs560426	Orofacial clefts
chr1	94611299	94611300	rs2774920	D-dimer levels
chr1	94674725	94674726	rs2274788	Thiazide-induced adverse metabolic effects in hypertensive patients
chr1	94721659	94721660	rs12750249	IgG glycosylation
chr1	95052475	95052476	rs2022309	End-stage coagulation
chr1	95053352	95053353	rs12029080	D-dimer levels
chr1	95070040	95070041	rs7542900	Type 2 diabetes
chr1	95081444	95081445	rs4474258	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)
chr1	95334186	95334187	rs17520351	Metabolite levels (Dihydroxy docosatrienoic acid)
chr1	95387207	95387208	rs860873	Stearic acid (18:0) plasma levels
chr1	95485824	95485825	rs2391388	Palmitic acid (16:0) plasma levels
chr1	95515636	95515637	rs6675668	Stearic acid (18:0) plasma levels
chr1	95549535	95549536	rs9437689	Phospholipid levels (plasma)
chr1	95692309	95692310	rs1414896	Non-alcoholic fatty liver disease histology (AST)
chr1	95697528	95697529	rs6671200	Stearic acid (18:0) plasma levels
chr1	96145967	96145968	rs6693882	Pain
chr1	96943993	96943994	rs1973993	Weight
chr1	96944796	96944797	rs1555543	Body mass index
chr1	97037082	97037083	rs10783050	Body mass index
chr1	97113914	97113915	rs12071951	Schizophrenia
chr1	97164342	97164343	rs7544736	Schizophrenia
chr1	97819666	97819667	rs11165846	Platelet counts
chr1	98502933	98502934	rs1625579	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr1	98502933	98502934	rs1625579	Schizophrenia
chr1	98552831	98552832	rs1198588	Schizophrenia
chr1	99177252	99177253	rs9727115	Proinsulin levels
chr1	99348835	99348836	rs11166135	Dental caries
chr1	99386292	99386293	rs1571500	Dental caries
chr1	99453286	99453287	rs10443196	Obesity-related traits
chr1	99524046	99524047	rs10747502	Obesity-related traits
chr1	99524046	99524047	rs10747502	Myopia (pathological)
chr1	99589378	99589379	rs303386	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)
chr1	99589378	99589379	rs303386	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
chr1	99782956	99782957	rs12743824	Non-alcoholic fatty liver disease histology (other)
chr1	100049784	100049785	rs7543130	Aortic root size
chr1	100268990	100268991	rs6689305	White matter integrity (interaction)
chr1	100335976	100335977	rs17121403	Pulmonary function decline
chr1	101331535	101331536	rs12048904	Multiple sclerosis
chr1	101407518	101407519	rs11581062	Multiple sclerosis
chr1	101540998	101540999	rs17450029	QT interval (interaction)
chr1	101551925	101551926	rs17410015	Response to antipsychotic treatment
chr1	101938476	101938477	rs1948368	Bipolar disorder
chr1	103133908	103133909	rs10874639	Protein quantitative trait loci
chr1	103379917	103379918	rs3753841	Glaucoma (primary open-angle)
chr1	103459536	103459537	rs11809524	Bone mineral density
chr1	104019630	104019631	rs7524694	Obesity-related traits
chr1	104598940	104598941	rs3934285	Obesity-related traits
chr1	104852737	104852738	rs10881542	Glaucoma (primary open-angle)
chr1	106430286	106430287	rs11184708	Waist-to-hip circumference ratio (interaction)
chr1	106640942	106640943	rs12408810	Obesity (early onset extreme)
chr1	106835942	106835943	rs1330225	Blood pressure measurement (low sodium intervention)
chr1	107336300	107336301	rs12097821	Non-obstructive azoospermia
chr1	107432575	107432576	rs12726652	Response to antipsychotic treatment in schizophrenia (working memory)
chr1	107463642	107463643	rs12125971	Intelligence
chr1	107546374	107546375	rs17496332	Sex hormone-binding globulin levels
chr1	107577831	107577832	rs4118325	AIDS
chr1	107830857	107830858	rs10494067	Anorexia nervosa
chr1	108302921	108302922	rs12142335	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
chr1	108366015	108366016	rs4915077	Hypothyroidism
chr1	109392836	109392837	rs1277203	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr1	109417678	109417679	rs7523050	Fat distribution (HIV)
chr1	109817191	109817192	rs7528419	Lipoprotein-associated phospholipase A2 activity and mass
chr1	109817589	109817590	rs12740374	Lipoprotein-associated phospholipase A2 activity and mass
chr1	109817589	109817590	rs12740374	Coronary heart disease
chr1	109817589	109817590	rs12740374	LDL cholesterol
chr1	109817837	109817838	rs660240	Cardiovascular disease risk factors
chr1	109817837	109817838	rs660240	LDL cholesterol
chr1	109818305	109818306	rs629301	LDL cholesterol
chr1	109818305	109818306	rs629301	Cholesterol, total
chr1	109818529	109818530	rs646776	Coronary heart disease
chr1	109818529	109818530	rs646776	Progranulin levels
chr1	109818529	109818530	rs646776	Response to statin therapy
chr1	109818529	109818530	rs646776	Lipid metabolism phenotypes
chr1	109818529	109818530	rs646776	Myocardial infarction (early onset)
chr1	109818529	109818530	rs646776	LDL cholesterol
chr1	109818529	109818530	rs646776	Cholesterol, total
chr1	109822165	109822166	rs599839	Metabolite levels
chr1	109822165	109822166	rs599839	Coronary heart disease
chr1	109822165	109822166	rs599839	Lipoprotein-associated phospholipase A2 activity and mass
chr1	109822165	109822166	rs599839	LDL cholesterol
chr1	109999837	109999838	rs1933182	Chronic kidney disease
chr1	110031187	110031188	rs12049330	Major depressive disorder
chr1	110042443	110042444	rs1043274	Obesity-related traits
chr1	110082885	110082886	rs7550711	Stearic acid (18:0) plasma levels
chr1	110119731	110119732	rs6537837	Major depressive disorder
chr1	110147320	110147321	rs17024258	Obesity
chr1	110352476	110352477	rs10494112	Paget's disease
chr1	110366082	110366083	rs484959	Paget's disease
chr1	110405270	110405271	rs6537883	Sensory disturbances after bilateral sagittal split ramus osteotomy
chr1	110439479	110439480	rs333960	Obesity-related traits
chr1	110645326	110645327	rs17025426	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr1	110770222	110770223	rs958798	Self-rated health
chr1	111033808	111033809	rs4839431	Immune reponse to smallpox (secreted IFN-alpha)
chr1	111237684	111237685	rs12061304	Panic disorder
chr1	111417914	111417915	rs2885805	Cytomegalovirus antibody response
chr1	111463623	111463624	rs12567355	Obesity-related traits
chr1	111684275	111684276	rs1335645	Liver enzyme levels (gamma-glutamyl transferase)
chr1	112107668	112107669	rs10776733	Obesity-related traits
chr1	112192121	112192122	rs494453	Osteoporosis
chr1	112392359	112392360	rs12044963	Immune reponse to smallpox (secreted IFN-alpha)
chr1	112437343	112437344	rs2798334	Visceral adipose tissue adjusted for BMI
chr1	112464375	112464376	rs17029069	Cardiac repolarization
chr1	112856569	112856570	rs7555668	Cognitive performance
chr1	113190806	113190807	rs17030613	Blood pressure
chr1	113216542	113216543	rs2932538	Systolic blood pressure
chr1	113216542	113216543	rs2932538	Hypertension
chr1	113216542	113216543	rs2932538	Diastolic blood pressure
chr1	113216542	113216543	rs2932538	Blood pressure
chr1	113313562	113313563	rs11590090	Hyperactive-impulsive symptoms
chr1	114226142	114226143	rs61742849	Bulimia nervosa
chr1	114303807	114303808	rs6679677	Crohn's disease
chr1	114303807	114303808	rs6679677	Hypothyroidism
chr1	114303807	114303808	rs6679677	Type 1 diabetes
chr1	114303807	114303808	rs6679677	Rheumatoid arthritis
chr1	114444593	114444594	rs12079716	Obesity-related traits
chr1	114448388	114448389	rs11552449	Breast cancer
chr1	114607363	114607364	rs79079833	Obesity-related traits
chr1	114670968	114670969	rs2774307	Breast cancer (prognosis)
chr1	114677947	114677948	rs529989	Illicit drug use
chr1	114715583	114715584	rs2774292	Bipolar disorder and schizophrenia
chr1	115677945	115677946	rs12134493	Migraine without aura
chr1	115677945	115677946	rs12134493	Migraine
chr1	115734090	115734091	rs195204	Alcoholism (heaviness of drinking)
chr1	115875644	115875645	rs4332358	Bipolar disorder and schizophrenia
chr1	115921354	115921355	rs7552722	Non-alcoholic fatty liver disease
chr1	116740449	116740450	rs4839516	Word reading
chr1	117038286	117038287	rs12025416	Multiple sclerosis
chr1	117100956	117100957	rs1335532	Multiple sclerosis
chr1	117104214	117104215	rs2300747	Multiple sclerosis
chr1	117129710	117129711	rs17036023	Asthma (childhood onset)
chr1	117469780	117469781	rs2806864	Erectile dysfunction and prostate cancer treatment
chr1	117751364	117751365	rs12046117	Arthritis (juvenile idiopathic)
chr1	118816728	118816729	rs7527203	Obesity-related traits
chr1	118855586	118855587	rs9428104	Height
chr1	118864615	118864616	rs7534091	Height
chr1	118868404	118868405	rs17038182	Height
chr1	118883972	118883973	rs12735613	Height
chr1	118902977	118902978	rs2474937	Congenital heart malformation
chr1	119503842	119503843	rs984222	Waist-hip ratio
chr1	120255125	120255126	rs478093	Metabolite levels
chr1	120257575	120257576	rs477992	Metabolic traits
chr1	120451189	120451190	rs3897478	Crohn's disease
chr1	120517958	120517959	rs10923931	Type 2 diabetes
chr1	121200489	121200490	rs6600671	Hip geometry
chr1	121280612	121280613	rs11249433	Breast cancer
chr1	144992180	144992181	rs2863344	Capecitabine sensitivity
chr1	145395603	145395604	rs12091564	Coronary heart disease
chr1	145416055	145416056	rs10218795	Coronary heart disease
chr1	145645605	145645606	rs12744221	Epilepsy (remission after treatment)
chr1	145723644	145723645	rs1967017	Urate levels
chr1	145723738	145723739	rs1471633	Urate levels
chr1	145725688	145725689	rs12129861	Uric acid levels
chr1	145727682	145727683	rs1797052	Contrast sensitivity
chr1	146508933	146508934	rs12122100	HIV-1 control
chr1	146560563	146560564	rs11239930	AIDS progression
chr1	146854835	146854836	rs4950322	Protein quantitative trait loci
chr1	147020455	147020456	rs594206	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
chr1	147083113	147083114	rs583583	Schizophrenia (negative symptoms)
chr1	147226790	147226791	rs1891498	Cognitive performance
chr1	149892871	149892872	rs11205277	Height
chr1	149906412	149906413	rs11205303	Height
chr1	149914356	149914357	rs1061955	Obesity-related traits
chr1	150278388	150278389	rs12403795	Illicit drug use
chr1	150324283	150324284	rs11587682	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr1	150727538	150727539	rs2230061	Fat body mass
chr1	150860470	150860471	rs7412746	Melanoma
chr1	150940624	150940625	rs267738	Rhegmatogenous retinal detachment
chr1	150950061	150950062	rs4970988	Urate levels
chr1	150951476	150951477	rs267734	Chronic kidney disease
chr1	150958835	150958836	rs267733	LDL cholesterol
chr1	150961868	150961869	rs1722784	Melanoma
chr1	151344740	151344741	rs2769264	Blood trace element (Cu levels)
chr1	151801679	151801680	rs4845604	Inflammatory bowel disease
chr1	151895092	151895093	rs10788819	Hair morphology
chr1	152037514	152037515	rs3124314	Hair morphology
chr1	152062766	152062767	rs17646946	Common traits (Other)
chr1	152083324	152083325	rs11803731	Hair morphology
chr1	152300816	152300817	rs3126085	Atopic dermatitis
chr1	152316589	152316590	rs3120665	Personality dimensions
chr1	152318160	152318161	rs3120667	Eating disorders
chr1	152442288	152442289	rs6661961	Atopic dermatitis
chr1	152454590	152454591	rs908922	Hair morphology
chr1	152487916	152487917	rs73004856	Obesity-related traits
chr1	152492558	152492559	rs4845783	Asthma
chr1	152493153	152493154	rs499697	Common traits (Other)
chr1	152537953	152537954	rs10888501	Response to antipsychotic treatment
chr1	152550017	152550018	rs4085613	Psoriasis
chr1	152551275	152551276	rs4112788	Psoriasis
chr1	153479997	153479998	rs4845552	Hippocampal atrophy
chr1	153640826	153640827	rs7536700	Multiple myeloma (IgH translocation)
chr1	153769399	153769400	rs9426935	Lentiform nucleus volume
chr1	153774275	153774276	rs4434872	Conduct disorder (symptom count)
chr1	153848995	153848996	rs7414227	Lentiform nucleus volume
chr1	153913769	153913770	rs2252508	Lentiform nucleus volume
chr1	153939129	153939130	rs11264736	Lentiform nucleus volume
chr1	154418878	154418879	rs4537545	C-reactive protein
chr1	154426263	154426264	rs4129267	Fibrinogen
chr1	154426263	154426264	rs4129267	Asthma
chr1	154426263	154426264	rs4129267	C-reactive protein
chr1	154426263	154426264	rs4129267	Protein quantitative trait loci
chr1	154426263	154426264	rs4129267	Pulmonary function
chr1	154437895	154437896	rs2229238	Coronary heart disease
chr1	154754193	154754194	rs6691316	Obesity-related traits
chr1	154814267	154814268	rs6666258	Atrial fibrillation
chr1	154814352	154814353	rs13376333	Atrial fibrillation
chr1	154834182	154834183	rs1218582	Prostate cancer
chr1	155098904	155098905	rs11264330	Obesity-related traits
chr1	155108166	155108167	rs12726330	Parkinson's disease
chr1	155126947	155126948	rs10908458	Liver enzyme levels (gamma-glutamyl transferase)
chr1	155151492	155151493	rs11264341	Urate levels
chr1	155162066	155162067	rs4072037	Esophageal cancer and gastric cancer
chr1	155162066	155162067	rs4072037	Magnesium levels
chr1	155194979	155194980	rs2049805	Renal function-related traits (BUN)
chr1	155868624	155868625	rs2282301	Conduct disorder (interaction)
chr1	155878731	155878732	rs670523	Inflammatory bowel disease
chr1	155927751	155927752	rs2364403	Amyotrophic lateral sclerosis (age of onset)
chr1	156030036	156030037	rs34372695	Parkinson's disease
chr1	156169609	156169610	rs2072499	Testicular germ cell tumor
chr1	156255455	156255456	rs6684514	mean corpuscular hemoglobin concentration
chr1	156341493	156341494	rs7525133	Visceral adipose tissue adjusted for BMI
chr1	156356479	156356480	rs6686886	Subcutaneous adipose tissue
chr1	156446241	156446242	rs2274316	Migraine - clinic-based
chr1	156446241	156446242	rs2274316	Migraine
chr1	156456300	156456301	rs3790455	Migraine
chr1	156700650	156700651	rs12145743	HDL cholesterol
chr1	156869046	156869047	rs12566888	Platelet aggregation
chr1	157130565	157130566	rs6427356	Attention deficit hyperactivity disorder and conduct disorder
chr1	157437509	157437510	rs6686423	Renal sinus fat
chr1	157669277	157669278	rs3761959	Graves' disease
chr1	157669277	157669278	rs3761959	Multiple sclerosis
chr1	157670815	157670816	rs7528684	Type 1 diabetes autoantibodies
chr1	158058108	158058109	rs6427419	Obesity-related traits
chr1	158575728	158575729	rs857684	Red blood cell traits
chr1	158585414	158585415	rs2779116	Glycated hemoglobin levels
chr1	158612547	158612548	rs857721	Other erythrocyte phenotypes
chr1	158932554	158932555	rs1101999	Asthma
chr1	158971085	158971086	rs4657616	Hematology traits
chr1	159002221	159002222	rs861318	Obesity-related traits
chr1	159005648	159005649	rs1772408	Celiac disease and Rheumatoid arthritis
chr1	159147451	159147452	rs3026968	Inflammatory biomarkers
chr1	159148512	159148513	rs1474747	Select biomarker traits
chr1	159173886	159173887	rs3027009	Lean body mass and age at menarche (combined)
chr1	159174682	159174683	rs2814778	White blood cell count
chr1	159174682	159174683	rs2814778	Neutrophil count
chr1	159175353	159175354	rs12075	Obesity-related traits
chr1	159175353	159175354	rs12075	Monocyte chemoattractant protein-1
chr1	159175353	159175354	rs12075	Inflammatory biomarkers
chr1	159175353	159175354	rs12075	White blood cell count
chr1	159175526	159175527	rs13962	IgE levels
chr1	159196764	159196765	rs10489849	Select biomarker traits
chr1	159218265	159218266	rs3845624	Inflammatory biomarkers
chr1	159272059	159272060	rs2251746	IgE levels
chr1	159278250	159278251	rs2494250	Select biomarker traits
chr1	159326879	159326880	rs4656784	IgE levels
chr1	159342438	159342439	rs6687840	Chemerin levels
chr1	159357683	159357684	rs4446959	Chemerin levels
chr1	159405958	159405959	rs4128725	Select biomarker traits
chr1	159453936	159453937	rs4133289	Hemostatic factors and hematological phenotypes
chr1	159462380	159462381	rs4325129	Obesity-related traits
chr1	159647987	159647988	rs12093699	Protein quantitative trait loci
chr1	159655517	159655518	rs726640	C-reactive protein
chr1	159674932	159674933	rs876537	C-reactive protein
chr1	159676170	159676171	rs16842559	C-reactive protein
chr1	159678815	159678816	rs2794520	C-reactive protein
chr1	159678815	159678816	rs2794520	Metabolic traits
chr1	159678815	159678816	rs2794520	Select biomarker traits
chr1	159680867	159680868	rs2808630	Lung cancer
chr1	159684664	159684665	rs3091244	C-reactive protein
chr1	159685135	159685136	rs3093059	C-reactive protein
chr1	159691558	159691559	rs1341665	Inflammatory biomarkers
chr1	159692572	159692573	rs2808634	C-reactive protein
chr1	159698548	159698549	rs7553007	C-reactive protein
chr1	159700038	159700039	rs11265260	C-reactive protein
chr1	159710516	159710517	rs11265263	Vaccine-related adverse events
chr1	159753182	159753183	rs4233356	Interstitial lung disease
chr1	159818512	159818513	rs6659742	Multiple sclerosis (OCB status)
chr1	159856428	159856429	rs2501324	Bilirubin levels
chr1	160077853	160077854	rs6688363	Response to antipsychotic treatment
chr1	160421915	160421916	rs16832015	Cognitive performance
chr1	160464910	160464911	rs1265883	Graves' disease
chr1	160516307	160516308	rs6427528	Response to anti-TNF treatment in rheumatoid arthritis
chr1	160630142	160630143	rs11265461	Schizophrenia (treatment refractory)
chr1	160746075	160746076	rs576523	Capecitabine sensitivity
chr1	160830267	160830268	rs4656940	Crohn's disease
chr1	160852045	160852046	rs2274910	Crohn's disease
chr1	160856963	160856964	rs4656958	Inflammatory bowel disease
chr1	160864220	160864221	rs2199936	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr1	160864220	160864221	rs2199936	Cardiovascular disease risk factors
chr1	160864220	160864221	rs2199936	Urate levels
chr1	161272440	161272441	rs4657015	Visceral adipose tissue adjusted for BMI
chr1	161463586	161463587	rs7535475	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia
chr1	161472157	161472158	rs10800309	Ulcerative colitis
chr1	161479744	161479745	rs1801274	Inflammatory bowel disease
chr1	161479744	161479745	rs1801274	Kawasaki disease
chr1	161479744	161479745	rs1801274	Ulcerative colitis
chr1	161484209	161484210	rs368433	Helicobacter pylori serologic status
chr1	161540856	161540857	rs67418890	Lipid metabolism phenotypes
chr1	161826614	161826615	rs3767633	IgG glycosylation
chr1	161915500	161915501	rs10918270	Parkinson's disease (age of onset)
chr1	161946726	161946727	rs2340727	Hematology traits
chr1	162014631	162014632	rs2880058	QT interval
chr1	162033889	162033890	rs12143842	QT interval
chr1	162085308	162085309	rs1415259	Electrocardiographic traits
chr1	162085684	162085685	rs10494366	Electrocardiographic traits
chr1	162085684	162085685	rs10494366	QT interval
chr1	162089317	162089318	rs76662883	Obesity-related traits
chr1	162112909	162112910	rs16857031	QT interval
chr1	162133116	162133117	rs12029454	QT interval
chr1	162195737	162195738	rs4657175	QT interval
chr1	162210609	162210610	rs4657178	QT interval
chr1	162319523	162319524	rs11577628	Word reading
chr1	162821290	162821291	rs1912453	Colorectal cancer
chr1	163053288	163053289	rs2063142	Response to mTOR inhibitor (rapamycin)
chr1	163142554	163142555	rs12035879	Liver enzyme levels (alanine transaminase)
chr1	163956502	163956503	rs424950	Sex hormone-binding globulin levels
chr1	164689761	164689762	rs1387389	Breast cancer (prognosis)
chr1	164739170	164739171	rs6670655	Height
chr1	165180088	165180089	rs1532815	Response to acetaminophen (hepatotoxicity)
chr1	165394881	165394882	rs466639	Menarche (age at onset)
chr1	165403902	165403903	rs285480	Personality dimensions
chr1	165409094	165409095	rs10800098	AIDS
chr1	165448156	165448157	rs10918196	Lentiform nucleus volume
chr1	165616587	165616588	rs6686643	Total ventricular volume
chr1	165687204	165687205	rs4656461	Glaucoma
chr1	165718978	165718979	rs7555523	Intraocular pressure
chr1	165736879	165736880	rs7518099	Intraocular pressure
chr1	165831648	165831649	rs4657482	Testicular germ cell tumor
chr1	165873391	165873392	rs3790672	Testicular germ cell tumor
chr1	167156499	167156500	rs9803659	Liver enzyme levels
chr1	167408669	167408670	rs840016	Rheumatoid arthritis
chr1	167411383	167411384	rs864537	Celiac disease and Rheumatoid arthritis
chr1	167411383	167411384	rs864537	Celiac disease
chr1	167420424	167420425	rs2056626	Systemic sclerosis
chr1	167718498	167718499	rs4145462	Alzheimer's disease (late onset)
chr1	167903078	167903079	rs10489202	Schizophrenia
chr1	168618640	168618641	rs1412337	Morbidity-free survival
chr1	169073345	169073346	rs1320976	QT interval
chr1	169099482	169099483	rs10919071	QT interval
chr1	169135126	169135127	rs16861990	Venous thromboembolism
chr1	169135126	169135127	rs16861990	D-dimer levels
chr1	169477573	169477574	rs6687813	D-dimer levels
chr1	169481222	169481223	rs6427196	Venous thromboembolism
chr1	169491554	169491555	rs2420371	Hemostatic factors and hematological phenotypes
chr1	169498974	169498975	rs6030	Uric acid levels
chr1	169514005	169514006	rs1018827	Venous thromboembolism
chr1	169550962	169550963	rs6703865	Hippocampal atrophy
chr1	169551681	169551682	rs6028	Activated partial thromboplastin time
chr1	169563950	169563951	rs6136	Soluble levels of adhesion molecules
chr1	169580289	169580290	rs2235302	Soluble levels of adhesion molecules
chr1	169608916	169608917	rs1569476	Total ventricular volume
chr1	169995801	169995802	rs1541160	Amyotrophic lateral sclerosis
chr1	170128607	170128608	rs495524	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr1	170569316	170569317	rs3903239	Atrial fibrillation
chr1	170633895	170633896	rs659580	Response to angiotensin II receptor blocker therapy
chr1	171091874	171091875	rs1795240	Lentiform nucleus volume
chr1	171261192	171261193	rs6660565	Sudden cardiac arrest
chr1	171557599	171557600	rs2421847	Alzheimer's disease (cognitive decline)
chr1	171949749	171949750	rs10914144	Mean platelet volume
chr1	171949749	171949750	rs10914144	Platelet counts
chr1	172053286	172053287	rs17346452	Height
chr1	172189888	172189889	rs678962	Height
chr1	172199572	172199573	rs479336	Bone mineral density
chr1	172219994	172219995	rs12075079	Height
chr1	172241250	172241251	rs2421992	Height
chr1	172346547	172346548	rs1011731	Waist-hip ratio
chr1	172710999	172711000	rs859637	Celiac disease
chr1	172853459	172853460	rs7517810	Crohn's disease
chr1	172862233	172862234	rs9286879	Crohn's disease
chr1	172898376	172898377	rs12035082	Crohn's disease
chr1	173191474	173191475	rs2205960	Systemic lupus erythematosus
chr1	173226194	173226195	rs704840	Systemic lupus erythematosus and Systemic sclerosis
chr1	173284198	173284199	rs4916321	Multiple sclerosis
chr1	173301515	173301516	rs1342038	Diabetic retinopathy
chr1	173309712	173309713	rs10798269	Systemic lupus erythematosus
chr1	174552810	174552811	rs17301853	Migraine without aura
chr1	174552810	174552811	rs17301853	Migraine - clinic-based
chr1	175120078	175120079	rs6701037	Alcohol dependence
chr1	175296447	175296448	rs3766680	Tonometry
chr1	175715605	175715606	rs17312292	Corneal astigmatism
chr1	176792248	176792249	rs1325598	Height
chr1	177568798	177568799	rs16851585	Age-related macular degeneration
chr1	177722906	177722907	rs12140439	Schizophrenia
chr1	177852579	177852580	rs633715	Obesity
chr1	177852579	177852580	rs633715	Body mass index
chr1	177852579	177852580	rs633715	Menarche (age at onset)
chr1	177855516	177855517	rs516636	Body mass index
chr1	177889479	177889480	rs543874	Body mass index
chr1	177913518	177913519	rs10913469	Weight
chr1	177913518	177913519	rs10913469	Body mass index
chr1	178142207	178142208	rs316274	Immune response to smallpox vaccine (IL-6)
chr1	178471221	178471222	rs12760731	Obesity-related traits
chr1	178491878	178491879	rs12023718	Obesity-related traits
chr1	178515311	178515312	rs4650994	HDL cholesterol
chr1	179071755	179071756	rs1325195	IgE grass sensitization
chr1	179469313	179469314	rs12047808	Multiple sclerosis (age of onset)
chr1	180130722	180130723	rs55946907	Anorexia nervosa
chr1	180645440	180645441	rs7527074	Asthma (childhood onset)
chr1	180962281	180962282	rs1411478	Progressive supranuclear palsy
chr1	181426909	181426910	rs2332267	Coronary artery calcification
chr1	181655751	181655752	rs3845441	IgG glycosylation
chr1	182081959	182081960	rs10911021	Cardiovascular heart disease in diabetics
chr1	182168884	182168885	rs1689800	HDL cholesterol
chr1	182549018	182549019	rs533259	Multiple sclerosis
chr1	183081193	183081194	rs10911251	Colorectal cancer
chr1	183170947	183170948	rs1028771	Coronary heart disease
chr1	183176429	183176430	rs525410	Systemic lupus erythematosus
chr1	183180259	183180260	rs16860537	Systemic lupus erythematosus and Systemic sclerosis
chr1	183266181	183266182	rs4652795	Obesity-related traits
chr1	183358404	183358405	rs2078087	Obesity-related traits
chr1	183616883	183616884	rs10911390	Systemic lupus erythematosus
chr1	183837031	183837032	rs4651156	Response to antidepressants
chr1	183852913	183852914	rs10797919	Attention deficit hyperactivity disorder and conduct disorder
chr1	184002873	184002874	rs756199	Height
chr1	184007118	184007119	rs3814333	Height
chr1	184020944	184020945	rs2274432	Height
chr1	184023528	184023529	rs1046934	Height
chr1	184677463	184677464	rs3736757	Obesity-related traits
chr1	184761364	184761365	rs682331	Obesity-related traits
chr1	185014001	185014002	rs3753573	Obesity-related traits
chr1	185794882	185794883	rs13375391	QRS duration
chr1	186632316	186632317	rs10911902	Schizophrenia
chr1	186725002	186725003	rs4140564	Knee osteoarthritis
chr1	186870071	186870072	rs12720541	Epilepsy (generalized)
chr1	187412041	187412042	rs2244067	Metabolite levels (5-HIAA)
chr1	187902980	187902981	rs655167	Hypothyroidism
chr1	188379427	188379428	rs12125250	Economic and political preferences
chr1	188383315	188383316	rs12142669	Obesity-related traits
chr1	189589338	189589339	rs10489759	Immune response to smallpox vaccine (IL-6)
chr1	189723622	189723623	rs10737562	Systemic lupus erythematosus
chr1	189861403	189861404	rs1400544	Subclinical atherosclerosis traits (other)
chr1	190066385	190066386	rs1935881	Echocardiographic traits
chr1	190841672	190841673	rs2053302	Response to statin therapy
chr1	191559355	191559356	rs10801047	Crohn's disease
chr1	191939787	191939788	rs17403780	IgG glycosylation
chr1	192431997	192431998	rs12067906	Blood pressure
chr1	192536812	192536813	rs2816316	Celiac disease
chr1	192541020	192541021	rs1323292	Multiple sclerosis
chr1	192806240	192806241	rs7550636	Coronary artery calcification
chr1	192995212	192995213	rs9427573	Cannabis dependence
chr1	193625232	193625233	rs6678275	Alzheimer's disease (late onset)
chr1	193734899	193734900	rs2025934	Subcutaneous adipose tissue
chr1	193921547	193921548	rs606149	Major depressive disorder
chr1	194530913	194530914	rs3001167	Obesity-related traits
chr1	195531422	195531423	rs1890645	Neonatal lupus
chr1	195790657	195790658	rs6677435	Cocaine dependence
chr1	195914272	195914273	rs7517337	Total ventricular volume
chr1	196042661	196042662	rs7512769	Bipolar disorder and schizophrenia
chr1	196620916	196620917	rs3753394	Complement C3 and C4 levels
chr1	196642232	196642233	rs800292	Circulating myeloperoxidase levels (serum)
chr1	196646175	196646176	rs1329424	Age-related macular degeneration
chr1	196654323	196654324	rs1061147	Age-related macular degeneration
chr1	196659236	196659237	rs1061170	Age-related macular degeneration (GA)
chr1	196659236	196659237	rs1061170	Age-related macular degeneration (CNV)
chr1	196659236	196659237	rs1061170	Age-related macular degeneration
chr1	196660260	196660261	rs10801555	Age-related macular degeneration
chr1	196673992	196673993	rs1831282	Age-related macular degeneration (extreme sampling)
chr1	196673992	196673993	rs1831282	Age-related macular degeneration
chr1	196679454	196679455	rs10737680	Age-related macular degeneration
chr1	196686917	196686918	rs6677604	Nephropathy
chr1	196696932	196696933	rs1410996	End-stage coagulation
chr1	196696932	196696933	rs1410996	Age-related macular degeneration
chr1	196701050	196701051	rs380390	Age-related macular degeneration
chr1	196702809	196702810	rs1329428	Age-related macular degeneration
chr1	196760416	196760417	rs426736	Meningococcal disease
chr1	196844592	196844593	rs6428370	Acute lymphoblastic leukemia (childhood)
chr1	196886769	196886770	rs4915559	End-stage coagulation
chr1	196973182	196973183	rs12116643	End-stage coagulation
chr1	197020657	197020658	rs2990510	Erectile dysfunction
chr1	197070775	197070776	rs10922162	End-stage coagulation
chr1	197155020	197155021	rs7410943	End-stage coagulation
chr1	197325907	197325908	rs2786098	Asthma
chr1	197629341	197629342	rs1775453	Serum protein levels (sST2)
chr1	197631140	197631141	rs2488389	Inflammatory bowel disease
chr1	197727641	197727642	rs1998598	Crohn's disease
chr1	197781197	197781198	rs12134279	Primary biliary cirrhosis
chr1	198469161	198469162	rs10922438	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)
chr1	198595505	198595506	rs12127588	Mean corpuscular hemoglobin
chr1	199007207	199007208	rs7529925	Red blood cell traits
chr1	199356515	199356516	rs16844716	Dialysis-related mortality
chr1	200007431	200007432	rs3790844	Pancreatic cancer
chr1	200101919	200101920	rs2816958	Ulcerative colitis
chr1	200672905	200672906	rs7512898	Electrocardiographic conduction measures
chr1	200826768	200826769	rs2292096	Epilepsy
chr1	200877561	200877562	rs7554511	Inflammatory bowel disease
chr1	200877561	200877562	rs7554511	Ulcerative colitis
chr1	200877561	200877562	rs7554511	Crohn's disease
chr1	200881594	200881595	rs7522462	Multiple sclerosis
chr1	200892136	200892137	rs296547	Celiac disease
chr1	200935865	200935866	rs11584383	Ulcerative colitis
chr1	200935865	200935866	rs11584383	Crohn's disease
chr1	200960306	200960307	rs2297909	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr1	200960306	200960307	rs2297909	Ankylosing spondylitis
chr1	201081942	201081943	rs2281845	Permanent tooth development
chr1	201262431	201262432	rs860554	Panic disorder
chr1	201345486	201345487	rs12564445	Cardiac Troponin-T levels
chr1	201594664	201594665	rs2068824	Celiac disease
chr1	201630954	201630955	rs586688	Obesity-related traits
chr1	201884951	201884952	rs2819348	Breast size
chr1	201952573	201952574	rs4950806	Butyrylcholinesterase levels
chr1	202187175	202187176	rs6678914	Breast cancer
chr1	202391742	202391743	rs12739262	Obesity-related traits
chr1	202469722	202469723	rs12734338	Celiac disease
chr1	203155881	203155882	rs4950928	YKL-40 levels
chr1	203372484	203372485	rs1539143	Obesity-related traits
chr1	203492719	203492720	rs13303128	Metabolite levels (MHPG)
chr1	203651926	203651927	rs1541252	Mean corpuscular hemoglobin concentration
chr1	203654023	203654024	rs10900585	Malaria
chr1	204103617	204103618	rs2293335	Periodontitis (CDC/AAP)
chr1	204112983	204112984	rs3795578	Response to acetaminophen (hepatotoxicity)
chr1	204274518	204274519	rs7534537	Palmitoleic acid (16:1n-7) plasma levels
chr1	204516024	204516025	rs2290854	Breast Cancer in BRCA1 mutation carriers
chr1	204518841	204518842	rs4245739	Breast cancer
chr1	204518841	204518842	rs4245739	Prostate cancer
chr1	204572070	204572071	rs12143943	Cognitive performance
chr1	204576982	204576983	rs11584700	Educational attainment
chr1	204784017	204784018	rs7552806	Dental caries
chr1	204828040	204828041	rs12043259	Addiction
chr1	205180409	205180410	rs76872152	Obesity-related traits
chr1	205235989	205235990	rs1668873	Mean platelet volume
chr1	205237136	205237137	rs1668871	Platelet counts
chr1	205244952	205244953	rs1172130	Mean platelet volume
chr1	205249449	205249450	rs9660992	Mean platelet volume
chr1	205483594	205483595	rs12127944	IgG glycosylation
chr1	205638221	205638222	rs12409639	Prostate-specific antigen levels
chr1	205676262	205676263	rs12748961	White blood cell types
chr1	205678125	205678126	rs16856186	Pulmonary function decline
chr1	205689806	205689807	rs823094	Pubertal anthropometrics
chr1	205712529	205712530	rs188212039	Serum dimethylarginine levels (symmetric)
chr1	205713377	205713378	rs823128	Parkinson's disease
chr1	205752664	205752665	rs947211	Parkinson's disease
chr1	205764639	205764640	rs823156	Parkinson's disease
chr1	205896234	205896235	rs11240594	Response to antipsychotic treatment
chr1	205914756	205914757	rs4077468	Cystic fibrosis-related diabetes
chr1	206626827	206626828	rs2483058	Cholesterol and Triglycerides
chr1	206939903	206939904	rs3024505	Inflammatory bowel disease
chr1	206939903	206939904	rs3024505	Type 1 diabetes autoantibodies
chr1	206939903	206939904	rs3024505	Ulcerative colitis
chr1	206939903	206939904	rs3024505	Crohn's disease
chr1	206939903	206939904	rs3024505	Type 1 diabetes
chr1	206943967	206943968	rs3024493	Ulcerative colitis
chr1	206944644	206944645	rs1518111	Behcet's disease
chr1	206946633	206946634	rs1800871	Behcet's disease
chr1	207032750	207032751	rs574773	Economic and political preferences
chr1	207269857	207269858	rs3813948	C4b binding protein levels
chr1	207652175	207652176	rs17045328	Type 2 diabetes
chr1	207692048	207692049	rs6656401	Alzheimer's disease (late onset)
chr1	207692048	207692049	rs6656401	Alzheimer's disease
chr1	207757514	207757515	rs12034598	Inflammatory biomarkers
chr1	207784967	207784968	rs3818361	Alzheimer's disease
chr1	207786288	207786289	rs6701713	Alzheimer's disease (late onset)
chr1	207803594	207803595	rs12034383	Erythrocyte sedimentation rate
chr1	207872289	207872290	rs7527798	Erythrocyte sedimentation rate
chr1	207875174	207875175	rs4844614	LDL cholesterol
chr1	207938235	207938236	rs7545126	Obesity-related traits
chr1	207940852	207940853	rs11118555	Heart rate
chr1	208024819	208024820	rs12731740	Biomedical quantitative traits
chr1	208039470	208039471	rs1967689	Age-related macular degeneration
chr1	208128721	208128722	rs2745967	Resting heart rate
chr1	208129064	208129065	rs11578508	Heart rate
chr1	208757585	208757586	rs17259784	Cardiac hypertrophy
chr1	209334216	209334217	rs4382726	Response to amphetamines
chr1	209712888	209712889	rs6703183	Amyotrophic lateral sclerosis
chr1	209727256	209727257	rs12130212	Obesity (extreme)
chr1	209977110	209977111	rs861020	Orofacial clefts
chr1	209988046	209988047	rs10863790	Cleft lip
chr1	209989269	209989270	rs642961	Orofacial clefts
chr1	210536024	210536025	rs7527939	Schizophrenia
chr1	210898262	210898263	rs1934620	Smooth-surface caries
chr1	211168758	211168759	rs1501550	Circulating vasoactive peptide levels
chr1	211691705	211691706	rs7553035	Retinopathy in non-diabetics
chr1	211918243	211918244	rs11119805	Stearic acid (18:0) plasma levels
chr1	212155007	212155008	rs17018311	Temperament (bipolar disorder)
chr1	212237797	212237798	rs10863936	Height
chr1	212392162	212392163	rs6540731	Intelligence (childhood)
chr1	213126564	213126565	rs3002288	Eye color
chr1	213834642	213834643	rs4655303	Metabolite levels (5-HIAA)
chr1	213855587	213855588	rs17706439	RR interval (heart rate)
chr1	213910493	213910494	rs1704198	Obesity
chr1	214118089	214118090	rs340849	Alzheimer's disease
chr1	214125126	214125127	rs17762192	HIV-1 progression
chr1	214159255	214159256	rs340874	Fasting glucose-related traits (interaction with BMI)
chr1	214159255	214159256	rs340874	Fasting glucose-related traits
chr1	214261349	214261350	rs1440620	Dietary macronutrient intake
chr1	214457008	214457009	rs9308433	IgG glycosylation
chr1	214830616	214830617	rs438034	Response to antineoplastic agents
chr1	214954938	214954939	rs6695352	Migraine without aura
chr1	216056347	216056348	rs17025548	IgG glycosylation
chr1	216504268	216504269	rs7532570	IgG glycosylation
chr1	216632947	216632948	rs10495024	Testosterone levels
chr1	216716319	216716320	rs12145418	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr1	216716536	216716537	rs12757165	Cardiac hypertrophy
chr1	216738787	216738788	rs7553212	Alcohol consumption
chr1	217058478	217058479	rs1436900	Optic disc size (cup)
chr1	217200882	217200883	rs2377360	Major depressive disorder
chr1	217527023	217527024	rs1497828	Dialysis-related mortality
chr1	217718131	217718132	rs2059397	Visceral adipose tissue adjusted for BMI
chr1	218609701	218609702	rs6684205	Height
chr1	218705813	218705814	rs1018040	Hyperactive-impulsive symptoms
chr1	218705813	218705814	rs1018040	Attention deficit hyperactivity disorder
chr1	218860067	218860068	rs993925	Pulmonary function
chr1	218995272	218995273	rs7552186	Height
chr1	219644223	219644224	rs2605100	Adiposity
chr1	219651132	219651133	rs12022722	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr1	219657162	219657163	rs11118316	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr1	219673827	219673828	rs1417066	Osteoarthritis
chr1	219676041	219676042	rs2791553	Adiponectin levels
chr1	219693219	219693220	rs2820464	Waist-hip ratio
chr1	219700518	219700519	rs2785980	Fasting insulin-related traits (interaction with BMI)
chr1	219727778	219727779	rs3001032	Adiponectin levels
chr1	219743718	219743719	rs11118346	Height
chr1	219750716	219750717	rs4846567	Waist-hip ratio
chr1	219753508	219753509	rs2820443	Sexual dimorphism in anthropometric traits
chr1	219775431	219775432	rs994767	Axial length
chr1	220601622	220601623	rs7512221	Fat distribution (HIV)
chr1	220658233	220658234	rs12563333	Bipolar disorder
chr1	220914919	220914920	rs337161	Response to antipsychotic therapy (extrapyramidal side effects)
chr1	220929355	220929356	rs1494373	Response to antipsychotic therapy (extrapyramidal side effects)
chr1	220973562	220973563	rs2642442	LDL cholesterol
chr1	220973562	220973563	rs2642442	Cholesterol, total
chr1	220977332	220977333	rs6693017	Monocyte early outgrowth colony forming units
chr1	221010204	221010205	rs12073837	F-cell distribution
chr1	221028507	221028508	rs11118620	Heart failure
chr1	221111779	221111780	rs7542375	Obesity-related traits
chr1	221551538	221551539	rs12733856	Mortality among heart failure patients
chr1	221617075	221617076	rs12032381	Dupuytren's disease
chr1	222045445	222045446	rs6691170	Colorectal cancer
chr1	222164947	222164948	rs6687758	Progressive supranuclear palsy
chr1	222164947	222164948	rs6687758	Colorectal cancer
chr1	222245257	222245258	rs10863681	Metabolite levels (HVA-5-HIAA Factor score)
chr1	222271766	222271767	rs873549	Keloid
chr1	222823528	222823529	rs17465637	Coronary heart disease
chr1	222823528	222823529	rs17465637	Myocardial infarction (early onset)
chr1	222923350	222923351	rs6683071	Cognitive performance
chr1	224256347	224256348	rs10916248	QT interval (interaction)
chr1	224538939	224538940	rs11579964	Major depressive disorder
chr1	225590674	225590675	rs16844841	IgG glycosylation
chr1	225592926	225592927	rs16844846	IgG glycosylation
chr1	225901005	225901006	rs10915864	Obesity-related traits
chr1	226564690	226564691	rs3219090	Melanoma
chr1	226855888	226855889	rs10916025	Subcutaneous adipose tissue
chr1	227667789	227667790	rs12410462	Major depressive disorder
chr1	227797949	227797950	rs1390401	Height
chr1	227911882	227911883	rs10799445	Height
chr1	228703288	228703289	rs1925714	Tuberculosis
chr1	228880114	228880115	rs6426514	Type 2 diabetes
chr1	228996621	228996622	rs801112	Endometriosis
chr1	228997834	228997835	rs801114	Basal cell carcinoma
chr1	229019147	229019148	rs11585386	Aging
chr1	229285857	229285858	rs9793739	Dental caries
chr1	229718000	229718001	rs12049351	Circulating myeloperoxidase levels (plasma)
chr1	230294915	230294916	rs2144300	Circulating myeloperoxidase levels (serum)
chr1	230294915	230294916	rs2144300	Triglycerides
chr1	230294915	230294916	rs2144300	HDL cholesterol
chr1	230295690	230295691	rs4846914	Triglycerides
chr1	230295690	230295691	rs4846914	HDL cholesterol
chr1	230295788	230295789	rs10127775	Metabolite levels
chr1	230304987	230304988	rs10489615	HDL cholesterol
chr1	230307181	230307182	rs4846922	Metabolic syndrome
chr1	230388988	230388989	rs3761944	Hematology traits
chr1	230674825	230674826	rs701157	Attention deficit hyperactivity disorder and conduct disorder
chr1	230922950	230922951	rs12038826	Myopia (pathological)
chr1	231270635	231270636	rs12023396	Obesity-related traits
chr1	231816841	231816842	rs12042938	Neuranatomic and neurocognitive phenotypes
chr1	231844346	231844347	rs12044355	Alzheimer's disease
chr1	231899703	231899704	rs2793086	Response to antineoplastic agents
chr1	232155150	232155151	rs16856202	Amyotrophic lateral sclerosis
chr1	232246026	232246027	rs10746514	Response to statin therapy
chr1	232519149	232519150	rs669408	Immunoglobulin A
chr1	233339210	233339211	rs4649444	Homeostasis model assessment of beta-cell function (interaction)
chr1	233340153	233340154	rs12027542	Type 2 diabetes
chr1	233643855	233643856	rs10910200	Diabetic retinopathy
chr1	233719983	233719984	rs11800854	Periodontal microbiota
chr1	234583617	234583618	rs10489896	Cognitive test performance
chr1	234662889	234662890	rs271738	Bipolar disorder
chr1	234726011	234726012	rs744487	Coronary heart disease
chr1	234726355	234726356	rs11581667	IgG glycosylation
chr1	234816553	234816554	rs482329	Life threatening arrhythmia
chr1	234858596	234858597	rs514230	LDL cholesterol
chr1	234858596	234858597	rs514230	Cholesterol, total
chr1	234984987	234984988	rs2069084	HIV-1 control
chr1	235092599	235092600	rs908327	Immune reponse to smallpox (secreted IL-2)
chr1	235267126	235267127	rs11577354	Obesity-related traits
chr1	235600128	235600129	rs6429082	Adiposity
chr1	235720897	235720898	rs291353	Aging traits
chr1	236179868	236179869	rs3768080	Cutaneous nevi
chr1	236313126	236313127	rs7520258	Response to antipsychotic treatment in schizophrenia (working memory)
chr1	236912056	236912057	rs12048046	Periodontitis (CDC/AAP)
chr1	237048675	237048676	rs2275565	Homocysteine levels
chr1	237266602	237266603	rs7554607	Acute lymphoblastic leukemia (childhood)
chr1	237349737	237349738	rs6683225	Obesity-related traits
chr1	237355984	237355985	rs268786	Obesity-related traits
chr1	237598415	237598416	rs7529251	IgG glycosylation
chr1	237621238	237621239	rs1478912	Response to taxane treatment (docetaxel)
chr1	237911003	237911004	rs2819770	Exercise treadmill test traits
chr1	237990121	237990122	rs2819742	Response to cerivastatin
chr1	238103500	238103501	rs2499604	Non-alcoholic fatty liver disease histology (AST)
chr1	238669775	238669776	rs6692700	Serum selenium levels
chr1	238724740	238724741	rs10754644	Economic and political preferences (feminism/equality)
chr1	238908352	238908353	rs2689154	Pancreatic cancer
chr1	239075713	239075714	rs1915279	Treatment response for severe sepsis
chr1	239397103	239397104	rs1339738	IgG glycosylation
chr1	239436541	239436542	rs2820037	Hypertension
chr1	239601968	239601969	rs6677208	Platelet counts
chr1	239644170	239644171	rs13373941	Obesity-related traits
chr1	239970096	239970097	rs12059546	Epilepsy (generalized)
chr1	240283735	240283736	rs11810574	Thiazide-induced adverse metabolic effects in hypertensive patients
chr1	240445595	240445596	rs17672135	Coronary heart disease
chr1	240597213	240597214	rs9287237	Bone mineral density
chr1	240605051	240605052	rs12091371	Alzheimer's disease (cognitive decline)
chr1	240706106	240706107	rs10495471	Immune response to smallpox vaccine (IL-6)
chr1	240846123	240846124	rs4659996	Ankle-brachial index
chr1	240987753	240987754	rs7544372	Obesity-related traits
chr1	241755566	241755567	rs1053221	Obesity-related traits
chr1	241878546	241878547	rs12569163	Radiation response
chr1	241892234	241892235	rs9782914	Behavioural disinhibition (generation interaction)
chr1	241894085	241894086	rs10926554	Illicit drug use
chr1	242040774	242040775	rs1635501	Menopause (age at onset)
chr1	242274907	242274908	rs10803016	Coronary artery calcification
chr1	242522041	242522042	rs2919024	IgG glycosylation
chr1	242531653	242531654	rs1439523	IgG glycosylation
chr1	242874884	242874885	rs6676375	Tuberculosis
chr1	242955562	242955563	rs12751297	Obesity-related traits
chr1	243290641	243290642	rs55716084	Bronchopulmonary dysplasia
chr1	243483753	243483754	rs12145833	Obesity (early onset extreme)
chr1	243544826	243544827	rs1538774	Schizophrenia
chr1	243608966	243608967	rs6703335	Schizophrenia, schizoaffective disorder or bipolar disorder
chr1	243608966	243608967	rs6703335	Schizophrenia
chr1	243663892	243663893	rs14403	Schizophrenia
chr1	243835185	243835186	rs320320	Menarche (age at onset)
chr1	243943083	243943084	rs4132509	RR interval (heart rate)
chr1	244015992	244015993	rs4430311	Post-traumatic stress disorder (asjusted for relatedness)
chr1	244167800	244167801	rs12127679	Thiazide-induced adverse metabolic effects in hypertensive patients
chr1	244173871	244173872	rs10927101	Diabetic retinopathy
chr1	244176423	244176424	rs476141	Diabetic retinopathy
chr1	244390563	244390564	rs10429924	Schizophrenia
chr1	244511175	244511176	rs4658627	Asthma (childhood onset)
chr1	244533213	244533214	rs3101457	Smoking behavior
chr1	244576716	244576717	rs3102460	Obesity-related traits
chr1	245733607	245733608	rs10924245	Schizophrenia
chr1	246223119	246223120	rs6693295	Migraine with aura
chr1	246223119	246223120	rs6693295	Migraine - clinic-based
chr1	246661235	246661236	rs11800820	Obesity-related traits
chr1	247214877	247214878	rs4925540	Response to taxane treatment (docetaxel)
chr1	247348188	247348189	rs3738443	Alcohol dependence
chr1	247583676	247583677	rs10925015	Word reading
chr1	247600300	247600301	rs1539019	Fibrinogen
chr1	247601594	247601595	rs12239046	C-reactive protein
chr1	247605598	247605599	rs10157379	Fibrinogen
chr1	247675558	247675559	rs7550918	Platelet counts
chr1	247689531	247689532	rs1881797	Acute lymphoblastic leukemia (childhood)
chr1	248039450	248039451	rs3811444	Red blood cell traits
chr1	248039450	248039451	rs3811444	Platelet counts
chr1	248046271	248046272	rs11204538	Mean corpuscular volume
chr1	248496862	248496863	rs4481887	Common traits (Other)
chr1	249168435	249168436	rs12032643	Myopia (pathological)
chr10	566378	566379	rs11252926	Alzheimer's disease
chr10	618684	618685	rs17221323	Immune reponse to smallpox (secreted IFN-alpha)
chr10	759267	759268	rs7916968	Migraine
chr10	771531	771532	rs877282	Uric acid levels
chr10	1078781	1078782	rs12762955	Response to angiotensin II receptor blocker therapy
chr10	1156164	1156165	rs10794720	Chronic kidney disease
chr10	1246882	1246883	rs4880487	Migraine
chr10	1343016	1343017	rs11599315	Thiazide-induced adverse metabolic effects in hypertensive patients
chr10	1406363	1406364	rs11250464	Radiation response
chr10	1471764	1471765	rs2820651	Migraine with aura
chr10	1630820	1630821	rs2999399	Emphysema-related traits
chr10	1676530	1676531	rs6560749	Quantitative traits
chr10	1897977	1897978	rs12360000	Metabolite levels (Dihydroxy docosatrienoic acid)
chr10	2424555	2424556	rs12571964	Obesity-related traits
chr10	2532018	2532019	rs729397	Response to statin therapy
chr10	3155172	3155173	rs7896691	Disc degeneration (lumbar)
chr10	3284006	3284007	rs2764980	Attention deficit hyperactivity disorder and conduct disorder
chr10	3408946	3408947	rs17135159	Reading and spelling
chr10	3418123	3418124	rs1570854	Economic and political preferences (environmentalism)
chr10	3516104	3516105	rs2165468	Bone mineral density
chr10	3538793	3538794	rs7092929	Coronary artery calcification
chr10	3658918	3658919	rs705469	Capecitabine sensitivity
chr10	3667725	3667726	rs705471	Capecitabine sensitivity
chr10	3862541	3862542	rs6601764	Crohn's disease
chr10	4001896	4001897	rs2031573	Word reading
chr10	4050002	4050003	rs2031577	Longevity
chr10	4151120	4151121	rs10795130	Sex hormone-binding globulin levels
chr10	4240869	4240870	rs11252394	Asthma (bronchodilator response)
chr10	4655564	4655565	rs10458787	Body mass index
chr10	4676195	4676196	rs7086888	Multiple myeloma (IgH translocation)
chr10	4716541	4716542	rs2165953	Obesity-related traits
chr10	4719795	4719796	rs1391511	Neonatal lupus
chr10	5009758	5009759	rs2904804	Economic and political preferences (immigration/crime)
chr10	5138035	5138036	rs2518049	Metabolic traits
chr10	5254846	5254847	rs1832007	Triglycerides
chr10	5348336	5348337	rs1987511	Intelligence
chr10	5349870	5349871	rs7475343	Intelligence
chr10	5353689	5353690	rs9423406	Intelligence
chr10	5354676	5354677	rs7896729	Intelligence
chr10	5665773	5665774	rs17141741	Breast cancer
chr10	5670274	5670275	rs2386661	Breast cancer
chr10	5672018	5672019	rs4414128	Breast cancer
chr10	5804530	5804531	rs2797501	Osteosarcoma
chr10	5886733	5886734	rs2380205	Breast cancer
chr10	5918431	5918432	rs17145612	Obesity-related traits
chr10	6037725	6037726	rs7911500	Inflammatory biomarkers
chr10	6053162	6053163	rs12722605	Inflammatory biomarkers
chr10	6067687	6067688	rs2025345	Self-reported allergy
chr10	6081229	6081230	rs12722515	Inflammatory bowel disease
chr10	6094696	6094697	rs61839660	Type 1 diabetes
chr10	6097282	6097283	rs12722495	Type 1 diabetes autoantibodies
chr10	6098823	6098824	rs706779	Vitiligo
chr10	6098948	6098949	rs706778	Rheumatoid arthritis
chr10	6099044	6099045	rs2104286	Rheumatoid arthritis
chr10	6099044	6099045	rs2104286	Multiple sclerosis
chr10	6101712	6101713	rs3118470	Multiple sclerosis
chr10	6101712	6101713	rs3118470	Alopecia areata
chr10	6102011	6102012	rs12722489	Multiple sclerosis
chr10	6102011	6102012	rs12722489	Crohn's disease
chr10	6110828	6110829	rs7090512	Multiple sclerosis
chr10	6123494	6123495	rs12251307	Type 1 diabetes
chr10	6315793	6315794	rs7077335	Myopia (pathological)
chr10	6390449	6390450	rs947474	Type 1 diabetes
chr10	6393259	6393260	rs4750316	Rheumatoid arthritis
chr10	6407736	6407737	rs11258317	Bipolar disorder and schizophrenia
chr10	6472890	6472891	rs11258747	Type 1 diabetes
chr10	6572224	6572225	rs11259403	Body mass index (asthmatics)
chr10	6606540	6606541	rs4748153	Immune response to smallpox vaccine (IL-6)
chr10	6789462	6789463	rs12570744	Response to anti-TNF treatment in rheumatoid arthritis
chr10	6924443	6924444	rs11816922	Migraine
chr10	6946262	6946263	rs6602217	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	6946751	6946752	rs2501677	Fasting insulin-related traits (interaction with BMI)
chr10	7089015	7089016	rs10905099	Orofacial clefts
chr10	7736903	7736904	rs11255291	Ovarian reserve
chr10	7887620	7887621	rs11255400	IgG glycosylation
chr10	8093033	8093034	rs501764	Hodgkin's lymphoma
chr10	8104207	8104208	rs3824662	Acute lymphoblastic leukemia (B-cell precursor)
chr10	8150712	8150713	rs10508343	Response to treatment for acute lymphoblastic leukemia
chr10	8324888	8324889	rs11255615	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
chr10	8633860	8633861	rs4749791	Obesity-related traits
chr10	8701218	8701219	rs10795668	Colorectal cancer
chr10	8719268	8719269	rs827382	Migraine
chr10	8954223	8954224	rs2388896	Tetralogy of Fallot
chr10	8972017	8972018	rs10508372	Asthma
chr10	9053131	9053132	rs962993	Self-reported allergy
chr10	9328650	9328651	rs10491003	Calcium levels
chr10	9363876	9363877	rs12247397	Immune reponse to smallpox (secreted IL-1beta)
chr10	9568909	9568910	rs17515642	IgG glycosylation
chr10	9996989	9996990	rs12263766	Obesity-related traits
chr10	10073543	10073544	rs10905651	Dental caries
chr10	10084565	10084566	rs17147135	Obesity-related traits
chr10	10296118	10296119	rs7097577	Obesity-related traits
chr10	10388194	10388195	rs7092703	Corneal astigmatism
chr10	10601859	10601860	rs11256676	Dental caries
chr10	10974255	10974256	rs10905868	Obesity-related traits
chr10	11000338	11000339	rs62209	Alzheimer's disease (late onset)
chr10	11224664	11224665	rs596406	Liver enzyme levels (aspartate transaminase)
chr10	11224664	11224665	rs596406	Liver enzyme levels (alanine transaminase)
chr10	11719009	11719010	rs12265836	Obesity-related traits
chr10	11720307	11720308	rs7920721	Alzheimer's disease (late onset)
chr10	12051815	12051816	rs10795917	Prostate cancer (gene x gene interaction)
chr10	12277991	12277992	rs7068966	Pulmonary function (interaction)
chr10	12277991	12277992	rs7068966	Pulmonary function
chr10	12307893	12307894	rs11257655	Type 2 diabetes
chr10	12314996	12314997	rs10906115	Type 2 diabetes
chr10	12328009	12328010	rs12779790	Type 2 diabetes
chr10	12435378	12435379	rs4750211	Obesity-related traits
chr10	12438782	12438783	rs10906142	Obesity-related traits
chr10	12675060	12675061	rs10906189	QT interval (interaction)
chr10	12702568	12702569	rs75263140	Anorexia nervosa
chr10	12872879	12872880	rs2431623	Serum dimethylarginine levels (asymmetric)
chr10	12875207	12875208	rs10906233	Eating disorders
chr10	12918763	12918764	rs7909670	Height
chr10	13103284	13103285	rs525455	Platelet aggregation
chr10	13155725	13155726	rs1561570	Paget's disease
chr10	13310070	13310071	rs10796051	Self-reported allergy
chr10	13355130	13355131	rs1095368	IgG glycosylation
chr10	13361975	13361976	rs1747683	IgG glycosylation
chr10	13363045	13363046	rs10508459	IgG glycosylation
chr10	13530216	13530217	rs17153352	IgG glycosylation
chr10	13667730	13667731	rs7089227	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)
chr10	13755543	13755544	rs1541010	RR interval (heart rate)
chr10	13790264	13790265	rs10906466	Migraine
chr10	13991864	13991865	rs7081208	Alzheimer's disease
chr10	14008444	14008445	rs2446581	Alzheimer's disease
chr10	14016158	14016159	rs17314229	Alzheimer's disease
chr10	14945405	14945406	rs11594111	Migraine
chr10	15129401	15129402	rs11259474	Obesity-related traits
chr10	15561542	15561543	rs7077361	Parkinson's disease
chr10	15600670	15600671	rs28643277	Periodontitis (CDC/AAP)
chr10	15719620	15719621	rs7895372	Quantitative traits
chr10	16299950	16299951	rs10508503	Obesity
chr10	16634298	16634299	rs7068341	Migraine
chr10	16744522	16744523	rs11254160	Obesity-related traits
chr10	16748609	16748610	rs7916663	Obesity-related traits
chr10	16919051	16919052	rs1801239	Urinary albumin excretion
chr10	16997890	16997891	rs10508517	Quantitative traits
chr10	17130692	17130693	rs11254363	Folate pathway vitamin levels
chr10	17142525	17142526	rs6602175	MRI atrophy measures
chr10	17156150	17156151	rs1801222	Homocysteine levels
chr10	17156150	17156151	rs1801222	Folate pathway vitamin levels
chr10	17223243	17223244	rs12780845	Homocysteine levels
chr10	17260289	17260290	rs10904908	Cholesterol, total
chr10	17388142	17388143	rs359312	Response to treatment for acute lymphoblastic leukemia
chr10	17875815	17875816	rs2477664	Hematological and biochemical traits
chr10	17891821	17891822	rs2437258	Cardiovascular disease risk factors
chr10	18122769	18122770	rs2477664	Hematological and biochemical traits
chr10	18138746	18138747	rs2437258	Cardiovascular disease risk factors
chr10	18388433	18388434	rs10508558	Bipolar disorder and schizophrenia
chr10	18397246	18397247	rs17661538	Response to antipsychotic treatment
chr10	18419971	18419972	rs4373814	Systolic blood pressure
chr10	18419971	18419972	rs4373814	Hypertension
chr10	18419971	18419972	rs4373814	Diastolic blood pressure
chr10	18442481	18442482	rs10740993	Primary tooth development (time to first tooth eruption)
chr10	18442481	18442482	rs10740993	Primary tooth development (number of teeth)
chr10	18525169	18525170	rs2482109	Metabolite levels (HVA/MHPG ratio)
chr10	18601927	18601928	rs2799573	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	18708797	18708798	rs11014166	Systolic blood pressure
chr10	18708797	18708798	rs11014166	Hypertension
chr10	18708797	18708798	rs11014166	Diastolic blood pressure
chr10	18727958	18727959	rs12258967	Blood pressure
chr10	18730367	18730368	rs7069923	Quantitative traits
chr10	18734527	18734528	rs17691888	Schizophrenia
chr10	18759628	18759629	rs7076247	Protein quantitative trait loci
chr10	18782879	18782880	rs8181477	Obesity-related traits
chr10	18950554	18950555	rs10829156	Sudden cardiac arrest
chr10	19160028	19160029	rs16917919	Brain structure (hippocampal volume)
chr10	19405530	19405531	rs16918253	Obesity-related traits
chr10	19929512	19929513	rs1326986	Ankylosing spondylitis
chr10	20434779	20434780	rs4634985	Bronchopulmonary dysplasia
chr10	20542633	20542634	rs1571942	Diabetic retinopathy
chr10	20593086	20593087	rs12219125	Diabetic retinopathy
chr10	20674652	20674653	rs12772794	Neutrophil count
chr10	20792333	20792334	rs7897194	Bipolar disorder
chr10	20810524	20810525	rs16920624	Response to antidepressants
chr10	20899607	20899608	rs2359536	Peripheral artery disease
chr10	21567564	21567565	rs3847375	Schizophrenia
chr10	21830103	21830104	rs11012732	Meningioma
chr10	21915618	21915619	rs1243180	Ovarian cancer
chr10	22032941	22032942	rs7072776	Breast cancer
chr10	22315842	22315843	rs11814448	Breast cancer
chr10	22847438	22847439	rs7094131	Obesity-related traits
chr10	23303252	23303253	rs1054052	IgG glycosylation
chr10	23369420	23369421	rs722258	Sleep time
chr10	23434743	23434744	rs7893600	Obesity-related traits
chr10	23665437	23665438	rs1398024	Crohn's disease and sarcoidosis (combined)
chr10	23858210	23858211	rs16923476	Obesity (early onset extreme)
chr10	24495585	24495586	rs11013962	Common traits (Other)
chr10	24634955	24634956	rs2484873	Cognitive performance
chr10	25111909	25111910	rs11014249	Obesity-related traits
chr10	25224461	25224462	rs11014306	Metabolite levels (Pyroglutamine)
chr10	25880458	25880459	rs17558301	IgG glycosylation
chr10	25918878	25918879	rs12775535	Immune response to smallpox vaccine (IL-6)
chr10	26002247	26002248	rs2504183	IgG glycosylation
chr10	26162765	26162766	rs4749080	Obesity-related traits
chr10	26294827	26294828	rs16926523	PR interval
chr10	26433365	26433366	rs2096176	Obesity-related traits
chr10	26484153	26484154	rs12764197	Obesity-related traits
chr10	26734586	26734587	rs2992257	Response to angiotensin II receptor blocker therapy
chr10	26774693	26774694	rs786870	Inflammatory biomarkers
chr10	27693304	27693305	rs1334893	Fasting insulin-related traits (interaction with BMI)
chr10	28025770	28025771	rs10508727	Immune response to smallpox vaccine (IL-6)
chr10	28150934	28150935	rs11006747	Obesity-related traits
chr10	28382932	28382933	rs927675	MRI atrophy measures
chr10	28388149	28388150	rs10763642	Obesity-related traits
chr10	28479941	28479942	rs3905706	Bone mineral density
chr10	28504943	28504944	rs11006923	Alzheimer's disease
chr10	28617634	28617635	rs1148186	Pulmonary function decline
chr10	28752105	28752106	rs2153299	Obesity-related traits
chr10	29027222	29027223	rs1248993	Preeclampsia
chr10	29289030	29289031	rs11007350	Cannabis dependence
chr10	29291897	29291898	rs1612122	Major depressive disorder (broad)
chr10	29336848	29336849	rs788076	Palmitoleic acid (16:1n-7) plasma levels
chr10	29364696	29364697	rs10826566	Migraine with aura
chr10	29487364	29487365	rs4387258	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr10	30008662	30008663	rs1927457	Normalized brain volume
chr10	30087358	30087359	rs2986961	Migraine with aura
chr10	30096627	30096628	rs2986971	Non-alcoholic fatty liver disease histology (lobular)
chr10	30177887	30177888	rs3006564	Orofacial clefts
chr10	30316071	30316072	rs3739998	Coronary heart disease
chr10	30335121	30335122	rs2505083	Coronary heart disease
chr10	30490703	30490704	rs2462021	Suicide risk
chr10	30519831	30519832	rs2995271	Pancreatitis
chr10	30728100	30728101	rs1042058	Inflammatory bowel disease
chr10	30834631	30834632	rs11008099	QT interval
chr10	30912029	30912030	rs399593	Dental caries
chr10	31366270	31366271	rs2994684	Response to antipsychotic treatment
chr10	31415105	31415106	rs793108	Multiple sclerosis
chr10	31495973	31495974	rs1250307	Disc degeneration (lumbar)
chr10	31512097	31512098	rs2484992	Disc degeneration (lumbar)
chr10	31515131	31515132	rs2484990	Disc degeneration (lumbar)
chr10	31990622	31990623	rs7081678	Waist-hip ratio
chr10	32309004	32309005	rs1775715	Bipolar disorder (mood-incongruent)
chr10	32625017	32625018	rs143713361	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr10	32634971	32634972	rs2370759	Sexual dysfunction (female)
chr10	33294774	33294775	rs11009175	Depression (quantitative trait)
chr10	33405086	33405087	rs7902627	IgG glycosylation
chr10	33475281	33475282	rs2228638	Tetralogy of Fallot
chr10	33503178	33503179	rs2506155	Migraine
chr10	34088052	34088053	rs1412115	Schizophrenia
chr10	34231274	34231275	rs7905537	Emphysema-related traits
chr10	34257611	34257612	rs1780436	Major depressive disorder
chr10	34817987	34817988	rs563507	Acute lymphoblastic leukemia (childhood)
chr10	35287649	35287650	rs17582416	Crohn's disease
chr10	35295430	35295431	rs11010067	Inflammatory bowel disease
chr10	35535694	35535695	rs12242110	Crohn's disease
chr10	35554053	35554054	rs12261843	Ulcerative colitis
chr10	36060308	36060309	rs11010290	Antineutrophil cytoplasmic antibody-associated vasculitis
chr10	36648039	36648040	rs1779876	Protein quantitative trait loci
chr10	36885920	36885921	rs1360573	Periodontal microbiota
chr10	37508449	37508450	rs1148259	Metabolite levels
chr10	37559579	37559580	rs1200821	Hemostatic factors and hematological phenotypes
chr10	37982096	37982097	rs7474896	Obesity (extreme)
chr10	43341104	43341105	rs2142991	Progressive supranuclear palsy
chr10	43612608	43612609	rs2742234	Hirschsprung's disease
chr10	43755753	43755754	rs28461806	Obesity-related traits
chr10	43814048	43814049	rs2503875	Multiple sclerosis
chr10	44458713	44458714	rs898549	Obesity-related traits
chr10	44524674	44524675	rs17154929	HIV-associated dementia
chr10	44541564	44541565	rs10508881	Endometriosis
chr10	44753866	44753867	rs501120	Coronary heart disease
chr10	44775823	44775824	rs1746048	Coronary heart disease
chr10	44775823	44775824	rs1746048	Myocardial infarction (early onset)
chr10	44827196	44827197	rs10900020	Schizophrenia
chr10	45034671	45034672	rs7072122	Estradiol plasma levels (breast cancer)
chr10	45123378	45123379	rs11239177	Bipolar disorder and schizophrenia
chr10	45161108	45161109	rs1480597	Parkinson's disease
chr10	45319653	45319654	rs7911712	Emphysema-related traits
chr10	45553728	45553729	rs12358699	Lung function (forced expiratory volume in 1 second to forced vital capacity ratio)
chr10	45955063	45955064	rs2279434	Mean corpuscular volume
chr10	45955063	45955064	rs2279434	Mean corpuscular hemoglobin
chr10	45966421	45966422	rs901683	Red blood cell traits
chr10	46013276	46013277	rs970548	HDL cholesterol
chr10	46013276	46013277	rs970548	Cholesterol, total
chr10	46024728	46024729	rs11239550	Mean corpuscular volume
chr10	49699956	49699957	rs4838605	Diabetic retinopathy
chr10	49735562	49735563	rs10776612	Conduct disorder (case status)
chr10	49763165	49763166	rs10776614	Self-employment
chr10	49936335	49936336	rs11101442	Systemic lupus erythematosus
chr10	49985109	49985110	rs10857636	Response to antidepressant treatment
chr10	50025395	50025396	rs7097397	Systemic lupus erythematosus
chr10	50042950	50042951	rs877819	Systemic lupus erythematosus
chr10	50109222	50109223	rs3849150	Subclinical atherosclerosis traits (other)
chr10	50119053	50119054	rs1913517	Systemic lupus erythematosus
chr10	50224765	50224766	rs2244967	Uric acid levels
chr10	50229637	50229638	rs2137920	Migraine with aura
chr10	50500458	50500459	rs17774576	Oleic acid (18:1n-9) plasma levels
chr10	50561506	50561507	rs4838508	HIV-1 control
chr10	50576632	50576633	rs12220898	Inflammatory biomarkers
chr10	51524970	51524971	rs3123078	Prostate cancer
chr10	51549495	51549496	rs10993994	PCA3 expression level
chr10	51549495	51549496	rs10993994	Prostate-specific antigen levels
chr10	51549495	51549496	rs10993994	Prostate cancer
chr10	51549495	51549496	rs10993994	Serum prostate-specific antigen levels
chr10	51593353	51593354	rs7085433	Mean corpuscular volume
chr10	51593353	51593354	rs7085433	Mean corpuscular hemoglobin
chr10	52010707	52010708	rs10508921	Thiazide-induced adverse metabolic effects in hypertensive patients
chr10	52119296	52119297	rs2574975	Response to amphetamines
chr10	52646092	52646093	rs10821905	Urate levels
chr10	52789354	52789355	rs6479874	Migraine
chr10	53242702	53242703	rs293314	Obesity-related traits
chr10	53262632	53262633	rs1952138	IgG glycosylation
chr10	53493472	53493473	rs7922491	Asthma
chr10	53681793	53681794	rs11000137	Migraine
chr10	54130752	54130753	rs112125027	Periodontitis (Mean PAL)
chr10	54223976	54223977	rs1733724	QRS duration
chr10	54223976	54223977	rs1733724	Electrocardiographic traits
chr10	54341872	54341873	rs2222800	Metabolite levels  (X-11787)
chr10	54427824	54427825	rs1373004	Bone mineral density
chr10	54574995	54574996	rs6480975	Age-related macular degeneration
chr10	55294873	55294874	rs583012	Select biomarker traits
chr10	55384742	55384743	rs12256830	Immune response to smallpox vaccine (IL-6)
chr10	55407090	55407091	rs7077606	Thiazide-induced adverse metabolic effects in hypertensive patients
chr10	56204290	56204291	rs7476422	Adverse response to chemotherapy in breast cancer (alopecia)
chr10	56391302	56391303	rs1937395	Pulmonary function decline
chr10	56790968	56790969	rs10740609	Weight
chr10	56848984	56848985	rs16906916	Response to tocilizumab in rheumatoid arthritis
chr10	57416960	57416961	rs1916521	Cardiac hypertrophy
chr10	57549295	57549296	rs16907840	Post-traumatic stress disorder (asjusted for relatedness)
chr10	58339240	58339241	rs1907926	Nicotine use
chr10	59189177	59189178	rs4462262	Diabetic retinopathy
chr10	59724387	59724388	rs7070038	Coronary artery calcification
chr10	59724402	59724403	rs7088591	Blood pressure
chr10	59913150	59913151	rs1819658	Crohn's disease
chr10	59985670	59985671	rs2790232	Obesity-related traits
chr10	59997925	59997926	rs2790216	Inflammatory bowel disease
chr10	60082667	60082668	rs16912145	Brain imaging
chr10	60204601	60204602	rs7085387	Migraine without aura
chr10	60210789	60210790	rs10509091	Height
chr10	60265403	60265404	rs7084402	Refractive error
chr10	60318896	60318897	rs1658442	Corneal astigmatism
chr10	60555577	60555578	rs11006263	Obesity-related traits
chr10	61146581	61146582	rs11006464	Oleic acid (18:1n-9) plasma levels
chr10	61413352	61413353	rs12356193	Uric acid levels
chr10	61449563	61449564	rs7094971	Metabolic traits
chr10	61469537	61469538	rs1171614	Urate levels
chr10	62085336	62085337	rs10761482	Schizophrenia
chr10	62179811	62179812	rs10994336	Bipolar disorder
chr10	62181127	62181128	rs10994338	Bipolar disorder and major depressive disorder (combined)
chr10	62185493	62185494	rs4948418	Bipolar disorder
chr10	62222106	62222107	rs10994359	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	62279123	62279124	rs10994397	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	62279123	62279124	rs10994397	Bipolar disorder
chr10	62346637	62346638	rs16915157	Schizophrenia
chr10	62548389	62548390	rs3213056	Reading and spelling
chr10	62551889	62551890	rs2456778	Cocaine dependence
chr10	63192413	63192414	rs7088627	Serum dimethylarginine levels (asymmetric)
chr10	63307474	63307475	rs2787702	Response to taxane treatment (placlitaxel)
chr10	63348766	63348767	rs1350172	Response to taxane treatment (placlitaxel)
chr10	63361986	63361987	rs2814021	Obesity-related traits
chr10	63467552	63467553	rs4590817	Blood pressure
chr10	63524590	63524591	rs1530440	Diastolic blood pressure
chr10	63636530	63636531	rs2675609	Serum total protein level
chr10	63695047	63695048	rs6479779	IgG glycosylation
chr10	63721175	63721176	rs7090445	Acute lymphoblastic leukemia (B-cell precursor)
chr10	63723576	63723577	rs10821936	Acute lymphoblastic leukemia (childhood)
chr10	63752158	63752159	rs7089424	Acute lymphoblastic leukemia (childhood)
chr10	63785088	63785089	rs10821944	Rheumatoid arthritis
chr10	63805616	63805617	rs4948496	Systemic lupus erythematosus
chr10	63830285	63830286	rs7090871	Corneal structure
chr10	63958111	63958112	rs3125734	Rheumatoid arthritis
chr10	64187563	64187564	rs7089814	Breast size
chr10	64223382	64223383	rs10995170	Intelligence
chr10	64251976	64251977	rs10822013	Breast cancer
chr10	64278681	64278682	rs10995190	Breast cancer
chr10	64278681	64278682	rs10995190	Mammographic density
chr10	64391374	64391375	rs10995245	Narcolepsy
chr10	64398465	64398466	rs10995251	Atopic dermatitis
chr10	64415183	64415184	rs7076156	Crohn's disease
chr10	64438485	64438486	rs10995271	Crohn's disease
chr10	64445563	64445564	rs10761659	Inflammatory bowel disease
chr10	64445563	64445564	rs10761659	Crohn's disease
chr10	64470674	64470675	rs224136	Crohn's disease
chr10	64560469	64560470	rs1444418	Atopic dermatitis
chr10	64580574	64580575	rs224278	Ewing sarcoma
chr10	64655912	64655913	rs10995356	Temperament
chr10	64866911	64866912	rs10995439	IgG glycosylation
chr10	64872410	64872411	rs10822136	IgG glycosylation
chr10	64963448	64963449	rs4379723	Platelet counts
chr10	65006455	65006456	rs6479891	Arthritis (juvenile idiopathic)
chr10	65026857	65026858	rs10995485	Response to fenofibrate
chr10	65027609	65027610	rs10761731	Triglycerides
chr10	65027609	65027610	rs10761731	Platelet counts
chr10	65050658	65050659	rs7075195	Mean platelet volume
chr10	65104499	65104500	rs7896518	Mean platelet volume
chr10	65121564	65121565	rs12355784	Liver enzyme levels
chr10	65133155	65133156	rs2393967	Mean platelet volume
chr10	65133821	65133822	rs7923609	Liver enzyme levels (alkaline phosphatase)
chr10	65138909	65138910	rs7910927	Sex hormone-binding globulin levels
chr10	65162152	65162153	rs7896783	Fibrinogen
chr10	65261183	65261184	rs2893923	Platelet aggregation
chr10	65274926	65274927	rs10761779	Liver enzyme levels
chr10	65315396	65315397	rs12411988	Arthritis (juvenile idiopathic)
chr10	65337152	65337153	rs10822184	Androgen levels
chr10	65658743	65658744	rs938036	Tooth agenesis (mandibular third molar)
chr10	66448471	66448472	rs7900909	Response to statin therapy
chr10	67743653	67743654	rs72791417	Bronchopulmonary dysplasia
chr10	67964372	67964373	rs1471384	Lung function (forced vital capacity)
chr10	67966573	67966574	rs12251332	Metabolite levels (Pyroglutamine)
chr10	68088507	68088508	rs10762058	Asthma (toluene diisocyanate-induced)
chr10	68165266	68165267	rs2441755	Dental caries
chr10	68224885	68224886	rs2441727	Interstitial lung disease
chr10	68374083	68374084	rs7909235	Obesity-related traits
chr10	68598291	68598292	rs7902091	Schizophrenia (cytomegalovirus infection interaction)
chr10	68640950	68640951	rs4142041	Nicotine dependence
chr10	68879802	68879803	rs10997517	Migraine without aura
chr10	69967446	69967447	rs6480314	Optic disc size (disc)
chr10	69991852	69991853	rs7916697	Optic disc parameters
chr10	70000880	70000881	rs1900004	Vertical cup-disc ratio
chr10	70000880	70000881	rs1900004	Optic disc parameters
chr10	70011837	70011838	rs3858145	Optic disc size (disc)
chr10	70011837	70011838	rs3858145	Optic disc size (cup)
chr10	70014229	70014230	rs10998035	Eating disorders (purging via substances)
chr10	70019370	70019371	rs12571093	Optic disc size (disc)
chr10	70626428	70626429	rs10998466	Disc degeneration (lumbar)
chr10	70712061	70712062	rs2017305	Depression (quantitative trait)
chr10	70931473	70931474	rs1802295	Type 2 diabetes
chr10	70939800	70939801	rs10998624	Immune reponse to smallpox (secreted IL-1beta)
chr10	70982940	70982941	rs4746822	Glycemic traits (pregnancy)
chr10	71093391	71093392	rs16926246	Glycated hemoglobin levels
chr10	71093391	71093392	rs16926246	Hemoglobin
chr10	71093391	71093392	rs16926246	Hematocrit
chr10	71099887	71099888	rs10159477	Red blood cell traits
chr10	71099912	71099913	rs7072268	Glycated hemoglobin levels
chr10	71263263	71263264	rs1227969	Response to taxane treatment (placlitaxel)
chr10	71538291	71538292	rs4746003	Alzheimer's disease
chr10	71580119	71580120	rs17497526	Parkinson's disease
chr10	71583197	71583198	rs7077164	Non-alcoholic fatty liver disease histology (lobular)
chr10	71588503	71588504	rs1227756	Non-alcoholic fatty liver disease histology (lobular)
chr10	72040804	72040805	rs41322152	Acute lymphoblastic leukemia (childhood)
chr10	72114377	72114378	rs4747011	Brain connectivity
chr10	72332439	72332440	rs10999409	Obesity (extreme)
chr10	72462993	72462994	rs17600642	Bipolar disorder
chr10	72483009	72483010	rs1816002	Weight
chr10	72500762	72500763	rs10823607	Sleep duration
chr10	72527516	72527517	rs12761224	Prion diseases
chr10	72688370	72688371	rs1466576	Obesity-related traits
chr10	72767408	72767409	rs10509328	Multiple myeloma (IgH translocation)
chr10	72795876	72795877	rs1891159	Obesity-related traits
chr10	72982984	72982985	rs16928529	Attention deficit hyperactivity disorder
chr10	73115941	73115942	rs2252996	Systemic lupus erythematosus
chr10	73121944	73121945	rs1084004	Obesity-related traits
chr10	73135918	73135919	rs1417210	Vitiligo
chr10	73527046	73527047	rs1867982	Pulmonary function decline
chr10	73591529	73591530	rs11000019	Asthma (childhood onset)
chr10	73778266	73778267	rs1245582	Disc degeneration (lumbar)
chr10	73806287	73806288	rs1678618	Smoking behavior
chr10	73849638	73849639	rs1245541	Insulin-like growth factors
chr10	75421207	75421208	rs10824026	Atrial fibrillation
chr10	75673100	75673101	rs2227564	Inflammatory bowel disease
chr10	76295788	76295789	rs7924176	Primary tooth development (time to first tooth eruption)
chr10	76295788	76295789	rs7924176	Primary tooth development (number of teeth)
chr10	76295788	76295789	rs7924176	Permanent tooth development
chr10	76703005	76703006	rs10466033	Breast size
chr10	76808759	76808760	rs7919006	Weight
chr10	77298608	77298609	rs2043090	Anorexia nervosa
chr10	77911031	77911032	rs10740455	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr10	78157571	78157572	rs10509373	Response to tamoxifen in breast cancer
chr10	78315223	78315224	rs11001819	Pulmonary function (interaction)
chr10	78315223	78315224	rs11001819	Pulmonary function
chr10	78331317	78331318	rs2637266	Pulmonary function
chr10	78646535	78646536	rs2116830	Obesity
chr10	79401315	79401316	rs7071206	Bone mineral density
chr10	79444752	79444753	rs4979906	Mortality among heart failure patients
chr10	79540834	79540835	rs12261589	Obesity-related traits
chr10	79680433	79680434	rs754466	Liver enzyme levels (gamma-glutamyl transferase)
chr10	80100860	80100861	rs2395528	Conduct disorder (interaction)
chr10	80515080	80515081	rs7900239	Migraine
chr10	80841147	80841148	rs704010	Breast cancer
chr10	80925576	80925577	rs7916441	Height
chr10	80931480	80931481	rs780151	Height
chr10	80953135	80953136	rs703970	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	80955066	80955067	rs703965	Bipolar disorder
chr10	81015895	81015896	rs11593576	Vitiligo
chr10	81032531	81032532	rs1250546	Inflammatory bowel disease
chr10	81032884	81032885	rs1250544	Crohn's disease and psoriasis
chr10	81034669	81034670	rs1250542	Multiple sclerosis
chr10	81036006	81036007	rs1250540	Multiple sclerosis
chr10	81055625	81055626	rs12355688	Breast cancer
chr10	81058026	81058027	rs1250552	Celiac disease
chr10	81060316	81060317	rs1250550	Multiple sclerosis
chr10	81060316	81060317	rs1250550	Crohn's disease
chr10	81060316	81060317	rs1250550	Inflammatory bowel disease (early onset)
chr10	81121695	81121696	rs2145998	Height
chr10	81139461	81139462	rs941873	Height
chr10	81185313	81185314	rs181715218	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr10	81694949	81694950	rs1923539	Chronic obstructive pulmonary disease-related biomarkers
chr10	81705432	81705433	rs7078012	Chronic obstructive pulmonary disease-related biomarkers
chr10	81735980	81735981	rs3923564	Chronic obstructive pulmonary disease-related biomarkers
chr10	81788103	81788104	rs12220777	Chronic obstructive pulmonary disease-related biomarkers
chr10	81847913	81847914	rs728616	Chronic obstructive pulmonary disease-related biomarkers
chr10	81882369	81882370	rs3851050	Chronic obstructive pulmonary disease-related biomarkers
chr10	81911724	81911725	rs1953600	Sarcoidosis
chr10	81933747	81933748	rs6585424	Chronic obstructive pulmonary disease-related biomarkers
chr10	82254046	82254047	rs6586030	Inflammatory bowel disease
chr10	82377589	82377590	rs6586111	Capecitabine sensitivity
chr10	82699490	82699491	rs1484170	Cardiac hypertrophy
chr10	83153245	83153246	rs588517	Carotid atherosclerosis in HIV infection
chr10	83188952	83188953	rs1329201	Retinopathy in non-diabetics
chr10	83566685	83566686	rs9787485	Homeostasis model assessment of insulin resistance (interaction)
chr10	83566685	83566686	rs9787485	Fasting insulin (interaction)
chr10	83819124	83819125	rs4933824	Response to iloperidone treatment (QT prolongation)
chr10	84419409	84419410	rs2219937	IgG glycosylation
chr10	84870075	84870076	rs7915137	Obesity-related traits
chr10	85253680	85253681	rs1414874	Self-reported allergy
chr10	85422853	85422854	rs2224865	Eosinophilic esophagitis (pediatric)
chr10	86588901	86588902	rs11201253	Obesity-related traits
chr10	86721180	86721181	rs12266096	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr10	86953326	86953327	rs12098564	Stearic acid (18:0) plasma levels
chr10	87608459	87608460	rs7076096	Post-traumatic stress disorder (asjusted for relatedness)
chr10	87634923	87634924	rs1970525	Periodontal microbiota
chr10	87694291	87694292	rs76765968	Anorexia nervosa
chr10	87740752	87740753	rs10788473	Pancreatic cancer
chr10	87846958	87846959	rs7910620	Cardiac structure and function
chr10	88116478	88116479	rs7904985	Barrett's esophagus
chr10	88216401	88216402	rs7075426	Migraine without aura
chr10	89338632	89338633	rs9664222	Longevity
chr10	89443309	89443310	rs10887741	Exercise (leisure time)
chr10	89752210	89752211	rs149784093	Periodontitis (Mean PAL)
chr10	90023032	90023033	rs10509540	Type 1 diabetes
chr10	90727333	90727334	rs1926203	Lung cancer
chr10	90749962	90749963	rs1800682	Chronic lymphocytic leukemia
chr10	90759723	90759724	rs4406737	Chronic lymphocytic leukemia
chr10	90771828	90771829	rs2234978	Immunoglobulin A
chr10	90818376	90818377	rs7920888	Obesity-related traits
chr10	90826778	90826779	rs1937332	Atrioventricular conduction
chr10	90964613	90964614	rs11203032	Heart failure
chr10	91002926	91002927	rs1412444	Coronary heart disease
chr10	91372532	91372533	rs11185790	Metabolic traits
chr10	91962669	91962670	rs2250245	Economic and political preferences (feminism/equality)
chr10	91963462	91963463	rs2250149	Economic and political preferences (feminism/equality)
chr10	92632898	92632899	rs4586057	Economic and political preferences (time)
chr10	93348119	93348120	rs1329650	Smoking behavior
chr10	94168796	94168797	rs2263638	Airflow obstruction
chr10	94347829	94347830	rs6583826	Type 2 diabetes
chr10	94436850	94436851	rs7911264	Inflammatory bowel disease
chr10	94462881	94462882	rs1111875	Type 2 diabetes
chr10	94465558	94465559	rs5015480	Type 2 diabetes
chr10	94481916	94481917	rs7923837	Multiple sclerosis
chr10	94485210	94485211	rs2497306	Dehydroepiandrosterone sulphate levels
chr10	94839641	94839642	rs2068888	Triglycerides
chr10	94924323	94924324	rs10882165	Refractive error
chr10	95348181	95348182	rs10882272	Retinol levels
chr10	95895176	95895177	rs9663362	Blood pressure
chr10	95895939	95895940	rs932764	Systolic blood pressure
chr10	95895939	95895940	rs932764	Hypertension
chr10	95895939	95895940	rs932764	Diastolic blood pressure
chr10	96013704	96013705	rs9419788	Personality dimensions
chr10	96035979	96035980	rs11187837	Sudden cardiac arrest
chr10	96058297	96058298	rs3765524	Dengue shock syndrome
chr10	96058297	96058298	rs3765524	Esophageal cancer and gastric cancer
chr10	96058635	96058636	rs117607728	Chronic obstructive pulmonary disease
chr10	96066340	96066341	rs2274223	Esophageal cancer
chr10	96070374	96070375	rs3781264	Esophageal cancer and gastric cancer
chr10	96405328	96405329	rs12772169	Acenocoumarol maintenance dosage
chr10	96405501	96405502	rs12777823	Warfarin maintenance dose
chr10	96405501	96405502	rs12777823	Response to clopidogrel therapy
chr10	96534262	96534263	rs6583954	Migraine
chr10	96547462	96547463	rs12767583	Acenocoumarol maintenance dosage
chr10	96702046	96702047	rs1799853	Warfarin maintenance dose
chr10	96707201	96707202	rs4086116	Warfarin maintenance dose
chr10	96734338	96734339	rs10509680	Warfarin maintenance dose
chr10	96741052	96741053	rs1057910	Warfarin maintenance dose
chr10	96751269	96751270	rs2185570	Dehydroepiandrosterone sulphate levels
chr10	96766933	96766934	rs2860975	Immune response to smallpox vaccine (IL-6)
chr10	96792201	96792202	rs1934954	Tuberculosis
chr10	96797469	96797470	rs1934953	Immune response to smallpox vaccine (IL-6)
chr10	96798547	96798548	rs1934951	Osteonecrosis of the jaw
chr10	96852689	96852690	rs72820627	Response to amphetamines
chr10	97122240	97122241	rs4918918	Suicide risk
chr10	97196977	97196978	rs2274491	Migraine - clinic-based
chr10	97229761	97229762	rs579342	Obesity-related traits
chr10	97295588	97295589	rs12772243	IgG glycosylation
chr10	97301003	97301004	rs11188352	IgG glycosylation
chr10	98135504	98135505	rs10786284	Attention deficit hyperactivity disorder
chr10	98417929	98417930	rs7098785	Orthostatic hypotension
chr10	98432702	98432703	rs7895244	IgG glycosylation
chr10	98639845	98639846	rs17112190	Multiple myeloma (IgH translocation)
chr10	98800098	98800099	rs3824789	Obesity-related traits
chr10	98908732	98908733	rs7072055	IgG glycosylation
chr10	99294796	99294797	rs12767760	Obesity-related traits
chr10	99359738	99359739	rs2297644	Metabolite levels
chr10	99637577	99637578	rs531676	Metabolic syndrome
chr10	100127550	100127551	rs17109512	Aspartate aminotransferase
chr10	100147059	100147060	rs4345897	Metabolite levels
chr10	100156852	100156853	rs7072216	Metabolite levels
chr10	100170382	100170383	rs6584202	Obesity-related traits
chr10	100291175	100291176	rs577969	Migraine
chr10	100300181	100300182	rs10786436	Type 1 diabetes
chr10	100580122	100580123	rs17470570	Migraine without aura
chr10	100583914	100583915	rs2801405	Obesity-related traits
chr10	100646180	100646181	rs11189853	Migraine without aura
chr10	100855701	100855702	rs12570188	Asthma (childhood onset)
chr10	101157437	101157438	rs76850691	Liver enzyme levels (aspartate transaminase)
chr10	101274364	101274365	rs7078219	Dental caries
chr10	101282199	101282200	rs11190134	Red blood cell traits
chr10	101284236	101284237	rs4409764	Inflammatory bowel disease
chr10	101284236	101284237	rs4409764	Crohn's disease
chr10	101287763	101287764	rs10883365	Crohn's disease
chr10	101290300	101290301	rs6584283	Ulcerative colitis
chr10	101291592	101291593	rs11190140	Ulcerative colitis
chr10	101291592	101291593	rs11190140	Crohn's disease
chr10	101292389	101292390	rs11190141	Crohn's disease
chr10	101365312	101365313	rs11190179	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr10	101492402	101492403	rs2281636	Obesity-related traits
chr10	101795360	101795361	rs10883437	Liver enzyme levels (alanine transaminase)
chr10	101805441	101805442	rs11599750	Height
chr10	101813801	101813802	rs7084921	Bone mineral density
chr10	101861434	101861435	rs11597390	Liver enzyme levels
chr10	102066184	102066185	rs17112901	Obesity-related traits
chr10	102075478	102075479	rs603424	Palmitoleic acid (16:1n-7) plasma levels
chr10	102075478	102075479	rs603424	Palmitic acid (16:0) plasma levels
chr10	102075478	102075479	rs603424	Phospholipid levels (plasma)
chr10	102075478	102075479	rs603424	Metabolic traits
chr10	102256196	102256197	rs9420790	Thiazide-induced adverse metabolic effects in hypertensive patients
chr10	102302456	102302457	rs11190604	Palmitoleic acid (16:1n-7) plasma levels
chr10	102501570	102501571	rs4509693	Alzheimer's disease
chr10	102979206	102979207	rs11190870	Scoliosis
chr10	103698704	103698705	rs34014631	Coronary artery calcification
chr10	104207798	104207799	rs927821	Social autistic-like traits
chr10	104414220	104414221	rs3850699	Prostate cancer
chr10	104591392	104591393	rs17115100	Parkinson's disease
chr10	104594506	104594507	rs1004467	Systolic blood pressure
chr10	104595848	104595849	rs3824755	Blood pressure
chr10	104628872	104628873	rs7085104	Schizophrenia
chr10	104660003	104660004	rs11191454	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	104662457	104662458	rs7897654	Schizophrenia
chr10	104719095	104719096	rs12413409	Coronary heart disease
chr10	104719095	104719096	rs12413409	Intracranial aneurysm
chr10	104748717	104748718	rs1890185	Migraine
chr10	104775907	104775908	rs7914558	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	104775907	104775908	rs7914558	Schizophrenia
chr10	104846177	104846178	rs11191548	Systolic blood pressure
chr10	104846177	104846178	rs11191548	Blood pressure
chr10	104906210	104906211	rs11191580	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	104906210	104906211	rs11191580	Schizophrenia
chr10	104939214	104939215	rs11191593	Blood pressure
chr10	105033014	105033015	rs1712517	Migraine
chr10	105257785	105257786	rs7071247	Platelet aggregation
chr10	105297769	105297770	rs7069733	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr10	105647094	105647095	rs3814219	Endothelial function traits
chr10	105672841	105672842	rs11191865	Interstitial lung disease
chr10	105675945	105675946	rs9419958	Telomere length
chr10	105676464	105676465	rs9420907	Telomere length
chr10	105677896	105677897	rs4387287	Telomere length
chr10	105714398	105714399	rs7913069	Uterine fibroids
chr10	105846073	105846074	rs1320448	Cardiac hypertrophy
chr10	105884115	105884116	rs10883969	Preeclampsia
chr10	105966403	105966404	rs515910	Attention deficit hyperactivity disorder
chr10	107516351	107516352	rs17119461	Melanoma
chr10	108254463	108254464	rs2039964	Metabolite levels (MHPG)
chr10	108498077	108498078	rs2486152	Metabolite levels (Pyroglutamine)
chr10	109374383	109374384	rs11193561	Endometriosis
chr10	109569849	109569850	rs12570947	Prion diseases
chr10	109626065	109626066	rs1834180	Social communication problems
chr10	110971434	110971435	rs17783561	IgG glycosylation
chr10	111735749	111735750	rs17095355	Biliary atresia
chr10	112006485	112006486	rs716595	Normalized brain volume
chr10	112036974	112036975	rs11195062	Multiple myeloma
chr10	112186147	112186148	rs11195128	Crohn's disease
chr10	112877800	112877801	rs2065779	Insomnia (caffeine-induced)
chr10	112909104	112909105	rs869244	Platelet aggregation
chr10	113042092	113042093	rs10885122	Fasting glucose-related traits (interaction with BMI)
chr10	113042092	113042093	rs10885122	Fasting glucose-related traits
chr10	113933885	113933886	rs2255141	LDL cholesterol
chr10	113933885	113933886	rs2255141	Cholesterol, total
chr10	114202525	114202526	rs12355831	Migraine
chr10	114388271	114388272	rs17267338	Multiple sclerosis
chr10	114498475	114498476	rs7086803	Lung cancer
chr10	114734095	114734096	rs11196174	Breast Cancer in BRCA1 mutation carriers
chr10	114754087	114754088	rs7901695	Coronary heart disease
chr10	114754087	114754088	rs7901695	Type 2 diabetes
chr10	114756040	114756041	rs4506565	Fasting glucose-related traits
chr10	114756040	114756041	rs4506565	Type 2 diabetes
chr10	114758348	114758349	rs7903146	Type 2 diabetes
chr10	114758348	114758349	rs7903146	Fasting insulin-related traits (interaction with BMI)
chr10	114758348	114758349	rs7903146	Fasting glucose-related traits (interaction with BMI)
chr10	114758348	114758349	rs7903146	Proinsulin levels
chr10	114758348	114758349	rs7903146	Glycated hemoglobin levels
chr10	114758348	114758349	rs7903146	Metabolic syndrome
chr10	114758348	114758349	rs7903146	Type 2 diabetes and other traits
chr10	114773926	114773927	rs7904519	Breast cancer
chr10	114788814	114788815	rs12243326	Two-hour glucose challenge
chr10	114877866	114877867	rs74157220	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr10	115235113	115235114	rs1472750	Myopia (pathological)
chr10	115238763	115238764	rs17770015	Migraine without aura
chr10	115481017	115481018	rs3814231	Vitiligo
chr10	115515119	115515120	rs3981351	Obesity-related traits
chr10	115756129	115756130	rs82625	Gaucher disease severity
chr10	115781526	115781527	rs2782980	Blood pressure
chr10	115805055	115805056	rs1801253	Birth weight
chr10	115814391	115814392	rs10885531	Adiponectin levels
chr10	116139028	116139029	rs4751674	Cognitive performance
chr10	116199174	116199175	rs941853	Obesity-related traits
chr10	116327549	116327550	rs10885582	Prostate cancer (gene x gene interaction)
chr10	117512587	117512588	rs10490919	Information processing speed
chr10	117824887	117824888	rs2302105	IgG glycosylation
chr10	117973596	117973597	rs12413355	Migraine with aura
chr10	118397970	118397971	rs10885997	Phospholipid levels (plasma)
chr10	118487099	118487100	rs1665650	Colorectal cancer
chr10	118575605	118575606	rs740363	Heart failure
chr10	118827559	118827560	rs7078160	Orofacial clefts
chr10	119181870	119181871	rs181500	Bipolar disorder and schizophrenia
chr10	119210374	119210375	rs6585436	Cardiac repolarization
chr10	119227341	119227342	rs4752066	Pulmonary function in asthmatics
chr10	119336745	119336746	rs384627	Obesity-related traits
chr10	119379655	119379656	rs181654	Airflow obstruction
chr10	119418103	119418104	rs2184898	Conduct disorder (case status)
chr10	119533756	119533757	rs7088969	Homeostasis model assessment of beta-cell function (interaction)
chr10	119604937	119604938	rs1925265	Metabolite levels (MHPG)
chr10	119613609	119613610	rs10886159	Celiac disease
chr10	120278943	120278944	rs12413624	Pancreatic cancer
chr10	120966338	120966339	rs1397615	Obesity-related traits
chr10	121149402	121149403	rs10886471	Type 2 diabetes
chr10	121429632	121429633	rs2234962	Dilated cardiomyopathy
chr10	121821537	121821538	rs17621444	IgG glycosylation
chr10	122043488	122043489	rs11199254	IgG glycosylation
chr10	122279475	122279476	rs118048115	Alzheimer's disease (cognitive decline)
chr10	122591372	122591373	rs2919009	Obesity-related traits
chr10	122720973	122720974	rs4752485	Pulmonary function decline
chr10	122900622	122900623	rs2901286	Response to treatment for acute lymphoblastic leukemia
chr10	122939373	122939374	rs7085142	Visceral fat
chr10	122945085	122945086	rs3943077	Adiponectin levels
chr10	123032518	123032519	rs11199874	Prostate cancer
chr10	123033548	123033549	rs10788160	Serum prostate-specific antigen levels
chr10	123093900	123093901	rs11199914	Breast cancer
chr10	123280657	123280658	rs3135753	Gout
chr10	123332576	123332577	rs3750817	Breast cancer
chr10	123337334	123337335	rs2981579	Breast cancer
chr10	123338974	123338975	rs1078806	Breast cancer
chr10	123340310	123340311	rs2981578	Breast cancer
chr10	123346115	123346116	rs2981575	Breast cancer in BRCA2 mutation carriers
chr10	123346189	123346190	rs1219648	Breast cancer
chr10	123352316	123352317	rs2981582	Breast cancer
chr10	123625189	123625190	rs10510102	Breast cancer
chr10	123851826	123851827	rs11200392	Obesity-related traits
chr10	123913329	123913330	rs17103138	Myopia (pathological)
chr10	124165614	124165615	rs6585827	Height
chr10	124214447	124214448	rs10490924	Age-related macular degeneration
chr10	124214447	124214448	rs10490924	Age-related macular degeneration (GA)
chr10	124214447	124214448	rs10490924	Age-related macular degeneration (CNV)
chr10	124214447	124214448	rs10490924	Age-related macular degeneration (CNV vs. GA)
chr10	124215314	124215315	rs3750848	Age-related macular degeneration (extreme sampling)
chr10	124219274	124219275	rs3793917	Age-related macular degeneration
chr10	124220543	124220544	rs11200638	Age-related macular degeneration (wet)
chr10	124729875	124729876	rs7069346	Migraine without aura
chr10	124887124	124887125	rs61862032	Periodontitis (Mean PAL)
chr10	124988152	124988153	rs11597068	Menopause (age at onset)
chr10	125207500	125207501	rs17666963	Cardiac Troponin-T levels
chr10	125251674	125251675	rs705162	Migraine
chr10	126144178	126144179	rs2459210	Hemostatic factors and hematological phenotypes
chr10	126144838	126144839	rs908366	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
chr10	126275913	126275914	rs12773846	Subcutaneous adipose tissue
chr10	126294166	126294167	rs3740540	Obesity-related traits
chr10	126426147	126426148	rs2629540	Cocaine dependence
chr10	126438018	126438019	rs10510138	Obesity-related traits
chr10	126696871	126696872	rs4962416	Prostate cancer
chr10	127135837	127135838	rs989507	Obesity-related traits
chr10	127699935	127699936	rs10901513	Visceral fat
chr10	127823150	127823151	rs1278329	Metabolite levels (5-HIAA/ MHPG Ratio)
chr10	127829011	127829012	rs1551678	Thiazide-induced adverse metabolic effects in hypertensive patients
chr10	127846668	127846669	rs12778749	Endometrial cancer
chr10	128267639	128267640	rs11245052	Metabolite levels (MHPG)
chr10	128777389	128777390	rs9733352	Apolipoprotein Levels
chr10	129274502	129274503	rs4363506	Amyotrophic lateral sclerosis
chr10	129678673	129678674	rs6482992	Parkinson's disease (motor and cognition)
chr10	129737630	129737631	rs12049671	Response to amphetamines
chr10	129933455	129933456	rs2387326	Select biomarker traits
chr10	129998371	129998372	rs1329189	Orofacial clefts
chr10	130137104	130137105	rs11818629	HIV-1 control
chr10	130233807	130233808	rs10764775	IgG glycosylation
chr10	130248925	130248926	rs9804317	Cognitive performance
chr10	130369489	130369490	rs749141	Serum dimethylarginine levels (symmetric)
chr10	130383237	130383238	rs193189882	Serum dimethylarginine levels (asymmetric)
chr10	131234371	131234372	rs2388328	Metabolite levels  (X-11787)
chr10	131426021	131426022	rs477692	Response to temozolomide
chr10	131500939	131500940	rs11016883	Waist-to-hip circumference ratio (interaction)
chr10	131673985	131673986	rs9804200	Sleep time
chr10	131992244	131992245	rs4751178	Speech perception in dyslexia
chr10	132056414	132056415	rs4751185	HIV-1 susceptibility
chr10	132168064	132168065	rs11017221	Migraine
chr10	132547260	132547261	rs4750829	Obesity-related traits
chr10	132637304	132637305	rs7094308	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr10	132747886	132747887	rs10829848	Insulin-related traits
chr10	132947961	132947962	rs10741243	Type 2 diabetes
chr10	133172118	133172119	rs10734105	Crohn's disease
chr10	133330025	133330026	rs11018023	Temperament
chr10	133957760	133957761	rs954820	Chronic obstructive pulmonary disease-related biomarkers
chr10	134295814	134295815	rs73389468	Periodontitis (CDC/AAP)
chr10	135306157	135306158	rs1536827	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr10	135352152	135352153	rs2249694	Obesity-related traits
chr11	202855	202856	rs11602954	Platelet counts
chr11	202855	202856	rs11602954	Bone mineral density
chr11	202855	202856	rs11602954	Mean platelet volume
chr11	203787	203788	rs2280543	Intracranial aneurysm
chr11	203787	203788	rs2280543	Uterine fibroids
chr11	243267	243268	rs505404	Platelet counts
chr11	270714	270715	rs17655730	Mean platelet volume
chr11	589563	589564	rs4963128	Systemic lupus erythematosus
chr11	601784	601785	rs2396545	Systemic lupus erythematosus and Systemic sclerosis
chr11	831882	831883	rs35694355	Obesity-related traits
chr11	941940	941941	rs10751667	Alzheimer's disease (late onset)
chr11	1093944	1093945	rs7934606	Interstitial lung disease
chr11	1874071	1874072	rs907611	Bladder cancer
chr11	1874071	1874072	rs907611	Inflammatory bowel disease
chr11	1874071	1874072	rs907611	Ulcerative colitis
chr11	1909005	1909006	rs3817198	Breast cancer
chr11	1941945	1941946	rs909116	Breast cancer
chr11	1985126	1985127	rs10769945	DNA methylation (variation)
chr11	2024543	2024544	rs4930103	DNA methylation (variation)
chr11	2024543	2024544	rs4930103	DNA methylation (parent-of-origin)
chr11	2048487	2048488	rs4930144	Celiac disease
chr11	2138138	2138139	rs6578985	Femoral neck bone geometry and menarche (age at onset)
chr11	2169773	2169774	rs3741208	Type 1 diabetes
chr11	2170142	2170143	rs1004446	Type 1 diabetes autoantibodies
chr11	2170142	2170143	rs1004446	Type 1 diabetes
chr11	2182223	2182224	rs689	Type 1 diabetes autoantibodies
chr11	2213165	2213166	rs7111341	Type 1 diabetes
chr11	2233573	2233574	rs7127900	Prostate cancer
chr11	2308761	2308762	rs2521263	Obesity-related traits
chr11	2311151	2311152	rs7944004	Chronic lymphocytic leukemia
chr11	2322828	2322829	rs11022157	Chronic lymphocytic leukemia
chr11	2484802	2484803	rs2074238	QT interval
chr11	2486119	2486120	rs16928297	QT interval
chr11	2489341	2489342	rs12296050	Electrocardiographic traits
chr11	2489341	2489342	rs12296050	QT interval
chr11	2502318	2502319	rs12576239	QT interval
chr11	2550729	2550730	rs179429	Platelet aggregation
chr11	2652656	2652657	rs10832417	Blood pressure measurement (high sodium intervention)
chr11	2691470	2691471	rs231362	Type 2 diabetes
chr11	2752608	2752609	rs231906	QT interval
chr11	2766281	2766282	rs2237878	Protein quantitative trait loci
chr11	2810730	2810731	rs2237886	Height
chr11	2831540	2831541	rs8181588	Type 2 diabetes
chr11	2839750	2839751	rs2237892	Type 2 diabetes
chr11	2844215	2844216	rs163182	Type 2 diabetes
chr11	2857193	2857194	rs2237895	Type 2 diabetes
chr11	2858545	2858546	rs2237897	Type 2 diabetes
chr11	2936951	2936952	rs16928809	Bilirubin levels
chr11	2953722	2953723	rs3847646	Calcium levels
chr11	3029088	3029089	rs7481584	Calcium levels
chr11	3036323	3036324	rs739401	Longevity
chr11	3259808	3259809	rs11026091	Multiple sclerosis
chr11	3722303	3722304	rs685782	Metabolite levels (Dihydroxy docosatrienoic acid)
chr11	4496845	4496846	rs2278170	Amyotrophic lateral sclerosis
chr11	4516575	4516576	rs10160399	Obesity-related traits
chr11	4563217	4563218	rs12416860	Obesity-related traits
chr11	4790574	4790575	rs12788102	Malaria
chr11	5029702	5029703	rs2445284	Sickle cell anemia (haemolysis)
chr11	5225446	5225447	rs7950726	HbA2 levels
chr11	5225634	5225635	rs11036238	Malaria
chr11	5230906	5230907	rs7120391	Red blood cell traits
chr11	5263852	5263853	rs16912210	Obesity-related traits
chr11	5264145	5264146	rs2071348	Beta thalassemia/hemoglobin E disease
chr11	5303062	5303063	rs2213169	Mean corpuscular hemoglobin concentration
chr11	5303062	5303063	rs2213169	Hematology traits
chr11	5306508	5306509	rs4910742	Inflammatory biomarkers
chr11	5306508	5306509	rs4910742	Fetal hemoglobin levels
chr11	5373250	5373251	rs5006884	Fetal hemoglobin levels
chr11	5471745	5471746	rs7948471	Sickle cell anemia (haemolysis)
chr11	5518155	5518156	rs372091	Malaria
chr11	5625602	5625603	rs7108470	IgG glycosylation
chr11	5688023	5688024	rs11820502	IgG glycosylation
chr11	5959756	5959757	rs3858526	DNA methylation (variation)
chr11	6522803	6522804	rs2555155	DNA methylation (variation)
chr11	7367094	7367095	rs10769780	Phospholipid levels (plasma)
chr11	7464371	7464372	rs4076555	IgG glycosylation
chr11	7701502	7701503	rs11041530	Blood pressure
chr11	7708280	7708281	rs7932813	Waist circumference
chr11	7968358	7968359	rs878860	Atopic dermatitis
chr11	8014776	8014777	rs12420464	Depression (quantitative trait)
chr11	8243797	8243798	rs11041816	Fasting glucose-related traits (interaction with BMI)
chr11	8250810	8250811	rs4758317	Alcohol consumption
chr11	8252852	8252853	rs110419	Neuroblastoma
chr11	8484088	8484089	rs10769908	Body mass index
chr11	8604592	8604593	rs4929949	Body mass index
chr11	8639199	8639200	rs4929923	Menarche (age at onset)
chr11	8662515	8662516	rs11042023	Obesity
chr11	9109286	9109287	rs2647528	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr11	9111557	9111558	rs963167	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr11	9973061	9973062	rs10500715	Pancreatic cancer
chr11	10350537	10350538	rs7129220	Systolic blood pressure
chr11	10350537	10350538	rs7129220	Diastolic blood pressure
chr11	10350537	10350538	rs7129220	Blood pressure
chr11	10368118	10368119	rs2957692	Circulating vasoactive peptide levels
chr11	10388781	10388782	rs2923084	HDL cholesterol
chr11	10390580	10390581	rs6484218	Schizophrenia, bipolar disorder and depression (combined)
chr11	10669227	10669228	rs7940646	Platelet aggregation
chr11	10673738	10673739	rs4909945	Migraine
chr11	10740365	10740366	rs2018368	Bipolar disorder and schizophrenia
chr11	11228373	11228374	rs2722769	Type 2 diabetes
chr11	11504227	11504228	rs7940423	Response to tocilizumab in rheumatoid arthritis
chr11	11983884	11983885	rs1472189	Metabolite levels (Dihydroxy docosatrienoic acid)
chr11	12070664	12070665	rs16910421	Visceral fat
chr11	12072502	12072503	rs923175	Response to taxane treatment (docetaxel)
chr11	12159660	12159661	rs1994318	PR interval
chr11	12469396	12469397	rs7120489	Mortality among heart failure patients
chr11	12698039	12698040	rs7926971	Height
chr11	13090941	13090942	rs2727405	Obesity-related traits
chr11	13293904	13293905	rs900145	Menarche (age at onset)
chr11	13331225	13331226	rs4757144	Schizophrenia
chr11	13361523	13361524	rs6486122	Plasminogen activator inhibitor type 1 levels (PAI-1)
chr11	13620171	13620172	rs9630182	Bone mineral density
chr11	13996154	13996155	rs1819084	Tuberculosis
chr11	14021638	14021639	rs2618516	Brain connectivity
chr11	14098481	14098482	rs17556665	Inflammatory biomarkers
chr11	14224345	14224346	rs11023139	Alzheimer's disease (cognitive decline)
chr11	14784109	14784110	rs11023332	Adiponectin levels
chr11	14910233	14910234	rs1993116	Vitamin D levels
chr11	14914877	14914878	rs10741657	Vitamin D insufficiency
chr11	14915309	14915310	rs2060793	Vitamin D levels
chr11	15355245	15355246	rs11605083	Prostate cancer (gene x gene interaction)
chr11	15457466	15457467	rs7114467	Menarche (age at onset)
chr11	15620585	15620586	rs17439299	Obesity-related traits
chr11	15694461	15694462	rs7117858	Bone mineral density (hip)
chr11	15710083	15710084	rs7108738	Bone mineral density
chr11	15952293	15952294	rs11023787	Wrist bone mass
chr11	16040174	16040175	rs16932455	Capecitabine sensitivity
chr11	16250182	16250183	rs1401454	Blood pressure
chr11	16389593	16389594	rs297325	Obesity and osteoporosis
chr11	16403510	16403511	rs4756846	Obesity and osteoporosis
chr11	16902267	16902268	rs381815	Blood pressure
chr11	16902267	16902268	rs381815	Systolic blood pressure
chr11	16917218	16917219	rs11024074	Diastolic blood pressure
chr11	17008604	17008605	rs11024102	Glaucoma (primary open-angle)
chr11	17160147	17160148	rs4356203	Schizophrenia or bipolar disorder
chr11	17160147	17160148	rs4356203	Schizophrenia
chr11	17316028	17316029	rs1330	Height
chr11	17408629	17408630	rs5215	Type 2 diabetes
chr11	17409571	17409572	rs5219	Type 2 diabetes
chr11	17796110	17796111	rs60349741	Opioid sensitivity
chr11	18265798	18265799	rs12282742	Bipolar disorder and schizophrenia
chr11	18285773	18285774	rs4638289	Amyloid A serum levels
chr11	18323516	18323517	rs4353250	Amyloid A serum levels
chr11	18325145	18325146	rs2403254	Metabolic traits
chr11	18370897	18370898	rs4150642	Amyloid A serum levels
chr11	18384937	18384938	rs9783347	Pancreatic cancer
chr11	18419805	18419806	rs2896526	Amyloid A serum levels
chr11	18632983	18632984	rs10128711	Cholesterol, total
chr11	18689652	18689653	rs12295403	Ovarian reserve
chr11	18822036	18822037	rs4627050	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
chr11	19051871	19051872	rs7111562	IgG glycosylation
chr11	19569562	19569563	rs874426	Attention deficit hyperactivity disorder (time to onset)
chr11	19584501	19584502	rs10500856	Obesity-related traits
chr11	19599970	19599971	rs10741780	HIV-1 susceptibility
chr11	20356443	20356444	rs7128099	Obesity-related traits
chr11	20378123	20378124	rs11025523	Obesity-related traits
chr11	20562518	20562519	rs7128311	Response to treatment for acute lymphoblastic leukemia
chr11	20623022	20623023	rs2241941	Obesity-related traits
chr11	20698928	20698929	rs1793004	Crohn's disease
chr11	20984204	20984205	rs61883261	Response to amphetamines
chr11	21058730	21058731	rs4569005	Adverse response to lamotrigine and phenytoin
chr11	21565078	21565079	rs12279250	Thiazide-induced adverse metabolic effects in hypertensive patients
chr11	21620947	21620948	rs1573535	Cannabis use (initiation)
chr11	21669292	21669293	rs10833583	Obesity-related traits
chr11	21677341	21677342	rs2051457	Obesity-related traits
chr11	21896879	21896880	rs11026318	Multiple myeloma (hyperdiploidy)
chr11	22114092	22114093	rs11026412	Parkinson's disease
chr11	22312565	22312566	rs11827962	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr11	22829756	22829757	rs7111546	Dialysis-related mortality
chr11	22843154	22843155	rs712022	Dialysis-related mortality
chr11	23044591	23044592	rs10833905	Sudden cardiac arrest
chr11	24252527	24252528	rs16912285	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr11	24611129	24611130	rs12361953	Alzheimer's disease (late onset)
chr11	24678818	24678819	rs4561213	Magnesium levels
chr11	24739803	24739804	rs10834449	Intelligence
chr11	24740433	24740434	rs2716458	Intelligence
chr11	24741658	24741659	rs12798374	Intelligence
chr11	24741756	24741757	rs1021261	Intelligence
chr11	24849565	24849566	rs10500991	Iron status biomarkers
chr11	25207703	25207704	rs12794435	Ovarian cancer
chr11	25490481	25490482	rs10834691	IgG glycosylation
chr11	26605330	26605331	rs12295638	Obesity (extreme)
chr11	27505676	27505677	rs10835187	Bone mineral density
chr11	27563381	27563382	rs988712	Obesity
chr11	27583128	27583129	rs7481311	Weight
chr11	27583128	27583129	rs7481311	Body mass index
chr11	27667201	27667202	rs925946	Weight
chr11	27667201	27667202	rs925946	Body mass index
chr11	27679915	27679916	rs6265	Smoking behavior
chr11	27679915	27679916	rs6265	Weight
chr11	27679915	27679916	rs6265	Body mass index
chr11	27725985	27725986	rs10767664	Body mass index
chr11	27728538	27728539	rs2030323	Obesity
chr11	27728538	27728539	rs2030323	Body mass index
chr11	28009462	28009463	rs1568889	Bipolar disorder
chr11	28233767	28233768	rs11601602	Obesity-related traits
chr11	29162135	29162136	rs1602565	Schizophrenia
chr11	29195136	29195137	rs1491818	Amyotrophic lateral sclerosis (age of onset)
chr11	30382898	30382899	rs12294104	Menopause (age at onset)
chr11	30467499	30467500	rs11031093	Dental caries
chr11	30508107	30508108	rs545610	Dental caries
chr11	30749089	30749090	rs963837	Renal function-related traits (sCR)
chr11	30749089	30749090	rs963837	Renal function-related traits (eGRFcrea)
chr11	30760334	30760335	rs3925584	Chronic kidney disease
chr11	30760334	30760335	rs3925584	Magnesium levels
chr11	30768677	30768678	rs10767873	Renal function-related traits (BUN)
chr11	30951673	30951674	rs163879	Bone mineral density
chr11	31210770	31210771	rs16921914	Bone mineral density (spine)
chr11	31884918	31884919	rs11031492	Metabolite levels (HVA/5-HIAA ratio)
chr11	31905533	31905534	rs652722	Body mass index
chr11	32364186	32364187	rs2057178	Tuberculosis
chr11	32522006	32522007	rs10767942	Attention deficit hyperactivity disorder
chr11	32895663	32895664	rs10767971	Parkinson's disease (age of onset)
chr11	33588209	33588210	rs10437629	Suicide attempts in bipolar disorder
chr11	33806821	33806822	rs11825259	Coronary artery calcification
chr11	33868606	33868607	rs11032423	Cognitive performance
chr11	34555190	34555191	rs836132	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr11	34605434	34605435	rs5028798	Volumetric brain MRI
chr11	34655362	34655363	rs286913	Response to antipsychotic treatment
chr11	34662960	34662961	rs286905	Obesity-related traits
chr11	34764478	34764479	rs1355223	Systemic lupus erythematosus and Systemic sclerosis
chr11	34805848	34805849	rs7929679	Chronic obstructive pulmonary disease-related biomarkers
chr11	34834203	34834204	rs12793173	Cystic fibrosis severity
chr11	35093069	35093070	rs2785197	Systemic lupus erythematosus
chr11	35123050	35123051	rs1559759	Thiazide-induced adverse metabolic effects in hypertensive patients
chr11	35155731	35155732	rs2785173	Response to Vitamin E supplementation
chr11	35280851	35280852	rs10768122	Vitiligo
chr11	35329614	35329615	rs3794087	Essential tremor
chr11	35495440	35495441	rs1996369	Relative hand skill in reading disability
chr11	35539268	35539269	rs650950	Bronchopulmonary dysplasia
chr11	35701235	35701236	rs7928794	Response to antipsychotic therapy (extrapyramidal side effects)
chr11	37012536	37012537	rs391317	Inflammatory biomarkers
chr11	37870980	37870981	rs16930685	Cutaneous nevi
chr11	38278949	38278950	rs5004866	Metabolite levels (MHPG)
chr11	38285500	38285501	rs10836945	Bronchopulmonary dysplasia
chr11	38288592	38288593	rs11034653	Immune reponse to smallpox (secreted IL-12p40)
chr11	39327958	39327959	rs12808199	Osteoporosis
chr11	39908661	39908662	rs11035577	Temperament (bipolar disorder)
chr11	40837712	40837713	rs4611189	Response to antipsychotic treatment in schizophrenia (reasoning)
chr11	41225432	41225433	rs2862035	IgG glycosylation
chr11	41225953	41225954	rs980952	IgG glycosylation
chr11	41852663	41852664	rs1484948	RR interval (heart rate)
chr11	41915365	41915366	rs9300039	Type 2 diabetes
chr11	42315885	42315886	rs7394570	Immune response to smallpox vaccine (IL-6)
chr11	42874001	42874002	rs4129601	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr11	43086093	43086094	rs10501293	Cognitive performance
chr11	43236060	43236061	rs12365397	Migraine
chr11	43728329	43728330	rs11037575	Neuroblastoma
chr11	44378155	44378156	rs11037965	Blood pressure measurement (high sodium intervention)
chr11	44603327	44603328	rs730129	Hemostatic factors and hematological phenotypes
chr11	44843133	44843134	rs11038167	Schizophrenia
chr11	45084530	45084531	rs7951911	IgG glycosylation
chr11	45227566	45227567	rs17723470	Thyroid hormone levels
chr11	45528115	45528116	rs1488665	Obesity-related traits
chr11	45813580	45813581	rs12285276	Visceral fat
chr11	45873090	45873091	rs11605924	Fasting glucose-related traits (interaction with BMI)
chr11	45873090	45873091	rs11605924	Fasting glucose-related traits
chr11	45947463	45947464	rs10838532	Axial length
chr11	46052574	46052575	rs16938437	Menarche (age at onset)
chr11	46379441	46379442	rs11038871	Immunoglobulin A
chr11	46722220	46722221	rs7932354	Bone mineral density
chr11	46722220	46722221	rs7932354	Bone mineral density (hip)
chr11	46743246	46743247	rs3136441	HDL cholesterol
chr11	46849359	46849360	rs1007738	Bone mineral density (hip)
chr11	46893107	46893108	rs2306029	D-dimer levels
chr11	47127152	47127153	rs7117404	D-dimer levels
chr11	47275063	47275064	rs10838681	Metabolic syndrome
chr11	47286289	47286290	rs7120118	HDL cholesterol
chr11	47293798	47293799	rs10501320	Proinsulin levels
chr11	47312891	47312892	rs10838687	Proinsulin levels
chr11	47336319	47336320	rs7944584	Fasting glucose-related traits (interaction with BMI)
chr11	47336319	47336320	rs7944584	Fasting glucose-related traits
chr11	47440757	47440758	rs2293579	Serum albumin level
chr11	47441512	47441513	rs10838708	Height
chr11	47557870	47557871	rs10838725	Alzheimer's disease (late onset)
chr11	47650992	47650993	rs3817334	Body mass index
chr11	47663048	47663049	rs10838738	Body mass index
chr11	48091302	48091303	rs10838798	Height
chr11	48098279	48098280	rs10838801	Height
chr11	48115088	48115089	rs3942852	Acute lymphoblastic leukemia (childhood)
chr11	48207258	48207259	rs11039571	D-dimer levels
chr11	48332027	48332028	rs12282928	Migraine - clinic-based
chr11	48333359	48333360	rs1483121	Fasting glucose-related traits (interaction with BMI)
chr11	48382470	48382471	rs1351696	D-dimer levels
chr11	48518892	48518893	rs7395662	HDL cholesterol
chr11	48540222	48540223	rs11039798	Axial length
chr11	49559171	49559172	rs1814175	Height
chr11	51414217	51414218	rs5017948	Height
chr11	51512089	51512090	rs11246602	HDL cholesterol
chr11	55136218	55136219	rs7927370	Systemic lupus erythematosus
chr11	55862090	55862091	rs2945816	Phospholipid levels (plasma)
chr11	55895744	55895745	rs2220004	Odorant perception (B-damascenone)
chr11	56019924	56019925	rs17150243	Obesity-related traits
chr11	56175670	56175671	rs1945213	Acute lymphoblastic leukemia (childhood)
chr11	56242260	56242261	rs7939886	Myopia (pathological)
chr11	56440235	56440236	rs11228719	Orofacial clefts
chr11	56466098	56466099	rs1397048	Hemostatic factors and hematological phenotypes
chr11	57203008	57203009	rs11229030	Crohn's disease
chr11	57365722	57365723	rs28362944	Obesity-related traits
chr11	58060191	58060192	rs12289961	Lymphoma
chr11	58339123	58339124	rs10896794	Inflammatory bowel disease
chr11	58347764	58347765	rs948562	Lymphoma
chr11	58472798	58472799	rs2507838	Body mass (lean)
chr11	59224143	59224144	rs7943953	Odorant perception (B-ionone)
chr11	59633492	59633493	rs526934	Folate pathway vitamin levels
chr11	59837191	59837192	rs2298585	Vitamin B12 levels
chr11	59923507	59923508	rs983392	Alzheimer's disease (late onset)
chr11	59939306	59939307	rs610932	Alzheimer's disease
chr11	59997665	59997666	rs600550	Lipoprotein-associated phospholipase A2 activity and mass
chr11	60023086	60023087	rs1562990	Alzheimer's disease
chr11	60034428	60034429	rs4938933	Alzheimer's disease (late onset)
chr11	60312862	60312863	rs1941027	Metabolite levels  (X-11787)
chr11	60592275	60592276	rs595018	Wegener's granulomatosis
chr11	60760611	60760612	rs17824933	Multiple sclerosis
chr11	60776208	60776209	rs11230563	Inflammatory bowel disease
chr11	60793650	60793651	rs4939490	Multiple sclerosis
chr11	60832281	60832282	rs650258	Multiple sclerosis
chr11	61417471	61417472	rs1692120	Phospholipid levels (plasma)
chr11	61490485	61490486	rs198426	Phospholipid levels (plasma)
chr11	61494326	61494327	rs4963243	Immune reponse to smallpox (secreted IL-2)
chr11	61551355	61551356	rs174535	Phospholipid levels (plasma)
chr11	61551926	61551927	rs174536	Phospholipid levels (plasma)
chr11	61557802	61557803	rs102275	Stearic acid (18:0) plasma levels
chr11	61557802	61557803	rs102275	Palmitoleic acid (16:1n-7) plasma levels
chr11	61557802	61557803	rs102275	Oleic acid (18:1n-9) plasma levels
chr11	61557802	61557803	rs102275	Metabolite levels
chr11	61557802	61557803	rs102275	Phospholipid levels (plasma)
chr11	61557802	61557803	rs102275	Crohn's disease
chr11	61557802	61557803	rs102275	Metabolic syndrome
chr11	61560080	61560081	rs174538	Phospholipid levels (plasma)
chr11	61564298	61564299	rs4246215	Inflammatory bowel disease
chr11	61564298	61564299	rs4246215	Platelet counts
chr11	61564298	61564299	rs4246215	Phospholipid levels (plasma)
chr11	61565907	61565908	rs174541	Metabolite levels
chr11	61569829	61569830	rs174546	Triglycerides
chr11	61569829	61569830	rs174546	LDL cholesterol
chr11	61569829	61569830	rs174546	HDL cholesterol
chr11	61569829	61569830	rs174546	Cholesterol, total
chr11	61569829	61569830	rs174546	Metabolic syndrome
chr11	61570782	61570783	rs174547	Comprehensive strength and appendicular lean mass
chr11	61570782	61570783	rs174547	Lipid metabolism phenotypes
chr11	61570782	61570783	rs174547	Metabolic traits
chr11	61570782	61570783	rs174547	Phospholipid levels (plasma)
chr11	61570782	61570783	rs174547	Resting heart rate
chr11	61570782	61570783	rs174547	Metabolite levels
chr11	61570782	61570783	rs174547	Triglycerides
chr11	61570782	61570783	rs174547	HDL cholesterol
chr11	61571347	61571348	rs174548	Hematology traits
chr11	61571347	61571348	rs174548	Triglycerides
chr11	61571347	61571348	rs174548	HDL cholesterol
chr11	61571347	61571348	rs174548	Metabolite levels
chr11	61571381	61571382	rs174549	Heart rate
chr11	61571381	61571382	rs174549	Metabolite levels
chr11	61571381	61571382	rs174549	Comprehensive strength and appendicular lean mass
chr11	61571477	61571478	rs174550	Fasting glucose-related traits (interaction with BMI)
chr11	61571477	61571478	rs174550	Phospholipid levels (plasma)
chr11	61571477	61571478	rs174550	Fasting glucose-related traits
chr11	61597211	61597212	rs174570	LDL cholesterol
chr11	61597211	61597212	rs174570	HDL cholesterol
chr11	61597211	61597212	rs174570	Cholesterol, total
chr11	61597971	61597972	rs1535	Phospholipid levels (plasma)
chr11	61597971	61597972	rs1535	Metabolic syndrome
chr11	61597971	61597972	rs1535	Response to statin therapy
chr11	61600341	61600342	rs174574	Phospholipid levels (plasma)
chr11	61609749	61609750	rs174583	Response to statin therapy
chr11	61623139	61623140	rs174601	Liver enzyme levels (alkaline phosphatase)
chr11	61639572	61639573	rs174448	Phospholipid levels (plasma)
chr11	61655304	61655305	rs1000778	Sphingolipid levels
chr11	61663690	61663691	rs174468	Phospholipid levels (plasma)
chr11	61678753	61678754	rs174479	Sphingolipid levels
chr11	61711474	61711475	rs2521572	Phospholipid levels (plasma)
chr11	61712130	61712131	rs2727261	Estradiol levels
chr11	61722644	61722645	rs1109748	Phospholipid levels (plasma)
chr11	61746290	61746291	rs10792320	Phospholipid levels (plasma)
chr11	61795585	61795586	rs11230874	Phospholipid levels (plasma)
chr11	61815802	61815803	rs4963452	Phospholipid levels (plasma)
chr11	62103419	62103420	rs2463822	Chronic obstructive pulmonary disease-related biomarkers
chr11	62186541	62186542	rs3741240	Chronic obstructive pulmonary disease-related biomarkers
chr11	62197426	62197427	rs2077224	Chronic obstructive pulmonary disease-related biomarkers
chr11	62199816	62199817	rs17157266	Chronic obstructive pulmonary disease-related biomarkers
chr11	62771387	62771388	rs11231299	Visceral fat
chr11	63173683	63173684	rs7101446	Economic and political preferences
chr11	63592620	63592621	rs10897449	Electroencephalographic traits in alcoholism
chr11	63666943	63666944	rs12099085	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)
chr11	63963946	63963947	rs11607165	Attention deficit hyperactivity disorder
chr11	63979642	63979643	rs12575642	Attention deficit hyperactivity disorder
chr11	63991800	63991801	rs1059440	Attention deficit hyperactivity disorder
chr11	64048911	64048912	rs477895	Mean platelet volume
chr11	64097232	64097233	rs694739	Crohn's disease
chr11	64097232	64097233	rs694739	Alopecia areata
chr11	64107476	64107477	rs479777	Sarcoidosis
chr11	64129721	64129722	rs538147	Leprosy
chr11	64129721	64129722	rs538147	Primary biliary cirrhosis
chr11	64150369	64150370	rs559928	Inflammatory bowel disease
chr11	64313290	64313291	rs7124676	Obesity-related traits
chr11	64331461	64331462	rs17300741	Uric acid levels
chr11	64334113	64334114	rs2078267	Urate levels
chr11	64357071	64357072	rs505802	Uric acid levels
chr11	64359220	64359221	rs12800450	Urate levels
chr11	64440919	64440920	rs506338	Urate levels
chr11	64464084	64464085	rs504915	Renal function-related traits (urea)
chr11	64478062	64478063	rs478607	Urate levels
chr11	64525215	64525216	rs589691	Urate levels
chr11	64546390	64546391	rs606458	Urate levels
chr11	64557053	64557054	rs493573	Urate levels
chr11	64584230	64584231	rs470763	Economic and political preferences (fairness)
chr11	65143891	65143892	rs34400381	Serum dimethylarginine levels (symmetric)
chr11	65143891	65143892	rs34400381	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr11	65249144	65249145	rs17146964	Vertical cup-disc ratio
chr11	65260645	65260646	rs600231	Bone mineral density
chr11	65336818	65336819	rs3782089	Height
chr11	65349755	65349756	rs6591182	Non-alcoholic fatty liver disease histology (lobular)
chr11	65391316	65391317	rs12801636	HDL cholesterol
chr11	65506821	65506822	rs4014195	Chronic kidney disease
chr11	65513106	65513107	rs593982	Atopic dermatitis
chr11	65551956	65551957	rs479844	Atopic dermatitis
chr11	65560619	65560620	rs642803	Urate levels
chr11	65578671	65578672	rs11227306	DNA methylation (variation)
chr11	65583065	65583066	rs3903072	Breast cancer
chr11	65656563	65656564	rs2231884	Inflammatory bowel disease
chr11	65895165	65895166	rs564343	Obesity (early onset extreme)
chr11	66335307	66335308	rs2242663	Bipolar disorder
chr11	66551001	66551002	rs10896135	Bipolar disorder
chr11	66662730	66662731	rs7122539	HIV-1 susceptibility
chr11	66826159	66826160	rs7112925	Height
chr11	67715027	67715028	rs308309	QRS duration
chr11	67931760	67931761	rs4930561	IgG glycosylation
chr11	68192345	68192346	rs599083	Bone mineral density (spine)
chr11	68201294	68201295	rs3736228	Bone mineral density
chr11	68556781	68556782	rs2924679	Obesity-related traits
chr11	68840159	68840160	rs3750965	Hair color
chr11	68846398	68846399	rs35264875	Blond vs. brown hair color
chr11	68978579	68978580	rs11228565	Prostate cancer
chr11	68994496	68994497	rs7931342	Prostate cancer
chr11	68994666	68994667	rs10896449	Prostate cancer
chr11	68995957	68995958	rs7130881	Prostate cancer
chr11	69143283	69143284	rs7102705	Breast size
chr11	69234493	69234494	rs4980785	Renal cell carcinoma
chr11	69239740	69239741	rs7105934	Renal cell carcinoma
chr11	69328763	69328764	rs614367	Breast cancer
chr11	69457292	69457293	rs1352075	Multiple myeloma (hyperdiploidy)
chr11	69596522	69596523	rs4084127	Type 1 diabetes
chr11	69602411	69602412	rs10796849	IgG glycosylation
chr11	70506205	70506206	rs525304	Response to fenofibrate (adiponectin levels)
chr11	70665520	70665521	rs3017493	Renal transplant outcome
chr11	70845203	70845204	rs35198051	Obesity-related traits
chr11	71167448	71167449	rs12785878	Vitamin D insufficiency
chr11	71194558	71194559	rs3829251	Vitamin D levels
chr11	71234106	71234107	rs11234027	Vitamin D levels
chr11	72250122	72250123	rs12418204	Optic disc size (cup)
chr11	72275908	72275909	rs183778342	Serum dimethylarginine levels (asymmetric)
chr11	72373495	72373496	rs3781913	Rheumatoid arthritis
chr11	72432984	72432985	rs11603334	Fasting glucose-related traits (interaction with BMI)
chr11	72432984	72432985	rs11603334	Proinsulin levels
chr11	72433097	72433098	rs1552224	Type 2 diabetes
chr11	72670899	72670900	rs72981516	Crohn's disease
chr11	72863696	72863697	rs11235667	Crohn's disease
chr11	72894272	72894273	rs11603160	Body mass index (asthmatics)
chr11	72894847	72894848	rs1791933	Insomnia (caffeine-induced)
chr11	73036480	73036481	rs2027760	Pulmonary function (interaction)
chr11	73312251	73312252	rs10751226	Pulmonary function (interaction)
chr11	73477044	73477045	rs1723838	Obesity-related traits
chr11	74168410	74168411	rs2270676	Corneal astigmatism
chr11	74345549	74345550	rs3824999	Colorectal cancer
chr11	74971556	74971557	rs17133858	Thiazide-induced adverse metabolic effects in hypertensive patients
chr11	75276177	75276178	rs606452	Height
chr11	75282051	75282052	rs634552	Height
chr11	75455020	75455021	rs499974	HDL cholesterol
chr11	75909618	75909619	rs4944092	PR interval
chr11	76270682	76270683	rs7130588	Atopic dermatitis
chr11	76270682	76270683	rs7130588	Asthma
chr11	76299193	76299194	rs2155219	Allergic sensitization
chr11	76299193	76299194	rs2155219	Self-reported allergy
chr11	76299193	76299194	rs2155219	Inflammatory bowel disease
chr11	76299193	76299194	rs2155219	IgE grass sensitization
chr11	76299193	76299194	rs2155219	Allergic rhinitis
chr11	76299193	76299194	rs2155219	Ulcerative colitis
chr11	76301315	76301316	rs7927894	Atopic dermatitis
chr11	76301315	76301316	rs7927894	Crohn's disease
chr11	76301374	76301375	rs7927997	Crohn's disease
chr11	76332209	76332210	rs11236809	Atopic dermatitis
chr11	76465780	76465781	rs147269019	Serum dimethylarginine levels (symmetric)
chr11	76823483	76823484	rs3781684	Cognitive performance
chr11	77154638	77154639	rs527589	Orofacial clefts
chr11	77300047	77300048	rs7129556	Weight loss (gastric bypass surgery)
chr11	78091149	78091150	rs2373115	Alzheimer's disease (late onset)
chr11	78095372	78095373	rs10899489	Menarche (age at onset)
chr11	78659144	78659145	rs11826937	Retinopathy in non-diabetics
chr11	78992685	78992686	rs1151200	Obesity-related traits
chr11	79065100	79065101	rs530965	Cognitive test performance
chr11	79077192	79077193	rs12576775	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr11	79077192	79077193	rs12576775	Bipolar disorder
chr11	79083619	79083620	rs12290811	Bipolar disorder
chr11	80058478	80058479	rs7395555	Response to antipsychotic treatment
chr11	80311670	80311671	rs2140930	IgG glycosylation
chr11	80377051	80377052	rs17140547	Lentiform nucleus volume
chr11	80562737	80562738	rs11232369	Cognitive performance
chr11	80854374	80854375	rs1357339	HIV-1 control
chr11	80928808	80928809	rs11232535	Blood trace element (Zn levels)
chr11	80985547	80985548	rs1458095	Body mass index
chr11	81235149	81235150	rs2032381	Smooth-surface caries
chr11	82649767	82649768	rs10792665	Obesity-related traits
chr11	82723071	82723072	rs11233413	Economic and political preferences (feminism/equality)
chr11	82821381	82821382	rs4293143	Age-related macular degeneration
chr11	82876269	82876270	rs1943345	Obesity-related traits
chr11	83256867	83256868	rs2116483	Obesity-related traits
chr11	83455706	83455707	rs3885683	Protein quantitative trait loci
chr11	83620786	83620787	rs790356	Wilms tumor
chr11	84417845	84417846	rs10501570	Parkinson's disease
chr11	84822320	84822321	rs1452928	Hip geometry
chr11	85017475	85017476	rs17148090	Phospholipid levels (plasma)
chr11	85164750	85164751	rs10898392	Height
chr11	85677470	85677471	rs17817600	Alzheimer's disease
chr11	85783737	85783738	rs621942	Tourette syndrome
chr11	85787823	85787824	rs536841	Alzheimer's disease
chr11	85800278	85800279	rs561655	Alzheimer's disease (late onset)
chr11	85838807	85838808	rs10792830	Alzheimer's disease
chr11	85867874	85867875	rs10792832	Alzheimer's disease (late onset)
chr11	85868639	85868640	rs3851179	Alzheimer's disease
chr11	86055900	86055901	rs6592284	Cognitive performance
chr11	86188151	86188152	rs1870323	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
chr11	86414281	86414282	rs2512987	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)
chr11	87125437	87125438	rs6592362	Inflammatory bowel disease
chr11	87819426	87819427	rs1386330	Multiple sclerosis (age of onset)
chr11	88321723	88321724	rs16914280	HIV-1 control
chr11	88557990	88557991	rs10831496	Tanning
chr11	88741659	88741660	rs5016282	Attention deficit hyperactivity disorder
chr11	88891113	88891114	rs10830228	Age-related macular degeneration
chr11	88911695	88911696	rs1042602	Skin pigmentation
chr11	88911695	88911696	rs1042602	Freckles
chr11	88913662	88913663	rs621313	Age-related macular degeneration
chr11	89005252	89005253	rs1847134	Eye color
chr11	89011045	89011046	rs1393350	Melanoma
chr11	89011045	89011046	rs1393350	Eye color
chr11	89011045	89011046	rs1393350	Vitiligo
chr11	89011045	89011046	rs1393350	Tanning
chr11	89011045	89011046	rs1393350	Skin sensitivity to sun
chr11	89011045	89011046	rs1393350	Blue vs. green eyes
chr11	89017960	89017961	rs1126809	Tanning
chr11	89017960	89017961	rs1126809	Sunburns
chr11	89112649	89112650	rs10830265	Obesity-related traits
chr11	89148371	89148372	rs7130284	Homocysteine levels
chr11	89201626	89201627	rs957140	Homocysteine levels
chr11	89345024	89345025	rs1488902	Amyotrophic lateral sclerosis
chr11	89502375	89502376	rs2130017	Response to taxane treatment (docetaxel)
chr11	89875436	89875437	rs11018874	White blood cell types
chr11	90586899	90586900	rs12274302	HIV-1 control
chr11	90884338	90884339	rs1528753	Aging traits
chr11	90956213	90956214	rs4491175	Response to angiotensin II receptor blocker therapy
chr11	91952153	91952154	rs1350445	Subclinical atherosclerosis traits (other)
chr11	92100355	92100356	rs7129229	Homeostasis model assessment of beta-cell function (interaction)
chr11	92651001	92651002	rs7950811	Conduct disorder (symptom count)
chr11	92651001	92651002	rs7950811	Conduct disorder (case status)
chr11	92673827	92673828	rs1387153	Metabolic syndrome (bivariate traits)
chr11	92673827	92673828	rs1387153	Glycated hemoglobin levels
chr11	92673827	92673828	rs1387153	Type 2 diabetes
chr11	92673827	92673828	rs1387153	Fasting plasma glucose
chr11	92681012	92681013	rs10830956	Metabolic syndrome (bivariate traits)
chr11	92690031	92690032	rs7936247	Glycemic traits (pregnancy)
chr11	92691531	92691532	rs2166706	Fasting plasma glucose
chr11	92698426	92698427	rs10830962	Glycemic traits
chr11	92698426	92698427	rs10830962	Metabolic syndrome
chr11	92698426	92698427	rs10830962	Diabetes (gestational)
chr11	92698426	92698427	rs10830962	Metabolite levels
chr11	92708709	92708710	rs10830963	Obesity-related traits
chr11	92708709	92708710	rs10830963	Fasting glucose-related traits (interaction with BMI)
chr11	92708709	92708710	rs10830963	Fasting plasma glucose
chr11	92708709	92708710	rs10830963	Metabolite levels
chr11	92708709	92708710	rs10830963	Fasting glucose-related traits
chr11	92719680	92719681	rs10830964	Insomnia (caffeine-induced)
chr11	92722760	92722761	rs1447352	Metabolic traits
chr11	92784202	92784203	rs7931462	DNA methylation (parent-of-origin)
chr11	92792099	92792100	rs7120482	Adverse response to radiation therapy
chr11	92920401	92920402	rs12296063	Obesity-related traits
chr11	93093136	93093137	rs12098946	Obesity-related traits
chr11	93166730	93166731	rs2658782	Pulmonary function decline
chr11	93704048	93704049	rs11825709	Obesity-related traits
chr11	94132138	94132139	rs3758785	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)
chr11	94271662	94271663	rs11020821	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)
chr11	94271662	94271663	rs11020821	Response to angiotensin II receptor blocker therapy
chr11	94312322	94312323	rs2212361	Attention deficit hyperactivity disorder symptoms (interaction)
chr11	94667963	94667964	rs10831284	Attention deficit hyperactivity disorder and conduct disorder
chr11	95311421	95311422	rs4409785	Vitiligo
chr11	95311421	95311422	rs4409785	Multiple sclerosis
chr11	95422866	95422867	rs1939875	Eosinophilic esophagitis (pediatric)
chr11	95866699	95866700	rs10765792	Sudden cardiac arrest
chr11	95992128	95992129	rs11021499	Waist-to-hip circumference ratio (interaction)
chr11	95995447	95995448	rs11021504	Height
chr11	96000099	96000100	rs7115578	Response to treatment for acute lymphoblastic leukemia
chr11	96023213	96023214	rs485842	Corneal astigmatism
chr11	96023426	96023427	rs483905	Ulcerative colitis
chr11	96108427	96108428	rs7118648	Parkinson's disease
chr11	96959524	96959525	rs11224899	Formal thought disorder in schizophrenia
chr11	97574983	97574984	rs11212364	Information processing speed
chr11	97682563	97682564	rs2405657	Amyotrophic lateral sclerosis
chr11	98125403	98125404	rs2509843	Bipolar disorder and schizophrenia
chr11	98466267	98466268	rs4237591	Non-alcoholic fatty liver disease histology (lobular)
chr11	98723215	98723216	rs11217223	Obesity-related traits
chr11	99493172	99493173	rs10501920	Atrial fibrillation
chr11	99585735	99585736	rs952700	Volumetric brain MRI
chr11	100043419	100043420	rs12803066	Myopia (pathological)
chr11	100173536	100173537	rs11223581	Immune reponse to smallpox (secreted IL-2)
chr11	100406639	100406640	rs12800752	Menarche (age at onset)
chr11	100593537	100593538	rs633185	Systolic blood pressure
chr11	100593537	100593538	rs633185	Hypertension
chr11	100593537	100593538	rs633185	Diastolic blood pressure
chr11	100593537	100593538	rs633185	Blood pressure
chr11	102009279	102009280	rs11225148	Pubertal anthropometrics
chr11	102070638	102070639	rs1894116	Polycystic ovary syndrome
chr11	102155473	102155474	rs2852894	MRI atrophy measures
chr11	102401660	102401661	rs11568818	Prostate cancer
chr11	102628051	102628052	rs7924357	Multiple sclerosis
chr11	102691481	102691482	rs11225434	Matrix metalloproteinase levels
chr11	102695107	102695108	rs495366	Matrix metalloproteinase levels
chr11	102733162	102733163	rs12808148	Alzheimer's disease
chr11	102947464	102947465	rs7947821	Tuberculosis
chr11	102980593	102980594	rs12283022	Tuberculosis
chr11	103127064	103127065	rs12294076	Tuberculosis
chr11	103418157	103418158	rs716274	Small-cell lung cancer (survival)
chr11	103525753	103525754	rs7118412	Disc degeneration (lumbar)
chr11	103526023	103526024	rs7103004	Disc degeneration (lumbar)
chr11	103529631	103529632	rs12805875	Disc degeneration (lumbar)
chr11	103530365	103530366	rs4554859	Disc degeneration (lumbar)
chr11	103589093	103589094	rs1917445	Neutrophil count
chr11	103660566	103660567	rs974819	Coronary heart disease
chr11	103808151	103808152	rs10895547	Coronary heart disease
chr11	104334238	104334239	rs11226373	Matrix metalloproteinase levels
chr11	104972517	104972518	rs11226613	Bronchopulmonary dysplasia
chr11	105556597	105556598	rs11601239	Refractive error
chr11	106330161	106330162	rs10895959	Inattentive symptoms
chr11	106496037	106496038	rs1791581	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr11	106523223	106523224	rs12364992	Obesity-related traits
chr11	107347276	107347277	rs11212260	IgG glycosylation
chr11	107481517	107481518	rs10431058	Common traits (Other)
chr11	107756550	107756551	rs2186903	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr11	108175461	108175462	rs1801516	Melanoma
chr11	108283160	108283161	rs11212617	Response to metformin
chr11	108283160	108283161	rs11212617	Response to metformin in type 2 diabetes (glycemic)
chr11	108873118	108873119	rs10890920	QT interval (interaction)
chr11	108893366	108893367	rs7101378	IgG glycosylation
chr11	109995943	109995944	rs746463	Exercise treadmill test traits
chr11	110395857	110395858	rs12785341	Renal sinus fat
chr11	110499252	110499253	rs326946	Alzheimer's disease (cognitive decline)
chr11	110741013	110741014	rs1469170	Malaria
chr11	110913239	110913240	rs4938174	Corneal structure
chr11	111171708	111171709	rs3802842	Colorectal cancer
chr11	111275132	111275133	rs4938534	Primary biliary cirrhosis
chr11	111411607	111411608	rs11213935	Obesity-related traits
chr11	112023826	112023827	rs1834481	Interleukin-18 levels
chr11	112051168	112051169	rs2115763	Interleukin-18 levels
chr11	112064430	112064431	rs7105056	Immune reponse to smallpox (secreted IL-12p40)
chr11	112085315	112085316	rs2250417	Inflammatory biomarkers
chr11	112085315	112085316	rs2250417	Protein quantitative trait loci
chr11	112456220	112456221	rs7105881	Response to antipsychotic treatment
chr11	112991617	112991618	rs1436109	Cardiac muscle measurement
chr11	113106454	113106455	rs12279261	Entorhinal cortical thickness
chr11	113296618	113296619	rs1079596	Select biomarker traits
chr11	113309868	113309869	rs11214606	Response to antipsychotic treatment in schizophrenia (working memory)
chr11	113424557	113424558	rs7952106	Systolic blood pressure in sickle cell anemia
chr11	113961761	113961762	rs17116334	Conduct disorder (interaction)
chr11	114191015	114191016	rs2847476	Volumetric brain MRI
chr11	114231254	114231255	rs11214966	Asthma
chr11	114386829	114386830	rs561722	Ulcerative colitis
chr11	114387101	114387102	rs4466877	IgG glycosylation
chr11	114390105	114390106	rs9326244	IgG glycosylation
chr11	114431955	114431956	rs678170	Ulcerative colitis
chr11	114621468	114621469	rs1712790	Urinary albumin excretion
chr11	115140552	115140553	rs7950069	Orofacial clefts
chr11	115301870	115301871	rs220836	Obesity-related traits
chr11	115398745	115398746	rs7483296	Metabolite levels (HVA/MHPG ratio)
chr11	115398745	115398746	rs7483296	Metabolite levels (5-HIAA/ MHPG Ratio)
chr11	115764044	115764045	rs638882	Hip geometry
chr11	115943252	115943253	rs1426391	Hypertriglyceridemia
chr11	116298366	116298367	rs490592	Brain structure
chr11	116400381	116400382	rs7941534	Bipolar disorder and schizophrenia
chr11	116520526	116520527	rs1240773	HIV-1 susceptibility
chr11	116584986	116584987	rs4938303	Triglycerides
chr11	116586282	116586283	rs7350481	Triglycerides
chr11	116586282	116586283	rs7350481	Hematological and biochemical traits
chr11	116599391	116599392	rs180358	Multiple sclerosis (severity)
chr11	116603723	116603724	rs12272004	Carotenoid and tocopherol levels
chr11	116603723	116603724	rs12272004	Triglycerides
chr11	116603723	116603724	rs12272004	LDL cholesterol
chr11	116603723	116603724	rs12272004	Cholesterol, total
chr11	116607436	116607437	rs1558861	LDL cholesterol
chr11	116607436	116607437	rs1558861	Triglycerides
chr11	116613659	116613660	rs12280753	Cardiovascular disease risk factors
chr11	116617239	116617240	rs11216126	HDL cholesterol
chr11	116619072	116619073	rs28927680	Lipid traits
chr11	116619072	116619073	rs28927680	Triglycerides
chr11	116626257	116626258	rs11825181	Triglycerides-Blood Pressure (TG-BP)
chr11	116633861	116633862	rs11820589	Metabolic syndrome (bivariate traits)
chr11	116639103	116639104	rs10790162	Waist Circumference - Triglycerides (WC-TG)
chr11	116639103	116639104	rs10790162	Metabolic syndrome
chr11	116639103	116639104	rs10790162	HDL Cholesterol - Triglycerides (HDLC-TG)
chr11	116647606	116647607	rs2160669	Triglycerides
chr11	116647606	116647607	rs2160669	Obesity-related traits
chr11	116648916	116648917	rs964184	Triglycerides
chr11	116648916	116648917	rs964184	LDL cholesterol
chr11	116648916	116648917	rs964184	HDL cholesterol
chr11	116648916	116648917	rs964184	Cholesterol, total
chr11	116648916	116648917	rs964184	Hypertriglyceridemia
chr11	116648916	116648917	rs964184	Metabolite levels
chr11	116648916	116648917	rs964184	Response to Vitamin E supplementation
chr11	116648916	116648917	rs964184	Metabolic syndrome
chr11	116648916	116648917	rs964184	Phospholipid levels (plasma)
chr11	116648916	116648917	rs964184	Lipoprotein-associated phospholipase A2 activity and mass
chr11	116648916	116648917	rs964184	Vitamin E levels
chr11	116648916	116648917	rs964184	Coronary heart disease
chr11	116649134	116649135	rs11823543	Triglycerides-Blood Pressure (TG-BP)
chr11	116652206	116652207	rs12286037	Metabolic syndrome (bivariate traits)
chr11	116652206	116652207	rs12286037	Lipoprotein-associated phospholipase A2 activity and mass
chr11	116652206	116652207	rs12286037	Triglycerides
chr11	116652422	116652423	rs6589566	Triglycerides
chr11	116652422	116652423	rs6589566	LDL cholesterol
chr11	116653295	116653296	rs2075290	Waist Circumference - Triglycerides (WC-TG)
chr11	116653295	116653296	rs2075290	Metabolic syndrome
chr11	116653295	116653296	rs2075290	HDL Cholesterol - Triglycerides (HDLC-TG)
chr11	116654434	116654435	rs603446	Triglycerides
chr11	116657560	116657561	rs3741298	Obesity-related traits
chr11	116660685	116660686	rs2266788	Waist Circumference - Triglycerides (WC-TG)
chr11	116660685	116660686	rs2266788	Triglycerides-Blood Pressure (TG-BP)
chr11	116660685	116660686	rs2266788	Metabolic syndrome
chr11	116660685	116660686	rs2266788	HDL Cholesterol - Triglycerides (HDLC-TG)
chr11	116662578	116662579	rs651821	Lipid metabolism phenotypes
chr11	116662578	116662579	rs651821	Triglycerides
chr11	116663706	116663707	rs662799	Lipid traits
chr11	116681007	116681008	rs1263173	Coronary heart disease
chr11	116684027	116684028	rs7396835	Quantitative traits
chr11	116706046	116706047	rs12721025	Infantile hypertrophic pyloric stenosis
chr11	116722040	116722041	rs10047462	Iron status biomarkers
chr11	116732511	116732512	rs2075292	Triglycerides
chr11	116782973	116782974	rs11216185	Infantile hypertrophic pyloric stenosis
chr11	116829652	116829653	rs7120173	Visceral adipose tissue adjusted for BMI
chr11	116973928	116973929	rs12269901	Coronary heart disease
chr11	117037360	117037361	rs7112513	Protein quantitative trait loci
chr11	117075565	117075566	rs508487	Cardiovascular disease risk factors
chr11	117091608	117091609	rs236918	Iron status biomarkers
chr11	117156892	117156893	rs1047964	Cardiovascular disease risk factors
chr11	117388931	117388932	rs11216435	Menarche (age at onset)
chr11	117531730	117531731	rs10892151	Triglycerides
chr11	117851051	117851052	rs58603829	Obesity-related traits
chr11	118031985	118031986	rs11600901	Preeclampsia
chr11	118117017	118117018	rs11216831	Thiazide-induced adverse metabolic effects in hypertensive patients
chr11	118145685	118145686	rs17122021	Pain
chr11	118241994	118241995	rs502514	Fat distribution (HIV)
chr11	118341648	118341649	rs7948661	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr11	118477366	118477367	rs498872	Glioma
chr11	118486066	118486067	rs11603023	Cholesterol, total
chr11	118573518	118573519	rs4639966	Systemic lupus erythematosus
chr11	118574674	118574675	rs494459	Height
chr11	118611780	118611781	rs10892279	Celiac disease and Rheumatoid arthritis
chr11	118698536	118698537	rs638893	Vitiligo
chr11	118743771	118743772	rs6421571	Primary biliary cirrhosis
chr11	118754352	118754353	rs630923	Inflammatory bowel disease
chr11	118754352	118754353	rs630923	Multiple sclerosis
chr11	119099905	119099906	rs4938642	Platelet counts
chr11	119235403	119235404	rs2195525	Urate levels
chr11	120026747	120026748	rs2084898	Stroke (pediatric)
chr11	120040441	120040442	rs2444240	Corneal curvature
chr11	120520628	120520629	rs4245040	Attention deficit hyperactivity disorder
chr11	120809459	120809460	rs12797755	Cognitive performance
chr11	121204600	121204601	rs4936613	Response to taxane treatment (placlitaxel)
chr11	121206448	121206449	rs116875324	Serum dimethylarginine levels (symmetric)
chr11	121243715	121243716	rs72991	Response to tocilizumab in rheumatoid arthritis
chr11	121435586	121435587	rs11218343	Alzheimer's disease (late onset)
chr11	121954656	121954657	rs7121446	Cardiovascular disease risk factors
chr11	122030189	122030190	rs577948	Myopia (pathological)
chr11	122189464	122189465	rs565229	Hemostatic factors and hematological phenotypes
chr11	122522374	122522375	rs7941030	HDL cholesterol
chr11	122522374	122522375	rs7941030	Cholesterol, total
chr11	122870682	122870683	rs6589964	Menarche (age at onset)
chr11	122873075	122873076	rs2126200	IgG glycosylation
chr11	123361396	123361397	rs735665	Chronic lymphocytic leukemia
chr11	123361396	123361397	rs735665	Follicular lymphoma
chr11	123595926	123595927	rs2126709	Response to antipsychotic therapy (extrapyramidal side effects)
chr11	123648332	123648333	rs17744026	IgE levels in asthmatics (D.p. specific)
chr11	123751827	123751828	rs12280105	Oleic acid (18:1n-9) plasma levels
chr11	123956465	123956466	rs1893767	Obesity-related traits
chr11	124017492	124017493	rs4936894	Aging (time to death)
chr11	124537994	124537995	rs544368	Bipolar disorder
chr11	124606284	124606285	rs12807809	Schizophrenia
chr11	125170638	125170639	rs1426153	Alcohol and nictotine co-dependence
chr11	125172592	125172593	rs750338	Alcohol dependence
chr11	125178402	125178403	rs10893366	Alcohol dependence
chr11	125179852	125179853	rs12284594	Substance dependence
chr11	125241045	125241046	rs12273350	Creutzfeldt-Jakob disease (variant)
chr11	125277493	125277494	rs7112365	Obesity-related traits
chr11	125304008	125304009	rs1783925	Formal thought disorder in schizophrenia
chr11	125313598	125313599	rs7930295	Schizophrenia
chr11	125323964	125323965	rs11220082	Schizophrenia
chr11	125461708	125461709	rs548181	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr11	125461708	125461709	rs548181	Schizophrenia
chr11	125826701	125826702	rs4937076	Primary tooth development (time to first tooth eruption)
chr11	125873101	125873102	rs7104745	Breast size
chr11	125905257	125905258	rs472926	Alzheimer's disease (late onset)
chr11	126028716	126028717	rs563519	Heart failure
chr11	126030614	126030615	rs10501858	Estradiol plasma levels (breast cancer)
chr11	126243951	126243952	rs11220462	LDL cholesterol
chr11	126243951	126243952	rs11220462	Cholesterol, total
chr11	126281896	126281897	rs4937126	Coronary heart disease
chr11	126283784	126283785	rs2236653	Liver enzyme levels (alkaline phosphatase)
chr11	126296588	126296589	rs4935969	Hair color
chr11	126607579	126607580	rs7114000	Menarche (age at onset)
chr11	126619189	126619190	rs1557488	Attention deficit hyperactivity disorder and conduct disorder
chr11	126809704	126809705	rs1939992	Protein quantitative trait loci
chr11	126859156	126859157	rs620875	Response to antipsychotic treatment
chr11	127081590	127081591	rs4529888	Amyotrophic lateral sclerosis
chr11	127110182	127110183	rs2514895	IgG glycosylation
chr11	127761665	127761666	rs7927044	Asthma (childhood onset)
chr11	128186881	128186882	rs10893845	Self-reported allergy
chr11	128189100	128189101	rs4937314	Alzheimer's disease (late onset)
chr11	128206409	128206410	rs6590322	Hippocampal atrophy
chr11	128311058	128311059	rs6590330	Systemic lupus erythematosus
chr11	128328958	128328959	rs1128334	Systemic lupus erythematosus
chr11	128380973	128380974	rs11221332	Celiac disease
chr11	128436952	128436953	rs7117932	Obesity-related traits
chr11	128492738	128492739	rs4937362	Rheumatoid arthritis
chr11	128582556	128582557	rs665440	Myopia (pathological)
chr11	128586154	128586155	rs654723	Height
chr11	128816220	128816221	rs11221522	Metabolite levels (5-HIAA)
chr11	129461170	129461171	rs11820646	Breast cancer
chr11	129473689	129473690	rs7107217	Breast cancer
chr11	129473689	129473690	rs7107217	Type 2 diabetes
chr11	129698855	129698856	rs10894147	Obesity-related traits
chr11	130273229	130273230	rs11222084	Blood pressure
chr11	130529218	130529219	rs12792526	Periodontitis (Mean PAL)
chr11	130629121	130629122	rs10894239	Obesity-related traits
chr11	130817578	130817579	rs7940866	Schizophrenia
chr11	130830747	130830748	rs10894294	Schizophrenia
chr11	131320069	131320070	rs1550976	Asperger disorder
chr11	131325245	131325246	rs11601906	Obesity-related traits
chr11	131336073	131336074	rs992564	Bipolar disorder and schizophrenia
chr11	131350967	131350968	rs12421680	Sunburns
chr11	131807170	131807171	rs12098973	Cardiac Troponin-T levels
chr11	132010116	132010117	rs4468361	Chronic obstructive pulmonary disease-related biomarkers
chr11	132584118	132584119	rs1793257	Alcohol dependence
chr11	132641745	132641746	rs10894604	Waist-hip ratio
chr11	132829861	132829862	rs1567127	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr11	133120936	133120937	rs2078454	Smooth-surface caries
chr11	133566984	133566985	rs4397868	Menopause (age at onset)
chr11	133800218	133800219	rs1682859	Obesity-related traits
chr11	134088681	134088682	rs1031381	Cognitive test performance
chr11	134139779	134139780	rs478881	Obesity-related traits
chr11	134265966	134265967	rs7928758	Alcohol consumption (maxi-drinks)
chr11	134482465	134482466	rs1944866	Myopia (pathological)
chr11	134573809	134573810	rs11825685	IgG glycosylation
chr11	134626886	134626887	rs11223996	Myopia (pathological)
chr11	134738269	134738270	rs906628	Tooth agenesis (mandibular third molar)
chr12	219987	219988	rs2011738	Response to angiotensin II receptor blocker therapy
chr12	320919	320920	rs499368	Metabolite levels
chr12	349297	349298	rs10774021	Chronic kidney disease
chr12	551549	551550	rs1048466	Obesity (early onset extreme)
chr12	783483	783484	rs12425791	Stroke
chr12	1064437	1064438	rs10849605	Lung cancer
chr12	1638170	1638171	rs2887571	Bone mineral density
chr12	1856952	1856953	rs12230440	Adverse response to lamotrigine and phenytoin
chr12	1934580	1934581	rs2887631	Behavioural disinhibition (generation interaction)
chr12	2056362	2056363	rs10505725	Obesity-related traits
chr12	2091256	2091257	rs11062040	Response to gemcitabine in pancreatic cancer
chr12	2345294	2345295	rs1006737	Schizophrenia or bipolar disorder
chr12	2345294	2345295	rs1006737	Schizophrenia
chr12	2345294	2345295	rs1006737	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr12	2345294	2345295	rs1006737	Bipolar disorder and major depressive disorder (combined)
chr12	2345294	2345295	rs1006737	Bipolar disorder
chr12	2349583	2349584	rs4765905	Schizophrenia
chr12	2419895	2419896	rs4765913	Bipolar disorder
chr12	2523354	2523355	rs7312105	Red blood cell traits
chr12	2729631	2729632	rs216013	Warfarin maintenance dose
chr12	2783971	2783972	rs2302729	Sleep quality
chr12	2882543	2882544	rs10848704	Quantitative traits
chr12	3164922	3164923	rs12425451	Narcolepsy with cataplexy
chr12	3287278	3287279	rs878962	Temporomandibular joint disorders
chr12	3750127	3750128	rs4766152	Cytomegalovirus antibody response
chr12	3757547	3757548	rs887304	Non-alcoholic fatty liver disease histology (lobular)
chr12	3814237	3814238	rs10848911	Male infertility
chr12	3868167	3868168	rs10744625	Homeostasis model assessment of insulin resistance (interaction)
chr12	3868167	3868168	rs10744625	Fasting insulin (interaction)
chr12	3913426	3913427	rs2058350	Cognitive performance
chr12	4118316	4118317	rs4238010	Major depressive disorder
chr12	4305882	4305883	rs12827476	Obesity-related traits
chr12	4332477	4332478	rs10849023	Red blood cell traits
chr12	4333918	4333919	rs11611647	Red blood cell count
chr12	4368351	4368352	rs10774214	Colorectal cancer
chr12	4388270	4388271	rs3217810	Colorectal cancer
chr12	4399969	4399970	rs3217869	QT interval (interaction)
chr12	4405388	4405389	rs3217901	Colorectal cancer
chr12	4416303	4416304	rs4625554	Major depressive disorder
chr12	4425121	4425122	rs10849033	Acute lymphoblastic leukemia (childhood)
chr12	4523455	4523456	rs10849061	Migraine without aura
chr12	4523455	4523456	rs10849061	Migraine - clinic-based
chr12	4523455	4523456	rs10849061	Migraine
chr12	4606167	4606168	rs2970818	Phosphorus levels
chr12	5131552	5131553	rs16932667	Intelligence (childhood)
chr12	5140483	5140484	rs12302829	Conduct disorder (symptom count)
chr12	5751341	5751342	rs2110166	IgG glycosylation
chr12	5797100	5797101	rs12579350	Panic disorder
chr12	5981352	5981353	rs7307889	Obesity-related traits
chr12	6153513	6153514	rs1063857	Coagulation factor levels
chr12	6153533	6153534	rs1063856	Coagulation factor levels
chr12	6289218	6289219	rs1558324	Mean platelet volume
chr12	6291092	6291093	rs7342306	Platelet counts
chr12	6308522	6308523	rs3181157	Paclitaxel-induced neuropathy
chr12	6435570	6435571	rs10849441	Obesity-related traits
chr12	6440008	6440009	rs1800693	Multiple sclerosis
chr12	6440008	6440009	rs1800693	Primary biliary cirrhosis
chr12	6442000	6442001	rs4149639	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
chr12	6442000	6442001	rs4149639	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
chr12	6442642	6442643	rs4149584	Multiple sclerosis
chr12	6466080	6466081	rs3782724	Obesity (early onset extreme)
chr12	6502741	6502742	rs11616188	Ankylosing spondylitis
chr12	6580581	6580582	rs10492096	Hip geometry
chr12	6683286	6683287	rs1057510	Myopia (pathological)
chr12	6938871	6938872	rs3741920	Response to Vitamin E supplementation
chr12	7334812	7334813	rs7973719	IgG glycosylation
chr12	7335216	7335217	rs12828421	IgG glycosylation
chr12	7691133	7691134	rs7136716	Hematological and biochemical traits
chr12	7855270	7855271	rs12307997	Thiazide-induced adverse metabolic effects in hypertensive patients
chr12	9082580	9082581	rs4883201	Cholesterol, total
chr12	9371331	9371332	rs6487679	Non-alcoholic fatty liver disease histology (AST)
chr12	9380858	9380859	rs10771431	Breast size
chr12	9463805	9463806	rs10771515	Obesity-related traits
chr12	9546961	9546962	rs7397814	IgG glycosylation
chr12	9833627	9833628	rs3764021	Type 1 diabetes
chr12	9855957	9855958	rs11052552	Type 1 diabetes
chr12	9876090	9876091	rs10466829	Multiple sclerosis
chr12	9910163	9910164	rs4763879	Type 1 diabetes
chr12	10170160	10170161	rs1054611	Sensory disturbances after bilateral sagittal split ramus osteotomy
chr12	10170726	10170727	rs11053548	Systolic blood pressure in sickle cell anemia
chr12	10471049	10471050	rs12303914	Thiazide-induced adverse metabolic effects in hypertensive patients
chr12	10521388	10521389	rs10743889	Obesity-related traits
chr12	10560956	10560957	rs2617170	Behcet's disease
chr12	11216314	11216315	rs2708377	Bitter taste perception
chr12	11279091	11279092	rs1031391	Bitter taste perception
chr12	11324558	11324559	rs8181	Bitter taste perception
chr12	11547531	11547532	rs2900174	Response to gemcitabine in pancreatic cancer
chr12	11558876	11558877	rs71455379	Periodontitis (CDC/AAP)
chr12	11648417	11648418	rs2908835	Information processing speed
chr12	11855623	11855624	rs2187642	Height
chr12	11855772	11855773	rs2856321	Height
chr12	11942719	11942720	rs2856329	Lung function (forced expiratory volume in 1 second)
chr12	11962572	11962573	rs7314811	IgG glycosylation
chr12	12376464	12376465	rs11054731	Coronary artery calcification
chr12	12657512	12657513	rs11612508	Inflammatory bowel disease
chr12	12729315	12729316	rs12302103	Homeostasis model assessment of beta-cell function (interaction)
chr12	12773520	12773521	rs12822507	Systemic lupus erythematosus
chr12	12834893	12834894	rs10845606	Systemic lupus erythematosus
chr12	12870694	12870695	rs34330	Systemic lupus erythematosus
chr12	13452779	13452780	rs899435	Coronary artery calcification
chr12	13519995	13519996	rs11055387	Major depressive disorder
chr12	13629380	13629381	rs1531228	Barrett's esophagus
chr12	13641705	13641706	rs1457614	Major depressive disorder
chr12	13787845	13787846	rs2160519	Cognitive performance
chr12	13872043	13872044	rs2268118	Immune reponse to smallpox (secreted IL-2)
chr12	13923327	13923328	rs11055612	Brain structure (temporal lobe volume)
chr12	13927895	13927896	rs6488619	Ovarian reserve
chr12	14064460	14064461	rs4764039	Total ventricular volume
chr12	14115481	14115482	rs4764043	Aging (time to event)
chr12	14410484	14410485	rs17221259	Breast cancer
chr12	14413930	14413931	rs12422552	Breast cancer
chr12	14587300	14587301	rs3213764	Prostate-specific antigen levels
chr12	14653866	14653867	rs2900333	Testicular germ cell tumor
chr12	14653866	14653867	rs2900333	Testicular germ cell cancer
chr12	14660183	14660184	rs3827886	Response to amphetamines
chr12	14966603	14966604	rs4764124	Pubertal anthropometrics
chr12	15389636	15389637	rs12311304	Behavioural disinhibition (generation interaction)
chr12	15735441	15735442	rs2300290	Cognitive function
chr12	15930804	15930805	rs17415853	Protein quantitative trait loci
chr12	16406689	16406690	rs10772915	Visceral fat
chr12	16609037	16609038	rs10772939	Economic and political preferences
chr12	17362815	17362816	rs1513049	Word reading
chr12	17373738	17373739	rs9971637	Amyotrophic lateral sclerosis
chr12	17662234	17662235	rs1706631	Major depressive disorder
chr12	18508251	18508252	rs11044045	Gray matter volume (schizophrenia interaction)
chr12	19052179	19052180	rs1873386	Personality dimensions
chr12	19779792	19779793	rs10841287	Obesity-related traits
chr12	19801594	19801595	rs6486986	Cognitive performance
chr12	19866128	19866129	rs4762767	Pulmonary function
chr12	20063967	20063968	rs10841397	Response to amphetamines
chr12	20230638	20230639	rs10770612	Aortic root size
chr12	20473757	20473758	rs7134375	HDL cholesterol
chr12	20498035	20498036	rs7955516	Adiponectin levels
chr12	20521653	20521654	rs10841496	Male infertility
chr12	20531755	20531756	rs1348582	QT interval
chr12	20758612	20758613	rs11611208	Height
chr12	20840838	20840839	rs11045392	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr12	20857466	20857467	rs10770705	Height
chr12	20860092	20860093	rs3794271	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr12	21017874	21017875	rs2417940	Bilirubin levels
chr12	21074121	21074122	rs2117032	Bilirubin levels
chr12	21321369	21321370	rs10841753	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr12	21329760	21329761	rs11045818	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr12	21331548	21331549	rs4149056	Sex hormone-binding globulin levels
chr12	21331548	21331549	rs4149056	Bilirubin levels
chr12	21331548	21331549	rs4149056	Response to statin therapy
chr12	21368721	21368722	rs4363657	Bilirubin levels
chr12	21377558	21377559	rs4149080	Methotrexate clearance (acute lymphoblastic leukemia)
chr12	21378020	21378021	rs4149081	Metabolic traits
chr12	21382618	21382619	rs11045879	Metabolite levels
chr12	21382618	21382619	rs11045879	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr12	21451394	21451395	rs16923647	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr12	21457433	21457434	rs11568563	Progressive supranuclear palsy
chr12	21996044	21996045	rs11046207	Obesity-related traits
chr12	22151572	22151573	rs10743430	Entorhinal cortical thickness
chr12	22365834	22365835	rs2216228	Non-alcoholic fatty liver disease histology (lobular)
chr12	22566428	22566429	rs11046430	Coronary artery calcification
chr12	23639916	23639917	rs2120771	Economic and political preferences (feminism/equality)
chr12	23946145	23946146	rs11047102	Systemic sclerosis
chr12	24184543	24184544	rs10842262	Non-obstructive azoospermia
chr12	24278820	24278821	rs7979575	Response to statin therapy
chr12	24389659	24389660	rs1464500	Response to antipsychotic treatment
chr12	24394371	24394372	rs1522232	AIDS
chr12	24770877	24770878	rs17287293	Heart rate
chr12	24770877	24770878	rs17287293	Resting heart rate
chr12	24788338	24788339	rs11047543	PR interval
chr12	25484192	25484193	rs7965364	Thiazide-induced adverse metabolic effects in hypertensive patients
chr12	26453282	26453283	rs718314	Renal cell carcinoma
chr12	26453282	26453283	rs718314	Waist-hip ratio
chr12	26636385	26636386	rs2306677	Amyotrophic lateral sclerosis
chr12	28008768	28008769	rs258401	Retinopathy in non-diabetics
chr12	28017158	28017159	rs7953528	Bone mineral density
chr12	28155079	28155080	rs10771399	Breast Cancer in BRCA1 mutation carriers
chr12	28155079	28155080	rs10771399	Breast cancer
chr12	28156080	28156081	rs12371778	Breast size
chr12	28192988	28192989	rs7964407	IgG glycosylation
chr12	28228566	28228567	rs522958	Hyperactive-impulsive symptoms
chr12	28228566	28228567	rs522958	Attention deficit hyperactivity disorder
chr12	28534414	28534415	rs2638953	Height
chr12	28569713	28569714	rs10843164	Height
chr12	28744640	28744641	rs10843215	Obesity-related traits
chr12	28815791	28815792	rs1606355	Metabolite levels (Pyroglutamine)
chr12	29435479	29435480	rs2015599	Mean platelet volume
chr12	29872317	29872318	rs16934812	Schizophrenia
chr12	30104141	30104142	rs2046383	Heart failure
chr12	30113882	30113883	rs1463605	Aging traits
chr12	32097359	32097360	rs1151008	Corneal astigmatism
chr12	32150242	32150243	rs4931594	Obesity-related traits
chr12	32261238	32261239	rs1144713	Obesity-related traits
chr12	32380500	32380501	rs10844154	Emphysema-related traits
chr12	32380500	32380501	rs10844154	Weight
chr12	32436408	32436409	rs708224	Pancreatic cancer
chr12	32476726	32476727	rs261902	Normalized brain volume
chr12	32537487	32537488	rs11051970	Response to tocilizumab in rheumatoid arthritis
chr12	33017042	33017043	rs1454933	Obesity-related traits
chr12	33576989	33576990	rs7980799	Heart rate
chr12	33701165	33701166	rs9300212	Cognitive test performance
chr12	38439202	38439203	rs2204008	Bladder cancer
chr12	38743507	38743508	rs6582630	Drug-induced liver injury (flucloxacillin)
chr12	39106730	39106731	rs826838	Heart rate
chr12	39253107	39253108	rs11169838	IgG glycosylation
chr12	40341084	40341085	rs1005956	Sleep quality
chr12	40352995	40352996	rs10877840	Parkinson's disease
chr12	40354243	40354244	rs11174478	Insomnia
chr12	40428560	40428561	rs1994090	Parkinson's disease
chr12	40601939	40601940	rs11175593	Crohn's disease
chr12	40620807	40620808	rs1491942	Parkinson's disease
chr12	40734201	40734202	rs34637584	Parkinson's disease
chr12	40757327	40757328	rs34778348	Parkinson's disease
chr12	40767361	40767362	rs10467147	Obesity-related traits
chr12	40792299	40792300	rs11564258	Inflammatory bowel disease
chr12	40792299	40792300	rs11564258	Crohn's disease
chr12	41246279	41246280	rs312274	Metabolite levels  (X-11787)
chr12	41247741	41247742	rs312273	Bipolar disorder
chr12	41353748	41353749	rs13328933	IgG glycosylation
chr12	41721429	41721430	rs1880887	Protein quantitative trait loci
chr12	41965860	41965861	rs1458175	Multiple sclerosis
chr12	42171981	42171982	rs871392	Biochemical measures
chr12	43160743	43160744	rs12316797	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr12	43160824	43160825	rs2731006	Panic disorder
chr12	43253414	43253415	rs1520832	Heart failure
chr12	43434281	43434282	rs1167125	Obesity-related traits
chr12	43929995	43929996	rs275380	Adverse response to lamotrigine and phenytoin
chr12	43967676	43967677	rs7295246	Alzheimer's disease (late onset)
chr12	44153825	44153826	rs4251424	Immune reponse to smallpox (secreted TNF-alpha)
chr12	45774907	45774908	rs17095830	Ankylosing spondylitis
chr12	45925754	45925755	rs7960483	Hypertension
chr12	45930972	45930973	rs10785581	Hypertension
chr12	46485837	46485838	rs1373549	Hippocampal atrophy
chr12	47372269	47372270	rs2711721	Prostate cancer (gene x gene interaction)
chr12	47639525	47639526	rs11610206	Alzheimer's disease
chr12	47771428	47771429	rs2074193	Migraine with aura
chr12	47814971	47814972	rs1881744	Metabolite levels (HVA/5-HIAA ratio)
chr12	47923015	47923016	rs7307902	Obesity-related traits
chr12	48173351	48173352	rs4760636	Urate levels
chr12	48187253	48187254	rs75365750	Obesity-related traits
chr12	48208367	48208368	rs11168249	Inflammatory bowel disease
chr12	48403764	48403765	rs11168351	Bipolar disorder and schizophrenia
chr12	48811099	48811100	rs4489787	Prostate cancer (gene x gene interaction)
chr12	48933232	48933233	rs11168618	Adiponectin levels
chr12	49218170	49218171	rs2070615	Bipolar disorder
chr12	49474604	49474605	rs12821008	Bone mineral density
chr12	49676009	49676010	rs10875943	Prostate cancer
chr12	50226466	50226467	rs10875976	Obesity
chr12	50247467	50247468	rs7138803	Obesity
chr12	50247467	50247468	rs7138803	Body mass index
chr12	50247467	50247468	rs7138803	Waist circumference
chr12	50247467	50247468	rs7138803	Weight
chr12	50319085	50319086	rs297941	Obsessive-compulsive disorder
chr12	51134740	51134741	rs7968440	Fibrinogen
chr12	51155662	51155663	rs11169552	Colorectal cancer
chr12	51213432	51213433	rs17291650	Sudden cardiac arrest
chr12	51357541	51357542	rs12304921	Type 2 diabetes
chr12	51703833	51703834	rs766903	Aging (time to death)
chr12	51727595	51727596	rs3951439	Obesity-related traits
chr12	51878759	51878760	rs147845115	Alzheimer's disease (cognitive decline)
chr12	52251271	52251272	rs7976059	Urate levels
chr12	52263955	52263956	rs17126180	Response to antipsychotic treatment in schizophrenia (reasoning)
chr12	53273903	53273904	rs902774	Prostate cancer
chr12	53554282	53554283	rs2272306	Obesity-related traits
chr12	53727954	53727955	rs2016266	Bone mineral density
chr12	53727954	53727955	rs2016266	Bone mineral density (spine)
chr12	53731890	53731891	rs10876432	Bone mineral density (spine)
chr12	53916714	53916715	rs12321906	Height
chr12	53995076	53995077	rs1485395	Migraine without aura
chr12	54041191	54041192	rs11170631	Height
chr12	54114157	54114158	rs941184	Panic disorder
chr12	54159276	54159277	rs7969151	Tanning
chr12	54270227	54270228	rs2120991	Biliary atresia
chr12	54319726	54319727	rs894734	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
chr12	54342683	54342684	rs1443512	Waist-hip ratio
chr12	54417575	54417576	rs736825	Bone mineral density
chr12	54687231	54687232	rs10506328	Mean platelet volume
chr12	54712307	54712308	rs10876550	Mean platelet volume
chr12	54736469	54736470	rs4326844	Platelet counts
chr12	54909143	54909144	rs1629826	Obesity-related traits
chr12	55098995	55098996	rs1153188	Type 2 diabetes
chr12	55424915	55424916	rs1386809	IgG glycosylation
chr12	55916779	55916780	rs12230513	Contrast sensitivity
chr12	56070667	56070668	rs55874825	Response to amphetamines
chr12	56114768	56114769	rs3138144	Refractive error
chr12	56364320	56364321	rs2069408	Asthma
chr12	56390635	56390636	rs705702	Polycystic ovary syndrome
chr12	56401084	56401085	rs10876864	Vitiligo
chr12	56412486	56412487	rs1701704	Type 1 diabetes autoantibodies
chr12	56412486	56412487	rs1701704	Asthma
chr12	56412486	56412487	rs1701704	Alopecia areata
chr12	56412486	56412487	rs1701704	Type 1 diabetes
chr12	56416927	56416928	rs2456973	Vitiligo
chr12	56439208	56439209	rs12580100	Psoriasis
chr12	56470624	56470625	rs11171739	Type 1 diabetes
chr12	56474142	56474143	rs34379766	Obesity-related traits
chr12	56482179	56482180	rs2292239	Type 1 diabetes autoantibodies
chr12	56482179	56482180	rs2292239	Type 1 diabetes
chr12	56518407	56518408	rs11171747	Systemic sclerosis
chr12	56680744	56680745	rs3816804	Height
chr12	56737972	56737973	rs2066808	Psoriasis
chr12	56740681	56740682	rs2066807	Height
chr12	56815280	56815281	rs2291738	Axial length
chr12	56828055	56828056	rs11171846	Immune reponse to smallpox (secreted IFN-alpha)
chr12	56863769	56863770	rs2657880	Metabolite levels
chr12	56865055	56865056	rs2638315	Metabolite levels
chr12	56865337	56865338	rs2657879	Metabolic traits
chr12	56938382	56938383	rs2657888	Adiponectin levels
chr12	57023283	57023284	rs941207	Platelet counts
chr12	57055290	57055291	rs2950390	Mean platelet volume
chr12	57146068	57146069	rs2277339	Menopause (age at onset)
chr12	57204159	57204160	rs12367822	Platelet aggregation
chr12	57377346	57377347	rs4759042	Migraine
chr12	57489708	57489709	rs1059513	Sensory disturbances after bilateral sagittal split ramus osteotomy
chr12	57489708	57489709	rs1059513	Allergic sensitization
chr12	57489708	57489709	rs1059513	IgE levels
chr12	57503774	57503775	rs167769	Eosinophilic esophagitis (pediatric)
chr12	57527282	57527283	rs11172113	Migraine without aura
chr12	57527282	57527283	rs11172113	Migraine - clinic-based
chr12	57527282	57527283	rs11172113	Migraine
chr12	57527282	57527283	rs11172113	Pulmonary function (interaction)
chr12	57527282	57527283	rs11172113	Pulmonary function
chr12	57534469	57534470	rs1466535	Abdominal aortic aneurysm
chr12	57792579	57792580	rs11613352	Triglycerides
chr12	57792579	57792580	rs11613352	HDL cholesterol
chr12	57809455	57809456	rs1106766	Urate levels
chr12	57844048	57844049	rs3741414	Urate levels
chr12	57968714	57968715	rs1678542	Rheumatoid arthritis
chr12	58062666	58062667	rs10876993	Celiac disease and Rheumatoid arthritis
chr12	58133255	58133256	rs12368653	Multiple sclerosis
chr12	58162738	58162739	rs703842	Multiple sclerosis
chr12	58750679	58750680	rs1795708	Obesity-related traits
chr12	59259627	59259628	rs11172782	Heart failure
chr12	59440231	59440232	rs17121944	Temperament (bipolar disorder)
chr12	59849676	59849677	rs276000	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr12	60735172	60735173	rs7974425	Obesity-related traits
chr12	60797702	60797703	rs10506410	Cardiac hypertrophy
chr12	60810651	60810652	rs2655898	Obesity-related traits
chr12	61549080	61549081	rs17124610	IgG glycosylation
chr12	62234832	62234833	rs2198776	Obesity-related traits
chr12	62610859	62610860	rs11615916	Pulmonary function decline
chr12	62818480	62818481	rs10877839	IgG glycosylation
chr12	62886122	62886123	rs7301016	IgG glycosylation
chr12	63004582	63004583	rs7302017	Waist circumference
chr12	63180815	63180816	rs549433	Obesity-related traits
chr12	63445091	63445092	rs10506458	Hemostatic factors and hematological phenotypes
chr12	63445961	63445962	rs10877945	Obesity-related traits
chr12	65252117	65252118	rs939876	Cognitive performance
chr12	65534623	65534624	rs6581612	Hippocampal volume
chr12	65718298	65718299	rs17178006	Hippocampal volume
chr12	65762057	65762058	rs12229918	Primary tooth development (time to first tooth eruption)
chr12	65762057	65762058	rs12229918	Primary tooth development (number of teeth)
chr12	65783377	65783378	rs10506525	Primary tooth development (time to first tooth eruption)
chr12	65783377	65783378	rs10506525	Primary tooth development (number of teeth)
chr12	65842257	65842258	rs1494508	Temperament
chr12	66117557	66117558	rs2358944	Type 2 diabetes nephropathy
chr12	66160970	66160971	rs10784496	AB1-42
chr12	66174893	66174894	rs1531343	Type 2 diabetes
chr12	66224460	66224461	rs2272046	Polycystic ovary syndrome
chr12	66227256	66227257	rs7979673	Height
chr12	66338201	66338202	rs17101923	Primary tooth development (time to first tooth eruption)
chr12	66338201	66338202	rs17101923	Primary tooth development (number of teeth)
chr12	66343809	66343810	rs10784502	Brain structure
chr12	66351825	66351826	rs1351394	Height
chr12	66358346	66358347	rs1042725	Birth weight
chr12	66358346	66358347	rs1042725	Head circumference (infant)
chr12	66358346	66358347	rs1042725	Height
chr12	66359751	66359752	rs8756	Height
chr12	66364508	66364509	rs12424086	Permanent tooth development
chr12	66364508	66364509	rs12424086	Primary tooth development (time to first tooth eruption)
chr12	66364508	66364509	rs12424086	Primary tooth development (number of teeth)
chr12	66371879	66371880	rs7968682	Height
chr12	66389967	66389968	rs10400419	Axial length
chr12	66394663	66394664	rs4026608	Aortic root size
chr12	67628830	67628831	rs1082714	Hippocampal atrophy
chr12	68500074	68500075	rs7134599	Inflammatory bowel disease
chr12	68500074	68500075	rs7134599	Ulcerative colitis
chr12	68504591	68504592	rs1558744	Ulcerative colitis
chr12	68532076	68532077	rs12321565	Bipolar disorder and schizophrenia
chr12	68596660	68596661	rs2870946	Ulcerative colitis
chr12	68779412	68779413	rs416350	Temperament (bipolar disorder)
chr12	68961583	68961584	rs12313946	White blood cell count
chr12	69370755	69370756	rs9943849	Major depressive disorder
chr12	69523922	69523923	rs10784762	QRS duration
chr12	69581221	69581222	rs12367448	IgG glycosylation
chr12	69727189	69727190	rs317689	Response to diuretic therapy
chr12	69762986	69762987	rs315135	Response to diuretic therapy
chr12	69824023	69824024	rs7297610	Response to diuretic therapy
chr12	69827657	69827658	rs10748128	Height
chr12	69828680	69828681	rs11177669	Height
chr12	70054909	70054910	rs1373453	Orofacial clefts
chr12	70331826	70331827	rs789560	Attention deficit hyperactivity disorder and conduct disorder
chr12	70690084	70690085	rs2904524	Amyotrophic lateral sclerosis (age of onset)
chr12	71249995	71249996	rs12229663	Refractive error
chr12	71289555	71289556	rs4760854	IgG glycosylation
chr12	71577100	71577101	rs1495377	Creutzfeldt-Jakob disease (variant)
chr12	71577100	71577101	rs1495377	Type 2 diabetes
chr12	71634793	71634794	rs4760790	Type 2 diabetes
chr12	71663101	71663102	rs7961581	Type 2 diabetes
chr12	72071044	72071045	rs10748180	Economic and political preferences (time)
chr12	72125284	72125285	rs11178918	Economic and political preferences (time)
chr12	72414562	72414563	rs10879357	Colorectal cancer
chr12	72724033	72724034	rs12831974	Rheumatoid arthritis
chr12	73163150	73163151	rs10879490	Metabolite levels (Dihydroxy docosatrienoic acid)
chr12	73307581	73307582	rs10879517	Cognitive performance
chr12	73601131	73601132	rs11615274	Body mass index and cholesterol (psychopharmacological treatment)
chr12	73828955	73828956	rs7963521	Chemerin levels
chr12	73989836	73989837	rs1154865	Breast cancer
chr12	74087807	74087808	rs7964120	Obesity-related traits
chr12	74586209	74586210	rs10506701	Bone mineral density
chr12	75054592	75054593	rs7311660	Obesity-related traits
chr12	75718422	75718423	rs12318506	Coronary artery calcification
chr12	76064527	76064528	rs12582659	Blood trace element (Cu levels)
chr12	76220617	76220618	rs7307780	Sudden cardiac arrest
chr12	76476955	76476956	rs1368578	Obesity-related traits
chr12	77009059	77009060	rs2669010	Systemic lupus erythematosus
chr12	77729384	77729385	rs1402279	Smoking behavior
chr12	77738004	77738005	rs6538140	Tuberculosis
chr12	77899509	77899510	rs17788937	Myopia (pathological)
chr12	78485993	78485994	rs300489	Self-rated health
chr12	79775247	79775248	rs11114027	Obesity-related traits
chr12	80062229	80062230	rs7297018	Attention deficit hyperactivity disorder and conduct disorder
chr12	80463083	80463084	rs10778699	Thiazide-induced adverse metabolic effects in hypertensive patients
chr12	80496922	80496923	rs10506821	Hip geometry
chr12	81337457	81337458	rs1163656	Dental caries
chr12	81544535	81544536	rs10492002	Response to antidepressant treatment (citalopram)
chr12	81843127	81843128	rs12426725	Schizophrenia
chr12	82462225	82462226	rs7137515	IgG glycosylation
chr12	82984878	82984879	rs12425131	Immune response to smallpox vaccine (IL-6)
chr12	83019187	83019188	rs11115322	Immune response to smallpox vaccine (IL-6)
chr12	83164555	83164556	rs12317459	Prostate cancer (gene x gene interaction)
chr12	84008274	84008275	rs2403106	Neonatal lupus
chr12	84196528	84196529	rs11116045	Obesity-related traits
chr12	84564067	84564068	rs1545843	Major depressive disorder
chr12	85187510	85187511	rs4761097	Behavioural disinhibition (generation interaction)
chr12	88829293	88829294	rs11104870	Red blood cell traits
chr12	88890670	88890671	rs995030	Testicular germ cell tumor
chr12	88953560	88953561	rs3782181	Testicular germ cell cancer
chr12	88953958	88953959	rs4474514	Testicular cancer
chr12	89328334	89328335	rs12821256	Hair color
chr12	89328334	89328335	rs12821256	Blond vs. brown hair color
chr12	90008958	90008959	rs2681472	Hypertension
chr12	90008958	90008959	rs2681472	Diastolic blood pressure
chr12	90013088	90013089	rs2681492	Systolic blood pressure
chr12	90060585	90060586	rs17249754	Blood pressure
chr12	90060585	90060586	rs17249754	Biomedical quantitative traits
chr12	90081187	90081188	rs7136259	Coronary heart disease
chr12	90305778	90305779	rs7965584	Magnesium levels
chr12	90443481	90443482	rs10858945	Optic disc size (cup)
chr12	90609016	90609017	rs10745527	vWF and FVIII levels
chr12	91077507	91077508	rs1847461	Smoking behavior
chr12	91473797	91473798	rs10777288	Pulmonary function (interaction)
chr12	91980373	91980374	rs10777317	Sudden cardiac arrest
chr12	92164301	92164302	rs10777332	Biochemical measures
chr12	92305269	92305270	rs17019682	Heart failure
chr12	92890519	92890520	rs10219495	Sudden cardiac arrest
chr12	92987207	92987208	rs11829373	Periodontitis (Mean PAL)
chr12	93550300	93550301	rs1836127	Non-alcoholic fatty liver disease histology (other)
chr12	93976953	93976954	rs3825199	Height
chr12	93978503	93978504	rs11107116	Height
chr12	93980087	93980088	rs10492321	Height
chr12	93983553	93983554	rs7953508	Pubertal anthropometrics
chr12	94120338	94120339	rs10859563	Height
chr12	94235164	94235165	rs61144803	Alzheimer's disease (cognitive decline)
chr12	94528824	94528825	rs3847794	Behavioural disinhibition (generation interaction)
chr12	94532764	94532765	rs11613298	Breast cancer
chr12	94543505	94543506	rs2230754	Breast cancer
chr12	94683203	94683204	rs4761470	Estradiol plasma levels (breast cancer)
chr12	94865476	94865477	rs1520724	Obesity-related traits
chr12	95490247	95490248	rs12310399	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
chr12	95696419	95696420	rs3596	Endometriosis
chr12	95711875	95711876	rs10859871	Endometriosis
chr12	95959787	95959788	rs7136572	Response to antidepressant treatment
chr12	96027758	96027759	rs17356907	Breast cancer
chr12	96027758	96027759	rs17356907	Breast size
chr12	96057183	96057184	rs2367563	Allergic dermatitis (nickel)
chr12	96271427	96271428	rs1036429	Pulmonary function (interaction)
chr12	96271427	96271428	rs1036429	Pulmonary function
chr12	96479266	96479267	rs2660869	Height
chr12	96807916	96807917	rs11108495	Weight
chr12	96858361	96858362	rs12423247	Phospholipid levels (plasma)
chr12	97528139	97528140	rs7953959	IgG glycosylation
chr12	97689767	97689768	rs10777845	Sudden cardiac arrest
chr12	97901269	97901270	rs11109072	Obesity (early onset extreme)
chr12	99190371	99190372	rs2036225	Amyotrophic lateral sclerosis (age of onset)
chr12	99334528	99334529	rs483610	Obesity-related traits
chr12	99498186	99498187	rs10860392	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr12	99816841	99816842	rs7968606	Response to antipsychotic treatment
chr12	99904539	99904540	rs1961649	Metabolite levels (HVA/5-HIAA ratio)
chr12	99961348	99961349	rs2373011	Waist circumference
chr12	99961348	99961349	rs2373011	Body mass index
chr12	100266112	100266113	rs11110077	Response to antipsychotic treatment in schizophrenia (working memory)
chr12	100820084	100820085	rs12296850	Squamous cell carcinoma
chr12	101221238	101221239	rs1399439	Alzheimer's disease (cognitive decline)
chr12	101687042	101687043	rs2290720	Brain structure (hippocampal volume)
chr12	101753953	101753954	rs10507130	Coronary artery calcification
chr12	102020445	102020446	rs10860757	Lung function (forced expiratory volume in 1 second)
chr12	102321934	102321935	rs4622329	Systemic lupus erythematosus
chr12	102373787	102373788	rs7971536	Height
chr12	102513530	102513531	rs2292303	Height
chr12	102726337	102726338	rs1520223	Height
chr12	102799597	102799598	rs5742692	Height
chr12	102875568	102875569	rs35767	Fasting insulin-related traits
chr12	102875568	102875569	rs35767	Fasting glucose-related traits
chr12	102912557	102912558	rs35747	Fasting insulin-related traits (interaction with BMI)
chr12	102965328	102965329	rs7964748	Thiazide-induced adverse metabolic effects in hypertensive patients
chr12	103125689	103125690	rs2172873	Uterine fibroids
chr12	103483093	103483094	rs10745954	C-reactive protein
chr12	103495150	103495151	rs10778213	C-reactive protein
chr12	103912505	103912506	rs10861032	Coronary restenosis
chr12	104034318	104034319	rs1650123	IgG glycosylation
chr12	104139033	104139034	rs7306642	vWF and FVIII levels
chr12	104192823	104192824	rs4964805	Attention deficit hyperactivity disorder
chr12	104317995	104317996	rs1165668	Coronary heart disease
chr12	104318171	104318172	rs1165669	Coronary heart disease
chr12	104421807	104421808	rs2629751	Hepatitis C induced liver fibrosis
chr12	104445741	104445742	rs1564892	Corneal structure
chr12	104818191	104818192	rs11112046	Obesity-related traits
chr12	105017163	105017164	rs12811699	Cannabis dependence
chr12	105452441	105452442	rs10861337	IgG glycosylation
chr12	105458796	105458797	rs10861342	IgG glycosylation
chr12	106108718	106108719	rs10219670	Alzheimer's disease biomarkers
chr12	106785553	106785554	rs6539267	Tourette syndrome
chr12	106949986	106949987	rs4964469	Parkinson's disease
chr12	106950694	106950695	rs3891355	Cognitive test performance
chr12	107149421	107149422	rs2067615	Heart rate
chr12	107229704	107229705	rs10444533	Social autistic-like traits
chr12	107367224	107367225	rs1053051	Bone mineral density
chr12	107704704	107704705	rs1820460	Cognitive performance
chr12	108602969	108602970	rs7313402	Temperament (bipolar disorder)
chr12	108699031	108699032	rs1878022	Response to platinum-based chemotherapy in non-small-cell lung cancer
chr12	108742819	108742820	rs17040430	Bipolar disorder
chr12	108767332	108767333	rs10861905	Erectile dysfunction and prostate cancer treatment
chr12	108841862	108841863	rs11113894	Obesity-related traits
chr12	108877540	108877541	rs918304	IgG glycosylation
chr12	109025426	109025427	rs8179116	Conduct disorder (symptom count)
chr12	109840939	109840940	rs9943753	HDL cholesterol
chr12	109895167	109895168	rs2338104	HDL cholesterol
chr12	110000192	110000193	rs7134594	HDL cholesterol
chr12	110368200	110368201	rs2292354	Metabolic syndrome
chr12	110398144	110398145	rs4766646	Metabolite levels (MHPG)
chr12	110704486	110704487	rs11065611	Protein quantitative trait loci
chr12	111155530	111155531	rs11065706	Heart rate
chr12	111333621	111333622	rs10849915	Alcohol consumption
chr12	111340242	111340243	rs10774610	Drinking behavior
chr12	111350654	111350655	rs3782889	Coronary heart disease
chr12	111414460	111414461	rs12229654	Glycemic traits
chr12	111414460	111414461	rs12229654	HDL cholesterol
chr12	111414460	111414461	rs12229654	Gamma glutamyl transpeptidase
chr12	111414460	111414461	rs12229654	Alcohol consumption
chr12	111679213	111679214	rs886126	Coronary heart disease
chr12	111708457	111708458	rs1265564	Type 1 diabetes
chr12	111884607	111884608	rs3184504	Platelet counts
chr12	111884607	111884608	rs3184504	Beta-2 microglubulin plasma levels
chr12	111884607	111884608	rs3184504	Red blood cell traits
chr12	111884607	111884608	rs3184504	Hypothyroidism
chr12	111884607	111884608	rs3184504	Diastolic blood pressure
chr12	111884607	111884608	rs3184504	Type 1 diabetes autoantibodies
chr12	111884607	111884608	rs3184504	Coronary heart disease
chr12	111884607	111884608	rs3184504	Rheumatoid arthritis
chr12	111884607	111884608	rs3184504	Type 1 diabetes
chr12	111884607	111884608	rs3184504	Systolic blood pressure
chr12	111884607	111884608	rs3184504	Eosinophil counts
chr12	111887658	111887659	rs739496	Platelet counts
chr12	111904370	111904371	rs4766578	Vitiligo
chr12	111910218	111910219	rs10774625	Retinal vascular caliber
chr12	112007755	112007756	rs653178	Urate levels
chr12	112007755	112007756	rs653178	Blood pressure
chr12	112007755	112007756	rs653178	Celiac disease and Rheumatoid arthritis
chr12	112007755	112007756	rs653178	Chronic kidney disease
chr12	112007755	112007756	rs653178	Celiac disease
chr12	112007755	112007756	rs653178	Diastolic blood pressure
chr12	112072423	112072424	rs11065987	LDL cholesterol
chr12	112072423	112072424	rs11065987	Cholesterol, total
chr12	112072423	112072424	rs11065987	Tetralogy of Fallot
chr12	112072423	112072424	rs11065987	Hemoglobin
chr12	112072423	112072424	rs11065987	Hematocrit
chr12	112110488	112110489	rs3782886	Hematological and biochemical traits
chr12	112168008	112168009	rs11066015	Coronary heart disease
chr12	112168008	112168009	rs11066015	Esophageal cancer
chr12	112190437	112190438	rs6490294	Mean platelet volume
chr12	112211832	112211833	rs2238151	Stroke (ischemic)
chr12	112241765	112241766	rs671	Response to alcohol consumption (flushing response)
chr12	112241765	112241766	rs671	Alcohol dependence
chr12	112241765	112241766	rs671	Alcohol consumption (maxi-drinks)
chr12	112241765	112241766	rs671	Renal function-related traits (sCR)
chr12	112241765	112241766	rs671	Intracranial aneurysm
chr12	112241765	112241766	rs671	Triglycerides
chr12	112241765	112241766	rs671	Coronary heart disease
chr12	112241765	112241766	rs671	Drinking behavior
chr12	112241765	112241766	rs671	mean corpuscular hemoglobin concentration
chr12	112241765	112241766	rs671	Hematological and biochemical traits
chr12	112241765	112241766	rs671	Esophageal cancer
chr12	112486817	112486818	rs17696736	Type 1 diabetes
chr12	112521447	112521448	rs4767364	Upper aerodigestive tract cancers
chr12	112645400	112645401	rs2074356	Glycemic traits
chr12	112645400	112645401	rs2074356	Renal function-related traits (BUN)
chr12	112645400	112645401	rs2074356	HDL cholesterol
chr12	112645400	112645401	rs2074356	Gamma glutamyl transpeptidase
chr12	112645400	112645401	rs2074356	Esophageal cancer
chr12	112645400	112645401	rs2074356	Alcohol consumption
chr12	112645400	112645401	rs2074356	Biomedical quantitative traits
chr12	112817782	112817783	rs11066280	Drinking behavior
chr12	112817782	112817783	rs11066280	Coronary heart disease
chr12	112817782	112817783	rs11066280	Metabolite levels
chr12	112817782	112817783	rs11066280	Esophageal cancer
chr12	112817782	112817783	rs11066280	Blood pressure
chr12	112871371	112871372	rs11066301	Hematological parameters
chr12	113100993	113100994	rs17824620	Platelet counts
chr12	113158837	113158838	rs7312122	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr12	113173493	113173494	rs3803064	Platelet counts
chr12	113365620	113365621	rs11066453	Glycemic traits
chr12	113365620	113365621	rs11066453	Gamma glutamyl transpeptidase
chr12	113409175	113409176	rs2072134	HDL cholesterol
chr12	113409175	113409176	rs2072134	Alcohol consumption
chr12	113491783	113491784	rs7956193	Visceral adipose tissue adjusted for BMI
chr12	113607501	113607502	rs2384207	Response to fenofibrate (adiponectin levels)
chr12	113979655	113979656	rs11066587	Quantitative traits
chr12	114637422	114637423	rs7294372	Visceral fat
chr12	114637847	114637848	rs4767234	Airflow obstruction
chr12	114685570	114685571	rs1270884	Prostate cancer
chr12	114705585	114705586	rs1920592	Schizophrenia
chr12	114714265	114714266	rs10744816	Obesity-related traits
chr12	114793239	114793240	rs883079	QRS duration
chr12	114795442	114795443	rs3825214	Electrocardiographic traits
chr12	114802137	114802138	rs1895585	PR interval
chr12	114868137	114868138	rs1265507	Mammographic density
chr12	115094259	115094260	rs11067228	Serum prostate-specific antigen levels
chr12	115116351	115116352	rs59336	Colorectal cancer
chr12	115346423	115346424	rs1896312	PR interval
chr12	115352730	115352731	rs2384550	Blood pressure
chr12	115352730	115352731	rs2384550	Diastolic blood pressure
chr12	115380392	115380393	rs10850408	Alzheimer's disease
chr12	115502717	115502718	rs2194980	Metabolite levels
chr12	115552436	115552437	rs35444	Blood pressure
chr12	115836521	115836522	rs1292011	Breast cancer
chr12	115891402	115891403	rs7315438	Colorectal cancer
chr12	116211862	116211863	rs17719439	IgG glycosylation
chr12	117002657	117002658	rs2089222	Acute lymphoblastic leukemia (childhood)
chr12	117199413	117199414	rs12322695	Obesity-related traits
chr12	117295332	117295333	rs17429217	Alzheimer's disease (age of onset)
chr12	117327591	117327592	rs7294919	Hippocampal volume
chr12	117327591	117327592	rs7294919	Brain structure
chr12	117751424	117751425	rs478597	Inattentive symptoms
chr12	118106193	118106194	rs10431397	Endometriosis
chr12	118169908	118169909	rs4304868	Visceral adipose tissue adjusted for BMI
chr12	118272870	118272871	rs2723279	Migraine
chr12	118311742	118311743	rs4767631	Biochemical measures
chr12	118353870	118353871	rs10444502	Biochemical measures
chr12	118454668	118454669	rs5745796	Obesity-related traits
chr12	118524425	118524426	rs7957470	Obesity-related traits
chr12	118893247	118893248	rs11613092	Hemostatic factors and hematological phenotypes
chr12	119163078	119163079	rs11069062	Obesity-related traits
chr12	119387917	119387918	rs1997111	T-tau
chr12	119818508	119818509	rs11064768	Schizophrenia
chr12	119989645	119989646	rs7137869	Aging traits
chr12	120455763	120455764	rs11064994	Cognitive performance
chr12	120562973	120562974	rs11065028	Obesity-related traits
chr12	120880433	120880434	rs17431357	Insulin resistance/response
chr12	120974509	120974510	rs614226	Type 1 diabetes nephropathy
chr12	121160614	121160615	rs2066938	Metabolic traits
chr12	121175523	121175524	rs2014355	Metabolite levels
chr12	121236257	121236258	rs1039302	Quantitative traits
chr12	121363723	121363724	rs6489785	Longevity
chr12	121388961	121388962	rs2650000	Metabolic traits
chr12	121388961	121388962	rs2650000	LDL cholesterol
chr12	121402931	121402932	rs7305618	C-reactive protein
chr12	121402931	121402932	rs7305618	Type 2 diabetes
chr12	121403723	121403724	rs7953249	Chronic obstructive pulmonary disease-related biomarkers
chr12	121403723	121403724	rs7953249	N-glycan levels
chr12	121405125	121405126	rs2251468	Homocysteine levels
chr12	121416649	121416650	rs1169288	LDL cholesterol
chr12	121416649	121416650	rs1169288	Cholesterol, total
chr12	121416649	121416650	rs1169288	Gamma gluatamyl transferase levels
chr12	121416987	121416988	rs2244608	Urate levels
chr12	121420259	121420260	rs7979473	C-reactive protein
chr12	121420806	121420807	rs1183910	C-reactive protein
chr12	121423955	121423956	rs2393791	C-reactive protein and white blood cell count
chr12	121423955	121423956	rs2393791	Gamma glutamyl transpeptidase
chr12	121424860	121424861	rs7310409	Liver enzyme levels (gamma-glutamyl transferase)
chr12	121424860	121424861	rs7310409	C-reactive protein
chr12	121435586	121435587	rs2259816	C-reactive protein
chr12	121435586	121435587	rs2259816	Coronary heart disease
chr12	121438843	121438844	rs735396	N-glycan levels
chr12	121439432	121439433	rs1169310	C-reactive protein
chr12	121442669	121442670	rs1169313	Liver enzyme levels
chr12	121460685	121460686	rs7957197	Type 2 diabetes
chr12	121471336	121471337	rs3213545	Cardiovascular disease risk factors
chr12	121622303	121622304	rs3751143	Chronic obstructive pulmonary disease-related biomarkers
chr12	121938184	121938185	rs10849893	Fasting glucose-related traits (interaction with BMI)
chr12	122276254	122276255	rs4298948	Obesity-related traits
chr12	122365582	122365583	rs7961894	Mean platelet volume
chr12	122365582	122365583	rs7961894	Platelet counts
chr12	122395776	122395777	rs830124	Urinary metabolites
chr12	122625991	122625992	rs7953704	Urate levels
chr12	122630908	122630909	rs1043763	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr12	123174742	123174743	rs601339	Adiponectin levels
chr12	123296293	123296294	rs12817488	Parkinson's disease
chr12	123387921	123387922	rs10847980	Adiponectin levels
chr12	123414348	123414349	rs2270788	IgG glycosylation
chr12	123457618	123457619	rs7296418	Platelet counts
chr12	123575741	123575742	rs1727307	Platelet counts
chr12	123656724	123656725	rs1790100	Multiple sclerosis
chr12	123731422	123731423	rs11532322	Schizophrenia
chr12	123796237	123796238	rs4759375	HDL cholesterol
chr12	123822710	123822711	rs7980687	Head circumference (infant)
chr12	123823545	123823546	rs11830103	Height
chr12	124085501	124085502	rs786425	Pubertal anthropometrics
chr12	124203831	124203832	rs6488898	Adiponectin levels
chr12	124316875	124316876	rs7978454	IgG glycosylation
chr12	124375209	124375210	rs10773046	Osteoarthritis (hip)
chr12	124399549	124399550	rs1316952	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr12	124399549	124399550	rs1316952	Visceral adipose tissue adjusted for BMI
chr12	124460166	124460167	rs4765127	Triglycerides
chr12	124460166	124460167	rs4765127	HDL cholesterol
chr12	124491528	124491529	rs1187415	Adiponectin levels
chr12	124499541	124499542	rs1048497	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr12	124499541	124499542	rs1048497	Visceral adipose tissue adjusted for BMI
chr12	124519845	124519846	rs1716403	Response to fenofibrate (adiponectin levels)
chr12	124894183	124894184	rs12582168	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
chr12	125002322	125002323	rs150954431	Cocaine dependence
chr12	125033932	125033933	rs12423712	Cognitive performance
chr12	125261592	125261593	rs838880	HDL cholesterol
chr12	125307052	125307053	rs11057830	Vitamin E levels
chr12	125312424	125312425	rs10846744	Lipoprotein-associated phospholipase A2 activity and mass
chr12	125316742	125316743	rs11057841	Lipoprotein-associated phospholipase A2 activity and mass
chr12	125320849	125320850	rs4765623	Renal cell carcinoma
chr12	127792613	127792614	rs1823172	Sudden cardiac arrest
chr12	127813740	127813741	rs10744304	Depression (quantitative trait)
chr12	128304417	128304418	rs11059374	Response to amphetamines
chr12	128736521	128736522	rs12297524	Palmitic acid (16:0) plasma levels
chr12	128782021	128782022	rs11059635	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)
chr12	129095071	129095072	rs7296262	Suicide attempts in bipolar disorder
chr12	129186189	129186190	rs10773568	Height
chr12	129300693	129300694	rs1385374	Systemic lupus erythematosus
chr12	129324937	129324938	rs10744391	Renal sinus fat
chr12	129475938	129475939	rs643473	Aging
chr12	129637347	129637348	rs12824981	Heart rate
chr12	129646571	129646572	rs12580240	IgG glycosylation
chr12	129646600	129646601	rs12580533	IgG glycosylation
chr12	130230406	130230407	rs7979367	Illicit drug use
chr12	130230406	130230407	rs7979367	Behavioural disinhibition (generation interaction)
chr12	130497471	130497472	rs1624802	Obesity-related traits
chr12	130630934	130630935	rs11060736	Gambling
chr12	131022009	131022010	rs1464108	Alzheimer's disease
chr12	131352561	131352562	rs7304057	Response to amphetamines
chr12	131390753	131390754	rs7299940	Panic disorder
chr12	131525052	131525053	rs3847687	Longevity
chr12	131576190	131576191	rs1569019	Height
chr12	131621761	131621762	rs885389	RR interval (heart rate)
chr12	131862902	131862903	rs7965445	Mortality among heart failure patients
chr12	131939919	131939920	rs10466868	Protein quantitative trait loci
chr12	132014205	132014206	rs10773920	Obesity-related traits
chr12	132085195	132085196	rs7315621	Longevity
chr12	132325238	132325239	rs6598163	Migraine
chr12	133345808	133345809	rs12282	Immune response to smallpox vaccine (IL-6)
chr13	19311240	19311241	rs9552416	Fasting insulin-related traits (interaction with BMI)
chr13	20736215	20736216	rs6490525	Capecitabine sensitivity
chr13	21050574	21050575	rs7989332	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr13	21093603	21093604	rs4770049	Obesity-related traits
chr13	21131210	21131211	rs9506514	Coronary artery calcification
chr13	21209511	21209512	rs7326068	Schizophrenia, bipolar disorder and depression (combined)
chr13	21280033	21280034	rs735539	Dental caries
chr13	21815868	21815869	rs17064136	Obesity-related traits
chr13	21876095	21876096	rs9788333	Thiazide-induced adverse metabolic effects in hypertensive patients
chr13	21915113	21915114	rs17356983	Obesity-related traits
chr13	22305098	22305099	rs518590	Response to antipsychotic treatment
chr13	22487624	22487625	rs17369571	Protein quantitative trait loci
chr13	22709669	22709670	rs7318731	RR interval (heart rate)
chr13	22754092	22754093	rs9580312	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
chr13	23228690	23228691	rs1034200	Corneal structure
chr13	23228690	23228691	rs1034200	Central corneal thickness
chr13	23294032	23294033	rs373767	Myopia (pathological)
chr13	23692977	23692978	rs4770394	Bipolar disorder
chr13	23744378	23744379	rs9507041	Cannabis dependence
chr13	23755126	23755127	rs4770403	Alcohol dependence
chr13	23864656	23864657	rs9552911	Type 2 diabetes
chr13	23903790	23903791	rs4770433	Protein quantitative trait loci
chr13	24042509	24042510	rs10162002	Hypothyroidism
chr13	24127209	24127210	rs1572072	Nasopharyngeal carcinoma
chr13	24205194	24205195	rs9510787	Nasopharyngeal carcinoma
chr13	24293858	24293859	rs753955	Lung cancer
chr13	24296861	24296862	rs7324557	Visceral adipose tissue adjusted for BMI
chr13	24432466	24432467	rs9318086	Myopia (pathological)
chr13	24504954	24504955	rs2765086	Weight
chr13	24598383	24598384	rs17079773	Inattentive symptoms
chr13	24654227	24654228	rs17079928	Orofacial clefts
chr13	24658355	24658356	rs9805786	Depression and alcohol dependence
chr13	24795488	24795489	rs715921	Airflow obstruction
chr13	24980948	24980949	rs1816752	Obesity-related traits
chr13	25082629	25082630	rs9581094	Sudden cardiac arrest
chr13	25247285	25247286	rs1530530	Obesity-related traits
chr13	25533830	25533831	rs2483374	Obesity-related traits
chr13	26007976	26007977	rs7322916	Eating disorders
chr13	26037959	26037960	rs4770837	Bipolar disorder and schizophrenia
chr13	26724327	26724328	rs17511627	Alzheimer's disease
chr13	27415672	27415673	rs9319321	Asthma (toluene diisocyanate-induced)
chr13	27531266	27531267	rs17085007	Ulcerative colitis
chr13	27531266	27531267	rs17085007	Inflammatory bowel disease
chr13	27879525	27879526	rs10507380	Electrocardiographic traits
chr13	27920610	27920611	rs9512637	Alcoholism (heaviness of drinking)
chr13	28020179	28020180	rs4771122	Body mass index
chr13	28058403	28058404	rs7336332	Weight
chr13	28077143	28077144	rs9512730	Schizophrenia
chr13	28197435	28197436	rs7097	Large B-cell lymphoma
chr13	28360486	28360487	rs1923834	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
chr13	28429737	28429738	rs9512900	Attention deficit hyperactivity disorder and conduct disorder
chr13	28491197	28491198	rs2293941	Fasting glucose-related traits (interaction with BMI)
chr13	28929710	28929711	rs17086609	Cognitive performance
chr13	28984062	28984063	rs9508025	Coronary heart disease
chr13	29164782	29164783	rs9579199	Breast cancer (menopausal hormone therapy interaction)
chr13	29278449	29278450	rs1305088	Non-alcoholic fatty liver disease histology (other)
chr13	29368705	29368706	rs954108	Obesity-related traits
chr13	29431337	29431338	rs1161463	Attention deficit hyperactivity disorder symptoms (interaction)
chr13	29620653	29620654	rs2479768	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr13	29898782	29898783	rs61999321	Obesity-related traits
chr13	29961331	29961332	rs2388082	Insomnia (caffeine-induced)
chr13	30347834	30347835	rs2892463	Non-word repetition
chr13	30458736	30458737	rs9314986	Biliary atresia
chr13	30885222	30885223	rs185694	Antineutrophil cytoplasmic antibody-associated vasculitis
chr13	30957687	30957688	rs7335631	Fat distribution (HIV)
chr13	31113378	31113379	rs11618202	MRI atrophy measures
chr13	31314454	31314455	rs3885907	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)
chr13	31314679	31314680	rs3922435	Non-word repetition
chr13	31819324	31819325	rs9542236	Age-related macular degeneration
chr13	32125314	32125315	rs1902272	Metabolite levels (HVA/MHPG ratio)
chr13	32710519	32710520	rs7331540	IgG glycosylation
chr13	32953387	32953388	rs4942486	LDL cholesterol
chr13	32972625	32972626	rs11571833	Breast cancer
chr13	33147051	33147052	rs718444	Height
chr13	33147547	33147548	rs7332115	Height
chr13	33387245	33387246	rs990324	Total ventricular volume
chr13	33680853	33680854	rs642899	Behavioural disinhibition (generation interaction)
chr13	33693836	33693837	rs9315204	Intracranial aneurysm
chr13	33798261	33798262	rs2555603	Body mass index (asthmatics)
chr13	34654917	34654918	rs690705	Alzheimer's disease
chr13	34894788	34894789	rs492452	Response to cholinesterase inhibitors in Alzheimer's disease
chr13	34903091	34903092	rs571411	Obesity-related traits
chr13	34906054	34906055	rs627871	Obesity-related traits
chr13	34950526	34950527	rs17798800	Response to cholinesterase inhibitors in Alzheimer's disease
chr13	35768788	35768789	rs17051917	Migraine with aura
chr13	36177818	36177819	rs1777672	HIV-1 control
chr13	36351765	36351766	rs7328278	Asthma (childhood onset)
chr13	36441098	36441099	rs12428086	Obesity-related traits
chr13	36454192	36454193	rs2051090	Non-alcoholic fatty liver disease
chr13	36476446	36476447	rs6563210	Height
chr13	36531547	36531548	rs34065801	Breast size
chr13	36652616	36652617	rs1926320	Vertical cup-disc ratio
chr13	36663301	36663302	rs9315385	Heart rate variability traits
chr13	36771016	36771017	rs7327064	Economic and political preferences
chr13	37762636	37762637	rs2323397	Palmitoleic acid (16:1n-7) plasma levels
chr13	38035188	38035189	rs1590305	Hip geometry
chr13	38065445	38065446	rs9646096	Age-related macular degeneration
chr13	38363449	38363450	rs9548050	Obesity-related traits
chr13	38531580	38531581	rs9548119	Self-rated health
chr13	39370594	39370595	rs9594293	Cytomegalovirus antibody response
chr13	39516626	39516627	rs9315632	Metabolic syndrome
chr13	39903242	39903243	rs6563695	Preeclampsia
chr13	40118067	40118068	rs9315702	Hippocampal atrophy
chr13	40350911	40350912	rs7993214	Psoriasis
chr13	40505509	40505510	rs9548988	Ulcerative colitis
chr13	40741906	40741907	rs9315762	Presence of antiphospholipid antibodies
chr13	40807482	40807483	rs10492681	Select biomarker traits
chr13	40948150	40948151	rs913246	Bipolar disorder and schizophrenia
chr13	41013976	41013977	rs941823	Inflammatory bowel disease
chr13	41013976	41013977	rs941823	Ulcerative colitis
chr13	41109428	41109429	rs2755237	Central corneal thickness
chr13	41110883	41110884	rs2721051	Corneal structure
chr13	41110883	41110884	rs2721051	Central corneal thickness
chr13	41558109	41558110	rs7329174	Systemic lupus erythematosus
chr13	41558109	41558110	rs7329174	Crohn's disease
chr13	42139244	42139245	rs17594362	Multiple sclerosis
chr13	42505673	42505674	rs1900442	Tuberculosis
chr13	42559075	42559076	rs7336933	Calcium levels
chr13	42591838	42591839	rs9532969	Metabolite levels  (X-11787)
chr13	42631718	42631719	rs6561030	Height
chr13	42653436	42653437	rs1012053	Bipolar disorder
chr13	42754521	42754522	rs4142110	Nephrolithiasis
chr13	42951448	42951449	rs9533090	Bone mineral density
chr13	42951448	42951449	rs9533090	Bone mineral density (spine)
chr13	42952144	42952145	rs9594738	Bone mineral density
chr13	42952144	42952145	rs9594738	Bone mineral density (hip)
chr13	42956620	42956621	rs17638544	Bone mineral density
chr13	43032592	43032593	rs9594759	Bone mineral density (spine)
chr13	43052879	43052880	rs2062305	Crohn's disease
chr13	43116132	43116133	rs1021188	Bone mineral density
chr13	43128576	43128577	rs9525638	Cortical thickness
chr13	43570800	43570801	rs17064002	Obesity-related traits
chr13	43727848	43727849	rs1324015	Cognitive performance
chr13	43770473	43770474	rs9533425	End-stage coagulation
chr13	43834269	43834270	rs17538444	Major depressive disorder
chr13	44217063	44217064	rs4942242	Response to tocilizumab in rheumatoid arthritis
chr13	44457924	44457925	rs3764147	Crohn's disease
chr13	44457924	44457925	rs3764147	Leprosy
chr13	44627787	44627788	rs17065323	Uric acid levels
chr13	44637404	44637405	rs9567349	Prostate cancer (gene x gene interaction)
chr13	44702868	44702869	rs9525916	Homeostasis model assessment of insulin resistance (interaction)
chr13	44702868	44702869	rs9525916	Fasting insulin (interaction)
chr13	44808173	44808174	rs9533799	Amyotrophic lateral sclerosis
chr13	45055090	45055091	rs17065868	Antineutrophil cytoplasmic antibody-associated vasculitis
chr13	45493880	45493881	rs17648246	Oleic acid (18:1n-9) plasma levels
chr13	45900266	45900267	rs7323755	Myopia (pathological)
chr13	46703141	46703142	rs7324845	Non-alcoholic fatty liver disease histology (other)
chr13	46833716	46833717	rs958546	Atrial fibrillation
chr13	47573615	47573616	rs12583882	Subcutaneous adipose tissue
chr13	47898878	47898879	rs1417205	Cannabis use (initiation)
chr13	48162557	48162558	rs2478333	QT interval
chr13	48198715	48198716	rs1575891	Cardiac hypertrophy
chr13	48387721	48387722	rs8001976	Aging (time to event)
chr13	48436924	48436925	rs11620399	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr13	48436924	48436925	rs11620399	Visceral adipose tissue adjusted for BMI
chr13	49466930	49466931	rs1449572	Multiple myeloma (IgH translocation)
chr13	50080846	50080847	rs2031532	Cardiac hypertrophy
chr13	50185203	50185204	rs9568281	Multiple sclerosis
chr13	50291841	50291842	rs9535307	Obesity-related traits
chr13	50306220	50306221	rs3736830	Menopause (age at onset)
chr13	50563446	50563447	rs9596219	Height
chr13	50835714	50835715	rs2762051	Celiac disease
chr13	50841322	50841323	rs806321	Multiple sclerosis
chr13	50842439	50842440	rs9596270	Multiple sclerosis
chr13	50986117	50986118	rs201789	Anthropometric traits
chr13	51066622	51066623	rs1262778	Bipolar disorder and major depressive disorder (combined)
chr13	51094113	51094114	rs9316500	Pulmonary function decline
chr13	51105333	51105334	rs3118905	Height
chr13	51106554	51106555	rs1239947	Height
chr13	51106787	51106788	rs3118906	Height
chr13	51106787	51106788	rs3118906	Pubertal anthropometrics
chr13	51111354	51111355	rs3116602	Height
chr13	51116900	51116901	rs3118914	Height
chr13	51119136	51119137	rs1239954	Obesity-related traits
chr13	51194404	51194405	rs573666	Osteosarcoma
chr13	51390597	51390598	rs9316505	Primary tooth development (number of teeth)
chr13	51724663	51724664	rs7325564	IgG glycosylation
chr13	53494693	53494694	rs9536318	Airflow obstruction
chr13	53517883	53517884	rs732949	Immune response to anthrax vaccine
chr13	53968090	53968091	rs10507577	Select biomarker traits
chr13	54064980	54064981	rs9568856	Obesity
chr13	54107351	54107352	rs9568867	Obesity
chr13	54290332	54290333	rs2806731	Obesity-related traits
chr13	54435236	54435237	rs6561750	Bipolar disorder and schizophrenia
chr13	54581086	54581087	rs9536591	Stroke
chr13	54633372	54633373	rs9596905	DNA methylation (variation)
chr13	55984995	55984996	rs2315885	Blood pressure
chr13	56772695	56772696	rs1512651	Warfarin maintenance dose
chr13	58904312	58904313	rs10492604	Sleep duration
chr13	59128525	59128526	rs4886088	Subcutaneous adipose tissue
chr13	59953465	59953466	rs12585963	Breast size
chr13	61113738	61113739	rs4886238	Menopause (age at onset)
chr13	61513668	61513669	rs7337573	Phospholipid levels (plasma)
chr13	61678911	61678912	rs3106598	Longevity
chr13	61965302	61965303	rs2323266	Schizophrenia
chr13	62930299	62930300	rs9563960	IgG glycosylation
chr13	63436799	63436800	rs2204037	QT interval
chr13	63634349	63634350	rs9317284	Bone mineral density
chr13	63638328	63638329	rs3119939	Asthma
chr13	64141912	64141913	rs1000589	Pancreatic cancer
chr13	66120783	66120784	rs1333026	Body mass index
chr13	66212019	66212020	rs11619878	IgG glycosylation
chr13	66356340	66356341	rs17077331	Pulmonary function decline
chr13	66481814	66481815	rs1585440	Pancreatic cancer
chr13	66967621	66967622	rs17081231	Obesity
chr13	67696144	67696145	rs2875517	Dental caries
chr13	68572036	68572037	rs7318913	Serum dimethylarginine levels (symmetric)
chr13	69530663	69530664	rs2066219	Diabetes related insulin traits
chr13	69919398	69919399	rs2593525	Obesity-related traits
chr13	70023684	70023685	rs352236	Obesity-related traits
chr13	70086329	70086330	rs9572182	Homeostasis model assessment of beta-cell function (interaction)
chr13	70430092	70430093	rs2325244	Response to amphetamines
chr13	70454959	70454960	rs11843309	Bilirubin levels
chr13	70455660	70455661	rs7984606	Cognitive performance
chr13	70810222	70810223	rs1928007	Word reading
chr13	70846202	70846203	rs9572423	Major depressive disorder
chr13	71883213	71883214	rs9592783	Longevity
chr13	72174352	72174353	rs9919839	Adverse response to lamotrigine and phenytoin
chr13	72345504	72345505	rs584480	Urate levels
chr13	72347695	72347696	rs626277	Chronic kidney disease
chr13	72688773	72688774	rs9652236	Obsessive-compulsive disorder
chr13	72768708	72768709	rs4083578	Cognitive performance
chr13	73559981	73559982	rs8002688	Blood pressure measurement (low sodium intervention)
chr13	73728138	73728139	rs9600079	Prostate cancer
chr13	73741148	73741149	rs11838472	Myopia (pathological)
chr13	73908845	73908846	rs9573163	Pancreatic cancer
chr13	73916627	73916628	rs9543325	Pancreatic cancer
chr13	73932113	73932114	rs1886449	Pancreatic cancer
chr13	74433806	74433807	rs4883955	Bronchopulmonary dysplasia
chr13	74520185	74520186	rs1886512	QRS duration
chr13	74730391	74730392	rs8000245	Optic disc size (rim)
chr13	74742321	74742322	rs12429889	Sudden cardiac arrest
chr13	74995659	74995660	rs17714988	Immune reponse to smallpox (secreted IFN-alpha)
chr13	75128113	75128114	rs17718828	Phospholipid levels (plasma)
chr13	75776267	75776268	rs548097	Heart failure
chr13	76136647	76136648	rs9543976	Diabetic retinopathy
chr13	76249102	76249103	rs11841001	Corneal astigmatism
chr13	76326281	76326282	rs539514	Type 1 diabetes
chr13	77879375	77879376	rs7322722	Preeclampsia
chr13	78381145	78381146	rs975739	Hair color
chr13	78808913	78808914	rs9574199	Total ventricular volume
chr13	79359423	79359424	rs17070284	Cognitive performance
chr13	79380815	79380816	rs2184180	IgG glycosylation
chr13	79382100	79382101	rs9574309	IgG glycosylation
chr13	79410573	79410574	rs11838918	Conduct disorder (symptom count)
chr13	79410573	79410574	rs11838918	Conduct disorder (case status)
chr13	79455831	79455832	rs1218282	Response to statin therapy
chr13	79550933	79550934	rs7319358	Ulcerative colitis
chr13	79888475	79888476	rs1155848	Response to anti-TNF alpha therapy in inflammatory bowel disease
chr13	80169003	80169004	rs9601248	Major depressive disorder
chr13	80299721	80299722	rs2039553	Pancreatic cancer
chr13	80623345	80623346	rs7981942	Fasting insulin-related traits (interaction with BMI)
chr13	80644617	80644618	rs12431307	Obesity-related traits
chr13	80668873	80668874	rs9574565	Orofacial clefts
chr13	80692810	80692811	rs8001641	Orofacial clefts
chr13	80717155	80717156	rs1359790	Type 2 diabetes
chr13	80959206	80959207	rs534870	Adiposity
chr13	81357670	81357671	rs11149178	Major depressive disorder
chr13	82075591	82075592	rs9545740	Obesity-related traits
chr13	84130231	84130232	rs6563353	Response to citalopram treatment
chr13	85032326	85032327	rs17371334	Temperament (bipolar disorder)
chr13	85054265	85054266	rs9546711	Coronary heart disease
chr13	85251711	85251712	rs9319064	Obesity-related traits
chr13	85549735	85549736	rs9531686	Anorexia nervosa
chr13	85665878	85665879	rs17079247	Bipolar disorder (mania)
chr13	86690526	86690527	rs7984869	Economic and political preferences (fairness)
chr13	87242856	87242857	rs4773460	Hippocampal atrophy
chr13	88704705	88704706	rs7323893	Coronary heart disease
chr13	88762345	88762346	rs969962	Cognitive performance
chr13	90622454	90622455	rs2882281	Longevity
chr13	90865545	90865546	rs16944141	Prostate cancer (gene x gene interaction)
chr13	91732769	91732770	rs61970269	Metabolite levels (5-HIAA)
chr13	92015976	92015977	rs8002779	Height
chr13	92024573	92024574	rs7319045	Height
chr13	92203812	92203813	rs16946160	Nephrotic syndrome (acquired)
chr13	92445228	92445229	rs2352028	Lung cancer
chr13	92501663	92501664	rs7328464	Obesity-related traits
chr13	92988322	92988323	rs7982677	Tetralogy of Fallot
chr13	93088650	93088651	rs4771859	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr13	93213475	93213476	rs1413191	HIV-1 control
chr13	93323145	93323146	rs17267292	Metabolite levels
chr13	93331885	93331886	rs9523762	Multiple sclerosis
chr13	93581790	93581791	rs9523848	Breast size
chr13	93938705	93938706	rs11839514	Visceral fat
chr13	93945857	93945858	rs143258881	Alzheimer's disease (cognitive decline)
chr13	94011168	94011169	rs9561329	Neuroticism
chr13	94208648	94208649	rs190494527	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr13	94233128	94233129	rs7998314	Obesity-related traits
chr13	94341095	94341096	rs9561428	Bipolar disorder and schizophrenia
chr13	94408505	94408506	rs7995215	Attention deficit hyperactivity disorder
chr13	94870764	94870765	rs1572050	Renal sinus fat
chr13	94952831	94952832	rs9301951	Disc degeneration (lumbar)
chr13	95388116	95388117	rs184488877	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr13	95463391	95463392	rs9302001	Panic disorder
chr13	95505261	95505262	rs11070098	Obesity-related traits
chr13	95680284	95680285	rs4148546	Longevity
chr13	95775431	95775432	rs16950650	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
chr13	95874955	95874956	rs1926657	Breast cancer
chr13	95898206	95898207	rs4148441	Platelet counts
chr13	96951432	96951433	rs2038823	Diabetic retinopathy
chr13	97017547	97017548	rs7989336	Obesity
chr13	98016415	98016416	rs9556711	Alcoholism (alcohol use disorder factor score)
chr13	98016415	98016416	rs9556711	Alcoholism (alcohol dependence factor score)
chr13	98053791	98053792	rs4771996	Obesity-related traits
chr13	98200571	98200572	rs2770228	Metabolite levels (Dihydroxy docosatrienoic acid)
chr13	98203726	98203727	rs349114	Obesity-related traits
chr13	98827034	98827035	rs285098	Migraine
chr13	98831594	98831595	rs9556893	Response to amphetamines
chr13	98960761	98960762	rs4318070	Total ventricular volume
chr13	98966316	98966317	rs688872	Brain structure
chr13	98994029	98994030	rs9584805	Non-alcoholic fatty liver disease histology (lobular)
chr13	99096033	99096034	rs9517302	Obesity-related traits
chr13	99111208	99111209	rs3783006	Educational attainment
chr13	99126302	99126303	rs9517320	Longevity
chr13	99131293	99131294	rs912330	Alzheimer's disease
chr13	99385989	99385990	rs9582259	Immune reponse to smallpox (secreted IL-1beta)
chr13	99774646	99774647	rs11069349	Self-reported allergy
chr13	99956621	99956622	rs9557195	Inflammatory bowel disease
chr13	100041737	100041738	rs7335046	Basal cell carcinoma
chr13	100196951	100196952	rs9513627	Obesity-related traits
chr13	100493159	100493160	rs9513675	Obesity-related traits
chr13	100518633	100518634	rs41281112	Vitamin B12 levels
chr13	100555037	100555038	rs7992643	Attention deficit hyperactivity disorder
chr13	100638391	100638392	rs13542	Orofacial clefts
chr13	100818091	100818092	rs2184971	Refractive error
chr13	101708309	101708310	rs2044117	Bipolar disorder and schizophrenia
chr13	102000944	102000945	rs7996217	HIV-associated dementia
chr13	102051089	102051090	rs9557635	Non-small cell lung cancer
chr13	102060075	102060076	rs1572591	Psychosis (atypical)
chr13	102145559	102145560	rs1335587	Obesity-related traits
chr13	102227494	102227495	rs9557704	Waist-to-hip circumference ratio (interaction)
chr13	102553247	102553248	rs9557754	QT interval
chr13	102680125	102680126	rs11617740	Preeclampsia
chr13	102849264	102849265	rs544434	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)
chr13	103867103	103867104	rs912969	Smoking behavior
chr13	103928006	103928007	rs1529276	Prostate cancer
chr13	103969490	103969491	rs4771450	Uric acid levels
chr13	104060086	104060087	rs9586179	Phospholipid levels (plasma)
chr13	104091544	104091545	rs583464	Response to amphetamines
chr13	104186918	104186919	rs16962638	Insulin resistance/response
chr13	105039145	105039146	rs17450420	Esophageal cancer  (alcohol interaction)
chr13	105807022	105807023	rs16965962	Response to citalopram treatment
chr13	105835169	105835170	rs16966085	Obesity-related traits
chr13	106067919	106067920	rs17655948	Periodontitis (DPAL)
chr13	106096811	106096812	rs11618212	Myopia (pathological)
chr13	106249308	106249309	rs1549059	Obesity-related traits
chr13	106589140	106589141	rs7336109	Visceral fat
chr13	106596718	106596719	rs488248	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
chr13	106651660	106651661	rs4996815	Bipolar disorder and schizophrenia
chr13	106785264	106785265	rs1372791	Immune reponse to smallpox (secreted IL-2)
chr13	107700217	107700218	rs9558942	Obesity-related traits
chr13	107780315	107780316	rs1927745	Depression (quantitative trait)
chr13	108134908	108134909	rs9520462	Reading and spelling
chr13	108257219	108257220	rs957788	Anorexia nervosa
chr13	108484453	108484454	rs2036707	Obesity-related traits
chr13	108491591	108491592	rs1509091	Metabolite levels (Pyroglutamine)
chr13	108668546	108668547	rs12871532	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr13	108816224	108816225	rs10492664	Attention deficit hyperactivity disorder and conduct disorder
chr13	109347658	109347659	rs7984522	Blood pressure
chr13	109380725	109380726	rs10492418	Presence of antiphospholipid antibodies
chr13	109455834	109455835	rs984300	Obesity-related traits
chr13	109473945	109473946	rs17393344	Alzheimer's disease (cognitive decline)
chr13	109502848	109502849	rs17485138	Dental caries
chr13	109511058	109511059	rs814141	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr13	110572209	110572210	rs7323507	Lung function (forced vital capacity)
chr13	110790231	110790232	rs641862	Obesity-related traits
chr13	110818597	110818598	rs3742207	Arterial stiffness
chr13	110929161	110929162	rs494558	Obesity-related traits
chr13	110960711	110960712	rs4773144	Coronary heart disease
chr13	110960942	110960943	rs3809346	Coronary artery calcification
chr13	111030577	111030578	rs7319311	Bipolar disorder and schizophrenia
chr13	111449114	111449115	rs167890	Obesity-related traits
chr13	111470037	111470038	rs767210	Cognitive performance
chr13	111781059	111781060	rs12853515	Homeostasis model assessment of insulin resistance (interaction)
chr13	111781059	111781060	rs12853515	Fasting insulin (interaction)
chr13	111818831	111818832	rs4773330	Bilirubin levels
chr13	112181436	112181437	rs9555810	Menarche (age at onset)
chr13	112221296	112221297	rs7333181	Menopause (age at onset)
chr13	112575603	112575604	rs9577381	Axial length
chr13	112836654	112836655	rs9324268	Renal transplant outcome
chr13	113331867	113331868	rs7998202	Glycated hemoglobin levels
chr13	113536626	113536627	rs1278769	Interstitial lung disease
chr13	113659107	113659108	rs4907479	Bladder cancer
chr13	113694508	113694509	rs11842874	Osteoarthritis
chr13	113752830	113752831	rs10665	End-stage coagulation
chr13	113753163	113753164	rs2181540	End-stage coagulation
chr13	113756539	113756540	rs555212	End-stage coagulation
chr13	113760033	113760034	rs561241	Prothrombin time
chr13	113760033	113760034	rs561241	Factor VII
chr13	113772706	113772707	rs6041	End-stage coagulation
chr13	113793848	113793849	rs3211770	End-stage coagulation
chr13	114012897	114012898	rs7317038	Mean platelet volume
chr13	114507238	114507239	rs9329350	IgG glycosylation
chr13	114622596	114622597	rs9604529	Response to tocilizumab in rheumatoid arthritis
chr14	20957432	20957433	rs12147450	Response to antipsychotic therapy (extrapyramidal side effects)
chr14	21024618	21024619	rs1243647	Prostate cancer (gene x gene interaction)
chr14	21261732	21261733	rs10131141	Obesity-related traits
chr14	21725653	21725654	rs17197037	Bipolar disorder
chr14	22235889	22235890	rs718433	Intraocular pressure
chr14	22481823	22481824	rs3811321	Renal transplant outcome
chr14	22607501	22607502	rs1474476	Obesity-related traits
chr14	22782376	22782377	rs11845134	Obesity-related traits
chr14	22937655	22937656	rs12589282	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
chr14	22956709	22956710	rs227869	Relative hand skill in reading disability
chr14	23002683	23002684	rs1154155	Narcolepsy
chr14	23464481	23464482	rs997154	Primary tooth development (time to first tooth eruption)
chr14	23464481	23464482	rs997154	Primary tooth development (number of teeth)
chr14	23585332	23585333	rs4982731	Acute lymphoblastic leukemia (childhood)
chr14	23589056	23589057	rs2239633	Acute lymphoblastic leukemia (B-cell precursor)
chr14	23589056	23589057	rs2239633	Acute lymphoblastic leukemia (childhood)
chr14	23840032	23840033	rs10137082	Type 1 diabetes
chr14	23861810	23861811	rs365990	Heart rate
chr14	23861810	23861811	rs365990	Electrocardiographic traits
chr14	23865884	23865885	rs452036	Resting heart rate
chr14	23977009	23977010	rs223116	Resting heart rate
chr14	24033069	24033070	rs2281680	Sudden cardiac arrest
chr14	24381514	24381515	rs12436436	Bipolar disorder
chr14	24609146	24609147	rs8010715	IgG glycosylation
chr14	24830849	24830850	rs1950500	Height
chr14	24883886	24883887	rs8017377	LDL cholesterol
chr14	25102159	25102160	rs8192917	Vitiligo
chr14	25271519	25271520	rs854384	MRI atrophy measures
chr14	25479541	25479542	rs11850957	Subcutaneous adipose tissue
chr14	25503798	25503799	rs10147992	White blood cell types
chr14	26129565	26129566	rs12586774	Obesity-related traits
chr14	26488466	26488467	rs862946	Liver enzyme levels (aspartate transaminase)
chr14	27260042	27260043	rs1951082	Attention deficit hyperactivity disorder and conduct disorder
chr14	27406891	27406892	rs17111920	Bipolar disorder and schizophrenia
chr14	27800176	27800177	rs2877832	Diabetes related insulin traits
chr14	29021927	29021928	rs7493138	Longevity
chr14	29116694	29116695	rs12587311	Phospholipid levels (plasma)
chr14	29132876	29132877	rs1956388	Ulcerative colitis
chr14	29249348	29249349	rs2038256	Multiple sclerosis--Brain Glutamate Levels
chr14	30088137	30088138	rs12431702	IgG glycosylation
chr14	30489622	30489623	rs718545	Obesity-related traits
chr14	30515111	30515112	rs11847697	Body mass index
chr14	30594656	30594657	rs225848	Sexual dysfunction (SSRI/SNRI-related)
chr14	32093547	32093548	rs7142881	Response to iloperidone treatment (QT prolongation)
chr14	32353249	32353250	rs2039485	Brain lesion load
chr14	32433857	32433858	rs915071	Bipolar disorder and schizophrenia
chr14	32851024	32851025	rs1951681	Economic and political preferences (environmentalism)
chr14	33207521	33207522	rs2300835	Fasting insulin-related traits (interaction with BMI)
chr14	33282469	33282470	rs2383378	Anorexia nervosa
chr14	33381097	33381098	rs12146962	Ankylosing spondylitis
chr14	33476265	33476266	rs4982029	Schizophrenia, bipolar disorder and depression (combined)
chr14	33480921	33480922	rs8015959	Bipolar disorder
chr14	33586562	33586563	rs17460823	Inflammatory biomarkers
chr14	33918037	33918038	rs11845867	Self-reported allergy
chr14	34844375	34844376	rs1958589	Celiac disease
chr14	35135185	35135186	rs7141276	Response to anti-TNF treatment in rheumatoid arthritis
chr14	35682171	35682172	rs12586317	Psoriasis
chr14	35832665	35832666	rs8016947	Psoriasis
chr14	36397679	36397680	rs1168987	Response to antineoplastic agents
chr14	36574017	36574018	rs1537424	Thyroid hormone levels
chr14	36649245	36649246	rs944289	Thyroid cancer
chr14	36738360	36738361	rs116909374	Thyroid cancer
chr14	36854135	36854136	rs12590640	Malaria
chr14	36989418	36989419	rs2076751	Menarche (age at onset)
chr14	37000048	37000049	rs17104630	Height
chr14	37132768	37132769	rs2236007	Breast cancer
chr14	38066574	38066575	rs12587630	Periodontitis (CDC/AAP)
chr14	38077147	38077148	rs1998359	Self-reported allergy
chr14	38683260	38683261	rs11622412	Metabolite levels (5-HIAA/ MHPG Ratio)
chr14	39020504	39020505	rs10498345	Coronary spasm
chr14	41523461	41523462	rs1959947	Hemostatic factors and hematological phenotypes
chr14	41702597	41702598	rs1612141	QT interval (interaction)
chr14	42655274	42655275	rs2154294	Alcoholism (12-month weekly alcohol consumption)
chr14	43403458	43403459	rs11157317	Multiple myeloma (hyperdiploidy)
chr14	45106631	45106632	rs12884395	Obesity-related traits
chr14	46029686	46029687	rs7140958	Bilirubin levels
chr14	47403683	47403684	rs12883384	Neuroticism
chr14	47454985	47454986	rs11627056	Obesity-related traits
chr14	47863834	47863835	rs7159841	Hemostatic factors and hematological phenotypes
chr14	47874556	47874557	rs17118552	Response to tocilizumab in rheumatoid arthritis
chr14	48015981	48015982	rs1160351	Sexual dysfunction (SSRI/SNRI-related)
chr14	48054158	48054159	rs4143912	IgG glycosylation
chr14	48564955	48564956	rs7151223	Cognitive performance
chr14	49372800	49372801	rs2352904	Cognitive test performance
chr14	49426841	49426842	rs7158872	Post-traumatic stress disorder (asjusted for relatedness)
chr14	49437930	49437931	rs2352908	Social communication problems
chr14	49463483	49463484	rs11845208	Immune reponse to smallpox (secreted IL-2)
chr14	49534424	49534425	rs8013477	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr14	49951349	49951350	rs1530947	Visceral fat
chr14	50877982	50877983	rs1265879	Cognitive performance
chr14	50973631	50973632	rs17718580	Cognitive performance
chr14	51084234	51084235	rs17122693	Cognitive performance
chr14	51170878	51170879	rs8020441	Cognitive performance
chr14	51323741	51323742	rs8019546	Dietary macronutrient intake
chr14	51403530	51403531	rs7142143	Acute lymphoblastic leukemia (childhood)
chr14	51446770	51446771	rs1959536	Psychosis (atypical)
chr14	51919821	51919822	rs7153703	Total ventricular volume
chr14	52010798	52010799	rs7140150	Brain structure
chr14	52077088	52077089	rs1006973	Anticoagulant levels
chr14	52233275	52233276	rs11626056	Hippocampal atrophy
chr14	52310103	52310104	rs8015138	Non-melanoma skin cancer
chr14	52518810	52518811	rs730532	Pulmonary function
chr14	52989227	52989228	rs745080	Orofacial clefts
chr14	53372329	53372330	rs8008270	Prostate cancer
chr14	53400628	53400629	rs17125944	Alzheimer's disease (late onset)
chr14	53837484	53837485	rs12434047	Economic and political preferences (fairness)
chr14	54072857	54072858	rs1380131	Alcoholism (heaviness of drinking)
chr14	54167471	54167472	rs210359	Immune reponse to smallpox (secreted IFN-alpha)
chr14	54290829	54290830	rs12431733	Parkinson's disease
chr14	54410918	54410919	rs4444235	Colorectal cancer
chr14	54417521	54417522	rs17563	Primary tooth development (time to first tooth eruption)
chr14	54652478	54652479	rs1953743	Dental caries
chr14	54723922	54723923	rs2143963	Metabolite levels  (X-11787)
chr14	54857285	54857286	rs4293296	Response to antipsychotic treatment in schizophrenia (working memory)
chr14	54876183	54876184	rs4251631	Dental caries
chr14	55122917	55122918	rs17127713	Obesity-related traits
chr14	55176343	55176344	rs17657012	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr14	55348117	55348118	rs3783637	Obesity-related traits
chr14	55348117	55348118	rs3783637	Rheumatoid arthritis
chr14	55614635	55614636	rs2274273	Protein biomarker
chr14	56231799	56231800	rs7494275	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
chr14	56333512	56333513	rs7350721	Body mass index (interaction)
chr14	56418118	56418119	rs10151037	Obesity-related traits
chr14	56525568	56525569	rs398652	Telomere length
chr14	56886685	56886686	rs17832777	Chronic obstructive pulmonary disease-related biomarkers
chr14	57221138	57221139	rs878889	Type 1 diabetes nephropathy
chr14	57607066	57607067	rs7144018	Multiple myeloma (IgH translocation)
chr14	57669532	57669533	rs11851015	Alcohol consumption
chr14	57822215	57822216	rs7144649	Alcohol consumption
chr14	58119195	58119196	rs10134944	Bipolar disorder
chr14	58200724	58200725	rs1092015	Bipolar disorder and schizophrenia
chr14	58355047	58355048	rs8013190	HIV-1 control
chr14	58385364	58385365	rs1335515	Attention deficit hyperactivity disorder (time to onset)
chr14	58397915	58397916	rs808225	Pulmonary function
chr14	59189360	59189361	rs17094983	Colorectal cancer
chr14	59334127	59334128	rs4901869	Panic disorder
chr14	59366314	59366315	rs405460	Obesity-related traits
chr14	60683429	60683430	rs216518	Allergic rhinitis
chr14	60903756	60903757	rs1254319	Refractive error
chr14	60957278	60957279	rs2093210	Height
chr14	61072874	61072875	rs10483727	Glaucoma (primary open-angle)
chr14	61072874	61072875	rs10483727	Vertical cup-disc ratio
chr14	61072874	61072875	rs10483727	Optic disc size (rim)
chr14	61308336	61308337	rs6573333	Immune reponse to smallpox (secreted IFN-alpha)
chr14	61734639	61734640	rs7141238	Obesity-related traits
chr14	61895044	61895045	rs11158345	Word reading
chr14	61898838	61898839	rs17098356	Reading and spelling
chr14	61908110	61908111	rs1957894	Obesity (early onset extreme)
chr14	61908331	61908332	rs1957895	Rheumatoid arthritis
chr14	62185294	62185295	rs8005745	Select biomarker traits
chr14	62518347	62518348	rs6573416	Self-rated health
chr14	62654697	62654698	rs973968	Iron status biomarkers
chr14	62678302	62678303	rs1514928	Attention deficit hyperactivity disorder
chr14	62732663	62732664	rs10146615	Economic and political preferences (immigration/crime)
chr14	62968394	62968395	rs4902141	Estradiol plasma levels (breast cancer)
chr14	63177143	63177144	rs869834	Subcutaneous adipose tissue
chr14	63322346	63322347	rs8012941	Major depressive disorder
chr14	63953521	63953522	rs11158493	Response to antineoplastic agents
chr14	64232385	64232386	rs17101394	Sphingolipid levels
chr14	64235555	64235556	rs7157785	Sphingolipid levels
chr14	64275811	64275812	rs7144584	Pulmonary function decline
chr14	64680847	64680848	rs1152591	Atrial fibrillation
chr14	64899054	64899055	rs10498514	Cognitive performance
chr14	65240948	65240949	rs11158559	Obesity-related traits
chr14	65473195	65473196	rs7148590	Blood trace element (Zn levels)
chr14	65475539	65475540	rs4466998	Mean corpuscular volume
chr14	65502238	65502239	rs7155454	Red blood cell traits
chr14	65604727	65604728	rs17102423	Obesity-related traits
chr14	65645249	65645250	rs7158173	Anthropometric traits
chr14	65747758	65747759	rs1256531	Conduct disorder (symptom count)
chr14	65758641	65758642	rs7159888	IgG glycosylation
chr14	65758641	65758642	rs7159888	N-glycan levels
chr14	65775694	65775695	rs11847263	IgG glycosylation
chr14	65865624	65865625	rs7147624	Chronic obstructive pulmonary disease-related biomarkers
chr14	65914866	65914867	rs10483776	N-glycan levels
chr14	66262962	66262963	rs8007846	Multiple sclerosis--Brain Glutamate Levels
chr14	66287909	66287910	rs7494064	Obesity-related traits
chr14	67453857	67453858	rs8020095	Depression (quantitative trait)
chr14	67939482	67939483	rs17104363	Obesity-related traits
chr14	67975821	67975822	rs1077989	Phospholipid levels (plasma)
chr14	68520905	68520906	rs8022206	Platelet counts
chr14	68660427	68660428	rs2588809	Breast cancer
chr14	68699593	68699594	rs1314913	Breast cancer (male)
chr14	68749926	68749927	rs3784099	Breast cancer (survival)
chr14	68752642	68752643	rs8008961	Acute urticaria and angiodema (non-steroidal anti-inflammatory drug-induced)
chr14	68753592	68753593	rs911263	Primary biliary cirrhosis
chr14	68785076	68785077	rs8017304	Age-related macular degeneration
chr14	68788923	68788924	rs1956529	Primary tooth development (number of teeth)
chr14	68813114	68813115	rs1570106	Height
chr14	68963745	68963746	rs765899	Breast cancer
chr14	68967381	68967382	rs737387	Breast cancer
chr14	68971775	68971776	rs2842347	Breast cancer
chr14	68973545	68973546	rs757369	Breast cancer
chr14	68974276	68974277	rs10132579	Breast cancer
chr14	68975373	68975374	rs2842346	Breast cancer
chr14	68986156	68986157	rs11624164	Obesity-related traits
chr14	69034681	69034682	rs999737	Breast cancer
chr14	69126743	69126744	rs7141529	Prostate cancer
chr14	69210198	69210199	rs4902642	Crohn's disease
chr14	69254190	69254191	rs4902647	Multiple sclerosis
chr14	69263598	69263599	rs1465788	Type 1 diabetes
chr14	69273904	69273905	rs194749	Inflammatory bowel disease
chr14	69278203	69278204	rs4899260	Celiac disease
chr14	69314058	69314059	rs434943	Fibrinogen
chr14	69360630	69360631	rs12050161	Periodontitis (Mean PAL)
chr14	69408696	69408697	rs2268983	Smoking behavior
chr14	70347347	70347348	rs11158820	Digit length ratio
chr14	70365923	70365924	rs11627546	Red blood cell traits
chr14	70502049	70502050	rs17175227	Tuberculosis
chr14	70517182	70517183	rs12883884	Cystic fibrosis severity
chr14	70620641	70620642	rs4899329	IgG glycosylation
chr14	70644168	70644169	rs7146198	Corneal curvature
chr14	71249801	71249802	rs17108533	Response to antipsychotic treatment in schizophrenia (reasoning)
chr14	71352647	71352648	rs36563	Alcohol dependence
chr14	71395603	71395604	rs2810114	Alcohol dependence
chr14	71507600	71507601	rs11848070	Alzheimer's disease (late onset)
chr14	71666296	71666297	rs17767225	Alzheimer's disease (late onset)
chr14	71987064	71987065	rs11158907	Response to alcohol consumption (flushing response)
chr14	72194400	72194401	rs17100926	Obesity-related traits
chr14	72432148	72432149	rs4902960	Economic and political preferences (environmentalism)
chr14	72692492	72692493	rs699363	Obesity (extreme)
chr14	72883873	72883874	rs7159300	Smoking cessation
chr14	73019235	73019236	rs4903031	C-reactive protein
chr14	73081067	73081068	rs2526932	C-reactive protein and white blood cell count
chr14	73756298	73756299	rs10483853	Coronary artery calcification
chr14	73767213	73767214	rs2333194	Bipolar disorder (mood-incongruent)
chr14	74551969	74551970	rs2239557	Common traits (Other)
chr14	74990745	74990746	rs862034	Height
chr14	75322793	75322794	rs8014204	Caffeine consumption
chr14	75327442	75327443	rs722599	IgG glycosylation
chr14	75365728	75365729	rs732765	Non-small cell lung cancer
chr14	75626041	75626042	rs910316	Height
chr14	75701220	75701221	rs4899554	Inflammatory bowel disease
chr14	75814027	75814028	rs11621969	Periodontal microbiota
chr14	75916463	75916464	rs84044	Obesity-related traits
chr14	75960535	75960536	rs7155603	Rheumatoid arthritis
chr14	76005556	76005557	rs2300603	Multiple sclerosis
chr14	76129590	76129591	rs724743	Height
chr14	76500302	76500303	rs9323624	Acute urticaria and angiodema (non-steroidal anti-inflammatory drug-induced)
chr14	76613677	76613678	rs935334	Blood pressure
chr14	76650763	76650764	rs2121070	Blood pressure
chr14	76703350	76703351	rs7156960	Acute lymphoblastic leukemia (childhood)
chr14	76812490	76812491	rs2360997	Attention deficit hyperactivity disorder symptoms (interaction)
chr14	77497974	77497975	rs183266	Adverse response to lamotrigine and phenytoin
chr14	77513843	77513844	rs1986116	Sleep quality
chr14	77684669	77684670	rs4467006	Bipolar disorder
chr14	77684841	77684842	rs2287375	Bipolar disorder
chr14	78534905	78534906	rs3850370	Response to platinum-based chemotherapy in non-small-cell lung cancer
chr14	78775305	78775306	rs7155434	Brain structure (temporal lobe volume)
chr14	78786076	78786077	rs11624704	Obesity
chr14	78786158	78786159	rs6574433	Cognitive performance
chr14	79899453	79899454	rs7141420	Obesity
chr14	79903375	79903376	rs2370983	Obesity
chr14	79936963	79936964	rs10150332	Body mass index
chr14	79945161	79945162	rs10146997	Waist circumference
chr14	80002095	80002096	rs7147705	Amyotrophic lateral sclerosis (age of onset)
chr14	80587140	80587141	rs10220309	Lung function (forced expiratory volume in 1 second)
chr14	81405921	81405922	rs12587252	Palmitoleic acid (16:1n-7) plasma levels
chr14	81451228	81451229	rs12101261	Graves' disease
chr14	81523127	81523128	rs17111394	Optic disc size (rim)
chr14	81575453	81575454	rs8017455	Hair morphology
chr14	81594379	81594380	rs3783938	Visceral fat
chr14	81635322	81635323	rs10131728	IgG glycosylation
chr14	81778643	81778644	rs6574644	Obesity-related traits
chr14	83255204	83255205	rs746630	Obesity-related traits
chr14	83342321	83342322	rs10130259	Obesity-related traits
chr14	83378002	83378003	rs12050412	Word reading
chr14	84597384	84597385	rs7152554	Obesity-related traits
chr14	84775208	84775209	rs11159647	Alzheimer's disease
chr14	85654018	85654019	rs12436689	Pulmonary function decline
chr14	85683052	85683053	rs1550584	IgG glycosylation
chr14	85737168	85737169	rs1867082	QRS duration
chr14	85809910	85809911	rs17796783	Heart rate
chr14	85963855	85963856	rs8014131	Menarche (age at onset)
chr14	86817095	86817096	rs10484100	Blood trace element (Zn levels)
chr14	86902053	86902054	rs12882718	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr14	87506247	87506248	rs11624056	Sudden cardiac arrest
chr14	87741024	87741025	rs1756650	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
chr14	88295599	88295600	rs4322600	Breast cancer
chr14	88472594	88472595	rs8005161	Inflammatory bowel disease
chr14	88472594	88472595	rs8005161	Crohn's disease
chr14	88487688	88487689	rs2119704	Multiple sclerosis
chr14	88559991	88559992	rs6574988	Bipolar disorder
chr14	88826481	88826482	rs17772222	Coronary artery calcification
chr14	88826681	88826682	rs17124581	Information processing speed
chr14	89372750	89372751	rs17124955	Obesity-related traits
chr14	89437415	89437416	rs12589060	Hormone measurements
chr14	89594294	89594295	rs7158359	Weight loss (gastric bypass surgery)
chr14	90034971	90034972	rs8004664	Fasting glucose-related traits (interaction with BMI)
chr14	90227250	90227251	rs2093746	IgG glycosylation
chr14	90298274	90298275	rs8021963	Metabolite levels (HVA/MHPG ratio)
chr14	90301034	90301035	rs12100561	Hepatocellular carcinoma
chr14	90396573	90396574	rs7147996	Thiazide-induced adverse metabolic effects in hypertensive patients
chr14	90615512	90615513	rs4900022	Coronary artery calcification
chr14	90679909	90679910	rs8017423	Mortality among heart failure patients
chr14	90758890	90758891	rs2282032	Longevity
chr14	91022184	91022185	rs17793829	Cytomegalovirus antibody response
chr14	91442778	91442779	rs1286083	Bone mineral density
chr14	91841068	91841069	rs941764	Breast cancer
chr14	92427221	92427222	rs7153027	Height
chr14	92459957	92459958	rs8007661	Height
chr14	92485880	92485881	rs7155279	Height
chr14	92536958	92536959	rs12588287	Coronary artery calcification
chr14	92556054	92556055	rs17807815	Orofacial clefts
chr14	92636712	92636713	rs1009170	Dialysis-related mortality
chr14	92702595	92702596	rs1741439	Obesity-related traits
chr14	92763390	92763391	rs4900109	Iris characteristics
chr14	92773662	92773663	rs12896399	Hair color
chr14	92773662	92773663	rs12896399	Eye color
chr14	92773662	92773663	rs12896399	Black vs. blond hair color
chr14	92773662	92773663	rs12896399	Blue vs. green eyes
chr14	92773662	92773663	rs12896399	Blond vs. brown hair color
chr14	92926951	92926952	rs10498633	Alzheimer's disease (late onset)
chr14	92972161	92972162	rs4904947	Dialysis-related mortality
chr14	93103308	93103309	rs10498635	Paget's disease
chr14	93223989	93223990	rs7160685	IgG glycosylation
chr14	93501025	93501026	rs8006385	Platelet counts
chr14	93595590	93595591	rs11624776	Thyroid hormone levels
chr14	93644378	93644379	rs1268843	Endometriosis
chr14	94205344	94205345	rs6575353	Insomnia (caffeine-induced)
chr14	94563192	94563193	rs7157940	Anthropometric traits
chr14	94796183	94796184	rs61280460	Breast size
chr14	94844842	94844843	rs1303	Metabolite levels
chr14	94863635	94863636	rs7151526	Antineutrophil cytoplasmic antibody-associated vasculitis
chr14	94957713	94957714	rs1998207	Obesity-related traits
chr14	94972241	94972242	rs11627075	Obesity-related traits
chr14	95012383	95012384	rs11160190	Vaspin levels
chr14	95094396	95094397	rs8005845	Body mass index
chr14	95410528	95410529	rs10133840	Body mass index (interaction)
chr14	95671870	95671871	rs1187614	Response to antipsychotic treatment
chr14	95720677	95720678	rs8014194	Response to statin therapy
chr14	95764563	95764564	rs115102486	Alzheimer's disease (cognitive decline)
chr14	95848293	95848294	rs12432260	Obesity-related traits
chr14	95892273	95892274	rs12895389	Follicule stimulating hormone
chr14	95942446	95942447	rs11622887	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
chr14	96010588	96010589	rs7120	Obesity-related traits
chr14	96027152	96027153	rs8005962	Tuberculosis
chr14	96122407	96122408	rs8015016	QT interval
chr14	96169130	96169131	rs7158782	Adverse response to aromatase inhibitors
chr14	96175977	96175978	rs11849538	Adverse response to aromatase inhibitors
chr14	96206069	96206070	rs2369304	Neutrophil count
chr14	97103806	97103807	rs17094273	Tanning
chr14	97345805	97345806	rs4905558	Neutrophil count
chr14	97393684	97393685	rs8016620	Obesity-related traits
chr14	97523744	97523745	rs724210	DNA methylation (variation)
chr14	97987856	97987857	rs8022296	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr14	98303330	98303331	rs1471356	Radiation response
chr14	98463156	98463157	rs7140601	Immune response to smallpox vaccine (IL-6)
chr14	98486544	98486545	rs10142119	IgE levels in asthmatics (D.f. specific)
chr14	98488006	98488007	rs1456988	Graves' disease
chr14	98498950	98498951	rs4900384	Type 1 diabetes
chr14	98499457	98499458	rs10144042	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr14	98588320	98588321	rs7152623	Aortic stiffness
chr14	98642571	98642572	rs10484128	Hemostatic factors and hematological phenotypes
chr14	98670157	98670158	rs857228	Sexual dysfunction (SSRI/SNRI-related)
chr14	98840442	98840443	rs1459148	Response to antipsychotic therapy (extrapyramidal side effects)
chr14	99240315	99240316	rs11623713	Obesity-related traits
chr14	99607479	99607480	rs2693676	Corneal curvature
chr14	99742186	99742187	rs2664299	IgG glycosylation
chr14	99746273	99746274	rs2614463	IgG glycosylation
chr14	100133941	100133942	rs2895811	Coronary heart disease
chr14	100625901	100625902	rs7157599	Sudden cardiac arrest
chr14	100684191	100684192	rs2766692	Electroencephalographic traits in alcoholism
chr14	101032216	101032217	rs6575793	Menarche (age at onset)
chr14	101142889	101142890	rs730570	Type 2 diabetes
chr14	101159415	101159416	rs7149242	Platelet counts
chr14	101251988	101251989	rs1884537	Optic disc size (disc)
chr14	101306044	101306045	rs941576	Type 1 diabetes
chr14	101539383	101539384	rs7147503	Corneal astigmatism
chr14	101679254	101679255	rs6575836	Tuberculosis
chr14	101690044	101690045	rs8008758	Body mass index (interaction)
chr14	101727106	101727107	rs2400997	Prostate cancer (gene x gene interaction)
chr14	102360744	102360745	rs7142002	Autism
chr14	102454932	102454933	rs4906172	Menopause (age at onset)
chr14	102595624	102595625	rs1190596	Behavioural disinhibition (generation interaction)
chr14	103040086	103040087	rs11628318	Platelet counts
chr14	103377320	103377321	rs10133111	Brain imaging in schizophrenia (interaction)
chr14	103484824	103484825	rs751837	Large B-cell lymphoma
chr14	103563194	103563195	rs8017161	Primary biliary cirrhosis
chr14	103566784	103566785	rs2297067	Platelet counts
chr14	103572814	103572815	rs944002	Mean platelet volume
chr14	103572814	103572815	rs944002	Gamma gluatamyl transferase levels
chr14	103572814	103572815	rs944002	Liver enzyme levels (gamma-glutamyl transferase)
chr14	103822761	103822762	rs17616316	Red blood cell traits
chr14	103883632	103883633	rs11623869	Bone mineral density
chr14	104509075	104509076	rs11622475	Bipolar disorder
chr14	105277208	105277209	rs4983559	HDL cholesterol
chr14	105346906	105346907	rs2841233	IgG glycosylation
chr14	105349387	105349388	rs2028414	IgG glycosylation
chr14	105391004	105391005	rs2841277	Rheumatoid arthritis
chr14	105729791	105729792	rs3000073	Mean platelet volume
chr14	106232584	106232585	rs10136766	IgG levels
chr14	107176212	107176213	rs10129255	Kawasaki disease
chr14	107180573	107180574	rs2337406	Alzheimer's disease (late onset)
chr15	23817720	23817721	rs2900	IgG glycosylation
chr15	24062914	24062915	rs7164923	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr15	24741290	24741291	rs35600665	Obesity-related traits
chr15	24924662	24924663	rs12902137	Periodontitis (DPAL)
chr15	25022987	25022988	rs8030136	Periodontitis (DPAL)
chr15	25078786	25078787	rs3867498	Pulmonary function
chr15	25133985	25133986	rs2030062	Obesity-related traits
chr15	25602949	25602950	rs8025093	Obesity-related traits
chr15	25894657	25894658	rs6576443	Immune reponse to smallpox (secreted IFN-alpha)
chr15	25912338	25912339	rs17636733	Cardiac hypertrophy
chr15	26277544	26277545	rs4906844	Cortical thickness
chr15	26288393	26288394	rs6576507	Insulin resistance/response
chr15	26424046	26424047	rs547843	Smoking behavior
chr15	26973085	26973086	rs8043440	Cognitive performance
chr15	27012140	27012141	rs3212335	Longevity
chr15	27507772	27507773	rs17137734	Corneal curvature
chr15	27712643	27712644	rs74006954	Alzheimer's disease (cognitive decline)
chr15	27997246	27997247	rs17565841	Parkinson's disease (age of onset)
chr15	28196820	28196821	rs7173419	Eye color
chr15	28205563	28205564	rs4778214	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr15	28356858	28356859	rs1129038	Vitiligo
chr15	28365617	28365618	rs12913832	Tanning
chr15	28365617	28365618	rs12913832	Hair color
chr15	28365617	28365618	rs12913832	Eye color
chr15	28365617	28365618	rs12913832	Eye color traits
chr15	28365617	28365618	rs12913832	Black vs. red hair color
chr15	28365617	28365618	rs12913832	Black vs. blond hair color
chr15	28488887	28488888	rs8028689	Multiple myeloma (IgH translocation)
chr15	28513363	28513364	rs916977	Iris color
chr15	28530181	28530182	rs1667394	Eye color
chr15	28530181	28530182	rs1667394	Blue vs. green eyes
chr15	28530181	28530182	rs1667394	Blue vs. brown eyes
chr15	28530181	28530182	rs1667394	Blond vs. brown hair color
chr15	29006092	29006093	rs8033165	Black vs. red hair color
chr15	29006092	29006093	rs8033165	Black vs. blond hair color
chr15	29239816	29239817	rs17680945	Temperament
chr15	29338501	29338502	rs1873283	Response to mTOR inhibitor (rapamycin)
chr15	29424754	29424755	rs2636061	Obesity-related traits
chr15	29731443	29731444	rs11856574	Life threatening arrhythmia
chr15	29888395	29888396	rs1471225	Inattentive symptoms
chr15	30173884	30173885	rs785422	Corneal structure
chr15	30193467	30193468	rs711355	Response to antipsychotic treatment
chr15	30898331	30898332	rs143536437	Epilepsy (remission after treatment)
chr15	31215934	31215935	rs7178375	Hypertriglyceridemia
chr15	31334361	31334362	rs17815774	Response to antipsychotic treatment
chr15	31463377	31463378	rs7169523	Myasthenia gravis
chr15	31793929	31793930	rs7164569	Venous thromboembolism
chr15	31829706	31829707	rs2125623	Mortality among heart failure patients
chr15	32927475	32927476	rs8037818	Obesity-related traits
chr15	32994755	32994756	rs4779584	Colorectal cancer
chr15	33050422	33050423	rs1258763	Orofacial clefts
chr15	33493220	33493221	rs6494964	IgG glycosylation
chr15	33505066	33505067	rs974379	Major depressive disorder
chr15	33597075	33597076	rs2676071	Periodontitis (Mean PAL)
chr15	33905409	33905410	rs2229116	Carotid atherosclerosis in HIV infection
chr15	34989625	34989626	rs11073058	Axial length
chr15	35005885	35005886	rs524952	Refractive error
chr15	35006072	35006073	rs634990	Refractive error
chr15	35068308	35068309	rs543686	Prostate cancer (gene x gene interaction)
chr15	35346540	35346541	rs10162694	Bronchopulmonary dysplasia
chr15	35858582	35858583	rs6495785	Menopause (age at onset)
chr15	36049491	36049492	rs2947253	Paclitaxel-induced neuropathy
chr15	36293604	36293605	rs4923705	Attention deficit hyperactivity disorder
chr15	36313964	36313965	rs10520045	Major depressive disorder
chr15	36349845	36349846	rs1898036	Response to tocilizumab in rheumatoid arthritis
chr15	37342601	37342602	rs8041675	Hyperactive-impulsive symptoms
chr15	37349801	37349802	rs1568679	Response to antipsychotic treatment
chr15	37449618	37449619	rs17439560	Response to amphetamines
chr15	37660048	37660049	rs587847	Intraocular pressure
chr15	38464873	38464874	rs16966389	Hypersomnia (HLA-DQB1*06:02 negative)
chr15	38511982	38511983	rs16966460	Bipolar disorder
chr15	38733846	38733847	rs8029989	Psychosis (atypical)
chr15	38822904	38822905	rs7403531	Type 2 diabetes
chr15	38838263	38838264	rs8035957	Type 1 diabetes
chr15	38899189	38899190	rs16967103	Crohn's disease
chr15	38907040	38907041	rs7171171	Type 1 diabetes autoantibodies
chr15	38986367	38986368	rs12912251	Bipolar disorder
chr15	38986367	38986368	rs12912251	Bipolar disorder and major depressive disorder (combined)
chr15	38995490	38995491	rs12899449	Bipolar disorder
chr15	39003762	39003763	rs2643217	Bipolar disorder and schizophrenia
chr15	39148648	39148649	rs2624265	Metabolic traits
chr15	39315357	39315358	rs12907914	Cardiac hypertrophy
chr15	39543945	39543946	rs17691453	Metabolite levels (Dihydroxy docosatrienoic acid)
chr15	39573534	39573535	rs12595668	PR interval
chr15	39576559	39576560	rs746265	PR interval
chr15	40038432	40038433	rs8033957	Obesity-related traits
chr15	40322551	40322552	rs2250402	Corneal curvature
chr15	40334575	40334576	rs2412475	Obesity-related traits
chr15	40339493	40339494	rs4924410	Ewing sarcoma
chr15	40360740	40360741	rs7181230	Dehydroepiandrosterone sulphate levels
chr15	40414115	40414116	rs8023845	Chronic lymphocytic leukemia
chr15	40532867	40532868	rs4924439	Obesity-related traits
chr15	40595626	40595627	rs1869901	Schizophrenia
chr15	40700021	40700022	rs10518693	Metabolic traits
chr15	40717301	40717302	rs2034650	Interstitial lung disease
chr15	41196383	41196384	rs8036080	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr15	41563949	41563950	rs28374715	Ulcerative colitis
chr15	42683786	42683787	rs2412710	Triglycerides
chr15	42984287	42984288	rs16957063	Protein quantitative trait loci
chr15	43559230	43559231	rs748404	Lung cancer
chr15	43836477	43836478	rs2251844	Tumor biomarkers
chr15	44219606	44219607	rs16948098	Serum albumin level
chr15	44245930	44245931	rs2929282	Triglycerides
chr15	45500046	45500047	rs765787	Uric acid levels
chr15	45641224	45641225	rs2453533	Chronic kidney disease
chr15	45652702	45652703	rs1153858	Homoarginine levels
chr15	45698792	45698793	rs2467853	Renal function and chronic kidney disease
chr15	45719186	45719187	rs17536527	Glomerular filtration rate
chr15	45801034	45801035	rs950027	Response to fenofibrate (adiponectin levels)
chr15	45934868	45934869	rs607541	Obesity-related traits
chr15	45985070	45985071	rs12594515	Weight
chr15	45985070	45985071	rs12594515	Waist circumference
chr15	46122935	46122936	rs35053544	Serum dimethylarginine levels (symmetric)
chr15	46122935	46122936	rs35053544	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr15	46569465	46569466	rs6493206	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)
chr15	46639807	46639808	rs4775302	Prostate cancer
chr15	47892297	47892298	rs1898111	Eating disorders
chr15	48005469	48005470	rs8028579	Coronary artery calcification
chr15	48392164	48392165	rs1834640	Skin pigmentation
chr15	48597513	48597514	rs964611	Metabolite levels (Pyroglutamine)
chr15	48633152	48633153	rs11637235	Protein quantitative trait loci
chr15	48900585	48900586	rs1876206	Breast cancer
chr15	48914774	48914775	rs1036476	Thoracic aortic aneurysms and dissections
chr15	48992896	48992897	rs2725544	Insomnia
chr15	49039796	49039797	rs784411	Prostate cancer (gene x gene interaction)
chr15	49048127	49048128	rs16961557	Obesity-related traits
chr15	49192790	49192791	rs8023445	Major depressive disorder
chr15	49221590	49221591	rs10519201	Eating disorders
chr15	49735296	49735297	rs4338740	Thyroid volume
chr15	49746363	49746364	rs10519227	Thyroid hormone levels
chr15	49939845	49939846	rs8039808	Response to antidepressant treatment
chr15	50873343	50873344	rs2414059	QT interval
chr15	51040797	51040798	rs8035452	Alzheimer's disease (late onset)
chr15	51048601	51048602	rs12915708	Fibrinogen
chr15	51352248	51352249	rs1124769	Cognitive performance
chr15	51513728	51513729	rs6493487	Thiazide-induced adverse metabolic effects in hypertensive patients
chr15	51516054	51516055	rs2899472	AB1-42
chr15	51524291	51524292	rs2414095	Hormone measurements
chr15	51524291	51524292	rs2414095	Follicule stimulating hormone
chr15	51530494	51530495	rs16964211	Height
chr15	51534546	51534547	rs727479	Estradiol levels
chr15	51545453	51545454	rs12907866	Menarche (age at onset)
chr15	51569409	51569410	rs2305707	Height
chr15	51573532	51573533	rs3751599	Height
chr15	51617707	51617708	rs2445762	Hormone measurements
chr15	51653118	51653119	rs12148477	Follicule stimulating hormone
chr15	51969667	51969668	rs17525472	Asthma
chr15	52773022	52773023	rs2222656	Metabolite levels (Pyroglutamine)
chr15	53203300	53203301	rs2414208	Obesity-related traits
chr15	53279377	53279378	rs719714	Cognitive function
chr15	53805824	53805825	rs7168365	Longevity
chr15	53907947	53907948	rs17730281	Renal function-related traits (BUN)
chr15	53940306	53940307	rs10518733	Hematological and biochemical traits
chr15	53942927	53942928	rs17730436	Renal function-related traits (sCR)
chr15	53942927	53942928	rs17730436	Renal function-related traits (eGRFcrea)
chr15	53946592	53946593	rs491567	Chronic kidney disease
chr15	54341464	54341465	rs1897031	Cognitive performance
chr15	54380199	54380200	rs11071033	Menarche (age at onset)
chr15	54680631	54680632	rs10518765	Select biomarker traits
chr15	54868667	54868668	rs2553218	Immune response to smallpox vaccine (IL-6)
chr15	55456509	55456510	rs16976033	Neutrophil count
chr15	55950081	55950082	rs11071200	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr15	56194876	56194877	rs8032158	Keloid
chr15	56210928	56210929	rs17819300	Brain connectivity
chr15	56340895	56340896	rs7169431	Chronic lymphocytic leukemia
chr15	56382294	56382295	rs16976734	Chronic lymphocytic leukemia
chr15	56736477	56736478	rs6493858	Relative hand skill in reading disability
chr15	56775596	56775597	rs11636802	Chronic lymphocytic leukemia
chr15	57762792	57762793	rs2934442	Bipolar disorder (age of onset and psychomotor symptoms)
chr15	57910163	57910164	rs937254	Coronary heart disease
chr15	58080616	58080617	rs1559777	Myopia (pathological)
chr15	58213413	58213414	rs1550576	Hypertension
chr15	58253105	58253106	rs3784262	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)
chr15	58253105	58253106	rs3784262	Barrett's esophagus
chr15	58471978	58471979	rs16939881	Metabolite levels
chr15	58635582	58635583	rs4775031	Cognitive performance
chr15	58674668	58674669	rs539901	Non-small cell lung cancer
chr15	58674694	58674695	rs4775041	Metabolite levels
chr15	58674694	58674695	rs4775041	Triglycerides
chr15	58674694	58674695	rs4775041	HDL cholesterol
chr15	58678511	58678512	rs10468017	Phospholipid levels (plasma)
chr15	58678511	58678512	rs10468017	Cardiovascular disease risk factors
chr15	58678511	58678512	rs10468017	Age-related macular degeneration
chr15	58678511	58678512	rs10468017	Metabolic syndrome (bivariate traits)
chr15	58678511	58678512	rs10468017	HDL cholesterol
chr15	58680642	58680643	rs35853021	Lipid metabolism phenotypes
chr15	58680953	58680954	rs2043085	Metabolic syndrome (bivariate traits)
chr15	58683365	58683366	rs1532085	Triglycerides
chr15	58683365	58683366	rs1532085	HDL cholesterol
chr15	58683365	58683366	rs1532085	Cholesterol, total
chr15	58683365	58683366	rs1532085	Red blood cell traits
chr15	58683365	58683366	rs1532085	Metabolite levels
chr15	58683365	58683366	rs1532085	Metabolic syndrome
chr15	58683365	58683366	rs1532085	Lipid metabolism phenotypes
chr15	58687879	58687880	rs493258	Age-related macular degeneration
chr15	58688466	58688467	rs920915	Age-related macular degeneration
chr15	58694019	58694020	rs16940212	HDL cholesterol
chr15	58712202	58712203	rs11857380	Obesity-related traits
chr15	58723425	58723426	rs1077835	HDL cholesterol
chr15	58723478	58723479	rs1077834	Hematological and biochemical traits
chr15	58723674	58723675	rs1800588	HDL cholesterol
chr15	58726743	58726744	rs261334	HDL cholesterol
chr15	58730497	58730498	rs588136	Lipid traits
chr15	58730638	58730639	rs17301739	Alzheimer's disease (cognitive decline)
chr15	58731152	58731153	rs261342	Metabolite levels
chr15	58746829	58746830	rs3825776	Amyotrophic lateral sclerosis
chr15	59174538	59174539	rs7179456	Asperger disorder
chr15	59428657	59428658	rs4218	Social communication problems
chr15	59487929	59487930	rs2306786	Metabolite levels
chr15	59719168	59719169	rs28890483	Bipolar disorder and schizophrenia
chr15	59824986	59824987	rs17302400	Visceral adipose tissue adjusted for BMI
chr15	60781512	60781513	rs3743266	Menarche (age at onset)
chr15	60878029	60878030	rs340005	Gamma gluatamyl transferase levels
chr15	60883280	60883281	rs339969	Liver enzyme levels (gamma-glutamyl transferase)
chr15	60894964	60894965	rs340029	C-reactive protein
chr15	60900962	60900963	rs980000	Menarche (age at onset)
chr15	60910549	60910550	rs3784609	Total ventricular volume
chr15	60937401	60937402	rs339978	Menarche (age at onset)
chr15	61060706	61060707	rs12591650	Subcutaneous adipose tissue
chr15	61069987	61069988	rs11071559	Asthma
chr15	61164198	61164199	rs1902618	Pulmonary function decline
chr15	61267095	61267096	rs12912233	Depression (quantitative trait)
chr15	61329787	61329788	rs809736	Response to citalopram treatment
chr15	61336441	61336442	rs7172342	Schizophrenia
chr15	61702778	61702779	rs3884558	Breast cancer (prognosis)
chr15	61702778	61702779	rs3884558	Response to amphetamines
chr15	61840102	61840103	rs4775413	Schizophrenia
chr15	61870942	61870943	rs12592967	Schizophrenia
chr15	62001131	62001132	rs10519131	Parkinson's disease
chr15	62312839	62312840	rs4143844	Bipolar disorder and schizophrenia
chr15	62332979	62332980	rs17271305	Two-hour glucose challenge
chr15	62338796	62338797	rs1436958	IgG glycosylation
chr15	62380258	62380259	rs7178424	Height
chr15	62383154	62383155	rs4502156	Proinsulin levels
chr15	62396388	62396389	rs7172432	Type 2 diabetes
chr15	62396941	62396942	rs7173964	Fasting glucose-related traits (interaction with BMI)
chr15	62404381	62404382	rs1436955	Type 2 diabetes
chr15	62414013	62414014	rs1436953	Type 2 diabetes
chr15	62433961	62433962	rs11071657	Fasting glucose-related traits
chr15	62687338	62687339	rs2456930	Brain structure (temporal lobe volume)
chr15	62899159	62899160	rs12913538	Sleep depth
chr15	63290644	63290645	rs12595433	Obesity-related traits
chr15	63312631	63312632	rs1873147	Orofacial clefts
chr15	63333723	63333724	rs3809566	Platelet counts
chr15	63341995	63341996	rs11071720	Mean platelet volume
chr15	63396866	63396867	rs2652834	HDL cholesterol
chr15	63422771	63422772	rs2652822	Metabolic traits
chr15	63737924	63737925	rs10519210	Heart failure
chr15	63915785	63915786	rs11630290	Iris characteristics
chr15	64725489	64725490	rs74615166	Alzheimer's disease (late onset)
chr15	65153689	65153690	rs12595292	Coronary heart disease
chr15	65183800	65183801	rs1719271	Platelet counts
chr15	66051344	66051345	rs6494537	Mean corpuscular hemoglobin
chr15	66070692	66070693	rs2572207	Red blood cell traits
chr15	67066562	67066563	rs11858577	Subcutaneous adipose tissue
chr15	67442595	67442596	rs17293632	Inflammatory bowel disease
chr15	67442595	67442596	rs17293632	Crohn's disease
chr15	67446784	67446785	rs744910	Asthma
chr15	67450304	67450305	rs17228058	Self-reported allergy
chr15	67458638	67458639	rs17228212	Coronary heart disease
chr15	67467506	67467507	rs12913547	Corneal structure
chr15	67702906	67702907	rs7359257	Menarche (age at onset)
chr15	68036851	68036852	rs12593813	Restless legs syndrome
chr15	68043056	68043057	rs8028313	Obesity
chr15	68080885	68080886	rs4776970	Body mass index
chr15	68086837	68086838	rs2241423	Body mass index
chr15	68198910	68198911	rs448720	Cognitive performance
chr15	68597126	68597127	rs7174755	Major depressive disorder
chr15	68715031	68715032	rs7164335	Attention deficit hyperactivity disorder
chr15	68718986	68718987	rs16952065	IgG glycosylation
chr15	68735585	68735586	rs1445021	Coronary heart disease
chr15	68892988	68892989	rs11856323	Cognitive performance
chr15	69059083	69059084	rs8030672	Esophageal cancer
chr15	69346945	69346946	rs311904	Obesity-related traits
chr15	69398025	69398026	rs1392635	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr15	69650052	69650053	rs11072089	Bipolar disorder and schizophrenia
chr15	69995343	69995344	rs17374222	Rheumatoid arthritis
chr15	70006872	70006873	rs4776472	Atrial fibrillation
chr15	70018989	70018990	rs7176508	Chronic lymphocytic leukemia
chr15	70048156	70048157	rs10152591	Height
chr15	70480613	70480614	rs6494849	Bipolar disorder
chr15	70576137	70576138	rs1971791	Amyotrophic lateral sclerosis
chr15	70634708	70634709	rs11072158	Migraine with aura
chr15	70798558	70798559	rs8034004	Self-reported allergy
chr15	71109146	71109147	rs1549318	Proinsulin levels
chr15	71424008	71424009	rs12904863	Thiazide-induced adverse metabolic effects in hypertensive patients
chr15	71572953	71572954	rs76917273	Serum dimethylarginine levels (symmetric)
chr15	71574798	71574799	rs9806183	Periodontitis (PAL4Q3)
chr15	71576754	71576755	rs1442779	Periodontitis (PAL4Q3)
chr15	71576754	71576755	rs1442779	Periodontitis (Mean PAL)
chr15	71645119	71645120	rs12899618	Pulmonary function (interaction)
chr15	71645119	71645120	rs12899618	Pulmonary function
chr15	71679958	71679959	rs2044029	Airflow obstruction
chr15	71696885	71696886	rs12441227	Pulmonary function
chr15	72161402	72161403	rs12902421	Height
chr15	72169465	72169466	rs12050794	Metabolite levels (HVA/MHPG ratio)
chr15	73082365	73082366	rs4777542	Urate levels
chr15	73652173	73652174	rs7164883	Atrial fibrillation
chr15	73665505	73665506	rs4489968	Heart rate
chr15	73749607	73749608	rs11635553	IgG glycosylation
chr15	73978336	73978337	rs8038465	Liver enzyme levels (gamma-glutamyl transferase)
chr15	74012436	74012437	rs1038094	Bipolar disorder
chr15	74219581	74219582	rs3825942	Glaucoma (exfoliation)
chr15	74226764	74226765	rs4337252	Height
chr15	74229064	74229065	rs893817	Aortic root size
chr15	74241505	74241506	rs750460	Height
chr15	74305965	74305966	rs8039584	Myopia (pathological)
chr15	74336632	74336633	rs5742915	Paget's disease
chr15	74336632	74336633	rs5742915	Height
chr15	74548772	74548773	rs9783698	Obesity-related traits
chr15	74716608	74716609	rs8036030	Airflow obstruction
chr15	75019448	75019449	rs2470893	Coffee consumption
chr15	75019448	75019449	rs2470893	Caffeine consumption
chr15	75027879	75027880	rs2472297	Coffee consumption
chr15	75033399	75033400	rs2472299	Coronary heart disease
chr15	75044237	75044238	rs2472304	Caffeine consumption
chr15	75077366	75077367	rs1378942	Systolic blood pressure
chr15	75077366	75077367	rs1378942	Diastolic blood pressure
chr15	75077366	75077367	rs1378942	Blood pressure
chr15	75125644	75125645	rs6495122	Coffee consumption
chr15	75125644	75125645	rs6495122	Caffeine consumption
chr15	75125644	75125645	rs6495122	Diastolic blood pressure
chr15	75132318	75132319	rs936229	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr15	75334183	75334184	rs2120019	Blood trace element (Zn levels)
chr15	75382541	75382542	rs12148488	Caffeine consumption
chr15	75424592	75424593	rs7172677	Systemic lupus erythematosus and Systemic sclerosis
chr15	75449673	75449674	rs4886670	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
chr15	75449673	75449674	rs4886670	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
chr15	75718668	75718669	rs8028182	Sudden cardiac arrest
chr15	75755466	75755467	rs4886707	Height
chr15	76158982	76158983	rs1394125	Urate levels
chr15	76158982	76158983	rs1394125	Chronic kidney disease
chr15	76293970	76293971	rs11072566	Red blood cell traits
chr15	76546932	76546933	rs1914816	Response to tocilizumab in rheumatoid arthritis
chr15	77747189	77747190	rs7178572	Type 2 diabetes
chr15	77777631	77777632	rs7119	Type 2 diabetes
chr15	77851534	77851535	rs2137111	Anticoagulant levels
chr15	77963886	77963887	rs9652490	Essential tremor
chr15	78164705	78164706	rs11857176	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)
chr15	78269471	78269472	rs12906542	Breast cancer
chr15	78530939	78530940	rs1533665	Personality dimensions
chr15	78698758	78698759	rs7163013	Obesity-related traits
chr15	78783276	78783277	rs11858836	Chronic obstructive pulmonary disease
chr15	78789487	78789488	rs13180	Chronic obstructive pulmonary disease
chr15	78806022	78806023	rs8034191	Lung cancer
chr15	78806022	78806023	rs8034191	Chronic obstructive pulmonary disease
chr15	78816056	78816057	rs8031948	Airflow obstruction
chr15	78827630	78827631	rs28675338	Chronic obstructive pulmonary disease
chr15	78833222	78833223	rs12901682	Response to tocilizumab in rheumatoid arthritis
chr15	78851614	78851615	rs2036527	Smoking behavior
chr15	78851614	78851615	rs2036527	Pulmonary function
chr15	78863471	78863472	rs667282	Smoking behavior
chr15	78867481	78867482	rs17486278	Airflow obstruction
chr15	78894338	78894339	rs1051730	Smoking behavior
chr15	78894338	78894339	rs1051730	Lung adenocarcinoma
chr15	78894338	78894339	rs1051730	Lung cancer
chr15	78894338	78894339	rs1051730	Nicotine dependence
chr15	78898722	78898723	rs12914385	Serum albumin level
chr15	78898722	78898723	rs12914385	Pulmonary function
chr15	78908031	78908032	rs8042374	Lung cancer
chr15	78911180	78911181	rs8040868	Pulmonary function (interaction)
chr15	78911180	78911181	rs8040868	Obesity-related traits
chr15	78926017	78926018	rs950776	Sudden cardiac arrest
chr15	79080233	79080234	rs1994016	Coronary heart disease
chr15	79089110	79089111	rs3825807	Coronary artery calcification
chr15	79089110	79089111	rs3825807	Coronary heart disease
chr15	79111092	79111093	rs4380028	Coronary heart disease
chr15	79224682	79224683	rs2289700	Bipolar disorder
chr15	79235445	79235446	rs3825932	Type 1 diabetes
chr15	79274045	79274046	rs3743200	RR interval (heart rate)
chr15	79372874	79372875	rs4778879	Refractive error
chr15	79451868	79451869	rs939658	Refractive error
chr15	79463846	79463847	rs1474256	Bronchopulmonary dysplasia
chr15	79533371	79533372	rs4779031	IgG glycosylation
chr15	80013421	80013422	rs2692194	IgG glycosylation
chr15	80192974	80192975	rs36035742	Periodontitis (Mean PAL)
chr15	80219592	80219593	rs75598935	Periodontitis (Mean PAL)
chr15	80432221	80432222	rs11634397	Type 2 diabetes
chr15	80694921	80694922	rs2278702	Bipolar disorder
chr15	81001277	81001278	rs12148329	Immune response to smallpox vaccine (IL-6)
chr15	81359136	81359137	rs2663905	QT interval (interaction)
chr15	81533694	81533695	rs7172689	Inattentive symptoms
chr15	81626724	81626725	rs3935740	Parkinson's disease
chr15	82352199	82352200	rs12324805	Body mass index
chr15	83352281	83352282	rs11638815	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr15	83726178	83726179	rs1568657	Kawasaki disease
chr15	84286491	84286492	rs2562784	Height
chr15	84315883	84315884	rs2554380	Height
chr15	84522754	84522755	rs1383484	Height
chr15	84568157	84568158	rs10906982	Height
chr15	84573040	84573041	rs7183263	Height
chr15	84580155	84580156	rs11259933	Height
chr15	84580581	84580582	rs11259936	Height
chr15	84582123	84582124	rs4842838	Height
chr15	85187244	85187245	rs34069323	Periodontitis (CDC/AAP)
chr15	85415385	85415386	rs12900463	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
chr15	85430968	85430969	rs3743162	Alzheimer's disease (age of onset)
chr15	85699206	85699207	rs8040855	Bulimia nervosa
chr15	85825566	85825567	rs6496932	Corneal structure
chr15	85825566	85825567	rs6496932	Central corneal thickness
chr15	86067305	86067306	rs6496044	Interstitial lung disease
chr15	86369429	86369430	rs7176093	Aging traits
chr15	86462851	86462852	rs4262906	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)
chr15	86462851	86462852	rs4262906	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
chr15	86660719	86660720	rs12914656	Homeostasis model assessment of insulin resistance (interaction)
chr15	86660719	86660720	rs12914656	Fasting insulin (interaction)
chr15	86854589	86854590	rs10152811	Thiazide-induced adverse metabolic effects in hypertensive patients
chr15	86859475	86859476	rs12901001	Barrett's esophagus
chr15	86984239	86984240	rs16977195	Schizophrenia
chr15	87053845	87053846	rs2011905	Cytomegalovirus antibody response
chr15	87064088	87064089	rs12591257	Psychosis (methamphetamine induced)
chr15	87191976	87191977	rs2469184	Activated partial thromboplastin time
chr15	87436744	87436745	rs17647114	Response to antidepressant treatment
chr15	87695510	87695511	rs11636768	Migraine
chr15	87710065	87710066	rs8024343	Bulimia nervosa
chr15	87977475	87977476	rs2679073	Coronary artery calcification
chr15	88661738	88661739	rs9806762	Gaucher disease severity
chr15	88723711	88723712	rs1104918	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr15	89119103	89119104	rs17776563	Thyroid hormone levels
chr15	89245238	89245239	rs4932194	Dupuytren's disease
chr15	89249138	89249139	rs8027587	Obesity-related traits
chr15	89359688	89359689	rs8041863	Height
chr15	89388904	89388905	rs16942341	Height
chr15	89395625	89395626	rs2280470	Height
chr15	89398104	89398105	rs2351491	Height
chr15	89617080	89617081	rs420017	Obesity-related traits
chr15	89617080	89617081	rs420017	Height
chr15	89863927	89863928	rs2307449	Menopause (age at onset)
chr15	89902031	89902032	rs4932217	Height
chr15	90168107	90168108	rs894157	Obesity-related traits
chr15	90374256	90374257	rs2028299	Type 2 diabetes
chr15	90447945	90447946	rs7178909	Common traits (Other)
chr15	90893667	90893668	rs6496667	Rheumatoid arthritis
chr15	91114375	91114376	rs12915189	Information processing speed
chr15	91172900	91172901	rs7495132	Inflammatory bowel disease
chr15	91437387	91437388	rs2521501	Systolic blood pressure
chr15	91437387	91437388	rs2521501	Hypertension
chr15	91437387	91437388	rs2521501	Diastolic blood pressure
chr15	91437387	91437388	rs2521501	Blood pressure
chr15	91450440	91450441	rs2677744	Attention deficit hyperactivity disorder
chr15	91521336	91521337	rs8042680	Type 2 diabetes
chr15	91717351	91717352	rs886144	Metabolite levels
chr15	92211773	92211774	rs7164176	Response to tocilizumab in rheumatoid arthritis
chr15	92445872	92445873	rs3924426	Response to iloperidone treatment (QT prolongation)
chr15	92552028	92552029	rs7495052	Inattentive symptoms
chr15	92657372	92657373	rs207954	Acute lymphoblastic leukemia (childhood)
chr15	92685777	92685778	rs2238355	Obesity-related traits
chr15	92705030	92705031	rs2238341	Serum dimethylarginine levels (symmetric)
chr15	92806290	92806291	rs4304977	DNA methylation (variation)
chr15	92883839	92883840	rs12905014	Airflow obstruction
chr15	92930410	92930411	rs17702901	Weight loss (gastric bypass surgery)
chr15	93044338	93044339	rs8040009	Alcoholism (heaviness of drinking)
chr15	93044338	93044339	rs8040009	Bipolar I disorder
chr15	93050965	93050966	rs1455782	Pulmonary function
chr15	93131631	93131632	rs2173063	Subcutaneous adipose tissue
chr15	93179174	93179175	rs285757	HIV-1 susceptibility
chr15	93564971	93564972	rs7179432	IgG glycosylation
chr15	93638400	93638401	rs7168353	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)
chr15	93713665	93713666	rs6497031	Periodontitis (CDC/AAP)
chr15	93815128	93815129	rs17612678	Obesity-related traits
chr15	93877424	93877425	rs4777845	Adiponectin levels
chr15	94036687	94036688	rs7175404	Attention deficit hyperactivity disorder
chr15	94141832	94141833	rs12437854	Type 1 diabetes nephropathy
chr15	94689652	94689653	rs2388436	Hoarding
chr15	94939507	94939508	rs4984390	Drug-induced liver injury (flucloxacillin)
chr15	95165579	95165580	rs1014922	Sudden cardiac arrest
chr15	95270466	95270467	rs7173947	Hematological and biochemical traits
chr15	95318585	95318586	rs17664713	Response to mTOR inhibitor (rapamycin)
chr15	95318766	95318767	rs16949516	Stearic acid (18:0) plasma levels
chr15	95511836	95511837	rs6496074	Cognitive performance
chr15	96052741	96052742	rs933769	Alcoholism (alcohol dependence factor score)
chr15	96141866	96141867	rs10520789	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr15	96156367	96156368	rs4321143	Conduct disorder (interaction)
chr15	96332860	96332861	rs2567426	Information processing speed
chr15	96372628	96372629	rs744738	Obesity-related traits
chr15	96647792	96647793	rs4984499	Migraine
chr15	96708290	96708291	rs8023580	Sex hormone-binding globulin levels
chr15	96809781	96809782	rs1437588	Migraine
chr15	96830549	96830550	rs2398162	Hypertension
chr15	96844726	96844727	rs7181753	Electroencephalographic traits in alcoholism
chr15	97002652	97002653	rs11637980	Prostate cancer (gene x gene interaction)
chr15	97018732	97018733	rs113154706	Response to amphetamines
chr15	97262426	97262427	rs4533251	Attention deficit hyperactivity disorder and conduct disorder
chr15	97750334	97750335	rs1513859	Obesity-related traits
chr15	98518791	98518792	rs4965121	Neuroticism
chr15	98606312	98606313	rs1993976	Fat distribution (HIV)
chr15	98876028	98876029	rs970843	Obesity (extreme)
chr15	99072904	99072905	rs12719740	Arthritis (juvenile idiopathic)
chr15	99194895	99194896	rs2871865	Height
chr15	99271134	99271135	rs6598541	Urate levels
chr15	100297662	100297663	rs1993293	Coronary artery calcification
chr15	100299238	100299239	rs6598266	Major depressive disorder
chr15	100357434	100357435	rs1823874	IgG glycosylation
chr15	100728662	100728663	rs2086452	Osteosarcoma
chr15	100758384	100758385	rs4965593	Height
chr15	100759613	100759614	rs4965598	Height
chr15	100786270	100786271	rs4533267	Height
chr15	101251718	101251719	rs184234	Response to taxane treatment (placlitaxel)
chr15	101558561	101558562	rs930847	Corneal structure
chr15	101721891	101721892	rs12593811	Corneal astigmatism
chr15	101781933	101781934	rs752092	Corneal structure
chr15	101865471	101865472	rs7182874	Relative hand skill in reading disability
chr15	101875122	101875123	rs11855415	Handedness in dyslexia
chr16	163597	163598	rs11248850	Red blood cell traits
chr16	184389	184390	rs7203560	Sickle cell anemia (haemolysis)
chr16	184389	184390	rs7203560	Mean corpuscular volume
chr16	184389	184390	rs7203560	Mean corpuscular hemoglobin concentration
chr16	184389	184390	rs7203560	Mean corpuscular hemoglobin
chr16	184389	184390	rs7203560	Hematology traits
chr16	225652	225653	rs2858942	Mean corpuscular hemoglobin
chr16	240279	240280	rs1211375	Mean corpuscular volume
chr16	240279	240280	rs1211375	Mean corpuscular hemoglobin
chr16	240279	240280	rs1211375	Hematology traits
chr16	298587	298588	rs13339636	Red blood cell traits
chr16	304802	304803	rs7189020	Mean corpuscular volume
chr16	309154	309155	rs1122794	Red blood cell traits
chr16	309154	309155	rs1122794	Mean corpuscular hemoglobin
chr16	310379	310380	rs13335629	Red blood cell traits
chr16	314779	314780	rs9924561	Red blood cell traits
chr16	375781	375782	rs9921222	Bone mineral density
chr16	580123	580124	rs2266928	Mean corpuscular hemoglobin concentration
chr16	630664	630665	rs1981483	Disc degeneration (lumbar)
chr16	637211	637212	rs2017567	Disc degeneration (lumbar)
chr16	661334	661335	rs7204439	Disc degeneration (lumbar)
chr16	675679	675680	rs763014	Height
chr16	792189	792190	rs11648796	Height
chr16	1073551	1073552	rs2744148	Multiple sclerosis
chr16	1532462	1532463	rs13336428	Bone mineral density
chr16	1838835	1838836	rs1065656	Insulin-like growth factors
chr16	2097157	2097158	rs2516739	Longevity
chr16	2107112	2107113	rs45502703	Obesity-related traits
chr16	2249375	2249376	rs26868	Height
chr16	3023604	3023605	rs886427	Metabolic syndrome
chr16	3124919	3124920	rs4349147	HIV-1 susceptibility
chr16	3185736	3185737	rs560947	Metabolite levels  (X-11787)
chr16	3509055	3509056	rs40363	Tuberculosis
chr16	3769580	3769581	rs56240109	Metabolite levels (HVA/5-HIAA ratio)
chr16	3778336	3778337	rs3751845	Obesity-related traits
chr16	3796146	3796147	rs129963	QT interval (interaction)
chr16	4013466	4013467	rs2531995	Obesity
chr16	4038386	4038387	rs2444217	Body mass index
chr16	4103870	4103871	rs2601828	Partial epilepsies
chr16	4257312	4257313	rs75825892	Obesity-related traits
chr16	4646877	4646878	rs8050907	Obesity-related traits
chr16	5001379	5001380	rs9635542	Lung cancer-asbestos exposure interaction
chr16	5003073	5003074	rs34924084	Metabolite levels (HVA/MHPG ratio)
chr16	5585851	5585852	rs870288	Subcutaneous adipose tissue
chr16	5585851	5585852	rs870288	Phospholipid levels (plasma)
chr16	6108429	6108430	rs1906060	Intraocular pressure
chr16	6113660	6113661	rs6500744	Conduct disorder (interaction)
chr16	6148029	6148030	rs4786816	Obesity-related traits
chr16	6156325	6156326	rs7403856	Obesity-related traits
chr16	6699260	6699261	rs11643447	Visceral adipose tissue adjusted for BMI
chr16	6817374	6817375	rs6500818	Dengue shock syndrome
chr16	6896127	6896128	rs11645781	Heart rate
chr16	6910384	6910385	rs12921846	Attention deficit hyperactivity disorder and conduct disorder
chr16	7139172	7139173	rs11866781	Periodontitis (PAL4Q3)
chr16	7164218	7164219	rs1478693	Sleep time
chr16	7227121	7227122	rs9302841	Response to antipsychotic therapy (extrapyramidal side effects)
chr16	7415551	7415552	rs4787008	Diabetic retinopathy
chr16	7459346	7459347	rs10500355	Refractive error
chr16	7459682	7459683	rs17648524	Refractive error
chr16	7504853	7504854	rs9924951	Metabolite levels
chr16	7753703	7753704	rs12444931	Bipolar disorder and schizophrenia
chr16	7836296	7836297	rs3112740	Smoking behavior
chr16	7903608	7903609	rs12446289	Metabolite levels (MHPG)
chr16	8329326	8329327	rs2034588	Response to antidepressant treatment
chr16	8503221	8503222	rs8045405	QT interval
chr16	8517744	8517745	rs11861787	Epilepsy (remission after treatment)
chr16	9213879	9213880	rs3743832	Non-substance related behavioral disinhibition
chr16	9213879	9213880	rs3743832	Behavioural disinhibition (generation interaction)
chr16	9343346	9343347	rs1397142	Obesity-related traits
chr16	9382328	9382329	rs8061903	HIV-1 viral setpoint
chr16	9399723	9399724	rs631208	IgE grass sensitization
chr16	9675245	9675246	rs12325410	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr16	9744094	9744095	rs17550532	Sudden cardiac arrest
chr16	9862555	9862556	rs11866328	Hepatitis B
chr16	9911385	9911386	rs8058295	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr16	10183086	10183087	rs1463132	HIV-1 control
chr16	10188059	10188060	rs7203315	Thiazide-induced adverse metabolic effects in hypertensive patients
chr16	10559262	10559263	rs13335336	Response to antipsychotic treatment
chr16	10630776	10630777	rs6498068	Metabolite levels (MHPG)
chr16	10633164	10633165	rs11074889	Attention deficit hyperactivity disorder
chr16	10663626	10663627	rs2221433	Eating disorders
chr16	10975310	10975311	rs4781011	Ulcerative colitis
chr16	11081248	11081249	rs6498142	Immunoglobulin A
chr16	11158884	11158885	rs887864	Allergic rhinitis
chr16	11166687	11166688	rs11865121	Multiple sclerosis
chr16	11177800	11177801	rs7200786	Multiple sclerosis
chr16	11179872	11179873	rs12708716	Type 1 diabetes autoantibodies
chr16	11179872	11179873	rs12708716	Type 1 diabetes
chr16	11187782	11187783	rs12924729	Primary biliary cirrhosis
chr16	11189887	11189888	rs12599402	Systemic lupus erythematosus
chr16	11210414	11210415	rs9923856	Atopic dermatitis
chr16	11222237	11222238	rs78394940	Obesity-related traits
chr16	11230702	11230703	rs7203459	Self-reported allergy
chr16	11238782	11238783	rs2903692	Type 1 diabetes
chr16	11249328	11249329	rs6498169	Multiple sclerosis
chr16	11347857	11347858	rs4780355	Crohn's disease and psoriasis
chr16	11364078	11364079	rs416603	Type 1 diabetes
chr16	11373319	11373320	rs529866	Inflammatory bowel disease
chr16	11374865	11374866	rs737008	Obesity-related traits
chr16	11386959	11386960	rs117096873	Bulimia nervosa
chr16	11403892	11403893	rs12928822	Celiac disease
chr16	11406802	11406803	rs7191700	Multiple sclerosis
chr16	11641179	11641180	rs7203193	Coronary heart disease
chr16	11691752	11691753	rs8049607	QT interval
chr16	12016918	12016919	rs10852344	Menopause (age at onset)
chr16	12077631	12077632	rs12922317	Schizophrenia
chr16	12185809	12185810	rs8048589	Homeostasis model assessment of insulin resistance (interaction)
chr16	12185809	12185810	rs8048589	Fasting insulin (interaction)
chr16	12596934	12596935	rs117147010	Serum dimethylarginine levels (symmetric)
chr16	12596934	12596935	rs117147010	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr16	12641114	12641115	rs1641895	Visceral adipose tissue adjusted for BMI
chr16	12708207	12708208	rs1560104	Obesity-related traits
chr16	13061610	13061611	rs7192086	Schizophrenia
chr16	13154877	13154878	rs4465599	Palmitoleic acid (16:1n-7) plasma levels
chr16	13238896	13238897	rs150063	Lung function (forced expiratory volume in 1 second to forced vital capacity ratio)
chr16	13253955	13253956	rs153091	Response to antipsychotic treatment
chr16	13656884	13656885	rs2903308	Response to citalopram treatment
chr16	13976355	13976356	rs2113334	Metabolic syndrome
chr16	14038173	14038174	rs3136202	Conduct disorder (symptom count)
chr16	14045398	14045399	rs4781563	Bilirubin levels
chr16	14388304	14388305	rs1659127	Menarche (age at onset)
chr16	14388304	14388305	rs1659127	Height
chr16	15082864	15082865	rs4985167	Phospholipid levels (plasma)
chr16	15129458	15129459	rs4985155	Bone mineral density
chr16	15129939	15129940	rs3198697	Triglycerides
chr16	15129969	15129970	rs7200543	Metabolic traits
chr16	15131973	15131974	rs1136001	Height
chr16	15140210	15140211	rs4500751	Phospholipid levels (plasma)
chr16	15148645	15148646	rs11075253	Lipid metabolism phenotypes
chr16	15881966	15881967	rs17213965	Waist-hip ratio
chr16	16256766	16256767	rs3213473	IgG glycosylation
chr16	16730727	16730728	rs9937036	Obesity-related traits
chr16	16957914	16957915	rs7186128	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
chr16	17739691	17739692	rs12445126	Corneal astigmatism
chr16	18024849	18024850	rs9922516	Obesity-related traits
chr16	18062135	18062136	rs7194356	IgG glycosylation
chr16	19028548	19028549	rs4265793	Response to angiotensin II receptor blocker therapy
chr16	19156015	19156016	rs8062326	Alcohol dependence
chr16	19404644	19404645	rs4780805	Sleep duration
chr16	19933599	19933600	rs12444979	Body mass index
chr16	19935072	19935073	rs12446554	Obesity
chr16	19935388	19935389	rs12446632	Obesity
chr16	19944362	19944363	rs11639988	Obesity
chr16	19960319	19960320	rs4527026	Obesity-related traits
chr16	20031204	20031205	rs2764743	IgG glycosylation
chr16	20056992	20056993	rs12596252	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20057660	20057661	rs1902813	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20059676	20059677	rs12926725	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20060829	20060830	rs12931939	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20089753	20089754	rs10521114	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20090644	20090645	rs10521115	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20094053	20094054	rs7201408	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20094545	20094546	rs12924103	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20094885	20094886	rs7185264	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20095627	20095628	rs11647507	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20100369	20100370	rs12926729	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20109652	20109653	rs11642377	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20122289	20122290	rs2608200	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20123514	20123515	rs6497436	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20126973	20126974	rs12919130	Attention deficit hyperactivity disorder (inattention symptoms)
chr16	20257866	20257867	rs12597579	Body mass index
chr16	20342571	20342572	rs12444268	Type 1 diabetes
chr16	20351230	20351231	rs11859916	Femoral neck bone geometry
chr16	20364587	20364588	rs4293393	Chronic kidney disease and serum creatinine levels
chr16	20365653	20365654	rs13333226	Hypertension
chr16	20367689	20367690	rs12917707	Chronic kidney disease
chr16	20367689	20367690	rs12917707	Renal function and chronic kidney disease
chr16	20400838	20400839	rs11864909	Renal function-related traits (sCR)
chr16	20400838	20400839	rs11864909	Renal function-related traits (eGRFcrea)
chr16	20674491	20674492	rs151222	Schizophrenia
chr16	20680205	20680206	rs433598	Schizophrenia
chr16	21113271	21113272	rs16970881	Immune reponse to smallpox (secreted IL-10)
chr16	22889185	22889186	rs2519974	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)
chr16	23067259	23067260	rs8049603	Multiple sclerosis
chr16	23634025	23634026	rs420259	Bipolar disorder
chr16	23640466	23640467	rs249954	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr16	23765773	23765774	rs4968031	Platelet counts
chr16	23864589	23864590	rs7404095	Inflammatory bowel disease
chr16	23888839	23888840	rs7404928	Rheumatoid arthritis
chr16	24531717	24531718	rs11643520	Brain structure
chr16	24578457	24578458	rs7195386	Obesity-related traits
chr16	24675588	24675589	rs8045064	Alzheimer's disease (cognitive decline)
chr16	24810680	24810681	rs17177078	Type 2 diabetes (dietary heme iron intake interaction)
chr16	26170939	26170940	rs9933429	Obesity-related traits
chr16	27056454	27056455	rs2203512	Cognitive performance
chr16	27214983	27214984	rs16976587	Obesity-related traits
chr16	27374399	27374400	rs1801275	IgE levels
chr16	27410828	27410829	rs2107357	Self-reported allergy
chr16	27434926	27434927	rs8057551	Bone mineral density
chr16	28052962	28052963	rs205391	Obesity-related traits
chr16	28490516	28490517	rs151181	Crohn's disease
chr16	28517708	28517709	rs26528	Inflammatory bowel disease
chr16	28539847	28539848	rs4788084	Type 1 diabetes autoantibodies
chr16	28539847	28539848	rs4788084	Type 1 diabetes
chr16	28837514	28837515	rs8049439	Educational attainment
chr16	28837514	28837515	rs8049439	Inflammatory bowel disease (early onset)
chr16	28883240	28883241	rs7498665	Obesity
chr16	28883240	28883241	rs7498665	Body mass index
chr16	28883240	28883241	rs7498665	Weight
chr16	28885658	28885659	rs7359397	Body mass index
chr16	28921808	28921809	rs7184597	Obesity
chr16	29882489	29882490	rs12917712	Systemic lupus erythematosus
chr16	29885446	29885447	rs4787483	Anthropometric traits
chr16	29906545	29906546	rs4787484	Response to taxane treatment (placlitaxel)
chr16	29967433	29967434	rs4788196	Pubertal anthropometrics
chr16	30482493	30482494	rs11150589	Ulcerative colitis
chr16	30635658	30635659	rs7186852	Systemic lupus erythematosus
chr16	30642866	30642867	rs7197475	Systemic lupus erythematosus
chr16	30918486	30918487	rs11649653	Triglycerides
chr16	30942624	30942625	rs10782001	Psoriasis
chr16	31048078	31048079	rs10871454	Warfarin maintenance dose
chr16	31095170	31095171	rs11865038	Parkinson's disease
chr16	31107688	31107689	rs9923231	Warfarin maintenance dose
chr16	31298938	31298939	rs9937837	Systemic lupus erythematosus
chr16	31313252	31313253	rs9888739	Systemic lupus erythematosus
chr16	31326705	31326706	rs11860650	Systemic lupus erythematosus and Systemic sclerosis
chr16	31334235	31334236	rs11150610	Systemic lupus erythematosus
chr16	31347747	31347748	rs3925075	IgA nephropathy
chr16	31368873	31368874	rs11574637	Systemic lupus erythematosus
chr16	32480923	32480924	rs13380637	Response to amphetamines
chr16	34682192	34682193	rs62057608	Obesity-related traits
chr16	35088130	35088131	rs12599426	Palmitoleic acid (16:1n-7) plasma levels
chr16	48621401	48621402	rs6500395	Response to tocilizumab in rheumatoid arthritis
chr16	49142505	49142506	rs16946931	Social autistic-like traits
chr16	49394275	49394276	rs8057939	Prostate cancer (gene x gene interaction)
chr16	49643565	49643566	rs2080501	IgG glycosylation
chr16	49652778	49652779	rs16944158	IgG glycosylation
chr16	49750789	49750790	rs17281813	Inattentive symptoms
chr16	50103733	50103734	rs4785204	Esophageal cancer (squamous cell)
chr16	50142943	50142944	rs8046148	Testicular germ cell tumor
chr16	50437527	50437528	rs9941219	Liver enzyme levels (alanine transaminase)
chr16	50719102	50719103	rs9302752	Leprosy
chr16	50739581	50739582	rs17221417	Crohn's disease
chr16	50756773	50756774	rs5743289	Inflammatory bowel disease
chr16	50756773	50756774	rs5743289	Crohn's disease
chr16	50756880	50756881	rs2076756	Crohn's disease
chr16	50756880	50756881	rs2076756	Inflammatory bowel disease
chr16	50763778	50763779	rs2066847	Crohn's disease
chr16	50854417	50854418	rs16948876	Leprosy
chr16	50986307	50986308	rs1564981	Bone mineral density
chr16	51021802	51021803	rs1566045	Bone mineral density
chr16	51158709	51158710	rs10521222	C-reactive protein
chr16	51245486	51245487	rs7185923	Weight loss (gastric bypass surgery)
chr16	51330530	51330531	rs4131099	Personality dimensions
chr16	51458289	51458290	rs1362756	Optic disc parameters
chr16	51609946	51609947	rs2030114	Blood pressure measurement (high sodium and potassium intervention)
chr16	52321975	52321976	rs16951021	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr16	52347818	52347819	rs4784165	Polycystic ovary syndrome
chr16	52586340	52586341	rs3803662	Breast cancer
chr16	52586340	52586341	rs3803662	Breast cancer (male)
chr16	52599187	52599188	rs4784227	Breast cancer
chr16	52624737	52624738	rs3104767	Restless legs syndrome
chr16	52634999	52635000	rs12922061	Breast cancer
chr16	52635163	52635164	rs3112612	Breast cancer
chr16	52831461	52831462	rs6499100	Tetralogy of Fallot
chr16	52912298	52912299	rs1344484	Bipolar disorder
chr16	53073787	53073788	rs10852453	IgG glycosylation
chr16	53192330	53192331	rs7204230	Fibrinogen
chr16	53639437	53639438	rs3213758	Vitiligo (non-segmental)
chr16	53757739	53757740	rs1421084	Subcutaneous adipose tissue
chr16	53769676	53769677	rs6499640	Weight
chr16	53769676	53769677	rs6499640	Body mass index
chr16	53799976	53799977	rs9930333	Triglycerides
chr16	53800753	53800754	rs9940128	Body mass index
chr16	53800753	53800754	rs9940128	Metabolic syndrome
chr16	53800953	53800954	rs1421085	Dietary macronutrient intake
chr16	53800953	53800954	rs1421085	Obesity (early onset extreme)
chr16	53800953	53800954	rs1421085	Obesity
chr16	53803573	53803574	rs1558902	Obesity
chr16	53803573	53803574	rs1558902	Body mass index
chr16	53803573	53803574	rs1558902	Obesity (early onset extreme)
chr16	53803573	53803574	rs1558902	Waist circumference
chr16	53809246	53809247	rs1121980	Triglycerides
chr16	53809246	53809247	rs1121980	HDL cholesterol
chr16	53809246	53809247	rs1121980	Body mass index
chr16	53809246	53809247	rs1121980	Obesity (early onset extreme)
chr16	53811787	53811788	rs62033400	Body mass index
chr16	53813366	53813367	rs17817449	Breast cancer
chr16	53813366	53813367	rs17817449	Obesity
chr16	53813449	53813450	rs8043757	Obesity
chr16	53816274	53816275	rs8050136	Type 2 diabetes
chr16	53816274	53816275	rs8050136	Adiposity
chr16	53816274	53816275	rs8050136	Body mass in chronic obstructive pulmonary disease
chr16	53816274	53816275	rs8050136	Weight
chr16	53816274	53816275	rs8050136	Body mass index
chr16	53819892	53819893	rs11075990	Body mass index
chr16	53820526	53820527	rs9939609	Type 2 diabetes
chr16	53820526	53820527	rs9939609	Menarche (age at onset)
chr16	53820526	53820527	rs9939609	Biomedical quantitative traits
chr16	53820526	53820527	rs9939609	Body mass index
chr16	53821614	53821615	rs7202116	Body mass index
chr16	53822650	53822651	rs7185735	Obesity
chr16	53825487	53825488	rs9941349	Obesity (extreme)
chr16	53828065	53828066	rs17817964	Body mass index
chr16	53830464	53830465	rs9930506	Obesity-related traits
chr16	53831770	53831771	rs9922619	Subcutaneous adipose tissue
chr16	53839134	53839135	rs8044769	Osteoarthritis
chr16	53842907	53842908	rs12149832	Body mass index
chr16	53845486	53845487	rs11642841	Type 2 diabetes
chr16	53855290	53855291	rs11075995	Breast cancer
chr16	54027970	54027971	rs12596210	Sex hormone-binding globulin levels
chr16	54114823	54114824	rs16953002	Melanoma
chr16	54494423	54494424	rs9921518	Dialysis-related mortality
chr16	55245036	55245037	rs17291845	Information processing speed
chr16	55255190	55255191	rs2001970	Visceral fat
chr16	55604127	55604128	rs6499766	Thyroid hormone levels
chr16	55844608	55844609	rs2244613	Response to dabigatran etexilate treatment
chr16	55861793	55861794	rs8192935	Response to dabigatran etexilate treatment
chr16	56725172	56725173	rs8064100	Gambling
chr16	56969147	56969148	rs2217332	Metabolic syndrome
chr16	56985138	56985139	rs9989419	Lipid traits
chr16	56985138	56985139	rs9989419	HDL cholesterol
chr16	56988043	56988044	rs173539	Metabolite levels
chr16	56988043	56988044	rs173539	Cardiovascular disease risk factors
chr16	56988043	56988044	rs173539	Metabolic syndrome (bivariate traits)
chr16	56988043	56988044	rs173539	Metabolic syndrome
chr16	56988043	56988044	rs173539	HDL Cholesterol - Triglycerides (HDLC-TG)
chr16	56988043	56988044	rs173539	HDL cholesterol
chr16	56989589	56989590	rs247616	Lipoprotein-associated phospholipase A2 activity and mass
chr16	56989589	56989590	rs247616	Cardiovascular disease risk factors
chr16	56990715	56990716	rs247617	HDL cholesterol
chr16	56990715	56990716	rs247617	Metabolic syndrome
chr16	56993323	56993324	rs3764261	Triglycerides
chr16	56993323	56993324	rs3764261	LDL cholesterol
chr16	56993323	56993324	rs3764261	HDL cholesterol
chr16	56993323	56993324	rs3764261	Cholesterol, total
chr16	56993323	56993324	rs3764261	Lipoprotein-associated phospholipase A2 activity and mass
chr16	56993323	56993324	rs3764261	Lipid metabolism phenotypes
chr16	56993323	56993324	rs3764261	Age-related macular degeneration
chr16	56993323	56993324	rs3764261	Metabolic syndrome (bivariate traits)
chr16	56993323	56993324	rs3764261	Metabolic syndrome
chr16	56993323	56993324	rs3764261	Hematological and biochemical traits
chr16	56993323	56993324	rs3764261	Waist circumference and related phenotypes
chr16	56995235	56995236	rs1800775	Lipid traits
chr16	56995235	56995236	rs1800775	HDL cholesterol
chr16	56995235	56995236	rs1800775	Lipid metabolism phenotypes
chr16	56995235	56995236	rs1800775	Triglycerides
chr16	56997232	56997233	rs1864163	Age-related macular degeneration
chr16	56997232	56997233	rs1864163	Lipid metabolism phenotypes
chr16	56997232	56997233	rs1864163	HDL cholesterol
chr16	57002731	57002732	rs9939224	Metabolic syndrome (bivariate traits)
chr16	57005478	57005479	rs1532624	HDL cholesterol
chr16	57005478	57005479	rs1532624	Cholesterol
chr16	57005478	57005479	rs1532624	Lipid metabolism phenotypes
chr16	57006589	57006590	rs7499892	Lipid metabolism phenotypes
chr16	57006589	57006590	rs7499892	Biochemical measures
chr16	57012378	57012379	rs12708980	HDL cholesterol
chr16	57024316	57024317	rs17290922	Schizophrenia
chr16	57047298	57047299	rs16965039	Coronary heart disease
chr16	57058581	57058582	rs821470	Bipolar disorder and schizophrenia
chr16	57303193	57303194	rs11640439	Sleep duration
chr16	57563670	57563671	rs8052123	Cataracts in type 2 diabetes
chr16	58075281	58075282	rs12447804	Pulmonary function (interaction)
chr16	58075281	58075282	rs12447804	Pulmonary function
chr16	58566303	58566304	rs37060	QT interval
chr16	58567237	58567238	rs37062	Electrocardiographic traits
chr16	58567237	58567238	rs37062	QT interval
chr16	58622177	58622178	rs7188697	QT interval
chr16	58759331	58759332	rs12600277	Aortic root size
chr16	59890697	59890698	rs8056650	Brain structure (hippocampal volume)
chr16	59940187	59940188	rs16961543	Obesity-related traits
chr16	60314655	60314656	rs9932186	Phospholipid levels (plasma)
chr16	60733602	60733603	rs17822114	Myopia (pathological)
chr16	61123146	61123147	rs2639889	Morbidity-free survival
chr16	61778094	61778095	rs8048207	Non-small cell lung cancer
chr16	62100210	62100211	rs8050940	Myopia (pathological)
chr16	62377152	62377153	rs11645366	Cystic fibrosis severity
chr16	62798851	62798852	rs2962462	Relative hand skill in reading disability
chr16	63955446	63955447	rs1381102	Attention deficit hyperactivity disorder and conduct disorder
chr16	64635402	64635403	rs16967753	Metabolite levels (Pyroglutamine)
chr16	65895363	65895364	rs1126179	Molar-incisor hypomineralization
chr16	66158735	66158736	rs8050896	Response to antipsychotic treatment
chr16	67225500	67225501	rs3729639	Coronary heart disease
chr16	67693796	67693797	rs7204371	Obesity-related traits
chr16	67708896	67708897	rs12449157	HDL cholesterol
chr16	67902069	67902070	rs2271293	HDL cholesterol
chr16	67911516	67911517	rs8060686	Metabolic syndrome
chr16	67911516	67911517	rs8060686	Coronary heart disease
chr16	67928041	67928042	rs16942887	HDL cholesterol
chr16	67971379	67971380	rs11574514	Crohn's disease
chr16	68013470	68013471	rs255049	HDL cholesterol
chr16	68024994	68024995	rs255052	HDL cholesterol
chr16	68326199	68326200	rs6499165	Metabolic traits
chr16	68383046	68383047	rs7197653	Magnesium levels
chr16	68591229	68591230	rs1728785	Ulcerative colitis
chr16	68600350	68600351	rs17689437	HIV-1 viral setpoint
chr16	68600350	68600351	rs17689437	Response to antipsychotic treatment in schizophrenia (reasoning)
chr16	68674787	68674788	rs6499188	Ulcerative colitis
chr16	68757768	68757769	rs192253604	Serum dimethylarginine levels (asymmetric)
chr16	68820945	68820946	rs9929218	Colorectal cancer
chr16	69135048	69135049	rs8047014	Attention deficit hyperactivity disorder
chr16	69542375	69542376	rs744972	Homeostasis model assessment of beta-cell function (interaction)
chr16	69563889	69563890	rs7193778	Urate levels
chr16	69588571	69588572	rs1364063	Menarche (age at onset)
chr16	69830327	69830328	rs6499255	IgE levels
chr16	70505358	70505359	rs11861805	Obesity-related traits
chr16	70913983	70913984	rs12149070	Chronic obstructive pulmonary disease-related biomarkers
chr16	71047483	71047484	rs195656	Celiac disease
chr16	71634810	71634811	rs4788815	Metabolite levels
chr16	71653636	71653637	rs2334880	Malaria
chr16	71965195	71965196	rs16973500	Attention deficit hyperactivity disorder and conduct disorder
chr16	72108092	72108093	rs2000999	LDL cholesterol
chr16	72108092	72108093	rs2000999	Cholesterol, total
chr16	72108092	72108093	rs2000999	Haptoglobin levels
chr16	72114001	72114002	rs217181	Metabolite levels
chr16	72220372	72220373	rs7186908	Liver enzyme levels (alkaline phosphatase)
chr16	72257698	72257699	rs17668704	Thiazide-induced adverse metabolic effects in hypertensive patients
chr16	72756100	72756101	rs10500569	Metabolite levels
chr16	72931084	72931085	rs16971384	Coronary heart disease
chr16	73009023	73009024	rs7199343	Kawasaki disease
chr16	73029159	73029160	rs7193343	Atrial fibrillation
chr16	73051619	73051620	rs2106261	Atrial fibrillation
chr16	73068677	73068678	rs879324	Stroke (ischemic)
chr16	73439354	73439355	rs9934948	Breast cancer (survival)
chr16	73501535	73501536	rs12446956	Major depressive disorder
chr16	73581057	73581058	rs7191888	Multiple sclerosis (severity)
chr16	73713682	73713683	rs764255	Word reading
chr16	73829269	73829270	rs427576	Thiazide-induced adverse metabolic effects in hypertensive patients
chr16	74076251	74076252	rs2716601	Treatment response for severe sepsis
chr16	74472695	74472696	rs10871290	Breast cancer
chr16	74670457	74670458	rs4888262	Testicular germ cell tumor
chr16	74881819	74881820	rs16948255	HIV-1 control
chr16	74978617	74978618	rs2042415	Obesity-related traits
chr16	75167578	75167579	rs7195303	Crohn's disease (time to surgery)
chr16	75247244	75247245	rs7202877	Type 1 diabetes
chr16	75390315	75390316	rs2865531	Pulmonary function (interaction)
chr16	75390315	75390316	rs2865531	Pulmonary function
chr16	75991445	75991446	rs1948632	Tuberculosis
chr16	76318541	76318542	rs7193230	Response to amphetamines
chr16	76566156	76566157	rs4485401	Sphingolipid levels
chr16	76846265	76846266	rs113716969	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr16	76878861	76878862	rs13330107	Inattentive symptoms
chr16	76890125	76890126	rs17679567	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr16	77328894	77328895	rs12935229	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr16	77329640	77329641	rs7192208	White matter integrity
chr16	77427768	77427769	rs11864477	Bone mineral density
chr16	77783579	77783580	rs4888671	Obesity-related traits
chr16	77876762	77876763	rs9934540	Alzheimer's disease (cognitive decline)
chr16	77916190	77916191	rs435746	Bipolar disorder and schizophrenia
chr16	78187902	78187903	rs12716850	Pulmonary function (interaction)
chr16	78188495	78188496	rs8056446	Pulmonary function (interaction)
chr16	78188737	78188738	rs12716852	Pulmonary function
chr16	78258809	78258810	rs2059238	Cardiac structure and function
chr16	78335043	78335044	rs78867184	Metabolite levels (5-HIAA)
chr16	78569956	78569957	rs17706989	Response to antipsychotic treatment in schizophrenia (reasoning)
chr16	78631793	78631794	rs2859631	Radiation response
chr16	78952438	78952439	rs9923451	Obesity
chr16	79073420	79073421	rs17713676	Response to amphetamines
chr16	79186885	79186886	rs8050187	Anorexia nervosa
chr16	79363813	79363814	rs7191820	Obesity-related traits
chr16	79406917	79406918	rs17797882	Type 2 diabetes
chr16	79431852	79431853	rs4888966	Dental caries
chr16	79585020	79585021	rs7498403	Height
chr16	79645988	79645989	rs889472	Renal function-related traits (urea)
chr16	79652540	79652541	rs386965	Multiple sclerosis
chr16	79682750	79682751	rs1424233	Obesity
chr16	79734986	79734987	rs7188445	Urate levels
chr16	79744547	79744548	rs17767419	Thyroid volume
chr16	79749275	79749276	rs3813579	Thyroid volume
chr16	79749352	79749353	rs3813582	Thyroid hormone levels
chr16	79749352	79749353	rs3813582	Thyroid function
chr16	80192604	80192605	rs8060581	Presence of antiphospholipid antibodies
chr16	80305550	80305551	rs11859036	Corneal astigmatism
chr16	80497600	80497601	rs4581712	Liver enzyme levels (gamma-glutamyl transferase)
chr16	80650804	80650805	rs13329835	Breast cancer
chr16	81156521	81156522	rs4889240	Attention deficit hyperactivity disorder and conduct disorder
chr16	81264596	81264597	rs6564851	Carotenoid and tocopherol levels
chr16	81303758	81303759	rs4889294	Protein quantitative trait loci
chr16	81473648	81473649	rs310008	Menarche (age at onset)
chr16	81489372	81489373	rs16955379	Type 2 diabetes
chr16	81534789	81534790	rs2925979	Adiponectin levels
chr16	81534789	81534790	rs2925979	HDL cholesterol
chr16	81774797	81774798	rs12446319	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr16	81958297	81958298	rs7192724	Breast cancer (menopausal hormone therapy interaction)
chr16	81960957	81960958	rs3813009	IgG glycosylation
chr16	82326804	82326805	rs11863065	Obesity-related traits
chr16	82377780	82377781	rs4087296	Bone mineral density
chr16	82379952	82379953	rs4082514	Cognitive performance
chr16	82457732	82457733	rs7187223	Non-word repetition
chr16	82485250	82485251	rs8053728	Response to fenofibrate (adiponectin levels)
chr16	82519227	82519228	rs1991867	D-dimer levels
chr16	82594382	82594383	rs4783227	Response to antipsychotic treatment
chr16	82642650	82642651	rs11646213	Hypertension
chr16	82646332	82646333	rs3844412	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)
chr16	82650716	82650717	rs3865188	Adiponectin levels
chr16	82662267	82662268	rs4783244	Adiponectin levels
chr16	82663287	82663288	rs12051272	Adiponectin levels
chr16	82664832	82664833	rs139419280	Serum dimethylarginine levels (symmetric)
chr16	82692811	82692812	rs8057927	Schizophrenia
chr16	82746936	82746937	rs11646411	Attention deficit hyperactivity disorder
chr16	82787052	82787053	rs8056064	Multiple myeloma (IgH translocation)
chr16	82817590	82817591	rs12386026	Tuberculosis
chr16	82962762	82962763	rs17675602	Migraine - clinic-based
chr16	83212397	83212398	rs8055236	Coronary heart disease
chr16	83284337	83284338	rs10514585	Depression (quantitative trait)
chr16	83326058	83326059	rs11644424	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
chr16	83358775	83358776	rs6563898	IgE levels in asthmatics (D.f. specific)
chr16	83360774	83360775	rs9940464	Malaria
chr16	83487470	83487471	rs17216786	Response to antipsychotic treatment
chr16	83555524	83555525	rs4074373	Homeostasis model assessment of beta-cell function (interaction)
chr16	83639334	83639335	rs6563943	Height
chr16	83712434	83712435	rs3784943	Response to amphetamines
chr16	83757327	83757328	rs3784962	Cognitive performance
chr16	83764203	83764204	rs3096277	Blood pressure
chr16	83771495	83771496	rs444881	IgG glycosylation
chr16	83783827	83783828	rs149740259	Periodontitis (Mean PAL)
chr16	84046714	84046715	rs11864146	Non-alcoholic fatty liver disease histology (other)
chr16	84213683	84213684	rs4150167	Autism
chr16	84274404	84274405	rs746080	Visceral adipose tissue adjusted for BMI
chr16	84310398	84310399	rs138642423	Serum dimethylarginine levels (asymmetric)
chr16	84423033	84423034	rs8048576	Chronic obstructive pulmonary disease-related biomarkers
chr16	84446383	84446384	rs10514604	Attention deficit hyperactivity disorder
chr16	84578240	84578241	rs371915	Eosinophilic esophagitis (pediatric)
chr16	84685508	84685509	rs11647936	Waist circumference
chr16	84796602	84796603	rs12932018	Response to mTOR inhibitor (everolimus)
chr16	84987678	84987679	rs2326458	Height
chr16	85092747	85092748	rs8056742	Amyotrophic lateral sclerosis
chr16	85906615	85906616	rs11648716	Thiazide-induced adverse metabolic effects in hypertensive patients
chr16	85927813	85927814	rs391023	Chronic lymphocytic leukemia
chr16	85944438	85944439	rs391525	Chronic lymphocytic leukemia
chr16	85944822	85944823	rs2292982	Chronic lymphocytic leukemia
chr16	85946449	85946450	rs424971	Monocyte count
chr16	85955670	85955671	rs1044873	Chronic lymphocytic leukemia
chr16	85961561	85961562	rs17444745	QRS duration
chr16	85973027	85973028	rs12711490	Systemic lupus erythematosus and Systemic sclerosis
chr16	85975658	85975659	rs305061	Chronic lymphocytic leukemia
chr16	85991704	85991705	rs11642873	Systemic sclerosis
chr16	86009739	86009740	rs16940186	Ulcerative colitis
chr16	86011032	86011033	rs13333054	Multiple sclerosis
chr16	86011336	86011337	rs10521318	Inflammatory bowel disease
chr16	86014240	86014241	rs16940202	Ulcerative colitis
chr16	86017662	86017663	rs17445836	Multiple sclerosis
chr16	86018632	86018633	rs2280381	Rheumatoid arthritis
chr16	86019270	86019271	rs11117432	Primary biliary cirrhosis
chr16	86104141	86104142	rs8050326	Major depressive disorder
chr16	86322458	86322459	rs987052	Obesity-related traits
chr16	86365570	86365571	rs2696835	Diabetic retinopathy
chr16	86368525	86368526	rs4083242	Obesity-related traits
chr16	86381183	86381184	rs11641231	Response to statin therapy
chr16	86403117	86403118	rs9936833	Barrett's esophagus
chr16	86463694	86463695	rs2178146	Esophageal adenocarcinoma
chr16	86463694	86463695	rs2178146	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)
chr16	86485130	86485131	rs11644988	Corneal astigmatism
chr16	86511914	86511915	rs7187365	Obesity (early onset extreme)
chr16	86680995	86680996	rs300032	IgG glycosylation
chr16	86681030	86681031	rs1867485	Obesity-related traits
chr16	86710659	86710660	rs10048146	Bone mineral density
chr16	86710659	86710660	rs10048146	Bone mineral density (spine)
chr16	86710659	86710660	rs10048146	Bone mineral density (hip)
chr16	87111629	87111630	rs12933233	Alzheimer's disease (age of onset)
chr16	87461968	87461969	rs9646303	Major depressive disorder
chr16	87991050	87991051	rs4843747	Menopause (age at onset)
chr16	88298123	88298124	rs12447690	Central corneal thickness
chr16	88321435	88321436	rs6540223	Axial length
chr16	88331639	88331640	rs9938149	Corneal structure
chr16	88331639	88331640	rs9938149	Central corneal thickness
chr16	88528779	88528780	rs904790	Follicule stimulating hormone
chr16	88777241	88777242	rs8052560	Height
chr16	88840461	88840462	rs10445033	Red blood cell traits
chr16	88853728	88853729	rs837763	mean corpuscular hemoglobin concentration
chr16	88967436	88967437	rs533581	Social autistic-like traits
chr16	89448662	89448663	rs3096299	Multiple myeloma (IgH translocation)
chr16	89471245	89471246	rs2086824	Multiple myeloma (IgH translocation)
chr16	89667336	89667337	rs154659	Tanning
chr16	89708095	89708096	rs154657	Homocysteine levels
chr16	89726034	89726035	rs154663	Height
chr16	89741495	89741496	rs12443954	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr16	89755902	89755903	rs258322	Melanoma
chr16	89755902	89755903	rs258322	Black vs. red hair color
chr16	89818088	89818089	rs9926296	Vitiligo
chr16	89818731	89818732	rs12931267	Hair color
chr16	89818731	89818732	rs12931267	Freckling
chr16	89851032	89851033	rs16966142	Caffeine consumption
chr16	89859752	89859753	rs12921383	Homocysteine levels
chr16	89986116	89986117	rs1805007	Tanning
chr16	89986116	89986117	rs1805007	Sunburns
chr16	89986116	89986117	rs1805007	Non-melanoma skin cancer
chr16	89986116	89986117	rs1805007	Hair color
chr16	89986116	89986117	rs1805007	Basal cell carcinoma
chr16	89986116	89986117	rs1805007	Skin sensitivity to sun
chr16	89986116	89986117	rs1805007	Red vs non-red hair color
chr16	89986116	89986117	rs1805007	Freckles
chr16	89986116	89986117	rs1805007	Blond vs. brown hair color
chr16	90066935	90066936	rs4785763	Melanoma
chr16	90084560	90084561	rs11648785	Tanning
chr17	38923	38924	rs7217319	AIDS progression
chr17	618964	618965	rs684232	Prostate cancer
chr17	700019	700020	rs623323	Type 2 diabetes
chr17	831666	831667	rs2360111	Economic and political preferences
chr17	1618362	1618363	rs11078597	Serum albumin level
chr17	1634103	1634104	rs12150338	Calcium levels
chr17	2068931	2068932	rs4790881	Bone mineral density
chr17	2125604	2125605	rs1231206	Coronary heart disease
chr17	2126503	2126504	rs216172	Coronary heart disease
chr17	2143459	2143460	rs10852932	Aortic root size
chr17	2145192	2145193	rs11078884	Metabolite levels (5-HIAA)
chr17	2171636	2171637	rs17761864	Esophageal cancer (squamous cell)
chr17	2208898	2208899	rs4523957	Schizophrenia
chr17	2216257	2216258	rs391300	Type 2 diabetes
chr17	2262702	2262703	rs4790333	Proinsulin levels
chr17	2428507	2428508	rs9891572	HDL cholesterol
chr17	2771511	2771512	rs12603284	Sudden cardiac arrest
chr17	3029553	3029554	rs12449465	Endometriosis
chr17	3188011	3188012	rs2005290	Cocaine dependence
chr17	3393067	3393068	rs923375	Myopia (pathological)
chr17	3664974	3664975	rs220470	Attention deficit hyperactivity disorder
chr17	3786906	3786907	rs758642	Smoking behavior
chr17	4007593	4007594	rs7221595	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia
chr17	4393497	4393498	rs333119	Obesity-related traits
chr17	4683034	4683035	rs12051548	Metabolite levels
chr17	4683034	4683035	rs12051548	Sphingolipid levels
chr17	4836380	4836381	rs6065	Platelet counts
chr17	4901981	4901982	rs11658587	Obesity-related traits
chr17	5137046	5137047	rs7225151	Alzheimer's disease (late onset)
chr17	5907442	5907443	rs9303196	Non-small cell lung cancer
chr17	6093950	6093951	rs3744728	Bipolar disorder (mood-incongruent)
chr17	6141676	6141677	rs7503953	Wegener's granulomatosis
chr17	6607017	6607018	rs218676	Economic and political preferences (time)
chr17	6940392	6940393	rs312457	Type 2 diabetes
chr17	7091649	7091650	rs314253	LDL cholesterol
chr17	7091649	7091650	rs314253	Cholesterol, total
chr17	7091649	7091650	rs314253	Liver enzyme levels (alkaline phosphatase)
chr17	7118321	7118322	rs507506	Adiponectin levels
chr17	7142850	7142851	rs117616209	Metabolite levels
chr17	7184480	7184481	rs5415	Birth weight
chr17	7417662	7417663	rs6761	Protein quantitative trait loci
chr17	7462554	7462555	rs11552708	IgM levels
chr17	7462968	7462969	rs3803800	IgA levels
chr17	7462968	7462969	rs3803800	Non-albumin protein levels
chr17	7462968	7462969	rs3803800	IgA nephropathy
chr17	7469228	7469229	rs11078697	IgM levels
chr17	7484811	7484812	rs9901675	Sex hormone-binding globulin levels
chr17	7487107	7487108	rs2075230	Hormone measurements
chr17	7491176	7491177	rs4227	IgA nephropathy
chr17	7512073	7512074	rs11653545	IgM levels
chr17	7521914	7521915	rs12150660	Sex hormone-binding globulin levels
chr17	7521914	7521915	rs12150660	Testosterone levels
chr17	7534677	7534678	rs6258	Sex hormone-binding globulin levels
chr17	7534677	7534678	rs6258	Testosterone levels
chr17	7537791	7537792	rs727428	Androgen levels
chr17	7537791	7537792	rs727428	Sex hormone-binding globulin levels
chr17	7545720	7545721	rs1641537	Sex hormone-binding globulin levels
chr17	7552122	7552123	rs72829446	Androgen levels
chr17	7571751	7571752	rs78378222	Basal cell carcinoma
chr17	7578114	7578115	rs1625895	Sex hormone-binding globulin levels
chr17	7633691	7633692	rs16956936	Type 1 diabetes
chr17	8130866	8130867	rs3027247	Parkinson's disease (motor and cognition)
chr17	8136091	8136092	rs3027234	Telomere length
chr17	8943928	8943929	rs8076457	Orofacial clefts
chr17	9090223	9090224	rs3785982	Breast cancer (prognosis)
chr17	9875204	9875205	rs3786094	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
chr17	10031089	10031090	rs12150284	Intraocular pressure
chr17	10033678	10033679	rs11656696	Intraocular pressure
chr17	10567482	10567483	rs169313	Relative hand skill in reading disability
chr17	10574158	10574159	rs6503319	Malaria
chr17	11100664	11100665	rs8076220	Obesity-related traits
chr17	11250218	11250219	rs8076431	IgG glycosylation
chr17	11342607	11342608	rs1877644	Obesity-related traits
chr17	11407900	11407901	rs2969180	Refractive error
chr17	11803460	11803461	rs4792192	Myopia (pathological)
chr17	12047543	12047544	rs1870584	Response to amphetamines
chr17	12637370	12637371	rs9905820	Testosterone levels
chr17	12777401	12777402	rs11651483	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr17	12804549	12804550	rs7209847	Economic and political preferences
chr17	13062794	13062795	rs9900808	Cannabis use (initiation)
chr17	13539803	13539804	rs10521232	Tonometry
chr17	13559079	13559080	rs10521233	Asthma (childhood onset)
chr17	13684916	13684917	rs4792394	Conduct disorder (symptom count)
chr17	13708860	13708861	rs7215286	IgG glycosylation
chr17	13733805	13733806	rs12949531	Systemic lupus erythematosus
chr17	13910548	13910549	rs17608059	Temperament
chr17	14294020	14294021	rs3848445	Protein quantitative trait loci
chr17	14561015	14561016	rs12940030	Corneal structure
chr17	14629745	14629746	rs9899891	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr17	14889924	14889925	rs8066099	Obesity-related traits
chr17	15193055	15193056	rs1380181	QT interval
chr17	15331516	15331517	rs2906966	Pulmonary function
chr17	15826020	15826021	rs859267	Immune reponse to smallpox (secreted IL-12p40)
chr17	16246015	16246016	rs7477	Amyotrophic lateral sclerosis
chr17	16816542	16816543	rs4792793	Metabolite levels (Pyroglutamine)
chr17	16845166	16845167	rs4792800	IgG levels
chr17	16848749	16848750	rs4561508	Hematology traits
chr17	16848749	16848750	rs4561508	Serum total protein level
chr17	16849138	16849139	rs4273077	Multiple myeloma
chr17	16849138	16849139	rs4273077	Hematological and biochemical traits
chr17	16863637	16863638	rs4985726	Non-albumin protein levels
chr17	16933403	16933404	rs11867934	Diabetic retinopathy
chr17	16960977	16960978	rs6502557	IgG glycosylation
chr17	17068181	17068182	rs61744862	Obesity-related traits
chr17	17142895	17142896	rs12600635	IgG glycosylation
chr17	17543721	17543722	rs12936587	Coronary heart disease
chr17	17715100	17715101	rs11868035	Parkinson's disease
chr17	18064729	18064730	rs8077577	Obesity-related traits
chr17	18753869	18753870	rs4924935	Pancreatic cancer
chr17	19804246	19804247	rs397969	Platelet counts
chr17	20023098	20023099	rs2013441	Obesity-related traits
chr17	20924076	20924077	rs7226229	Blood trace element (Se levels)
chr17	21284222	21284223	rs4640244	Height
chr17	21707059	21707060	rs1975974	Psoriasis
chr17	25320888	25320889	rs73317122	Response to amphetamines
chr17	25541277	25541278	rs4795519	Chronic myeloid leukemia
chr17	25567079	25567080	rs12602978	Dental caries
chr17	25843642	25843643	rs2945412	Crohn's disease
chr17	26106674	26106675	rs4795067	Psoriasis
chr17	26601132	26601133	rs2006933	Amyotrophic lateral sclerosis
chr17	26610251	26610252	rs34517613	Amyotrophic lateral sclerosis (sporadic)
chr17	27675225	27675226	rs11653144	Mean platelet volume
chr17	27703348	27703349	rs2138852	Mean platelet volume
chr17	27714586	27714587	rs8076739	Mean platelet volume
chr17	27769597	27769598	rs9900280	Mean platelet volume
chr17	27814495	27814496	rs559972	Platelet counts
chr17	27917770	27917771	rs3110496	Height
chr17	29164022	29164023	rs3764419	Height
chr17	29247714	29247715	rs3760318	Height
chr17	29333515	29333516	rs17826255	Myopia (pathological)
chr17	30343281	30343282	rs17780086	Height
chr17	30535855	30535856	rs17780304	Obesity-related traits
chr17	30877657	30877658	rs225190	Pancreatic cancer
chr17	30896454	30896455	rs225212	Hypertension risk in short sleep duration
chr17	31078271	31078272	rs17183295	Refractive error
chr17	31393701	31393702	rs17808461	Obesity-related traits
chr17	31737420	31737421	rs1354492	vWF and FVIII levels
chr17	32287448	32287449	rs11650066	Coronary heart disease
chr17	32464153	32464154	rs9901756	Hypothyroidism
chr17	32593664	32593665	rs3091315	Crohn's disease
chr17	32593973	32593974	rs3091316	Inflammatory bowel disease
chr17	32593973	32593974	rs3091316	Crohn's disease
chr17	32972728	32972729	rs4990638	Personality dimensions
chr17	32989537	32989538	rs11654964	Lobular breast cancer (menopausal hormone therapy interaction)
chr17	33324381	33324382	rs2074518	QT interval
chr17	33843511	33843512	rs8070473	Depression (quantitative trait)
chr17	33884803	33884804	rs10512472	Platelet counts
chr17	33944054	33944055	rs16971217	Mean platelet volume
chr17	34358296	34358297	rs712046	Pulmonary function
chr17	34819190	34819191	rs4796217	Protein quantitative trait loci
chr17	35189090	35189091	rs17138064	Orofacial clefts
chr17	35306311	35306312	rs2306658	Obesity-related traits
chr17	35850552	35850553	rs712039	Tuberculosis
chr17	35898341	35898342	rs2074409	Response to angiotensin II receptor blocker therapy
chr17	36026334	36026335	rs6607284	Bipolar disorder and schizophrenia
chr17	36096514	36096515	rs757210	Ovarian cancer
chr17	36098039	36098040	rs4430796	Type 2 diabetes
chr17	36098039	36098040	rs4430796	Endometrial cancer
chr17	36098039	36098040	rs4430796	Serum prostate-specific antigen levels
chr17	36098039	36098040	rs4430796	Prostate cancer
chr17	36101155	36101156	rs7501939	Prostate cancer
chr17	36922195	36922196	rs1043515	Height
chr17	37101379	37101380	rs9906595	Obesity-related traits
chr17	37331344	37331345	rs523516	IgG glycosylation
chr17	37332962	37332963	rs626657	IgG glycosylation
chr17	37543448	37543449	rs7208487	Primary biliary cirrhosis
chr17	37813855	37813856	rs11869286	HDL cholesterol
chr17	37912376	37912377	rs12946510	Inflammatory bowel disease
chr17	37922258	37922259	rs907092	Primary biliary cirrhosis
chr17	37976468	37976469	rs9303277	Systemic lupus erythematosus and Systemic sclerosis
chr17	37976468	37976469	rs9303277	Primary biliary cirrhosis
chr17	38040762	38040763	rs2872507	Type 1 diabetes autoantibodies
chr17	38040762	38040763	rs2872507	Ulcerative colitis
chr17	38040762	38040763	rs2872507	Crohn's disease
chr17	38040762	38040763	rs2872507	Rheumatoid arthritis
chr17	38051347	38051348	rs8067378	Cervical cancer
chr17	38051347	38051348	rs8067378	Ulcerative colitis
chr17	38062195	38062196	rs2305480	Asthma
chr17	38062195	38062196	rs2305480	Ulcerative colitis
chr17	38064404	38064405	rs11078927	Asthma
chr17	38066239	38066240	rs2290400	Type 1 diabetes
chr17	38069948	38069949	rs7216389	Asthma
chr17	38074030	38074031	rs9303280	Self-reported allergy
chr17	38089343	38089344	rs4794820	Asthma
chr17	38095173	38095174	rs6503525	Asthma
chr17	38110688	38110689	rs17609240	Hematological parameters
chr17	38121992	38121993	rs3894194	Asthma
chr17	38128647	38128648	rs3859192	White blood cell count
chr17	38143547	38143548	rs4065321	White blood cell count
chr17	38156711	38156712	rs4794822	White blood cell count
chr17	38156711	38156712	rs4794822	White blood cell types
chr17	38156711	38156712	rs4794822	Neutrophil count
chr17	38166878	38166879	rs8078723	C-reactive protein and white blood cell count
chr17	38166878	38166879	rs8078723	White blood cell count
chr17	38179491	38179492	rs2302777	Multiple myeloma (hyperdiploidy)
chr17	38599171	38599172	rs584438	Height
chr17	38770285	38770286	rs7221109	Type 1 diabetes
chr17	39046880	39046881	rs2315504	Height
chr17	39250638	39250639	rs4006360	Bipolar disorder and schizophrenia
chr17	39897263	39897264	rs6503659	Esophageal cancer (squamous cell)
chr17	40481528	40481529	rs2293152	Multiple sclerosis
chr17	40507979	40507980	rs9891119	Crohn's disease
chr17	40507979	40507980	rs9891119	Multiple sclerosis
chr17	40514200	40514201	rs744166	Multiple sclerosis
chr17	40514200	40514201	rs744166	Crohn's disease
chr17	40527543	40527544	rs12942547	Inflammatory bowel disease
chr17	40570771	40570772	rs11871801	Crohn's disease
chr17	41798823	41798824	rs4792909	Bone mineral density
chr17	41807330	41807331	rs1513670	Bone mineral density (hip)
chr17	41878165	41878166	rs8077889	Triglycerides
chr17	42064986	42064987	rs9895585	Response to taxane treatment (placlitaxel)
chr17	42193184	42193185	rs228769	Bone mineral density (spine)
chr17	42193184	42193185	rs228769	Bone mineral density (hip)
chr17	42225546	42225547	rs227584	Bone mineral density
chr17	42225546	42225547	rs227584	Bone mineral density (hip)
chr17	42330728	42330729	rs5023	Obesity-related traits
chr17	42442343	42442344	rs708382	Platelet counts
chr17	43038208	43038209	rs1007190	DNA methylation (variation)
chr17	43208120	43208121	rs12946454	Systolic blood pressure
chr17	43212962	43212963	rs2291447	Economic and political preferences
chr17	43216280	43216281	rs4986172	Height
chr17	43403004	43403005	rs4792814	Multiple sclerosis
chr17	43513440	43513441	rs11012	Parkinson's disease
chr17	43516401	43516402	rs17631303	Ovarian cancer in BRCA1 mutation carriers
chr17	43666491	43666492	rs2458179	Response to amphetamines
chr17	43714849	43714850	rs2942168	Parkinson's disease
chr17	43719142	43719143	rs393152	Parkinson's disease
chr17	43795432	43795433	rs11655470	Head circumference (infant)
chr17	43805193	43805194	rs9303521	Bone mineral density (spine)
chr17	43805193	43805194	rs9303521	Bone mineral density (hip)
chr17	43923682	43923683	rs12185268	Parkinson's disease
chr17	43924218	43924219	rs12373124	Male-pattern baldness
chr17	43977826	43977827	rs1864325	Bone mineral density
chr17	44019711	44019712	rs242557	Progressive supranuclear palsy
chr17	44056766	44056767	rs1981997	Interstitial lung disease
chr17	44081063	44081064	rs8070723	Progressive supranuclear palsy
chr17	44081063	44081064	rs8070723	Parkinson's disease
chr17	44187256	44187257	rs9303525	Intracranial volume
chr17	44334706	44334707	rs2458179	Response to amphetamines
chr17	44788309	44788310	rs183211	Ovarian cancer in BRCA1 mutation carriers
chr17	44788309	44788310	rs183211	Parkinson's disease
chr17	44828930	44828931	rs199533	Parkinson's disease
chr17	44856640	44856641	rs199515	Parkinson's disease
chr17	44859143	44859144	rs415430	Parkinson's disease
chr17	44865438	44865439	rs2074404	Celiac disease
chr17	44949099	44949100	rs11079740	Antineutrophil cytoplasmic antibody-associated vasculitis
chr17	45013270	45013271	rs17608766	Systolic blood pressure
chr17	45013270	45013271	rs17608766	Blood pressure
chr17	45013270	45013271	rs17608766	QRS duration
chr17	45309692	45309693	rs11079764	IgG glycosylation
chr17	45351117	45351118	rs7209700	IgG glycosylation
chr17	45425114	45425115	rs7206971	LDL cholesterol
chr17	45425114	45425115	rs7206971	Cholesterol, total
chr17	45768835	45768836	rs8070463	Multiple sclerosis
chr17	45768835	45768836	rs8070463	Ankylosing spondylitis
chr17	45830947	45830948	rs12950390	IgG glycosylation
chr17	45835277	45835278	rs11651000	IgG glycosylation
chr17	45930538	45930539	rs4794202	Alzheimer's disease (cognitive decline)
chr17	46047655	46047656	rs2597167	Metabolite levels (Pyroglutamine)
chr17	46123003	46123004	rs72823592	Epilepsy (generalized)
chr17	46123931	46123932	rs3764400	Body mass index
chr17	46357119	46357120	rs2084881	Ovarian cancer
chr17	46411499	46411500	rs9303542	Ovarian cancer
chr17	46617018	46617019	rs6504340	Primary tooth development (number of teeth)
chr17	46669429	46669430	rs9299	Obesity
chr17	46720564	46720565	rs2326017	Body mass index (non-asthmatics)
chr17	46720564	46720565	rs2326017	Cognitive performance
chr17	46749790	46749791	rs8074700	Body mass index (non-asthmatics)
chr17	46757574	46757575	rs3096644	Metabolite levels (Dihydroxy docosatrienoic acid)
chr17	46840540	46840541	rs7219021	Schizophrenia or bipolar disorder
chr17	46988596	46988597	rs46522	Coronary heart disease
chr17	47080430	47080431	rs1994969	Primary tooth development (time to first tooth eruption)
chr17	47080430	47080431	rs1994969	Primary tooth development (number of teeth)
chr17	47084710	47084711	rs9674544	Primary tooth development (time to first tooth eruption)
chr17	47084710	47084711	rs9674544	Primary tooth development (number of teeth)
chr17	47290794	47290795	rs627386	IgG glycosylation
chr17	47345185	47345186	rs11650494	Prostate cancer
chr17	47390013	47390014	rs2072153	Height
chr17	47402806	47402807	rs12940887	Blood pressure
chr17	47436748	47436749	rs7210100	Prostate cancer
chr17	47440465	47440466	rs16948048	Diastolic blood pressure
chr17	47445750	47445751	rs2411984	Sex hormone-binding globulin levels
chr17	47564011	47564012	rs1035050	Bipolar disorder
chr17	47566311	47566312	rs16948200	Immune reponse to smallpox (secreted IL-2)
chr17	48274290	48274291	rs2075555	Breast cancer
chr17	48289069	48289070	rs2586502	Response to taxane treatment (docetaxel)
chr17	48591208	48591209	rs6504663	Visceral fat
chr17	48692081	48692082	rs117964204	Alzheimer's disease (cognitive decline)
chr17	49244746	49244747	rs4605213	Height
chr17	49613784	49613785	rs9635759	Menarche (age at onset)
chr17	50293637	50293638	rs16951120	Thiazide-induced adverse metabolic effects in hypertensive patients
chr17	51237940	51237941	rs8073783	Conduct disorder (interaction)
chr17	52548124	52548125	rs6504909	Obesity-related traits
chr17	53056470	53056471	rs6504950	Breast cancer
chr17	53364787	53364788	rs7224610	Urate levels
chr17	53519843	53519844	rs11653011	Obesity-related traits
chr17	53757786	53757787	rs1549519	Height
chr17	54123972	54123973	rs2060070	IgG glycosylation
chr17	54192522	54192523	rs1431318	Cannabis dependence
chr17	54203359	54203360	rs8065311	Cannabis dependence
chr17	54278714	54278715	rs1019238	Cannabis dependence
chr17	54430154	54430155	rs12449568	Height
chr17	54611290	54611291	rs17760268	Celiac disease
chr17	54615616	54615617	rs17760296	Orofacial clefts
chr17	54773237	54773238	rs227731	Orofacial clefts
chr17	54778816	54778817	rs227724	Height
chr17	54839758	54839759	rs1401796	Height
chr17	54850328	54850329	rs4794665	Height
chr17	55108733	55108734	rs6503782	Age-related macular degeneration
chr17	55119993	55119994	rs8073390	Response to amphetamines
chr17	55747415	55747416	rs11079321	Coronary artery calcification
chr17	55823551	55823552	rs8077059	Sex hormone-binding globulin levels
chr17	55866286	55866287	rs12938916	Bipolar disorder
chr17	56010959	56010960	rs8074980	Multiple sclerosis--Brain Glutamate Levels
chr17	56313903	56313904	rs8067912	IgG glycosylation
chr17	56369848	56369849	rs12940923	Circulating myeloperoxidase levels (plasma)
chr17	56448296	56448297	rs2257205	Pancreatic cancer
chr17	56584204	56584205	rs2302189	Dental caries
chr17	56632542	56632543	rs9905704	Testicular germ cell tumor
chr17	56709057	56709058	rs412000	Primary tooth development (time to first tooth eruption)
chr17	56847944	56847945	rs9303401	Cognitive test performance
chr17	57287453	57287454	rs6503905	Circulating myeloperoxidase levels (plasma)
chr17	57850250	57850251	rs11650106	Lipoprotein-associated phospholipase A2 activity and mass
chr17	57963536	57963537	rs1292053	Inflammatory bowel disease
chr17	58024274	58024275	rs180515	Multiple sclerosis
chr17	58024323	58024324	rs1051424	Obesity-related traits
chr17	58966537	58966538	rs7224438	Immune reponse to smallpox (secreted IL-2)
chr17	59239220	59239221	rs11868441	Renal function-related traits (BUN)
chr17	59286643	59286644	rs8068952	Vertical cup-disc ratio
chr17	59292435	59292436	rs72832584	Alzheimer's disease (cognitive decline)
chr17	59323042	59323043	rs17513268	Obesity-related traits
chr17	59391378	59391379	rs3785856	Breast cancer
chr17	59396448	59396449	rs10853029	Breast cancer
chr17	59456588	59456589	rs9895661	Renal function-related traits (sCR)
chr17	59456588	59456589	rs9895661	Renal function-related traits (eGRFcrea)
chr17	59456588	59456589	rs9895661	Chronic kidney disease
chr17	59465696	59465697	rs2079742	Urate levels
chr17	59483765	59483766	rs8068318	Creatinine levels
chr17	59496648	59496649	rs2079795	Height
chr17	59497276	59497277	rs757608	Height
chr17	59667952	59667953	rs17610181	Osteoarthritis (hip)
chr17	59880645	59880646	rs34289250	Ovarian cancer
chr17	59897454	59897455	rs12453935	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr17	60778931	60778932	rs2251393	Sudden cardiac arrest
chr17	61563457	61563458	rs4329	Metabolic traits
chr17	61566030	61566031	rs4343	Angiotensin-converting enzyme activity
chr17	61569731	61569732	rs4351	Metabolite levels
chr17	61712963	61712964	rs7209435	Height
chr17	61763030	61763031	rs11658329	Height
chr17	61966464	61966465	rs2665838	Height
chr17	61977247	61977248	rs2854160	Height
chr17	61978547	61978548	rs2941551	Height
chr17	62007497	62007498	rs2070776	Height
chr17	62408298	62408299	rs6504218	Coronary heart disease
chr17	62600934	62600935	rs111854052	Periodontitis (Mean PAL)
chr17	63642541	63642542	rs8074751	Attention deficit hyperactivity disorder
chr17	64098544	64098545	rs2319125	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr17	64133725	64133726	rs7209395	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr17	64133725	64133726	rs7209395	Weight
chr17	64210579	64210580	rs1801689	LDL cholesterol
chr17	64227362	64227363	rs11867410	Blood pressure measurement (high sodium and potassium intervention)
chr17	64236317	64236318	rs10048158	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr17	64447164	64447165	rs7207499	Post-traumatic stress disorder (asjusted for relatedness)
chr17	64517312	64517313	rs11651708	Coronary artery calcification
chr17	64779429	64779430	rs3889237	Height
chr17	64917032	64917033	rs17645023	Bipolar disorder and schizophrenia
chr17	65488020	65488021	rs2017854	Pulmonary function
chr17	65898808	65898809	rs7216064	Lung cancer
chr17	65898808	65898809	rs7216064	Lung adenocarcinoma
chr17	66875293	66875294	rs4148008	HDL cholesterol
chr17	67802351	67802352	rs11870477	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr17	67850900	67850901	rs2366017	Palmitoleic acid (16:1n-7) plasma levels
chr17	68090206	68090207	rs11867479	Height
chr17	68108416	68108417	rs12936361	Periodontitis (DPAL)
chr17	68185585	68185586	rs8080944	Primary tooth development (time to first tooth eruption)
chr17	68185585	68185586	rs8080944	Primary tooth development (number of teeth)
chr17	68190825	68190826	rs8079702	Primary tooth development (time to first tooth eruption)
chr17	68190825	68190826	rs8079702	Primary tooth development (number of teeth)
chr17	68259445	68259446	rs623011	Thyrotoxic hypokalemic periodic paralysis
chr17	68291132	68291133	rs6501384	Eosinophilic esophagitis (pediatric)
chr17	68326337	68326338	rs312691	Thyrotoxic hypokalemic periodic paralysis
chr17	68494991	68494992	rs17779747	QT interval
chr17	68521860	68521861	rs7219669	Cardiac repolarization
chr17	68634064	68634065	rs16975985	Obesity-related traits
chr17	68644188	68644189	rs17718586	Sudden cardiac arrest
chr17	68718733	68718734	rs4793501	Refractive error
chr17	68828088	68828089	rs1990193	Obesity-related traits
chr17	68878486	68878487	rs1015657	Formal thought disorder in schizophrenia
chr17	69108752	69108753	rs1859962	Prostate cancer
chr17	69125605	69125606	rs11654749	Pulmonary function (interaction)
chr17	69236997	69236998	rs12946942	Adolescent idiopathic scoliosis (severe)
chr17	69490072	69490073	rs9907236	Coronary artery calcification
chr17	69949015	69949016	rs7217932	Bone mineral density
chr17	70098160	70098161	rs9913711	Liver enzyme levels (gamma-glutamyl transferase)
chr17	70127535	70127536	rs9915657	Thyroid hormone levels
chr17	70363394	70363395	rs12941150	Pulmonary function decline
chr17	70584264	70584265	rs718073	Relative hand skill in reading disability
chr17	70594628	70594629	rs11077614	Thiazide-induced adverse metabolic effects in hypertensive patients
chr17	70641697	70641698	rs7210086	Ulcerative colitis
chr17	70696102	70696103	rs8066857	Amyotrophic lateral sclerosis
chr17	70713538	70713539	rs891684	Serum selenium levels
chr17	70826403	70826404	rs12943829	Visceral adipose tissue adjusted for BMI
chr17	71000939	71000940	rs4969049	Body mass index (interaction)
chr17	71061933	71061934	rs903107	Liver enzyme levels (alanine transaminase)
chr17	71335259	71335260	rs3816995	Panic disorder
chr17	71807712	71807713	rs12451840	IgG glycosylation
chr17	72268207	72268208	rs7219585	Information processing speed
chr17	72699832	72699833	rs10512597	Fibrinogen
chr17	73060072	73060073	rs11077773	Information processing speed
chr17	73872947	73872948	rs1055129	White matter hyperintensity burden
chr17	73888671	73888672	rs3744028	White matter hyperintensity burden
chr17	74283668	74283669	rs164009	Urate levels
chr17	74733402	74733403	rs3744061	Retinal arteriolar caliber
chr17	74997896	74997897	rs4789400	Cannabis use (initiation)
chr17	75004212	75004213	rs11653989	Cardiac repolarization
chr17	75211207	75211208	rs3744064	Cognitive performance
chr17	75313334	75313335	rs4788985	Illicit drug use
chr17	75400099	75400100	rs892961	Airflow obstruction
chr17	75701696	75701697	rs9906155	Body mass index
chr17	75944649	75944650	rs16970672	Alzheimer's disease
chr17	76110517	76110518	rs2613514	Thiazide-induced adverse metabolic effects in hypertensive patients
chr17	76219590	76219591	rs2071214	Behavioural disinhibition (generation interaction)
chr17	76219944	76219945	rs17879146	Periodontitis (Mean PAL)
chr17	76304509	76304510	rs8081523	Blood trace element (Se levels)
chr17	76311990	76311991	rs4789580	IgG glycosylation
chr17	76403983	76403984	rs4129767	HDL cholesterol
chr17	76868613	76868614	rs9900972	Obesity-related traits
chr17	76870580	76870581	rs2009196	Periodontitis (CDC/AAP)
chr17	76881702	76881703	rs4789939	Dupuytren's disease
chr17	77410858	77410859	rs1316453	Self-reported allergy
chr17	78060742	78060743	rs1467979	IgG glycosylation
chr17	78066616	78066617	rs2361701	IgG glycosylation
chr17	78324258	78324259	rs12051723	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr17	78348493	78348494	rs6565681	Moyamoya disease
chr17	78591110	78591111	rs7503807	Obesity
chr17	78737286	78737287	rs7215564	Myopia (pathological)
chr17	79118572	79118573	rs7220048	Obesity-related traits
chr17	79168267	79168268	rs2279913	IgG glycosylation
chr17	79218713	79218714	rs2659005	IgG glycosylation
chr17	79235787	79235788	rs7224668	IgG glycosylation
chr17	79261808	79261809	rs10445407	Longevity
chr17	79596810	79596811	rs9894429	Eye color traits
chr17	79682050	79682051	rs3204270	Dental caries
chr17	80408814	80408815	rs9303029	Protein quantitative trait loci
chr17	80685532	80685533	rs1046896	Glycated hemoglobin levels
chr18	120295	120296	rs57440971	Periodontitis (Mean PAL)
chr18	278795	278796	rs7226677	Bipolar disorder and major depressive disorder (combined)
chr18	278795	278796	rs7226677	Bipolar disorder
chr18	322521	322522	rs621636	Obesity-related traits
chr18	355943	355944	rs644435	Obesity-related traits
chr18	849177	849178	rs1291183	Pulmonary function in asthmatics
chr18	905124	905125	rs1893154	Obesity-related traits
chr18	1206983	1206984	rs1826508	Metabolite levels (Dihydroxy docosatrienoic acid)
chr18	1595020	1595021	rs8097348	Exercise (leisure time)
chr18	2498053	2498054	rs1879352	Acute lymphoblastic leukemia (childhood)
chr18	2946290	2946291	rs643507	Body mass index (asthmatics)
chr18	2948028	2948029	rs10460009	Type 2 diabetes
chr18	3041396	3041397	rs78192384	Serum dimethylarginine levels (symmetric)
chr18	3328745	3328746	rs1623523	Antineutrophil cytoplasmic antibody-associated vasculitis
chr18	3415830	3415831	rs12457997	Periodontitis (DPAL)
chr18	3512215	3512216	rs17724172	Cardiac Troponin-T levels
chr18	3522005	3522006	rs8083633	Economic and political preferences (time)
chr18	3879738	3879739	rs76205593	Obesity-related traits
chr18	4539084	4539085	rs7228133	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
chr18	4721358	4721359	rs1557305	Eating disorders
chr18	4773109	4773110	rs7237848	White blood cell types
chr18	5762617	5762618	rs11662748	Obesity-related traits
chr18	5857090	5857091	rs11662763	Immunoglobulin A
chr18	5978930	5978931	rs1539808	Sleep time
chr18	6567181	6567182	rs948426	Hypothyroidism
chr18	6668049	6668050	rs11662297	Obesity-related traits
chr18	6939946	6939947	rs597503	Sudden cardiac arrest
chr18	6941107	6941108	rs4398173	Response to citalopram treatment
chr18	6941661	6941662	rs3810046	Response to citalopram treatment
chr18	7042910	7042911	rs16951095	Non-small cell lung cancer
chr18	7068461	7068462	rs8090011	Type 2 diabetes
chr18	7755770	7755771	rs7243299	Dialysis-related mortality
chr18	8209268	8209269	rs8098064	Dialysis-related mortality
chr18	8966143	8966144	rs10502386	Obesity-related traits
chr18	9288455	9288456	rs2864527	Dental caries
chr18	10078070	10078071	rs8089099	Pulmonary function (interaction)
chr18	10321346	10321347	rs206626	Metabolite levels (Pyroglutamine)
chr18	10382882	10382883	rs206548	Serum protein levels (sST2)
chr18	10766424	10766425	rs2865126	Metabolite levels (5-HIAA/ MHPG Ratio)
chr18	10899027	10899028	rs11080466	Non-small cell lung cancer
chr18	10923807	10923808	rs264272	Major depressive disorder
chr18	11064408	11064409	rs12455924	Thiazide-induced adverse metabolic effects in hypertensive patients
chr18	11282318	11282319	rs7243066	Dental caries
chr18	11494198	11494199	rs1455244	Schizophrenia
chr18	11759431	11759432	rs9947295	QT interval (interaction)
chr18	11987271	11987272	rs7506045	Stroke
chr18	12550746	12550747	rs1940973	Immune response to smallpox vaccine (IL-6)
chr18	12606462	12606463	rs9959145	Immune response to smallpox vaccine (IL-6)
chr18	12779946	12779947	rs2542151	Type 1 diabetes autoantibodies
chr18	12779946	12779947	rs2542151	Type 1 diabetes
chr18	12779946	12779947	rs2542151	Crohn's disease
chr18	12797693	12797694	rs2847297	Rheumatoid arthritis
chr18	12809339	12809340	rs1893217	Inflammatory bowel disease
chr18	12809339	12809340	rs1893217	Celiac disease and Rheumatoid arthritis
chr18	12809339	12809340	rs1893217	Crohn's disease
chr18	12809339	12809340	rs1893217	Celiac disease
chr18	12809339	12809340	rs1893217	Type 1 diabetes
chr18	12821592	12821593	rs2847281	Esophageal cancer (squamous cell)
chr18	12821592	12821593	rs2847281	C-reactive protein
chr18	13366861	13366862	rs12456874	Pancreatic cancer
chr18	13708573	13708574	rs4796995	Bone mineral density
chr18	19261412	19261413	rs11662721	Phospholipid levels (plasma)
chr18	19654136	19654137	rs4800353	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)
chr18	20084673	20084674	rs473518	Migraine - clinic-based
chr18	20190794	20190795	rs4331426	Tuberculosis
chr18	20223694	20223695	rs11661542	Intracranial aneurysm
chr18	20720972	20720973	rs11082304	Platelet counts
chr18	20720972	20720973	rs11082304	Height
chr18	20720972	20720973	rs11082304	Smoking behavior
chr18	20724327	20724328	rs4800148	Height
chr18	20727610	20727611	rs4800452	Height
chr18	20735407	20735408	rs4369779	Height
chr18	20879216	20879217	rs9949617	Hypertriglyceridemia
chr18	21140431	21140432	rs1805081	Obesity
chr18	21244036	21244037	rs1788776	Amyotrophic lateral sclerosis (sporadic)
chr18	21365852	21365853	rs11082762	Amyotrophic lateral sclerosis
chr18	21749614	21749615	rs9635963	Protein quantitative trait loci
chr18	21938657	21938658	rs7227401	Osteoporosis
chr18	22106775	22106776	rs7235440	Obesity-related traits
chr18	22136568	22136569	rs12954803	Response to taxane treatment (docetaxel)
chr18	22731359	22731360	rs8083432	Adverse response to lamotrigine and phenytoin
chr18	23257185	23257186	rs1840440	Weight
chr18	23393103	23393104	rs7231041	Obesity-related traits
chr18	23405187	23405188	rs9966832	Periodontitis (Mean PAL)
chr18	23614702	23614703	rs12960119	Rhegmatogenous retinal detachment
chr18	23764234	23764235	rs11877878	Periodontitis (Mean PAL)
chr18	23785647	23785648	rs8097810	Periodontitis (Mean PAL)
chr18	23892671	23892672	rs1791780	Visceral adipose tissue adjusted for BMI
chr18	24156424	24156425	rs16942421	Sudden cardiac arrest
chr18	24337423	24337424	rs527616	Breast cancer
chr18	24570666	24570667	rs1436904	Breast cancer
chr18	24687323	24687324	rs9961915	Dental caries
chr18	24687370	24687371	rs9953270	Bronchopulmonary dysplasia
chr18	25070354	25070355	rs4800279	White matter integrity
chr18	25167944	25167945	rs1420956	Obesity-related traits
chr18	25569057	25569058	rs2298574	vWF and FVIII levels
chr18	25700790	25700791	rs11564386	Obesity-related traits
chr18	25773015	25773016	rs4800843	Response to amphetamines
chr18	25926058	25926059	rs11083271	Non-alcoholic fatty liver disease histology (lobular)
chr18	26059111	26059112	rs4131805	Hip geometry
chr18	26124687	26124688	rs879500	Lung function (forced vital capacity)
chr18	26606646	26606647	rs2155929	Temperament (bipolar disorder)
chr18	26676671	26676672	rs4145170	Cognitive performance
chr18	27956442	27956443	rs6508673	Obesity-related traits
chr18	28141687	28141688	rs2729409	Protein quantitative trait loci
chr18	28639547	28639548	rs1126214	Bronchopulmonary dysplasia
chr18	28789724	28789725	rs2920001	Multiple sclerosis
chr18	28902321	28902322	rs7236477	Eosinophilic esophagitis (pediatric)
chr18	29038122	29038123	rs1941184	Parkinson's disease (age of onset)
chr18	29187278	29187279	rs1667255	Retinol levels
chr18	29273128	29273129	rs10438933	Amyotrophic lateral sclerosis
chr18	29336590	29336591	rs10502575	Coronary artery calcification
chr18	30927774	30927775	rs6507016	Prostate cancer (gene x gene interaction)
chr18	30998130	30998131	rs6507022	Metabolite levels  (X-11787)
chr18	31266740	31266741	rs4799710	Pulmonary function
chr18	31420009	31420010	rs1013696	Response to antidepressants
chr18	31645378	31645379	rs7239368	Response to citalopram treatment
chr18	33097959	33097960	rs9953852	Capecitabine sensitivity
chr18	33557465	33557466	rs2276314	Drug-induced torsades de pointes
chr18	33694119	33694120	rs1050631	Esophageal squamous cell cancer (length of survival)
chr18	34107451	34107452	rs17651157	Response to antipsychotic treatment
chr18	34371860	34371861	rs7226408	Obesity-related traits
chr18	34928638	34928639	rs4799915	Response to iloperidone treatment (QT prolongation)
chr18	35198295	35198296	rs10502675	Response to amphetamines
chr18	35214005	35214006	rs2162440	Telomere length
chr18	37165304	37165305	rs7226835	Obesity-related traits
chr18	38220098	38220099	rs10502739	Metabolite levels  (X-11787)
chr18	38765658	38765659	rs17697518	Obesity
chr18	39228309	39228310	rs9958032	Blood trace element (Zn levels)
chr18	39937508	39937509	rs9304270	Obesity-related traits
chr18	39940965	39940966	rs346452	Periodontitis (PAL4Q3)
chr18	40023305	40023306	rs346221	Periodontitis (PAL4Q3)
chr18	40023781	40023782	rs12606301	Economic and political preferences (immigration/crime)
chr18	40058881	40058882	rs7235528	Economic and political preferences (immigration/crime)
chr18	40059620	40059621	rs16976171	Coronary artery calcification
chr18	40075955	40075956	rs8090196	Economic and political preferences (immigration/crime)
chr18	40102640	40102641	rs1346987	Economic and political preferences (immigration/crime)
chr18	40105656	40105657	rs7231412	Economic and political preferences (immigration/crime)
chr18	40288292	40288293	rs8085804	Cognitive performance
chr18	40437650	40437651	rs16977065	Response to tocilizumab in rheumatoid arthritis
chr18	40591083	40591084	rs9958208	Acute lymphoblastic leukemia (childhood)
chr18	40673379	40673380	rs12456492	Parkinson's disease
chr18	40678234	40678235	rs4130047	Parkinson's disease
chr18	40808797	40808798	rs17664267	Conduct disorder (interaction)
chr18	40872272	40872273	rs12457996	Major depressive disorder
chr18	41480526	41480527	rs1380836	Obesity-related traits
chr18	42090666	42090667	rs2048485	Schizophrenia
chr18	42725661	42725662	rs998124	Prostate cancer (gene x gene interaction)
chr18	42800147	42800148	rs10502861	Male-pattern baldness
chr18	42956671	42956672	rs2243803	Menarche (age at onset)
chr18	43153948	43153949	rs10502868	Biochemical measures
chr18	43187129	43187130	rs7227483	Renal function-related traits (BUN)
chr18	43202403	43202404	rs7232775	Metabolite levels
chr18	43231621	43231622	rs4890568	Hematological and biochemical traits
chr18	43309910	43309911	rs17674580	Bladder cancer
chr18	43316965	43316966	rs7238033	Bladder cancer
chr18	43317281	43317282	rs10775480	Bladder cancer
chr18	43317546	43317547	rs10853535	Bladder cancer
chr18	43688575	43688576	rs11874712	Migraine - clinic-based
chr18	44585419	44585420	rs2576037	Personality dimensions
chr18	44752237	44752238	rs1398217	Menarche (age at onset)
chr18	44860263	44860264	rs9947662	Migraine
chr18	45815416	45815417	rs1944582	Response to taxane treatment (docetaxel)
chr18	45865596	45865597	rs11082671	Height
chr18	46227443	46227444	rs16949825	IgG glycosylation
chr18	46240710	46240711	rs9947954	IgG glycosylation
chr18	46317087	46317088	rs12455557	Lung function (forced vital capacity)
chr18	46336701	46336702	rs7227892	Migraine with aura
chr18	46395021	46395022	rs7240004	Inflammatory bowel disease
chr18	46453462	46453463	rs4939827	Colorectal cancer
chr18	46579969	46579970	rs357894	Dental caries
chr18	46587653	46587654	rs1787200	Height
chr18	46959499	46959500	rs9967417	Height
chr18	46991159	46991160	rs8099594	Height
chr18	47109692	47109693	rs9951026	Testicular germ cell tumor
chr18	47121315	47121316	rs17798991	Obesity-related traits
chr18	47159089	47159090	rs7240405	HDL cholesterol
chr18	47160813	47160814	rs7228085	Lipid metabolism phenotypes
chr18	47160952	47160953	rs7241918	HDL cholesterol
chr18	47160952	47160953	rs7241918	Cholesterol, total
chr18	47167213	47167214	rs4939883	Lipid metabolism phenotypes
chr18	47167213	47167214	rs4939883	HDL cholesterol
chr18	47167213	47167214	rs4939883	Cholesterol, total
chr18	47181667	47181668	rs2156552	HDL cholesterol
chr18	48378233	48378234	rs732528	Entorhinal cortical thickness
chr18	48524160	48524161	rs9807334	Immune reponse to smallpox (secreted IFN-alpha)
chr18	48690618	48690619	rs7230711	Immune response to anthrax vaccine
chr18	48713039	48713040	rs8096445	Immune response to smallpox vaccine (IL-6)
chr18	49404963	49404964	rs1351435	Obesity-related traits
chr18	50192395	50192396	rs4940203	Obesity-related traits
chr18	50215411	50215412	rs1460196	Response to mTOR inhibitor (everolimus)
chr18	50285397	50285398	rs768048	Alcoholism (alcohol use disorder factor score)
chr18	50517775	50517776	rs7504990	Gallbladder cancer
chr18	50906030	50906031	rs11876941	Body mass index (interaction)
chr18	51526567	51526568	rs1995138	Periodontitis (Mean PAL)
chr18	52752016	52752017	rs12966547	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr18	52752016	52752017	rs12966547	Schizophrenia
chr18	52752699	52752700	rs4801131	Schizophrenia
chr18	52821123	52821124	rs9951150	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr18	52863107	52863108	rs1970671	Diabetic retinopathy
chr18	52949656	52949657	rs1261117	Schizophrenia
chr18	53026356	53026357	rs1631486	Obesity (early onset extreme)
chr18	53058237	53058238	rs17594526	Schizophrenia
chr18	53066327	53066328	rs11152369	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr18	53155001	53155002	rs9960767	Schizophrenia
chr18	53194960	53194961	rs17512836	Schizophrenia
chr18	53207206	53207207	rs1452787	Sclerosing cholangitis and ulcerative colitis (combined)
chr18	53210301	53210302	rs613872	Fuchs's corneal dystrophy
chr18	53664281	53664282	rs1978503	Breast cancer
chr18	53855524	53855525	rs12604483	HIV-1 susceptibility
chr18	54397621	54397622	rs17750015	Depression and alcohol dependence
chr18	54752313	54752314	rs1557351	Multiple sclerosis (age of onset)
chr18	54983553	54983554	rs1120787	HIV-1 control
chr18	55322501	55322502	rs12968116	Liver enzyme levels (gamma-glutamyl transferase)
chr18	55434201	55434202	rs7236632	Attention deficit hyperactivity disorder and conduct disorder
chr18	55454376	55454377	rs10503019	Vitiligo
chr18	55496304	55496305	rs62094879	Metabolite levels (MHPG)
chr18	55627839	55627840	rs11875185	Antineutrophil cytoplasmic antibody-associated vasculitis
chr18	55810732	55810733	rs549476	Response to amphetamines
chr18	55910522	55910523	rs158856	Insomnia (caffeine-induced)
chr18	56009603	56009604	rs12454023	Migraine with aura
chr18	56084053	56084054	rs4503880	Liver enzyme levels (gamma-glutamyl transferase)
chr18	56109858	56109859	rs8099014	Platelet counts
chr18	56213389	56213390	rs12456021	Multiple sclerosis
chr18	56384191	56384192	rs7238078	Multiple sclerosis
chr18	56752053	56752054	rs1037757	Alzheimer's disease (age of onset)
chr18	57314806	57314807	rs11152166	Major depressive disorder
chr18	57503377	57503378	rs8093763	Bleomycin sensitivity
chr18	57622286	57622287	rs4368253	Chronic lymphocytic leukemia
chr18	57734856	57734857	rs7234864	Body mass index
chr18	57751013	57751014	rs12957347	Metabolic syndrome
chr18	57811981	57811982	rs17700144	Obesity (early onset extreme)
chr18	57828636	57828637	rs2331841	Body mass index
chr18	57829134	57829135	rs6567160	Fat body mass
chr18	57829134	57829135	rs6567160	Body mass index
chr18	57839768	57839769	rs571312	Body mass index
chr18	57849022	57849023	rs12967135	HDL cholesterol
chr18	57850421	57850422	rs538656	Obesity
chr18	57851096	57851097	rs17782313	Height
chr18	57851096	57851097	rs17782313	Obesity
chr18	57851096	57851097	rs17782313	Body mass index
chr18	57851762	57851763	rs10871777	Obesity
chr18	57851762	57851763	rs10871777	Obesity (early onset extreme)
chr18	57852586	57852587	rs476828	Obesity (early onset extreme)
chr18	57852947	57852948	rs11152213	Obesity
chr18	57858828	57858829	rs8089364	Body mass index
chr18	57872988	57872989	rs12955983	Urate levels
chr18	57882786	57882787	rs489693	Antipsychotic drug-induced weight gain
chr18	57882786	57882787	rs489693	Waist circumference
chr18	57884749	57884750	rs12970134	Weight
chr18	57884749	57884750	rs12970134	Body mass index
chr18	57884749	57884750	rs12970134	Waist circumference and related phenotypes
chr18	57963116	57963117	rs17773430	Obesity and blood pressure
chr18	58109189	58109190	rs4257308	Tuberculosis
chr18	58375933	58375934	rs2168303	Gout
chr18	59266370	59266371	rs2032366	Obesity-related traits
chr18	60054856	60054857	rs884205	Bone mineral density
chr18	60054856	60054857	rs884205	Bone mineral density (spine)
chr18	60060734	60060735	rs2957128	Paget's disease
chr18	60080111	60080112	rs2980976	Response to antipsychotic treatment
chr18	60082092	60082093	rs3018362	Paget's disease
chr18	60082092	60082093	rs3018362	Bone mineral density (hip)
chr18	60126111	60126112	rs694419	Serum albumin level
chr18	60793548	60793549	rs4987855	Chronic lymphocytic leukemia
chr18	60793920	60793921	rs4987852	Chronic lymphocytic leukemia
chr18	60859320	60859321	rs899967	Cardiac Troponin-T levels
chr18	61176265	61176266	rs2032224	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
chr18	61877155	61877156	rs4534959	Airflow obstruction
chr18	62170725	62170726	rs4553720	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
chr18	62418443	62418444	rs17073641	Age-related macular degeneration (smoking status interaction)
chr18	62884917	62884918	rs605920	Cardiac Troponin-T levels
chr18	62898665	62898666	rs637644	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
chr18	62998774	62998775	rs8083346	D-dimer levels
chr18	63031235	63031236	rs470490	Atrioventricular conduction
chr18	64952212	64952213	rs8099213	Multiple myeloma (IgH translocation)
chr18	65017099	65017100	rs2124349	Cognitive performance
chr18	65285278	65285279	rs17077540	Major depressive disorder
chr18	65400424	65400425	rs13353224	Hyperactive-impulsive symptoms
chr18	66292258	66292259	rs17232800	Attention deficit hyperactivity disorder
chr18	66314071	66314072	rs1704734	Bipolar disorder and schizophrenia
chr18	66544754	66544755	rs1539893	Liver enzyme levels (alanine transaminase)
chr18	67142856	67142857	rs17184557	Osteoporosis
chr18	67516845	67516846	rs893001	Mean platelet volume
chr18	67530438	67530439	rs727088	Inflammatory bowel disease
chr18	67531641	67531642	rs763361	Type 1 diabetes autoantibodies
chr18	67531641	67531642	rs763361	Type 1 diabetes
chr18	67536495	67536496	rs12969657	Mean platelet volume
chr18	68142413	68142414	rs8092443	Response to antipsychotic treatment
chr18	68153619	68153620	rs11663206	Response to antipsychotic treatment
chr18	68628077	68628078	rs2660917	Iron status biomarkers
chr18	68842242	68842243	rs17083844	Systemic lupus erythematosus
chr18	69248594	69248595	rs1539909	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr18	69365299	69365300	rs11665307	IgG glycosylation
chr18	69379389	69379390	rs2887004	IgG glycosylation
chr18	69439072	69439073	rs17085106	Orofacial clefts
chr18	69774277	69774278	rs337718	Multiple sclerosis (severity)
chr18	70150938	70150939	rs2217560	Pulmonary arterial hypertension (without BMPR2 mutations)
chr18	70227020	70227021	rs17086172	Airflow obstruction
chr18	70442067	70442068	rs41418949	Economic and political preferences (time)
chr18	71058621	71058622	rs1943816	P-tau181p
chr18	71167751	71167752	rs7240777	Thyroid hormone levels
chr18	71476132	71476133	rs17088339	Coronary artery calcification
chr18	71581505	71581506	rs2278331	Sleep duration
chr18	71878516	71878517	rs9951925	Chronic obstructive pulmonary disease-related biomarkers
chr18	72174022	72174023	rs12971120	Refractive error
chr18	72787045	72787046	rs17056274	Estradiol levels
chr18	72897160	72897161	rs9948784	IgG glycosylation
chr18	73050333	73050334	rs62090893	Anorexia nervosa
chr18	73192445	73192446	rs1865721	Intelligence
chr18	73507568	73507569	rs12326088	Obesity-related traits
chr18	73527635	73527636	rs1017745	Response to amphetamines
chr18	73536710	73536711	rs9956878	Obesity-related traits
chr18	73549962	73549963	rs9959259	Obesity-related traits
chr18	74101940	74101941	rs4891159	Longevity
chr18	74182974	74182975	rs6565887	Renal transplant outcome
chr18	74318609	74318610	rs13381277	Dental caries
chr18	74488279	74488280	rs2406342	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
chr18	74735134	74735135	rs11663697	QT interval
chr18	74859043	74859044	rs1789110	Age-related macular degeneration (GA)
chr18	74952757	74952758	rs8084125	Obesity-related traits
chr18	74987631	74987632	rs2717128	RR interval (heart rate)
chr18	75605398	75605399	rs9961113	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
chr18	75638022	75638023	rs12455580	IgG glycosylation
chr18	75653522	75653523	rs11661856	Inflammatory biomarkers
chr18	75912921	75912922	rs4798896	Schizophrenia
chr18	76409596	76409597	rs2002842	Rheumatoid arthritis
chr18	76415449	76415450	rs66591657	Response to amphetamines
chr18	76591634	76591635	rs12967884	Subcutaneous adipose tissue
chr18	76657778	76657779	rs9951602	Obesity-related traits
chr18	76773972	76773973	rs7241993	Prostate cancer
chr18	77392378	77392379	rs7233060	Schizophrenia
chr18	77573547	77573548	rs4799088	Amyotrophic lateral sclerosis
chr18	77624478	77624479	rs62103177	Opioid sensitivity
chr19	348742	348743	rs6510725	Non-small cell lung cancer
chr19	406933	406934	rs12978500	Obesity-related traits
chr19	950379	950380	rs2159128	Vertical cup-disc ratio
chr19	1046519	1046520	rs3764650	Alzheimer's disease
chr19	1050419	1050420	rs115550680	Alzheimer's disease (late onset)
chr19	1056491	1056492	rs3752246	Alzheimer's disease (late onset)
chr19	1063442	1063443	rs4147929	Alzheimer's disease (late onset)
chr19	1124030	1124031	rs2024092	Crohn's disease
chr19	1124834	1124835	rs740495	Crohn's disease
chr19	1207237	1207238	rs3764640	Alzheimer's disease
chr19	1423198	1423199	rs4807927	Word reading
chr19	1423198	1423199	rs4807927	Reading and spelling
chr19	1803581	1803582	rs7253430	Obesity-related traits
chr19	1811602	1811603	rs7250872	Bipolar disorder
chr19	2160528	2160529	rs3803915	Body mass index
chr19	2170953	2170954	rs12986413	Height
chr19	2176402	2176403	rs11880992	Height
chr19	2177192	2177193	rs12982744	Osteoarthritis
chr19	2177192	2177193	rs12982744	Height
chr19	2275078	2275079	rs2523178	Height
chr19	2410483	2410484	rs4806846	Neuroticism
chr19	3159768	3159769	rs11880198	Heart failure
chr19	3251218	3251219	rs17764205	Bipolar disorder and schizophrenia
chr19	3318509	3318510	rs11669592	Non-alcoholic fatty liver disease histology (other)
chr19	3428833	3428834	rs7507204	Height
chr19	3613471	3613472	rs12977510	Obesity-related traits
chr19	3797099	3797100	rs12104221	Obesity-related traits
chr19	3927770	3927771	rs10412199	Aging (time to event)
chr19	3944239	3944240	rs10406174	Age-related macular degeneration
chr19	4717671	4717672	rs12610495	Interstitial lung disease
chr19	4830627	4830628	rs6510827	Vitiligo
chr19	5022603	5022604	rs263063	Periodontitis (CDC/AAP)
chr19	5080646	5080647	rs11673509	Periodontitis (CDC/AAP)
chr19	5582534	5582535	rs732505	vWF and FVIII levels
chr19	5834211	5834212	rs17271883	Tumor biomarkers
chr19	5839745	5839746	rs3760776	Tumor biomarkers
chr19	5839745	5839746	rs3760776	Vitamin B12 levels
chr19	5839745	5839746	rs3760776	N-glycan levels
chr19	5841355	5841356	rs3760775	Tumor biomarkers
chr19	6080481	6080482	rs11880706	Bipolar disorder and schizophrenia
chr19	6475612	6475613	rs3745571	Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)
chr19	6668971	6668972	rs1077667	Multiple sclerosis
chr19	6690770	6690771	rs3745567	Complement C3 and C4 levels
chr19	6718386	6718387	rs2230199	Age-related macular degeneration
chr19	6718386	6718387	rs2230199	Age-related macular degeneration (GA)
chr19	6718386	6718387	rs2230199	Age-related macular degeneration (CNV)
chr19	6887735	6887736	rs3826782	Periodontitis
chr19	7166108	7166109	rs2059807	Polycystic ovary syndrome
chr19	7184761	7184762	rs891088	Height
chr19	7196564	7196565	rs2115386	Diabetic retinopathy
chr19	7199802	7199803	rs1035942	Urate levels
chr19	7223847	7223848	rs4804416	Thyroid hormone levels
chr19	7223847	7223848	rs4804416	Hypothyroidism
chr19	7224430	7224431	rs7248104	Triglycerides
chr19	7424527	7424528	rs6603109	Sexual dysfunction (SSRI/SNRI-related)
chr19	7734510	7734511	rs3745367	Resistin levels
chr19	7739176	7739177	rs1423096	Resistin levels
chr19	7909882	7909883	rs558718	HIV-1 control
chr19	8271720	8271721	rs7258249	Sphingolipid levels
chr19	8433195	8433196	rs7255436	HDL cholesterol
chr19	8469737	8469738	rs2967605	HDL cholesterol
chr19	8644030	8644031	rs4072910	Height
chr19	8671999	8672000	rs7249094	Height
chr19	8789380	8789381	rs2164983	Atopic dermatitis
chr19	10000321	10000322	rs1862471	Menarche (age at onset)
chr19	10213153	10213154	rs8109578	Protein quantitative trait loci
chr19	10218029	10218030	rs1551570	Narcolepsy
chr19	10226051	10226052	rs2305795	Narcolepsy
chr19	10310391	10310392	rs2116940	Thiazide-induced adverse metabolic effects in hypertensive patients
chr19	10394791	10394792	rs1799969	Soluble ICAM-1
chr19	10395682	10395683	rs5498	Soluble ICAM-1
chr19	10397237	10397238	rs281437	Soluble ICAM-1
chr19	10397402	10397403	rs3093030	Soluble levels of adhesion molecules
chr19	10469974	10469975	rs12720356	Crohn's disease
chr19	10469974	10469975	rs12720356	Psoriasis
chr19	10472932	10472933	rs280519	Psoriasis
chr19	10475651	10475652	rs2304256	Type 1 diabetes autoantibodies
chr19	10475651	10475652	rs2304256	Type 1 diabetes
chr19	10512910	10512911	rs11879191	Inflammatory bowel disease
chr19	10520063	10520064	rs8112449	Multiple sclerosis
chr19	10798903	10798904	rs2569507	Obesity-related traits
chr19	10838485	10838486	rs11671653	Coronary heart disease
chr19	11092138	11092139	rs11669133	Coronary heart disease
chr19	11163600	11163601	rs1122608	Coronary heart disease
chr19	11163600	11163601	rs1122608	Myocardial infarction (early onset)
chr19	11188152	11188153	rs55791371	Lipid metabolism phenotypes
chr19	11195029	11195030	rs11668477	LDL cholesterol
chr19	11200007	11200008	rs17249141	LDL cholesterol
chr19	11202305	11202306	rs6511720	LDL cholesterol
chr19	11202305	11202306	rs6511720	Cholesterol, total
chr19	11202305	11202306	rs6511720	Abdominal aortic aneurysm
chr19	11202305	11202306	rs6511720	Metabolite levels
chr19	11202305	11202306	rs6511720	Lipoprotein-associated phospholipase A2 activity and mass
chr19	11202305	11202306	rs6511720	Cardiovascular disease risk factors
chr19	11202305	11202306	rs6511720	Carotid intima media thickness
chr19	11202305	11202306	rs6511720	Lipid metabolism phenotypes
chr19	11210911	11210912	rs2228671	LDL cholesterol
chr19	11210911	11210912	rs2228671	Cholesterol, total
chr19	11227325	11227326	rs2738446	Metabolite levels
chr19	11238472	11238473	rs2738459	LDL cholesterol
chr19	11330941	11330942	rs17699030	Bipolar disorder and schizophrenia
chr19	11334294	11334295	rs4804155	Coronary heart disease
chr19	11342702	11342703	rs12979813	HDL cholesterol
chr19	11347492	11347493	rs737337	HDL cholesterol
chr19	11350487	11350488	rs2278426	HDL cholesterol
chr19	11655009	11655010	rs11880637	IgG glycosylation
chr19	11682494	11682495	rs7253363	Multiple sclerosis (severity)
chr19	12146369	12146370	rs3745672	Multiple sclerosis
chr19	12225371	12225372	rs17638629	Cognitive performance
chr19	12691184	12691185	rs7247513	Bipolar disorder
chr19	12932268	12932269	rs7255045	Mean corpuscular volume
chr19	13001546	13001547	rs11085824	Mean corpuscular hemoglobin
chr19	13024249	13024250	rs741702	Red blood cell traits
chr19	13245967	13245968	rs10408126	Obesity-related traits
chr19	14139920	14139921	rs12327666	Obesity-related traits
chr19	14351573	14351574	rs4528684	Mortality among heart failure patients
chr19	14713492	14713493	rs7254215	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr19	15677709	15677710	rs1273516	Response to tocilizumab in rheumatoid arthritis
chr19	15724202	15724203	rs3764563	Inflammatory biomarkers
chr19	15990430	15990431	rs2108622	Metabolite levels
chr19	15990430	15990431	rs2108622	Response to Vitamin E supplementation
chr19	15990430	15990431	rs2108622	Vitamin E levels
chr19	15990430	15990431	rs2108622	Warfarin maintenance dose
chr19	15990430	15990431	rs2108622	Acenocoumarol maintenance dosage
chr19	16185558	16185559	rs8109288	Mean platelet volume
chr19	16185558	16185559	rs8109288	Platelet counts
chr19	16467758	16467759	rs875622	White matter integrity
chr19	16548374	16548375	rs10411936	Multiple sclerosis
chr19	16548374	16548375	rs10411936	White blood cell count
chr19	17118432	17118433	rs11666377	Brain lesion load
chr19	17283302	17283303	rs2279008	Height
chr19	17389703	17389704	rs8170	Breast Cancer in BRCA1 mutation carriers
chr19	17389703	17389704	rs8170	Breast cancer
chr19	17389703	17389704	rs8170	Ovarian cancer
chr19	17392893	17392894	rs8100241	Breast cancer
chr19	17394123	17394124	rs2363956	Ovarian cancer
chr19	17420288	17420289	rs2303745	Systemic lupus erythematosus
chr19	17590280	17590281	rs11666579	Response to antidepressants
chr19	17752688	17752689	rs12608932	Amyotrophic lateral sclerosis (sporadic)
chr19	17752688	17752689	rs12608932	Amyotrophic lateral sclerosis
chr19	17762889	17762890	rs10416963	Obesity-related traits
chr19	17902333	17902334	rs265548	Tumor biomarkers
chr19	18132539	18132540	rs12984174	Pulmonary function in asthmatics
chr19	18304699	18304700	rs874628	Multiple sclerosis
chr19	18467885	18467886	rs7248363	Bipolar disorder and schizophrenia
chr19	18487666	18487667	rs78015699	Periodontitis (Mean PAL)
chr19	18567038	18567039	rs731945	Self-reported allergy
chr19	18571140	18571141	rs4808801	Breast cancer
chr19	18747604	18747605	rs3764628	Orofacial clefts
chr19	18803171	18803172	rs10419226	Esophageal adenocarcinoma
chr19	18803171	18803172	rs10419226	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)
chr19	18803171	18803172	rs10419226	Barrett's esophagus
chr19	18817902	18817903	rs10423674	Menarche (age at onset)
chr19	19276358	19276359	rs7249142	IgG glycosylation
chr19	19361734	19361735	rs1064395	Bipolar disorder
chr19	19407717	19407718	rs10401969	Triglycerides
chr19	19407717	19407718	rs10401969	LDL cholesterol
chr19	19407717	19407718	rs10401969	Cholesterol, total
chr19	19473444	19473445	rs2905424	Schizophrenia
chr19	19658471	19658472	rs16996148	Triglycerides
chr19	19658471	19658472	rs16996148	LDL cholesterol
chr19	19662219	19662220	rs17216525	Triglycerides
chr19	19721721	19721722	rs12610185	Obesity-related traits
chr19	19789527	19789528	rs2304130	Sphingolipid levels
chr19	19789527	19789528	rs2304130	Triglycerides
chr19	19789527	19789528	rs2304130	LDL cholesterol
chr19	19789527	19789528	rs2304130	Cholesterol, total
chr19	20036175	20036176	rs10411195	Smoking behavior
chr19	20329110	20329111	rs1654260	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
chr19	20846270	20846271	rs4808260	Thiazide-induced adverse metabolic effects in hypertensive patients
chr19	21666209	21666210	rs2562456	Pain
chr19	21956135	21956136	rs8101143	Capecitabine sensitivity
chr19	22359439	22359440	rs412658	Telomere length
chr19	22515250	22515251	rs1975174	Telomere length
chr19	22554853	22554854	rs1865075	Dental caries
chr19	22608373	22608374	rs10404998	Dental caries
chr19	22614121	22614122	rs931608	Dental caries
chr19	22614121	22614122	rs931608	Response to statin therapy (LDL-C)
chr19	22741674	22741675	rs8111998	Corneal structure
chr19	23056345	23056346	rs7246967	Bronchopulmonary dysplasia
chr19	24222785	24222786	rs7260598	Response to taxane treatment (placlitaxel)
chr19	24355492	24355493	rs11668609	Response to taxane treatment (docetaxel)
chr19	28866595	28866596	rs995834	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
chr19	29012920	29012921	rs8113142	Femoral neck bone geometry and menarche (age at onset)
chr19	29035555	29035556	rs4141232	Femoral neck bone geometry and menarche (age at onset)
chr19	29736341	29736342	rs11083866	Lentiform nucleus volume
chr19	29903676	29903677	rs12986207	Bulimia nervosa
chr19	29908106	29908107	rs10425935	Obesity-related traits
chr19	29912293	29912294	rs892073	Obesity-related traits
chr19	30079603	30079604	rs10403021	Diabetic retinopathy
chr19	30296852	30296853	rs8102137	Bladder cancer
chr19	30937842	30937843	rs33428	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
chr19	30943676	30943677	rs33436	Obesity-related traits
chr19	30990699	30990700	rs3786800	Myopia (pathological)
chr19	31035685	31035686	rs10418356	Serum dimethylarginine levels (asymmetric)
chr19	31099889	31099890	rs746961	Select biomarker traits
chr19	31596777	31596778	rs12459897	Phospholipid levels (plasma)
chr19	31801129	31801130	rs1078373	Cognitive performance
chr19	31911128	31911129	rs11880316	Estradiol levels
chr19	32158463	32158464	rs16966122	Narcolepsy with cataplexy
chr19	32917454	32917455	rs2111504	Bipolar disorder
chr19	33089430	33089431	rs17692896	Major depressive disorder
chr19	33181483	33181484	rs3892630	Red blood cell traits
chr19	33356890	33356891	rs12460876	Chronic kidney disease
chr19	33364627	33364628	rs8101881	Urinary metabolites
chr19	33453658	33453659	rs4805834	Creatinine levels
chr19	33524918	33524919	rs73039434	Obesity-related traits
chr19	33532299	33532300	rs10411210	Colorectal cancer
chr19	33599126	33599127	rs10416218	Bone mineral density
chr19	33713927	33713928	rs8106493	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr19	33713927	33713928	rs8106493	Visceral adipose tissue adjusted for BMI
chr19	33731550	33731551	rs17694108	Inflammatory bowel disease
chr19	33750313	33750314	rs10500264	Inflammatory bowel disease (early onset)
chr19	33757061	33757062	rs736289	Crohn's disease
chr19	33888999	33889000	rs889140	Adiponectin levels
chr19	33893007	33893008	rs3786897	Type 2 diabetes
chr19	33899064	33899065	rs731839	Triglycerides
chr19	33899064	33899065	rs731839	HDL cholesterol
chr19	33899064	33899065	rs731839	Adiponectin levels
chr19	33906122	33906123	rs4805885	Adiponectin levels
chr19	33909709	33909710	rs8182584	Fasting insulin-related traits (interaction with BMI)
chr19	34168272	34168273	rs4805924	Response to antipsychotic treatment in schizophrenia (working memory)
chr19	34309531	34309532	rs29941	Body mass index
chr19	34309531	34309532	rs29941	Weight
chr19	34320853	34320854	rs2546057	Major depressive disorder
chr19	34321257	34321258	rs398426	Major depressive disorder
chr19	34322136	34322137	rs11084753	Body mass index
chr19	34333913	34333914	rs166988	Obesity-related traits
chr19	34766587	34766588	rs10407640	Functional MRI
chr19	35555189	35555190	rs4806073	Serum albumin level
chr19	35559473	35559474	rs11671010	Serum albumin level
chr19	35973288	35973289	rs6510489	Bipolar disorder
chr19	37684965	37684966	rs11673344	Obesity-related traits
chr19	37747107	37747108	rs7246657	Coronary artery calcification
chr19	38325535	38325536	rs16975963	Longevity
chr19	38735612	38735613	rs8102476	Prostate cancer
chr19	38912763	38912764	rs892055	Asperger disorder
chr19	39174331	39174332	rs973009	Migraine with aura
chr19	39188111	39188112	rs11083475	Heart rate
chr19	39580736	39580737	rs472265	Type 2 diabetes
chr19	39731782	39731783	rs12980275	Lipid levels in hepatitis C treatment
chr19	39738786	39738787	rs12979860	Chronic Hepatitis C infection
chr19	39738786	39738787	rs12979860	Response to hepatitis C treatment
chr19	39743164	39743165	rs8099917	Response to hepatitis C treatment
chr19	39743164	39743165	rs8099917	Chronic Hepatitis C infection
chr19	39849788	39849789	rs562638	Obesity-related traits
chr19	40170052	40170053	rs8103033	Obesity-related traits
chr19	40229408	40229409	rs12611334	Schizophrenia
chr19	41224203	41224204	rs28493229	Kawasaki disease
chr19	41281015	41281016	rs2233152	Kawasaki disease
chr19	41302705	41302706	rs7937	Chronic obstructive pulmonary disease
chr19	41310570	41310571	rs3733829	Smoking behavior
chr19	41354532	41354533	rs1801272	Smoking behavior
chr19	41358623	41358624	rs4105144	Smoking behavior
chr19	41363764	41363765	rs8102683	Smoking behavior
chr19	41521637	41521638	rs7260329	Smoking behavior
chr19	41673847	41673848	rs8105815	Prion diseases
chr19	41851508	41851509	rs4803455	Migraine
chr19	41937094	41937095	rs17318596	Height
chr19	41985586	41985587	rs11672691	Prostate cancer
chr19	42066278	42066279	rs4803480	Schizophrenia
chr19	42521107	42521108	rs8099939	Bipolar disorder
chr19	44286512	44286513	rs3760982	Breast cancer
chr19	44511388	44511389	rs2191566	Acute lymphoblastic leukemia (childhood)
chr19	44614207	44614208	rs2061333	Alzheimer's disease
chr19	44888275	44888276	rs4142248	Myopia (pathological)
chr19	44932971	44932972	rs1434579	Tuberculosis
chr19	44970934	44970935	rs644148	Personality dimensions
chr19	45146102	45146103	rs7255066	Multiple sclerosis
chr19	45242106	45242107	rs2927438	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)
chr19	45247626	45247627	rs4803750	Lipid metabolism phenotypes
chr19	45326767	45326768	rs1871045	Waist-to-hip circumference ratio (interaction)
chr19	45376283	45376284	rs519113	Alzheimer's disease (late onset)
chr19	45376283	45376284	rs519113	HDL cholesterol
chr19	45382033	45382034	rs6859	Alzheimer's disease
chr19	45382033	45382034	rs6859	Alzheimer's disease (late onset)
chr19	45392253	45392254	rs6857	Alzheimer's disease biomarkers
chr19	45392253	45392254	rs6857	Age-related macular degeneration
chr19	45392253	45392254	rs6857	Alzheimer's disease (age of onset)
chr19	45395265	45395266	rs157580	Alzheimer's disease
chr19	45395265	45395266	rs157580	Alzheimer's disease biomarkers
chr19	45395265	45395266	rs157580	LDL cholesterol
chr19	45395265	45395266	rs157580	HDL cholesterol
chr19	45395618	45395619	rs2075650	C-reactive protein
chr19	45395618	45395619	rs2075650	Age-related macular degeneration
chr19	45395618	45395619	rs2075650	Cognitive decline
chr19	45395618	45395619	rs2075650	Cardiovascular disease risk factors
chr19	45395618	45395619	rs2075650	Longevity
chr19	45395618	45395619	rs2075650	Alzheimer's disease biomarkers
chr19	45395618	45395619	rs2075650	AB1-42
chr19	45395618	45395619	rs2075650	Alzheimer's disease (late onset)
chr19	45395618	45395619	rs2075650	Alzheimer's disease
chr19	45395618	45395619	rs2075650	Brain imaging
chr19	45395618	45395619	rs2075650	Cholesterol, total
chr19	45396218	45396219	rs157582	Metabolic syndrome
chr19	45396664	45396665	rs59007384	Alzheimer's disease biomarkers
chr19	45403411	45403412	rs1160985	LDL cholesterol
chr19	45403411	45403412	rs1160985	C-reactive protein
chr19	45410001	45410002	rs769449	Alzheimer's disease biomarkers
chr19	45410001	45410002	rs769449	C-reactive protein
chr19	45411940	45411941	rs429358	Alzheimer's disease biomarkers
chr19	45411940	45411941	rs429358	Brain imaging
chr19	45412078	45412079	rs7412	Lipid traits
chr19	45412078	45412079	rs7412	LDL cholesterol
chr19	45412078	45412079	rs7412	Response to statin therapy (LDL-C)
chr19	45412078	45412079	rs7412	Lipid metabolism phenotypes
chr19	45414450	45414451	rs439401	HDL Cholesterol - Triglycerides (HDLC-TG)
chr19	45414450	45414451	rs439401	Alzheimer's disease biomarkers
chr19	45414450	45414451	rs439401	Triglycerides
chr19	45415639	45415640	rs445925	Lipoprotein-associated phospholipase A2 activity and mass
chr19	45415639	45415640	rs445925	Apolipoprotein Levels
chr19	45415639	45415640	rs445925	Metabolite levels
chr19	45415639	45415640	rs445925	Carotid intima media thickness
chr19	45415639	45415640	rs445925	Cardiovascular disease risk factors
chr19	45422586	45422587	rs12721054	Triglycerides
chr19	45422845	45422846	rs56131196	Alzheimer's disease biomarkers
chr19	45422945	45422946	rs4420638	LDL cholesterol
chr19	45422945	45422946	rs4420638	HDL cholesterol
chr19	45422945	45422946	rs4420638	Cholesterol, total
chr19	45422945	45422946	rs4420638	Lipid traits
chr19	45422945	45422946	rs4420638	Age-related macular degeneration
chr19	45422945	45422946	rs4420638	Alzheimer's disease
chr19	45422945	45422946	rs4420638	Cognitive decline
chr19	45422945	45422946	rs4420638	Alzheimer's disease (age of onset)
chr19	45422945	45422946	rs4420638	Lipoprotein-associated phospholipase A2 activity and mass
chr19	45422945	45422946	rs4420638	Longevity
chr19	45422945	45422946	rs4420638	C-reactive protein
chr19	45422945	45422946	rs4420638	Quantitative traits
chr19	45422945	45422946	rs4420638	Alzheimer's disease (late onset)
chr19	45422945	45422946	rs4420638	Triglycerides
chr19	45432556	45432557	rs7259004	Sphingolipid levels
chr19	45695737	45695738	rs2159324	Quantitative traits
chr19	45740770	45740771	rs17356664	Platelet counts
chr19	45854918	45854919	rs13181	Lung Cancer (DNA repair capacity)
chr19	46034557	46034558	rs8111589	Depression and alcohol dependence
chr19	46172277	46172278	rs11671664	Body mass index
chr19	46181391	46181392	rs1800437	Obesity
chr19	46182303	46182304	rs10423928	Obesity
chr19	46182303	46182304	rs10423928	Two-hour glucose challenge
chr19	46195755	46195756	rs7245708	Subcutaneous adipose tissue
chr19	46202171	46202172	rs2287019	Body mass index
chr19	46307405	46307406	rs8111071	Sudden cardiac arrest
chr19	46849805	46849806	rs4802307	Crohn's disease
chr19	47123782	47123783	rs1126510	Ulcerative colitis
chr19	47207653	47207654	rs11083846	Chronic lymphocytic leukemia
chr19	47208480	47208481	rs425105	Type 1 diabetes
chr19	47569002	47569003	rs3810291	Body mass index
chr19	47575715	47575716	rs3745618	Obesity-related traits
chr19	47661492	47661493	rs307896	Multiple sclerosis
chr19	48205724	48205725	rs3745760	HIV-1 susceptibility
chr19	48348362	48348363	rs11668505	Lung function (forced vital capacity)
chr19	48401892	48401893	rs2637125	Dehydroepiandrosterone sulphate levels
chr19	48522868	48522869	rs3815908	Intelligence
chr19	48525506	48525507	rs2303690	Intelligence
chr19	48527581	48527582	rs3936340	Intelligence
chr19	48531215	48531216	rs2560966	Intelligence
chr19	49206171	49206172	rs516246	Obesity-related traits
chr19	49206171	49206172	rs516246	Crohn's disease
chr19	49206171	49206172	rs516246	Liver enzyme levels (gamma-glutamyl transferase)
chr19	49206416	49206417	rs492602	Cholesterol, total
chr19	49206416	49206417	rs492602	Vitamin B12 levels
chr19	49206602	49206603	rs281377	Liver enzyme levels (alkaline phosphatase)
chr19	49206630	49206631	rs1047781	Tumor biomarkers
chr19	49206630	49206631	rs1047781	Vitamin B12 levels
chr19	49206984	49206985	rs602662	Folate pathway vitamin levels
chr19	49208864	49208865	rs504963	Crohn's disease
chr19	49209009	49209010	rs503279	Metabolic traits
chr19	49214273	49214274	rs281379	Pubertal anthropometrics
chr19	49214273	49214274	rs281379	Crohn's disease
chr19	49214469	49214470	rs281380	Multiple sclerosis
chr19	49228271	49228272	rs2287921	Bipolar disorder
chr19	49228271	49228272	rs2287921	Retinal vascular caliber
chr19	49246865	49246866	rs838147	Dietary macronutrient intake
chr19	49248729	49248730	rs838145	Dietary macronutrient intake
chr19	49259528	49259529	rs838133	Homocysteine levels
chr19	49259528	49259529	rs838133	Dietary macronutrient intake
chr19	49497154	49497155	rs3764618	Follicule stimulating hormone
chr19	49869050	49869051	rs2303759	Multiple sclerosis
chr19	50000008	50000009	rs2280401	Serum total protein level
chr19	50000008	50000009	rs2280401	Serum albumin level
chr19	50000008	50000009	rs2280401	Metabolite levels
chr19	50000008	50000009	rs2280401	Hematological and biochemical traits
chr19	50223265	50223266	rs3810265	Panic disorder
chr19	50338235	50338236	rs2017698	Blood trace element (Se levels)
chr19	50721073	50721074	rs4802666	Disc degeneration (lumbar)
chr19	50909764	50909765	rs2230245	Obesity-related traits
chr19	50926741	50926742	rs3745516	Primary biliary cirrhosis
chr19	51349089	51349090	rs266849	Serum prostate-specific antigen levels
chr19	51361756	51361757	rs17632542	Serum prostate-specific antigen levels
chr19	51364622	51364623	rs2735839	Prostate-specific antigen levels
chr19	51364622	51364623	rs2735839	Prostate cancer
chr19	51374966	51374967	rs10424878	PCA3 expression level
chr19	51377162	51377163	rs2664156	Celiac disease
chr19	51393117	51393118	rs1354774	Prostate-specific antigen levels
chr19	51419545	51419546	rs1701930	Obesity-related traits
chr19	51430595	51430596	rs7245858	Alzheimer's disease (cognitive decline)
chr19	51726612	51726613	rs3826656	Alzheimer's disease
chr19	51727961	51727962	rs3865444	Alzheimer's disease (late onset)
chr19	51773801	51773802	rs1878047	Body mass index
chr19	51796298	51796299	rs10414689	Palmitic acid (16:0) plasma levels
chr19	52084835	52084836	rs1543922	Response to tocilizumab in rheumatoid arthritis
chr19	52324215	52324216	rs17695224	HDL cholesterol
chr19	52372975	52372976	rs10411161	Breast cancer
chr19	52494777	52494778	rs1715	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr19	53284134	53284135	rs10404486	Phospholipid levels (plasma)
chr19	53384184	53384185	rs6509701	Alzheimer's disease
chr19	53682041	53682042	rs16984547	Asthma
chr19	53780025	53780026	rs2965260	IgG glycosylation
chr19	54604821	54604822	rs10423754	Response to taxane treatment (docetaxel)
chr19	54612627	54612628	rs254262	Obesity-related traits
chr19	54697078	54697079	rs7595	Obesity-related traits
chr19	54792760	54792761	rs386000	HDL cholesterol
chr19	54797847	54797848	rs103294	Prostate cancer
chr19	54916103	54916104	rs11084337	Blood trace element (Se levels)
chr19	55383050	55383051	rs11672983	Inflammatory bowel disease
chr19	55526344	55526345	rs1671152	Platelet aggregation
chr19	55819844	55819845	rs1172822	Menarche and menopause (age at onset)
chr19	55819844	55819845	rs1172822	Menopause (age at onset)
chr19	55833663	55833664	rs11668344	Menopause (age at onset)
chr19	55879871	55879872	rs1126757	Response to antidepressants
chr19	56091331	56091332	rs149546760	Periodontitis (Mean PAL)
chr19	56111074	56111075	rs140900046	Periodontitis (Mean PAL)
chr19	56265663	56265664	rs17634917	Major depressive disorder
chr19	56313527	56313528	rs299175	Multiple sclerosis (severity)
chr19	56320662	56320663	rs12461110	Menopause (age at onset)
chr19	56451048	56451049	rs2043599	Immune reponse to smallpox (secreted IFN-alpha)
chr19	56497959	56497960	rs16986856	Obesity-related traits
chr19	57089834	57089835	rs34863160	Obesity-related traits
chr19	57132237	57132238	rs10404342	IgE levels in asthmatics
chr19	57678193	57678194	rs11672517	Dupuytren's disease
chr19	57760017	57760018	rs2014572	Hyperactive-impulsive symptoms
chr19	58469015	58469016	rs8106858	Obesity-related traits
chr19	58770882	58770883	rs260461	Attention deficit hyperactivity disorder
chr19	58992000	58992001	rs58632700	Obesity-related traits
chr2	38937	38938	rs11542478	Information processing speed
chr2	112495	112496	rs300774	Suicide attempts in bipolar disorder
chr2	315214	315215	rs4643574	Cognitive performance
chr2	614167	614168	rs2947411	Menarche (age at onset)
chr2	622530	622531	rs939583	Body mass index
chr2	622826	622827	rs2867125	Body mass index
chr2	624033	624034	rs6711012	Obesity
chr2	624677	624678	rs2903492	Body mass index
chr2	629243	629244	rs12463617	Body mass index
chr2	629243	629244	rs12463617	Obesity (early onset extreme)
chr2	632027	632028	rs11127485	Obesity (early onset extreme)
chr2	634904	634905	rs6548238	Body mass index
chr2	644952	644953	rs7561317	Weight
chr2	644952	644953	rs7561317	Body mass index
chr2	646363	646364	rs10189761	Obesity
chr2	663482	663483	rs12999373	Response to fenofibrate (adiponectin levels)
chr2	663482	663483	rs12999373	Uric acid levels
chr2	679178	679179	rs1320333	Obesity-related traits
chr2	773277	773278	rs4380275	Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)
chr2	1557926	1557927	rs10206020	IgG glycosylation
chr2	1777149	1777150	rs6735179	Response to antipsychotic treatment
chr2	1925992	1925993	rs2241685	Attention deficit hyperactivity disorder
chr2	2519512	2519513	rs10199521	Diabetic retinopathy
chr2	2545733	2545734	rs181867028	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr2	2590380	2590381	rs2598592	White matter integrity
chr2	2926012	2926013	rs17491951	White matter integrity (interaction)
chr2	3392074	3392075	rs10865541	Obesity-related traits
chr2	3748970	3748971	rs6730148	Obesity-related traits
chr2	3841419	3841420	rs11677370	Type 2 diabetes
chr2	4318975	4318976	rs11686135	Pulmonary function decline
chr2	5253597	5253598	rs1075309	Tuberculosis
chr2	5437542	5437543	rs13004938	Obesity-related traits
chr2	5664007	5664008	rs11894081	Crohn's disease
chr2	5907879	5907880	rs16864170	Chronic kidney disease
chr2	6052750	6052751	rs7586540	Coronary artery calcification
chr2	6134939	6134940	rs1405262	HIV-1 control
chr2	6461420	6461421	rs7591996	Osteosarcoma
chr2	6694518	6694519	rs10495537	Visceral adipose tissue adjusted for BMI
chr2	6697087	6697088	rs962528	Visceral fat
chr2	7147972	7147973	rs6741819	Response to antipsychotic treatment
chr2	8036259	8036260	rs2193071	Obesity-related traits
chr2	8053596	8053597	rs4669226	Multiple sclerosis
chr2	8434184	8434185	rs3102947	IgE levels
chr2	8442247	8442248	rs10174949	Self-reported allergy
chr2	8530255	8530256	rs13008689	Longevity
chr2	8949069	8949070	rs7587928	Neutrophil count
chr2	9250037	9250038	rs1109670	Multiple sclerosis
chr2	9259597	9259598	rs9636252	IgG glycosylation
chr2	9645631	9645632	rs55794209	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr2	9721895	9721896	rs6432018	Heart rate variability traits
chr2	9924386	9924387	rs2357266	Self-rated health
chr2	10117867	10117868	rs11902236	Prostate cancer
chr2	10903411	10903412	rs1198872	Cardiac Troponin-T levels
chr2	11220561	11220562	rs6739054	Cognitive performance
chr2	11255339	11255340	rs12692432	Metabolite levels (HVA/MHPG ratio)
chr2	11257504	11257505	rs16857178	Obesity-related traits
chr2	11510947	11510948	rs6716724	Sudden cardiac arrest
chr2	11727506	11727507	rs13394619	Endometriosis
chr2	11758430	11758431	rs73175262	Obesity-related traits
chr2	12037178	12037179	rs17605562	Hair morphology
chr2	12037491	12037492	rs4027132	Bipolar disorder
chr2	12212444	12212445	rs16858228	Obesity-related traits
chr2	12252349	12252350	rs17551536	Bronchopulmonary dysplasia
chr2	12568995	12568996	rs10929808	Bipolar disorder and schizophrenia
chr2	12640740	12640741	rs1534422	Type 1 diabetes
chr2	12964496	12964497	rs10198628	Pericardial fat
chr2	12968899	12968900	rs10180496	Dental caries
chr2	14029747	14029748	rs1598106	IgG glycosylation
chr2	14398051	14398052	rs16861531	Response to antidepressant treatment
chr2	14801500	14801501	rs7602441	Visceral adipose tissue adjusted for BMI
chr2	15664755	15664756	rs7581919	Conduct disorder (case status)
chr2	15729819	15729820	rs3755132	Wilms tumor
chr2	15782470	15782471	rs807624	Wilms tumor
chr2	15863001	15863002	rs6431731	Chronic kidney disease
chr2	15926167	15926168	rs2544527	Pulmonary function (interaction)
chr2	15926167	15926168	rs2544527	Pulmonary function
chr2	15961598	15961599	rs7586898	Hair morphology
chr2	16715407	16715408	rs4441471	Orofacial clefts
chr2	17427584	17427585	rs11889338	Alzheimer's disease
chr2	17609238	17609239	rs12185578	Subcutaneous adipose tissue
chr2	17775031	17775032	rs4038131	Alzheimer's disease
chr2	17988657	17988658	rs214034	Response to amphetamines
chr2	18234445	18234446	rs16984239	Amyotrophic lateral sclerosis
chr2	18243533	18243534	rs4075511	Temperament (bipolar disorder)
chr2	18540643	18540644	rs7580332	Amyotrophic lateral sclerosis
chr2	18834650	18834651	rs1445130	Bulimia nervosa
chr2	19134747	19134748	rs1876040	Cognitive performance
chr2	19320802	19320803	rs12710696	Breast cancer
chr2	19629303	19629304	rs13398721	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
chr2	19945576	19945577	rs2123536	Coronary heart disease
chr2	19958495	19958496	rs17564315	Inflammatory biomarkers
chr2	19999345	19999346	rs6728440	Inflammatory biomarkers
chr2	20261684	20261685	rs7565124	Major depressive disorder
chr2	20335708	20335709	rs4666360	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
chr2	20688518	20688519	rs13021401	Systemic sclerosis
chr2	20888264	20888265	rs13385191	Prostate cancer
chr2	20903014	20903015	rs4971516	LDL cholesterol
chr2	21100777	21100778	rs7569328	Coronary heart disease
chr2	21123351	21123352	rs6711016	Metabolic syndrome
chr2	21198899	21198900	rs11902417	HDL cholesterol
chr2	21204024	21204025	rs6544366	Triglycerides
chr2	21206182	21206183	rs6754295	Lipid metabolism phenotypes
chr2	21206182	21206183	rs6754295	Triglycerides
chr2	21206182	21206183	rs6754295	HDL cholesterol
chr2	21208210	21208211	rs7557067	Triglycerides
chr2	21225280	21225281	rs1042034	Triglycerides
chr2	21225280	21225281	rs1042034	HDL cholesterol
chr2	21231523	21231524	rs676210	LDL (oxidized)
chr2	21231523	21231524	rs676210	Lipid metabolism phenotypes
chr2	21231591	21231592	rs6413458	Lipoprotein-associated phospholipase A2 activity and mass
chr2	21232194	21232195	rs693	LDL cholesterol
chr2	21232194	21232195	rs693	Cholesterol, total
chr2	21232194	21232195	rs693	Triglycerides
chr2	21237543	21237544	rs673548	Metabolite levels
chr2	21237543	21237544	rs673548	Metabolic syndrome
chr2	21237543	21237544	rs673548	Lipid metabolism phenotypes
chr2	21237543	21237544	rs673548	Metabolic traits
chr2	21241504	21241505	rs12713956	LDL cholesterol
chr2	21243999	21244000	rs10199768	Cardiovascular disease risk factors
chr2	21263899	21263900	rs1367117	LDL cholesterol
chr2	21263899	21263900	rs1367117	Cholesterol, total
chr2	21263899	21263900	rs1367117	Lipid metabolism phenotypes
chr2	21286056	21286057	rs515135	LDL cholesterol
chr2	21288320	21288321	rs562338	LDL cholesterol
chr2	21294974	21294975	rs541041	Response to statin therapy
chr2	21378804	21378805	rs312985	Lipid metabolism phenotypes
chr2	21389658	21389659	rs4635554	Hypertriglyceridemia
chr2	21397181	21397182	rs506585	Lipid metabolism phenotypes
chr2	21577742	21577743	rs219553	Erectile dysfunction and prostate cancer treatment
chr2	21840092	21840093	rs1117324	Response to antipsychotic treatment
chr2	22297002	22297003	rs7600502	C-reactive protein and white blood cell count
chr2	22576099	22576100	rs1605834	Bipolar disorder and schizophrenia
chr2	22736986	22736987	rs17043947	Self-rated health
chr2	22822158	22822159	rs13015955	Coronary heart disease
chr2	23124557	23124558	rs10189050	Obesity-related traits
chr2	23187503	23187504	rs2681019	Dialysis-related mortality
chr2	23238942	23238943	rs41458646	Alzheimer's disease (late onset)
chr2	23414650	23414651	rs1449984	Depression (quantitative trait)
chr2	23548613	23548614	rs2577720	F-cell distribution
chr2	23592144	23592145	rs2577704	IgG glycosylation
chr2	23898316	23898317	rs4665630	Coronary heart disease
chr2	23948952	23948953	rs7608623	Obesity-related traits
chr2	24154191	24154192	rs11674248	Obesity-related traits
chr2	24247513	24247514	rs7561273	Quantitative traits
chr2	24521765	24521766	rs6707600	Response to antipsychotic treatment in schizophrenia (working memory)
chr2	24692808	24692809	rs2165738	Type 1 diabetes
chr2	25036857	25036858	rs11895026	Height
chr2	25097643	25097644	rs13407913	Body mass index (non-asthmatics)
chr2	25103107	25103108	rs2033654	Body mass index (non-asthmatics)
chr2	25116976	25116977	rs7586879	Body mass index
chr2	25118884	25118885	rs6545800	Inflammatory bowel disease
chr2	25131315	25131316	rs6545814	Body mass index
chr2	25150295	25150296	rs10182181	Obesity
chr2	25158007	25158008	rs713586	Body mass index
chr2	25158280	25158281	rs713587	Body mass index (non-asthmatics)
chr2	25169199	25169200	rs1172294	Pubertal anthropometrics
chr2	25187598	25187599	rs4665736	Height
chr2	25276283	25276284	rs6733301	Height
chr2	25301754	25301755	rs478222	Type 1 diabetes
chr2	25305755	25305756	rs1530016	Body mass index (non-asthmatics)
chr2	25369001	25369002	rs1561288	Body mass index
chr2	25373297	25373298	rs13428823	Height
chr2	25492466	25492467	rs13428812	Crohn's disease
chr2	25613145	25613146	rs7577599	Multiple myeloma (IgH translocation)
chr2	25633241	25633242	rs10180663	Multiple myeloma (IgH translocation)
chr2	25659243	25659244	rs6746082	Multiple myeloma
chr2	25887557	25887558	rs11684202	Coronary heart disease
chr2	26228206	26228207	rs112288323	Metabolite levels (HVA/MHPG ratio)
chr2	26249898	26249899	rs68184094	Metabolite levels (HVA-5-HIAA Factor score)
chr2	26249898	26249899	rs68184094	Metabolite levels (HVA)
chr2	26272601	26272602	rs13388915	Immune response to smallpox vaccine (IL-6)
chr2	26526418	26526419	rs6753473	Non-small cell lung cancer
chr2	26667129	26667130	rs3795958	Metabolite levels (HVA/MHPG ratio)
chr2	26667129	26667130	rs3795958	Metabolite levels (HVA)
chr2	26782620	26782621	rs1011108	Periodontal microbiota
chr2	27083268	27083269	rs11887277	Obesity-related traits
chr2	27152873	27152874	rs1371614	Fasting glucose-related traits (interaction with BMI)
chr2	27587723	27587724	rs1058065	IgG glycosylation
chr2	27598096	27598097	rs4665972	Triglycerides
chr2	27598096	27598097	rs4665972	Breast size
chr2	27635462	27635463	rs1728918	Crohn's disease
chr2	27715415	27715416	rs2303369	Menopause (age at onset)
chr2	27730939	27730940	rs1260326	Triglycerides
chr2	27730939	27730940	rs1260326	Cholesterol, total
chr2	27730939	27730940	rs1260326	Glycemic traits (pregnancy)
chr2	27730939	27730940	rs1260326	Hypertriglyceridemia
chr2	27730939	27730940	rs1260326	Urate levels
chr2	27730939	27730940	rs1260326	Lipoprotein-associated phospholipase A2 activity and mass
chr2	27730939	27730940	rs1260326	Serum total protein level
chr2	27730939	27730940	rs1260326	Serum albumin level
chr2	27730939	27730940	rs1260326	Metabolite levels
chr2	27730939	27730940	rs1260326	Non-albumin protein levels
chr2	27730939	27730940	rs1260326	Platelet counts
chr2	27730939	27730940	rs1260326	Liver enzyme levels (gamma-glutamyl transferase)
chr2	27730939	27730940	rs1260326	Cardiovascular disease risk factors
chr2	27730939	27730940	rs1260326	C-reactive protein
chr2	27730939	27730940	rs1260326	Chronic kidney disease
chr2	27730939	27730940	rs1260326	Hematological and biochemical traits
chr2	27730939	27730940	rs1260326	Two-hour glucose challenge
chr2	27730939	27730940	rs1260326	Lipid metabolism phenotypes
chr2	27730939	27730940	rs1260326	Metabolic traits
chr2	27730939	27730940	rs1260326	Waist circumference and related phenotypes
chr2	27741236	27741237	rs780094	Calcium levels
chr2	27741236	27741237	rs780094	Triglycerides
chr2	27741236	27741237	rs780094	Fasting insulin-related traits (interaction with BMI)
chr2	27741236	27741237	rs780094	Fasting glucose-related traits (interaction with BMI)
chr2	27741236	27741237	rs780094	Metabolic syndrome
chr2	27741236	27741237	rs780094	Metabolic traits
chr2	27741236	27741237	rs780094	Phospholipid levels (plasma)
chr2	27741236	27741237	rs780094	Urate levels
chr2	27741236	27741237	rs780094	Fasting insulin-related traits
chr2	27741236	27741237	rs780094	Fasting glucose-related traits
chr2	27741236	27741237	rs780094	Uric acid levels
chr2	27741236	27741237	rs780094	C-reactive protein
chr2	27741236	27741237	rs780094	LDL cholesterol
chr2	27742602	27742603	rs780093	Palmitoleic acid (16:1n-7) plasma levels
chr2	27742602	27742603	rs780093	Palmitic acid (16:0) plasma levels
chr2	27742602	27742603	rs780093	Sex hormone-binding globulin levels
chr2	27742602	27742603	rs780093	Breast size
chr2	27742602	27742603	rs780093	Waist Circumference - Triglycerides (WC-TG)
chr2	27742602	27742603	rs780093	Triglycerides-Blood Pressure (TG-BP)
chr2	27742602	27742603	rs780093	Crohn's disease
chr2	27742602	27742603	rs780093	Urate levels
chr2	27742602	27742603	rs780093	Calcium levels
chr2	27743153	27743154	rs780092	Lipid traits
chr2	27743153	27743154	rs780092	Triglycerides
chr2	27743153	27743154	rs780092	Metabolite levels
chr2	27748623	27748624	rs1260333	Triglycerides
chr2	27801758	27801759	rs1919128	Waist Circumference - Triglycerides (WC-TG)
chr2	27815509	27815510	rs13022873	Waist Circumference - Triglycerides (WC-TG)
chr2	27840639	27840640	rs4666002	Phospholipid levels (plasma)
chr2	27851917	27851918	rs3749147	Waist Circumference - Triglycerides (WC-TG)
chr2	27859316	27859317	rs111571364	Periodontitis (CDC/AAP)
chr2	27907472	27907473	rs17006206	Alzheimer's disease
chr2	27995780	27995781	rs3736594	Fasting glucose-related traits (interaction with BMI)
chr2	28347681	28347682	rs7601155	Waist circumference
chr2	28614793	28614794	rs925255	Inflammatory bowel disease
chr2	28646800	28646801	rs6547853	Type 1 diabetes
chr2	29280760	29280761	rs882632	Major depressive disorder
chr2	30445025	30445026	rs7579944	Celiac disease and Rheumatoid arthritis
chr2	30526779	30526780	rs6708166	vWF and FVIII levels
chr2	31314554	31314555	rs1000916	HIV-1 viral setpoint
chr2	31376653	31376654	rs6543610	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr2	31464384	31464385	rs649729	Mean platelet volume
chr2	31464828	31464829	rs647316	Mean platelet volume
chr2	31474241	31474242	rs597800	Estradiol levels
chr2	31482299	31482300	rs625132	Platelet counts
chr2	31590784	31590785	rs761926	Obesity-related traits
chr2	32278781	32278782	rs7577696	Inflammatory biomarkers
chr2	32865520	32865521	rs1031261	Hippocampal atrophy
chr2	33121503	33121504	rs6728021	Immune response to smallpox vaccine (IL-6)
chr2	33301946	33301947	rs542631	Immune reponse to smallpox (secreted IFN-alpha)
chr2	33360337	33360338	rs1545552	Height
chr2	33361424	33361425	rs6714546	Height
chr2	33471191	33471192	rs3769528	Height
chr2	33527298	33527299	rs41464348	Height
chr2	33701889	33701890	rs13385731	Systemic lupus erythematosus
chr2	34284851	34284852	rs9308945	Hypertension (young onset)
chr2	34284983	34284984	rs6711736	Hypertension (young onset)
chr2	34285193	34285194	rs6729869	Hypertension (young onset)
chr2	34305256	34305257	rs10495809	Hypertension (young onset)
chr2	34480074	34480075	rs6733379	Attention deficit hyperactivity disorder and conduct disorder
chr2	34631031	34631032	rs6543833	Ovarian reserve
chr2	35093292	35093293	rs7600259	Response to amphetamines
chr2	35526917	35526918	rs6750486	Conduct disorder (symptom count)
chr2	35662796	35662797	rs13402855	Metabolite levels (5-HIAA)
chr2	36526435	36526436	rs1863080	Anthropometric traits
chr2	36675529	36675530	rs848512	IgE levels in asthmatics
chr2	37467263	37467264	rs2041840	Chronic lymphocytic leukemia
chr2	37592627	37592628	rs2373000	Schizophrenia
chr2	37731664	37731665	rs960902	Response to TNF-alpha inhibitors in rheumatoid arthritis
chr2	37750979	37750980	rs4352210	RR interval (heart rate)
chr2	37940541	37940542	rs4670766	Total ventricular volume
chr2	37957479	37957480	rs13012266	Metabolite levels (HVA/MHPG ratio)
chr2	37960612	37960613	rs17511102	Height
chr2	37977016	37977017	rs604381	Conduct disorder (interaction)
chr2	38044343	38044344	rs4670779	Bone mineral density (spine)
chr2	38277831	38277832	rs6741148	Erectile dysfunction and prostate cancer treatment
chr2	38916969	38916970	rs6741892	5-HTT brain serotonin transporter levels
chr2	39101208	39101209	rs12479213	Obesity-related traits
chr2	39109557	39109558	rs3099950	Amyotrophic lateral sclerosis
chr2	39843196	39843197	rs7587205	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)
chr2	39939535	39939536	rs17024218	Obesity-related traits
chr2	39947720	39947721	rs2716734	Erectile dysfunction and prostate cancer treatment
chr2	39959059	39959060	rs2540226	Personality dimensions
chr2	40115695	40115696	rs6721181	Asthma (childhood onset)
chr2	40396077	40396078	rs404005	HIV-associated dementia
chr2	40578558	40578559	rs17025867	Obesity (early onset extreme)
chr2	40662545	40662546	rs4629203	Obesity-related traits
chr2	40757790	40757791	rs13017846	QT interval
chr2	41273630	41273631	rs17027130	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)
chr2	42004996	42004997	rs719593	Conduct disorder (interaction)
chr2	42250548	42250549	rs7584262	Bone mineral density
chr2	42276920	42276921	rs4952590	Atopy
chr2	42981238	42981239	rs930421	Attention deficit hyperactivity disorder
chr2	42985802	42985803	rs6719977	Hyperactive-impulsive symptoms
chr2	43325569	43325570	rs6718520	Multiple sclerosis
chr2	43359060	43359061	rs12466022	Multiple sclerosis
chr2	43540124	43540125	rs7590268	Orofacial clefts
chr2	43553948	43553949	rs1465618	Prostate cancer
chr2	43587503	43587504	rs6732426	Hair morphology
chr2	43638837	43638838	rs13429458	Response to amphetamines
chr2	43638837	43638838	rs13429458	Polycystic ovary syndrome
chr2	43687878	43687879	rs17030845	Platelet counts
chr2	43721507	43721508	rs12478601	Polycystic ovary syndrome
chr2	43732822	43732823	rs7578597	Type 2 diabetes
chr2	43806917	43806918	rs10495903	Inflammatory bowel disease
chr2	43806917	43806918	rs10495903	Crohn's disease
chr2	43817504	43817505	rs11897432	DNA methylation (variation)
chr2	44065089	44065090	rs6756629	LDL cholesterol
chr2	44065089	44065090	rs6756629	Cholesterol, total
chr2	44066246	44066247	rs11887534	Gallstones
chr2	44072575	44072576	rs4299376	LDL cholesterol
chr2	44072575	44072576	rs4299376	Cholesterol, total
chr2	44072575	44072576	rs4299376	Lipid metabolism phenotypes
chr2	44073655	44073656	rs41360247	Phytosterol levels
chr2	44073880	44073881	rs6544713	LDL cholesterol
chr2	44074430	44074431	rs4245791	LDL cholesterol
chr2	44074430	44074431	rs4245791	Phytosterol levels
chr2	44135313	44135314	rs13387221	Intelligence (childhood)
chr2	44480949	44480950	rs4953076	Height
chr2	44662474	44662475	rs13414205	Immune reponse to smallpox (secreted TNF-alpha)
chr2	44705614	44705615	rs698813	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)
chr2	44768201	44768202	rs2341459	Height
chr2	45154907	45154908	rs528301	Alcohol and nictotine co-dependence
chr2	45188352	45188353	rs895636	Metabolite levels
chr2	45646823	45646824	rs3213787	Glaucoma
chr2	46176961	46176962	rs6751349	QT interval
chr2	46205038	46205039	rs13396424	Metabolite levels  (X-11787)
chr2	46321093	46321094	rs12373805	Suicide risk
chr2	46332168	46332169	rs12712969	Pulmonary function decline
chr2	46353165	46353166	rs10495928	Red blood cell count
chr2	46353165	46353166	rs10495928	Hematological and biochemical traits
chr2	46353165	46353166	rs10495928	Hemoglobin
chr2	46355050	46355051	rs4953318	Red blood cell traits
chr2	46355847	46355848	rs13008603	Red blood cell traits
chr2	46360906	46360907	rs10168349	Hematological and biochemical traits
chr2	46360906	46360907	rs10168349	Hematocrit
chr2	46537603	46537604	rs7579899	Renal cell carcinoma
chr2	46550768	46550769	rs7582701	IgG glycosylation
chr2	46634644	46634645	rs12623288	Hair morphology
chr2	46642248	46642249	rs2346177	Coronary heart disease
chr2	46826025	46826026	rs17818399	Height
chr2	46921284	46921285	rs12474201	Height
chr2	47022542	47022543	rs76351433	Chronic obstructive pulmonary disease
chr2	47229838	47229839	rs17540621	Response to statin therapy
chr2	47240011	47240012	rs10194115	Erectile dysfunction and prostate cancer treatment
chr2	47399063	47399064	rs815815	Dialysis-related mortality
chr2	47844504	47844505	rs6544997	Vitiligo
chr2	47885475	47885476	rs2969775	Alzheimer's disease
chr2	48047334	48047335	rs4381823	Schizophrenia
chr2	48646398	48646399	rs10454142	Sex hormone-binding globulin levels
chr2	48649704	48649705	rs7565792	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr2	48978158	48978159	rs13405728	Polycystic ovary syndrome
chr2	49177600	49177601	rs7591064	Radiation response
chr2	49201327	49201328	rs2268363	Erectile dysfunction and prostate cancer treatment
chr2	49201611	49201612	rs2268361	Polycystic ovary syndrome
chr2	49715020	49715021	rs12987465	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)
chr2	49955496	49955497	rs17039212	Systemic lupus erythematosus
chr2	50184393	50184394	rs11681792	Behavioural disinhibition (generation interaction)
chr2	50516017	50516018	rs1356888	Longevity
chr2	50731317	50731318	rs6754640	Temperament
chr2	50744773	50744774	rs10176705	Personality dimensions
chr2	50760502	50760503	rs6750634	Metabolite levels (HVA/MHPG ratio)
chr2	51667738	51667739	rs1206397	Cognitive performance
chr2	51736993	51736994	rs1406428	Response to tocilizumab in rheumatoid arthritis
chr2	52511793	52511794	rs17042688	Estradiol plasma levels (breast cancer)
chr2	52703589	52703590	rs12619788	Economic and political preferences (immigration/crime)
chr2	52713806	52713807	rs1526687	Cardiac Troponin-T levels
chr2	52949317	52949318	rs1349882	Serum dimethylarginine levels (asymmetric)
chr2	53237319	53237320	rs1160297	Hemostatic factors and hematological phenotypes
chr2	53266128	53266129	rs2357013	Hemostatic factors and hematological phenotypes
chr2	53502774	53502775	rs996712	Obesity-related traits
chr2	53756541	53756542	rs56148675	Bulimia nervosa
chr2	53782558	53782559	rs13407662	Stroke (ischemic)
chr2	54347749	54347750	rs1559040	Sudden cardiac arrest
chr2	54659706	54659707	rs4233949	Bone mineral density
chr2	54684556	54684557	rs11898505	Bone mineral density (spine)
chr2	54718180	54718181	rs4557020	Myopia (pathological)
chr2	55081375	55081376	rs12713280	Economic and political preferences
chr2	55156629	55156630	rs6726292	Obesity (extreme)
chr2	55516322	55516323	rs2589113	Height
chr2	55843412	55843413	rs782590	Metabolic syndrome
chr2	55973731	55973732	rs2163237	IgG glycosylation
chr2	56008903	56008904	rs7577894	Amyotrophic lateral sclerosis
chr2	56089539	56089540	rs1367226	Height
chr2	56096891	56096892	rs3791679	Height
chr2	56111308	56111309	rs3791675	Height
chr2	56363376	56363377	rs6751715	HIV-1 control
chr2	56592082	56592083	rs17268785	Menarche (age at onset)
chr2	57934054	57934055	rs13026414	Epilepsy (generalized)
chr2	58094872	58094873	rs2717068	Epilepsy (generalized)
chr2	58222927	58222928	rs2312147	Schizophrenia
chr2	58833492	58833493	rs6731302	Obesity
chr2	59036915	59036916	rs6719884	Myasthenia gravis
chr2	59072968	59072969	rs17552189	Cannabis dependence
chr2	59202028	59202029	rs111835151	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr2	59282590	59282591	rs991964	Uterine fibroids
chr2	59302876	59302877	rs887912	Obesity
chr2	59302876	59302877	rs887912	Body mass index
chr2	59499346	59499347	rs10490113	Breast cancer
chr2	59789704	59789705	rs10203166	IgG glycosylation
chr2	60126310	60126311	rs145433814	Eating disorders (purging via substances)
chr2	60281607	60281608	rs6712720	Monocyte early outgrowth colony forming units
chr2	60459805	60459806	rs359268	Hypersomnia (HLA-DQB1*06:02 negative)
chr2	60500143	60500144	rs10202231	Response to antipsychotic treatment
chr2	60534198	60534199	rs6545803	Nevirapine-induced rash
chr2	60584818	60584819	rs243021	Type 2 diabetes
chr2	60608758	60608759	rs2540917	Mean corpuscular volume
chr2	60620285	60620286	rs243070	Red blood cell traits
chr2	60713234	60713235	rs10189857	F-cell distribution
chr2	60714860	60714861	rs6545816	F-cell distribution
chr2	60715178	60715179	rs6545817	F-cell distribution
chr2	60718042	60718043	rs1427407	F-cell distribution
chr2	60718346	60718347	rs7599488	F-cell distribution
chr2	60719073	60719074	rs1896294	F-cell distribution
chr2	60719969	60719970	rs766432	Sickle cell anemia (haemolysis)
chr2	60719969	60719970	rs766432	F-cell distribution
chr2	60719969	60719970	rs766432	Beta thalassemia/hemoglobin E disease
chr2	60719969	60719970	rs766432	Fetal hemoglobin levels
chr2	60720245	60720246	rs11886868	F-cell distribution
chr2	60720245	60720246	rs11886868	Fetal hemoglobin levels
chr2	60720588	60720589	rs10195871	F-cell distribution
chr2	60720756	60720757	rs10172646	F-cell distribution
chr2	60720950	60720951	rs4671393	F-cell distribution
chr2	60721310	60721311	rs7584113	F-cell distribution
chr2	60721346	60721347	rs7557939	F-cell distribution
chr2	60722039	60722040	rs6706648	F-cell distribution
chr2	60722240	60722241	rs6738440	F-cell distribution
chr2	60723265	60723266	rs7565301	F-cell distribution
chr2	60723671	60723672	rs6729815	F-cell distribution
chr2	60724085	60724086	rs1896295	F-cell distribution
chr2	60724086	60724087	rs1896296	F-cell distribution
chr2	60725450	60725451	rs7606173	F-cell distribution
chr2	60762501	60762502	rs2556378	Attention deficit hyperactivity disorder
chr2	60924019	60924020	rs7589998	Obesity-related traits
chr2	61066665	61066666	rs1432295	Hodgkin's lymphoma
chr2	61081541	61081542	rs702873	Psoriatic arthritis
chr2	61081541	61081542	rs702873	Psoriasis
chr2	61091949	61091950	rs842636	Psoriasis
chr2	61136128	61136129	rs13031237	Rheumatoid arthritis
chr2	61164330	61164331	rs13017599	Psoriatic arthritis
chr2	61164330	61164331	rs13017599	Rheumatoid arthritis
chr2	61186828	61186829	rs13003464	Crohn's disease
chr2	61186828	61186829	rs13003464	Ulcerative colitis
chr2	61186828	61186829	rs13003464	Celiac disease
chr2	61204855	61204856	rs7608910	Inflammatory bowel disease
chr2	61204855	61204856	rs7608910	Ulcerative colitis
chr2	61217541	61217542	rs10188217	Crohn's disease and celiac disease
chr2	61224258	61224259	rs10181042	Crohn's disease
chr2	61772256	61772257	rs6545883	Tuberculosis
chr2	61876964	61876965	rs2421332	Homeostasis model assessment of beta-cell function (interaction)
chr2	62452660	62452661	rs11900673	Rheumatoid arthritis
chr2	62551471	62551472	rs10865331	Crohn's disease
chr2	62551471	62551472	rs10865331	Ankylosing spondylitis
chr2	62713532	62713533	rs6545946	Crohn's disease
chr2	63131730	63131731	rs721048	Prostate cancer
chr2	63149556	63149557	rs2710642	LDL cholesterol
chr2	63301163	63301164	rs6545977	Prostate cancer
chr2	63511434	63511435	rs2138798	Obesity-related traits
chr2	63596835	63596836	rs11683229	Protein quantitative trait loci
chr2	64349201	64349202	rs7604693	Kawasaki disease
chr2	64364631	64364632	rs6733160	Allergic dermatitis (nickel)
chr2	64495626	64495627	rs1529102	Breast size
chr2	64503894	64503895	rs2698530	Iron status biomarkers
chr2	65027623	65027624	rs11683197	Visceral fat
chr2	65208073	65208074	rs10211524	Metabolite levels
chr2	65220909	65220910	rs2160387	Metabolite levels
chr2	65595585	65595586	rs934734	Rheumatoid arthritis
chr2	65608908	65608909	rs1876518	Celiac disease and Rheumatoid arthritis
chr2	65667271	65667272	rs6740462	Inflammatory bowel disease
chr2	65758524	65758525	rs3845817	Bipolar disorder
chr2	65862377	65862378	rs1457451	Iron status biomarkers
chr2	66756975	66756976	rs3891585	PR interval
chr2	66771999	66772000	rs11897119	PR interval
chr2	66781452	66781453	rs2300478	Restless legs syndrome
chr2	67297408	67297409	rs1833219	Periodontitis (CDC/AAP)
chr2	67601970	67601971	rs6739392	Waist-hip ratio
chr2	67864674	67864675	rs4141819	Endometriosis
chr2	67942479	67942480	rs724568	Major depressive disorder (broad)
chr2	67973886	67973887	rs13432159	Response to antidepressant treatment
chr2	67976787	67976788	rs6724422	Response to antidepressant treatment
chr2	68070224	68070225	rs6747972	Restless legs syndrome
chr2	68359896	68359897	rs4078978	Immune reponse to smallpox (secreted IFN-alpha)
chr2	68570771	68570772	rs9309413	Metabolite levels
chr2	68598954	68598955	rs17035378	Celiac disease
chr2	68646782	68646783	rs7592330	Multiple sclerosis
chr2	68647094	68647095	rs7595037	Multiple sclerosis
chr2	68650996	68650997	rs6759808	Obesity-related traits
chr2	68652579	68652580	rs11126185	Obesity-related traits
chr2	69033582	69033583	rs115522963	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr2	69063908	69063909	rs10496166	RR interval (heart rate)
chr2	69198387	69198388	rs4254535	Lung cancer
chr2	69287942	69287943	rs4315565	Height
chr2	69723709	69723710	rs7577851	Parkinson's disease (age of onset)
chr2	69813457	69813458	rs12987661	Metabolite levels (Dihydroxy docosatrienoic acid)
chr2	69985434	69985435	rs7597155	Palmitoleic acid (16:1n-7) plasma levels
chr2	70182804	70182805	rs7583236	Obesity-related traits
chr2	70368922	70368923	rs6708331	Obesity-related traits
chr2	70697666	70697667	rs3771514	Obesity-related traits
chr2	70736218	70736219	rs454305	Neutrophil count
chr2	70764687	70764688	rs432203	Longevity
chr2	71063941	71063942	rs4852708	IgG glycosylation
chr2	71133013	71133014	rs3771395	Corneal astigmatism
chr2	71525784	71525785	rs12612930	Height
chr2	71958479	71958480	rs2900976	Protein quantitative trait loci
chr2	73743981	73743982	rs9309473	Metabolite levels
chr2	73818935	73818936	rs13391552	Metabolic traits
chr2	73837954	73837955	rs6546857	Metabolite levels  (X-11787)
chr2	73868327	73868328	rs13538	Metabolite levels  (X-11787)
chr2	73868327	73868328	rs13538	Chronic kidney disease
chr2	73900899	73900900	rs10206899	Glomerular filtration rate
chr2	73900899	73900900	rs10206899	Creatinine levels
chr2	74202577	74202578	rs4852324	Systemic lupus erythematosus
chr2	74208361	74208362	rs6705628	Systemic lupus erythematosus
chr2	74245776	74245777	rs6546886	Dialysis-related mortality
chr2	74463565	74463566	rs13006863	Post-traumatic stress disorder (asjusted for relatedness)
chr2	74463565	74463566	rs13006863	Immune reponse to smallpox (secreted TNF-alpha)
chr2	74939175	74939176	rs1137	Myopia (pathological)
chr2	74972080	74972081	rs205611	Iris characteristics
chr2	75074966	75074967	rs681900	Femoral neck bone geometry
chr2	75419713	75419714	rs3771863	Brain connectivity
chr2	75459667	75459668	rs765684	Sexual dimorphism in anthropometric traits
chr2	75790488	75790489	rs17011455	Presence of antiphospholipid antibodies
chr2	75792142	75792143	rs17011478	Obesity-related traits
chr2	75926564	75926565	rs2298948	Hippocampal atrophy
chr2	76240360	76240361	rs436000	Economic and political preferences (fairness)
chr2	76375710	76375711	rs10204325	Economic and political preferences (fairness)
chr2	76759574	76759575	rs74529274	Response to amphetamines
chr2	77223937	77223938	rs1470506	IgG glycosylation
chr2	77246330	77246331	rs6547115	IgG glycosylation
chr2	78075243	78075244	rs7595103	Attention deficit hyperactivity disorder and conduct disorder
chr2	78539665	78539666	rs2037723	Lung function (forced expiratory volume in 1 second to forced vital capacity ratio)
chr2	79198167	79198168	rs11683503	Contrast sensitivity
chr2	79539987	79539988	rs13409348	Bipolar disorder
chr2	79632346	79632347	rs2100290	Alcohol consumption
chr2	79687251	79687252	rs399885	Response to antipsychotic treatment
chr2	79709353	79709354	rs7570469	Response to antipsychotic treatment
chr2	79922801	79922802	rs11695685	Protein quantitative trait loci
chr2	80281172	80281173	rs6738962	Alzheimer's disease (cognitive decline)
chr2	81668807	81668808	rs10496265	Aging traits
chr2	81751123	81751124	rs10496262	Aging traits
chr2	81855724	81855725	rs6736587	Orthostatic hypotension
chr2	81856525	81856526	rs12615721	Pulmonary function decline
chr2	81872921	81872922	rs12052359	Bilirubin levels
chr2	83029468	83029469	rs17022444	Response to antipsychotic therapy (extrapyramidal side effects)
chr2	83292564	83292565	rs10496288	Hypertension
chr2	83293379	83293380	rs10496289	Hypertension
chr2	84245167	84245168	rs13398848	Conduct disorder (case status)
chr2	84246585	84246586	rs1447537	RR interval (heart rate)
chr2	84350916	84350917	rs1534238	Response to antipsychotic treatment
chr2	84444885	84444886	rs6547537	IgG glycosylation
chr2	84709214	84709215	rs7581224	Coronary artery calcification
chr2	85699749	85699750	rs7577642	Protein quantitative trait loci
chr2	85705676	85705677	rs11688246	Estradiol plasma levels (breast cancer)
chr2	85794296	85794297	rs10187424	Prostate cancer
chr2	86360572	86360573	rs2241437	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)
chr2	86860630	86860631	rs114532231	Serum dimethylarginine levels (asymmetric)
chr2	87044315	87044316	rs6547705	Progressive supranuclear palsy
chr2	88166460	88166461	rs9636470	Alcohol and nictotine co-dependence
chr2	88315792	88315793	rs12714207	Bilirubin levels
chr2	88388537	88388538	rs2919856	IgG glycosylation
chr2	88659587	88659588	rs1659258	Visceral fat
chr2	88895350	88895351	rs7571971	Progressive supranuclear palsy
chr2	88924621	88924622	rs11684404	Height
chr2	96841792	96841793	rs11886999	Cardiac Troponin-T levels
chr2	97228038	97228039	rs4907240	Event-related brain oscillations
chr2	97405439	97405440	rs2271893	Bipolar disorder
chr2	97410948	97410949	rs6746896	Bipolar disorder
chr2	97413487	97413488	rs2314398	Bipolar disorder
chr2	97500799	97500800	rs9948	Erectile dysfunction and prostate cancer treatment
chr2	99083891	99083892	rs12617721	Bipolar disorder (mood-incongruent)
chr2	99239930	99239931	rs12618769	Bipolar disorder
chr2	99382891	99382892	rs7578035	Bipolar disorder
chr2	99465501	99465502	rs6733011	Bipolar disorder
chr2	99876243	99876244	rs2200578	IgG glycosylation
chr2	100460653	100460654	rs7583877	Type 1 diabetes nephropathy
chr2	100806939	100806940	rs11676922	Rheumatoid arthritis
chr2	100818478	100818479	rs4851266	Educational attainment
chr2	100825366	100825367	rs9653442	Type 1 diabetes
chr2	100835733	100835734	rs10865035	Rheumatoid arthritis
chr2	101424330	101424331	rs7565981	Creutzfeldt-Jakob disease (variant)
chr2	101668856	101668857	rs2278729	Osteoporosis
chr2	101922169	101922170	rs6711606	Pancreatic cancer
chr2	102029645	102029646	rs12620464	Estradiol plasma levels (breast cancer)
chr2	102613012	102613013	rs4321386	Hormone measurements
chr2	102663627	102663628	rs2310173	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr2	102663627	102663628	rs2310173	Ulcerative colitis
chr2	102663627	102663628	rs2310173	Ankylosing spondylitis
chr2	102726660	102726661	rs12712127	Fibrinogen
chr2	102776201	102776202	rs13019803	Serum protein levels (sST2)
chr2	102810167	102810168	rs1558648	Serum protein levels (sST2)
chr2	102851707	102851708	rs2302612	Serum protein levels (sST2)
chr2	102875586	102875587	rs1345301	Waist circumference
chr2	102879463	102879464	rs10189629	Self-reported allergy
chr2	102915661	102915662	rs11693697	Serum protein levels (sST2)
chr2	102932561	102932562	rs950880	Serum protein levels (sST2)
chr2	102948631	102948632	rs1420103	Serum protein levels (sST2)
chr2	102953443	102953444	rs17639215	Serum protein levels (sST2)
chr2	102953616	102953617	rs3771180	Asthma
chr2	102955081	102955082	rs13408661	Asthma
chr2	102957290	102957291	rs13029918	Serum protein levels (sST2)
chr2	102957715	102957716	rs1420101	Eosinophil counts
chr2	102960209	102960210	rs3771175	Allergic sensitization
chr2	102965391	102965392	rs12999542	Serum protein levels (sST2)
chr2	102971199	102971200	rs9807989	Asthma
chr2	102971864	102971865	rs13015714	Atopic dermatitis
chr2	102971864	102971865	rs13015714	Celiac disease
chr2	102986221	102986222	rs3771166	Asthma
chr2	103054448	103054449	rs2058660	Crohn's disease
chr2	103054766	103054767	rs11465699	Serum protein levels (sST2)
chr2	103070567	103070568	rs917997	Inflammatory bowel disease
chr2	103070567	103070568	rs917997	Celiac disease
chr2	103091539	103091540	rs17027258	White blood cell types
chr2	103149099	103149100	rs1014286	Serum protein levels (sST2)
chr2	103335440	103335441	rs33993717	Response to amphetamines
chr2	103388593	103388594	rs12465996	IgG glycosylation
chr2	103512291	103512292	rs13402330	Thiazide-induced adverse metabolic effects in hypertensive patients
chr2	103576087	103576088	rs12105421	Psychosis (atypical)
chr2	103770237	103770238	rs6735786	Bone mineral density (hip)
chr2	104298540	104298541	rs264943	HIV-1 viral setpoint
chr2	104573004	104573005	rs2119507	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr2	104578532	104578533	rs1036736	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr2	104580502	104580503	rs12613775	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr2	104587350	104587351	rs10193430	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr2	104589137	104589138	rs11903187	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr2	104667737	104667738	rs6758152	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr2	104808711	104808712	rs11890236	Obesity-related traits
chr2	104983266	104983267	rs7570682	Bipolar disorder
chr2	105158637	105158638	rs17624523	Response to taxane treatment (docetaxel)
chr2	105378956	105378957	rs12615966	Pancreatic cancer
chr2	105837597	105837598	rs6712932	Type 2 diabetes
chr2	105877869	105877870	rs17636747	Preeclampsia
chr2	105897739	105897740	rs1020064	AIDS
chr2	105910512	105910513	rs1030877	Obesity-related traits
chr2	106431855	106431856	rs6747023	Addiction
chr2	106433477	106433478	rs7589342	Addiction
chr2	106436365	106436366	rs12995333	Addiction
chr2	106437255	106437256	rs4851870	Addiction
chr2	106438935	106438936	rs1465641	Addiction
chr2	106439180	106439181	rs1465639	Addiction
chr2	106440058	106440059	rs6741172	Addiction
chr2	106443110	106443111	rs12995849	Addiction
chr2	106445280	106445281	rs2163350	Addiction
chr2	106454084	106454085	rs7589561	Addiction
chr2	106455548	106455549	rs4851095	Addiction
chr2	106457290	106457291	rs2377339	Addiction
chr2	106457647	106457648	rs2163349	Addiction
chr2	106615273	106615274	rs1669539	Systolic blood pressure in sickle cell anemia
chr2	107678487	107678488	rs1357692	Alzheimer's disease
chr2	109635256	109635257	rs4676049	Alzheimer's disease (late onset)
chr2	111599705	111599706	rs4849121	IgA nephropathy
chr2	111616103	111616104	rs13401811	Chronic lymphocytic leukemia
chr2	111707404	111707405	rs3789119	Economic and political preferences (immigration/crime)
chr2	111797457	111797458	rs17483466	Chronic lymphocytic leukemia
chr2	111797530	111797531	rs3789080	Prostate cancer (gene x gene interaction)
chr2	111836537	111836538	rs7578982	White blood cell types
chr2	111849658	111849659	rs10207392	Red blood cell traits
chr2	111871896	111871897	rs1439287	Chronic lymphocytic leukemia
chr2	111949326	111949327	rs6738028	Dehydroepiandrosterone sulphate levels
chr2	111989371	111989372	rs6720394	Primary sclerosing cholangitis
chr2	112003866	112003867	rs2271404	Atopic dermatitis
chr2	112375962	112375963	rs1448190	Obesity-related traits
chr2	112470154	112470155	rs11122895	Allergic sensitization
chr2	112500034	112500035	rs17040773	Bone mineral density
chr2	112665200	112665201	rs17174870	Multiple sclerosis
chr2	112770769	112770770	rs4374383	Hepatitis C induced liver fibrosis
chr2	113529182	113529183	rs6542095	Endometriosis
chr2	113529239	113529240	rs11677416	Response to antipsychotic treatment in schizophrenia (working memory)
chr2	113683874	113683875	rs10864907	Pulmonary function
chr2	113691403	113691404	rs12467847	Response to amphetamines
chr2	113832311	113832312	rs6761276	Protein quantitative trait loci
chr2	113832332	113832333	rs6743376	Inflammatory biomarkers
chr2	113841029	113841030	rs6734238	Fibrinogen
chr2	113841029	113841030	rs6734238	C-reactive protein
chr2	113890372	113890373	rs4252023	Obesity-related traits
chr2	113978939	113978940	rs11123170	Renal function-related traits (BUN)
chr2	114980966	114980967	rs3105491	Systolic blood pressure in sickle cell anemia
chr2	115049817	115049818	rs4513299	Inflammatory biomarkers
chr2	115586938	115586939	rs6732028	Obesity-related traits
chr2	116241185	116241186	rs1375144	Bipolar disorder
chr2	116655794	116655795	rs272000	Attention deficit hyperactivity disorder
chr2	118815957	118815958	rs17526895	Cholesterol, total
chr2	118835840	118835841	rs10490626	LDL cholesterol
chr2	118835840	118835841	rs10490626	Cholesterol, total
chr2	119038597	119038598	rs1878526	Bone mineral density
chr2	119395690	119395691	rs651477	Multiple sclerosis
chr2	119845316	119845317	rs17189298	T-tau
chr2	120023691	120023692	rs72840936	Cocaine dependence
chr2	120145654	120145655	rs1374313	Obesity-related traits
chr2	120321816	120321817	rs2587695	Attention deficit hyperactivity disorder
chr2	120513132	120513133	rs13401620	Breast size
chr2	121089730	121089731	rs17625845	Breast size
chr2	121195180	121195181	rs7581710	Obesity
chr2	121245121	121245122	rs4849887	Breast cancer
chr2	121245121	121245122	rs4849887	Breast size
chr2	121282629	121282630	rs17050244	Age-related macular degeneration
chr2	121301910	121301911	rs6721654	Age-related macular degeneration
chr2	121306439	121306440	rs17050272	Urate levels
chr2	121309487	121309488	rs2030746	LDL cholesterol
chr2	121701288	121701289	rs11122834	Erectile dysfunction and prostate cancer treatment
chr2	121812223	121812224	rs4848143	Capecitabine sensitivity
chr2	122018762	122018763	rs17006292	Behcet's disease
chr2	123126478	123126479	rs10496584	Lentiform nucleus volume
chr2	123127788	123127789	rs2037892	Lentiform nucleus volume
chr2	123136889	123136890	rs1919922	Lentiform nucleus volume
chr2	123141544	123141545	rs4848768	Lentiform nucleus volume
chr2	123225622	123225623	rs17007761	Immune reponse to smallpox (secreted IFN-alpha)
chr2	123291021	123291022	rs1527243	Erectile dysfunction and prostate cancer treatment
chr2	123641610	123641611	rs17367118	Attention deficit hyperactivity disorder
chr2	124515040	124515041	rs13006237	Attention deficit hyperactivity disorder (inattention symptoms)
chr2	124983055	124983056	rs1170612	Schizophrenia
chr2	124998363	124998364	rs1367248	Tonometry
chr2	125256735	125256736	rs11899928	IgG glycosylation
chr2	125281909	125281910	rs17727261	Response to antipsychotic treatment
chr2	125291836	125291837	rs13021885	IgG glycosylation
chr2	125327949	125327950	rs2901331	Response to statin therapy
chr2	127330953	127330954	rs1550404	Intelligence
chr2	127662896	127662897	rs13418717	Heart failure
chr2	127852020	127852021	rs10207628	Alzheimer's disease
chr2	127887984	127887985	rs12989701	Alzheimer's disease (late onset)
chr2	127889636	127889637	rs7561528	Alzheimer's disease
chr2	127889636	127889637	rs7561528	Alzheimer's disease (late onset)
chr2	127892809	127892810	rs6733839	Alzheimer's disease (late onset)
chr2	127894614	127894615	rs744373	Alzheimer's disease
chr2	127894614	127894615	rs744373	Alzheimer's disease (late onset)
chr2	127982644	127982645	rs7567389	Self-rated health
chr2	128176039	128176040	rs1799810	Self-rated health
chr2	128177376	128177377	rs1158867	Protein C levels
chr2	128396166	128396167	rs78022502	Alzheimer's disease (cognitive decline)
chr2	128502584	128502585	rs17015535	Coronary artery calcification
chr2	128519796	128519797	rs13013415	Lung function (forced expiratory volume in 1 second to forced vital capacity ratio)
chr2	129478841	129478842	rs4662834	Bleomycin sensitivity
chr2	129504350	129504351	rs7561966	Palmitic acid (16:0) plasma levels
chr2	129542766	129542767	rs11690256	Serum dimethylarginine levels (symmetric)
chr2	130034011	130034012	rs837841	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
chr2	130034325	130034326	rs7567687	Periodontitis (PAL4Q3)
chr2	130468365	130468366	rs10928927	Chronic obstructive pulmonary disease
chr2	131545191	131545192	rs13395546	Metabolite levels (Dihydroxy docosatrienoic acid)
chr2	133144391	133144392	rs16831128	Conduct disorder (symptom count)
chr2	133144391	133144392	rs16831128	Conduct disorder (case status)
chr2	133188105	133188106	rs13420028	Hypertension
chr2	133189238	133189239	rs10188442	Hypertension
chr2	133746629	133746630	rs1437898	Multiple sclerosis (age of onset)
chr2	134005568	134005569	rs10496702	Bipolar disorder and schizophrenia
chr2	134040518	134040519	rs7577925	Attention deficit hyperactivity disorder
chr2	134230216	134230217	rs1821625	Multiple sclerosis
chr2	134266000	134266001	rs16826005	Hypersomnia (HLA-DQB1*06:02 negative)
chr2	134363031	134363032	rs7588567	Glaucoma (primary open-angle)
chr2	134434823	134434824	rs7567288	Height
chr2	134437958	134437959	rs1901440	Response to gemcitabine in pancreatic cancer
chr2	134529090	134529091	rs6722456	Palmitoleic acid (16:1n-7) plasma levels
chr2	135068793	135068794	rs4953911	Multiple sclerosis (severity)
chr2	135143286	135143287	rs12467609	Subcutaneous adipose tissue
chr2	135479979	135479980	rs6723108	Type 2 diabetes
chr2	135539966	135539967	rs6430538	Parkinson's disease
chr2	135592380	135592381	rs6710823	Parkinson's disease
chr2	135599875	135599876	rs10198552	Obesity-related traits
chr2	135803424	135803425	rs4954218	Corneal structure
chr2	135837905	135837906	rs7570971	Cholesterol, total
chr2	136506926	136506927	rs6430585	Corneal structure
chr2	136545298	136545299	rs16832011	Phospholipid levels (plasma)
chr2	136976254	136976255	rs882300	Multiple sclerosis
chr2	136976254	136976255	rs882300	Electrocardiographic traits
chr2	137015990	137015991	rs4452212	Telomere length
chr2	137338939	137338940	rs934299	Cognitive test performance
chr2	137491120	137491121	rs1582861	Subcutaneous adipose tissue
chr2	137555223	137555224	rs1427593	Pancreatic cancer
chr2	137768701	137768702	rs979976	Corneal astigmatism
chr2	137873346	137873347	rs892877	Liver enzyme levels (aspartate transaminase)
chr2	137875874	137875875	rs1469622	Tooth agenesis (third molar)
chr2	138142163	138142164	rs13405020	Non-small cell lung cancer
chr2	139278921	139278922	rs10170310	Response to antipsychotic treatment
chr2	139399353	139399354	rs58938945	Metabolite levels (MHPG)
chr2	139671954	139671955	rs9636231	Alcohol dependence
chr2	140147831	140147832	rs1399645	Male infertility
chr2	140626730	140626731	rs16842994	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr2	141226308	141226309	rs72899866	Periodontitis (CDC/AAP)
chr2	141269441	141269442	rs183373550	Serum dimethylarginine levels (symmetric)
chr2	141362057	141362058	rs491391	Optic disc size (disc)
chr2	141721141	141721142	rs12474609	Aging
chr2	141741589	141741590	rs4954683	IgG glycosylation
chr2	141795619	141795620	rs10210358	Erectile dysfunction and prostate cancer treatment
chr2	142228508	142228509	rs12472911	Menarche (age at onset)
chr2	142959930	142959931	rs2890652	Body mass index
chr2	144428607	144428608	rs10928195	Quantitative traits
chr2	144690116	144690117	rs1011397	Obesity-related traits
chr2	145141540	145141541	rs12991836	Schizophrenia
chr2	145208192	145208193	rs12105918	Renal cell carcinoma
chr2	145223619	145223620	rs13382811	Myopia (severe)
chr2	145351820	145351821	rs7355746	Obesity-related traits
chr2	145359908	145359909	rs10496964	Epilepsy (generalized)
chr2	146044051	146044052	rs1822881	Attention deficit hyperactivity disorder (inattention symptoms)
chr2	146045564	146045565	rs11687420	Attention deficit hyperactivity disorder (inattention symptoms)
chr2	146071852	146071853	rs10180522	Attention deficit hyperactivity disorder (inattention symptoms)
chr2	146092755	146092756	rs13407123	Attention deficit hyperactivity disorder (inattention symptoms)
chr2	146105253	146105254	rs10445672	Obesity-related traits
chr2	146125522	146125523	rs10427255	Common traits (Other)
chr2	147372023	147372024	rs10928302	HIV-1 control
chr2	148478335	148478336	rs7584099	Response to statin therapy
chr2	148716427	148716428	rs2307394	Urate levels
chr2	149387967	149387968	rs10191411	Protein quantitative trait loci
chr2	149557859	149557860	rs2121433	Alzheimer's disease biomarkers
chr2	149568395	149568396	rs4499362	Alzheimer's disease biomarkers
chr2	149865249	149865250	rs6435387	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr2	150147277	150147278	rs10432496	Immune reponse to smallpox (secreted IL-2)
chr2	150397217	150397218	rs7578361	Acute lymphoblastic leukemia (childhood)
chr2	150457623	150457624	rs10170236	Acute lymphoblastic leukemia (childhood)
chr2	150509331	150509332	rs16827293	Waist-to-hip circumference ratio (interaction)
chr2	150564483	150564484	rs17801127	Liver enzyme levels (alanine transaminase)
chr2	150697147	150697148	rs11889862	Menopause (age at onset)
chr2	151126402	151126403	rs6716455	Alcoholism (alcohol use disorder factor score)
chr2	151126402	151126403	rs6716455	Alcoholism (alcohol dependence factor score)
chr2	151635831	151635832	rs6757804	Endometriosis
chr2	151637935	151637936	rs7560163	Type 2 diabetes
chr2	151725791	151725792	rs10195263	Immune reponse to smallpox (secreted IFN-alpha)
chr2	152253917	152253918	rs10197940	Lung cancer
chr2	152957410	152957411	rs3820706	Adverse response to chemotherapy in breast cancer (alopecia)
chr2	152981334	152981335	rs16830728	Adverse response to chemotherapy in breast cancer (alopecia)
chr2	153436569	153436570	rs11675841	IgG glycosylation
chr2	153749367	153749368	rs78683678	Serum dimethylarginine levels (asymmetric)
chr2	154568756	154568757	rs10931753	Blood trace element (Zn levels)
chr2	155002846	155002847	rs16836124	Obesity-related traits
chr2	155070566	155070567	rs958672	Aging traits
chr2	155226676	155226677	rs707040	Sudden cardiac arrest
chr2	155234317	155234318	rs12621256	Liver enzyme levels (alanine transaminase)
chr2	156888499	156888500	rs1918172	Attention deficit hyperactivity disorder
chr2	156925285	156925286	rs16839962	Response to statin therapy
chr2	157096775	157096776	rs17188434	Menarche (age at onset)
chr2	157552859	157552860	rs7601713	QT interval
chr2	158780203	158780204	rs10183640	Sudden cardiac arrest
chr2	158977793	158977794	rs2074955	P-tau181p
chr2	159670448	159670449	rs16843372	Obesity-related traits
chr2	160069755	160069756	rs13022357	Sudden cardiac arrest
chr2	160190208	160190209	rs4665058	Sudden cardiac arrest
chr2	160867058	160867059	rs2667011	Bilirubin levels
chr2	160917496	160917497	rs4664308	Nephropathy (idiopathic membranous)
chr2	161171453	161171454	rs7593730	Type 2 diabetes
chr2	161380887	161380888	rs10192369	Amyotrophic lateral sclerosis
chr2	161757128	161757129	rs10208407	Obesity-related traits
chr2	161781772	161781773	rs1722636	Subcutaneous adipose tissue
chr2	161785168	161785169	rs1829975	Treatment response for severe sepsis
chr2	161886102	161886103	rs2357982	Presence of antiphospholipid antibodies
chr2	161894662	161894663	rs197273	Dietary macronutrient intake
chr2	162092639	162092640	rs7309	Educational attainment
chr2	162910222	162910223	rs6741949	Hippocampal volume
chr2	162959747	162959748	rs2270447	Common traits (Other)
chr2	163110535	163110536	rs2111485	Inflammatory bowel disease
chr2	163110535	163110536	rs2111485	Vitiligo
chr2	163124050	163124051	rs1990760	Type 1 diabetes autoantibodies
chr2	163124050	163124051	rs1990760	Immunoglobulin A
chr2	163124050	163124051	rs1990760	Type 1 diabetes
chr2	163260690	163260691	rs17716942	Psoriasis
chr2	163781786	163781787	rs1424760	Phospholipid levels (plasma)
chr2	164317875	164317876	rs12476047	Response to antipsychotic treatment
chr2	164490528	164490529	rs982393	Folate pathway vitamin levels
chr2	164906819	164906820	rs16849225	Blood pressure
chr2	164915207	164915208	rs13002573	Blood pressure
chr2	164963485	164963486	rs1446468	Blood pressure
chr2	165501848	165501849	rs3923113	Type 2 diabetes
chr2	165513090	165513091	rs10195252	Waist-hip ratio
chr2	165513090	165513091	rs10195252	Triglycerides
chr2	165528875	165528876	rs13389219	Waist-hip ratio
chr2	165539660	165539661	rs6717858	Sexual dimorphism in anthropometric traits
chr2	165540799	165540800	rs12328675	HDL cholesterol
chr2	165551200	165551201	rs7607980	Fasting insulin-related traits (interaction with BMI)
chr2	165577163	165577164	rs10221833	Response to statin therapy
chr2	165750389	165750390	rs13424957	Coronary heart disease
chr2	165890732	165890733	rs776488	Common traits (Other)
chr2	166144413	166144414	rs16850317	Periodontitis (DPAL)
chr2	166583243	166583244	rs6710518	Bone mineral density
chr2	166601045	166601046	rs1346004	Bone mineral density
chr2	166704293	166704294	rs5001812	Response to fenofibrate
chr2	166942139	166942140	rs11904006	Response to amphetamines
chr2	166943276	166943277	rs11890028	Epilepsy (generalized)
chr2	166978749	166978750	rs7587026	Mesial temporal lobe epilepsy with hippocampal sclerosis
chr2	167177358	167177359	rs4438497	Dental caries
chr2	167377977	167377978	rs13015447	Amyotrophic lateral sclerosis
chr2	168159350	168159351	rs10497324	DNA methylation (parent-of-origin)
chr2	168565692	168565693	rs13408808	Obesity-related traits
chr2	168641969	168641970	rs1004368	Obesity-related traits
chr2	169041385	169041386	rs6749447	Blood pressure
chr2	169117024	169117025	rs2102808	Parkinson's disease
chr2	169143034	169143035	rs9917256	Parkinson's disease
chr2	169389090	169389091	rs13393173	Response to TNF antagonist treatment
chr2	169757353	169757354	rs1402837	Glycated hemoglobin levels
chr2	169763147	169763148	rs560887	Glycemic traits (pregnancy)
chr2	169763147	169763148	rs560887	Metabolite levels
chr2	169763147	169763148	rs560887	Fasting glucose-related traits (interaction with BMI)
chr2	169763147	169763148	rs560887	Fasting plasma glucose
chr2	169763147	169763148	rs560887	Metabolic syndrome
chr2	169763147	169763148	rs560887	Fasting glucose-related traits
chr2	169763147	169763148	rs560887	Metabolic traits
chr2	169774070	169774071	rs563694	Fasting plasma glucose
chr2	169782879	169782880	rs569805	Metabolic syndrome (bivariate traits)
chr2	169784412	169784413	rs16856247	Metabolite levels
chr2	169791437	169791438	rs552976	Glycated hemoglobin levels
chr2	169830154	169830155	rs2287623	Cholesterol, total
chr2	169840573	169840574	rs16856332	Liver enzyme levels (alkaline phosphatase)
chr2	169853219	169853220	rs11568377	Systolic blood pressure in sickle cell anemia
chr2	170133085	170133086	rs830998	Anorexia nervosa
chr2	170204845	170204846	rs2544390	Urate levels
chr2	170624220	170624221	rs2114646	Obesity-related traits
chr2	171256596	171256597	rs7561268	Obesity-related traits
chr2	171318893	171318894	rs2118674	Palmitoleic acid (16:1n-7) plasma levels
chr2	171365888	171365889	rs10176755	Visceral fat
chr2	171461131	171461132	rs6749331	Obesity-related traits
chr2	171540822	171540823	rs2080401	Coronary heart disease
chr2	171733224	171733225	rs4668338	Uric acid levels
chr2	171822465	171822466	rs4668356	Cognitive performance
chr2	171990970	171990971	rs10183486	Menopause (age at onset)
chr2	172127919	172127920	rs4667682	Hippocampal atrophy
chr2	172972970	172972971	rs2016394	Breast cancer
chr2	173311552	173311553	rs12621278	Prostate cancer
chr2	173493077	173493078	rs836589	Erectile dysfunction
chr2	174212893	174212894	rs1550623	Breast cancer
chr2	174297658	174297659	rs10497394	Otitis media (chronic/recurrent)
chr2	174326844	174326845	rs10930597	Blood pressure measurement (low sodium intervention)
chr2	174326844	174326845	rs10930597	Blood pressure measurement (high sodium and potassium intervention)
chr2	174362348	174362349	rs7590983	Anthropometric traits
chr2	174462853	174462854	rs4972593	End-stage renal disease in Type 1 diabetics
chr2	174504923	174504924	rs13028485	Multiple myeloma (IgH translocation)
chr2	176239848	176239849	rs4972755	Bipolar disorder and major depressive disorder (combined)
chr2	176289318	176289319	rs2461751	Electrocardiographic conduction measures
chr2	176654737	176654738	rs7566934	Information processing speed
chr2	176717740	176717741	rs9287989	Periodontal microbiota
chr2	176734597	176734598	rs4972489	Obesity-related traits
chr2	176784137	176784138	rs1020410	Obesity-related traits
chr2	176991778	176991779	rs2592394	Magnesium levels
chr2	177012577	177012578	rs4972806	IgG glycosylation
chr2	177042632	177042633	rs2072590	Ovarian cancer
chr2	177909594	177909595	rs1529093	Non-alcoholic fatty liver disease histology (other)
chr2	178680430	178680431	rs13413635	Heart rate
chr2	178684719	178684720	rs7567851	Height
chr2	179104297	179104298	rs34479159	Breast size
chr2	179248419	179248420	rs7580640	QT interval
chr2	179296270	179296271	rs9283487	Multiple sclerosis (OCB status)
chr2	179641974	179641975	rs12476289	QT interval
chr2	179721045	179721046	rs17362588	Heart rate
chr2	179738268	179738269	rs11693319	Blood pressure measurement (cold pressor test)
chr2	180146274	180146275	rs6733818	Migraine without aura
chr2	180216730	180216731	rs13403289	Presence of antiphospholipid antibodies
chr2	180566677	180566678	rs16866933	Sudden cardiac arrest
chr2	181041285	181041286	rs16867225	Prostate cancer (gene x gene interaction)
chr2	181076748	181076749	rs13418455	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr2	181362378	181362379	rs16867321	Obesity
chr2	181513728	181513729	rs918959	Systemic lupus erythematosus
chr2	181996044	181996045	rs13010713	Celiac disease
chr2	182007799	182007800	rs1018326	Ankylosing spondylitis
chr2	182261868	182261869	rs7602460	Atrioventricular conduction
chr2	182319300	182319301	rs1449263	White blood cell count
chr2	182323664	182323665	rs12988934	White blood cell types
chr2	182328213	182328214	rs2124440	Monocyte count
chr2	182455993	182455994	rs993648	Response to iloperidone treatment (QT prolongation)
chr2	182511855	182511856	rs1441147	Lung function (forced vital capacity)
chr2	182511855	182511856	rs1441147	Lung function (forced expiratory volume in 1 second)
chr2	183685561	183685562	rs10931041	Waist-to-hip circumference ratio (interaction)
chr2	185436261	185436262	rs17430279	Obesity-related traits
chr2	185533579	185533580	rs7597593	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr2	185778427	185778428	rs1344706	Schizophrenia
chr2	185797227	185797228	rs6755404	Malaria
chr2	185811939	185811940	rs4380187	Schizophrenia
chr2	186024734	186024735	rs11678036	IgG glycosylation
chr2	186184029	186184030	rs1364477	IgG glycosylation
chr2	188196468	188196469	rs840616	Coronary heart disease
chr2	188333063	188333064	rs4140885	Heart rate
chr2	188343496	188343497	rs7586970	Coronary heart disease
chr2	189718961	189718962	rs2675399	Obesity-related traits
chr2	190607152	190607153	rs12053254	Obesity-related traits
chr2	190643648	190643649	rs7606224	Bilirubin levels
chr2	190678544	190678545	rs5743030	Subcutaneous adipose tissue
chr2	190985679	190985680	rs13034723	Body mass index
chr2	191538561	191538562	rs10931468	Primary biliary cirrhosis
chr2	191902757	191902758	rs3821236	Systemic sclerosis
chr2	191902757	191902758	rs3821236	Systemic lupus erythematosus
chr2	191931463	191931464	rs1517352	Inflammatory bowel disease
chr2	191935803	191935804	rs10168266	Sjogren's syndrome
chr2	191940450	191940451	rs7601754	Systemic lupus erythematosus and Systemic sclerosis
chr2	191964632	191964633	rs7574865	Systemic lupus erythematosus
chr2	191964632	191964633	rs7574865	Hepatocellular carcinoma (hepatitis B virus related)
chr2	191964632	191964633	rs7574865	Primary biliary cirrhosis
chr2	191964632	191964633	rs7574865	Systemic sclerosis
chr2	191964632	191964633	rs7574865	Celiac disease and Rheumatoid arthritis
chr2	191964632	191964633	rs7574865	Rheumatoid arthritis
chr2	192010487	192010488	rs7574070	Behcet's disease
chr2	192015071	192015072	rs7572482	Behcet's disease
chr2	192017770	192017771	rs897200	Behcet's disease
chr2	192117237	192117238	rs13030978	Liver enzyme levels (gamma-glutamyl transferase)
chr2	192118046	192118047	rs1823913	Obesity-related traits
chr2	192465597	192465598	rs6706693	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)
chr2	192587203	192587204	rs11903757	Colorectal cancer
chr2	192914361	192914362	rs10497721	Diabetes (incident)
chr2	192955504	192955505	rs13007495	Sudden cardiac arrest
chr2	193333902	193333903	rs1385351	HIV-1 control
chr2	193742172	193742173	rs10174573	Major depressive disorder
chr2	193984620	193984621	rs17662626	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr2	193984620	193984621	rs17662626	Schizophrenia
chr2	194872182	194872183	rs2176528	Bipolar disorder
chr2	195871818	195871819	rs10172965	Temperament
chr2	196365889	196365890	rs4591358	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr2	198631713	198631714	rs700651	Intracranial aneurysm
chr2	198881667	198881668	rs1016883	Ulcerative colitis
chr2	198896894	198896895	rs6738825	Dermatomyositis
chr2	198896894	198896895	rs6738825	Crohn's disease
chr2	198911165	198911166	rs67031482	Alcohol consumption
chr2	198914071	198914072	rs10497813	Self-reported allergy
chr2	198929805	198929806	rs7572733	Dermatomyositis
chr2	198962242	198962243	rs7595412	Hip bone size
chr2	198987934	198987935	rs988583	Neutrophil count
chr2	199169095	199169096	rs13398206	Prostate cancer (gene x gene interaction)
chr2	199385720	199385721	rs2054125	Educational attainment
chr2	199523121	199523122	rs17229285	Ulcerative colitis
chr2	199585555	199585556	rs16830366	Waist circumference
chr2	199601924	199601925	rs11893063	Brain cytoarchitecture
chr2	199632564	199632565	rs12617311	Menarche (age at onset)
chr2	199679109	199679110	rs10189905	Corneal astigmatism
chr2	200014482	200014483	rs12471454	Insomnia
chr2	200290358	200290359	rs1992950	Ulcerative colitis
chr2	200638508	200638509	rs12615435	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
chr2	200676925	200676926	rs7605378	Osteoporosis
chr2	200715387	200715388	rs2949006	Schizophrenia
chr2	201021953	201021954	rs1569175	Response to treatment for acute lymphoblastic leukemia
chr2	201150039	201150040	rs295137	Asthma (bronchodilator response)
chr2	201158121	201158122	rs12612420	Exercise (leisure time)
chr2	201571142	201571143	rs2540051	Intelligence
chr2	201576283	201576284	rs7563911	Intelligence
chr2	201580953	201580954	rs7589014	Intelligence
chr2	201582192	201582193	rs2348114	Intelligence
chr2	201648638	201648639	rs13430864	Response to citalopram treatment
chr2	202111379	202111380	rs3769825	Chronic lymphocytic leukemia
chr2	202162810	202162811	rs13016963	Melanoma
chr2	202807195	202807196	rs17385675	Response to antipsychotic treatment
chr2	202859616	202859617	rs6754521	Response to amphetamines
chr2	202949850	202949851	rs1521882	Attention deficit hyperactivity disorder and conduct disorder
chr2	203337000	203337001	rs12468226	Urate levels
chr2	203532303	203532304	rs11694172	Cholesterol, total
chr2	203745884	203745885	rs6725887	Coronary heart disease
chr2	203745884	203745885	rs6725887	Myocardial infarction (early onset)
chr2	204089729	204089730	rs16839626	Obesity-related traits
chr2	204165170	204165171	rs11888559	Height
chr2	204249398	204249399	rs11675251	Butyrylcholinesterase levels
chr2	204272089	204272090	rs1376877	Subclinical atherosclerosis traits (other)
chr2	204693875	204693876	rs231735	Rheumatoid arthritis
chr2	204721751	204721752	rs1024161	Graves' disease
chr2	204721751	204721752	rs1024161	Alopecia areata
chr2	204734486	204734487	rs231779	Hypothyroidism
chr2	204738918	204738919	rs3087243	Type 1 diabetes autoantibodies
chr2	204738918	204738919	rs3087243	Rheumatoid arthritis
chr2	204738918	204738919	rs3087243	Type 1 diabetes
chr2	204802577	204802578	rs4675374	Celiac disease
chr2	204983553	204983554	rs16840760	Obesity-related traits
chr2	205128020	205128021	rs6738181	Alzheimer's disease (late onset)
chr2	205368457	205368458	rs4673301	Lung function (forced expiratory volume in 1 second)
chr2	205864831	205864832	rs2335704	Tuberculosis
chr2	206060636	206060637	rs10153620	Attention deficit hyperactivity disorder (combined symptoms)
chr2	206063297	206063298	rs11681930	Attention deficit hyperactivity disorder (combined symptoms)
chr2	206086170	206086171	rs4675502	Autism
chr2	206150593	206150594	rs1207421	Knee osteoarthritis
chr2	206318592	206318593	rs11884476	AIDS progression
chr2	206836611	206836612	rs7603514	Obesity (extreme)
chr2	207121781	207121782	rs2058710	Bipolar disorder and schizophrenia
chr2	207634235	207634236	rs2277912	Height
chr2	207717782	207717783	rs6755560	QT interval (interaction)
chr2	207840331	207840332	rs4675644	Pulmonary function decline
chr2	207877464	207877465	rs1453160	Subcutaneous adipose tissue
chr2	208494233	208494234	rs2952768	Opioid sensitivity
chr2	208994044	208994045	rs2242073	Attention deficit hyperactivity disorder
chr2	209578599	209578600	rs13383928	Lung cancer-asbestos exposure interaction
chr2	211060049	211060050	rs2286963	Metabolite levels
chr2	211074908	211074909	rs3764913	Metabolite levels
chr2	211495586	211495587	rs12468557	Body mass index (asthmatics)
chr2	211540506	211540507	rs1047891	HDL cholesterol
chr2	211543054	211543055	rs715	Fibrinogen
chr2	211543054	211543055	rs715	Metabolite levels
chr2	211569721	211569722	rs2371030	Non-small cell lung cancer
chr2	211616893	211616894	rs2216405	Metabolic traits
chr2	212868623	212868624	rs1879637	Personality dimensions
chr2	213168767	213168768	rs7588550	Type 1 diabetes nephropathy
chr2	213296862	213296863	rs13393577	Breast cancer
chr2	213297252	213297253	rs1505368	Serum dimethylarginine levels (symmetric)
chr2	213824044	213824045	rs12619285	Eosinophil counts
chr2	214548536	214548537	rs6707387	Homeostasis model assessment of insulin resistance (interaction)
chr2	214548536	214548537	rs6707387	Fasting insulin (interaction)
chr2	214838512	214838513	rs9789347	Obesity-related traits
chr2	214917401	214917402	rs1510552	Contrast sensitivity
chr2	215188618	215188619	rs16851771	Obesity-related traits
chr2	215341889	215341890	rs7604827	PR interval
chr2	215635793	215635794	rs3768716	Neuroblastoma
chr2	215653886	215653887	rs7587476	Neuroblastoma
chr2	215672545	215672546	rs6435862	Neuroblastoma (high-risk)
chr2	216285374	216285375	rs17458018	Coronary heart disease
chr2	216304383	216304384	rs1250229	LDL cholesterol
chr2	216860549	216860550	rs3770549	Blood trace element (Se levels)
chr2	216893636	216893637	rs1344694	Alcohol dependence
chr2	216898657	216898658	rs7590720	Alcohol dependence
chr2	217208570	217208571	rs6756590	Migraine
chr2	217481270	217481271	rs9288520	Esophageal cancer  (alcohol interaction)
chr2	217554212	217554213	rs2241193	Visceral fat
chr2	217625522	217625523	rs13015993	Thyroid hormone levels
chr2	217863480	217863481	rs10932688	Primary tooth development (number of teeth)
chr2	217878208	217878209	rs6435957	Primary tooth development (number of teeth)
chr2	217894755	217894756	rs4491709	Permanent tooth development
chr2	217905831	217905832	rs13387042	Breast cancer
chr2	218123647	218123648	rs2553026	Height
chr2	218271718	218271719	rs6759952	Thyroid cancer
chr2	218271897	218271898	rs1351164	Height
chr2	218296507	218296508	rs16857609	Breast cancer
chr2	218310339	218310340	rs966423	Thyroid cancer
chr2	218314252	218314253	rs11689435	Metabolite levels (MHPG)
chr2	218523161	218523162	rs6435999	Height
chr2	218683153	218683154	rs2571445	Pulmonary function (interaction)
chr2	218683153	218683154	rs2571445	Pulmonary function
chr2	218729864	218729865	rs3791950	Height
chr2	219010145	219010146	rs11676348	Ulcerative colitis
chr2	219081296	219081297	rs13403276	Obesity-related traits
chr2	219084532	219084533	rs6733051	Obesity-related traits
chr2	219130513	219130514	rs1079204	Smooth-surface caries
chr2	219151217	219151218	rs2382817	Inflammatory bowel disease
chr2	219279096	219279097	rs7607369	Amyotrophic lateral sclerosis
chr2	219514758	219514759	rs10187066	Height
chr2	219545308	219545309	rs2303565	Amyotrophic lateral sclerosis
chr2	219756382	219756383	rs7349332	Common traits (Other)
chr2	219756382	219756383	rs7349332	Hair morphology
chr2	219829205	219829206	rs359980	Obesity-related traits
chr2	219840890	219840891	rs359965	Immune response to smallpox vaccine (IL-6)
chr2	219908368	219908369	rs12470505	Height
chr2	219934347	219934348	rs1052483	Height
chr2	219943845	219943846	rs6724465	Height
chr2	219949183	219949184	rs16859517	Height
chr2	220668737	220668738	rs3815854	Orofacial clefts
chr2	220698124	220698125	rs10498070	Systemic lupus erythematosus and Systemic sclerosis
chr2	220864653	220864654	rs10198756	IgG glycosylation
chr2	221720087	221720088	rs10932886	Brain imaging
chr2	221899443	221899444	rs10498091	Echocardiographic traits
chr2	222072177	222072178	rs17348202	Paclitaxel-induced neuropathy
chr2	222801698	222801699	rs824931	Body mass index
chr2	223068285	223068286	rs7559271	Facial morphology
chr2	223353445	223353446	rs17496827	Anorexia nervosa
chr2	223917982	223917983	rs12621643	Acute lymphoblastic leukemia (childhood)
chr2	223936737	223936738	rs1440072	Waist circumference
chr2	223936737	223936738	rs1440072	Body mass index
chr2	223937558	223937559	rs960246	C-reactive protein and white blood cell count
chr2	224274621	224274622	rs16864755	Osteoporosis-related phenotypes
chr2	224459682	224459683	rs16864968	Response to hepatitis C treatment
chr2	224943684	224943685	rs6740660	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)
chr2	225047743	225047744	rs2629046	Height
chr2	225558041	225558042	rs1843834	IgE levels in asthmatics (D.p. specific)
chr2	226225622	226225623	rs1473307	Menopause (age at onset)
chr2	226237909	226237910	rs1517484	Attention deficit hyperactivity disorder (time to onset)
chr2	227000985	227000986	rs6758183	Corneal astigmatism
chr2	227020652	227020653	rs7578326	Type 2 diabetes
chr2	227068079	227068080	rs2943634	Fasting insulin-related traits (interaction with BMI)
chr2	227068079	227068080	rs2943634	Coronary heart disease
chr2	227087283	227087284	rs2943636	Sexual dimorphism in anthropometric traits
chr2	227093584	227093585	rs2943640	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr2	227093744	227093745	rs2943641	Type 2 diabetes and other traits
chr2	227100697	227100698	rs2972146	Triglycerides
chr2	227100697	227100698	rs2972146	HDL cholesterol
chr2	227105920	227105921	rs2943650	Adiposity
chr2	227122215	227122216	rs1515110	Adiponectin levels
chr2	227179629	227179630	rs925735	Adiponectin levels
chr2	227562138	227562139	rs7558386	P-tau181p
chr2	227773465	227773466	rs3820928	Pulmonary function
chr2	227915923	227915924	rs2272205	Immune reponse to smallpox (secreted IFN-alpha)
chr2	228092034	228092035	rs35212277	Metabolite levels (5-HIAA/ MHPG Ratio)
chr2	228135179	228135180	rs7606754	Corneal structure
chr2	228397565	228397566	rs6731443	Airway hyperresponsiveness
chr2	228481418	228481419	rs11889798	Immune reponse to smallpox (secreted TNF-alpha)
chr2	228584897	228584898	rs11691652	Obesity-related traits
chr2	228670574	228670575	rs10175070	Eating disorders (purging via substances)
chr2	228715374	228715375	rs7591163	Blood pressure
chr2	229510928	229510929	rs1435867	Pulmonary function (interaction)
chr2	229642421	229642422	rs11679180	Endometrial cancer
chr2	229969797	229969798	rs6436839	Response to antipsychotic treatment in schizophrenia (reasoning)
chr2	230224030	230224031	rs7594321	Pulmonary function (interaction)
chr2	230349988	230349989	rs11890081	IgG glycosylation
chr2	230522397	230522398	rs1861612	Type 2 diabetes
chr2	231035744	231035745	rs13010639	Obesity-related traits
chr2	231091222	231091223	rs13397985	Chronic lymphocytic leukemia
chr2	231097128	231097129	rs6716753	Crohn's disease
chr2	231106723	231106724	rs10201872	Multiple sclerosis
chr2	231116873	231116874	rs7423615	Crohn's disease
chr2	231230170	231230171	rs6712333	Nicotine use
chr2	231420400	231420401	rs17275498	Cognitive performance
chr2	232159211	232159212	rs745962	Hormone measurements
chr2	232176540	232176541	rs7580717	Multiple myeloma
chr2	232192304	232192305	rs1669070	Thiazide-induced adverse metabolic effects in hypertensive patients
chr2	232271283	232271284	rs13030174	Heart rate
chr2	232298075	232298076	rs12475512	Eating disorders (purging via substances)
chr2	232318753	232318754	rs16828074	Attention deficit hyperactivity disorder
chr2	232378230	232378231	rs6750795	Height
chr2	232796609	232796610	rs749052	Height
chr2	232797965	232797966	rs2580816	Height
chr2	232988581	232988582	rs3103267	Height
chr2	233077063	233077064	rs7571816	Height
chr2	233155109	233155110	rs6717918	Height
chr2	233379940	233379941	rs1656404	Refractive error
chr2	233406997	233406998	rs1881492	Refractive error
chr2	233426525	233426526	rs1656402	Non-small cell lung cancer (survival)
chr2	233513174	233513175	rs2140773	Liver enzyme levels (gamma-glutamyl transferase)
chr2	233736243	233736244	rs2675968	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr2	233743108	233743109	rs778371	Schizophrenia
chr2	233896497	233896498	rs2233375	Contrast sensitivity
chr2	233998480	233998481	rs10933436	Coronary heart disease
chr2	234068475	234068476	rs35349669	Alzheimer's disease (late onset)
chr2	234158838	234158839	rs10210302	Crohn's disease
chr2	234173502	234173503	rs12994997	Crohn's disease
chr2	234180409	234180410	rs3828309	Crohn's disease
chr2	234183367	234183368	rs2241880	Crohn's disease
chr2	234184416	234184417	rs3792109	Crohn's disease
chr2	234264847	234264848	rs1550532	Calcium levels
chr2	234264847	234264848	rs1550532	Bilirubin levels
chr2	234273241	234273242	rs838705	Calcium levels
chr2	234406654	234406655	rs6704644	Bilirubin levels
chr2	234502120	234502121	rs13394720	HIV-1 control
chr2	234565282	234565283	rs11892031	Bladder cancer
chr2	234584323	234584324	rs2602381	Attention deficit hyperactivity disorder
chr2	234639309	234639310	rs11891311	Bilirubin levels
chr2	234668569	234668570	rs887829	Bilirubin levels
chr2	234668569	234668570	rs887829	Metabolite levels
chr2	234668569	234668570	rs887829	Cholelithiasis-related traits in sickle cell anemia
chr2	234668569	234668570	rs887829	Metabolic traits
chr2	234669143	234669144	rs4148323	Bilirubin levels
chr2	234672638	234672639	rs6742078	Bilirubin levels
chr2	234672638	234672639	rs6742078	Circulating cell-free DNA
chr2	234673308	234673309	rs4148325	Bilirubin levels
chr2	234679383	234679384	rs11563251	LDL cholesterol
chr2	234679383	234679384	rs11563251	Cholesterol, total
chr2	234698789	234698790	rs2361502	Bilirubin levels
chr2	234814058	234814059	rs10187654	Pulmonary function decline
chr2	234818868	234818869	rs7577262	Blood pressure measurement (cold pressor test)
chr2	234825092	234825093	rs10166942	Migraine
chr2	234827660	234827661	rs6741751	Migraine without aura
chr2	234827660	234827661	rs6741751	Migraine with aura
chr2	234827660	234827661	rs6741751	Migraine - clinic-based
chr2	234827660	234827661	rs6741751	Migraine
chr2	234852691	234852692	rs12472151	Alcohol consumption
chr2	235210726	235210727	rs12151790	Osteoporosis
chr2	235302809	235302810	rs11887188	Blood pressure measurement (high sodium and potassium intervention)
chr2	235601063	235601064	rs4663476	Response to angiotensin II receptor blocker therapy
chr2	235615196	235615197	rs6736997	Pancreatic cancer
chr2	235900170	235900171	rs11676855	Dialysis-related mortality
chr2	235960892	235960893	rs10174126	Orofacial clefts
chr2	236128950	236128951	rs1991705	Obesity-related traits
chr2	236539306	236539307	rs6431393	Menarche (age at onset)
chr2	236795342	236795343	rs13025591	Schizophrenia
chr2	237058143	237058144	rs11687170	Educational attainment
chr2	237105517	237105518	rs13401104	Educational attainment
chr2	237156548	237156549	rs13390159	Response to statin therapy
chr2	237521841	237521842	rs7607316	Airflow obstruction
chr2	238270893	238270894	rs10202497	Aging (time to event)
chr2	238387227	238387228	rs7584330	Prostate cancer
chr2	238443225	238443226	rs2292884	Prostate cancer
chr2	238499443	238499444	rs2292873	Obesity-related traits
chr2	238672424	238672425	rs11680012	Adiposity
chr2	238822330	238822331	rs10185142	Obesity-related traits
chr2	239095421	239095422	rs12472274	Phospholipid levels (plasma)
chr2	239306267	239306268	rs3739070	Iris characteristics
chr2	239349361	239349362	rs3769124	Pulmonary function
chr2	239694630	239694631	rs9287638	Male-pattern baldness
chr2	239877147	239877148	rs12477314	Pulmonary function (interaction)
chr2	239877147	239877148	rs12477314	Pulmonary function
chr2	240112971	240112972	rs3791556	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr2	240418659	240418660	rs6743931	Response to antipsychotic therapy (extrapyramidal side effects)
chr2	240687288	240687289	rs10207060	Obesity-related traits
chr2	240745717	240745718	rs4852140	Obesity-related traits
chr2	240843637	240843638	rs12618573	Response to amphetamines
chr2	240900120	240900121	rs13424612	Odorant perception (isobutyraldehyde)
chr2	241308504	241308505	rs1574192	Brain imaging in schizophrenia (interaction)
chr2	241495012	241495013	rs4305276	Mean platelet volume
chr2	241515595	241515596	rs2953145	Bipolar disorder
chr2	241563738	241563739	rs4676410	Sclerosing cholangitis and ulcerative colitis (combined)
chr2	241569691	241569692	rs3749171	Inflammatory bowel disease
chr2	241579107	241579108	rs4676406	Ulcerative colitis
chr2	242012728	242012729	rs6721345	Sex hormone-binding globulin levels
chr2	242053545	242053546	rs17382723	Height
chr2	242262985	242262986	rs12694997	Height
chr2	242296448	242296449	rs1476698	Fibrinogen
chr2	242371100	242371101	rs757978	Chronic lymphocytic leukemia
chr2	242382863	242382864	rs3771570	Prostate cancer
chr2	242502955	242502956	rs12479254	Brain structure
chr2	243026494	243026495	rs749924	Coronary artery calcification
chr2	243048759	243048760	rs12478296	Obesity-related traits
chr20	168019	168020	rs13036722	Obesity-related traits
chr20	351943	351944	rs6051520	Information processing speed
chr20	549917	549918	rs6084946	IgG glycosylation
chr20	594779	594780	rs1533087	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr20	759314	759315	rs6117615	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)
chr20	819661	819662	rs6108038	Obesity-related traits
chr20	1205885	1205886	rs397020	Multiple sclerosis
chr20	1459059	1459060	rs6042507	Circulating myeloperoxidase levels (serum)
chr20	1610550	1610551	rs2281808	Type 1 diabetes
chr20	1759589	1759590	rs6080550	Non-obstructive azoospermia
chr20	1923733	1923734	rs6136489	Mean platelet volume
chr20	1924706	1924707	rs13042885	Mean platelet volume
chr20	1929541	1929542	rs6035126	Liver enzyme levels (alanine transaminase)
chr20	1941170	1941171	rs6045676	Aortic root size
chr20	1995533	1995534	rs6081597	Immune response to smallpox vaccine (IL-6)
chr20	2384971	2384972	rs34972666	Alzheimer's disease (cognitive decline)
chr20	2518564	2518565	rs6049839	Systemic lupus erythematosus
chr20	2575368	2575369	rs6050469	Obesity-related traits
chr20	2755487	2755488	rs6138892	Response to tocilizumab in rheumatoid arthritis
chr20	2800800	2800801	rs7360412	White matter integrity
chr20	3185122	3185123	rs11697186	Response to hepatitis C treatment
chr20	3187732	3187733	rs6139030	Response to hepatitis C treatment
chr20	3193841	3193842	rs1127354	Ribavirin-induced anemia
chr20	3193841	3193842	rs1127354	Chronic Hepatitis C infection
chr20	3193892	3193893	rs7270101	Chronic Hepatitis C infection
chr20	3381548	3381549	rs965469	IFN-related cytopenia
chr20	3756596	3756597	rs13043330	Visceral adipose tissue adjusted for BMI
chr20	3776174	3776175	rs3761218	Bipolar disorder
chr20	3827308	3827309	rs4815617	Asthma
chr20	4101799	4101800	rs1741344	Height
chr20	4169078	4169079	rs16989303	Panic disorder
chr20	4215556	4215557	rs1556832	Preeclampsia
chr20	4352103	4352104	rs159788	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr20	4387133	4387134	rs586446	IgG glycosylation
chr20	4611876	4611877	rs6052699	Platelet aggregation
chr20	4677091	4677092	rs6107516	Creutzfeldt-Jakob disease (variant)
chr20	4680250	4680251	rs1799990	Prion diseases
chr20	4680250	4680251	rs1799990	Creutzfeldt-Jakob disease
chr20	4698625	4698626	rs6116492	Creutzfeldt-Jakob disease (variant)
chr20	5037773	5037774	rs261360	Hair morphology
chr20	5588448	5588449	rs238295	Cortical structure
chr20	5840538	5840539	rs4815868	Information processing speed
chr20	5935384	5935385	rs236114	Menopause (age at onset)
chr20	5943692	5943693	rs454422	HIV-1 control
chr20	5948226	5948227	rs16991615	Menopause (age at onset)
chr20	5948226	5948227	rs16991615	Menarche and menopause (age at onset)
chr20	5949533	5949534	rs4815879	Preeclampsia
chr20	6035227	6035228	rs2326679	Menopause (age at onset)
chr20	6375459	6375460	rs6085533	Metabolite levels  (X-11787)
chr20	6404280	6404281	rs961253	Colorectal cancer
chr20	6609876	6609877	rs6107853	Body mass index
chr20	6620892	6620893	rs967417	Height
chr20	6621684	6621685	rs2145270	Height
chr20	6621684	6621685	rs2145270	Body mass index
chr20	6626217	6626218	rs2145272	Height
chr20	6699594	6699595	rs4813802	Colorectal cancer
chr20	6751088	6751089	rs2273074	Obesity-related traits
chr20	6761511	6761512	rs6054512	Axial length
chr20	6761764	6761765	rs235770	Refractive error
chr20	6980634	6980635	rs6085820	Alzheimer's disease (late onset)
chr20	7106288	7106289	rs1884302	Sagittal craniosynostosis
chr20	7180055	7180056	rs6085920	Uric acid levels
chr20	7294902	7294903	rs6054906	Response to amphetamines
chr20	7385957	7385958	rs6054973	Asthma (childhood onset)
chr20	7552503	7552504	rs6108011	Hemostatic factors and hematological phenotypes
chr20	7752365	7752366	rs6077251	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
chr20	7812349	7812350	rs2423279	Colorectal cancer
chr20	8114703	8114704	rs6118083	Cognitive performance
chr20	8277942	8277943	rs2745761	Response to irinotecan in non-small-cell lung cancer
chr20	8704551	8704552	rs6077414	Estradiol plasma levels (breast cancer)
chr20	8836770	8836771	rs6056209	Cognitive performance
chr20	9365302	9365303	rs2072910	Neutrophil count
chr20	9778728	9778729	rs6056891	Obesity-related traits
chr20	10183516	10183517	rs6039763	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)
chr20	10639542	10639543	rs2273061	Bone mineral density
chr20	10639987	10639988	rs3790160	Bone mineral density
chr20	10850463	10850464	rs1884136	Information processing speed
chr20	10969029	10969030	rs1327235	Systolic blood pressure
chr20	10969029	10969030	rs1327235	Diastolic blood pressure
chr20	10969029	10969030	rs1327235	Blood pressure
chr20	10988098	10988099	rs6104690	Bladder cancer
chr20	11157010	11157011	rs6040399	Response to citalopram treatment
chr20	11174902	11174903	rs2207418	Cardiac hypertrophy
chr20	11209521	11209522	rs6040449	Relative hand skill
chr20	12082641	12082642	rs11907106	Obesity-related traits
chr20	12730041	12730042	rs1413020	Body mass index (interaction)
chr20	12874584	12874585	rs2073233	Brain structure
chr20	12962717	12962718	rs364585	LDL cholesterol
chr20	12969399	12969400	rs680379	Sphingolipid levels
chr20	13123732	13123733	rs17190927	Personality dimensions
chr20	13148151	13148152	rs2144134	Body mass index (interaction)
chr20	13222857	13222858	rs1407335	Metabolite levels  (X-11787)
chr20	13296911	13296912	rs1223271	Parkinson's disease
chr20	13696128	13696129	rs6042314	Intelligence (childhood)
chr20	14327898	14327899	rs6079395	Non-alcoholic fatty liver disease histology (other)
chr20	14388214	14388215	rs6110278	Mean platelet volume
chr20	14747470	14747471	rs4141463	Autism
chr20	15120743	15120744	rs11087123	Eating disorders
chr20	15177579	15177580	rs199307	Obesity-related traits
chr20	15335753	15335754	rs6110577	Obesity (extreme)
chr20	15599530	15599531	rs200752	Hypertension
chr20	15606420	15606421	rs200759	Hypertension
chr20	16003405	16003406	rs6080100	Presence of antiphospholipid antibodies
chr20	16054981	16054982	rs16997087	Brain connectivity
chr20	16311309	16311310	rs2208059	Ileal carcinoids
chr20	16451641	16451642	rs6043979	Intelligence
chr20	16455773	16455774	rs932541	Intelligence
chr20	16459308	16459309	rs6044001	Intelligence
chr20	16460714	16460715	rs6044003	Intelligence
chr20	16536413	16536414	rs6044112	Response to taxane treatment (docetaxel)
chr20	16740824	16740825	rs4491792	Post-traumatic stress disorder (asjusted for relatedness)
chr20	17122592	17122593	rs852069	Menarche (age at onset)
chr20	17357572	17357573	rs4814615	Dialysis-related mortality
chr20	17368541	17368542	rs6044777	Biochemical measures
chr20	17436472	17436473	rs6044834	Obesity-related traits
chr20	17566068	17566069	rs17791782	Presence of antiphospholipid antibodies
chr20	17592299	17592300	rs12480819	Migraine - clinic-based
chr20	17825142	17825143	rs2077147	IgG glycosylation
chr20	17829279	17829280	rs2745851	IgG glycosylation
chr20	17845920	17845921	rs2328223	LDL cholesterol
chr20	18079130	18079131	rs17725255	Anorexia nervosa
chr20	18885737	18885738	rs742731	Homeostasis model assessment of insulin resistance (interaction)
chr20	18885737	18885738	rs742731	Fasting insulin (interaction)
chr20	19212889	19212890	rs6081541	Psychosis (atypical)
chr20	19363978	19363979	rs2424234	Pulmonary function decline
chr20	19571580	19571581	rs3790268	Matrix metalloproteinase levels
chr20	19802187	19802188	rs6046346	Obesity-related traits
chr20	19852502	19852503	rs6046396	Bipolar disorder and schizophrenia
chr20	20634105	20634106	rs6132333	IgG glycosylation
chr20	21853099	21853100	rs2180439	Male-pattern baldness
chr20	22037574	22037575	rs6047844	Male-pattern baldness
chr20	22050502	22050503	rs1160312	Male-pattern baldness
chr20	22559600	22559601	rs6048205	Fasting glucose-related traits (interaction with BMI)
chr20	22567941	22567942	rs1209523	Fasting plasma glucose
chr20	22887256	22887257	rs6075982	Obesity-related traits
chr20	23097879	23097880	rs1320561	Obesity-related traits
chr20	23141654	23141655	rs844917	Liver enzyme levels (alanine transaminase)
chr20	23268636	23268637	rs4815191	Obesity-related traits
chr20	23578188	23578189	rs1158167	Cystatin C
chr20	23612736	23612737	rs911119	Chronic kidney disease
chr20	23847008	23847009	rs6138150	Response to TNF antagonist treatment
chr20	24058406	24058407	rs6049375	Erectile dysfunction and prostate cancer treatment
chr20	24717084	24717085	rs2424635	Bipolar disorder and schizophrenia
chr20	25019098	25019099	rs6050267	Cognitive performance
chr20	25206653	25206654	rs1044573	Allergic rhinitis
chr20	25240188	25240189	rs2281558	Calcium levels
chr20	25266899	25266900	rs139672965	Serum dimethylarginine levels (asymmetric)
chr20	25298086	25298087	rs7267979	Liver enzyme levels (alkaline phosphatase)
chr20	30725647	30725648	rs6142618	Inflammatory bowel disease
chr20	31277093	31277094	rs210135	Hematological parameters
chr20	31376281	31376282	rs4911259	Inflammatory bowel disease
chr20	31376994	31376995	rs6119285	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31384879	31384880	rs6057648	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31395476	31395477	rs6119286	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31410336	31410337	rs6057651	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr20	31410336	31410337	rs6057651	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31419808	31419809	rs6057652	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr20	31419808	31419809	rs6057652	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31437606	31437607	rs7270085	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31445146	31445147	rs6057659	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31446857	31446858	rs8123073	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31447367	31447368	rs17123726	Attention deficit hyperactivity disorder (combined symptoms)
chr20	31531543	31531544	rs13045180	Type 1 diabetes nephropathy
chr20	31718652	31718653	rs6059101	Ulcerative colitis
chr20	31950844	31950845	rs291671	Hair color
chr20	32304652	32304653	rs1074683	Height
chr20	32333180	32333181	rs7274811	Height
chr20	32482631	32482632	rs742614	Stearic acid (18:0) plasma levels
chr20	32556776	32556777	rs6059594	IgG glycosylation
chr20	32588094	32588095	rs2284378	Breast cancer
chr20	32729443	32729444	rs4911414	Tanning
chr20	32729443	32729444	rs4911414	Skin sensitivity to sun
chr20	32729443	32729444	rs4911414	Red vs. non-red hair color
chr20	32729443	32729444	rs4911414	Freckles
chr20	32729443	32729444	rs4911414	Burning and freckling
chr20	32738611	32738612	rs1015362	Skin sensitivity to sun
chr20	32738611	32738612	rs1015362	Red vs. non-red hair color
chr20	32738611	32738612	rs1015362	Freckles
chr20	32738611	32738612	rs1015362	Burning and freckling
chr20	33171771	33171772	rs910873	Melanoma
chr20	33545615	33545616	rs17310467	Hemostatic factors and hematological phenotypes
chr20	33565754	33565755	rs11906160	Anticoagulant levels
chr20	33722862	33722863	rs2295888	Prothrombin time
chr20	33730386	33730387	rs6120849	Protein C levels
chr20	33745675	33745676	rs6088735	Hemostatic factors and hematological phenotypes
chr20	33753261	33753262	rs6060278	Hemostatic factors and hematological phenotypes
chr20	33764553	33764554	rs867186	Hemostatic factors and hematological phenotypes
chr20	33764553	33764554	rs867186	Anticoagulant levels
chr20	33764553	33764554	rs867186	D-dimer levels
chr20	33764553	33764554	rs867186	Protein C levels
chr20	33764553	33764554	rs867186	Coagulation factor levels
chr20	33789141	33789142	rs8114671	Height
chr20	33799279	33799280	rs6088765	Ulcerative colitis
chr20	33849178	33849179	rs1555322	Attention deficit hyperactivity disorder
chr20	33867696	33867697	rs619865	Freckling
chr20	33907160	33907161	rs6060369	Height
chr20	33909783	33909784	rs6088792	Height
chr20	33914207	33914208	rs6060373	Spine bone size
chr20	33914207	33914208	rs6060373	Height
chr20	33975180	33975181	rs6088813	Height
chr20	34023961	34023962	rs224333	Height
chr20	34025755	34025756	rs143384	Height
chr20	34097352	34097353	rs2236164	Height
chr20	34152781	34152782	rs2277862	Cholesterol, total
chr20	34383633	34383634	rs11906854	Migraine - clinic-based
chr20	34712309	34712310	rs6141600	Height
chr20	34865239	34865240	rs8115222	Obesity-related traits
chr20	35766336	35766337	rs8115854	Hippocampal atrophy
chr20	35809782	35809783	rs6031882	Hippocampal atrophy
chr20	36068388	36068389	rs17194885	Retinopathy in non-diabetics
chr20	36469693	36469694	rs4811196	Bone mineral density
chr20	36844037	36844038	rs6127471	Heart rate
chr20	36957836	36957837	rs6024905	Bipolar disorder and schizophrenia
chr20	36977635	36977636	rs11536940	Periodontitis (DPAL)
chr20	36977969	36977970	rs1739654	IgG glycosylation
chr20	37690463	37690464	rs926392	Dialysis-related mortality
chr20	37845476	37845477	rs6028335	Alcohol and nictotine co-dependence
chr20	38129001	38129002	rs6028466	Telomere length
chr20	38300806	38300807	rs6016142	Estradiol levels
chr20	38644557	38644558	rs8120917	Obesity-related traits
chr20	38685540	38685541	rs2870137	Cytomegalovirus antibody response
chr20	38820804	38820805	rs6028945	Response to TNF antagonist treatment
chr20	39028435	39028436	rs8124695	Dupuytren's disease
chr20	39091486	39091487	rs2902940	LDL cholesterol
chr20	39091486	39091487	rs2902940	Cholesterol, total
chr20	39228783	39228784	rs6102059	LDL cholesterol
chr20	39269073	39269074	rs13041247	Orofacial clefts
chr20	39439482	39439483	rs4812466	Metabolite levels (HVA-5-HIAA Factor score)
chr20	39471426	39471427	rs6072161	IgG glycosylation
chr20	39478532	39478533	rs6102185	IgG glycosylation
chr20	39672617	39672618	rs6029526	LDL cholesterol
chr20	39672617	39672618	rs6029526	Cholesterol, total
chr20	40064558	40064559	rs13037749	Hippocampal atrophy
chr20	40840778	40840779	rs7345986	Periodontitis (Mean PAL)
chr20	40994093	40994094	rs6030171	IgG glycosylation
chr20	41991600	41991601	rs2010809	Smooth-surface caries
chr20	42487203	42487204	rs6103489	Response to amphetamines
chr20	42573821	42573822	rs6031252	Conduct disorder (symptom count)
chr20	42854133	42854134	rs6017291	Cognitive performance
chr20	42946965	42946966	rs6017317	Type 2 diabetes
chr20	42989266	42989267	rs4812829	Type 2 diabetes
chr20	43042363	43042364	rs1800961	HDL cholesterol
chr20	43042363	43042364	rs1800961	Cholesterol, total
chr20	43042363	43042364	rs1800961	C-reactive protein
chr20	43065027	43065028	rs6017342	Ulcerative colitis
chr20	43371319	43371320	rs11696845	Obesity-related traits
chr20	43721492	43721493	rs6124684	Bipolar disorder
chr20	43773736	43773737	rs7361168	IgG glycosylation
chr20	43980725	43980726	rs1008953	Psoriasis
chr20	44124522	44124523	rs11696501	Brain structure
chr20	44534650	44534651	rs6065904	Lipid metabolism phenotypes
chr20	44545047	44545048	rs4810479	Metabolite levels
chr20	44554014	44554015	rs6065906	Triglycerides
chr20	44554014	44554015	rs6065906	HDL cholesterol
chr20	44554014	44554015	rs6065906	Lipid metabolism phenotypes
chr20	44576501	44576502	rs7679	Triglycerides
chr20	44576501	44576502	rs7679	HDL cholesterol
chr20	44702119	44702120	rs2425752	Multiple sclerosis
chr20	44740195	44740196	rs6074022	Multiple sclerosis
chr20	44742063	44742064	rs1569723	Inflammatory bowel disease
chr20	44742063	44742064	rs1569723	Kawasaki disease
chr20	44747946	44747947	rs4810485	Rheumatoid arthritis
chr20	44761484	44761485	rs12480534	Response to amphetamines
chr20	44763283	44763284	rs4813003	Kawasaki disease
chr20	44921630	44921631	rs6065945	IgG glycosylation
chr20	45460322	45460323	rs6066084	Quantitative traits
chr20	45497722	45497723	rs6124878	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr20	45680501	45680502	rs878131	Thiazide-induced adverse metabolic effects in hypertensive patients
chr20	46095648	46095649	rs6094710	Osteoarthritis (hip)
chr20	46208604	46208605	rs6125048	Response to treatment for acute lymphoblastic leukemia
chr20	46400712	46400713	rs4810685	Attention deficit hyperactivity disorder (time to onset)
chr20	46425575	46425576	rs13038095	Atrial fibrillation
chr20	46779234	46779235	rs11086243	Nephrotic syndrome (acquired)
chr20	46801223	46801224	rs62202398	Alcohol consumption
chr20	47088153	47088154	rs13043694	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr20	47088153	47088154	rs13043694	Attention deficit hyperactivity disorder (combined symptoms)
chr20	47088199	47088200	rs4810796	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr20	47088199	47088200	rs4810796	Attention deficit hyperactivity disorder (combined symptoms)
chr20	47088731	47088732	rs910191	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr20	47088731	47088732	rs910191	Attention deficit hyperactivity disorder (combined symptoms)
chr20	47089524	47089525	rs4402823	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr20	47089524	47089525	rs4402823	Attention deficit hyperactivity disorder (combined symptoms)
chr20	47089536	47089537	rs4458264	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr20	47089536	47089537	rs4458264	Attention deficit hyperactivity disorder (combined symptoms)
chr20	47343058	47343059	rs6063312	Tonometry
chr20	47379810	47379811	rs2426087	Narcolepsy with cataplexy
chr20	47903018	47903019	rs237743	Height
chr20	47982127	47982128	rs237450	QT interval
chr20	48019817	48019818	rs6063399	Obesity-related traits
chr20	48344310	48344311	rs1980946	Palmitic acid (16:0) plasma levels
chr20	48522329	48522330	rs495337	Psoriasis
chr20	48554976	48554977	rs2235617	Psoriasis
chr20	48955423	48955424	rs913678	Inflammatory bowel disease
chr20	49375241	49375242	rs6122972	Bipolar disorder
chr20	49671434	49671435	rs4811117	Molar-incisor hypomineralization
chr20	49739859	49739860	rs230014	QT interval (interaction)
chr20	50141263	50141264	rs6021270	Self-reported allergy
chr20	50559651	50559652	rs6068020	Male infertility
chr20	50637659	50637660	rs6013355	Subcutaneous adipose tissue
chr20	50702632	50702633	rs6013382	Amyotrophic lateral sclerosis
chr20	51092995	51092996	rs13041126	Obesity
chr20	51318350	51318351	rs6013509	Hemoglobin
chr20	51557160	51557161	rs6097169	Body mass index (non-asthmatics)
chr20	51583982	51583983	rs10485813	Attention deficit hyperactivity disorder
chr20	52268994	52268995	rs2041278	Obesity-related traits
chr20	52349891	52349892	rs6091737	Calcium levels
chr20	52447302	52447303	rs6022786	Polycystic ovary syndrome
chr20	52610495	52610496	rs2276498	Bipolar disorder and schizophrenia
chr20	52701292	52701293	rs6064045	IgG glycosylation
chr20	52774426	52774427	rs1570669	Calcium levels
chr20	52791517	52791518	rs2248359	Multiple sclerosis
chr20	52807220	52807221	rs16999165	Atopic dermatitis
chr20	52843798	52843799	rs2585417	Obesity-related traits
chr20	53267110	53267111	rs2023454	Functional MRI
chr20	53411018	53411019	rs13037755	Relative hand skill
chr20	53414538	53414539	rs157640	Celiac disease
chr20	53462974	53462975	rs1512060	Axial length
chr20	53801128	53801129	rs6092078	Response to antipsychotic treatment
chr20	54126508	54126509	rs11696973	Migraine without aura
chr20	55018259	55018260	rs7274581	Alzheimer's disease (late onset)
chr20	55109303	55109304	rs6024938	Obesity-related traits
chr20	55638536	55638537	rs331615	White blood cell types
chr20	55638749	55638750	rs6127921	Response to citalopram treatment
chr20	55683995	55683996	rs11699237	Schizophrenia
chr20	55990404	55990405	rs737092	Red blood cell traits
chr20	55991694	55991695	rs6092477	Mean corpuscular volume
chr20	56029603	56029604	rs328506	Type 2 diabetes
chr20	56044183	56044184	rs6070116	Response to statin therapy
chr20	56058354	56058355	rs59972978	Alcohol consumption
chr20	56070504	56070505	rs6025590	Obesity-related traits
chr20	56190633	56190634	rs2073145	Hippocampal atrophy
chr20	56428704	56428705	rs12481680	Response to fenofibrate (adiponectin levels)
chr20	56501978	56501979	rs6099847	Obesity-related traits
chr20	56663273	56663274	rs6070346	Pulmonary function decline
chr20	56796783	56796784	rs4811971	Height
chr20	57164854	57164855	rs127430	Cardiovascular disease risk factors
chr20	57408425	57408426	rs965808	DNA methylation (variation)
chr20	57469072	57469073	rs6026584	Renal function-related traits (BUN)
chr20	57475190	57475191	rs13831	Event-related brain oscillations
chr20	57562101	57562102	rs2273359	Response to diuretic therapy in hypertension
chr20	57587770	57587771	rs4812048	Mean platelet volume
chr20	57614001	57614002	rs151361	Mean platelet volume
chr20	57751116	57751117	rs6015450	Systolic blood pressure
chr20	57751116	57751117	rs6015450	Hypertension
chr20	57751116	57751117	rs6015450	Diastolic blood pressure
chr20	57751116	57751117	rs6015450	Blood pressure
chr20	57758719	57758720	rs16982520	Hypertension
chr20	57790435	57790436	rs12625057	Response to antipsychotic therapy (extrapyramidal side effects)
chr20	57824308	57824309	rs259964	Inflammatory bowel disease
chr20	58177614	58177615	rs6026990	Response to tocilizumab in rheumatoid arthritis
chr20	58895845	58895846	rs11698685	Type 1 diabetes nephropathy
chr20	58896714	58896715	rs6027506	Type 1 diabetes nephropathy
chr20	58898208	58898209	rs6027511	Lentiform nucleus volume
chr20	58946488	58946489	rs55681231	Metabolite levels (MHPG)
chr20	59268709	59268710	rs6027755	Non-alcoholic fatty liver disease histology (other)
chr20	59765294	59765295	rs860148	Metabolite levels  (X-11787)
chr20	59853937	59853938	rs1970546	Volumetric brain MRI
chr20	59928236	59928237	rs4468878	Longevity
chr20	59947043	59947044	rs4925189	T-tau
chr20	60212493	60212494	rs2024714	Longevity
chr20	60243410	60243411	rs944260	Sudden cardiac arrest
chr20	60258850	60258851	rs16985437	Axial length
chr20	60293562	60293563	rs16985493	Migraine - clinic-based
chr20	60381798	60381799	rs4925295	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr20	60508181	60508182	rs6061910	Obesity-related traits
chr20	60514223	60514224	rs4925325	Obesity-related traits
chr20	60921043	60921044	rs4925386	Colorectal cancer
chr20	61015610	61015611	rs2427345	Prostate cancer
chr20	61491493	61491494	rs17854409	Obesity-related traits
chr20	61669035	61669036	rs6089829	Prostate cancer (gene x gene interaction)
chr20	61895919	61895920	rs1406961	Cardiovascular disease risk factors
chr20	62297801	62297802	rs6011002	Dental caries
chr20	62309838	62309839	rs6010620	Glioma
chr20	62309838	62309839	rs6010620	Glioma (high-grade)
chr20	62318219	62318220	rs4809324	Glioma (high-grade)
chr20	62327581	62327582	rs2297441	Ulcerative colitis
chr20	62343955	62343956	rs2315008	Inflammatory bowel disease
chr20	62348906	62348907	rs6062504	Inflammatory bowel disease
chr20	62349585	62349586	rs4809330	Crohn's disease
chr20	62362562	62362563	rs6062509	Prostate cancer
chr20	62409712	62409713	rs6062314	Multiple sclerosis
chr20	62418336	62418337	rs2315656	Obesity-related traits
chr21	10971950	10971951	rs10439884	Celiac disease
chr21	11002010	11002011	rs240444	Bipolar disorder and schizophrenia
chr21	15681993	15681994	rs2192161	Non-word repetition
chr21	15845051	15845052	rs1006899	Bone mineral density (spine)
chr21	16340288	16340289	rs2229741	Cognitive performance
chr21	16520831	16520832	rs2823093	Breast cancer
chr21	16805219	16805220	rs1736135	Ulcerative colitis
chr21	16805219	16805220	rs1736135	Crohn's disease
chr21	16812551	16812552	rs1736020	Crohn's disease
chr21	16817050	16817051	rs1297265	Ulcerative colitis
chr21	16817937	16817938	rs2823286	Inflammatory bowel disease
chr21	16914904	16914905	rs2823357	Parkinson's disease
chr21	17069165	17069166	rs2823455	Panic disorder
chr21	17483132	17483133	rs2823615	Obesity-related traits
chr21	17667719	17667720	rs2823743	Chronic obstructive pulmonary disease-related biomarkers
chr21	17828290	17828291	rs2823819	Attention deficit hyperactivity disorder
chr21	18046231	18046232	rs2823962	Amyotrophic lateral sclerosis
chr21	19481353	19481354	rs2055011	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
chr21	19531441	19531442	rs77600076	Bulimia nervosa
chr21	20536648	20536649	rs2825388	Attention deficit hyperactivity disorder symptoms (interaction)
chr21	21777729	21777730	rs1888414	Hippocampal atrophy
chr21	21820407	21820408	rs1735884	Obesity-related traits
chr21	21885301	21885302	rs2826340	Attention deficit hyperactivity disorder and conduct disorder
chr21	22689343	22689344	rs11088859	Obesity
chr21	22910115	22910116	rs2826891	Longevity
chr21	23631675	23631676	rs2827312	Alcoholism (heaviness of drinking)
chr21	24198814	24198815	rs7279441	Self-rated health
chr21	24789555	24789557	rs3819055	Visceral fat
chr21	25080395	25080396	rs2829459	Dental caries
chr21	25143118	25143119	rs2828520	Major depressive disorder
chr21	26279350	26279351	rs2829459	Dental caries
chr21	26645082	26645083	rs9977253	Non-alcoholic fatty liver disease histology (other)
chr21	26826513	26826514	rs8127977	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
chr21	27002376	27002377	rs17001239	Cognitive performance
chr21	27716653	27716654	rs9975851	Airflow obstruction
chr21	28146188	28146189	rs2830487	Metabolite levels (HVA-5-HIAA Factor score)
chr21	28146188	28146189	rs2830487	Metabolite levels (HVA)
chr21	28657948	28657949	rs457603	Liver enzyme levels (aspartate transaminase)
chr21	28665346	28665347	rs2830840	Response to citalopram treatment
chr21	28696475	28696476	rs239713	AB1-42
chr21	28734996	28734997	rs9977499	Dialysis-related mortality
chr21	28744355	28744356	rs1452093	Dialysis-related mortality
chr21	29475195	29475196	rs9305354	Urinary albumin excretion
chr21	30141020	30141021	rs2832077	Cognitive test performance
chr21	30489299	30489300	rs2832191	Dental caries
chr21	30594531	30594532	rs2832270	Response to mTOR inhibitor (everolimus)
chr21	30713597	30713598	rs17744121	Visceral fat
chr21	30717736	30717737	rs372883	Pancreatic cancer
chr21	31013158	31013159	rs363598	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr21	31050816	31050817	rs363512	Hyperactive-impulsive symptoms
chr21	31100796	31100797	rs933117	Body mass index
chr21	31146168	31146169	rs455804	Hepatocellular carcinoma
chr21	31177510	31177511	rs458685	Breast cancer
chr21	31244477	31244478	rs457352	Periodontitis (DPAL)
chr21	31386242	31386243	rs9305406	Response to statin therapy
chr21	32060489	32060490	rs13046373	HDL cholesterol
chr21	32216252	32216253	rs7283316	Information processing speed
chr21	32440539	32440540	rs1475591	Coronary heart disease
chr21	32817506	32817507	rs580140	Renal sinus fat
chr21	32918293	32918294	rs13048019	Amyotrophic lateral sclerosis
chr21	33285299	33285300	rs2833556	Response to antipsychotic treatment in schizophrenia (reasoning)
chr21	33296112	33296113	rs11910494	IgG glycosylation
chr21	33381039	33381040	rs2833607	Vitiligo
chr21	33385185	33385186	rs2833610	Type 2 diabetes
chr21	33552511	33552512	rs2833693	Temperament
chr21	34168572	34168573	rs2154427	Bilirubin levels
chr21	34262686	34262687	rs2833991	IgG glycosylation
chr21	34369760	34369761	rs117124364	Bulimia nervosa
chr21	34542786	34542787	rs6517147	Inflammatory biomarkers
chr21	34688913	34688914	rs2409488	Narcolepsy
chr21	34689252	34689253	rs2834188	Narcolepsy
chr21	34776694	34776695	rs2284553	Crohn's disease
chr21	34781049	34781050	rs2268241	Obesity-related traits
chr21	34796885	34796886	rs2834215	Crohn's disease
chr21	35354522	35354523	rs2032314	Red blood cell traits
chr21	35599127	35599128	rs9982601	Coronary heart disease
chr21	35599127	35599128	rs9982601	Myocardial infarction (early onset)
chr21	35652238	35652239	rs9978142	Pulmonary function
chr21	35690785	35690786	rs2834442	Height
chr21	35698389	35698390	rs1013063	Body mass index (interaction)
chr21	35880071	35880072	rs727957	Electrocardiographic traits
chr21	36208061	36208062	rs9976946	Preeclampsia
chr21	36238506	36238507	rs2834655	Immune response to smallpox vaccine (IL-6)
chr21	36357860	36357861	rs2014300	Esophageal cancer
chr21	36416331	36416332	rs9983044	Phospholipid levels (plasma)
chr21	36533661	36533662	rs2834812	HIV-1 control
chr21	36688527	36688528	rs2834902	Corneal curvature
chr21	36849418	36849419	rs16993221	C-reactive protein and white blood cell count
chr21	37013620	37013621	rs12483148	Obesity-related traits
chr21	37485061	37485062	rs4817775	Bone mineral density
chr21	37801433	37801434	rs2835345	Pulmonary function
chr21	37809376	37809377	rs9984974	Myopia (pathological)
chr21	37833306	37833307	rs219780	Kidney stones
chr21	37935668	37935669	rs9984896	QT interval
chr21	38491094	38491095	rs1003719	Eye color traits
chr21	38740823	38740824	rs12483205	HIV-1 replication
chr21	38817811	38817812	rs11700462	IgG glycosylation
chr21	38932777	38932778	rs2835810	Metabolic syndrome
chr21	39027271	39027272	rs2835872	Electroencephalographic traits in alcoholism
chr21	39721763	39721764	rs2836326	Metabolite levels (HVA)
chr21	39852550	39852551	rs7275212	White blood cell types
chr21	40056422	40056423	rs743446	Neonatal lupus
chr21	40173527	40173528	rs1209950	Non-small cell lung cancer (survival)
chr21	40283732	40283733	rs9979250	Periodontitis (Mean PAL)
chr21	40291739	40291740	rs2836754	Crohn's disease
chr21	40314703	40314704	rs2836770	Immune response to smallpox vaccine (IL-6)
chr21	40380248	40380249	rs2836823	Nicotine dependence
chr21	40465177	40465178	rs2242944	Ankylosing spondylitis
chr21	40465511	40465512	rs4817986	Fibrinogen
chr21	40465533	40465534	rs2836878	Inflammatory bowel disease
chr21	40465533	40465534	rs2836878	C-reactive protein
chr21	40465533	40465534	rs2836878	Ulcerative colitis
chr21	40469519	40469520	rs378108	Ankylosing spondylitis
chr21	40569778	40569779	rs2150410	Temperament (bipolar disorder)
chr21	41021751	41021752	rs10854398	Suicide risk
chr21	41123300	41123301	rs1735151	Coronary heart disease
chr21	41415043	41415044	rs9981861	Non-small cell lung cancer (survival)
chr21	41702946	41702947	rs727333	Estradiol plasma levels (breast cancer)
chr21	41993706	41993707	rs3804024	Obesity-related traits
chr21	42174959	42174960	rs2837828	Neutrophil count
chr21	42216954	42216955	rs2837857	Tuberculosis
chr21	42471627	42471628	rs16998084	Economic and political preferences (immigration/crime)
chr21	42511917	42511918	rs2837960	Rheumatoid arthritis
chr21	42583737	42583738	rs6517656	Glycemic traits (pregnancy)
chr21	42698906	42698907	rs441810	Tumor biomarkers
chr21	42746080	42746081	rs45430	Melanoma
chr21	42793790	42793791	rs459482	IgG glycosylation
chr21	43092200	43092201	rs2838088	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)
chr21	43227914	43227915	rs7279297	Tanning
chr21	43275494	43275495	rs915832	Response to taxane treatment (placlitaxel)
chr21	43286351	43286352	rs2839398	Parkinson's disease
chr21	43343509	43343510	rs451390	Tuberculosis
chr21	43443497	43443498	rs2839440	Preeclampsia
chr21	43502761	43502762	rs220299	Obesity-related traits
chr21	43513479	43513480	rs1475911	IgG glycosylation
chr21	43707100	43707101	rs425215	Common traits (Other)
chr21	43778894	43778895	rs1547374	Pancreatic cancer
chr21	43836185	43836186	rs11203203	Celiac disease and Rheumatoid arthritis
chr21	43836185	43836186	rs11203203	Rheumatoid arthritis
chr21	43836185	43836186	rs11203203	Vitiligo
chr21	43836185	43836186	rs11203203	Type 1 diabetes
chr21	43836389	43836390	rs9976767	Type 1 diabetes
chr21	43841327	43841328	rs3788013	Type 1 diabetes autoantibodies
chr21	44156768	44156769	rs9979235	Pulmonary function decline
chr21	44436176	44436177	rs2839619	Biochemical measures
chr21	44445291	44445292	rs234720	Cognitive performance
chr21	44448717	44448718	rs2839627	Information processing speed
chr21	44478496	44478497	rs6586282	Blood trace element (Se levels)
chr21	44478496	44478497	rs6586282	Homocysteine levels
chr21	44486963	44486964	rs234709	Homocysteine levels
chr21	44487403	44487404	rs2851391	Homocysteine levels
chr21	44487403	44487404	rs2851391	Obesity-related traits
chr21	44768561	44768562	rs643608	Non-alcoholic fatty liver disease histology (other)
chr21	44779679	44779680	rs496300	Metabolic syndrome
chr21	45404337	45404338	rs7435	Phospholipid levels (plasma)
chr21	45615022	45615023	rs2838519	Ulcerative colitis
chr21	45615022	45615023	rs2838519	Crohn's disease
chr21	45615560	45615561	rs762421	Crohn's disease
chr21	45615740	45615741	rs7282490	Inflammatory bowel disease
chr21	45647420	45647421	rs4819388	Celiac disease
chr21	45709152	45709153	rs2075876	Rheumatoid arthritis
chr21	46629589	46629590	rs2838815	Pulmonary function
chr21	46846943	46846944	rs2838923	Hippocampal atrophy
chr21	47124177	47124178	rs4819143	Insulin resistance/response
chr21	47165428	47165429	rs8127571	Immune reponse to smallpox (secreted IFN-alpha)
chr21	47445790	47445791	rs4293630	Alcoholism (alcohol dependence factor score)
chr21	47690067	47690068	rs2839186	Testicular germ cell tumor
chr21	48019867	48019868	rs881827	Lymphocyte counts
chr22	16504398	16504399	rs4911642	Celiac disease
chr22	17057137	17057138	rs5746647	HIV-1 viral setpoint
chr22	18283246	18283247	rs5992105	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr22	18439957	18439958	rs1076540	Liver enzyme levels (gamma-glutamyl transferase)
chr22	18448112	18448113	rs1978968	Presence of antiphospholipid antibodies
chr22	18972449	18972450	rs2023634	Metabolic traits
chr22	19154521	19154522	rs807669	Metabolite levels
chr22	19156116	19156117	rs712964	Metabolite levels
chr22	19565256	19565257	rs2106139	IgG glycosylation
chr22	19691501	19691502	rs4819833	DNA methylation (parent-of-origin)
chr22	19889824	19889825	rs3788317	Glaucoma (primary open-angle)
chr22	19984276	19984277	rs1034566	Platelet counts
chr22	20228541	20228542	rs701428	Obesity-related traits
chr22	20797288	20797289	rs5763911	Retinopathy in non-diabetics
chr22	21917189	21917190	rs131654	Systemic lupus erythematosus
chr22	21922903	21922904	rs2266959	Inflammatory bowel disease
chr22	21928640	21928641	rs181359	Crohn's disease
chr22	21932067	21932068	rs181362	HDL cholesterol
chr22	21939674	21939675	rs5754217	Systemic lupus erythematosus
chr22	21939674	21939675	rs5754217	Red blood cell traits
chr22	21964760	21964761	rs4821112	Mean corpuscular volume
chr22	21973318	21973319	rs4821116	Hepatitis B
chr22	21982891	21982892	rs2298428	Celiac disease and Rheumatoid arthritis
chr22	21982891	21982892	rs2298428	Celiac disease
chr22	22131124	22131125	rs2283792	Multiple sclerosis
chr22	22307518	22307519	rs412050	Attention deficit hyperactivity disorder
chr22	22506568	22506569	rs11089937	Periodontitis (PAL4Q3)
chr22	22512414	22512415	rs987710	Iron status biomarkers
chr22	22512414	22512415	rs987710	Iron deficiency
chr22	22845239	22845240	rs5751168	Prostate cancer (gene x gene interaction)
chr22	23477969	23477970	rs4820539	Bone mineral density
chr22	23593050	23593051	rs5751614	Height
chr22	23644793	23644794	rs9608102	Immune response to smallpox vaccine (IL-6)
chr22	23765264	23765265	rs4822410	Pulmonary function decline
chr22	23922982	23922983	rs140174	Migraine
chr22	24170995	24170996	rs2186369	IgG glycosylation
chr22	24295285	24295286	rs2739330	Liver enzyme levels (gamma-glutamyl transferase)
chr22	24582040	24582041	rs8141797	Amyotrophic lateral sclerosis
chr22	24990212	24990213	rs4820599	Gamma glutamyl transpeptidase
chr22	24990212	24990213	rs4820599	Liver enzyme levels
chr22	24992265	24992266	rs5751901	Protein quantitative trait loci
chr22	24996629	24996630	rs5751902	Hematological and biochemical traits
chr22	24999103	24999104	rs2073398	Liver enzyme levels (gamma-glutamyl transferase)
chr22	25875264	25875265	rs1930961	Bipolar disorder (mood-incongruent)
chr22	26159288	26159289	rs133885	Mathematical ability in children with dyslexia
chr22	26394723	26394724	rs8139900	Uric acid levels
chr22	26403598	26403599	rs1001021	Schizophrenia, bipolar disorder and depression (combined)
chr22	26653361	26653362	rs1207393	Airflow obstruction
chr22	26689634	26689635	rs688034	Coronary heart disease
chr22	26697194	26697195	rs591044	Insulin resistance/response
chr22	27011419	27011420	rs4822752	Bipolar disorder and schizophrenia
chr22	27041282	27041283	rs16982515	IgG glycosylation
chr22	27042105	27042106	rs744016	RR interval (heart rate)
chr22	27051298	27051299	rs739310	Obesity-related traits
chr22	27416824	27416825	rs4417	Fat distribution (HIV)
chr22	27435819	27435820	rs742004	Metabolite levels (HVA/MHPG ratio)
chr22	27852182	27852183	rs6005451	Prostate cancer (gene x gene interaction)
chr22	28029537	28029538	rs16985179	Alcohol consumption
chr22	28090206	28090207	rs5762311	Sudden cardiac arrest
chr22	28378471	28378472	rs5762430	Obesity
chr22	29100710	29100711	rs1547014	Vertical cup-disc ratio
chr22	29115065	29115066	rs4822983	Esophageal cancer (squamous cell)
chr22	29130011	29130012	rs738722	Esophageal cancer and gastric cancer
chr22	29161006	29161007	rs4820792	Breast size
chr22	29192669	29192670	rs2239815	Esophageal cancer (squamous cell)
chr22	29451670	29451671	rs4823006	Waist-hip ratio
chr22	29621476	29621477	rs132390	Breast cancer
chr22	29793640	29793641	rs2267138	Myopia (pathological)
chr22	29847721	29847722	rs13053817	Carotid atherosclerosis in HIV infection
chr22	29929238	29929239	rs8135828	Lipid traits
chr22	30337585	30337586	rs36600	Lung cancer
chr22	30378702	30378703	rs5763662	LDL cholesterol
chr22	30423459	30423460	rs12537	IgA nephropathy
chr22	30486825	30486826	rs2412970	Inflammatory bowel disease
chr22	30494370	30494371	rs2412971	Nephropathy
chr22	30529630	30529631	rs2412973	Inflammatory bowel disease (early onset)
chr22	30581721	30581722	rs5753037	Type 1 diabetes
chr22	30592068	30592069	rs2412980	Dialysis-related mortality
chr22	30592486	30592487	rs713875	Crohn's disease
chr22	30681256	30681257	rs1043099	Rheumatoid arthritis
chr22	30751626	30751627	rs4820834	Coronary artery calcification
chr22	31013295	31013296	rs2283873	Wilms tumor
chr22	31153275	31153276	rs9609078	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
chr22	31438360	31438361	rs111383589	Bulimia nervosa
chr22	31645758	31645759	rs2106294	Type 2 diabetes nephropathy
chr22	31675184	31675185	rs4141404	Paclitaxel-induced neuropathy
chr22	32024979	32024980	rs11703808	Intelligence
chr22	32025912	32025913	rs761746	Intelligence
chr22	32027448	32027449	rs12627933	Intelligence
chr22	32049916	32049917	rs9621305	Intelligence
chr22	32229648	32229649	rs5994434	Intelligence
chr22	32265902	32265903	rs1012068	Chronic Hepatitis C infection
chr22	32745915	32745916	rs5998432	T-tau
chr22	32783903	32783904	rs12530	IgG glycosylation
chr22	32832873	32832874	rs2076054	Migraine with aura
chr22	32867527	32867528	rs9609565	Hematological parameters
chr22	32880584	32880585	rs5749446	Red blood cell traits
chr22	33056340	33056341	rs4821083	Height
chr22	33059664	33059665	rs5749482	Age-related macular degeneration
chr22	33059664	33059665	rs5749482	Height
chr22	33084510	33084511	rs9621532	Age-related macular degeneration
chr22	33561745	33561746	rs743793	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr22	33566586	33566587	rs4821132	Visceral adipose tissue adjusted for BMI
chr22	33746525	33746526	rs2267193	Visceral fat
chr22	34386472	34386473	rs7286472	Blood pressure measurement (cold pressor test)
chr22	34602187	34602188	rs5754891	Coronary artery calcification
chr22	34823827	34823828	rs1034394	Major depressive disorder
chr22	34859792	34859793	rs130575	Attention deficit hyperactivity disorder
chr22	34889096	34889097	rs738968	Immune reponse to smallpox (secreted TNF-alpha)
chr22	34941575	34941576	rs4821261	Behavioural disinhibition (generation interaction)
chr22	35371247	35371248	rs9619497	Metabolite levels (HVA-5-HIAA Factor score)
chr22	35711097	35711098	rs138777	Cholesterol, total
chr22	35777617	35777618	rs2071748	Obesity-related traits
chr22	36517931	36517932	rs1476029	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
chr22	36616444	36616445	rs4821469	End-stage renal disease (non-diabetic)
chr22	36661329	36661330	rs2239785	Glomerulosclerosis
chr22	36679057	36679058	rs735854	Optic disc size (rim)
chr22	37199805	37199806	rs2022068	Pit-and-Fissure caries
chr22	37208148	37208149	rs739031	Obesity-related traits
chr22	37209295	37209296	rs4820255	Sexual dysfunction (female)
chr22	37258502	37258503	rs4821544	Atopic dermatitis
chr22	37310045	37310046	rs2075726	Ankylosing spondylitis
chr22	37462935	37462936	rs855791	Mean corpuscular volume
chr22	37462935	37462936	rs855791	Mean corpuscular hemoglobin concentration
chr22	37462935	37462936	rs855791	Mean corpuscular hemoglobin
chr22	37462935	37462936	rs855791	Hematology traits
chr22	37462935	37462936	rs855791	Red blood cell traits
chr22	37462935	37462936	rs855791	Hepcidin levels
chr22	37462935	37462936	rs855791	Iron status biomarkers
chr22	37462935	37462936	rs855791	Glycated hemoglobin levels
chr22	37462935	37462936	rs855791	Hemoglobin
chr22	37467269	37467270	rs5756504	Hematological and biochemical traits
chr22	37467391	37467392	rs5756506	Hematological parameters
chr22	37469590	37469591	rs4820268	Iron levels
chr22	37469590	37469591	rs4820268	Red blood cell traits
chr22	37469590	37469591	rs4820268	Hematology traits
chr22	37469590	37469591	rs4820268	Iron status biomarkers
chr22	37470223	37470224	rs2413450	Red blood cell traits
chr22	37470223	37470224	rs2413450	Hematological and biochemical traits
chr22	37470223	37470224	rs2413450	Mean corpuscular volume
chr22	37470223	37470224	rs2413450	Mean corpuscular hemoglobin
chr22	37470223	37470224	rs2413450	Hematocrit
chr22	37534033	37534034	rs2284033	Asthma
chr22	37544485	37544486	rs3218255	Tuberculosis
chr22	37551606	37551607	rs743777	Type 1 diabetes autoantibodies
chr22	37551606	37551607	rs743777	Rheumatoid arthritis
chr22	37581421	37581422	rs229526	Hypothyroidism
chr22	37581484	37581485	rs229527	Graves' disease
chr22	37581484	37581485	rs229527	Vitiligo
chr22	37591317	37591318	rs229541	Type 1 diabetes
chr22	37613308	37613309	rs13053175	Longevity
chr22	37919266	37919267	rs9607469	Optic disc parameters
chr22	37982011	37982012	rs12157904	Response to antidepressant treatment
chr22	38071042	38071043	rs4820294	Fat distribution (HIV)
chr22	38476275	38476276	rs8135665	Age-related macular degeneration
chr22	38544297	38544298	rs2284063	Cutaneous nevi
chr22	38544297	38544298	rs2284063	Melanoma
chr22	38545618	38545619	rs6001027	Melanoma
chr22	38546032	38546033	rs5756931	Triglycerides
chr22	38569005	38569006	rs738322	Cutaneous nevi
chr22	39178374	39178375	rs738144	IgG glycosylation
chr22	39332622	39332623	rs1014971	Bladder cancer
chr22	39519195	39519196	rs139371	Multiple myeloma (hyperdiploidy)
chr22	39519195	39519196	rs139371	Multiple myeloma (IgH translocation)
chr22	39542291	39542292	rs877529	Multiple myeloma
chr22	39659772	39659773	rs2413583	Inflammatory bowel disease
chr22	39659772	39659773	rs2413583	Crohn's disease
chr22	39670850	39670851	rs968451	Primary biliary cirrhosis
chr22	39687483	39687484	rs54211	Sudden cardiac arrest
chr22	39739637	39739638	rs137686	IgG glycosylation
chr22	39748853	39748854	rs137699	IgG glycosylation
chr22	39835586	39835587	rs4821897	IgG glycosylation
chr22	39841699	39841700	rs5757676	IgG glycosylation
chr22	39859168	39859169	rs909674	IgG glycosylation
chr22	39955872	39955873	rs9611198	Schizophrenia
chr22	39972161	39972162	rs3788556	IgG glycosylation
chr22	40436972	40436973	rs11704416	Prostate cancer
chr22	40452118	40452119	rs9623117	Prostate cancer
chr22	40652872	40652873	rs12484776	Uterine fibroids
chr22	40654275	40654276	rs12628051	Prostate cancer (gene x gene interaction)
chr22	40675090	40675091	rs4821941	Prostate cancer (gene x gene interaction)
chr22	40697580	40697581	rs139909	Height
chr22	40820150	40820151	rs5757949	Height
chr22	40876233	40876234	rs6001930	Breast cancer
chr22	40996366	40996367	rs17002034	Bipolar disorder and schizophrenia
chr22	41042090	41042091	rs12159200	Treatment response for severe sepsis
chr22	41431341	41431342	rs4820425	Crohn's disease
chr22	41661153	41661154	rs2235852	Self-reported allergy
chr22	41757646	41757647	rs4822024	Vitiligo
chr22	42218855	42218856	rs7364180	Alzheimer's disease biomarkers
chr22	42336171	42336172	rs5758511	Birth weight
chr22	42670964	42670965	rs134882	Bipolar disorder and schizophrenia
chr22	43500211	43500212	rs5759167	Prostate cancer
chr22	43518274	43518275	rs742134	Prostate cancer
chr22	43579048	43579049	rs13058467	Molar-incisor hypomineralization
chr22	43624764	43624765	rs139014	IgG glycosylation
chr22	43635572	43635573	rs5751452	Response to fenofibrate (adiponectin levels)
chr22	44204318	44204319	rs8140172	IgG glycosylation
chr22	44248503	44248504	rs470089	Type 2 diabetes (dietary heme iron intake interaction)
chr22	44324726	44324727	rs738409	Nonalcoholic fatty liver disease
chr22	44324726	44324727	rs738409	Liver enzyme levels (alanine transaminase)
chr22	44325995	44325996	rs12483959	Metabolite levels
chr22	44332569	44332570	rs2281135	Liver enzyme levels
chr22	44333693	44333694	rs2896019	Non-alcoholic fatty liver disease
chr22	44333693	44333694	rs2896019	Hematological and biochemical traits
chr22	44391685	44391686	rs2143571	Nonalcoholic fatty liver disease
chr22	44394401	44394402	rs2073080	Nonalcoholic fatty liver disease
chr22	44526104	44526105	rs75617873	Alzheimer's disease (cognitive decline)
chr22	44561286	44561287	rs5764106	IgG glycosylation
chr22	44968529	44968530	rs138597	Economic and political preferences (time)
chr22	45011760	45011761	rs4823246	Economic and political preferences (feminism/equality)
chr22	45150658	45150659	rs5765956	Orofacial clefts
chr22	45183013	45183014	rs16992796	Electroencephalographic traits in alcoholism
chr22	45668011	45668012	rs58667	Pulmonary function in asthmatics
chr22	45961903	45961904	rs1985671	Temperament (bipolar disorder)
chr22	46421841	46421842	rs6519955	Dupuytren's disease
chr22	46627602	46627603	rs4253772	LDL cholesterol
chr22	46627602	46627603	rs4253772	Cholesterol, total
chr22	46629478	46629479	rs4253776	LDL cholesterol
chr22	47532395	47532396	rs5766691	Longevity
chr22	48188252	48188253	rs5767992	Obesity-related traits
chr22	48284513	48284514	rs9627183	Attention deficit hyperactivity disorder
chr22	48453590	48453591	rs117294	Economic and political preferences (fairness)
chr22	48630183	48630184	rs13054085	Obesity-related traits
chr22	48651996	48651997	rs1004689	DNA methylation (variation)
chr22	48741797	48741798	rs4407	Endometrial cancer
chr22	48929568	48929569	rs5768709	Pancreatic cancer
chr22	49812501	49812502	rs17000918	Immune reponse to smallpox (secreted IL-1beta)
chr22	49842288	49842289	rs9627735	Serum dimethylarginine levels (symmetric)
chr22	50086372	50086373	rs6009824	Natriuretic peptide levels
chr22	50218610	50218611	rs138880	Schizophrenia
chr22	50350970	50350971	rs28372448	Cannabis dependence
chr22	50435479	50435480	rs5771069	Ulcerative colitis
chr22	50557406	50557407	rs138229	Behavioural disinhibition (generation interaction)
chr22	50661868	50661869	rs5771242	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr22	50676258	50676259	rs7511006	Obesity-related traits
chr22	50902389	50902390	rs5771040	IgG glycosylation
chr22	50966913	50966914	rs470119	Mean corpuscular hemoglobin
chr22	50971265	50971266	rs140522	Red blood cell traits
chr22	50971265	50971266	rs140522	Multiple sclerosis
chr22	50971751	50971752	rs131794	Mean corpuscular volume
chr22	50976753	50976754	rs131788	Obesity-related traits
chr22	51017352	51017353	rs5770917	Narcolepsy
chr22	51101937	51101938	rs6010044	Fibrinogen
chr22	51104679	51104680	rs9616906	Longevity
chr3	108992	108993	rs9841287	Fasting insulin-related traits (interaction with BMI)
chr3	149985	149986	rs12485321	Prostate cancer (gene x gene interaction)
chr3	172476	172477	rs6795349	Response to antidepressant treatment
chr3	191046	191047	rs10510181	Adolescent idiopathic scoliosis
chr3	312348	312349	rs6764363	Sudden cardiac arrest
chr3	397552	397553	rs892295	Obesity-related traits
chr3	883850	883851	rs4684585	Response to statin therapy
chr3	898660	898661	rs35964523	Response to statin therapy
chr3	1046037	1046038	rs6764623	Venous thromboembolism
chr3	1345424	1345425	rs9861887	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr3	1512586	1512587	rs6763848	Prostate cancer (gene x gene interaction)
chr3	1623392	1623393	rs402675	Estradiol levels
chr3	1741764	1741765	rs73001827	Response to amphetamines
chr3	1839692	1839693	rs10510217	Total ventricular volume
chr3	1897972	1897973	rs2727943	Bipolar disorder
chr3	2034354	2034355	rs2729313	Serum dimethylarginine levels (asymmetric)
chr3	2624937	2624938	rs2619566	Amyotrophic lateral sclerosis
chr3	2654690	2654691	rs4370013	Blood pressure
chr3	2846315	2846316	rs975334	Gallbladder cancer
chr3	2881574	2881575	rs6781149	Intelligence
chr3	2886526	2886527	rs17584516	Intelligence
chr3	2893273	2893274	rs4629318	Intelligence
chr3	2895683	2895684	rs11713158	Intelligence
chr3	3055246	3055247	rs17024684	Brain connectivity
chr3	3130220	3130221	rs334809	Oleic acid (18:1n-9) plasma levels
chr3	3130644	3130645	rs3804795	Immune response to smallpox vaccine (IL-6)
chr3	3147980	3147981	rs17879755	QT interval
chr3	3199634	3199635	rs1669338	White matter integrity
chr3	3231837	3231838	rs1672743	IgG glycosylation
chr3	3356173	3356174	rs9874556	Pancreatic cancer
chr3	3375783	3375784	rs9835812	Immune response to smallpox vaccine (IL-6)
chr3	3614886	3614887	rs9815663	Asthma (childhood onset)
chr3	3628980	3628981	rs10865864	Callous-unemotional behaviour
chr3	3650238	3650239	rs9837561	Response to amphetamines
chr3	3658839	3658840	rs1601875	Bipolar disorder
chr3	3679851	3679852	rs17034687	Disc degeneration (lumbar)
chr3	4223615	4223616	rs2587949	Periodontitis (DPAL)
chr3	4437357	4437358	rs794185	Multiple sclerosis--Brain Glutamate Levels
chr3	4633491	4633492	rs2322734	Airflow obstruction
chr3	4703936	4703937	rs7632000	Obesity-related traits
chr3	4742275	4742276	rs6762644	Breast cancer
chr3	5013875	5013876	rs6442925	Corneal structure
chr3	5188245	5188246	rs11918654	Disc degeneration (lumbar)
chr3	5705051	5705052	rs11710433	Bipolar disorder (mood-incongruent)
chr3	6255996	6255997	rs6774280	Response to tocilizumab in rheumatoid arthritis
chr3	6377694	6377695	rs271066	Alzheimer's disease (age of onset)
chr3	6481624	6481625	rs17216035	Visceral adipose tissue adjusted for BMI
chr3	6903296	6903297	rs3749380	Panic disorder
chr3	7010080	7010081	rs480409	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
chr3	7262013	7262014	rs6797852	Breast cancer
chr3	7283968	7283969	rs1810320	Breast cancer
chr3	7403645	7403646	rs13080594	Personality dimensions
chr3	7529554	7529555	rs9870680	Major depressive disorder (broad)
chr3	7538201	7538202	rs1450100	Orofacial clefts
chr3	7982826	7982827	rs4591494	Factor VII
chr3	8250789	8250790	rs9866825	QT interval
chr3	8808514	8808515	rs237899	Depression and alcohol dependence
chr3	10535770	10535771	rs6807064	Metabolite levels
chr3	10774758	10774759	rs1682825	Economic and political preferences (feminism/equality)
chr3	10877610	10877611	rs1809529	Response to tocilizumab in rheumatoid arthritis
chr3	11040438	11040439	rs9990174	Conduct disorder (interaction)
chr3	11075013	11075014	rs2675163	Response to Vitamin E supplementation
chr3	11232778	11232779	rs4684059	IgG glycosylation
chr3	11400248	11400249	rs2606736	HDL cholesterol
chr3	11625413	11625414	rs6802119	Metabolite levels (HVA-5-HIAA Factor score)
chr3	11625413	11625414	rs6802119	Metabolite levels (HVA)
chr3	11675788	11675789	rs6782029	Anorexia nervosa
chr3	11694466	11694467	rs4684792	Relative hand skill in reading disability
chr3	11956597	11956598	rs6777876	Alcohol dependence
chr3	12116619	12116620	rs308971	Fasting insulin-related traits (interaction with BMI)
chr3	12267647	12267648	rs7616006	Platelet counts
chr3	12277844	12277845	rs17036101	Type 2 diabetes
chr3	12289799	12289800	rs13081389	Type 2 diabetes
chr3	12330410	12330411	rs17036170	Drug-induced liver injury
chr3	12385827	12385828	rs11128603	Plasminogen activator inhibitor type 1 levels (PAI-1)
chr3	12393124	12393125	rs1801282	Fasting insulin-related traits (interaction with BMI)
chr3	12393124	12393125	rs1801282	Type 2 diabetes
chr3	12488881	12488882	rs4684854	Sexual dimorphism in anthropometric traits
chr3	12551806	12551807	rs6766510	Prostate cancer (gene x gene interaction)
chr3	12626515	12626516	rs3729931	Cardiac hypertrophy
chr3	12628919	12628920	rs2290159	Cholesterol, total
chr3	12923196	12923197	rs2569991	Periodontitis (DPAL)
chr3	13555835	13555836	rs2597513	Height
chr3	13736999	13737000	rs4450798	Bipolar disorder (mood-incongruent)
chr3	13743131	13743132	rs9846232	Personality dimensions
chr3	13857968	13857969	rs1124480	Chronic obstructive pulmonary disease-related biomarkers
chr3	13961156	13961157	rs9875589	Ovarian reserve
chr3	14480777	14480778	rs6790433	Response to taxane treatment (docetaxel)
chr3	14530720	14530721	rs9036	Cognitive performance
chr3	15295363	15295364	rs1318937	Alcohol and nictotine co-dependence
chr3	15295363	15295364	rs1318937	Alcohol dependence
chr3	15440555	15440556	rs6442522	Uric acid levels
chr3	15648003	15648004	rs7651039	Coronary heart disease
chr3	16192142	16192143	rs6771632	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr3	16395667	16395668	rs690037	Optic disc size (cup)
chr3	16408488	16408489	rs12635698	Obesity (extreme)
chr3	16625047	16625048	rs10510452	Testicular germ cell tumor
chr3	16955258	16955259	rs1372072	Primary biliary cirrhosis
chr3	16970937	16970938	rs9821630	Multiple sclerosis
chr3	18311411	18311412	rs7641175	Platelet counts
chr3	18581847	18581848	rs7633075	Serum dimethylarginine levels (symmetric)
chr3	18706857	18706858	rs13073817	Crohn's disease
chr3	18767403	18767404	rs4256159	Inflammatory bowel disease
chr3	18784422	18784423	rs6809854	Psoriasis
chr3	19375790	19375791	rs2053506	Hip geometry
chr3	20108545	20108546	rs1124376	Bipolar disorder and schizophrenia
chr3	20136958	20136959	rs12636856	Response to mTOR inhibitor (rapamycin)
chr3	20220711	20220712	rs6767049	Temperament (bipolar disorder)
chr3	20352765	20352766	rs9871864	Behavioural disinhibition (generation interaction)
chr3	20615272	20615273	rs1395103	Bipolar disorder and schizophrenia
chr3	20957809	20957810	rs6787231	IgG glycosylation
chr3	21248641	21248642	rs11720452	Bipolar disorder
chr3	21706368	21706369	rs3821396	Bipolar disorder
chr3	21718840	21718841	rs9816269	Palmitic acid (16:0) plasma levels
chr3	21719245	21719246	rs1490157	Partial epilepsies
chr3	21955197	21955198	rs11719664	Attention deficit hyperactivity disorder
chr3	22122395	22122396	rs2593321	HIV-1 control
chr3	22171296	22171297	rs6797769	IgG glycosylation
chr3	22292570	22292571	rs1388551	Waist-to-hip circumference ratio (interaction)
chr3	22473728	22473729	rs17011371	Periodontitis (PAL4Q3)
chr3	23093573	23093574	rs9310709	Chronic kidney disease and serum creatinine levels
chr3	23143046	23143047	rs4591517	Colorectal cancer
chr3	23193927	23193928	rs4619807	Psychosis (atypical)
chr3	23198483	23198484	rs6780569	Type 2 diabetes
chr3	24268435	24268436	rs826221	Systolic blood pressure in sickle cell anemia
chr3	24350810	24350811	rs9310736	Red blood cell traits
chr3	24350810	24350811	rs9310736	Mean corpuscular volume
chr3	24350810	24350811	rs9310736	Mean corpuscular hemoglobin
chr3	25112170	25112171	rs993804	Bipolar disorder and schizophrenia
chr3	25343614	25343615	rs322668	IgG glycosylation
chr3	25520581	25520582	rs1529672	Pulmonary function (interaction)
chr3	25520581	25520582	rs1529672	Pulmonary function
chr3	25538316	25538317	rs1997352	Airflow obstruction
chr3	25560230	25560231	rs1435703	Obesity (extreme)
chr3	25922284	25922285	rs7644516	DNA methylation (variation)
chr3	26543419	26543420	rs2202157	Tuberculosis
chr3	27416012	27416013	rs4973768	Breast cancer
chr3	27537908	27537909	rs13082711	Systolic blood pressure
chr3	27537908	27537909	rs13082711	Diastolic blood pressure
chr3	27537908	27537909	rs13082711	Blood pressure
chr3	27764622	27764623	rs3806624	Hodgkin's lymphoma
chr3	27788779	27788780	rs11129295	Multiple sclerosis
chr3	28071443	28071444	rs669607	Multiple sclerosis
chr3	28079084	28079085	rs170934	Multiple sclerosis
chr3	28206876	28206877	rs9310862	Behavioural disinhibition (generation interaction)
chr3	28705763	28705764	rs7617877	Parkinson's disease
chr3	28928859	28928860	rs2221154	Alzheimer's disease
chr3	29209150	29209151	rs6549915	Breast size
chr3	29275645	29275646	rs4680719	Metabolite levels (HVA)
chr3	29575462	29575463	rs1530057	Lung cancer
chr3	29853402	29853403	rs10510628	Bone mineral density
chr3	30346967	30346968	rs10510634	Fasting plasma glucose
chr3	30372052	30372053	rs7634533	Dental caries
chr3	30462402	30462403	rs7640543	Migraine
chr3	30480084	30480085	rs6790925	Migraine - clinic-based
chr3	30682938	30682939	rs12493607	Breast cancer
chr3	30710242	30710243	rs3773643	Tonometry
chr3	31040502	31040503	rs1506203	Eating disorders (purging via substances)
chr3	31445579	31445580	rs17027625	HIV-1 control
chr3	31795569	31795570	rs1902341	Peripheral artery disease
chr3	32240118	32240119	rs9825310	Alcohol dependence
chr3	32264990	32264991	rs4376071	IgG glycosylation
chr3	32329496	32329497	rs4380451	Bipolar disorder
chr3	32347823	32347824	rs4627791	Bipolar disorder
chr3	32378270	32378271	rs6776297	HIV-1 viral setpoint
chr3	32488533	32488534	rs12638540	Mortality among heart failure patients
chr3	32533009	32533010	rs7640978	LDL cholesterol
chr3	32533009	32533010	rs7640978	Cholesterol, total
chr3	32842100	32842101	rs9845475	Attention deficit hyperactivity disorder (time to onset)
chr3	32929114	32929115	rs9310995	Pulmonary function
chr3	33015468	33015469	rs13314993	Celiac disease
chr3	33020034	33020035	rs4678680	Hepatocellular carcinoma
chr3	33065338	33065339	rs7613051	Atopic dermatitis
chr3	34013204	34013205	rs7620363	Non-substance related behavioral disinhibition
chr3	34212165	34212166	rs6781182	Visceral adipose tissue adjusted for BMI
chr3	34260091	34260092	rs145744974	Periodontitis (Mean PAL)
chr3	34962668	34962669	rs10514688	Tonometry
chr3	35142510	35142511	rs11129640	Entorhinal cortical thickness
chr3	35639825	35639826	rs17033506	Asthma (childhood onset)
chr3	35982129	35982130	rs6799705	Cognitive performance
chr3	36409600	36409601	rs2605393	Celiac disease
chr3	36680098	36680099	rs950146	Erectile dysfunction
chr3	36842622	36842623	rs13072940	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr3	36856029	36856030	rs9834970	Schizophrenia or bipolar disorder
chr3	36856029	36856030	rs9834970	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr3	36856029	36856030	rs9834970	Bipolar disorder (mood-incongruent)
chr3	36856029	36856030	rs9834970	Bipolar disorder
chr3	36862979	36862980	rs4624519	Schizophrenia
chr3	36864488	36864489	rs6550435	Schizophrenia
chr3	36864488	36864489	rs6550435	Bipolar disorder
chr3	37234588	37234589	rs7631605	P-tau181p
chr3	37515826	37515827	rs197770	Phospholipid levels (plasma)
chr3	37518544	37518545	rs189897	Nasopharyngeal carcinoma
chr3	37574023	37574024	rs267567	PR interval
chr3	37855113	37855114	rs11129773	Illicit drug use
chr3	37996476	37996477	rs9311171	Prostate cancer
chr3	38442489	38442490	rs2070488	Electrocardiographic conduction measures
chr3	38589162	38589163	rs11129795	Electrocardiographic traits
chr3	38589162	38589163	rs11129795	QT interval
chr3	38592405	38592406	rs1805126	Electrocardiographic conduction measures
chr3	38593392	38593393	rs12053903	Electrocardiographic traits
chr3	38593392	38593393	rs12053903	QT interval
chr3	38594972	38594973	rs7638909	Electrocardiographic conduction measures
chr3	38624252	38624253	rs3922844	PR interval
chr3	38633922	38633923	rs11708996	Brugada syndrome
chr3	38633922	38633923	rs11708996	QRS duration
chr3	38633922	38633923	rs11708996	PR interval
chr3	38657898	38657899	rs11710077	QRS duration
chr3	38681393	38681394	rs6763048	PR interval
chr3	38719934	38719935	rs9851724	QRS duration
chr3	38766674	38766675	rs6795970	Electrocardiographic conduction measures
chr3	38766674	38766675	rs6795970	Electrocardiographic traits
chr3	38767314	38767315	rs6801957	PR interval
chr3	38767314	38767315	rs6801957	QRS duration
chr3	38774831	38774832	rs6800541	Atrioventricular conduction
chr3	38774831	38774832	rs6800541	PR interval
chr3	38777553	38777554	rs10428132	Brugada syndrome
chr3	38843646	38843647	rs11717455	Systemic lupus erythematosus
chr3	38886412	38886413	rs3923518	Migraine
chr3	39055316	39055317	rs883565	Handedness
chr3	39475341	39475342	rs17038828	IgG glycosylation
chr3	39513277	39513278	rs538867	Alzheimer's disease (cognitive decline)
chr3	39523002	39523003	rs1768208	Progressive supranuclear palsy
chr3	39553787	39553788	rs816488	Cognitive performance
chr3	39555579	39555580	rs864643	Attention deficit hyperactivity disorder
chr3	39749592	39749593	rs9832461	Brain structure (temporal lobe volume)
chr3	39847071	39847072	rs17079534	Acute lymphoblastic leukemia (childhood)
chr3	40008633	40008634	rs9985399	Information processing speed
chr3	40096617	40096618	rs6599077	Sleep duration
chr3	41123734	41123735	rs10490823	Bone mineral density (hip)
chr3	41128563	41128564	rs430727	Bone mineral density
chr3	41137671	41137672	rs87938	Bone mineral density (hip)
chr3	41786008	41786009	rs6599175	Multiple myeloma (hyperdiploidy)
chr3	41877413	41877414	rs3774372	Blood pressure
chr3	41912650	41912651	rs9815354	Diastolic blood pressure
chr3	41925397	41925398	rs1052501	Multiple myeloma
chr3	41987919	41987920	rs1717027	Blood pressure
chr3	41996135	41996136	rs2272007	Multiple myeloma (hyperdiploidy)
chr3	42093421	42093422	rs1498095	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr3	42303073	42303074	rs4377469	Body mass index
chr3	42448470	42448471	rs2286720	Response to antipsychotic treatment in schizophrenia (reasoning)
chr3	42808070	42808071	rs339665	Periodontitis (DPAL)
chr3	42906115	42906116	rs2228467	Monocyte count
chr3	42907111	42907112	rs2228468	Monocyte count
chr3	42909159	42909160	rs3919627	Obesity-related traits
chr3	43230722	43230723	rs17075286	Bipolar disorder and schizophrenia
chr3	43297688	43297689	rs6767019	Obesity-related traits
chr3	43467894	43467895	rs7650267	Obesity-related traits
chr3	44333323	44333324	rs13323323	IgG glycosylation
chr3	45731450	45731451	rs2742417	Response to antidepressant treatment
chr3	45814093	45814094	rs17279437	Urinary metabolites
chr3	45817417	45817418	rs758386	Immune reponse to smallpox (secreted TNF-alpha)
chr3	46205685	46205686	rs7616215	Behcet's disease
chr3	46235200	46235201	rs13098911	Celiac disease
chr3	46282390	46282391	rs12636651	Obesity-related traits
chr3	46282390	46282391	rs12636651	Monocyte chemoattractant protein-1
chr3	46339811	46339812	rs9990343	Brain structure
chr3	46352383	46352384	rs6441961	Celiac disease
chr3	46428189	46428190	rs6441975	AIDS progression
chr3	46451679	46451680	rs1015164	AIDS progression
chr3	47061182	47061183	rs2290547	HDL cholesterol
chr3	47388946	47388947	rs8180040	Colorectal cancer
chr3	47927483	47927484	rs319690	Blood pressure
chr3	48487047	48487048	rs730566	Prion diseases
chr3	48487337	48487338	rs9876781	Longevity
chr3	48507574	48507575	rs3135940	Obesity-related traits
chr3	49210731	49210732	rs7617480	Menarche (age at onset)
chr3	49701982	49701983	rs9858542	Ulcerative colitis
chr3	49701982	49701983	rs9858542	Crohn's disease
chr3	49719728	49719729	rs9822268	Ulcerative colitis
chr3	49721531	49721532	rs3197999	Inflammatory bowel disease
chr3	49721531	49721532	rs3197999	Primary sclerosing cholangitis
chr3	49721531	49721532	rs3197999	Crohn's disease
chr3	49721531	49721532	rs3197999	Ulcerative colitis
chr3	50093208	50093209	rs6762477	Menarche (age at onset)
chr3	50129398	50129399	rs2013208	HDL cholesterol
chr3	50352199	50352200	rs11130248	Keloid
chr3	51071712	51071713	rs13088462	Height
chr3	52279593	52279594	rs7618915	Bipolar disorder
chr3	52506425	52506426	rs6784615	Waist-hip ratio
chr3	52532117	52532118	rs13326165	HDL cholesterol
chr3	52584786	52584787	rs2251219	Major mood disorders
chr3	52622085	52622086	rs2590838	Adiponectin levels
chr3	52718279	52718280	rs10865974	Bipolar disorder (mood-incongruent)
chr3	52720079	52720080	rs1108842	Adiponectin levels
chr3	52721304	52721305	rs11177	Osteoarthritis
chr3	52733105	52733106	rs6765687	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr3	52815904	52815905	rs2710323	Schizophrenia, schizoaffective disorder or bipolar disorder
chr3	52821010	52821011	rs1042779	Bipolar disorder
chr3	52833218	52833219	rs2535629	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr3	52835353	52835354	rs736408	Bipolar disorder
chr3	52838401	52838402	rs4687552	Schizophrenia
chr3	52844533	52844534	rs17331151	Immune reponse to smallpox (secreted IL-2)
chr3	52855228	52855229	rs2239547	Schizophrenia
chr3	52913278	52913279	rs3796352	Immune reponse to smallpox (secreted IL-2)
chr3	53062660	53062661	rs9847710	Ulcerative colitis
chr3	53100213	53100214	rs6770152	Urate levels
chr3	53118738	53118739	rs2336725	Height
chr3	53125584	53125585	rs2564921	Height
chr3	53147575	53147576	rs13088281	Immune reponse to smallpox (secreted IL-2)
chr3	53378244	53378245	rs2029213	Heart rate
chr3	53680123	53680124	rs1401492	Insulin resistance/response
chr3	53847061	53847062	rs893363	Axial length
chr3	53847407	53847408	rs14165	Refractive error
chr3	54632546	54632547	rs13064588	Bipolar disorder and schizophrenia
chr3	55017748	55017749	rs3773582	Endometrial cancer
chr3	55035873	55035874	rs4955826	Immune response to smallpox vaccine (IL-6)
chr3	55184212	55184213	rs6782380	Coronary artery calcification
chr3	55188272	55188273	rs11706236	Insomnia (caffeine-induced)
chr3	55313399	55313400	rs358806	Type 2 diabetes
chr3	55563343	55563344	rs1875110	Periodontitis (Mean PAL)
chr3	55571759	55571760	rs1795648	Bipolar disorder and schizophrenia
chr3	56530708	56530709	rs2054989	Hip geometry
chr3	56667681	56667682	rs9835332	Height
chr3	56735179	56735180	rs6773931	Height
chr3	56798494	56798495	rs13100723	Obesity-related traits
chr3	56849748	56849749	rs1354034	Platelet counts
chr3	56849748	56849749	rs1354034	Mean platelet volume
chr3	56865775	56865776	rs12485738	Mean platelet volume
chr3	56966245	56966246	rs2062583	Rheumatoid arthritis
chr3	57394765	57394766	rs1916284	Prostate cancer (gene x gene interaction)
chr3	57779835	57779836	rs6768930	Obesity-related traits
chr3	58027196	58027197	rs1623879	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr3	58105775	58105776	rs13077017	Eating disorders (purging via substances)
chr3	58331185	58331186	rs2176082	Systemic lupus erythematosus and Systemic sclerosis
chr3	58370176	58370177	rs6445975	Systemic lupus erythematosus
chr3	58381286	58381287	rs13315871	Cholesterol, total
chr3	58556840	58556841	rs13315591	Rheumatoid arthritis
chr3	59354157	59354158	rs6771019	Capecitabine sensitivity
chr3	59902800	59902801	rs1825630	Aortic root size
chr3	59921019	59921020	rs4502542	Response to citalopram treatment
chr3	59928850	59928851	rs931317	Myopia (pathological)
chr3	59981524	59981525	rs212016	Orofacial clefts
chr3	60001824	60001825	rs9311745	Pit-and-Fissure caries
chr3	60123521	60123522	rs10510829	Adverse response to lamotrigine and phenytoin
chr3	60289841	60289842	rs10510837	Asperger disorder
chr3	60508339	60508340	rs80171647	Response to amphetamines
chr3	60763255	60763256	rs11919041	Breast size
chr3	60771107	60771108	rs6791644	Attention deficit hyperactivity disorder
chr3	61127204	61127205	rs9877396	Bronchopulmonary dysplasia
chr3	61413813	61413814	rs10514718	Major depressive disorder
chr3	61794053	61794054	rs652889	QT interval
chr3	62036723	62036724	rs10490775	Fuchs's corneal dystrophy
chr3	62064768	62064769	rs11130874	Schizophrenia
chr3	62112140	62112141	rs35593266	Metabolite levels (HVA/5-HIAA ratio)
chr3	62478193	62478194	rs13325751	Economic and political preferences (environmentalism)
chr3	62601365	62601366	rs1231831	Metabolite levels  (X-11787)
chr3	62733365	62733366	rs580384	Breast size
chr3	62782467	62782468	rs304172	IgG glycosylation
chr3	63813653	63813654	rs7614311	Lung function (forced vital capacity)
chr3	63813653	63813654	rs7614311	Lung function (forced expiratory volume in 1 second)
chr3	64029382	64029383	rs831574	Metabolite levels (Dihydroxy docosatrienoic acid)
chr3	64048296	64048297	rs831571	Type 2 diabetes
chr3	64078008	64078009	rs153734	Folate pathway vitamin levels
chr3	64173900	64173901	rs1035275	IgG glycosylation
chr3	64292636	64292637	rs741013	Coronary artery calcification
chr3	64536647	64536648	rs80311637	Liver enzyme levels (aspartate transaminase)
chr3	64536647	64536648	rs80311637	Liver enzyme levels (alanine transaminase)
chr3	64705364	64705365	rs6795735	Age-related macular degeneration
chr3	64705364	64705365	rs6795735	Waist-hip ratio
chr3	64711903	64711904	rs4607103	Type 2 diabetes
chr3	64718257	64718258	rs2371767	Sexual dimorphism in anthropometric traits
chr3	64727085	64727086	rs7433808	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr3	64729891	64729892	rs7638389	Visceral adipose tissue adjusted for BMI
chr3	64886109	64886110	rs1036797	White matter integrity (interaction)
chr3	64927024	64927025	rs704454	Alzheimer's disease (age of onset)
chr3	65326881	65326882	rs6764388	Corneal astigmatism
chr3	65379293	65379294	rs1016553	Homeostasis model assessment of beta-cell function (interaction)
chr3	65398897	65398898	rs7649739	IgG glycosylation
chr3	65486387	65486388	rs1524976	PR interval
chr3	66431601	66431602	rs2242285	QRS duration
chr3	66525962	66525963	rs3845905	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr3	66525962	66525963	rs3845905	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
chr3	66768363	66768364	rs17045031	Carotid intima media thickness
chr3	66798949	66798950	rs13069000	Renal function-related traits (BUN)
chr3	66809941	66809942	rs13069049	Metabolite levels
chr3	66823156	66823157	rs11709625	Hematological and biochemical traits
chr3	67143837	67143838	rs4392363	Migraine - clinic-based
chr3	67373976	67373977	rs977102	Response to amphetamines
chr3	67416321	67416322	rs17806888	Height
chr3	67417104	67417105	rs2363709	IgE levels
chr3	67531387	67531388	rs6792584	Corneal astigmatism
chr3	69173374	69173375	rs7638995	Alzheimer's disease (late onset)
chr3	69252898	69252899	rs6806528	Celiac disease
chr3	69442636	69442637	rs922948	Hip geometry
chr3	69623187	69623188	rs7647307	Brain imaging
chr3	70463329	70463330	rs1024889	Body mass index
chr3	70626359	70626360	rs7628219	Insomnia (caffeine-induced)
chr3	70928929	70928930	rs2687201	Esophageal adenocarcinoma
chr3	70928929	70928930	rs2687201	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)
chr3	70928929	70928930	rs2687201	Barrett's esophagus
chr3	71020489	71020490	rs17651978	Attention deficit hyperactivity disorder
chr3	71055161	71055162	rs13093086	Intraocular pressure
chr3	71115750	71115751	rs7616330	QT interval
chr3	71300566	71300567	rs17008402	Subcutaneous adipose tissue
chr3	71414044	71414045	rs13072512	IgG glycosylation
chr3	71464334	71464335	rs13063872	Migraine - clinic-based
chr3	72023699	72023700	rs2135319	Bilirubin levels
chr3	72161232	72161233	rs6549438	Migraine - clinic-based
chr3	72393140	72393141	rs9832740	Height
chr3	72437412	72437413	rs9863706	Height
chr3	72509270	72509271	rs11128271	IgG glycosylation
chr3	72518039	72518040	rs9832314	IgG glycosylation
chr3	73540617	73540618	rs4557101	QT interval
chr3	73619560	73619561	rs11128347	Dialysis-related mortality
chr3	74627702	74627703	rs13073838	Economic and political preferences
chr3	76261819	76261820	rs1516459	Eating disorders (purging via substances)
chr3	76484182	76484183	rs3849491	Sex hormone-binding globulin levels
chr3	76722765	76722766	rs264537	Periodontitis (PAL4Q3)
chr3	76725902	76725903	rs10511052	IgG glycosylation
chr3	77652741	77652742	rs73114594	Metabolite levels (5-HIAA/ MHPG Ratio)
chr3	78044688	78044689	rs9836484	Brain imaging in schizophrenia (interaction)
chr3	78353590	78353591	rs9831754	Calcium levels
chr3	78498996	78498997	rs9834373	Protein quantitative trait loci
chr3	79604063	79604064	rs7617400	Liver enzyme levels (aspartate transaminase)
chr3	80368462	80368463	rs10511112	Migraine
chr3	80865763	80865764	rs9850225	Erectile dysfunction
chr3	84202202	84202203	rs4522784	Obesity-related traits
chr3	84481067	84481068	rs10511089	Brain structure
chr3	85502844	85502845	rs13323436	Visceral fat
chr3	85874475	85874476	rs12494658	Temperament
chr3	85884149	85884150	rs13078807	Obesity
chr3	85884149	85884150	rs13078807	Body mass index
chr3	86158884	86158885	rs2324999	Subcutaneous adipose tissue
chr3	86255671	86255672	rs7428796	Myopia (pathological)
chr3	86850617	86850618	rs7628864	Pubertal anthropometrics
chr3	86894477	86894478	rs9757252	Prostate cancer (gene x gene interaction)
chr3	86916881	86916882	rs7642134	Menarche (age at onset)
chr3	86968508	86968509	rs17023661	Obesity-related traits
chr3	87110673	87110674	rs2660753	Prostate cancer
chr3	87134799	87134800	rs17023900	Prostate cancer
chr3	87152168	87152169	rs9284813	Prostate cancer
chr3	87173323	87173324	rs17181170	Prostate cancer
chr3	87241496	87241497	rs7629490	Prostate cancer
chr3	87495549	87495550	rs9834692	Brain connectivity
chr3	87525448	87525449	rs9883474	Brain connectivity
chr3	87783975	87783976	rs9860340	Electroencephalographic traits in alcoholism
chr3	88524174	88524175	rs2880961	Response to acetaminophen (hepatotoxicity)
chr3	88977896	88977897	rs12497795	Periodontitis (Mean PAL)
chr3	89534376	89534377	rs7632427	Orofacial clefts
chr3	94243712	94243713	rs13067306	Blood pressure measurement (high sodium intervention)
chr3	95688842	95688843	rs9814870	Male infertility
chr3	95853631	95853632	rs111325002	Cocaine dependence
chr3	96328826	96328827	rs6796026	Obesity-related traits
chr3	96400598	96400599	rs6793516	Blood trace element (Zn levels)
chr3	96682261	96682262	rs7650621	Obesity-related traits
chr3	97168739	97168740	rs1458303	Blood trace element (Cu levels)
chr3	98034525	98034526	rs1497546	Drug-induced liver injury (flucloxacillin)
chr3	99167106	99167107	rs2670321	RR interval (heart rate)
chr3	99266336	99266337	rs13070584	Chronic kidney disease and serum creatinine levels
chr3	99396271	99396272	rs13095226	Age-related macular degeneration
chr3	99481538	99481539	rs13081855	Age-related macular degeneration
chr3	99592595	99592596	rs813218	Orofacial clefts
chr3	99844292	99844293	rs9811920	Axial length
chr3	99956555	99956556	rs12486865	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr3	100476712	100476713	rs9823506	Asthma (childhood onset)
chr3	100590924	100590925	rs9833094	Acute urticaria and angiodema (non-steroidal anti-inflammatory drug-induced)
chr3	101411977	101411978	rs112553552	Response to amphetamines
chr3	101748637	101748638	rs771767	Multiple sclerosis
chr3	101774042	101774043	rs991258	Hip geometry
chr3	101848560	101848561	rs10212363	Waist-to-hip circumference ratio (interaction)
chr3	102203044	102203045	rs2063640	Sensory disturbances after bilateral sagittal split ramus osteotomy
chr3	102203044	102203045	rs2063640	Type 2 diabetes
chr3	103245091	103245092	rs1397924	Economic and political preferences (environmentalism)
chr3	103292225	103292226	rs4856162	Economic and political preferences (environmentalism)
chr3	103307641	103307642	rs7612581	Economic and political preferences (environmentalism)
chr3	103331482	103331483	rs9820695	Economic and political preferences (environmentalism)
chr3	103345438	103345439	rs9821642	Economic and political preferences (environmentalism)
chr3	103359217	103359218	rs10937540	Economic and political preferences (environmentalism)
chr3	103363060	103363061	rs10937544	Economic and political preferences (environmentalism)
chr3	103380851	103380852	rs6775909	Economic and political preferences (environmentalism)
chr3	103397768	103397769	rs12485744	Economic and political preferences (environmentalism)
chr3	103400081	103400082	rs7628767	Economic and political preferences (environmentalism)
chr3	103403513	103403514	rs10511217	Economic and political preferences (environmentalism)
chr3	103438873	103438874	rs4493441	Economic and political preferences (environmentalism)
chr3	103450590	103450591	rs2677247	IgG glycosylation
chr3	103513435	103513436	rs1673866	IgG glycosylation
chr3	105010889	105010890	rs9810233	Erectile dysfunction
chr3	105586713	105586714	rs9657904	Multiple sclerosis
chr3	105869801	105869802	rs2199936	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr3	105869801	105869802	rs2199936	Cardiovascular disease risk factors
chr3	105869801	105869802	rs2199936	Urate levels
chr3	106288949	106288950	rs12491921	Cannabis dependence
chr3	107465816	107465817	rs6437740	Smoking behavior
chr3	108243550	108243551	rs2603127	Hemostatic factors and hematological phenotypes
chr3	108851790	108851791	rs4441659	Homeostasis model assessment of beta-cell function (interaction)
chr3	109204412	109204413	rs769554	Cardiac hypertrophy
chr3	109462399	109462400	rs1164064	Corneal astigmatism
chr3	109529549	109529550	rs679711	Sleep depth
chr3	109789569	109789570	rs10934011	DNA methylation (parent-of-origin)
chr3	109927375	109927376	rs13323983	Neutrophil count
chr3	111201784	111201785	rs76884941	Chronic obstructive pulmonary disease
chr3	111233238	111233239	rs56238310	Chronic obstructive pulmonary disease
chr3	111423128	111423129	rs4450776	Cognitive performance
chr3	112269286	112269287	rs2705520	Asthma (childhood onset)
chr3	112376307	112376308	rs12634229	Atopic dermatitis
chr3	112497879	112497880	rs1002979	Prostate cancer (gene x gene interaction)
chr3	112681584	112681585	rs1488193	Economic and political preferences
chr3	112822321	112822322	rs9811423	Alzheimer's disease
chr3	112995073	112995074	rs775227	Dental caries
chr3	113275623	113275624	rs7611694	Prostate cancer
chr3	113290467	113290468	rs13092825	Dental caries
chr3	113370009	113370010	rs1026364	Bone mineral density
chr3	113430598	113430599	rs11711311	IgG glycosylation
chr3	113680950	113680951	rs1386478	Crohn's disease and psoriasis
chr3	113842012	113842013	rs2087017	Personality dimensions
chr3	114362763	114362764	rs9841504	Gastric cancer
chr3	116445323	116445324	rs1432364	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)
chr3	117156254	117156255	rs9870146	Obesity-related traits
chr3	117243795	117243796	rs72951640	Serum dimethylarginine levels (asymmetric)
chr3	117307566	117307567	rs1875517	Waist circumference
chr3	117574821	117574822	rs6438424	Menarche (age at onset)
chr3	118121334	118121335	rs488628	White matter integrity (interaction)
chr3	118162622	118162623	rs10511378	Obesity-related traits
chr3	118676491	118676492	rs4687833	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr3	118745935	118745936	rs2160050	Response to amphetamines
chr3	119084330	119084331	rs17203055	Schizophrenia
chr3	119118795	119118796	rs11712165	Celiac disease
chr3	119219933	119219934	rs2293370	Primary biliary cirrhosis
chr3	119219933	119219934	rs2293370	Multiple sclerosis
chr3	119227246	119227247	rs4688011	Arthritis (juvenile idiopathic)
chr3	119260943	119260944	rs6804441	Systemic lupus erythematosus
chr3	119261374	119261375	rs7648642	Lobular breast cancer (menopausal hormone therapy interaction)
chr3	119288413	119288414	rs59374417	Vitiligo
chr3	119560605	119560606	rs6805251	HDL cholesterol
chr3	120017479	120017480	rs796825	HIV-1 susceptibility
chr3	120043835	120043836	rs10511400	Economic and political preferences (feminism/equality)
chr3	120236328	120236329	rs9289146	Obesity-related traits
chr3	120425330	120425331	rs13077101	Obesity-related traits
chr3	120585314	120585315	rs322458	Aging (facial)
chr3	121100282	121100283	rs17740066	Aging (facial)
chr3	121137975	121137976	rs6782025	Aging (facial)
chr3	121154192	121154193	rs6800901	Multiple myeloma (IgH translocation)
chr3	121319823	121319824	rs6775899	Aging (facial)
chr3	121344139	121344140	rs3772130	Cognitive performance
chr3	121660663	121660664	rs4285028	Multiple sclerosis
chr3	121769521	121769522	rs2681424	Multiple sclerosis
chr3	121793186	121793187	rs4308217	Multiple sclerosis
chr3	121796767	121796768	rs9282641	Multiple sclerosis
chr3	121993246	121993247	rs17251221	Calcium levels
chr3	122003756	122003757	rs1801725	Calcium levels
chr3	122014565	122014566	rs13083990	Cardiac Troponin-T levels
chr3	122048643	122048644	rs17265703	Phosphorus levels
chr3	122329159	122329160	rs2173763	Major depressive disorder
chr3	122356450	122356451	rs78411303	Periodontitis (CDC/AAP)
chr3	122368346	122368347	rs2650951	QT interval
chr3	122380922	122380923	rs790116	Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)
chr3	122388992	122388993	rs790123	Response to angiotensin II receptor blocker therapy
chr3	122730909	122730910	rs9868873	Esophageal cancer
chr3	122839875	122839876	rs3792366	Platelet counts
chr3	123003297	123003298	rs13317079	Obesity-related traits
chr3	123065777	123065778	rs11708067	Type 2 diabetes
chr3	123065777	123065778	rs11708067	Fasting glucose-related traits (interaction with BMI)
chr3	123065777	123065778	rs11708067	Fasting glucose-related traits
chr3	123094450	123094451	rs2877716	Two-hour glucose challenge
chr3	123096819	123096820	rs9883204	Birth weight
chr3	124340221	124340222	rs10512627	Mean platelet volume
chr3	125592856	125592857	rs71327718	Metabolite levels (HVA/5-HIAA ratio)
chr3	125904164	125904165	rs1107366	Metabolite levels
chr3	126950125	126950126	rs4234284	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)
chr3	126961147	126961148	rs13075436	Response to angiotensin II receptor blocker therapy
chr3	126993098	126993099	rs9871760	MRI atrophy measures
chr3	127895225	127895226	rs2687729	Menarche (age at onset)
chr3	128038372	128038373	rs10934853	Prostate cancer
chr3	128260549	128260550	rs4857855	Eosinophil counts
chr3	128282696	128282697	rs6806253	Pit-and-Fissure caries
chr3	128297568	128297569	rs9880192	White blood cell count
chr3	128316434	128316435	rs4328821	White blood cell count
chr3	128316434	128316435	rs4328821	White blood cell types
chr3	128338599	128338600	rs2712381	Monocyte count
chr3	128652552	128652553	rs9810890	Dental caries
chr3	128658491	128658492	rs2933343	IgG glycosylation
chr3	129050755	129050756	rs6439167	Height
chr3	129971100	129971101	rs9813712	Response to amphetamines
chr3	131713565	131713566	rs1320900	Amyotrophic lateral sclerosis
chr3	131813899	131813900	rs6775745	Neutrophil count
chr3	132163199	132163200	rs17404153	LDL cholesterol
chr3	132163199	132163200	rs17404153	HDL cholesterol
chr3	132610751	132610752	rs6439371	Menarche (age at onset)
chr3	132693587	132693588	rs2369955	Alcoholism (heaviness of drinking)
chr3	132727902	132727903	rs7617456	IgE grass sensitization
chr3	133260873	133260874	rs11708304	Bulimia nervosa
chr3	133399701	133399702	rs2718812	Iron status biomarkers
chr3	133410660	133410661	rs1867504	Iron status biomarkers
chr3	133475721	133475722	rs1799852	Iron status biomarkers
chr3	133475811	133475812	rs1799899	Alcohol consumption (transferrin glycosylation)
chr3	133484028	133484029	rs3811647	Hepcidin levels
chr3	133484028	133484029	rs3811647	Alcohol consumption (transferrin glycosylation)
chr3	133484028	133484029	rs3811647	Iron status biomarkers
chr3	133484028	133484029	rs3811647	Iron levels
chr3	133494353	133494354	rs1049296	Alcohol consumption (transferrin glycosylation)
chr3	133508463	133508464	rs1830084	Iron status biomarkers
chr3	133537066	133537067	rs1534166	Alcohol consumption (transferrin glycosylation)
chr3	133589323	133589324	rs9835973	Immune reponse to smallpox (secreted IL-1beta)
chr3	134233091	134233092	rs10935120	Height
chr3	135225248	135225249	rs11712655	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr3	135235357	135235358	rs1502172	Visceral adipose tissue adjusted for BMI
chr3	135587810	135587811	rs1401543	Anticoagulant levels
chr3	135925190	135925191	rs1154988	Fibrinogen
chr3	135926621	135926622	rs645040	Triglycerides
chr3	135950920	135950921	rs511154	Fibrinogen
chr3	135974215	135974216	rs9844666	Height
chr3	137108481	137108482	rs1382269	Metabolite levels
chr3	137447484	137447485	rs10935268	Acenocoumarol maintenance dosage
chr3	138025395	138025396	rs9846480	MRI atrophy measures
chr3	138119951	138119952	rs2306374	Coronary heart disease
chr3	138122121	138122122	rs9818870	Coronary heart disease
chr3	138713703	138713704	rs1511412	Keloid
chr3	138903984	138903985	rs7638110	Obesity and blood pressure
chr3	138916392	138916393	rs11706018	IgG glycosylation
chr3	139043235	139043236	rs4894410	Kawasaki disease
chr3	139073010	139073011	rs1044826	Obesity-related traits
chr3	139606793	139606794	rs2554152	Visceral adipose tissue adjusted for BMI
chr3	140099692	140099693	rs17411949	Multiple sclerosis (OCB status)
chr3	140175359	140175360	rs11708189	Sudden cardiac arrest
chr3	140223793	140223794	rs9862730	Homeostasis model assessment of insulin resistance (interaction)
chr3	140223793	140223794	rs9862730	Fasting insulin (interaction)
chr3	140247176	140247177	rs4683505	Myopia (pathological)
chr3	140540717	140540718	rs908821	Multiple sclerosis
chr3	140799212	140799213	rs16851055	Stroke (ischemic)
chr3	140979410	140979411	rs16851254	Cognitive performance
chr3	141078187	141078188	rs9857275	Prion diseases
chr3	141094208	141094209	rs6440003	Height
chr3	141102832	141102833	rs6763931	Prostate cancer
chr3	141102832	141102833	rs6763931	Height
chr3	141105569	141105570	rs724016	Height
chr3	141133449	141133450	rs1991431	Height
chr3	141137034	141137035	rs9825379	Height
chr3	141143429	141143430	rs10513137	Height
chr3	141266492	141266493	rs6776003	Red blood cell traits
chr3	141376139	141376140	rs11921014	Coronary artery calcification
chr3	141463297	141463298	rs16851720	Hepatitis C induced liver fibrosis
chr3	141807136	141807137	rs347685	Chronic kidney disease
chr3	142430999	142431000	rs3773506	Type 2 diabetes
chr3	142649109	142649110	rs9832727	Phospholipid levels (plasma)
chr3	142894410	142894411	rs894177	Non-alcoholic fatty liver disease histology (other)
chr3	142982898	142982899	rs9810857	Attention deficit hyperactivity disorder
chr3	143005028	143005029	rs17636071	Response to cholinesterase inhibitors in Alzheimer's disease
chr3	143056466	143056467	rs7632299	Non-alcoholic fatty liver disease histology (lobular)
chr3	143250069	143250070	rs1371924	Tonometry
chr3	143424821	143424822	rs2800	Non-alcoholic fatty liver disease histology (other)
chr3	143504532	143504533	rs2166775	Response to angiotensin II receptor blocker therapy
chr3	143772246	143772247	rs13068298	Economic and political preferences (feminism/equality)
chr3	143778707	143778708	rs16854884	Economic and political preferences (feminism/equality)
chr3	143902026	143902027	rs4839680	Myopia (pathological)
chr3	144340204	144340205	rs800082	Smoking behavior
chr3	145173787	145173788	rs345013	Prostate cancer
chr3	145888456	145888457	rs1913185	Obesity-related traits
chr3	146402170	146402171	rs1912785	Barrett's esophagus
chr3	146632163	146632164	rs12629805	Subcutaneous adipose tissue
chr3	146816710	146816711	rs4681346	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia
chr3	147756685	147756686	rs1841770	Multiple sclerosis
chr3	148913125	148913126	rs13072552	Serum ceruloplasmin levels
chr3	148977313	148977314	rs7617219	Subcutaneous adipose tissue
chr3	149250588	149250589	rs17787940	Preeclampsia
chr3	150042617	150042618	rs4301033	Adiponectin levels
chr3	150087007	150087008	rs1012583	IgG glycosylation
chr3	150467807	150467808	rs6788895	Breast cancer
chr3	150697207	150697208	rs16863118	IgG glycosylation
chr3	151042463	151042464	rs12107539	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr3	151579872	151579873	rs6798928	Immunoglobulin A
chr3	151763700	151763701	rs1351267	Schizophrenia
chr3	151830308	151830309	rs11712066	Infantile hypertrophic pyloric stenosis
chr3	152535364	152535365	rs10513432	Immune reponse to smallpox (secreted IL-2)
chr3	152672778	152672779	rs6785504	Response to antineoplastic agents
chr3	152721974	152721975	rs9883654	Response to antineoplastic agents
chr3	153184655	153184656	rs6778194	Immune reponse to smallpox (secreted IFN-alpha)
chr3	153350115	153350116	rs7623788	IgG glycosylation
chr3	153472162	153472163	rs573872	Infantile hypertrophic pyloric stenosis
chr3	153478422	153478423	rs6794649	IgG glycosylation
chr3	155267439	155267440	rs3851357	IgG glycosylation
chr3	156102733	156102734	rs3772255	Aging traits
chr3	156336554	156336555	rs7651778	Corneal astigmatism
chr3	156397748	156397749	rs2665390	Ovarian cancer in BRCA1 mutation carriers
chr3	156397748	156397749	rs2665390	Ovarian cancer
chr3	156406996	156406997	rs7651446	Ovarian cancer
chr3	156555983	156555984	rs344081	Bone mineral density
chr3	156626090	156626091	rs12638253	Multiple sclerosis (severity)
chr3	156797608	156797609	rs17451107	Adiposity in newborns
chr3	156798472	156798473	rs1482853	Adiposity in newborns
chr3	156798774	156798775	rs900400	Birth weight
chr3	156836905	156836906	rs7624327	Eating disorders
chr3	156854741	156854742	rs13064954	Diabetic retinopathy
chr3	156950578	156950579	rs9866141	Diabetic retinopathy
chr3	158109378	158109379	rs2362965	Height
chr3	158453278	158453279	rs7646881	Tetralogy of Fallot
chr3	158514359	158514360	rs6802315	Periodontitis (CDC/AAP)
chr3	159259290	159259291	rs2222328	Quantitative traits
chr3	159644296	159644297	rs6799788	Major depressive disorder
chr3	159665049	159665050	rs17810546	Behcet's disease
chr3	159665049	159665050	rs17810546	Celiac disease
chr3	159698944	159698945	rs4680534	Multiple sclerosis
chr3	159709650	159709651	rs2243123	Multiple sclerosis
chr3	159728877	159728878	rs6441286	Primary biliary cirrhosis
chr3	159745862	159745863	rs485499	Primary biliary cirrhosis
chr3	160340895	160340896	rs4679904	Primary biliary cirrhosis
chr3	160776963	160776964	rs9290065	Kawasaki disease
chr3	160820523	160820524	rs4557202	Menarche (age at onset)
chr3	161392575	161392576	rs6808138	Hyperactive-impulsive symptoms
chr3	162069008	162069009	rs12493123	Reading and spelling
chr3	162131407	162131408	rs12636148	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr3	162161615	162161616	rs11924705	Coronary heart disease
chr3	162167395	162167396	rs6789378	Coronary heart disease
chr3	162681994	162681995	rs1425609	Aging (time to death)
chr3	162834300	162834301	rs9824150	Capecitabine sensitivity
chr3	163761963	163761964	rs7427021	Bipolar disorder
chr3	163855068	163855069	rs78661745	Bulimia nervosa
chr3	165125158	165125159	rs9878522	Response to amphetamines
chr3	165280208	165280209	rs1523288	Heart failure
chr3	165480099	165480100	rs6445035	Aspirin hydrolysis (plasma)
chr3	165491279	165491280	rs1803274	Cardiovascular disease risk factors
chr3	165491279	165491280	rs1803274	Butyrylcholinesterase levels
chr3	166014468	166014469	rs509208	Alzheimer's disease biomarkers
chr3	167348837	167348838	rs7627289	Visceral fat
chr3	167508061	167508062	rs13090836	Heart rate
chr3	167725348	167725349	rs7632500	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)
chr3	167837747	167837748	rs4345115	Height
chr3	167897820	167897821	rs2686586	Thiazide-induced adverse metabolic effects in hypertensive patients
chr3	168686675	168686676	rs16852912	Aging (time to event)
chr3	168916239	168916240	rs9864370	Multiple myeloma (hyperdiploidy)
chr3	168971230	168971231	rs784288	Osteoporosis
chr3	169080184	169080185	rs9883650	Immune reponse to smallpox (secreted IL-1beta)
chr3	169082632	169082633	rs6774494	Nasopharyngeal carcinoma
chr3	169100885	169100886	rs419076	Systolic blood pressure
chr3	169100885	169100886	rs419076	Diastolic blood pressure
chr3	169100885	169100886	rs419076	Blood pressure
chr3	169100898	169100899	rs448378	Magnesium levels
chr3	169100898	169100899	rs448378	Systolic blood pressure
chr3	169150631	169150632	rs16853722	Renal function-related traits (BUN)
chr3	169165887	169165888	rs1918974	Diastolic blood pressure
chr3	169300218	169300219	rs1344555	Pulmonary function (interaction)
chr3	169300218	169300219	rs1344555	Pulmonary function
chr3	169477505	169477506	rs12638862	Multiple myeloma (IgH translocation)
chr3	169481270	169481271	rs12696304	Telomere length
chr3	169492100	169492101	rs10936599	Chronic lymphocytic leukemia
chr3	169492100	169492101	rs10936599	Bladder cancer
chr3	169492100	169492101	rs10936599	Multiple myeloma
chr3	169492100	169492101	rs10936599	Telomere length
chr3	169492100	169492101	rs10936599	Multiple sclerosis
chr3	169492100	169492101	rs10936599	Colorectal cancer
chr3	169492100	169492101	rs10936599	Celiac disease
chr3	169497584	169497585	rs1317082	Telomere length
chr3	169518454	169518455	rs6793295	Interstitial lung disease
chr3	169528448	169528449	rs10936601	Telomere length
chr3	170130101	170130102	rs10936632	Prostate cancer
chr3	170163473	170163474	rs6444931	Bipolar disorder and schizophrenia
chr3	170494408	170494409	rs4955755	Menopause (age at onset)
chr3	170717520	170717521	rs11920090	Fasting glucose-related traits (interaction with BMI)
chr3	170717520	170717521	rs11920090	Fasting glucose-related traits
chr3	170725541	170725542	rs10513686	Liver enzyme levels (gamma-glutamyl transferase)
chr3	170834558	170834559	rs11920719	Coronary heart disease
chr3	170971290	170971291	rs2088885	Brain imaging in schizophrenia (interaction)
chr3	171558343	171558344	rs6794092	Body mass index
chr3	171653902	171653903	rs3913363	Response to angiotensin II receptor blocker therapy
chr3	171785167	171785168	rs9647379	Heart rate
chr3	171926372	171926373	rs4535251	Height
chr3	171969076	171969077	rs7652177	Height
chr3	171995604	171995605	rs4894535	Corneal structure
chr3	172165726	172165727	rs572169	Height
chr3	172385692	172385693	rs11712263	Obesity-related traits
chr3	172476418	172476419	rs7646507	Obesity-related traits
chr3	172843276	172843277	rs11720607	Prostate cancer (gene x gene interaction)
chr3	173180632	173180633	rs11709498	Periodontitis (DPAL)
chr3	174029044	174029045	rs13074924	Major depressive disorder
chr3	174194242	174194243	rs10936797	Obesity-related traits
chr3	174893774	174893775	rs17531088	Kawasaki disease
chr3	174961386	174961387	rs1463525	Systemic lupus erythematosus
chr3	175055758	175055759	rs2042126	Sleep duration
chr3	175103613	175103614	rs62287976	Metabolite levels (MHPG)
chr3	175647164	175647165	rs6772209	Esophageal cancer
chr3	175927450	175927451	rs11923600	Height
chr3	176030095	176030096	rs6799767	Eosinophilic esophagitis (pediatric)
chr3	176422651	176422652	rs1490075	Response to amphetamines
chr3	177095071	177095072	rs12629106	Systemic lupus erythematosus
chr3	177228978	177228979	rs1353899	Alcohol consumption
chr3	177291696	177291697	rs644695	Major depressive disorder (broad)
chr3	177304297	177304298	rs7620503	Corneal structure
chr3	177596988	177596989	rs7612209	Cognitive performance
chr3	177766463	177766464	rs7634528	Myopia (pathological)
chr3	177793106	177793107	rs1982821	Uric acid levels
chr3	177855631	177855632	rs9883878	Asthma (childhood onset)
chr3	178341581	178341582	rs2054399	Bipolar disorder and schizophrenia
chr3	178429938	178429939	rs9290663	Acute lymphoblastic leukemia (childhood)
chr3	178782020	178782021	rs4955793	Post-traumatic stress disorder (asjusted for relatedness)
chr3	179172978	179172979	rs7612445	Heart rate
chr3	179661317	179661318	rs7630877	Type 2 diabetes
chr3	180550701	180550702	rs6782299	Schizophrenia
chr3	180551213	180551214	rs1879248	Schizophrenia
chr3	181851283	181851284	rs16832889	Estradiol plasma levels (breast cancer)
chr3	182760072	182760073	rs10513789	Parkinson's disease
chr3	182821274	182821275	rs11711441	Parkinson's disease
chr3	182869817	182869818	rs683395	Bipolar disorder
chr3	182870435	182870436	rs514636	Bipolar disorder
chr3	183843134	183843135	rs6806377	Obesity-related traits
chr3	183876511	183876512	rs1969253	Major depressive disorder
chr3	184010047	184010048	rs3914188	Menarche (age at onset)
chr3	184090265	184090266	rs6141	Platelet counts
chr3	184216129	184216130	rs3930234	Alcoholism (alcohol use disorder factor score)
chr3	184514612	184514613	rs4686760	vWF and FVIII levels
chr3	184876782	184876783	rs7647854	Major depressive disorder
chr3	184945848	184945849	rs7374394	Cognitive performance
chr3	185141856	185141857	rs7629245	Airflow obstruction
chr3	185511686	185511687	rs4402960	Type 2 diabetes
chr3	185529079	185529080	rs1470579	Type 2 diabetes
chr3	185529079	185529080	rs1470579	Fasting glucose-related traits (interaction with BMI)
chr3	185529079	185529080	rs1470579	Diabetes (gestational)
chr3	185530289	185530290	rs6769511	Type 2 diabetes
chr3	185531660	185531661	rs1374910	Type 2 diabetes
chr3	185548682	185548683	rs720390	Height
chr3	185621828	185621829	rs6444087	Smoking behavior
chr3	185629567	185629568	rs2002675	Menarche (age at onset)
chr3	185686740	185686741	rs10049246	Attention deficit hyperactivity disorder symptoms (interaction)
chr3	185824003	185824004	rs1516725	Obesity
chr3	185824003	185824004	rs1516725	Body mass index
chr3	185834289	185834290	rs7647305	Weight
chr3	185834289	185834290	rs7647305	Body mass index
chr3	185834498	185834499	rs9816226	Obesity
chr3	185834498	185834499	rs9816226	Body mass index
chr3	186220062	186220063	rs1868152	Illicit drug use
chr3	186390626	186390627	rs9898	Activated partial thromboplastin time
chr3	186433098	186433099	rs11924390	Adiponectin levels
chr3	186459926	186459927	rs710446	Activated partial thromboplastin time
chr3	186466251	186466252	rs1656966	Myopia (pathological)
chr3	186480205	186480206	rs822354	Adiponectin levels
chr3	186501647	186501648	rs266719	Adiponectin levels
chr3	186530483	186530484	rs266717	Adiponectin levels
chr3	186548564	186548565	rs6810075	Adiponectin levels
chr3	186549694	186549695	rs10937273	Adiponectin levels
chr3	186551710	186551711	rs1648707	Adiponectin levels
chr3	186554291	186554292	rs864265	Adiponectin levels
chr3	186560781	186560782	rs182052	Adiponectin levels
chr3	186570452	186570453	rs17366568	Adiponectin levels
chr3	186573704	186573705	rs6773957	Adiponectin levels
chr3	186650789	186650790	rs10937275	Drug-induced liver injury (flucloxacillin)
chr3	186666460	186666461	rs16861329	Type 2 diabetes
chr3	186684363	186684364	rs6778436	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)
chr3	186722943	186722944	rs7652995	IgG glycosylation
chr3	186725886	186725887	rs11710456	IgG glycosylation
chr3	186732678	186732679	rs17776120	IgG glycosylation
chr3	186732724	186732725	rs3821819	IgG glycosylation
chr3	186793241	186793242	rs2239612	Esophageal cancer (squamous cell)
chr3	187413990	187413991	rs6764050	Response to citalopram treatment
chr3	187456708	187456709	rs3733017	PR interval
chr3	187543341	187543342	rs10513821	Pulmonary function (interaction)
chr3	187649418	187649419	rs6773854	B cell non-Hodgkin lymphoma
chr3	187687073	187687074	rs9820070	Hematological and biochemical traits
chr3	187687889	187687890	rs16862782	Myopia (pathological)
chr3	187705886	187705887	rs184662298	Serum dimethylarginine levels (symmetric)
chr3	187705886	187705887	rs184662298	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr3	187713717	187713718	rs10937329	Renal function-related traits (BUN)
chr3	187716885	187716886	rs1553091	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
chr3	187717539	187717540	rs4686914	Metabolite levels
chr3	187763397	187763398	rs6789987	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr3	187763397	187763398	rs6789987	Visceral adipose tissue adjusted for BMI
chr3	187944923	187944924	rs1975991	White matter integrity (interaction)
chr3	188072512	188072513	rs9865818	Allergic sensitization
chr3	188087627	188087628	rs9851967	Vitiligo
chr3	188112553	188112554	rs1464510	Vitiligo
chr3	188112553	188112554	rs1464510	Celiac disease
chr3	188128978	188128979	rs9860547	Self-reported allergy
chr3	188289696	188289697	rs10937355	Obesity-related traits
chr3	188420896	188420897	rs1152846	Weight
chr3	188420896	188420897	rs1152846	Body mass index
chr3	188442479	188442480	rs9290877	IgE levels
chr3	188584678	188584679	rs13067593	Immune reponse to smallpox (secreted IFN-alpha)
chr3	189113260	189113261	rs6789327	Axial length
chr3	189343423	189343424	rs7610017	Brain imaging
chr3	189356260	189356261	rs4488809	Lung cancer
chr3	189383182	189383183	rs10937405	Lung adenocarcinoma
chr3	189401775	189401776	rs17505102	Acute lymphoblastic leukemia (childhood)
chr3	189645932	189645933	rs710521	Bladder cancer
chr3	189645932	189645933	rs710521	Urinary bladder cancer
chr3	189997395	189997396	rs16865258	Response to antipsychotic treatment in schizophrenia (working memory)
chr3	190252634	190252635	rs9290936	Waist circumference
chr3	190350460	190350461	rs7626795	Lung cancer
chr3	190669517	190669518	rs9877502	Alzheimer's disease biomarkers
chr3	191000807	191000808	rs10937470	Total ventricular volume
chr3	191196591	191196592	rs16822582	Bipolar disorder and schizophrenia
chr3	191521851	191521852	rs1516489	Immune response to smallpox vaccine (IL-6)
chr3	191667776	191667777	rs7635839	Response to antipsychotic treatment
chr3	191818641	191818642	rs4585146	Major depressive disorder
chr3	191897217	191897218	rs975121	Ileal carcinoids
chr3	191912869	191912870	rs9836672	Sleep quality
chr3	192093974	192093975	rs4453795	Metabolite levels
chr3	192772294	192772295	rs13068101	Sleep time
chr3	193583709	193583710	rs604222	Major depressive disorder
chr3	193722329	193722330	rs724767	Estradiol plasma levels (breast cancer)
chr3	194327097	194327098	rs789852	QT interval
chr3	194737872	194737873	rs2676917	Metabolite levels (Pyroglutamine)
chr3	194758009	194758010	rs3892715	Attention deficit hyperactivity disorder (time to onset)
chr3	194858373	194858374	rs2131877	Non-small cell lung cancer
chr3	195596906	195596907	rs2278034	Bronchopulmonary dysplasia
chr3	195751629	195751630	rs4927850	Pancreatic cancer
chr3	195800546	195800547	rs9859260	Mean corpuscular volume
chr3	195809138	195809139	rs11915082	Mean corpuscular hemoglobin
chr3	195834356	195834357	rs11717368	Red blood cell traits
chr3	195907652	195907653	rs4916483	Mean corpuscular volume
chr3	195907652	195907653	rs4916483	Mean corpuscular hemoglobin
chr3	195928853	195928854	rs11924930	HIV-1 susceptibility
chr3	196078426	196078427	rs6774852	Obesity-related traits
chr3	196187607	196187608	rs2342371	Fat distribution (HIV)
chr3	196553866	196553867	rs2084385	Total ventricular volume
chr4	282498	282499	rs11723261	Immune response to smallpox vaccine (IL-6)
chr4	735149	735150	rs4234853	Hemostatic factors and hematological phenotypes
chr4	852312	852313	rs1564282	Parkinson's disease (familial)
chr4	858331	858332	rs11248051	Parkinson's disease
chr4	939086	939087	rs6599388	Parkinson's disease
chr4	939112	939113	rs6599389	Parkinson's disease
chr4	964358	964359	rs11248060	Parkinson's disease
chr4	994413	994414	rs3755955	Bone mineral density
chr4	1039214	1039215	rs62296075	Obesity-related traits
chr4	1078186	1078187	rs1670533	Recombination rate (females)
chr4	1095280	1095281	rs3796619	Recombination rate (males)
chr4	1254534	1254535	rs7656416	Type 2 diabetes
chr4	1291112	1291113	rs13108904	Obesity-related traits
chr4	1309900	1309901	rs6815464	Type 2 diabetes
chr4	1365126	1365127	rs13118159	Longevity
chr4	1701316	1701317	rs2247341	Height
chr4	1734238	1734239	rs798766	Bladder cancer
chr4	1734238	1734239	rs798766	Urinary bladder cancer
chr4	2103095	2103096	rs1923775	Alzheimer's disease
chr4	2395296	2395297	rs959770	Schizophrenia
chr4	3449651	3449652	rs16844401	Fibrinogen
chr4	3473138	3473139	rs6831256	Triglycerides
chr4	3473138	3473139	rs6831256	LDL cholesterol
chr4	3473138	3473139	rs6831256	Cholesterol, total
chr4	4648046	4648047	rs870142	Congenital heart disease
chr4	4704013	4704014	rs4476553	Response to amphetamines
chr4	4719493	4719494	rs1000579	Alcohol dependence
chr4	5110139	5110140	rs6833812	Sensory disturbances after bilateral sagittal split ramus osteotomy
chr4	5162388	5162389	rs13128441	Celiac disease
chr4	5221537	5221538	rs2008242	Electrocardiographic conduction measures
chr4	5237152	5237153	rs78647349	Alzheimer's disease (cognitive decline)
chr4	5367984	5367985	rs7697839	Coronary heart disease
chr4	5368223	5368224	rs7673097	Coronary heart disease
chr4	5758868	5758869	rs735172	Prostate cancer (gene x gene interaction)
chr4	5930032	5930033	rs4333127	Blood trace element (Zn levels)
chr4	6058496	6058497	rs16838131	Response to angiotensin II receptor blocker therapy
chr4	6183183	6183184	rs10937705	IgG glycosylation
chr4	6270055	6270056	rs4689388	Type 2 diabetes and other traits
chr4	6303021	6303022	rs1801214	Type 2 diabetes
chr4	6697765	6697766	rs3822262	Obesity-related traits
chr4	6736364	6736365	rs7661864	IgG glycosylation
chr4	6891518	6891519	rs11734132	Mean platelet volume
chr4	7018184	7018185	rs16839553	IgG glycosylation
chr4	7159701	7159702	rs3894944	Coronary artery calcification
chr4	7219932	7219933	rs4234798	Insulin-like growth factors
chr4	7423750	7423751	rs7694661	Obesity-related traits
chr4	8503358	8503359	rs1949733	Response to antineoplastic agents
chr4	9790711	9790712	rs1850744	Economic and political preferences
chr4	9915740	9915741	rs11722228	Urate levels
chr4	9922166	9922167	rs16890979	Urate levels
chr4	9922166	9922167	rs16890979	Uric acid levels
chr4	9923003	9923004	rs734553	Serum uric acid levels
chr4	9923003	9923004	rs734553	Gout
chr4	9923003	9923004	rs734553	Uric acid levels
chr4	9926966	9926967	rs13129697	Uric acid levels
chr4	9926966	9926967	rs13129697	Urate levels
chr4	9926966	9926967	rs13129697	Biochemical measures
chr4	9934743	9934744	rs737267	Urate levels
chr4	9935909	9935910	rs6855911	Urate levels
chr4	9944051	9944052	rs12498742	Urate levels
chr4	9946655	9946656	rs4475146	Gout
chr4	9956078	9956079	rs4481233	Metabolic traits
chr4	9966379	9966380	rs7442295	Urate levels
chr4	9994214	9994215	rs6449213	Uric acid levels
chr4	9995181	9995182	rs3775948	Renal function-related traits (urea)
chr4	9995181	9995182	rs3775948	Uric acid levels
chr4	10050140	10050141	rs733175	Alzheimer's disease
chr4	10056375	10056376	rs7671266	Cardiovascular disease risk factors
chr4	10062325	10062326	rs6834555	Alzheimer's disease
chr4	10104669	10104670	rs717615	Uric acid levels
chr4	10286300	10286301	rs4698014	Uric acid levels
chr4	10324159	10324160	rs9291683	Bone mineral density
chr4	10331293	10331294	rs4698036	Cardiovascular disease risk factors
chr4	10726852	10726853	rs16872571	Myopia (pathological)
chr4	10726852	10726853	rs16872571	Vitiligo
chr4	11503603	11503604	rs1390096	Nonalcoholic fatty liver disease
chr4	11630048	11630049	rs6448799	Alzheimer's disease (late onset)
chr4	11674660	11674661	rs7671189	Obesity-related traits
chr4	12111548	12111549	rs187075894	Metabolite levels (MHPG)
chr4	12498886	12498887	rs7665957	Obesity-related traits
chr4	12500220	12500221	rs62295889	Obesity-related traits
chr4	12579845	12579846	rs10002492	IgG glycosylation
chr4	12769231	12769232	rs11945798	Word reading
chr4	12773993	12773994	rs16887552	Response to mTOR inhibitor (everolimus)
chr4	13102350	13102351	rs13122273	Inflammatory biomarkers
chr4	13116761	13116762	rs491376	Response to antidepressant treatment
chr4	13122534	13122535	rs573332	Response to antidepressant treatment
chr4	13794415	13794416	rs10489087	Hemostatic factors and hematological phenotypes
chr4	13914372	13914373	rs10805321	Response to antipsychotic therapy (extrapyramidal side effects)
chr4	14144207	14144208	rs6844339	Obesity-related traits
chr4	15397363	15397364	rs16891867	Conduct disorder (symptom count)
chr4	15397905	15397906	rs1861046	Conduct disorder (case status)
chr4	15482359	15482360	rs1861050	Conduct disorder (case status)
chr4	15545409	15545410	rs9918079	Obesity-related traits
chr4	15737100	15737101	rs11724635	Parkinson's disease
chr4	15737347	15737348	rs4698412	Parkinson's disease
chr4	15737936	15737937	rs4538475	Parkinson's disease
chr4	15964862	15964863	rs4698433	QT interval
chr4	16002287	16002288	rs17478107	Self-rated health
chr4	16018323	16018324	rs2531154	Dental caries
chr4	16022539	16022540	rs2677780	Smooth-surface caries
chr4	16514407	16514408	rs955943	Rhegmatogenous retinal detachment
chr4	16893892	16893893	rs1483012	QT interval
chr4	16908003	16908004	rs6819013	QT interval
chr4	17135342	17135343	rs4698169	Temperament (bipolar disorder)
chr4	17221232	17221233	rs12643440	Metabolite levels (Pyroglutamine)
chr4	17797965	17797966	rs7678436	Height
chr4	17919810	17919811	rs925098	Height
chr4	17944839	17944840	rs16896068	Height
chr4	17946431	17946432	rs2724475	Height
chr4	17952207	17952208	rs6845078	Height
chr4	17993409	17993410	rs724577	Birth weight
chr4	17993409	17993410	rs724577	Height
chr4	18017729	18017730	rs6830062	Height
chr4	18033487	18033488	rs6449353	Height
chr4	18128640	18128641	rs1503874	Illicit drug use
chr4	18866168	18866169	rs6845621	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
chr4	20495134	20495135	rs666088	Echocardiographic traits
chr4	20620682	20620683	rs1379659	Echocardiographic traits
chr4	21206489	21206490	rs1023721	IgG glycosylation
chr4	21455256	21455257	rs11942476	IgG glycosylation
chr4	21476989	21476990	rs358592	Suicidal ideation
chr4	21511382	21511383	rs16871289	Obesity-related traits
chr4	21571086	21571087	rs1604805	Obesity-related traits
chr4	22021499	22021500	rs16872248	Obesity-related traits
chr4	23588461	23588462	rs1511453	Thiazide-induced adverse metabolic effects in hypertensive patients
chr4	24375832	24375833	rs17650401	Molar-incisor hypomineralization
chr4	24578096	24578097	rs6841898	Myopia (pathological)
chr4	24740957	24740958	rs12500612	Major depressive disorder
chr4	25403265	25403266	rs16877106	Weight
chr4	25417243	25417244	rs3816587	Rheumatoid arthritis
chr4	25810095	25810096	rs959903	Non-alcoholic fatty liver disease histology (other)
chr4	25942750	25942751	rs7654585	Obesity-related traits
chr4	26062989	26062990	rs10019888	HDL cholesterol
chr4	26085510	26085511	rs10517086	Type 1 diabetes
chr4	26108196	26108197	rs874040	Rheumatoid arthritis
chr4	26137018	26137019	rs907499	Obesity-related traits
chr4	26944313	26944314	rs6844153	Phospholipid levels (plasma)
chr4	27000994	27000995	rs6822297	Obesity-related traits
chr4	27194070	27194071	rs13149020	QT interval
chr4	27744717	27744718	rs4692256	Brain imaging
chr4	29903051	29903052	rs7442317	Attention deficit hyperactivity disorder motor coordination
chr4	30068212	30068213	rs6818288	Obesity-related traits
chr4	30468165	30468166	rs6856768	Alzheimer's disease
chr4	31156177	31156178	rs74879986	Bulimia nervosa
chr4	31397617	31397618	rs6448771	Lipid traits
chr4	33079654	33079655	rs1448284	Brain structure (temporal lobe volume)
chr4	33203139	33203140	rs10517270	Alzheimer's disease (age of onset)
chr4	33624701	33624702	rs10517287	Response to antidepressant treatment
chr4	34893854	34893855	rs17390445	Response to antipsychotic treatment
chr4	34925063	34925064	rs1317830	Body mass index (non-asthmatics)
chr4	35372097	35372098	rs437943	Response to TNF antagonist treatment
chr4	35410630	35410631	rs1533317	QT interval
chr4	35983110	35983111	rs6834483	Obesity-related traits
chr4	36026746	36026747	rs1567482	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)
chr4	36079593	36079594	rs12651329	Amyotrophic lateral sclerosis (age of onset)
chr4	37064330	37064331	rs13117816	Multiple sclerosis--Brain Glutamate Levels
chr4	37645388	37645389	rs4832928	IgG glycosylation
chr4	37647233	37647234	rs13144232	IgG glycosylation
chr4	37651154	37651155	rs2292298	IgG glycosylation
chr4	37938517	37938518	rs10010758	Periodontal microbiota
chr4	38161063	38161064	rs115426111	Serum dimethylarginine levels (symmetric)
chr4	38161063	38161064	rs115426111	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr4	38325035	38325036	rs6856616	Crohn's disease
chr4	38335822	38335823	rs1487630	Crohn's disease
chr4	38465470	38465471	rs4615179	Obesity-related traits
chr4	38784723	38784724	rs10004195	Helicobacter pylori serologic status
chr4	38792523	38792524	rs4543123	Alcohol consumption
chr4	38798934	38798935	rs55731057	Alcohol consumption
chr4	38811550	38811551	rs2101521	Self-reported allergy
chr4	38812875	38812876	rs17616434	Allergic sensitization
chr4	38829561	38829562	rs55731057	Alcohol consumption
chr4	39088340	39088341	rs35141484	Asthma (childhood onset)
chr4	40303632	40303633	rs6832151	Graves' disease
chr4	40973526	40973527	rs4466078	Dental caries
chr4	41056715	41056716	rs114070671	Opioid sensitivity
chr4	41284710	41284711	rs4861096	Cognitive performance
chr4	41639515	41639516	rs4345220	Migraine with aura
chr4	42453252	42453253	rs10517025	Immune reponse to smallpox (secreted IFN-alpha)
chr4	43052185	43052186	rs9997524	Obesity-related traits
chr4	43320506	43320507	rs2006970	Metabolite levels (5-HIAA/ MHPG Ratio)
chr4	43537599	43537600	rs13130255	Anticoagulant levels
chr4	44212164	44212165	rs17641529	Response to amphetamines
chr4	45175690	45175691	rs13130484	Body mass index
chr4	45175690	45175691	rs13130484	Obesity
chr4	45182526	45182527	rs10938397	Obesity
chr4	45182526	45182527	rs10938397	Body mass index
chr4	45184441	45184442	rs348495	Body mass index
chr4	45364913	45364914	rs10517133	Adiponectin levels
chr4	45867460	45867461	rs7674482	HIV-1 viral setpoint
chr4	46823633	46823634	rs11726563	Migraine - clinic-based
chr4	46968049	46968050	rs2055942	Type 2 diabetes
chr4	47408708	47408709	rs6289	Obesity-related traits
chr4	47551862	47551863	rs13106975	Sphingolipid levels
chr4	47563447	47563448	rs10938494	Sphingolipid levels
chr4	48363982	48363983	rs6837335	Crohn's disease
chr4	49062891	49062892	rs11725957	Response to hepatitis C treatment
chr4	53412128	53412129	rs346923	Biochemical measures
chr4	53756999	53757000	rs2898681	Optic disc size (cup)
chr4	54330866	54330867	rs2412488	DNA methylation (variation)
chr4	54799244	54799245	rs871606	Blood pressure
chr4	55087580	55087581	rs17084051	Corneal curvature
chr4	55087580	55087581	rs17084051	Corneal astigmatism
chr4	55092625	55092626	rs2114039	Corneal curvature
chr4	55124459	55124460	rs7677751	Corneal astigmatism
chr4	55234824	55234825	rs17690232	Height
chr4	55241580	55241581	rs9312648	Response to amphetamines
chr4	55394171	55394172	rs218237	Red blood cell count
chr4	55394171	55394172	rs218237	Mean corpuscular volume
chr4	55394171	55394172	rs218237	Mean corpuscular hemoglobin
chr4	55395023	55395024	rs218238	Red blood cell traits
chr4	55407761	55407762	rs172629	Mean corpuscular volume
chr4	55482817	55482818	rs2537859	Bipolar disorder
chr4	56298193	56298194	rs6832769	Personality dimensions
chr4	56467213	56467214	rs13434995	Adiponectin levels
chr4	56668430	56668431	rs753129	Alzheimer's disease
chr4	56751739	56751740	rs13117307	Cervical cancer
chr4	57334111	57334112	rs12505749	Airflow obstruction
chr4	57786449	57786450	rs1713985	Age-related macular degeneration
chr4	57821308	57821309	rs708547	Bleomycin sensitivity
chr4	57823475	57823476	rs17081935	Height
chr4	57939862	57939863	rs10049992	IgG glycosylation
chr4	59008411	59008412	rs10517437	Cognitive performance
chr4	59213844	59213845	rs17218161	Asthma (childhood onset)
chr4	59305131	59305132	rs1869463	Corneal curvature
chr4	59503725	59503726	rs282708	Acute lymphoblastic leukemia (childhood)
chr4	60748828	60748829	rs10517480	Metabolite levels
chr4	61966272	61966273	rs4599440	Biochemical measures
chr4	62437317	62437318	rs6856328	Response to antipsychotic treatment in schizophrenia (working memory)
chr4	62453208	62453209	rs2172802	Partial epilepsies
chr4	63342269	63342270	rs6819266	Age-related macular degeneration
chr4	63424088	63424089	rs11944965	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
chr4	63893277	63893278	rs145379083	Bulimia nervosa
chr4	65170414	65170415	rs7656244	Kawasaki disease
chr4	65273839	65273840	rs6836944	Axial length
chr4	65392211	65392212	rs1425392	Post-traumatic stress disorder (asjusted for relatedness)
chr4	66470812	66470813	rs4404602	HIV-1 viral setpoint
chr4	67300801	67300802	rs2009314	Obesity-related traits
chr4	67301041	67301042	rs1949200	Sleep quality
chr4	67357453	67357454	rs17730929	Colorectal cancer
chr4	67733856	67733857	rs1155865	Cognitive test performance
chr4	68064439	68064440	rs10518025	Multiple sclerosis (severity)
chr4	68447248	68447249	rs2242330	Parkinson's disease
chr4	69167670	69167671	rs939207	Obesity-related traits
chr4	69591781	69591782	rs293428	Sex hormone-binding globulin levels
chr4	69972462	69972463	rs4356975	Obesity-related traits
chr4	71329489	71329490	rs1109501	Alcoholism (heaviness of drinking)
chr4	72126888	72126889	rs2579330	QT interval
chr4	72604298	72604299	rs222054	Non-alcoholic fatty liver disease histology (other)
chr4	72608382	72608383	rs2282679	Vitamin D levels
chr4	72608382	72608383	rs2282679	Vitamin D insufficiency
chr4	72707820	72707821	rs1851024	Metabolite levels
chr4	73322564	73322565	rs115136538	Lipid metabolism phenotypes
chr4	73417523	73417524	rs1383934	Dental caries
chr4	73515312	73515313	rs7697556	Height
chr4	73645350	73645351	rs12507628	Metabolite levels
chr4	73783403	73783404	rs6816344	Dialysis-related mortality
chr4	74319282	74319283	rs12506899	Tumor biomarkers
chr4	74349157	74349158	rs1894292	Prostate cancer
chr4	74857707	74857708	rs2472649	Inflammatory bowel disease
chr4	74872444	74872445	rs16850360	Metabolite levels
chr4	74956371	74956372	rs546829	White blood cell types
chr4	74977836	74977837	rs1371799	White blood cell count
chr4	75160823	75160824	rs16850864	Immune reponse to smallpox (secreted IL-1beta)
chr4	75170139	75170140	rs16850885	Immune reponse to smallpox (secreted IL-1beta)
chr4	75223710	75223711	rs2168889	Metabolite levels
chr4	75224589	75224590	rs1350666	Attention deficit hyperactivity disorder
chr4	75502486	75502487	rs62314947	Breast size
chr4	76030920	76030921	rs1426063	QT interval
chr4	76332974	76332975	rs2903698	Prion diseases
chr4	76416386	76416387	rs13137105	Response to tocilizumab in rheumatoid arthritis
chr4	76481729	76481730	rs17000647	Parkinson's disease (motor and cognition)
chr4	76889387	76889388	rs2273	Longevity
chr4	77198985	77198986	rs6812193	Parkinson's disease
chr4	77360430	77360431	rs9992101	Creatinine levels
chr4	77368846	77368847	rs17319721	Chronic kidney disease
chr4	77368846	77368847	rs17319721	Renal function and chronic kidney disease
chr4	77398014	77398015	rs10032549	Glomerular filtration rate
chr4	77410317	77410318	rs4859682	Glomerular filtration rate
chr4	77412139	77412140	rs13146355	Renal function-related traits (sCR)
chr4	77412139	77412140	rs13146355	Renal function-related traits (eGRFcrea)
chr4	77412139	77412140	rs13146355	Magnesium levels
chr4	77418680	77418681	rs13106227	Eosinophilic esophagitis (pediatric)
chr4	77420783	77420784	rs1986734	Eosinophilic esophagitis (pediatric)
chr4	77771344	77771345	rs17002253	Adverse response to lamotrigine and phenytoin
chr4	77955204	77955205	rs17002342	Waist-to-hip circumference ratio (interaction)
chr4	78136932	78136933	rs11937061	Response to tocilizumab in rheumatoid arthritis
chr4	78341659	78341660	rs7677281	Lung function (forced expiratory volume in 1 second to forced vital capacity ratio)
chr4	78605368	78605369	rs958617	Tuberculosis
chr4	79079756	79079757	rs17002988	Uric acid levels
chr4	79280692	79280693	rs1268789	Hair morphology
chr4	79513214	79513215	rs2867461	Rheumatoid arthritis
chr4	79589044	79589045	rs10007186	Non-albumin protein levels
chr4	80530670	80530671	rs9307551	Refractive error
chr4	80564507	80564508	rs10518224	Quantitative traits
chr4	80946474	80946475	rs4389526	Ankylosing spondylitis
chr4	80949828	80949829	rs4333130	Ankylosing spondylitis
chr4	81164722	81164723	rs1458038	Systolic blood pressure
chr4	81164722	81164723	rs1458038	Diastolic blood pressure
chr4	81164722	81164723	rs1458038	Blood pressure
chr4	81169911	81169912	rs11099098	Urate levels
chr4	81184340	81184341	rs16998073	Diastolic blood pressure
chr4	81535392	81535393	rs1385890	Obesity-related traits
chr4	81930813	81930814	rs1960445	Refractive error
chr4	82009706	82009707	rs3796804	HIV-1 susceptibility
chr4	82144925	82144926	rs1662853	Pubertal anthropometrics
chr4	82149830	82149831	rs710841	Height
chr4	82150005	82150006	rs788867	Height
chr4	82165789	82165790	rs994014	Height
chr4	82184233	82184234	rs1878528	Height
chr4	82462596	82462597	rs1822818	Major depressive disorder
chr4	83499312	83499313	rs7658637	Cognitive performance
chr4	84373621	84373622	rs4693089	Menopause (age at onset)
chr4	84374479	84374480	rs1494961	Upper aerodigestive tract cancers
chr4	84721813	84721814	rs4693646	Obesity-related traits
chr4	86129615	86129616	rs7691216	IgG glycosylation
chr4	86641148	86641149	rs7692808	PR interval
chr4	86651463	86651464	rs7660702	Electrocardiographic traits
chr4	86683559	86683560	rs11732231	PR interval
chr4	86715311	86715312	rs7687906	Obesity-related traits
chr4	87473775	87473776	rs4478147	Migraine - clinic-based
chr4	87683714	87683715	rs181519890	Serum dimethylarginine levels (symmetric)
chr4	87754418	87754419	rs10050311	Insulin-related traits
chr4	87832600	87832601	rs3113494	Amyotrophic lateral sclerosis
chr4	87931403	87931404	rs340635	Alzheimer's disease (cognitive decline)
chr4	87958394	87958395	rs340630	Systemic lupus erythematosus
chr4	88030260	88030261	rs442177	Triglycerides
chr4	88076128	88076129	rs115694618	Bulimia nervosa
chr4	88186508	88186509	rs7694379	Platelet counts
chr4	88213807	88213808	rs6834314	Liver enzyme levels (alanine transaminase)
chr4	88400109	88400110	rs4610302	Esophageal adenocarcinoma
chr4	88732691	88732692	rs1054627	Bone mineral density
chr4	88755827	88755828	rs7698623	Cardiovascular disease risk factors
chr4	88773848	88773849	rs6532023	Bone mineral density
chr4	88775242	88775243	rs1471403	Bone mineral density (spine)
chr4	88775242	88775243	rs1471403	Bone mineral density (hip)
chr4	88805207	88805208	rs12644436	HIV-1 viral setpoint
chr4	88919105	88919106	rs2725236	Caffeine consumption
chr4	88959921	88959922	rs2725220	Renal function-related traits (urea)
chr4	89039081	89039082	rs1481012	Gout
chr4	89039081	89039082	rs1481012	Response to statin therapy (LDL-C)
chr4	89052322	89052323	rs2231142	Urate levels
chr4	89052322	89052323	rs2231142	Uric acid levels
chr4	89052322	89052323	rs2231142	Serum uric acid levels
chr4	89052322	89052323	rs2231142	Gout
chr4	89054666	89054667	rs4148155	Urate levels
chr4	89064580	89064581	rs3114018	Dental caries
chr4	89203669	89203670	rs893971	Conduct disorder (interaction)
chr4	89220943	89220944	rs9995093	Bipolar disorder
chr4	89226421	89226422	rs1440581	Metabolite levels
chr4	89421085	89421086	rs10516809	Pulmonary function decline
chr4	89741268	89741269	rs3822072	HDL cholesterol
chr4	89811194	89811195	rs2609255	Interstitial lung disease
chr4	89869331	89869332	rs2869967	Pulmonary function (interaction)
chr4	89869331	89869332	rs2869967	Pulmonary function
chr4	89875908	89875909	rs1964516	Chronic obstructive pulmonary disease
chr4	89883978	89883979	rs7671167	Chronic obstructive pulmonary disease
chr4	89978799	89978800	rs16996151	Response to antipsychotic therapy (extrapyramidal side effects)
chr4	90637600	90637601	rs356219	Parkinson's disease
chr4	90639514	90639515	rs11931074	Parkinson's disease
chr4	90641339	90641340	rs356220	Parkinson's disease
chr4	90678540	90678541	rs2736990	Parkinson's disease
chr4	90780901	90780902	rs6532194	Parkinson's disease
chr4	90797300	90797301	rs6532197	Parkinson's disease
chr4	91401610	91401611	rs187200046	Metabolite levels (HVA-5-HIAA Factor score)
chr4	91401610	91401611	rs187200046	Metabolite levels (HVA)
chr4	92003896	92003897	rs6532271	Response to amphetamines
chr4	92415528	92415529	rs11933531	DNA methylation (variation)
chr4	92917214	92917215	rs6853847	IgG glycosylation
chr4	93321026	93321027	rs7666831	Obesity-related traits
chr4	94887030	94887031	rs13130787	Colorectal cancer
chr4	95146134	95146135	rs11097407	Bipolar disorder and schizophrenia
chr4	95153348	95153349	rs3106136	Capecitabine sensitivity
chr4	95224811	95224812	rs17021463	Testicular germ cell tumor
chr4	95514608	95514609	rs12500426	Prostate cancer
chr4	95562876	95562877	rs17021918	Prostate cancer
chr4	95614277	95614278	rs17022027	Visceral fat
chr4	95615768	95615769	rs4699587	Estradiol plasma levels (breast cancer)
chr4	95643956	95643957	rs10027628	QT interval
chr4	95834033	95834034	rs1859156	Attention deficit hyperactivity disorder
chr4	95856680	95856681	rs10021303	Hypertension
chr4	96159816	96159817	rs12643654	P-tau181p
chr4	96467502	96467503	rs11097470	Obesity-related traits
chr4	97880408	97880409	rs7694207	Response to mTOR inhibitor (everolimus)
chr4	99337880	99337881	rs10516430	Biochemical measures
chr4	99796783	99796784	rs7665590	Primary biliary cirrhosis
chr4	100011170	100011171	rs13132688	Obesity-related traits
chr4	100014804	100014805	rs2602836	HDL cholesterol
chr4	100056997	100056998	rs3805322	Esophageal cancer  (alcohol interaction)
chr4	100137493	100137494	rs6820368	QRS duration
chr4	100163872	100163873	rs2201728	Cardiac Troponin-T levels
chr4	100228465	100228466	rs1042026	Esophageal cancer  (alcohol interaction)
chr4	100239318	100239319	rs1229984	Alcohol consumption
chr4	100239318	100239319	rs1229984	Alcohol dependence
chr4	100239318	100239319	rs1229984	Upper aerodigestive tract cancers
chr4	100239318	100239319	rs1229984	Esophageal cancer
chr4	100250418	100250419	rs1789891	Alcohol dependence
chr4	100250418	100250419	rs1789891	Conduct disorder (interaction)
chr4	100274285	100274286	rs1789924	Upper aerodigestive tract cancers
chr4	100322444	100322445	rs991316	Hypertension
chr4	100341860	100341861	rs971074	Upper aerodigestive tract cancers
chr4	100395413	100395414	rs148915469	Eating disorders
chr4	100444683	100444684	rs13126513	Metabolite levels (MHPG)
chr4	100539895	100539896	rs1032355	Celiac disease
chr4	100713764	100713765	rs11735070	Response to antipsychotic treatment
chr4	101806531	101806532	rs13107740	Response to angiotensin II receptor blocker therapy
chr4	101931825	101931826	rs1405687	Response to antipsychotic treatment
chr4	102037718	102037719	rs2659546	Corneal structure
chr4	102402214	102402215	rs6846071	C-reactive protein and white blood cell count
chr4	102432701	102432702	rs890448	Acute urticaria and angiodema (non-steroidal anti-inflammatory drug-induced)
chr4	102560289	102560290	rs17031508	Blood pressure
chr4	102589282	102589283	rs7700191	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr4	102715887	102715888	rs4522865	Systemic lupus erythematosus
chr4	102751075	102751076	rs10516487	Systemic lupus erythematosus
chr4	102865303	102865304	rs13126505	Crohn's disease
chr4	103188708	103188709	rs13107325	HDL cholesterol
chr4	103188708	103188709	rs13107325	Systolic blood pressure
chr4	103188708	103188709	rs13107325	Hypertension
chr4	103188708	103188709	rs13107325	Diastolic blood pressure
chr4	103188708	103188709	rs13107325	Blood pressure
chr4	103188708	103188709	rs13107325	Body mass index
chr4	103349739	103349740	rs6533014	Homeostasis model assessment of beta-cell function (interaction)
chr4	103457417	103457418	rs230529	Schizophrenia (treatment refractory)
chr4	103511113	103511114	rs3774959	Ulcerative colitis
chr4	103551602	103551603	rs7665090	Primary biliary cirrhosis
chr4	103578636	103578637	rs228614	Multiple sclerosis
chr4	104054685	104054686	rs2720460	Testicular germ cell tumor
chr4	104137789	104137790	rs4699052	Testicular germ cell tumor
chr4	105844272	105844273	rs10005603	Tuberculosis
chr4	106048359	106048360	rs1541374	Pulmonary function
chr4	106061533	106061534	rs7679673	Prostate cancer
chr4	106084777	106084778	rs9790517	Breast cancer
chr4	106106352	106106353	rs10010325	Height
chr4	106134315	106134316	rs6855629	Height
chr4	106268593	106268594	rs2647264	Immune response to anthrax vaccine
chr4	106297512	106297513	rs2636697	Response to antipsychotic treatment
chr4	106451310	106451311	rs12499086	Economic and political preferences (time)
chr4	106457329	106457330	rs7669317	Response to antipsychotic therapy (extrapyramidal side effects)
chr4	106463712	106463713	rs11730243	Economic and political preferences (time)
chr4	106578753	106578754	rs1982346	Lung function (forced expiratory volume in 1 second)
chr4	106619139	106619140	rs11727189	Pulmonary function
chr4	106688903	106688904	rs10516526	Pulmonary function
chr4	106808106	106808107	rs17331332	Pulmonary function (interaction)
chr4	107000461	107000462	rs11097912	Airflow obstruction
chr4	108115221	108115222	rs10516541	Mean forced vital capacity from 2 exams
chr4	109016823	109016824	rs898518	Chronic lymphocytic leukemia
chr4	109046959	109046960	rs956237	Systemic lupus erythematosus
chr4	109217928	109217929	rs13144621	Airflow obstruction
chr4	109723125	109723126	rs4956211	Systemic lupus erythematosus
chr4	110590478	110590479	rs4698775	Age-related macular degeneration
chr4	110659066	110659067	rs10033900	Age-related macular degeneration (GA)
chr4	110659066	110659067	rs10033900	Age-related macular degeneration (CNV)
chr4	110659066	110659067	rs10033900	Age-related macular degeneration
chr4	110727559	110727560	rs4698790	Homeostasis model assessment of insulin resistance (interaction)
chr4	110727559	110727560	rs4698790	Fasting insulin (interaction)
chr4	110800096	110800097	rs6847149	Exercise treadmill test traits
chr4	110825633	110825634	rs17316633	Hair morphology
chr4	110897584	110897585	rs11568995	IgG glycosylation
chr4	110964361	110964362	rs10012953	Obesity-related traits
chr4	111026926	111026927	rs10011926	Attention deficit hyperactivity disorder
chr4	111227815	111227816	rs13148252	IgG glycosylation
chr4	111334729	111334730	rs2087160	Metabolic traits
chr4	111381637	111381638	rs6825911	Blood pressure
chr4	111705767	111705768	rs6817105	Atrial fibrillation
chr4	111708286	111708287	rs17042171	Atrial fibrillation
chr4	111710168	111710169	rs2200733	Atrial fibrillation
chr4	111710168	111710169	rs2200733	Stroke (ischemic)
chr4	111710168	111710169	rs2200733	Atrial fibrillation/atrial flutter
chr4	111718066	111718067	rs6843082	Stroke (ischemic)
chr4	111718066	111718067	rs6843082	Atrial fibrillation
chr4	111720760	111720761	rs10033464	Atrial fibrillation/atrial flutter
chr4	112611749	112611750	rs10034228	Myopia (pathological)
chr4	112702634	112702635	rs1585471	Myopia (pathological)
chr4	112923236	112923237	rs17589290	Coronary heart disease
chr4	113311789	113311790	rs4833407	Obesity
chr4	113328077	113328078	rs6838440	Epirubicin-induced leukopenia
chr4	113948789	113948790	rs10014072	Blood trace element (Cu levels)
chr4	114000955	114000956	rs7694725	Prostate cancer (gene x gene interaction)
chr4	114379378	114379379	rs1880529	White matter integrity (interaction)
chr4	114683843	114683844	rs6858698	Chronic lymphocytic leukemia
chr4	116196305	116196306	rs13144478	Resistin levels
chr4	116924183	116924184	rs17586843	Age-related macular degeneration
chr4	116934078	116934079	rs7676999	Age-related macular degeneration
chr4	117254288	117254289	rs2389202	Sudden cardiac arrest
chr4	117849448	117849449	rs2389339	IgG glycosylation
chr4	117875260	117875261	rs1440306	Bronchopulmonary dysplasia
chr4	118079906	118079907	rs10516635	Visceral adipose tissue adjusted for BMI
chr4	118093136	118093137	rs10433903	Obesity (extreme)
chr4	118332254	118332255	rs4318720	QT interval
chr4	118651822	118651823	rs4422476	Neutrophil count
chr4	119863475	119863476	rs1472066	IgE levels in asthmatics
chr4	120187610	120187611	rs11098499	Corneal astigmatism
chr4	120962384	120962385	rs1845344	F-cell distribution
chr4	121041285	121041286	rs1493682	HIV-1 viral setpoint
chr4	121513214	121513215	rs10017284	F-cell distribution
chr4	121801789	121801790	rs180730	Fasting plasma glucose
chr4	121862500	121862501	rs10018902	Obesity-related traits
chr4	122106292	122106293	rs17051310	Breast cancer
chr4	122110974	122110975	rs921551	Breast cancer
chr4	122121493	122121494	rs17435444	Breast cancer
chr4	122126807	122126808	rs13116936	Breast cancer
chr4	122136762	122136763	rs4455437	Breast cancer
chr4	122143663	122143664	rs6835704	Breast cancer
chr4	122607177	122607178	rs55645543	Chronic obstructive pulmonary disease
chr4	122665513	122665514	rs7659604	Type 2 diabetes
chr4	123115501	123115502	rs13151961	Celiac disease
chr4	123132491	123132492	rs4505848	Type 1 diabetes
chr4	123161618	123161619	rs7657746	Inflammatory bowel disease
chr4	123198434	123198435	rs6534347	Type 1 diabetes
chr4	123218312	123218313	rs13119723	Rheumatoid arthritis
chr4	123329361	123329362	rs17388568	Self-reported allergy
chr4	123329361	123329362	rs17388568	Type 1 diabetes autoantibodies
chr4	123329361	123329362	rs17388568	Ulcerative colitis
chr4	123329361	123329362	rs17388568	Type 1 diabetes
chr4	123353431	123353432	rs17454584	Allergic sensitization
chr4	123373132	123373133	rs2069772	IgE grass sensitization
chr4	123377979	123377980	rs2069762	Type 1 diabetes autoantibodies
chr4	123478715	123478716	rs6852535	Progressive supranuclear palsy
chr4	123509420	123509421	rs6822844	Celiac disease
chr4	123523874	123523875	rs7682241	Alopecia areata
chr4	125265312	125265313	rs2125000	Major depressive disorder
chr4	125415533	125415534	rs6534441	Major depressive disorder
chr4	125993501	125993502	rs1986655	Bilirubin levels
chr4	126359455	126359456	rs1395241	Bipolar disorder and major depressive disorder (combined)
chr4	126426694	126426695	rs12639834	Cognitive performance
chr4	126431918	126431919	rs950063	Smoking behavior
chr4	126933291	126933292	rs1320267	Subclinical atherosclerosis traits (other)
chr4	128320907	128320908	rs1443170	Obesity-related traits
chr4	128342119	128342120	rs724950	Obesity-related traits
chr4	128466699	128466700	rs2090104	IgG glycosylation
chr4	129696220	129696221	rs1974942	Thiazide-induced adverse metabolic effects in hypertensive patients
chr4	130731283	130731284	rs4864201	Obesity
chr4	131013139	131013140	rs11933661	Alcohol dependence
chr4	131026487	131026488	rs114646238	Metabolite levels (HVA/MHPG ratio)
chr4	131127632	131127633	rs1908039	Intelligence
chr4	131131415	131131416	rs11099040	Intelligence
chr4	131132899	131132900	rs13113376	Intelligence
chr4	131133490	131133491	rs1908038	Intelligence
chr4	131137760	131137761	rs1024020	RR interval (heart rate)
chr4	131790500	131790501	rs1478091	Multiple sclerosis (severity)
chr4	133326394	133326395	rs7690467	Eating disorders
chr4	134947800	134947801	rs1494978	Lung function (forced expiratory volume in 1 second)
chr4	135522739	135522740	rs10026364	Coronary heart disease
chr4	136193339	136193340	rs17639207	Sexual dimorphism in anthropometric traits
chr4	137526583	137526584	rs10012307	DNA methylation (parent-of-origin)
chr4	137660382	137660383	rs6813479	Longevity
chr4	138134580	138134581	rs10519410	Adverse response to radiation therapy
chr4	138154811	138154812	rs10004839	Retinopathy in non-diabetics
chr4	138227608	138227609	rs987360	Temperament
chr4	138582710	138582711	rs17049741	Obesity-related traits
chr4	138692249	138692250	rs2313132	Systemic lupus erythematosus
chr4	140423133	140423134	rs17050782	Smoking behavior
chr4	140795326	140795327	rs1531070	Congenital heart malformation
chr4	142005572	142005573	rs10007052	Chronic obstructive pulmonary disease-related biomarkers
chr4	142117423	142117424	rs1550057	Conduct disorder (case status)
chr4	142142728	142142729	rs17007017	Conduct disorder (case status)
chr4	142709722	142709723	rs17007695	Response to treatment for acute lymphoblastic leukemia
chr4	144003158	144003159	rs7686660	Asthma
chr4	144357736	144357737	rs3805236	Asthma
chr4	145436323	145436324	rs12504628	Pulmonary function
chr4	145460229	145460230	rs13147758	Pulmonary function
chr4	145480779	145480780	rs1828591	Chronic obstructive pulmonary disease
chr4	145485737	145485738	rs1980057	Pulmonary function (interaction)
chr4	145485737	145485738	rs1980057	Pulmonary function
chr4	145486388	145486389	rs13118928	Chronic obstructive pulmonary disease
chr4	145506455	145506456	rs13141641	Chronic obstructive pulmonary disease
chr4	145522757	145522758	rs2353398	Height
chr4	145568351	145568352	rs7689420	Height
chr4	145574843	145574844	rs1812175	Height
chr4	145643078	145643079	rs6854783	Height
chr4	145650020	145650021	rs1492820	Height
chr4	146769073	146769074	rs1027841	Behavioural disinhibition (generation interaction)
chr4	146794620	146794621	rs4547811	Liver enzyme levels (gamma-glutamyl transferase)
chr4	146821409	146821410	rs4835265	Gamma glutamyl transpeptidase
chr4	146853164	146853165	rs2048161	Immune reponse to smallpox (secreted IFN-alpha)
chr4	146875550	146875551	rs723794	Smooth-surface caries
chr4	146904303	146904304	rs11100904	Dental caries
chr4	147360130	147360131	rs191493117	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr4	147499337	147499338	rs10213084	Heart rate
chr4	148047549	148047550	rs1395821	Coronary heart disease
chr4	148282341	148282342	rs1429138	Dental caries
chr4	148322386	148322387	rs1429107	Obesity-related traits
chr4	148393663	148393664	rs1878406	Carotid intima media thickness
chr4	148400818	148400819	rs6842241	Intracranial aneurysm
chr4	148612487	148612488	rs11731298	Obesity-related traits
chr4	148884188	148884189	rs7658486	Immune reponse to smallpox (secreted IL-12p40)
chr4	148974601	148974602	rs6845865	QT interval
chr4	149079496	149079497	rs3931397	Corneal structure
chr4	149311727	149311728	rs11725509	Subcutaneous adipose tissue
chr4	149321345	149321346	rs1490453	Biochemical measures
chr4	149570679	149570680	rs2358462	Non-alcoholic fatty liver disease histology (other)
chr4	149635024	149635025	rs10519980	Hypothyroidism
chr4	149652609	149652610	rs10028213	Thyroid function
chr4	149669505	149669506	rs10032216	Thyroid hormone levels
chr4	150725211	150725212	rs10030601	Epilepsy (generalized)
chr4	150901756	150901757	rs11930273	Visceral adipose tissue adjusted for BMI
chr4	151101671	151101672	rs11947645	Social autistic-like traits
chr4	152907699	152907700	rs360929	Volumetric brain MRI
chr4	152908168	152908169	rs360932	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr4	153893353	153893354	rs11099864	Amyotrophic lateral sclerosis
chr4	153896159	153896160	rs77708442	Obesity-related traits
chr4	154153999	154154000	rs12644284	Multiple sclerosis
chr4	154374983	154374984	rs6817170	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr4	154703595	154703596	rs17030434	Electrocardiographic conduction measures
chr4	154864749	154864750	rs13135284	DNA methylation (parent-of-origin)
chr4	154995462	154995463	rs2404916	Obesity-related traits
chr4	155301058	155301059	rs12651106	Fibrinogen
chr4	155316121	155316122	rs902464	Immune reponse to smallpox (secreted IL-1beta)
chr4	155347392	155347393	rs1466662	Alzheimer's disease (age of onset)
chr4	155389246	155389247	rs17031671	Bilirubin levels
chr4	155451758	155451759	rs12511469	Fibrinogen
chr4	155481288	155481289	rs4508864	Fibrinogen
chr4	155481288	155481289	rs4508864	Chronic obstructive pulmonary disease-related biomarkers
chr4	155482742	155482743	rs1800789	Fibrinogen
chr4	155483913	155483914	rs1800788	Fibrinogen
chr4	155488820	155488821	rs6056	Fibrinogen
chr4	155495532	155495533	rs4463047	Fibrinogen
chr4	155507589	155507590	rs6050	Fibrinogen
chr4	155514878	155514879	rs13109457	D-dimer levels
chr4	155520929	155520930	rs7659024	Venous thromboembolism
chr4	155542247	155542248	rs7681423	Fibrinogen
chr4	155543368	155543369	rs6536024	Venous thromboembolism
chr4	155654420	155654421	rs727153	Alzheimer's disease
chr4	156511458	156511459	rs1842896	Coronary heart disease
chr4	156645512	156645513	rs13139571	Systolic blood pressure
chr4	156645512	156645513	rs13139571	Diastolic blood pressure
chr4	156645512	156645513	rs13139571	Blood pressure
chr4	156998540	156998541	rs4234898	Speech perception in dyslexia
chr4	157720123	157720124	rs4691380	Fasting insulin-related traits (interaction with BMI)
chr4	159630816	159630817	rs8396	Metabolic traits
chr4	159630816	159630817	rs8396	Metabolite levels
chr4	160282717	160282718	rs6536413	Intelligence (childhood)
chr4	161028816	161028817	rs17261688	DNA methylation (variation)
chr4	161506896	161506897	rs17291045	HIV-1 control
chr4	162173479	162173480	rs7676384	Response to amphetamines
chr4	162250931	162250932	rs4470583	Diabetic retinopathy
chr4	162602208	162602209	rs17638464	Height
chr4	163243052	163243053	rs4440177	Alcohol dependence
chr4	163738120	163738121	rs6840361	Hair morphology
chr4	164532800	164532801	rs3792615	Type 2 diabetes
chr4	165878334	165878335	rs3733418	Obesity-related traits
chr4	165908720	165908721	rs4691139	Ovarian cancer in BRCA1 mutation carriers
chr4	166255703	166255704	rs17046216	Insulin-related traits
chr4	166830363	166830364	rs12513380	Multiple sclerosis
chr4	166872535	166872536	rs6812849	Post-traumatic stress disorder (asjusted for relatedness)
chr4	166872535	166872536	rs6812849	Post-traumatic stress disorder
chr4	167343938	167343939	rs17635075	Obesity-related traits
chr4	167455492	167455493	rs11941399	Capecitabine sensitivity
chr4	168139379	168139380	rs9312517	Obesity-related traits
chr4	168264248	168264249	rs13111850	Immune reponse to smallpox (secreted IL-10)
chr4	169338519	169338520	rs1963569	Obesity-related traits
chr4	169409957	169409958	rs2710833	Non-alcoholic fatty liver disease histology (AST)
chr4	169530257	169530258	rs17054392	Response to iloperidone treatment (QT prolongation)
chr4	170880882	170880883	rs11723530	Myopia (pathological)
chr4	171053518	171053519	rs11726248	Thyroid hormone levels
chr4	174515681	174515682	rs12646107	Response to amphetamines
chr4	174547156	174547157	rs4129566	Cocaine dependence
chr4	174554831	174554832	rs11944332	Cocaine dependence
chr4	174574405	174574406	rs11723864	Type 1 diabetes nephropathy
chr4	174602047	174602048	rs11727767	Obesity-related traits
chr4	174655913	174655914	rs4521323	Multiple myeloma (IgH translocation)
chr4	175071601	175071602	rs12507634	Thiazide-induced adverse metabolic effects in hypertensive patients
chr4	175300778	175300779	rs6852435	Response to acetaminophen (hepatotoxicity)
chr4	175846425	175846426	rs6828523	Breast cancer
chr4	176008217	176008218	rs72698613	Epilepsy (remission after treatment)
chr4	176270884	176270885	rs2333163	Obesity-related traits
chr4	176626271	176626272	rs12640626	Educational attainment
chr4	176648331	176648332	rs9284954	IgG glycosylation
chr4	176662086	176662087	rs17599018	Temperament (bipolar disorder)
chr4	176859025	176859026	rs7687921	Mortality among heart failure patients
chr4	177542972	177542973	rs13111989	HIV-1 viral setpoint
chr4	178318190	178318191	rs1395479	Serum selenium levels
chr4	178318190	178318191	rs1395479	Heart rate variability traits
chr4	179401432	179401433	rs2702449	Response to mTOR inhibitor (everolimus)
chr4	180048361	180048362	rs17067123	Response to hepatitis C treatment
chr4	180284813	180284814	rs6811556	Ulcerative colitis
chr4	180383311	180383312	rs2716816	Breast size
chr4	180655624	180655625	rs17746001	Bipolar disorder and schizophrenia
chr4	180655624	180655625	rs17746001	Bipolar disorder
chr4	180664652	180664653	rs2383393	Body mass index
chr4	180667646	180667647	rs17090640	Multiple sclerosis
chr4	180687999	180688000	rs6844851	Bipolar disorder
chr4	180704917	180704918	rs11495908	Obesity-related traits
chr4	180968430	180968431	rs1994816	Multiple myeloma (IgH translocation)
chr4	181229199	181229200	rs17834666	Metabolite levels (HVA/MHPG ratio)
chr4	181229199	181229200	rs17834666	Metabolite levels (HVA)
chr4	182222726	182222727	rs17183114	Thiazide-induced adverse metabolic effects in hypertensive patients
chr4	182399694	182399695	rs7672826	Multiple sclerosis
chr4	182484768	182484769	rs1439283	Obesity-related traits
chr4	182609864	182609865	rs12641856	Preeclampsia
chr4	182704550	182704551	rs6855088	Obesity-related traits
chr4	182782544	182782545	rs10520514	Homeostasis model assessment of insulin resistance (interaction)
chr4	182782544	182782545	rs10520514	Fasting insulin (interaction)
chr4	183137397	183137398	rs2726807	Schizophrenia
chr4	183260600	183260601	rs10520528	Systolic blood pressure in sickle cell anemia
chr4	183300613	183300614	rs4862046	IgG glycosylation
chr4	183687788	183687789	rs10017238	Response to amphetamines
chr4	183751028	183751029	rs4862110	Wegener's granulomatosis
chr4	183821661	183821662	rs13114435	Obesity-related traits
chr4	184215674	184215675	rs955748	Height
chr4	184278130	184278131	rs17074636	Gout
chr4	184921298	184921299	rs12498735	Thiazide-induced adverse metabolic effects in hypertensive patients
chr4	185007392	185007393	rs4862307	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr4	185639168	185639169	rs2130392	Kawasaki disease
chr4	186612674	186612675	rs4376189	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr4	187148386	187148387	rs4253238	Circulating vasoactive peptide levels
chr4	187149539	187149540	rs1912826	Metabolite levels
chr4	187152326	187152327	rs4241816	Metabolite levels
chr4	187157457	187157458	rs4253252	Metabolic traits
chr4	187158033	187158034	rs3733402	Obesity-related traits
chr4	187185384	187185385	rs3756008	Venous thromboembolism
chr4	187188093	187188094	rs4253399	Venous thromboembolism
chr4	187195550	187195551	rs1593	Activated partial thromboplastin time
chr4	187207380	187207381	rs2289252	Activated partial thromboplastin time
chr4	187257575	187257576	rs13148903	Response to statin therapy
chr4	187338334	187338335	rs11935103	Response to citalopram treatment
chr4	187678865	187678866	rs925642	Obesity
chr4	188191305	188191306	rs4478239	Major depressive disorder
chr4	188345367	188345368	rs1431005	Response to statin therapy
chr4	189120910	189120911	rs6857559	Myopia (pathological)
chr4	189584352	189584353	rs7686384	Obesity-related traits
chr4	189587078	189587079	rs7659062	Cognitive performance
chr4	189590858	189590859	rs7662358	Cognitive performance
chr4	189861250	189861251	rs11731175	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr4	190123317	190123318	rs7665939	Amyotrophic lateral sclerosis
chr4	190538062	190538063	rs13145041	Periodontitis (CDC/AAP)
chr4	190641169	190641170	rs11132733	Testosterone levels
chr5	428235	428236	rs12188164	Cystic fibrosis severity
chr5	438101	438102	rs10078	Fat distribution (HIV)
chr5	583441	583442	rs4957048	Ulcerative colitis
chr5	594082	594083	rs11739663	Ulcerative colitis
chr5	618585	618586	rs7726839	Obesity-related traits
chr5	1113243	1113244	rs4580814	mean corpuscular hemoglobin concentration
chr5	1279789	1279790	rs10069690	Breast cancer
chr5	1280027	1280028	rs2242652	Prostate cancer
chr5	1286515	1286516	rs2736100	Interstitial lung disease
chr5	1286515	1286516	rs2736100	Lung cancer
chr5	1286515	1286516	rs2736100	Glioma
chr5	1286515	1286516	rs2736100	Lung adenocarcinoma
chr5	1286515	1286516	rs2736100	Testicular germ cell cancer
chr5	1286515	1286516	rs2736100	Red blood cell count
chr5	1286515	1286516	rs2736100	Idiopathic pulmonary fibrosis
chr5	1287193	1287194	rs2853677	Lung adenocarcinoma
chr5	1288546	1288547	rs2853676	Glioma
chr5	1308551	1308552	rs4635969	Testicular germ cell tumor
chr5	1308551	1308552	rs4635969	Testicular germ cell cancer
chr5	1315659	1315660	rs4975616	Lung cancer
chr5	1320721	1320722	rs402710	Lung cancer
chr5	1322086	1322087	rs401681	Bladder cancer
chr5	1322086	1322087	rs401681	Melanoma
chr5	1322086	1322087	rs401681	Serum prostate-specific antigen levels
chr5	1322086	1322087	rs401681	Pancreatic cancer
chr5	1322086	1322087	rs401681	Basal cell carcinoma
chr5	1322086	1322087	rs401681	Lung cancer
chr5	1342713	1342714	rs31489	Lung adenocarcinoma
chr5	1344457	1344458	rs31490	Chronic lymphocytic leukemia
chr5	1877279	1877280	rs4975709	Cardiovascular disease risk factors
chr5	1895828	1895829	rs12653946	Prostate cancer
chr5	2109900	2109901	rs6879627	Pancreatic cancer
chr5	2335580	2335581	rs17586674	Cognitive performance
chr5	2724361	2724362	rs2173226	Obesity-related traits
chr5	3092191	3092192	rs6873793	QT interval
chr5	3276695	3276696	rs61670327	Epilepsy (remission after treatment)
chr5	3558537	3558538	rs10512697	Immune response to smallpox vaccine (IL-6)
chr5	3939475	3939476	rs492478	Cognitive performance
chr5	4029788	4029789	rs11748327	Myocardial infarction
chr5	4488244	4488245	rs10462794	DNA methylation (variation)
chr5	4720584	4720585	rs7727102	Bipolar disorder and schizophrenia
chr5	4831600	4831601	rs816475	Heart rate
chr5	5297199	5297200	rs16875288	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia
chr5	5320255	5320256	rs3806872	Breast cancer
chr5	5324982	5324983	rs16875333	Breast cancer
chr5	5407813	5407814	rs2964475	Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
chr5	5792506	5792507	rs32566	Morbidity-free survival
chr5	5897693	5897694	rs7728043	QT interval
chr5	6324292	6324293	rs12518614	End-stage coagulation
chr5	6599221	6599222	rs6876835	Visceral fat
chr5	6635590	6635591	rs472402	Response to amphetamines
chr5	6767311	6767312	rs12520016	Eye color
chr5	6813936	6813937	rs275456	Paclitaxel-induced neuropathy
chr5	6821913	6821914	rs1566039	Sphingolipid levels
chr5	6834166	6834167	rs11134178	Attention deficit hyperactivity disorder
chr5	6879977	6879978	rs275437	Obesity-related traits
chr5	7155611	7155612	rs4702435	Obesity-related traits
chr5	7228046	7228047	rs7729273	Cognitive performance
chr5	7368844	7368845	rs13172324	Myopia (pathological)
chr5	7649859	7649860	rs4702484	Capecitabine sensitivity
chr5	7816644	7816645	rs326155	Visceral fat
chr5	8652869	8652870	rs200113	Uric acid levels
chr5	8983720	8983721	rs11134338	Obesity-related traits
chr5	9332280	9332281	rs7702187	Parkinson's disease
chr5	9474945	9474946	rs433755	Obesity-related traits
chr5	9623621	9623622	rs10513025	Autism
chr5	9756328	9756329	rs7725217	Hypersomnia (HLA-DQB1*06:02 negative)
chr5	9979083	9979084	rs553169	Age-related macular degeneration (smoking status interaction)
chr5	10159540	10159541	rs2009501	Metabolite levels (HVA/MHPG ratio)
chr5	10169822	10169823	rs13361160	Pain
chr5	10372617	10372618	rs2607292	Body mass index
chr5	10464106	10464107	rs2967951	Body mass index
chr5	10467701	10467702	rs1092913	Breast cancer
chr5	10512696	10512697	rs111426949	Metabolite levels (HVA/MHPG ratio)
chr5	10671039	10671040	rs4702718	Obesity-related traits
chr5	10695525	10695526	rs2930047	Inflammatory bowel disease
chr5	10701513	10701514	rs3756407	Metabolite levels (Pyroglutamine)
chr5	10752314	10752315	rs267939	Ulcerative colitis
chr5	10797885	10797886	rs6882716	Alcohol consumption (maxi-drinks)
chr5	10811473	10811474	rs17176973	Bipolar disorder and schizophrenia
chr5	11111770	11111771	rs6884431	Pulmonary function decline
chr5	11169944	11169945	rs6885224	Myopia (pathological)
chr5	11298222	11298223	rs2530215	Bipolar disorder and schizophrenia
chr5	13242973	13242974	rs10066447	Visceral fat
chr5	13505431	13505432	rs4463179	Prostate cancer (gene x gene interaction)
chr5	13740975	13740976	rs6554809	IgE grass sensitization
chr5	13764418	13764419	rs2896103	Subclinical atherosclerosis traits (other)
chr5	13769973	13769974	rs7715811	Subclinical atherosclerosis traits (other)
chr5	13779742	13779743	rs1502050	Subclinical atherosclerosis traits (other)
chr5	13798558	13798559	rs795544	Corneal astigmatism
chr5	14072056	14072057	rs163818	Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)
chr5	14393620	14393621	rs10065203	Paclitaxel-induced neuropathy
chr5	14752849	14752850	rs17250963	Homeostasis model assessment of insulin resistance (interaction)
chr5	15285413	15285414	rs745978	Visceral fat
chr5	15364483	15364484	rs1447276	Obesity-related traits
chr5	15582004	15582005	rs1978633	Economic and political preferences (feminism/equality)
chr5	15618180	15618181	rs12659622	Obesity-related traits
chr5	16038101	16038102	rs1039443	IgG glycosylation
chr5	16812637	16812638	rs17651119	Major depressive disorder
chr5	16913854	16913855	rs17614462	Obesity-related traits
chr5	17003084	17003085	rs6870564	Thiazide-induced adverse metabolic effects in hypertensive patients
chr5	17148910	17148911	rs682748	Hippocampal atrophy
chr5	17215443	17215444	rs2962370	Bipolar disorder (mood-incongruent)
chr5	18483650	18483651	rs4866334	IgG glycosylation
chr5	19440167	19440168	rs349475	Depression (quantitative trait)
chr5	21749347	21749348	rs12109285	Response to tocilizumab in rheumatoid arthritis
chr5	21779153	21779154	rs4701252	Waist circumference
chr5	22812263	22812264	rs780179	Multiple myeloma (IgH translocation)
chr5	23244024	23244025	rs17376026	Economic and political preferences (immigration/crime)
chr5	23542710	23542711	rs2914276	Recombination (males)
chr5	23542710	23542711	rs2914276	Recombination (females)
chr5	25087724	25087725	rs2047267	Uric acid levels
chr5	25420088	25420089	rs1904173	IgG glycosylation
chr5	25692972	25692973	rs193741	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
chr5	25760678	25760679	rs7727656	Hippocampal atrophy
chr5	25841612	25841613	rs396045	Obesity-related traits
chr5	25902341	25902342	rs10038113	Autism
chr5	25967702	25967703	rs4307059	Autism
chr5	26139137	26139138	rs4701523	Visceral fat
chr5	26389261	26389262	rs969088	Response to platinum-based chemotherapy in non-small-cell lung cancer
chr5	26723782	26723783	rs4479806	Anorexia nervosa
chr5	26928065	26928066	rs10057565	Coronary artery calcification
chr5	27611430	27611431	rs12054895	Major depressive disorder
chr5	28340172	28340173	rs11949289	Response to antidepressant treatment
chr5	28747322	28747323	rs2548003	Hip geometry
chr5	29040120	29040121	rs488884	Migraine without aura
chr5	30661572	30661573	rs9292394	Emphysema-related traits
chr5	30899516	30899517	rs6871087	Response to angiotensin II receptor blocker therapy
chr5	31020520	31020521	rs6888304	Liver enzyme levels (gamma-glutamyl transferase)
chr5	31927316	31927317	rs7719829	Obesity-related traits
chr5	32000482	32000483	rs10054504	Renal cell carcinoma
chr5	32689717	32689718	rs6450922	Height
chr5	32748636	32748637	rs10061804	Ovarian reserve
chr5	32768633	32768634	rs3792752	Height
chr5	32804527	32804528	rs1173766	Blood pressure
chr5	32815027	32815028	rs1173771	Systolic blood pressure
chr5	32815027	32815028	rs1173771	Hypertension
chr5	32815027	32815028	rs1173771	Diastolic blood pressure
chr5	32815027	32815028	rs1173771	Blood pressure
chr5	32819072	32819073	rs9292468	Height
chr5	32830520	32830521	rs1173727	Height
chr5	32888817	32888818	rs10472828	Height
chr5	33636593	33636594	rs6868223	Mortality among heart failure patients
chr5	33879791	33879792	rs1364044	Stroke (pediatric)
chr5	33951692	33951693	rs16891982	Hair color
chr5	33951692	33951693	rs16891982	Eye color
chr5	33951692	33951693	rs16891982	Skin pigmentation
chr5	33955325	33955326	rs35390	Melanoma
chr5	33955672	33955673	rs35391	Tanning
chr5	33958958	33958959	rs28777	Black vs. red hair color
chr5	33958958	33958959	rs28777	Black vs. blond hair color
chr5	34628626	34628627	rs409045	Left ventricular mass
chr5	34951149	34951150	rs37439	Response to angiotensin II receptor blocker therapy
chr5	35037114	35037115	rs37369	Serum dimethylarginine levels (symmetric)
chr5	35037114	35037115	rs37369	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr5	35037114	35037115	rs37369	Metabolite levels
chr5	35037114	35037115	rs37369	Urinary metabolites
chr5	35039485	35039486	rs37370	Serum dimethylarginine levels (asymmetric)
chr5	35461199	35461200	rs284737	Metabolite levels (HVA/5-HIAA ratio)
chr5	35799993	35799994	rs3822735	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr5	35803576	35803577	rs931555	Multiple sclerosis
chr5	35852310	35852311	rs6890853	Primary biliary cirrhosis
chr5	35874574	35874575	rs6897932	Multiple sclerosis
chr5	35874574	35874575	rs6897932	Type 1 diabetes
chr5	35876273	35876274	rs3194051	Ulcerative colitis
chr5	35910528	35910529	rs1445898	Type 1 diabetes
chr5	35943041	35943042	rs860413	Primary biliary cirrhosis
chr5	36137619	36137620	rs267759	Response to treatment for acute lymphoblastic leukemia
chr5	36309096	36309097	rs16902947	Serum tamsulosin hydrochloride concentration
chr5	36423930	36423931	rs7735940	Hypertension
chr5	36425592	36425593	rs12522034	Hypertension
chr5	36473236	36473237	rs2937550	IgG glycosylation
chr5	36473236	36473237	rs2937550	Height
chr5	36900842	36900843	rs293748	Obesity-related traits
chr5	38051592	38051593	rs270545	Major depressive disorder
chr5	38452893	38452894	rs7715172	Response to citalopram treatment
chr5	38955795	38955796	rs2043112	Obesity-related traits
chr5	39058355	39058356	rs13160161	Obesity-related traits
chr5	39394988	39394989	rs2255280	Pancreatic cancer
chr5	39397131	39397132	rs11959928	Chronic kidney disease
chr5	39902364	39902365	rs11954519	Urate levels
chr5	39979171	39979172	rs10053502	Myopia (pathological)
chr5	40134776	40134777	rs2548145	Alcoholism (alcohol use disorder factor score)
chr5	40237373	40237374	rs36019094	Obesity-related traits
chr5	40392727	40392728	rs4613763	Multiple sclerosis
chr5	40392727	40392728	rs4613763	Crohn's disease
chr5	40401508	40401509	rs17234657	Crohn's disease
chr5	40410583	40410584	rs11742570	Inflammatory bowel disease
chr5	40410583	40410584	rs11742570	Crohn's disease
chr5	40410934	40410935	rs6451493	Ulcerative colitis
chr5	40415066	40415067	rs1992660	Crohn's disease
chr5	40424425	40424426	rs6896969	Multiple sclerosis
chr5	40431182	40431183	rs1373692	Crohn's disease
chr5	40437947	40437948	rs9292777	Multiple sclerosis
chr5	40437947	40437948	rs9292777	Crohn's disease
chr5	40486895	40486896	rs7720838	Self-reported allergy
chr5	40490789	40490790	rs10440635	Ankylosing spondylitis
chr5	40626752	40626753	rs11955175	Bipolar disorder and schizophrenia
chr5	40791883	40791884	rs13361707	Gastric cancer
chr5	41234045	41234046	rs7443270	Response to fenofibrate (adiponectin levels)
chr5	42288592	42288593	rs11748684	Response to taxane treatment (docetaxel)
chr5	42375242	42375243	rs979233	Systemic lupus erythematosus
chr5	42473554	42473555	rs13188386	Iron status biomarkers
chr5	43382857	43382858	rs11951515	Metabolite levels  (X-11787)
chr5	44186667	44186668	rs4296809	Brain structure
chr5	44365544	44365545	rs2121875	Prostate cancer
chr5	44662514	44662515	rs4415084	Breast cancer
chr5	44706497	44706498	rs10941679	Breast cancer
chr5	44875004	44875005	rs7716600	Breast cancer
chr5	45197778	45197779	rs10941694	Chronic kidney disease and serum creatinine levels
chr5	45285717	45285718	rs981782	Breast cancer
chr5	50026464	50026465	rs282544	Myopia (pathological)
chr5	50233198	50233199	rs151997	Callous-unemotional behaviour
chr5	50634877	50634878	rs6449586	Barrett's esophagus
chr5	50928809	50928810	rs4865673	Dental caries
chr5	51164114	51164115	rs12186641	Congenital heart disease
chr5	51173323	51173324	rs17835853	IgG glycosylation
chr5	51217850	51217851	rs10042348	Bipolar disorder and schizophrenia
chr5	51236325	51236326	rs16879308	Migraine without aura
chr5	51706905	51706906	rs6889746	Presence of antiphospholipid antibodies
chr5	51805741	51805742	rs7702276	Alzheimer's disease biomarkers
chr5	52020395	52020396	rs830884	Response to platinum-based agents
chr5	52179789	52179790	rs2456203	Pulmonary function (interaction)
chr5	52193124	52193125	rs4074793	Liver enzyme levels (gamma-glutamyl transferase)
chr5	52195032	52195033	rs1551943	Pulmonary function
chr5	52552238	52552239	rs27323	IgG glycosylation
chr5	53298024	53298025	rs6450176	HDL cholesterol
chr5	53298024	53298025	rs6450176	Adiponectin levels
chr5	53300661	53300662	rs4311394	Adiponectin levels
chr5	53311501	53311502	rs255758	Rheumatoid arthritis
chr5	53380554	53380555	rs273218	Migraine
chr5	53902338	53902339	rs2548621	Immune response to smallpox vaccine (IL-6)
chr5	55001898	55001899	rs11958779	Height
chr5	55322894	55322895	rs17348299	IgG glycosylation
chr5	55324801	55324802	rs16884711	IgG glycosylation
chr5	55438579	55438580	rs6859219	Rheumatoid arthritis
chr5	55438850	55438851	rs10065637	Crohn's disease
chr5	55510655	55510656	rs4700060	Alzheimer's disease (cognitive decline)
chr5	55560026	55560027	rs1020388	Celiac disease and Rheumatoid arthritis
chr5	55811091	55811092	rs456867	Urate levels
chr5	55833518	55833519	rs30360	Homeostasis model assessment of insulin resistance (interaction)
chr5	55833518	55833519	rs30360	Fasting insulin (interaction)
chr5	55854152	55854153	rs6867983	Waist circumference
chr5	55854152	55854153	rs6867983	Triglycerides
chr5	55859951	55859952	rs11743303	Sexual dimorphism in anthropometric traits
chr5	55861785	55861786	rs9686661	Triglycerides
chr5	56023082	56023083	rs16886165	Breast cancer
chr5	56031883	56031884	rs889312	Breast cancer
chr5	56104307	56104308	rs10461617	Type 2 diabetes
chr5	56666499	56666500	rs10052004	Schizophrenia
chr5	56810137	56810138	rs6892553	Orthostatic hypotension
chr5	57130817	57130818	rs10940579	Prostate cancer (gene x gene interaction)
chr5	57172077	57172078	rs4432842	Birth weight
chr5	57320953	57320954	rs1844437	Hoarding
chr5	58082722	58082723	rs10065350	IgG glycosylation
chr5	58184060	58184061	rs10472076	Breast cancer
chr5	58337480	58337481	rs1353747	Breast cancer
chr5	58407770	58407771	rs10052657	Esophageal cancer
chr5	58560716	58560717	rs17444059	Immune response to smallpox vaccine (IL-6)
chr5	58676048	58676049	rs1823068	Sleepiness
chr5	58713679	58713680	rs2547917	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
chr5	58842773	58842774	rs702543	Neuroticism
chr5	58979945	58979946	rs17382202	Response to antipsychotic treatment
chr5	59096922	59096923	rs2963826	Obesity-related traits
chr5	59369793	59369794	rs1588265	Asthma
chr5	60499130	60499131	rs171748	Schizophrenia
chr5	60731457	60731458	rs7709645	Schizophrenia
chr5	60950210	60950211	rs11738335	Alzheimer's disease
chr5	61025081	61025082	rs4699982	IgG glycosylation
chr5	62074717	62074718	rs16891077	Homeostasis model assessment of insulin resistance (interaction)
chr5	62074717	62074718	rs16891077	Fasting insulin (interaction)
chr5	62384698	62384699	rs71627250	Bronchopulmonary dysplasia
chr5	62586300	62586301	rs7445832	Alcohol and nictotine co-dependence
chr5	62817899	62817900	rs255414	Body mass index
chr5	63033717	63033718	rs10042968	Alcohol and nictotine co-dependence
chr5	64347620	64347621	rs266590	Obesity-related traits
chr5	64417677	64417678	rs7729539	QT interval
chr5	64433399	64433400	rs17206232	Schizophrenia
chr5	64447776	64447777	rs17206779	Osteosarcoma
chr5	64534640	64534641	rs13183791	Bipolar disorder and schizophrenia
chr5	64625511	64625512	rs2307121	Corneal structure
chr5	65739438	65739439	rs10514995	RR interval (heart rate)
chr5	66152257	66152258	rs39861	Epilepsy (generalized)
chr5	66452174	66452175	rs1697137	Carotid atherosclerosis in HIV infection
chr5	66833256	66833257	rs7717572	Prostate cancer (gene x gene interaction)
chr5	67194468	67194469	rs10940138	Menarche (age at onset)
chr5	67307461	67307462	rs10067755	Waist-to-hip circumference ratio (interaction)
chr5	70834891	70834892	rs35131626	Obesity-related traits
chr5	71410355	71410356	rs2199161	Attention deficit hyperactivity disorder
chr5	71716927	71716928	rs10515148	Hip geometry
chr5	72431481	72431482	rs17632159	Urate levels
chr5	72432035	72432036	rs17663555	Renal function-related traits (BUN)
chr5	72551133	72551134	rs7702331	Crohn's disease
chr5	73215236	73215237	rs16871023	D-dimer levels
chr5	73248511	73248512	rs283610	Obesity-related traits
chr5	73276902	73276903	rs6894385	QT interval
chr5	74302657	74302658	rs4555772	Stearic acid (18:0) plasma levels
chr5	74480287	74480288	rs4704187	Response to amphetamines
chr5	74625486	74625487	rs7703051	LDL cholesterol
chr5	74648602	74648603	rs12654264	Metabolite levels
chr5	74648602	74648603	rs12654264	LDL cholesterol
chr5	74651083	74651084	rs3846662	LDL cholesterol
chr5	74651083	74651084	rs3846662	Cholesterol, total
chr5	74655725	74655726	rs3846663	Quantitative traits
chr5	74655725	74655726	rs3846663	LDL cholesterol
chr5	74656538	74656539	rs12916	LDL cholesterol
chr5	74656538	74656539	rs12916	Cholesterol, total
chr5	75003677	75003678	rs2307111	Obesity
chr5	75015241	75015242	rs2112347	Obesity
chr5	75015241	75015242	rs2112347	Body mass index
chr5	75502409	75502410	rs4704296	Migraine - clinic-based
chr5	75622813	75622814	rs3733860	Venous thromboembolism
chr5	75920971	75920972	rs457717	Hearing impairment
chr5	76023493	76023494	rs2227831	Mean platelet volume
chr5	76046938	76046939	rs17568628	Platelet counts
chr5	76224170	76224171	rs2460504	Thiazide-induced adverse metabolic effects in hypertensive patients
chr5	76424948	76424949	rs4457053	Type 2 diabetes
chr5	76518441	76518442	rs4704397	Hypothyroidism
chr5	76518441	76518442	rs4704397	Thyroid stimulating hormone
chr5	76530348	76530349	rs6885099	Thyroid hormone levels
chr5	76535810	76535811	rs2046045	Thyroid function
chr5	76781470	76781471	rs163030	Caudate nucleus volume
chr5	77291939	77291940	rs12655917	Insulin resistance/response
chr5	77630853	77630854	rs6881634	Hippocampal atrophy
chr5	77987523	77987524	rs784420	Economic and political preferences
chr5	78110531	78110532	rs6453417	Attention deficit hyperactivity disorder
chr5	78259887	78259888	rs337847	Hippocampal atrophy
chr5	78272941	78272942	rs2052550	Iron status biomarkers
chr5	78316475	78316476	rs921943	Blood trace element (Se levels)
chr5	78341296	78341297	rs17823642	Metabolite levels
chr5	78414336	78414337	rs506500	Blood trace element (Se levels)
chr5	78756777	78756778	rs10078095	Height
chr5	78829248	78829249	rs7713917	Major depressive disorder
chr5	78845710	78845711	rs13358260	Adiponectin levels
chr5	78943647	78943648	rs6859704	IgG glycosylation
chr5	79098997	79098998	rs259067	Obesity
chr5	79099463	79099464	rs7735699	Bipolar disorder and schizophrenia
chr5	79446903	79446904	rs73772260	Borderline personality disorder features
chr5	80406565	80406566	rs138206701	Eating disorders (purging via substances)
chr5	80406565	80406566	rs138206701	Eating disorders
chr5	80411220	80411221	rs4703822	Orofacial clefts
chr5	80502902	80502903	rs17228156	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)
chr5	80654965	80654966	rs4703516	Orofacial clefts
chr5	80719124	80719125	rs7732320	Glioblastoma
chr5	81087533	81087534	rs410644	Anorexia nervosa
chr5	81939317	81939318	rs1032757	Eosinophilic esophagitis (pediatric)
chr5	82433780	82433781	rs6452524	Hypertension
chr5	82436360	82436361	rs6887846	Hypertension
chr5	82889909	82889910	rs310501	Major depressive disorder
chr5	82960733	82960734	rs3846635	Visceral fat
chr5	82985738	82985739	rs4466137	Prostate cancer
chr5	83173592	83173593	rs4552569	Ankylosing spondylitis
chr5	83499642	83499643	rs347344	Chemerin levels
chr5	84084775	84084776	rs113524839	Alzheimer's disease biomarkers
chr5	84583768	84583769	rs12153606	Blood trace element (Cu levels)
chr5	84606527	84606528	rs4920799	Echocardiographic traits
chr5	85217868	85217869	rs1583686	Obesity-related traits
chr5	86174146	86174147	rs1493354	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
chr5	86177772	86177773	rs2471042	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
chr5	86432616	86432617	rs2032794	Personality dimensions
chr5	87034351	87034352	rs1673101	Major depressive disorder
chr5	87798235	87798236	rs2194025	Retinal arteriolar caliber
chr5	87847585	87847586	rs17421627	Retinal vascular caliber
chr5	88088438	88088439	rs770189	Tonometry
chr5	88099950	88099951	rs4521516	Mean platelet volume
chr5	88138730	88138731	rs11951031	Bone mineral density
chr5	88152116	88152117	rs700585	Platelet counts
chr5	88183650	88183651	rs17560407	Thiazide-induced adverse metabolic effects in hypertensive patients
chr5	88223419	88223420	rs190982	Alzheimer's disease (late onset)
chr5	88354674	88354675	rs10037512	Height
chr5	88376060	88376061	rs1366594	Bone mineral density
chr5	88376060	88376061	rs1366594	Bone mineral density (hip)
chr5	89021577	89021578	rs10514310	Obesity-related traits
chr5	89109749	89109750	rs10514317	Sex hormone-binding globulin levels
chr5	89546108	89546109	rs12518099	Type 2 diabetes and other traits
chr5	89780970	89780971	rs2562519	Nevirapine-induced rash
chr5	90209823	90209824	rs10074525	Obesity-related traits
chr5	90299222	90299223	rs1967256	Response to antipsychotic treatment
chr5	90424278	90424279	rs10514345	Hip geometry
chr5	90762747	90762748	rs933688	Smoking behavior
chr5	90981386	90981387	rs13153333	Subcutaneous adipose tissue
chr5	91275312	91275313	rs421379	Breast cancer (prognosis)
chr5	91518720	91518721	rs10055544	Immune reponse to smallpox (secreted IL-10)
chr5	91893791	91893792	rs1027643	Wilms tumor
chr5	92154578	92154579	rs17668565	Obesity-related traits
chr5	92464415	92464416	rs12519773	Migraine
chr5	92487542	92487543	rs13173682	Obesity-related traits
chr5	92567538	92567539	rs4869419	Natriuretic peptide levels
chr5	93557701	93557702	rs17376456	Diabetic retinopathy
chr5	93810207	93810208	rs6869388	Gallbladder cancer
chr5	94148537	94148538	rs469339	Anorexia nervosa
chr5	94154587	94154588	rs17418283	Bipolar disorder
chr5	94653872	94653873	rs255982	IgG glycosylation
chr5	95036699	95036700	rs153916	Pulmonary function
chr5	95234790	95234791	rs3777200	Serum total protein level
chr5	95241221	95241222	rs10069748	IgG glycosylation
chr5	95246759	95246760	rs3777193	IgG glycosylation
chr5	95262512	95262513	rs11738945	IgG glycosylation
chr5	95273409	95273410	rs7700895	IgG glycosylation
chr5	95301462	95301463	rs918629	IgG glycosylation
chr5	95428683	95428684	rs7734985	IgG glycosylation
chr5	95486939	95486940	rs4869266	IgG glycosylation
chr5	95521776	95521777	rs58263042	Breast size
chr5	95542725	95542726	rs13179048	Fasting glucose-related traits (interaction with BMI)
chr5	95728897	95728898	rs6235	Glycemic traits (pregnancy)
chr5	95728897	95728898	rs6235	Proinsulin levels
chr5	95850249	95850250	rs261967	Body mass index
chr5	95856678	95856679	rs2570467	Waist circumference
chr5	96101943	96101944	rs27524	Hodgkin's lymphoma
chr5	96101943	96101944	rs27524	Psoriasis
chr5	96111370	96111371	rs13160562	Alcohol dependence
chr5	96118865	96118866	rs17482078	Behcet's disease
chr5	96124329	96124330	rs30187	Ankylosing spondylitis
chr5	96129511	96129512	rs27434	Ankylosing spondylitis
chr5	96244548	96244549	rs2549794	Crohn's disease
chr5	96252802	96252803	rs1363907	Inflammatory bowel disease
chr5	97076547	97076548	rs10515260	Estradiol plasma levels (breast cancer)
chr5	97888735	97888736	rs4703129	Asperger disorder
chr5	97929965	97929966	rs461409	Acute urticaria and angiodema (non-steroidal anti-inflammatory drug-induced)
chr5	98579963	98579964	rs17736767	Renal sinus fat
chr5	98593452	98593453	rs1500251	Periodontitis (Mean PAL)
chr5	98715767	98715768	rs11745890	IgG glycosylation
chr5	98781102	98781103	rs1829883	Hemostatic factors and hematological phenotypes
chr5	99342046	99342047	rs10067427	Non-alcoholic fatty liver disease histology (lobular)
chr5	99991647	99991648	rs4702982	Panic disorder
chr5	100301805	100301806	rs17161553	IgG glycosylation
chr5	100948544	100948545	rs13188771	Conduct disorder (interaction)
chr5	101403585	101403586	rs6861497	QRS duration
chr5	101769725	101769726	rs6878284	Schizophrenia
chr5	101859316	101859317	rs1502844	Schizophrenia
chr5	101946797	101946798	rs7705924	Crohn's disease
chr5	102596719	102596720	rs26232	Rheumatoid arthritis
chr5	102759657	102759658	rs17155315	QT interval
chr5	102764047	102764048	rs2099077	Thiazide-induced adverse metabolic effects in hypertensive patients
chr5	104069916	104069917	rs161645	Depression (quantitative trait)
chr5	104199059	104199060	rs1632744	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
chr5	104208012	104208013	rs10074959	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
chr5	104347648	104347649	rs13178964	Blood pressure measurement (low sodium intervention)
chr5	104867935	104867936	rs7447447	Caffeine consumption
chr5	104954327	104954328	rs10479334	Personality dimensions
chr5	105297528	105297529	rs13189969	Obesity-related traits
chr5	105419512	105419513	rs6894797	Obesity-related traits
chr5	106724587	106724588	rs252817	Bipolar disorder and schizophrenia
chr5	106982559	106982560	rs10074258	Hippocampal atrophy
chr5	107111175	107111176	rs1422438	Alzheimer's disease biomarkers
chr5	107400504	107400505	rs288139	Eye color
chr5	107401450	107401451	rs11242661	Response to amphetamines
chr5	107731957	107731958	rs1001579	IgG glycosylation
chr5	107834246	107834247	rs4571457	Ulcerative colitis
chr5	107915735	107915736	rs10447248	Adiponectin levels
chr5	108113343	108113344	rs13177718	Height
chr5	108948936	108948937	rs367615	Colorectal cancer
chr5	109221025	109221026	rs112724034	Alzheimer's disease (cognitive decline)
chr5	109496959	109496960	rs4460176	Hemostatic factors and hematological phenotypes
chr5	110008213	110008214	rs17132261	Cardiac structure and function
chr5	110146445	110146446	rs17513503	IgE grass sensitization
chr5	110146445	110146446	rs17513503	Allergic rhinitis
chr5	110190051	110190052	rs10056340	Allergic sensitization
chr5	110401871	110401872	rs1837253	Asthma
chr5	110405674	110405675	rs3806932	Eosinophilic esophagitis (pediatric)
chr5	110408001	110408002	rs1898671	Allergic rhinitis
chr5	110435489	110435490	rs2416257	Eosinophil counts
chr5	110467498	110467499	rs1438673	Self-reported allergy
chr5	110502428	110502429	rs17132883	Periodontitis (PAL4Q3)
chr5	110539391	110539392	rs1370967	Periodontitis (PAL4Q3)
chr5	110719186	110719187	rs77636885	Alzheimer's disease (cognitive decline)
chr5	110772403	110772404	rs10491334	Longevity
chr5	110772403	110772404	rs10491334	Blood pressure
chr5	110958781	110958782	rs11241130	Obesity-related traits
chr5	111107114	111107115	rs173896	Bipolar disorder and schizophrenia
chr5	111693370	111693371	rs379440	vWF and FVIII levels
chr5	112242967	112242968	rs469727	Attention deficit hyperactivity disorder
chr5	112580289	112580290	rs17323670	Bipolar disorder and schizophrenia
chr5	112715373	112715374	rs6594713	Brain cytoarchitecture
chr5	112723566	112723567	rs1318772	F-cell distribution
chr5	112996653	112996654	rs17135859	F-cell distribution
chr5	113030163	113030164	rs4621553	Sudden cardiac arrest
chr5	113798985	113798986	rs17136627	Coronary arterial lesions in patients with Kawasaki disease
chr5	113849293	113849294	rs400028	Obesity-related traits
chr5	115138747	115138748	rs13174348	IgG glycosylation
chr5	115512351	115512352	rs1396485	Inflammatory biomarkers
chr5	115540572	115540573	rs7709377	Metabolite levels  (X-11787)
chr5	115568756	115568757	rs253959	Bipolar disorder and schizophrenia
chr5	115727837	115727838	rs7702057	Amyotrophic lateral sclerosis
chr5	115733804	115733805	rs7734156	IgG glycosylation
chr5	115759489	115759490	rs26595	Wegener's granulomatosis
chr5	115975655	115975656	rs6898653	Allergic rhinitis
chr5	116513604	116513605	rs12153048	Periodontitis (DPAL)
chr5	117337752	117337753	rs13166814	Subcutaneous adipose tissue
chr5	118356414	118356415	rs111649495	Response to amphetamines
chr5	118435126	118435127	rs116348108	Alzheimer's disease (cognitive decline)
chr5	119937690	119937691	rs1584468	Immune reponse to smallpox (secreted IL-12p40)
chr5	120216036	120216037	rs78975256	Bronchopulmonary dysplasia
chr5	121436595	121436596	rs890749	Thiazide-induced adverse metabolic effects in hypertensive patients
chr5	122264735	122264736	rs2447820	Migraine
chr5	122531346	122531347	rs17470137	Aortic root size
chr5	122615523	122615524	rs6881280	Self-reported allergy
chr5	122657198	122657199	rs1582931	Height
chr5	122685127	122685128	rs2115172	Weight
chr5	122774784	122774785	rs7705033	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr5	122855415	122855416	rs4530754	LDL cholesterol
chr5	122855415	122855416	rs4530754	Cholesterol, total
chr5	123119564	123119565	rs11241713	Amyotrophic lateral sclerosis
chr5	123157421	123157422	rs257016	Alzheimer's disease
chr5	123571159	123571160	rs17501712	Subcutaneous adipose tissue
chr5	123832651	123832652	rs12513663	Major depressive disorder
chr5	124332102	124332103	rs4836133	Body mass index
chr5	124347087	124347088	rs3936060	Body mass index
chr5	124365966	124365967	rs6862844	Erectile dysfunction and prostate cancer treatment
chr5	124743266	124743267	rs2637496	HIV-1 control
chr5	124848905	124848906	rs17468244	Obesity-related traits
chr5	125319455	125319456	rs1073203	Diabetic retinopathy
chr5	125338474	125338475	rs13169113	Cognitive performance
chr5	125918147	125918148	rs13182402	Osteoporosis
chr5	126032963	126032964	rs1546498	QT interval
chr5	126181861	126181862	rs959573	Parkinson's disease (motor and cognition)
chr5	126721852	126721853	rs10519937	IgG glycosylation
chr5	126729449	126729450	rs143954261	Alzheimer's disease (cognitive decline)
chr5	127054277	127054278	rs4835929	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr5	127059941	127059942	rs12513840	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr5	127061970	127061971	rs12523164	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr5	127110485	127110486	rs10463832	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr5	127122311	127122312	rs10463833	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr5	127125761	127125762	rs7722425	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr5	127139615	127139616	rs1515641	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr5	127151975	127151976	rs1421746	Amyotrophic lateral sclerosis (age of onset)
chr5	127169211	127169212	rs245201	Brain imaging in schizophrenia (interaction)
chr5	127382301	127382302	rs146579248	Alzheimer's disease (cognitive decline)
chr5	127522542	127522543	rs10089	Ileal carcinoids
chr5	127640860	127640861	rs27855	Height
chr5	127653021	127653022	rs10057405	Temperament
chr5	127699374	127699375	rs374748	Obesity (extreme)
chr5	127716566	127716567	rs17608902	Migraine with aura
chr5	127716566	127716567	rs17608902	Migraine - clinic-based
chr5	128722695	128722696	rs10077875	Obesity-related traits
chr5	129000385	129000386	rs13436218	Sexual dysfunction (SSRI/SNRI-related)
chr5	129792133	129792134	rs6894216	Response to amphetamines
chr5	129943318	129943319	rs7731657	Fasting plasma glucose
chr5	130017286	130017287	rs4836519	Inflammatory bowel disease
chr5	130413980	130413981	rs6867265	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr5	131402737	131402738	rs3091338	Crohn's disease
chr5	131430117	131430118	rs657075	Rheumatoid arthritis
chr5	131665377	131665378	rs272889	Metabolic traits
chr5	131686145	131686146	rs10058074	Height
chr5	131699866	131699867	rs274546	Height
chr5	131721748	131721749	rs7731390	IgG glycosylation
chr5	131723287	131723288	rs2073643	Asthma
chr5	131742227	131742228	rs6596075	Crohn's disease
chr5	131744573	131744574	rs1016988	Fibrinogen
chr5	131756057	131756058	rs11242111	Fibrinogen
chr5	131769173	131769174	rs2106854	Fibrinogen
chr5	131770804	131770805	rs2188962	Inflammatory bowel disease
chr5	131770804	131770805	rs2188962	Crohn's disease
chr5	131784392	131784393	rs12521868	Crohn's disease
chr5	131796921	131796922	rs11745587	Asthma
chr5	131801725	131801726	rs2522056	Fibrinogen
chr5	131819920	131819921	rs2070729	Platelet counts
chr5	131839617	131839618	rs4705952	C-reactive protein
chr5	131862976	131862977	rs4143832	Eosinophil counts
chr5	131901224	131901225	rs2244012	Asthma
chr5	131973176	131973177	rs2040704	IgE levels
chr5	131995842	131995843	rs1295686	Atopic dermatitis
chr5	131995842	131995843	rs1295686	Asthma
chr5	131995963	131995964	rs20541	Self-reported allergy
chr5	131995963	131995964	rs20541	Hodgkin's lymphoma
chr5	131995963	131995964	rs20541	IgE levels
chr5	131995963	131995964	rs20541	Psoriasis
chr5	132049026	132049027	rs2897442	Atopic dermatitis
chr5	132628883	132628884	rs17166496	Type 1 diabetes
chr5	133021850	133021851	rs6596140	Hypertension
chr5	133203595	133203596	rs1644305	Attention deficit hyperactivity disorder and conduct disorder
chr5	133446574	133446575	rs756699	Multiple sclerosis
chr5	133849176	133849177	rs13187289	Menarche (age at onset)
chr5	134321545	134321546	rs299362	Bulimia nervosa
chr5	134356704	134356705	rs526896	Height
chr5	134366199	134366200	rs3805663	Testicular germ cell tumor
chr5	134372684	134372685	rs31198	Height
chr5	134443605	134443606	rs254560	Ulcerative colitis
chr5	134467699	134467700	rs477687	AIDS progression
chr5	134499091	134499092	rs647161	Colorectal cancer
chr5	134563156	134563157	rs634308	Immune response to anthrax vaccine
chr5	134572228	134572229	rs606854	Obesity-related traits
chr5	135164617	135164618	rs13178541	IgG glycosylation
chr5	135214676	135214677	rs7734448	Obesity-related traits
chr5	136902695	136902696	rs1541364	Bronchopulmonary dysplasia
chr5	137194761	137194762	rs7722600	Heart rate
chr5	137419988	137419989	rs2040862	Atrial fibrillation
chr5	137599333	137599334	rs11242417	Immune reponse to smallpox (secreted IL-12p40)
chr5	137707314	137707315	rs757647	Menarche (age at onset)
chr5	138850904	138850905	rs13181561	Chronic obstructive pulmonary disease-related biomarkers
chr5	138850904	138850905	rs13181561	Immune reponse to smallpox (secreted IFN-alpha)
chr5	138949361	138949362	rs261532	Immune reponse to smallpox (secreted IFN-alpha)
chr5	140372221	140372222	rs31872	Visceral adipose tissue adjusted for BMI
chr5	140682890	140682891	rs3749779	Obesity-related traits
chr5	140700488	140700489	rs10875595	Pulmonary function decline
chr5	141189167	141189168	rs248471	Myopia (pathological)
chr5	141210752	141210753	rs166040	Major depressive disorder
chr5	141445979	141445980	rs6867913	Asthma
chr5	141479064	141479065	rs11167764	Crohn's disease
chr5	141513203	141513204	rs6863411	Inflammatory bowel disease
chr5	141522999	141523000	rs1062158	Multiple sclerosis
chr5	141681787	141681788	rs4624820	Testicular germ cell tumor
chr5	141681787	141681788	rs4624820	Testicular germ cell cancer
chr5	141863603	141863604	rs17577085	Coronary heart disease
chr5	142017859	142017860	rs152528	Cardiac hypertrophy
chr5	142441793	142441794	rs3776331	Uric acid levels
chr5	142899800	142899801	rs12153243	Migraine
chr5	143003604	143003605	rs17100498	Response to antipsychotic treatment
chr5	145038830	145038831	rs10515552	Vitamin B12 levels
chr5	145749534	145749535	rs7718446	Migraine without aura
chr5	146225243	146225244	rs609412	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr5	146320822	146320823	rs1864982	Alcohol dependence
chr5	146415215	146415216	rs9325032	Cognitive test performance
chr5	147225513	147225514	rs891992	Obesity-related traits
chr5	147603066	147603067	rs1368304	IgG glycosylation
chr5	147805119	147805120	rs10043775	Periodontal microbiota
chr5	147842352	147842353	rs11168048	Pulmonary function (interaction)
chr5	147842352	147842353	rs11168048	Pulmonary function
chr5	147845814	147845815	rs3995090	Pulmonary function
chr5	147856332	147856333	rs7733088	Airflow obstruction
chr5	148706298	148706299	rs10044242	Obesity-related traits
chr5	148904091	148904092	rs10058728	Esophageal cancer
chr5	149036975	149036976	rs17710780	Major depressive disorder
chr5	149142066	149142067	rs9285640	Response to fenofibrate
chr5	149210847	149210848	rs32579	Tanning
chr5	149213455	149213456	rs32576	Obesity-related traits
chr5	149406732	149406733	rs2304069	HIV-1 control
chr5	149623364	149623365	rs4958456	Obesity-related traits
chr5	149825869	149825870	rs13177918	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr5	150223386	150223387	rs13361189	Crohn's disease
chr5	150240075	150240076	rs1000113	Crohn's disease
chr5	150258866	150258867	rs11747270	Crohn's disease
chr5	150270419	150270420	rs7714584	Crohn's disease
chr5	150277908	150277909	rs11741861	Inflammatory bowel disease
chr5	150440096	150440097	rs2233287	Systemic sclerosis
chr5	150450235	150450236	rs4958881	Myasthenia gravis
chr5	150458145	150458146	rs10036748	Systemic lupus erythematosus
chr5	150461048	150461049	rs960709	Systemic lupus erythematosus and Systemic sclerosis
chr5	150473673	150473674	rs999556	Myopia (pathological)
chr5	150478317	150478318	rs17728338	Psoriasis
chr5	150585866	150585867	rs7724774	Bulimia nervosa
chr5	150594801	150594802	rs979455	Obesity-related traits
chr5	150746033	150746034	rs10463316	Metabolite levels (Pyroglutamine)
chr5	151344557	151344558	rs170020	Interstitial lung disease
chr5	151568098	151568099	rs294958	Periodontitis (PAL4Q3)
chr5	151734108	151734109	rs1010254	Optic disc size (cup)
chr5	152288452	152288453	rs4262150	Bipolar disorder and schizophrenia
chr5	152504928	152504929	rs1438949	Response to amphetamines
chr5	152540353	152540354	rs2910032	Schizophrenia
chr5	152639676	152639677	rs3112530	Aging (time to event)
chr5	152654478	152654479	rs17504622	Schizophrenia
chr5	152940404	152940405	rs10065813	Obesity-related traits
chr5	152979553	152979554	rs12658202	Anthropometric traits
chr5	153057547	153057548	rs12189362	Sudden cardiac arrest
chr5	153170373	153170374	rs4958351	Asparaginase hypersensitivity in acute lymphoblastic leukemia
chr5	153509595	153509596	rs2033195	Body mass index
chr5	153543465	153543466	rs7708584	Body mass index
chr5	153811489	153811490	rs10037670	Behavioural disinhibition (generation interaction)
chr5	153837105	153837106	rs148763909	Alzheimer's disease (cognitive decline)
chr5	155202527	155202528	rs11134474	Smoking behavior
chr5	155302581	155302582	rs1432723	Obesity-related traits
chr5	155394229	155394230	rs17053082	Type 2 diabetes
chr5	155500991	155500992	rs4704970	Multiple sclerosis (age of onset)
chr5	156139568	156139569	rs157350	Anthropometric traits
chr5	156182047	156182048	rs11135380	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr5	156390296	156390297	rs6882076	Triglycerides
chr5	156390296	156390297	rs6882076	LDL cholesterol
chr5	156390296	156390297	rs6882076	Cholesterol, total
chr5	156398168	156398169	rs1501908	LDL cholesterol
chr5	156464241	156464242	rs2036402	Hypertriglyceridemia
chr5	156506651	156506652	rs193098517	Serum dimethylarginine levels (asymmetric)
chr5	156608999	156609000	rs411174	Personality dimensions
chr5	156815762	156815763	rs871012	IgG glycosylation
chr5	156932375	156932376	rs2277027	Pulmonary function (interaction)
chr5	156932375	156932376	rs2277027	Pulmonary function
chr5	156942284	156942285	rs11740562	Bipolar disorder and schizophrenia
chr5	157410277	157410278	rs11958404	IgG glycosylation
chr5	157683524	157683525	rs11957368	Metabolite levels (Dihydroxy docosatrienoic acid)
chr5	157804456	157804457	rs9313772	Blood pressure
chr5	157845401	157845402	rs11953630	Systolic blood pressure
chr5	157845401	157845402	rs11953630	Hypertension
chr5	157845401	157845402	rs11953630	Diastolic blood pressure
chr5	158175668	158175669	rs13170526	Obesity-related traits
chr5	158244082	158244083	rs1432679	Breast cancer
chr5	158424390	158424391	rs10040979	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
chr5	158603570	158603571	rs1473247	Mean platelet volume
chr5	158604962	158604963	rs10076782	Mean platelet volume
chr5	158717788	158717789	rs2082412	Psoriasis
chr5	158750768	158750769	rs3213094	Psoriasis
chr5	158759899	158759900	rs2546890	Multiple sclerosis
chr5	158759899	158759900	rs2546890	Psoriasis
chr5	158787384	158787385	rs6556412	Crohn's disease
chr5	158814532	158814533	rs10045431	Crohn's disease
chr5	158818744	158818745	rs6556416	Ankylosing spondylitis
chr5	158822644	158822645	rs6887695	Crohn's disease
chr5	158826791	158826792	rs6871626	Inflammatory bowel disease
chr5	158826791	158826792	rs6871626	Ulcerative colitis
chr5	158829526	158829527	rs12188300	Psoriatic arthritis
chr5	158904312	158904313	rs12657996	Response to taxane treatment (placlitaxel)
chr5	158918893	158918894	rs10866713	Multiple sclerosis
chr5	159007777	159007778	rs10065906	Major depressive disorder
chr5	159367970	159367971	rs11750092	Migraine
chr5	159820930	159820931	rs10515808	Weight loss (gastric bypass surgery)
chr5	159849585	159849586	rs1895320	Insulin-related traits
chr5	159879977	159879978	rs2431697	Systemic lupus erythematosus
chr5	159972020	159972021	rs1592749	Response to anti-TNF alpha therapy in inflammatory bowel disease
chr5	162083517	162083518	rs7711337	Autism
chr5	162998514	162998515	rs294588	Aging
chr5	163889279	163889280	rs6556756	Breast cancer
chr5	164764086	164764087	rs1145652	Phospholipid levels (plasma)
chr5	165063883	165063884	rs958994	Carotid atherosclerosis in HIV infection
chr5	165377698	165377699	rs9313296	Weight
chr5	165377698	165377699	rs9313296	Waist circumference
chr5	165957085	165957086	rs2122554	Conduct disorder (symptom count)
chr5	166318189	166318190	rs3853240	Adverse response to lamotrigine and phenytoin
chr5	166389492	166389493	rs17404956	Diabetic retinopathy
chr5	167210471	167210472	rs2973662	Immune response to smallpox vaccine (IL-6)
chr5	167226978	167226979	rs1549309	Dietary macronutrient intake
chr5	167500459	167500460	rs13358864	Uric acid levels
chr5	167643544	167643545	rs6885116	Periodontal microbiota
chr5	168256239	168256240	rs4282339	Height
chr5	168899986	168899987	rs13156607	Waist circumference
chr5	169074055	169074056	rs169082	Protein quantitative trait loci
chr5	169461546	169461547	rs3763048	IgG glycosylation
chr5	169542599	169542600	rs1895302	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
chr5	169950393	169950394	rs11957313	Normalized brain volume
chr5	170240422	170240423	rs11134654	Smooth-surface caries
chr5	170720732	170720733	rs2278255	Visceral fat
chr5	171015622	171015623	rs6892884	Height
chr5	171076226	171076227	rs254893	Quantitative traits
chr5	171181236	171181237	rs153750	Height
chr5	171203437	171203438	rs12153391	Height
chr5	171559530	171559531	rs17570583	Migraine - clinic-based
chr5	172271006	172271007	rs792975	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
chr5	172292305	172292306	rs6890783	Periodontitis (CDC/AAP)
chr5	172480335	172480336	rs251253	PR interval
chr5	172595307	172595308	rs29784	Infantile hypertrophic pyloric stenosis
chr5	172664162	172664163	rs6882776	Heart rate
chr5	172934897	172934898	rs7722022	Adiponectin levels
chr5	172939425	172939426	rs6869841	Prostate cancer
chr5	172984113	172984114	rs889014	Height
chr5	173279841	173279842	rs359457	Crohn's disease
chr5	173337852	173337853	rs17695092	Crohn's disease
chr5	173352762	173352763	rs1106693	Obesity-related traits
chr5	173359330	173359331	rs17763373	Prion diseases
chr5	173362457	173362458	rs6861681	Waist-hip ratio
chr5	173625153	173625154	rs6863418	Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
chr5	173648437	173648438	rs10475598	Information processing speed
chr5	173695777	173695778	rs11952171	Subcutaneous adipose tissue
chr5	173777519	173777520	rs12659144	Multiple myeloma (hyperdiploidy)
chr5	174014113	174014114	rs145848414	Alzheimer's disease (late onset)
chr5	174611339	174611340	rs4336372	Response to anti-TNF treatment in rheumatoid arthritis
chr5	174761094	174761095	rs12652255	Treatment response for severe sepsis
chr5	174782118	174782119	rs251925	Obesity-related traits
chr5	175178874	175178875	rs10039217	Obesity-related traits
chr5	175244033	175244034	rs7448069	Attention deficit hyperactivity disorder (inattention symptoms)
chr5	175849988	175849989	rs2913737	Obesity-related traits
chr5	175956270	175956271	rs890835	Menopause (age at onset)
chr5	176378573	176378574	rs365132	Menopause (age at onset)
chr5	176378573	176378574	rs365132	Menarche and menopause (age at onset)
chr5	176517325	176517326	rs422421	Height
chr5	176691278	176691279	rs10037055	Migraine without aura
chr5	176734647	176734648	rs72813183	Obesity-related traits
chr5	176784511	176784512	rs4075958	Multiple sclerosis
chr5	176794190	176794191	rs12654812	Inflammatory bowel disease
chr5	176794190	176794191	rs12654812	Renal function-related traits (sCR)
chr5	176794190	176794191	rs12654812	Renal function-related traits (eGRFcrea)
chr5	176797342	176797343	rs4074995	Calcium levels
chr5	176798305	176798306	rs11746443	Nephrolithiasis
chr5	176817635	176817636	rs6420094	Chronic kidney disease
chr5	176841338	176841339	rs2545801	Activated partial thromboplastin time
chr5	176841338	176841339	rs2545801	Metabolite levels
chr5	176842473	176842474	rs2731672	Circulating vasoactive peptide levels
chr5	176842473	176842474	rs2731672	Metabolite levels
chr5	176842473	176842474	rs2731672	Platelet function and related traits
chr5	176842473	176842474	rs2731672	Activated partial thromboplastin time
chr5	177019261	177019262	rs57960711	Obesity-related traits
chr5	177808674	177808675	rs2910124	Bulimia nervosa
chr5	177840381	177840382	rs10070303	Obesity-related traits
chr5	178426318	178426319	rs11249608	Pubertal anthropometrics
chr5	178570913	178570914	rs10039254	Attention deficit hyperactivity disorder (time to onset)
chr5	178663407	178663408	rs469568	Stroke (pediatric)
chr5	178699310	178699311	rs901254	Visceral adipose tissue adjusted for BMI
chr5	179032487	179032488	rs6894268	Eating disorders
chr5	179238260	179238261	rs72807343	Alzheimer's disease (late onset)
chr5	179471200	179471201	rs13161895	Coronary heart disease
chr5	179731013	179731014	rs6879260	Height
chr5	179794207	179794208	rs10464059	Parkinson's disease
chr5	179812667	179812668	rs10479469	Fat distribution (HIV)
chr5	180170818	180170819	rs12517906	Weight
chr5	180170818	180170819	rs12517906	Body mass index
chr5	180205937	180205938	rs6859974	Thiazide-induced adverse metabolic effects in hypertensive patients
chr5	180226672	180226673	rs655601	Quantitative traits
chr5	180595137	180595138	rs1279750	Platelet counts
chr6	252144	252145	rs6927090	Hematology traits
chr6	383545	383546	rs1033180	Celiac disease
chr6	396320	396321	rs12203592	Tanning
chr6	396320	396321	rs12203592	Sunburns
chr6	396320	396321	rs12203592	Non-melanoma skin cancer
chr6	396320	396321	rs12203592	Hair color
chr6	396320	396321	rs12203592	Progressive supranuclear palsy
chr6	396320	396321	rs12203592	Freckling
chr6	396320	396321	rs12203592	Eye color
chr6	396320	396321	rs12203592	Black vs. red hair color
chr6	396320	396321	rs12203592	Black vs. blond hair color
chr6	411063	411064	rs872071	Chronic lymphocytic leukemia
chr6	417726	417727	rs9378805	Chronic lymphocytic leukemia
chr6	466032	466033	rs1540771	Freckles
chr6	471135	471136	rs12202284	Non-melanoma skin cancer
chr6	475488	475489	rs12210050	Schizophrenia
chr6	475488	475489	rs12210050	Basal cell carcinoma
chr6	475488	475489	rs12210050	Tanning
chr6	542158	542159	rs6918152	Black vs. red hair color
chr6	542158	542159	rs6918152	Black vs. blond hair color
chr6	566740	566741	rs2476842	Dental caries
chr6	577819	577820	rs9504361	Pit-and-Fissure caries
chr6	858969	858970	rs1572438	Aging
chr6	1318877	1318878	rs11242675	Breast cancer
chr6	1340188	1340189	rs9502893	Pancreatic cancer
chr6	1524569	1524570	rs2569872	Metabolite levels (HVA/MHPG ratio)
chr6	1535997	1535998	rs11242704	Response to hepatitis C treatment
chr6	1573612	1573613	rs2338	Response to platinum-based agents
chr6	1918261	1918262	rs3800131	Obesity-related traits
chr6	2235632	2235633	rs9378688	Caudate nucleus volume
chr6	2355674	2355675	rs2505675	Tuberculosis
chr6	2500819	2500820	rs4959677	Orthostatic hypotension
chr6	2565751	2565752	rs12195826	Obesity-related traits
chr6	3294823	3294824	rs9378357	Obesity-related traits
chr6	3307862	3307863	rs9391988	Homeostasis model assessment of insulin resistance (interaction)
chr6	3307862	3307863	rs9391988	Fasting insulin (interaction)
chr6	3359336	3359337	rs4959235	Antipsychotic-induced QTc interval prolongation
chr6	3433317	3433318	rs17309827	Crohn's disease
chr6	3837197	3837198	rs17318866	Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)
chr6	4379510	4379511	rs17138114	Obesity-related traits
chr6	4512978	4512979	rs6942328	Uric acid levels
chr6	4874758	4874759	rs73717741	Chronic obstructive pulmonary disease
chr6	5260935	5260936	rs2224391	Height
chr6	5600437	5600438	rs9328321	Obesity (early onset extreme)
chr6	6283665	6283666	rs749005	MRI atrophy measures
chr6	6318125	6318126	rs3024321	End-stage coagulation
chr6	6318794	6318795	rs5985	End-stage coagulation
chr6	6331935	6331936	rs1318606	End-stage coagulation
chr6	6337505	6337506	rs11243081	End-stage coagulation
chr6	6341286	6341287	rs17142067	End-stage coagulation
chr6	6612466	6612467	rs2326810	Major depressive disorder (broad)
chr6	6738751	6738752	rs1294410	Waist-hip ratio
chr6	6743148	6743149	rs1294421	Waist-hip ratio
chr6	7102083	7102084	rs675209	Urate levels
chr6	7106315	7106316	rs2842895	Visceral adipose tissue adjusted for BMI
chr6	7118989	7118990	rs11755724	Multiple sclerosis
chr6	7118989	7118990	rs11755724	Age-related macular degeneration
chr6	7217516	7217517	rs6931262	Waist-hip ratio
chr6	7240576	7240577	rs2714337	Fasting glucose-related traits (interaction with BMI)
chr6	7563231	7563232	rs2076295	Interstitial lung disease
chr6	7652716	7652717	rs7739678	Obesity-related traits
chr6	7695972	7695973	rs1885486	Height
chr6	7720058	7720059	rs12198986	Height
chr6	7725759	7725760	rs3812163	Height
chr6	7736742	7736743	rs2068361	Orofacial clefts
chr6	7743662	7743663	rs9505270	Myopia (pathological)
chr6	8001116	8001117	rs9328448	Coronary artery calcification
chr6	8228941	8228942	rs6929568	Coronary artery calcification
chr6	9030335	9030336	rs438259	Attention deficit hyperactivity disorder
chr6	9451196	9451197	rs10484246	Morbidity-free survival
chr6	9853918	9853919	rs4716055	Adiponectin levels
chr6	9937359	9937360	rs149747749	Serum dimethylarginine levels (asymmetric)
chr6	9993736	9993737	rs116201121	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr6	10163967	10163968	rs13195786	Calcium levels
chr6	10176035	10176036	rs12210761	Major depressive disorder
chr6	10897487	10897488	rs2153157	Menopause (age at onset)
chr6	10897487	10897488	rs2153157	Menarche and menopause (age at onset)
chr6	10921530	10921531	rs190994806	Serum dimethylarginine levels (symmetric)
chr6	10921530	10921531	rs190994806	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr6	10960157	10960158	rs6918936	Phospholipid levels (plasma)
chr6	10969140	10969141	rs4713103	Phospholipid levels (plasma)
chr6	10982358	10982359	rs17606561	Phospholipid levels (plasma)
chr6	10982972	10982973	rs3734398	Phospholipid levels (plasma)
chr6	10995014	10995015	rs2236212	Phospholipid levels (plasma)
chr6	11008621	11008622	rs3798713	Phospholipid levels (plasma)
chr6	11040422	11040423	rs3798722	Metabolite levels
chr6	11042908	11042909	rs9393903	Metabolic traits
chr6	11074346	11074347	rs4711171	Phospholipid levels (plasma)
chr6	11076025	11076026	rs1321535	Phospholipid levels (plasma)
chr6	11310418	11310419	rs4437462	HIV-1 susceptibility
chr6	11618166	11618167	rs479526	Reading and spelling
chr6	11730081	11730082	rs2294426	Orofacial clefts (interaction)
chr6	11943525	11943526	rs1205863	Disc degeneration (lumbar)
chr6	12048826	12048827	rs1570989	Alcohol and nictotine co-dependence
chr6	12197212	12197213	rs1040994	Response to antipsychotic treatment
chr6	12296254	12296255	rs5370	Circulating vasoactive peptide levels
chr6	12510126	12510127	rs12198798	Obesity-related traits
chr6	12889003	12889004	rs1332844	Coronary heart disease
chr6	12903956	12903957	rs9349379	Migraine without aura
chr6	12903956	12903957	rs9349379	Migraine - clinic-based
chr6	12903956	12903957	rs9349379	Migraine
chr6	12903956	12903957	rs9349379	Coronary heart disease
chr6	12903956	12903957	rs9349379	Coronary artery calcification
chr6	12927543	12927544	rs12526453	Coronary heart disease
chr6	12927543	12927544	rs12526453	Myocardial infarction (early onset)
chr6	13216057	13216058	rs4715166	Hip geometry
chr6	13270944	13270945	rs1223397	Blood pressure
chr6	13332466	13332467	rs499818	Major CVD
chr6	13722522	13722523	rs204247	Breast cancer
chr6	14096657	14096658	rs12529514	Rheumatoid arthritis
chr6	14173427	14173428	rs853356	Height
chr6	14200146	14200147	rs7758616	Obesity-related traits
chr6	14587002	14587003	rs12213875	Ovarian reserve
chr6	14596364	14596365	rs6914079	Cognitive test performance
chr6	14597981	14597982	rs9296949	Metabolite levels (HVA/MHPG ratio)
chr6	14598819	14598820	rs7770731	Response to antipsychotic treatment in schizophrenia (working memory)
chr6	14636962	14636963	rs707824	Lymphoma
chr6	14719495	14719496	rs17119	Inflammatory bowel disease
chr6	15089150	15089151	rs6941421	Multiple sclerosis (severity)
chr6	16127406	16127407	rs3757354	LDL cholesterol
chr6	16127406	16127407	rs3757354	Cholesterol, total
chr6	16161424	16161425	rs6924995	Response to statin therapy (LDL-C)
chr6	16197193	16197194	rs2142672	LDL cholesterol
chr6	16256042	16256043	rs10484358	Major depressive disorder
chr6	16343055	16343056	rs9383153	Gambling
chr6	16742032	16742033	rs697739	Amyotrophic lateral sclerosis
chr6	17241153	17241154	rs1322846	Immune response to smallpox vaccine (IL-6)
chr6	17633060	17633061	rs2274136	Obesity-related traits
chr6	17699321	17699322	rs12199222	Height
chr6	17813824	17813825	rs10456809	Prostate cancer (gene x gene interaction)
chr6	18791722	18791723	rs41441749	Hyperactive-impulsive symptoms
chr6	19443934	19443935	rs16882214	Breast cancer
chr6	19785587	19785588	rs7739264	Endometriosis
chr6	19803767	19803768	rs6907340	Endometriosis
chr6	19841492	19841493	rs1047014	Height
chr6	19969637	19969638	rs16883019	Response to statin therapy
chr6	20109591	20109592	rs2457335	Obesity-related traits
chr6	20156173	20156174	rs1202199	Hyperactive-impulsive symptoms
chr6	20382599	20382600	rs1570155	Obesity-related traits
chr6	20567540	20567541	rs9460521	Obesity-related traits
chr6	20641335	20641336	rs9348440	Glycemic traits
chr6	20652716	20652717	rs9295474	Type 2 diabetes
chr6	20657563	20657564	rs4712523	Type 2 diabetes and other traits
chr6	20657563	20657564	rs4712523	Type 2 diabetes
chr6	20657864	20657865	rs4712524	Type 2 diabetes
chr6	20661033	20661034	rs10946398	Type 2 diabetes
chr6	20661249	20661250	rs7754840	Type 2 diabetes
chr6	20661249	20661250	rs7754840	Diabetes (gestational)
chr6	20679708	20679709	rs7756992	Type 2 diabetes
chr6	20685485	20685486	rs9356744	Body mass index
chr6	20686572	20686573	rs7766070	Type 2 diabetes
chr6	20688120	20688121	rs10440833	Type 2 diabetes
chr6	20694883	20694884	rs2206734	Body mass index
chr6	20694883	20694884	rs2206734	Ileal carcinoids
chr6	20703951	20703952	rs6931514	Birth weight
chr6	20703951	20703952	rs6931514	Type 2 diabetes
chr6	20717254	20717255	rs9465871	Type 2 diabetes
chr6	20725422	20725423	rs7747752	Glycated hemoglobin levels
chr6	20728730	20728731	rs6908425	Crohn's disease
chr6	20751314	20751315	rs7747724	Bladder cancer
chr6	20766696	20766697	rs4510656	Bladder cancer
chr6	20812587	20812588	rs9358372	Inflammatory bowel disease
chr6	21384612	21384613	rs9466056	Bone mineral density
chr6	21430727	21430728	rs12663356	Crohn's disease
chr6	21455152	21455153	rs9460635	Metabolite levels (HVA-5-HIAA Factor score)
chr6	21996859	21996860	rs2078543	Pulmonary function (interaction)
chr6	22017737	22017738	rs1928168	Pulmonary function (interaction)
chr6	22017737	22017738	rs1928168	Pulmonary function
chr6	22125963	22125964	rs4712653	Neuroblastoma
chr6	22131928	22131929	rs9295536	Neuroblastoma
chr6	22140003	22140004	rs6939340	Neuroblastoma
chr6	22246603	22246604	rs4236016	Cardiac hypertrophy
chr6	22304203	22304204	rs1341239	Paget's disease
chr6	22709738	22709739	rs4712709	Metabolite levels (Pyroglutamine)
chr6	22743402	22743403	rs10498712	Quantitative traits
chr6	22753046	22753047	rs7356884	Obesity-related traits
chr6	23077310	23077311	rs9393366	Tourette syndrome
chr6	23437675	23437676	rs7771911	Immune reponse to smallpox (secreted IL-12p40)
chr6	23841131	23841132	rs9466930	Major depressive disorder
chr6	24062787	24062788	rs146696563	Periodontitis (Mean PAL)
chr6	24107092	24107093	rs6922632	Information processing speed
chr6	24234932	24234933	rs793834	Information processing speed
chr6	24306386	24306387	rs16889038	Airflow obstruction
chr6	24441745	24441746	rs9467160	Liver enzyme levels
chr6	24480294	24480295	rs6911965	Hematological and biochemical traits
chr6	24491474	24491475	rs1883415	Liver enzyme levels (alkaline phosphatase)
chr6	24544966	24544967	rs16889440	Radiation response
chr6	24749412	24749413	rs17419851	Neutrophil count
chr6	24863074	24863075	rs4256430	Electroencephalographic traits in alcoholism
chr6	25488582	25488583	rs2274089	Iron status biomarkers
chr6	25533533	25533534	rs12526480	Mean platelet volume
chr6	25548287	25548288	rs441460	Platelet counts
chr6	25607570	25607571	rs742132	Uric acid levels
chr6	25641199	25641200	rs932316	Iron status biomarkers
chr6	25772046	25772047	rs4712972	Carotid intima media thickness
chr6	25776948	25776949	rs11754288	Cardiovascular disease risk factors
chr6	25813149	25813150	rs1165196	Serum uric acid levels
chr6	25813149	25813150	rs1165196	Urate levels
chr6	25820438	25820439	rs17270561	Iron status biomarkers
chr6	25821615	25821616	rs1165151	Urate levels
chr6	25821769	25821770	rs17342717	Iron levels
chr6	25821769	25821770	rs17342717	Iron status biomarkers
chr6	25821769	25821770	rs17342717	Red blood cell traits
chr6	25823443	25823444	rs1183201	Uric acid levels
chr6	25842950	25842951	rs1408272	Red blood cell traits
chr6	25842950	25842951	rs1408272	Iron status biomarkers
chr6	25842950	25842951	rs1408272	Mean corpuscular hemoglobin
chr6	25842950	25842951	rs1408272	Hematology traits
chr6	25869370	25869371	rs548987	Homocysteine levels
chr6	25870541	25870542	rs1165205	Urate levels
chr6	25997457	25997458	rs12216125	Iron status biomarkers
chr6	26031612	26031613	rs10484434	HIV-1 viral setpoint
chr6	26091178	26091179	rs1799945	Systolic blood pressure
chr6	26091178	26091179	rs1799945	Hypertension
chr6	26091178	26091179	rs1799945	Diastolic blood pressure
chr6	26091178	26091179	rs1799945	Iron levels
chr6	26093140	26093141	rs1800562	LDL cholesterol
chr6	26093140	26093141	rs1800562	Cholesterol, total
chr6	26093140	26093141	rs1800562	Red blood cell traits
chr6	26093140	26093141	rs1800562	Mean corpuscular hemoglobin
chr6	26093140	26093141	rs1800562	Hematology traits
chr6	26093140	26093141	rs1800562	Cardiovascular disease risk factors
chr6	26093140	26093141	rs1800562	Hepcidin levels
chr6	26093140	26093141	rs1800562	Alcohol consumption (transferrin glycosylation)
chr6	26093140	26093141	rs1800562	Iron status biomarkers
chr6	26093140	26093141	rs1800562	Glycated hemoglobin levels
chr6	26093140	26093141	rs1800562	Mean corpuscular volume
chr6	26093140	26093141	rs1800562	Hemoglobin
chr6	26093140	26093141	rs1800562	Hematocrit
chr6	26093140	26093141	rs1800562	Hematological parameters
chr6	26107462	26107463	rs198846	Blood pressure
chr6	26107462	26107463	rs198846	Mean corpuscular volume
chr6	26107462	26107463	rs198846	Hemoglobin
chr6	26116981	26116982	rs12206204	Bilirubin levels
chr6	26200676	26200677	rs806794	Height
chr6	26233386	26233387	rs10946808	Height
chr6	26500562	26500563	rs13194984	Iron status biomarkers
chr6	26510563	26510564	rs1056667	Educational attainment
chr6	27037079	27037080	rs13194491	Iron status biomarkers
chr6	27143882	27143883	rs13194053	Schizophrenia
chr6	27248930	27248931	rs6932590	Schizophrenia
chr6	27278019	27278020	rs16897515	Schizophrenia
chr6	27710164	27710165	rs17693963	Schizophrenia or bipolar disorder
chr6	27710164	27710165	rs17693963	Schizophrenia, schizoaffective disorder or bipolar disorder
chr6	27710164	27710165	rs17693963	Schizophrenia
chr6	28020819	28020820	rs172166	Cardiac Troponin-T levels
chr6	28129788	28129789	rs1150668	Pubertal anthropometrics
chr6	28227603	28227604	rs1635	Schizophrenia
chr6	28322295	28322296	rs6903823	Pulmonary function
chr6	28776116	28776117	rs4324798	Lung adenocarcinoma
chr6	28916251	28916252	rs4947339	Platelet aggregation
chr6	29084231	29084232	rs3129109	Height
chr6	29180720	29180721	rs9257616	Social communication problems
chr6	29351783	29351784	rs9378134	Retinopathy in non-diabetics
chr6	29355201	29355202	rs3094548	Pulmonary function
chr6	29356330	29356331	rs9257809	Barrett's esophagus
chr6	29434413	29434414	rs4713226	Immune reponse to smallpox (secreted IFN-alpha)
chr6	29520876	29520877	rs16895057	Height
chr6	29607045	29607046	rs3095267	Migraine without aura
chr6	29611430	29611431	rs29232	Nasopharyngeal carcinoma
chr6	29626320	29626321	rs2252711	Pulmonary function (interaction)
chr6	29670260	29670261	rs3129055	Nasopharyngeal carcinoma
chr6	29702509	29702510	rs2523395	Prostate cancer (gene x gene interaction)
chr6	29705658	29705659	rs2523393	Multiple sclerosis
chr6	29723160	29723161	rs9258260	Crohn's disease
chr6	29789170	29789171	rs1610677	Rheumatoid arthritis
chr6	29828659	29828660	rs2523822	Drug-induced liver injury (amoxicillin-clavulanate)
chr6	29849618	29849619	rs2523809	IgE levels
chr6	29899676	29899677	rs2524005	Bipolar disorder and schizophrenia
chr6	29906690	29906691	rs2860580	Nasopharyngeal carcinoma
chr6	29913297	29913298	rs1061235	Adverse response to carbamapezine
chr6	29918098	29918099	rs2517713	Nasopharyngeal carcinoma
chr6	29920331	29920332	rs9260489	Beta-2 microglubulin plasma levels
chr6	29920331	29920332	rs9260489	Multiple sclerosis
chr6	29923837	29923838	rs2571391	IgE levels
chr6	29934162	29934163	rs6935053	Ulcerative colitis
chr6	29935249	29935250	rs3893464	Graves' disease
chr6	29941942	29941943	rs2523946	IgA nephropathy
chr6	29943066	29943067	rs6904029	Vitiligo
chr6	29970588	29970589	rs7758512	HIV-1 control
chr6	29973924	29973925	rs4313034	Graves' disease
chr6	30017070	30017071	rs6917603	Lipid metabolism phenotypes
chr6	30025502	30025503	rs259919	HIV-1 control
chr6	30032521	30032522	rs8321	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr6	30032521	30032522	rs8321	AIDS progression
chr6	30075863	30075864	rs2023472	Beta-2 microglubulin plasma levels
chr6	30080368	30080369	rs34704616	Cognitive performance
chr6	30093363	30093364	rs10947055	Cardiac hypertrophy
chr6	30119889	30119890	rs9468692	HIV-1 control
chr6	30165272	30165273	rs2523722	Schizophrenia
chr6	30174130	30174131	rs2021722	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr6	30174130	30174131	rs2021722	Schizophrenia
chr6	30537605	30537606	rs3132613	Graves' disease
chr6	30666668	30666669	rs9468811	IgG glycosylation
chr6	30679627	30679628	rs3094093	IgG glycosylation
chr6	30736150	30736151	rs12526186	Response to antipsychotic treatment
chr6	30737485	30737486	rs3094117	Migraine without aura
chr6	30774356	30774357	rs3130783	Age-related macular degeneration
chr6	30782001	30782002	rs886424	Bipolar disorder and schizophrenia
chr6	30795170	30795171	rs7772131	Response to angiotensin II receptor blocker therapy
chr6	30797990	30797991	rs7749924	IgG glycosylation
chr6	30799398	30799399	rs9501030	Ulcerative colitis
chr6	30848252	30848253	rs7756521	HIV-1 control
chr6	30876151	30876152	rs1052693	Complement C3 and C4 levels
chr6	30913457	30913458	rs3132581	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr6	30938882	30938883	rs9368649	Pulmonary function (interaction)
chr6	30976218	30976219	rs28360974	Preeclampsia
chr6	31002615	31002616	rs4248154	Graves' disease
chr6	31006854	31006855	rs2844665	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
chr6	31018406	31018407	rs2517532	Hypothyroidism
chr6	31024807	31024808	rs9262632	HIV-1 control
chr6	31030121	31030122	rs2517510	White blood cell count
chr6	31058177	31058178	rs4947296	Behcet's disease
chr6	31058177	31058178	rs4947296	Graves' disease
chr6	31058339	31058340	rs3130544	Hematology traits
chr6	31058339	31058340	rs3130544	Myasthenia gravis
chr6	31074029	31074030	rs6457327	Follicular lymphoma
chr6	31085769	31085770	rs3094212	White blood cell count
chr6	31093586	31093587	rs3815087	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
chr6	31093586	31093587	rs3815087	HIV-1 control
chr6	31097300	31097301	rs3130559	Chronic obstructive pulmonary disease-related biomarkers
chr6	31099576	31099577	rs4959053	Behcet's disease
chr6	31106267	31106268	rs3130573	Systemic sclerosis
chr6	31107186	31107187	rs1265093	Chronic obstructive pulmonary disease-related biomarkers
chr6	31107257	31107258	rs2285803	Multiple myeloma
chr6	31111355	31111356	rs9263739	Ulcerative colitis
chr6	31118018	31118019	rs1265112	Nevirapine-induced rash
chr6	31118510	31118511	rs130067	Prostate cancer
chr6	31130592	31130593	rs1419881	Chronic hepatitis B infection
chr6	31136452	31136453	rs3130501	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
chr6	31139451	31139452	rs879882	Height
chr6	31142244	31142245	rs3094188	Crohn's disease
chr6	31143581	31143582	rs3131018	HIV-1 control
chr6	31155784	31155785	rs1265181	Psoriasis
chr6	31168028	31168029	rs6903896	Common traits (Other)
chr6	31184195	31184196	rs3869109	Coronary heart disease
chr6	31186025	31186026	rs9263963	IgG glycosylation
chr6	31221667	31221668	rs3095254	White blood cell types
chr6	31232110	31232111	rs3130542	Hepatitis B
chr6	31238317	31238318	rs9264638	Beta-2 microglubulin plasma levels
chr6	31240430	31240431	rs2074488	Chronic obstructive pulmonary disease-related biomarkers
chr6	31241108	31241109	rs13191343	Psoriatic arthritis
chr6	31242173	31242174	rs2524079	White blood cell count
chr6	31252395	31252396	rs2524054	CD4:CD8 lymphocyte ratio
chr6	31252924	31252925	rs12191877	Psoriasis
chr6	31258836	31258837	rs9468925	Vitiligo
chr6	31263750	31263751	rs2894207	Nasopharyngeal carcinoma
chr6	31265489	31265490	rs2247056	Height
chr6	31265489	31265490	rs2247056	Triglycerides
chr6	31271715	31271716	rs9461688	Protein quantitative trait loci
chr6	31272320	31272321	rs9368677	Atopic dermatitis
chr6	31274379	31274380	rs9264942	Crohn's disease
chr6	31274379	31274380	rs9264942	HIV-1 control
chr6	31274554	31274555	rs10484554	Psoriasis
chr6	31274554	31274555	rs10484554	AIDS progression
chr6	31312325	31312326	rs3134792	Psoriasis
chr6	31322366	31322367	rs3819299	Platelet counts
chr6	31322558	31322559	rs2523608	Beta-2 microglubulin plasma levels
chr6	31322558	31322559	rs2523608	HIV-1 control
chr6	31327063	31327064	rs2523590	HIV-1 control
chr6	31327700	31327701	rs9378249	Bipolar disorder
chr6	31336099	31336100	rs7743761	Ankylosing spondylitis
chr6	31336417	31336418	rs9266406	Behcet's disease
chr6	31346821	31346822	rs9266629	Chronic obstructive pulmonary disease-related biomarkers
chr6	31350703	31350704	rs1521	Graves' disease
chr6	31352112	31352113	rs9266772	Self-reported allergy
chr6	31354181	31354182	rs6932730	Allergic sensitization
chr6	31354559	31354560	rs13437082	Height
chr6	31360254	31360255	rs7751505	Pubertal anthropometrics
chr6	31362309	31362310	rs16899524	Beta-2 microglubulin plasma levels
chr6	31365786	31365787	rs4349859	Ankylosing spondylitis
chr6	31366594	31366595	rs2596542	Hepatocellular carcinoma
chr6	31377586	31377587	rs12175489	Visceral adipose tissue adjusted for BMI
chr6	31379930	31379931	rs1063635	Rheumatoid arthritis
chr6	31380528	31380529	rs2256183	Height
chr6	31390409	31390410	rs2516448	Cervical cancer
chr6	31391400	31391401	rs4418214	HIV-1 susceptibility
chr6	31391400	31391401	rs4418214	HIV-1 control
chr6	31405616	31405617	rs2596466	Beta-2 microglubulin plasma levels
chr6	31407827	31407828	rs9469003	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
chr6	31408264	31408265	rs2524276	Capecitabine sensitivity
chr6	31431690	31431691	rs2255221	HIV-1 control
chr6	31431779	31431780	rs2395029	HIV-1 control
chr6	31431779	31431780	rs2395029	Drug-induced liver injury (flucloxacillin)
chr6	31431779	31431780	rs2395029	AIDS progression
chr6	31431779	31431780	rs2395029	Psoriasis
chr6	31440668	31440669	rs3828890	Renal function-related traits (sCR)
chr6	31440668	31440669	rs3828890	Renal function-related traits (eGRFcrea)
chr6	31446795	31446796	rs2248462	Hodgkin's lymphoma
chr6	31448975	31448976	rs3099844	Metabolic syndrome
chr6	31448975	31448976	rs3099844	Neonatal lupus
chr6	31472719	31472720	rs2855812	Pulmonary function
chr6	31475485	31475486	rs3132468	Dengue shock syndrome
chr6	31481298	31481299	rs2516399	White blood cell types
chr6	31499602	31499603	rs3853601	Atopic dermatitis
chr6	31505479	31505480	rs2734583	Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
chr6	31542307	31542308	rs1799964	Crohn's disease
chr6	31557790	31557791	rs11575839	Complement C3 and C4 levels
chr6	31568468	31568469	rs2857595	Pulmonary function (interaction)
chr6	31568468	31568469	rs2857595	Pulmonary function
chr6	31572955	31572956	rs2844479	Height
chr6	31572955	31572956	rs2844479	IgG glycosylation
chr6	31572955	31572956	rs2844479	Weight
chr6	31575275	31575276	rs9348876	Crohn's disease
chr6	31590897	31590898	rs2736172	Psychosis (atypical)
chr6	31602966	31602967	rs1046089	Schizophrenia
chr6	31602966	31602967	rs1046089	Menopause (age at onset)
chr6	31616365	31616366	rs805303	Systolic blood pressure
chr6	31616365	31616366	rs805303	Hypertension
chr6	31616365	31616366	rs805303	Diastolic blood pressure
chr6	31620519	31620520	rs3117582	Lung adenocarcinoma
chr6	31620519	31620520	rs3117582	Lung cancer
chr6	31622605	31622606	rs805297	Rheumatoid arthritis
chr6	31721032	31721033	rs3131379	Systemic lupus erythematosus
chr6	31778528	31778529	rs2075799	Complement C3 and C4 levels
chr6	31802464	31802465	rs4711279	IgG glycosylation
chr6	31802540	31802541	rs9368699	HIV-1 control
chr6	31837065	31837066	rs11966200	Vitiligo
chr6	31838712	31838713	rs494620	Menopause (age at onset)
chr6	31843923	31843924	rs2736428	Telomere length
chr6	31851233	31851234	rs652888	Chronic hepatitis B infection
chr6	31867252	31867253	rs9267663	Economic and political preferences (environmentalism)
chr6	31870855	31870856	rs9267665	Hepatitis B vaccine response
chr6	31883678	31883679	rs9267673	Hepatocellular carcinoma
chr6	31903803	31903804	rs9332739	Age-related macular degeneration (GA)
chr6	31903803	31903804	rs9332739	Age-related macular degeneration (CNV)
chr6	31903803	31903804	rs9332739	Age-related macular degeneration
chr6	31914179	31914180	rs641153	Age-related macular degeneration (GA)
chr6	31914179	31914180	rs641153	Age-related macular degeneration (CNV)
chr6	31914179	31914180	rs641153	Age-related macular degeneration
chr6	31916950	31916951	rs541862	Age-related macular degeneration
chr6	31919916	31919917	rs522162	Age-related macular degeneration (extreme sampling)
chr6	31919916	31919917	rs522162	Age-related macular degeneration
chr6	31930440	31930441	rs592229	IgG glycosylation
chr6	31930461	31930462	rs429608	Age-related macular degeneration
chr6	31933160	31933161	rs406936	Age-related macular degeneration
chr6	31940896	31940897	rs389884	Hematology traits
chr6	32019745	32019746	rs2857009	Complement C3 and C4 levels
chr6	32026807	32026808	rs12198173	HIV-1 control
chr6	32050066	32050067	rs185819	Height
chr6	32050757	32050758	rs1150754	Systemic lupus erythematosus
chr6	32071016	32071017	rs3117181	Phospholipid levels (plasma)
chr6	32074803	32074804	rs12153855	Atopic dermatitis
chr6	32074803	32074804	rs12153855	Age-related macular degeneration
chr6	32076498	32076499	rs2269426	Eosinophil counts
chr6	32079566	32079567	rs17207986	Ulcerative colitis
chr6	32109978	32109979	rs204999	Serum total protein level
chr6	32109978	32109979	rs204999	Nodular sclerosis Hodgkin lymphoma
chr6	32114514	32114515	rs9296009	IgG glycosylation
chr6	32127476	32127477	rs3134950	Oleic acid (18:1n-9) plasma levels
chr6	32136546	32136547	rs1061808	Phospholipid levels (plasma)
chr6	32151442	32151443	rs2070600	Pulmonary function (interaction)
chr6	32151442	32151443	rs2070600	Pulmonary function
chr6	32155580	32155581	rs204993	Asthma
chr6	32158318	32158319	rs176095	Atopic dermatitis
chr6	32163747	32163748	rs13215567	Obesity-related traits
chr6	32165443	32165444	rs2071278	Complement C3 and C4 levels
chr6	32171074	32171075	rs3132935	Schizophrenia
chr6	32171682	32171683	rs2071277	Age-related macular degeneration
chr6	32172992	32172993	rs3131296	Schizophrenia
chr6	32184344	32184345	rs404860	Asthma
chr6	32190027	32190028	rs3132946	Interstitial lung disease
chr6	32190405	32190406	rs443198	Systemic sclerosis
chr6	32190619	32190620	rs3134931	Circulating myeloperoxidase levels (serum)
chr6	32192330	32192331	rs3096702	Prostate cancer
chr6	32205109	32205110	rs9267911	Crohn's disease
chr6	32208323	32208324	rs424232	Celiac disease
chr6	32218842	32218843	rs3115573	Nephropathy
chr6	32218988	32218989	rs9296015	Systemic sclerosis
chr6	32218988	32218989	rs9296015	Rheumatoid arthritis
chr6	32223257	32223258	rs3130320	Systemic lupus erythematosus
chr6	32244626	32244627	rs3130340	Bone mineral density (spine)
chr6	32257565	32257566	rs926070	Chronic lymphocytic leukemia
chr6	32282853	32282854	rs6910071	Rheumatoid arthritis
chr6	32305978	32305979	rs3129900	Lumiracoxib-related liver injury
chr6	32308907	32308908	rs9469099	Atopic dermatitis
chr6	32315726	32315727	rs910049	Hepatitis C induced liver cirrhosis
chr6	32319636	32319637	rs9268301	Obesity-related traits
chr6	32321553	32321554	rs2395148	Primary biliary cirrhosis
chr6	32321553	32321554	rs2395148	Arthritis (juvenile idiopathic)
chr6	32325370	32325371	rs13196329	Visceral fat
chr6	32336186	32336187	rs3129934	Multiple sclerosis
chr6	32337629	32337630	rs2273017	Graves' disease
chr6	32338694	32338695	rs3129943	Asthma
chr6	32339075	32339076	rs2050190	Activated partial thromboplastin time
chr6	32341352	32341353	rs9268402	Coronary heart disease
chr6	32345282	32345283	rs7758128	Vitiligo
chr6	32358269	32358270	rs3117099	Bipolar disorder and schizophrenia
chr6	32358512	32358513	rs3117098	Asthma
chr6	32363214	32363215	rs1980493	Anti-cyclic Citrullinated Peptide Antibody
chr6	32363815	32363816	rs2076530	Sarcoidosis
chr6	32363843	32363844	rs9268480	Ulcerative colitis
chr6	32363954	32363955	rs2076529	Waist-hip ratio
chr6	32368086	32368087	rs3817963	Multiple sclerosis (OCB status)
chr6	32368086	32368087	rs3817963	Hepatitis C induced liver cirrhosis
chr6	32368086	32368087	rs3817963	Lung adenocarcinoma
chr6	32373231	32373232	rs10947261	Crohn's disease
chr6	32373311	32373312	rs10947262	Knee osteoarthritis
chr6	32373697	32373698	rs3806156	Vitiligo
chr6	32376470	32376471	rs3763313	HIV-1 control
chr6	32376787	32376788	rs3763317	Complement C3 and C4 levels
chr6	32379488	32379489	rs9268516	Asthma
chr6	32379735	32379736	rs9405098	Hepatitis C induced liver cirrhosis
chr6	32383049	32383050	rs4959027	Pubertal anthropometrics
chr6	32383107	32383108	rs9268528	Nodular sclerosis Hodgkin lymphoma
chr6	32384720	32384721	rs9268542	Nodular sclerosis Hodgkin lymphoma
chr6	32387808	32387809	rs2395163	Parkinson's disease
chr6	32389647	32389648	rs3135363	Hepatitis B vaccine response
chr6	32389647	32389648	rs3135363	Hepatitis C induced liver cirrhosis
chr6	32389647	32389648	rs3135363	Primary biliary cirrhosis
chr6	32401078	32401079	rs3129860	Hepatitis C induced liver cirrhosis
chr6	32401216	32401217	rs3135338	Multiple sclerosis
chr6	32406341	32406342	rs3129871	Multiple sclerosis (OCB status)
chr6	32408526	32408527	rs9268645	Type 1 diabetes
chr6	32409529	32409530	rs3129882	Systemic sclerosis
chr6	32409529	32409530	rs3129882	Parkinson's disease
chr6	32411645	32411646	rs7192	Non-obstructive azoospermia
chr6	32412434	32412435	rs3177928	LDL cholesterol
chr6	32412434	32412435	rs3177928	Cholesterol, total
chr6	32413050	32413051	rs3135388	Multiple sclerosis
chr6	32413458	32413459	rs2227139	Hematological parameters
chr6	32413544	32413545	rs3129889	Multiple sclerosis
chr6	32414272	32414273	rs3129890	Asthma
chr6	32428284	32428285	rs6903608	Hodgkin's lymphoma
chr6	32428284	32428285	rs6903608	Nodular sclerosis Hodgkin lymphoma
chr6	32429642	32429643	rs9268853	Ulcerative colitis
chr6	32429642	32429643	rs9268853	Lymphoma
chr6	32429642	32429643	rs9268853	Rheumatoid arthritis
chr6	32431146	32431147	rs9268877	Ulcerative colitis
chr6	32432076	32432077	rs9268905	Cystic fibrosis severity
chr6	32432834	32432835	rs9268923	Ulcerative colitis
chr6	32433166	32433167	rs2395185	Lung cancer
chr6	32433166	32433167	rs2395185	Hodgkin's lymphoma
chr6	32433166	32433167	rs2395185	Ulcerative colitis
chr6	32520906	32520907	rs3828840	Multiple sclerosis (OCB status)
chr6	32560858	32560859	rs28366298	Lung cancer
chr6	32569690	32569691	rs477515	Hepatitis B vaccine response
chr6	32569690	32569691	rs477515	Epstein-Barr virus immune response (EBNA-1)
chr6	32569690	32569691	rs477515	Inflammatory bowel disease
chr6	32572250	32572251	rs2858870	Nodular sclerosis Hodgkin lymphoma
chr6	32573470	32573471	rs9270965	Narcolepsy (onset before 2009 H1N1 influenza pandemic)
chr6	32573990	32573991	rs9270984	Systemic lupus erythematosus
chr6	32574170	32574171	rs615672	Rheumatoid arthritis
chr6	32576477	32576478	rs9271100	Systemic lupus erythematosus
chr6	32576794	32576795	rs9271117	Narcolepsy (onset before 2009 H1N1 influenza pandemic)
chr6	32577379	32577380	rs660895	IgA nephropathy
chr6	32577379	32577380	rs660895	Rheumatoid arthritis
chr6	32578081	32578082	rs674313	Chronic lymphocytic leukemia
chr6	32578529	32578530	rs9271192	Alzheimer's disease (late onset)
chr6	32581888	32581889	rs4530903	Lymphoma
chr6	32581888	32581889	rs4530903	Schizophrenia
chr6	32586853	32586854	rs9271366	Crohn's disease
chr6	32586853	32586854	rs9271366	Ulcerative colitis
chr6	32586853	32586854	rs9271366	Inflammatory bowel disease
chr6	32586853	32586854	rs9271366	Immunoglobulin A
chr6	32586853	32586854	rs9271366	Multiple sclerosis
chr6	32590924	32590925	rs3129763	Systemic sclerosis
chr6	32590952	32590953	rs9271588	Sjogren's syndrome
chr6	32592199	32592200	rs9271640	Multiple sclerosis (OCB status)
chr6	32592736	32592737	rs28421666	Nasopharyngeal carcinoma
chr6	32595222	32595223	rs9271858	Leishmaniasis (visceral)
chr6	32599998	32599999	rs9272105	Hepatocellular carcinoma
chr6	32599998	32599999	rs9272105	Response to interferon beta therapy
chr6	32600802	32600803	rs9272143	Cervical cancer
chr6	32602268	32602269	rs9272219	Rheumatoid arthritis
chr6	32602268	32602269	rs9272219	Schizophrenia
chr6	32603006	32603007	rs2040406	Multiple sclerosis
chr6	32604371	32604372	rs9272346	Asthma
chr6	32604371	32604372	rs9272346	Type 1 diabetes
chr6	32605883	32605884	rs2187668	Systemic lupus erythematosus
chr6	32605883	32605884	rs2187668	Nephropathy (idiopathic membranous)
chr6	32605883	32605884	rs2187668	Immunoglobulin A
chr6	32605883	32605884	rs2187668	Celiac disease
chr6	32606755	32606756	rs9272535	Chronic lymphocytic leukemia
chr6	32611640	32611641	rs9273012	Chronic lymphocytic leukemia
chr6	32612396	32612397	rs6927022	Ulcerative colitis
chr6	32625868	32625869	rs9273349	Asthma
chr6	32626129	32626130	rs7744020	Narcolepsy (age of onset)
chr6	32626271	32626272	rs9273363	Chronic lymphocytic leukemia
chr6	32626310	32626311	rs6906021	Allergic sensitization
chr6	32626310	32626311	rs6906021	Self-reported allergy
chr6	32628427	32628428	rs2854275	Epstein-Barr virus immune response (EBNA-1)
chr6	32632831	32632832	rs9274407	Drug-induced liver injury (amoxicillin-clavulanate)
chr6	32633712	32633713	rs9274477	Narcolepsy (age of onset)
chr6	32651539	32651540	rs17212223	Narcolepsy (age of onset)
chr6	32655217	32655218	rs2856683	Primary biliary cirrhosis
chr6	32657577	32657578	rs7774434	Primary biliary cirrhosis
chr6	32658078	32658079	rs7775228	IgE grass sensitization
chr6	32658078	32658079	rs7775228	Asthma
chr6	32658309	32658310	rs9469220	IgE levels
chr6	32658309	32658310	rs9469220	Crohn's disease
chr6	32663630	32663631	rs3129720	Multiple sclerosis (OCB status)
chr6	32663630	32663631	rs3129720	Hypothyroidism
chr6	32663850	32663851	rs6457617	Graves' disease
chr6	32663850	32663851	rs6457617	Systemic sclerosis
chr6	32663850	32663851	rs6457617	Rheumatoid arthritis
chr6	32663998	32663999	rs6457620	Height
chr6	32663998	32663999	rs6457620	Rheumatoid arthritis
chr6	32664457	32664458	rs2647012	Follicular lymphoma
chr6	32664457	32664458	rs2647012	Systemic lupus erythematosus
chr6	32664959	32664960	rs9357152	HPV seropositivity
chr6	32664959	32664960	rs9357152	Primary biliary cirrhosis
chr6	32665419	32665420	rs10484561	Follicular lymphoma
chr6	32666294	32666295	rs9275319	Hepatocellular carcinoma (hepatitis B virus related)
chr6	32667909	32667910	rs2647044	Pulmonary function
chr6	32667909	32667910	rs2647044	Type 1 diabetes
chr6	32668099	32668100	rs2647045	Lymphoma
chr6	32668335	32668336	rs2647046	Lymphoma
chr6	32669155	32669156	rs9275390	Systemic sclerosis
chr6	32669372	32669373	rs11752643	Coronary heart disease
chr6	32669954	32669955	rs9275406	Rheumatoid arthritis
chr6	32670254	32670255	rs2856718	Chronic hepatitis B infection
chr6	32670254	32670255	rs2856718	Hepatitis B
chr6	32671102	32671103	rs13192471	Rheumatoid arthritis
chr6	32671247	32671248	rs1794275	IgA nephropathy
chr6	32674736	32674737	rs1794265	IgG glycosylation
chr6	32675108	32675109	rs9275524	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr6	32677911	32677912	rs9275563	Multiple sclerosis (OCB status)
chr6	32678596	32678597	rs4273729	Chronic Hepatitis C infection
chr6	32678998	32678999	rs9275572	Hepatocellular carcinoma
chr6	32678998	32678999	rs9275572	Alopecia areata
chr6	32680575	32680576	rs7764819	Pulmonary function (interaction)
chr6	32680927	32680928	rs7765379	Crohn's disease
chr6	32680927	32680928	rs7765379	Rheumatoid arthritis
chr6	32681276	32681277	rs2858331	IgE levels
chr6	32681630	32681631	rs9275596	Nephropathy
chr6	32681675	32681676	rs3104402	Immune response to anthrax vaccine
chr6	32685549	32685550	rs3916765	Type 2 diabetes
chr6	32687972	32687973	rs9275698	Asthma
chr6	32697784	32697785	rs2859113	IgG glycosylation
chr6	32700082	32700083	rs2858884	Narcolepsy
chr6	32725192	32725193	rs2301271	Systemic lupus erythematosus
chr6	32726802	32726803	rs1049110	IgG glycosylation
chr6	32730011	32730012	rs7453920	Hepatitis B
chr6	32730011	32730012	rs7453920	Chronic hepatitis B infection
chr6	32730011	32730012	rs7453920	Lymphoma
chr6	32730085	32730086	rs2051549	Systemic lupus erythematosus
chr6	32736694	32736695	rs9276606	Complement C3 and C4 levels
chr6	32741867	32741868	rs2621416	Lymphoma
chr6	32763513	32763514	rs2857151	Kawasaki disease
chr6	32804069	32804070	rs241428	Complement C3 and C4 levels
chr6	32809847	32809848	rs9357155	Nephropathy
chr6	32852646	32852647	rs2187689	Disc degeneration (lumbar)
chr6	32854696	32854697	rs10046257	Disc degeneration (lumbar)
chr6	32855716	32855717	rs6457690	Disc degeneration (lumbar)
chr6	32856380	32856381	rs1029296	Disc degeneration (lumbar)
chr6	32856481	32856482	rs1029295	Disc degeneration (lumbar)
chr6	32856933	32856934	rs6936004	Disc degeneration (lumbar)
chr6	32857418	32857419	rs10214886	Disc degeneration (lumbar)
chr6	32859711	32859712	rs7744666	Disc degeneration (lumbar)
chr6	32859747	32859748	rs11969002	Disc degeneration (lumbar)
chr6	32860751	32860752	rs9469300	Disc degeneration (lumbar)
chr6	32862606	32862607	rs3749982	Disc degeneration (lumbar)
chr6	32913245	32913246	rs1480380	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr6	32915850	32915851	rs16871226	IgG glycosylation
chr6	32953279	32953280	rs3097645	IgG glycosylation
chr6	32961360	32961361	rs9500927	Asthma
chr6	32972403	32972404	rs3128935	Periodontitis (CDC/AAP)
chr6	32975013	32975014	rs399604	Platelet counts
chr6	33033021	33033022	rs3077	Chronic hepatitis B infection
chr6	33033021	33033022	rs3077	Hepatitis B (viral clearance)
chr6	33033021	33033022	rs3077	Hepatitis B
chr6	33042879	33042880	rs987870	Asthma
chr6	33042879	33042880	rs987870	Systemic sclerosis
chr6	33048660	33048661	rs1042151	Aspirin exacerbated respiratory disease in asthmatics
chr6	33054860	33054861	rs9277535	Chronic hepatitis B infection
chr6	33054860	33054861	rs9277535	Hepatitis B (viral clearance)
chr6	33054860	33054861	rs9277535	Hepatitis B vaccine response
chr6	33054860	33054861	rs9277535	Hepatitis B
chr6	33055537	33055538	rs9277554	Wegener's granulomatosis
chr6	33060117	33060118	rs2281388	Graves' disease
chr6	33060821	33060822	rs6928954	Bilirubin levels
chr6	33069892	33069893	rs3117242	Antineutrophil cytoplasmic antibody-associated vasculitis
chr6	33072171	33072172	rs4282438	Sjogren's syndrome
chr6	33072171	33072172	rs4282438	Cervical cancer
chr6	33086248	33086249	rs3117035	RR interval (heart rate)
chr6	33086447	33086448	rs1883414	Nephropathy
chr6	33089622	33089623	rs3117027	Cervical cancer
chr6	33143947	33143948	rs2254287	LDL cholesterol
chr6	33204273	33204274	rs9277952	Cervical cancer
chr6	33465481	33465482	rs9394152	Chronic obstructive pulmonary disease
chr6	33478495	33478496	rs9296092	Chronic obstructive pulmonary disease
chr6	33486731	33486732	rs6457730	Self-reported allergy
chr6	33489881	33489882	rs9469457	Obesity-related traits
chr6	33540208	33540209	rs210134	Chronic lymphocytic leukemia
chr6	33540208	33540209	rs210134	Platelet counts
chr6	33540208	33540209	rs210134	Mean platelet volume
chr6	33540691	33540692	rs210135	Hematological parameters
chr6	33541718	33541719	rs513349	Platelet counts
chr6	33542537	33542538	rs210138	Testicular germ cell tumor
chr6	33546836	33546837	rs210142	Chronic lymphocytic leukemia
chr6	33548393	33548394	rs5745568	Platelet counts
chr6	33618161	33618162	rs9394159	Graves' disease
chr6	33624732	33624733	rs999943	Obesity (extreme)
chr6	33659045	33659046	rs4711336	Height
chr6	33662294	33662295	rs3227	Educational attainment
chr6	33706478	33706479	rs9469578	Phosphorus levels
chr6	33740024	33740025	rs2296743	Obesity-related traits
chr6	33762241	33762242	rs2274459	Obesity (extreme)
chr6	33764032	33764033	rs751728	Crohn's disease
chr6	33817928	33817929	rs4713693	Graves' disease
chr6	33825357	33825358	rs2104362	Alzheimer's disease (age of onset)
chr6	33851172	33851173	rs16869652	Schizophrenia
chr6	34036445	34036446	rs1906953	Osteosarcoma
chr6	34165720	34165721	rs7742369	Height
chr6	34194865	34194866	rs1759645	Height
chr6	34195010	34195011	rs1776897	Height
chr6	34199091	34199092	rs2780226	Height
chr6	34214321	34214322	rs1150781	Height
chr6	34238513	34238514	rs6918981	Height
chr6	34302868	34302869	rs206936	Body mass index
chr6	34546559	34546560	rs2814982	Cholesterol, total
chr6	34552796	34552797	rs2814944	HDL cholesterol
chr6	34581635	34581636	rs2744971	Height
chr6	34618892	34618893	rs2814993	Height
chr6	34683634	34683635	rs6938239	Height
chr6	34763981	34763982	rs9469890	Pubertal anthropometrics
chr6	34823186	34823187	rs3734266	Systemic lupus erythematosus
chr6	34845448	34845449	rs4646949	Fasting insulin-related traits (interaction with BMI)
chr6	34923863	34923864	rs847845	Non-small cell lung cancer
chr6	34927279	34927280	rs1535001	Systemic lupus erythematosus and Systemic sclerosis
chr6	34975414	34975415	rs2140418	Alcoholism (alcohol use disorder factor score)
chr6	34975414	34975415	rs2140418	Alcoholism (alcohol dependence factor score)
chr6	35005083	35005084	rs13210323	Height
chr6	35034799	35034800	rs17609940	Coronary heart disease
chr6	35056442	35056443	rs2005	Obesity-related traits
chr6	35322762	35322763	rs7744392	Cataracts in type 2 diabetes
chr6	35341849	35341850	rs9470004	Height
chr6	35363756	35363757	rs9658108	Response to antipsychotic treatment
chr6	35402784	35402785	rs4713858	Height
chr6	35402804	35402805	rs6457821	Height
chr6	35404353	35404354	rs2206030	Pulmonary function (interaction)
chr6	35502201	35502202	rs9380516	Hepatitis C induced liver fibrosis
chr6	36618820	36618821	rs1321313	Electrocardiographic conduction measures
chr6	36622899	36622900	rs1321311	Colorectal cancer
chr6	36622899	36622900	rs1321311	Electrocardiographic traits
chr6	36623378	36623379	rs9470361	QRS duration
chr6	36792056	36792057	rs236373	Heart rate
chr6	36922683	36922684	rs1405069	Chemerin levels
chr6	37174744	37174745	rs1680005	Bipolar disorder (mood-incongruent)
chr6	37451695	37451696	rs904251	Cognitive performance
chr6	37487043	37487044	rs1757171	Cognitive performance
chr6	37532102	37532103	rs9394438	IgG glycosylation
chr6	38036419	38036420	rs17589516	Insulin resistance/response
chr6	38106843	38106844	rs9470794	Type 2 diabetes
chr6	38365840	38365841	rs9296249	Restless legs syndrome
chr6	38365872	38365873	rs9357271	Restless legs syndrome
chr6	38440969	38440970	rs3923809	Restless legs syndrome
chr6	39117697	39117698	rs2115200	Eating disorders
chr6	39183469	39183470	rs10456100	Migraine
chr6	39202156	39202157	rs9366999	Obesity-related traits
chr6	39250836	39250837	rs2758886	Cholesterol, total
chr6	39284049	39284050	rs1535500	Type 2 diabetes
chr6	39361853	39361854	rs9296295	Obesity-related traits
chr6	39528981	39528982	rs9380880	Immune response to smallpox vaccine (IL-6)
chr6	39539206	39539207	rs4714261	Attention deficit hyperactivity disorder symptoms (interaction)
chr6	39784364	39784365	rs2395730	Pulmonary function
chr6	40440499	40440500	rs9296335	Obesity-related traits
chr6	40536127	40536128	rs2494938	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)
chr6	40802260	40802261	rs10484761	Esophageal cancer
chr6	41127971	41127972	rs7748513	C-reactive protein
chr6	41129251	41129252	rs75932628	Alzheimer's disease
chr6	41154649	41154650	rs9381040	Alzheimer's disease (late onset)
chr6	41303804	41303805	rs9471576	Total ventricular volume
chr6	41336100	41336101	rs6922617	Alzheimer's disease biomarkers
chr6	41379314	41379315	rs7762544	Periodontitis
chr6	41536426	41536427	rs1983891	Prostate cancer
chr6	41623032	41623033	rs2143678	Cardiovascular disease risk factors
chr6	41650735	41650736	rs2842643	Attention deficit hyperactivity disorder
chr6	41905274	41905275	rs3218097	Mean corpuscular volume
chr6	41905274	41905275	rs3218097	Red blood cell count
chr6	41905274	41905275	rs3218097	Mean corpuscular hemoglobin
chr6	41914377	41914378	rs9349204	Red blood cell traits
chr6	41925158	41925159	rs9349205	Mean corpuscular volume
chr6	41925158	41925159	rs9349205	Mean corpuscular hemoglobin
chr6	41925289	41925290	rs11970772	Hematological parameters
chr6	41925303	41925304	rs11968166	Neutrophil count
chr6	41962670	41962671	rs9357377	Metabolite levels (5-HIAA/ MHPG Ratio)
chr6	42495277	42495278	rs16895812	Obesity-related traits
chr6	42731114	42731115	rs6458307	Bipolar disorder
chr6	43153786	43153787	rs61743561	Obesity-related traits
chr6	43272187	43272188	rs4149178	Urate levels
chr6	43757895	43757896	rs998584	Triglycerides
chr6	43757895	43757896	rs998584	HDL cholesterol
chr6	43757895	43757896	rs998584	Adiponectin levels
chr6	43758872	43758873	rs6905288	Coronary heart disease
chr6	43758872	43758873	rs6905288	Waist-hip ratio
chr6	43764550	43764551	rs1358980	Sexual dimorphism in anthropometric traits
chr6	43795967	43795968	rs943072	Ulcerative colitis
chr6	43804570	43804571	rs729761	Urate levels
chr6	43806608	43806609	rs881858	Chronic kidney disease
chr6	43811761	43811762	rs9472138	Thyroid hormone levels
chr6	43811761	43811762	rs9472138	Type 2 diabetes
chr6	43826626	43826627	rs943080	Age-related macular degeneration
chr6	43828581	43828582	rs4711751	Age-related macular degeneration
chr6	43897726	43897727	rs9472155	Vascular endothelial growth factor levels
chr6	43904779	43904780	rs11755845	Thyroid hormone levels
chr6	43925525	43925526	rs4513773	Vascular endothelial growth factor levels
chr6	44065310	44065311	rs7742824	Major depressive disorder
chr6	44232919	44232920	rs2233434	Rheumatoid arthritis
chr6	44424799	44424800	rs543844	Migraine
chr6	44594158	44594159	rs556621	Stroke (ischemic)
chr6	44639183	44639184	rs11755164	Bone mineral density
chr6	44739948	44739949	rs1342371	Obesity-related traits
chr6	44769236	44769237	rs7770848	Asthma (childhood onset)
chr6	44777690	44777691	rs10948172	Osteoarthritis
chr6	44837355	44837356	rs3799977	Attention deficit hyperactivity disorder
chr6	44946505	44946506	rs9472414	Height
chr6	44967489	44967490	rs10948197	Height
chr6	45095162	45095163	rs9395066	Height
chr6	45244414	45244415	rs10948222	Height
chr6	45696787	45696788	rs1932040	Periodontal microbiota
chr6	45885060	45885061	rs4714888	Age-related macular degeneration
chr6	46675024	46675025	rs7756935	Lipoprotein-associated phospholipase A2 activity and mass
chr6	46682078	46682079	rs1362931	Lipoprotein-associated phospholipase A2 activity and mass
chr6	46684221	46684222	rs1805017	Lipoprotein-associated phospholipase A2 activity and mass
chr6	47230614	47230615	rs2103868	Panic disorder
chr6	47453377	47453378	rs9349407	Alzheimer's disease (late onset)
chr6	47487761	47487762	rs10948363	Alzheimer's disease (late onset)
chr6	49382192	49382193	rs9369898	Homocysteine levels
chr6	49409486	49409487	rs9473555	Folate pathway vitamin levels
chr6	49488907	49488908	rs9473582	Brain structure
chr6	50786007	50786008	rs2206271	Renal function-related traits (BUN)
chr6	50798525	50798526	rs2206277	Obesity
chr6	50798525	50798526	rs2206277	Metabolic syndrome (bivariate traits)
chr6	50803049	50803050	rs987237	Body mass index
chr6	50803049	50803050	rs987237	Adiposity
chr6	50836278	50836279	rs734597	Obesity (extreme)
chr6	50845489	50845490	rs2207139	Obesity
chr6	50987767	50987768	rs190759	Sudden cardiac arrest
chr6	51058720	51058721	rs283566	Electrocardiographic conduction measures
chr6	51068716	51068717	rs7775861	Body mass index (non-asthmatics)
chr6	51099255	51099256	rs7762246	Obesity-related traits
chr6	51159994	51159995	rs1555967	Waist circumference
chr6	51622448	51622449	rs2025751	Intraocular pressure
chr6	51643013	51643014	rs728996	Weight loss (gastric bypass surgery)
chr6	51643267	51643268	rs2894788	Weight loss (gastric bypass surgery)
chr6	51655406	51655407	rs6458777	Weight loss (gastric bypass surgery)
chr6	51656387	51656388	rs4715233	Weight loss (gastric bypass surgery)
chr6	51666630	51666631	rs10498792	Prostate cancer
chr6	51673438	51673439	rs9296661	Weight loss (gastric bypass surgery)
chr6	51674160	51674161	rs1326589	Weight loss (gastric bypass surgery)
chr6	52101738	52101739	rs763780	Response to gemcitabine in pancreatic cancer
chr6	52835894	52835895	rs492146	Epilepsy (remission after treatment)
chr6	53123117	53123118	rs735860	Glaucoma
chr6	53307693	53307694	rs9395865	Electroencephalographic traits in alcoholism
chr6	53514945	53514946	rs9474614	Obesity-related traits
chr6	53924696	53924697	rs9296736	Liver enzyme levels (gamma-glutamyl transferase)
chr6	54265395	54265396	rs16885294	Radiation response
chr6	55148102	55148103	rs9367630	HIV-1 control
chr6	55473293	55473294	rs11754509	Obesity-related traits
chr6	55950373	55950374	rs12196860	Psychosis (atypical)
chr6	56210763	56210764	rs16887812	Allergic sensitization
chr6	58308954	58308955	rs9500256	Eosinophilic esophagitis (pediatric)
chr6	58764530	58764531	rs4513829	Serum dimethylarginine levels (symmetric)
chr6	61951859	61951860	rs2342002	Esophageal adenocarcinoma
chr6	61951859	61951860	rs2342002	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)
chr6	62697745	62697746	rs6455128	Protein quantitative trait loci
chr6	63160146	63160147	rs682238	Calcium levels
chr6	63803187	63803188	rs789942	Obesity-related traits
chr6	65635922	65635923	rs11754641	Disc degeneration (lumbar)
chr6	65662620	65662621	rs7767572	Metabolite levels (Dihydroxy docosatrienoic acid)
chr6	66178479	66178480	rs4710520	IgG glycosylation
chr6	66565352	66565353	rs9354308	Metabolite levels
chr6	66598193	66598194	rs10455590	HIV-1 viral setpoint
chr6	66929047	66929048	rs3857536	Blood trace element (Cu levels)
chr6	67248409	67248410	rs9445732	Corneal astigmatism
chr6	67649215	67649216	rs11970254	Brain structure
chr6	67653278	67653279	rs28631020	Bulimia nervosa
chr6	67885918	67885919	rs9342616	QT interval
chr6	68181696	68181697	rs4710654	Response to amphetamines
chr6	68327029	68327030	rs875033	Response to amphetamines
chr6	68984929	68984930	rs10455657	Cannabis use (initiation)
chr6	69142007	69142008	rs9363918	Pancreatic cancer
chr6	69294484	69294485	rs9351730	Prostate cancer (gene x gene interaction)
chr6	69337786	69337787	rs2585617	Phospholipid levels (plasma)
chr6	70074231	70074232	rs3757057	Response to statin therapy
chr6	70741208	70741209	rs3793039	IgG glycosylation
chr6	71289188	71289189	rs1048886	Type 2 diabetes
chr6	71660110	71660111	rs6922893	Obesity-related traits
chr6	71726538	71726539	rs1158058	Metabolite levels (MHPG)
chr6	71776970	71776971	rs11968814	F-cell distribution
chr6	72139571	72139572	rs1727638	AB1-42
chr6	72406318	72406319	rs4707930	Response to anti-TNF alpha therapy in inflammatory bowel disease
chr6	72482457	72482458	rs10455248	Cognitive performance
chr6	72906752	72906753	rs2249625	Acute urticaria and angiodema (non-steroidal anti-inflammatory drug-induced)
chr6	73193150	73193151	rs1334346	Response to mTOR inhibitor (rapamycin)
chr6	73643288	73643289	rs7744813	Refractive error
chr6	74458736	74458737	rs9447004	Calcium levels
chr6	74871230	74871231	rs6912405	Obesity-related traits
chr6	75158265	75158266	rs72960926	Metabolite levels (MHPG)
chr6	76265641	76265642	rs9360921	Height
chr6	76556618	76556619	rs3798440	Hypertension
chr6	76560497	76560498	rs9350602	Hypertension
chr6	77266187	77266188	rs4235898	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr6	77290798	77290799	rs12198063	Capecitabine sensitivity
chr6	77789807	77789808	rs7738636	Acute lymphoblastic leukemia (childhood)
chr6	79556165	79556166	rs16890334	Blood pressure measurement (low sodium intervention)
chr6	79556165	79556166	rs16890334	Blood pressure measurement (high sodium intervention)
chr6	79556165	79556166	rs16890334	Blood pressure measurement (high sodium and potassium intervention)
chr6	80156258	80156259	rs12204683	Presence of antiphospholipid antibodies
chr6	80257280	80257281	rs3747767	Hoarding
chr6	80466123	80466124	rs6925255	Aging
chr6	80533186	80533187	rs1321847	Body mass index
chr6	80564835	80564836	rs346291	Partial epilepsies
chr6	80845988	80845989	rs2322633	Height
chr6	81302804	81302805	rs10943724	Thiazide-induced adverse metabolic effects in hypertensive patients
chr6	81481353	81481354	rs6902257	Obesity-related traits
chr6	81800361	81800362	rs310405	Height
chr6	82193108	82193109	rs17530068	Breast cancer
chr6	82220551	82220552	rs6924906	Blood pressure
chr6	82515314	82515315	rs16893526	Coronary heart disease
chr6	82794593	82794594	rs1538138	Corneal structure
chr6	84226594	84226595	rs1171113	Bipolar disorder (mood-incongruent)
chr6	86117128	86117129	rs494562	Metabolic traits
chr6	86691939	86691940	rs1577917	Response to antipsychotic treatment
chr6	87155253	87155254	rs13202860	Sexual dysfunction (female)
chr6	87466491	87466492	rs493187	Bipolar disorder and schizophrenia
chr6	87606841	87606842	rs1853639	IgG glycosylation
chr6	87867062	87867063	rs1925690	MRI atrophy measures
chr6	88329941	88329942	rs13213285	Obesity-related traits
chr6	88377048	88377049	rs28381552	Obesity-related traits
chr6	88652579	88652580	rs2509458	Blood pressure
chr6	88717765	88717766	rs366676	Echocardiographic traits
chr6	88975976	88975977	rs16880441	Conduct disorder (interaction)
chr6	89112816	89112817	rs10485165	Select biomarker traits
chr6	89183579	89183580	rs11757661	Subcutaneous adipose tissue
chr6	89253648	89253649	rs2610739	IgG glycosylation
chr6	89293744	89293745	rs12527253	Response to statin therapy
chr6	89732100	89732101	rs12201676	Bipolar disorder and schizophrenia
chr6	90299209	90299210	rs6939321	Metabolite levels (Pyroglutamine)
chr6	90310965	90310966	rs6454764	vWF and FVIII levels
chr6	90640490	90640491	rs2289577	Cognitive performance
chr6	90657782	90657783	rs404256	IgG glycosylation
chr6	90681465	90681466	rs6917758	Obesity-related traits
chr6	90698273	90698274	rs12204127	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr6	90921739	90921740	rs370409	Graves' disease
chr6	90926611	90926612	rs10806425	Celiac disease
chr6	90957462	90957463	rs3757247	Vitiligo
chr6	90957462	90957463	rs3757247	Type 1 diabetes
chr6	90958230	90958231	rs11755527	Type 1 diabetes autoantibodies
chr6	90958230	90958231	rs11755527	Type 1 diabetes
chr6	90973158	90973159	rs1847472	Inflammatory bowel disease
chr6	90973158	90973159	rs1847472	Crohn's disease
chr6	90996768	90996769	rs12212193	Multiple sclerosis
chr6	91015038	91015039	rs12529935	Systemic lupus erythematosus
chr6	91207350	91207351	rs806276	Attention deficit hyperactivity disorder (time to onset)
chr6	91417751	91417752	rs713155	Brain structure
chr6	93197299	93197300	rs13207034	Metabolite levels (HVA-5-HIAA Factor score)
chr6	93197299	93197300	rs13207034	Metabolite levels (HVA)
chr6	93369654	93369655	rs6918777	Amyotrophic lateral sclerosis
chr6	93615449	93615450	rs2506933	Cognitive performance
chr6	93713804	93713805	rs652520	Chronic obstructive pulmonary disease-related biomarkers
chr6	93847883	93847884	rs594442	Dialysis-related mortality
chr6	93852251	93852252	rs1408282	C-reactive protein
chr6	93911118	93911119	rs12527818	Response to hepatitis C treatment
chr6	95156417	95156418	rs2224003	Brain connectivity
chr6	95156453	95156454	rs10485022	Brain connectivity
chr6	95422617	95422618	rs4145130	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr6	95967411	95967412	rs2380220	Behavioural disinhibition (generation interaction)
chr6	96179003	96179004	rs143247165	Serum dimethylarginine levels (symmetric)
chr6	96884885	96884886	rs11757063	Migraine
chr6	97065211	97065212	rs11759769	Migraine without aura
chr6	97065211	97065212	rs11759769	Migraine - clinic-based
chr6	97065211	97065212	rs11759769	Migraine
chr6	97080197	97080198	rs12200560	Coronary heart disease
chr6	97419597	97419598	rs974417	Body mass index
chr6	98019079	98019080	rs9320598	Multiple sclerosis (OCB status)
chr6	98462500	98462501	rs12529874	Oleic acid (18:1n-9) plasma levels
chr6	98495951	98495952	rs2505059	Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
chr6	98584732	98584733	rs9320913	Educational attainment
chr6	98588753	98588754	rs9375225	QT interval (interaction)
chr6	98739773	98739774	rs6909430	Quantitative traits
chr6	98896666	98896667	rs9321063	Metabolite levels  (X-11787)
chr6	98919263	98919264	rs9491640	Brain imaging in schizophrenia (interaction)
chr6	98937145	98937146	rs2213553	Response to amphetamines
chr6	98990488	98990489	rs6904416	C-reactive protein and white blood cell count
chr6	99011500	99011501	rs2086512	Cytomegalovirus antibody response
chr6	99028865	99028866	rs1383808	Obesity-related traits
chr6	99672013	99672014	rs2132683	Brain structure
chr6	99782878	99782879	rs17059400	Illicit drug use
chr6	100208437	100208438	rs4840086	Menarche (age at onset)
chr6	100328197	100328198	rs4840097	Age-related macular degeneration (smoking status interaction)
chr6	100756686	100756687	rs2841307	Bipolar disorder and schizophrenia
chr6	100957343	100957344	rs240768	Economic and political preferences (immigration/crime)
chr6	101395406	101395407	rs11969893	Economic and political preferences (immigration/crime)
chr6	101674289	101674290	rs2797369	Renal function-related traits (eGRFcrea)
chr6	102355866	102355867	rs12207601	Biochemical measures
chr6	102971245	102971246	rs17430337	Obesity-related traits
chr6	103799045	103799046	rs994988	Palmitic acid (16:0) plasma levels
chr6	104432164	104432165	rs4520040	Cardiac hypertrophy
chr6	104445366	104445367	rs9499708	Obsessive-compulsive disorder
chr6	104593866	104593867	rs9377619	Bipolar disorder and schizophrenia
chr6	104663777	104663778	rs2744203	IgG glycosylation
chr6	105180784	105180785	rs4336470	Neuroblastoma
chr6	105223863	105223864	rs733724	Multiple sclerosis
chr6	105232232	105232233	rs9322817	Thyroid stimulating hormone
chr6	105364420	105364421	rs11156429	Pubertal anthropometrics
chr6	105367615	105367616	rs9391253	Height
chr6	105378953	105378954	rs7759938	Pubertal anthropometrics
chr6	105378953	105378954	rs7759938	Menarche (age at onset)
chr6	105378953	105378954	rs7759938	Height
chr6	105400836	105400837	rs314280	Menarche (age at onset)
chr6	105406273	105406274	rs17065417	Neuroblastoma
chr6	105407661	105407662	rs314277	Digit length ratio
chr6	105407661	105407662	rs314277	Menarche and menopause (age at onset)
chr6	105407661	105407662	rs314277	Height
chr6	105407998	105407999	rs314276	Menarche (age at onset)
chr6	105417977	105417978	rs314268	Height
chr6	105443188	105443189	rs364663	Menarche (age at onset)
chr6	105612219	105612220	rs11962089	Multiple sclerosis
chr6	106094056	106094057	rs9386463	Primary tooth development (time to first tooth eruption)
chr6	106188817	106188818	rs6568401	Primary tooth development (time to first tooth eruption)
chr6	106252998	106252999	rs1355023	Age-related macular degeneration
chr6	106260127	106260128	rs7750345	Age-related macular degeneration
chr6	106329054	106329055	rs9386485	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
chr6	106329054	106329055	rs9386485	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr6	106435024	106435025	rs6568421	Inflammatory bowel disease
chr6	106435024	106435025	rs6568421	Crohn's disease
chr6	106435268	106435269	rs7746082	Crohn's disease
chr6	106522026	106522027	rs6911490	Ulcerative colitis
chr6	106568033	106568034	rs548234	Systemic lupus erythematosus
chr6	106582919	106582920	rs742108	Systemic lupus erythematosus
chr6	106685194	106685195	rs3827644	Systemic lupus erythematosus and Systemic sclerosis
chr6	106829536	106829537	rs6568433	Longevity
chr6	106899225	106899226	rs1417352	Select biomarker traits
chr6	106987369	106987370	rs783396	Stroke
chr6	107660645	107660646	rs2430457	IgG glycosylation
chr6	108017670	108017671	rs12525668	Myopia (pathological)
chr6	108323758	108323759	rs17069122	Bipolar disorder and schizophrenia
chr6	108853492	108853493	rs17041	Obesity-related traits
chr6	108916572	108916573	rs9480865	Normalized brain volume
chr6	108988183	108988184	rs2153960	Insulin-like growth factors
chr6	109268049	109268050	rs2798641	Pulmonary function (interaction)
chr6	109268049	109268050	rs2798641	Pulmonary function
chr6	109285188	109285189	rs2273669	Prostate cancer
chr6	109598963	109598964	rs13210693	Ankylosing spondylitis
chr6	109608496	109608497	rs9386791	Red blood cell traits
chr6	109616419	109616420	rs9374080	Mean corpuscular volume
chr6	109626964	109626965	rs1008084	Red blood cell traits
chr6	109634827	109634828	rs11966072	Red blood cell count
chr6	109634827	109634828	rs11966072	Mean corpuscular volume
chr6	109634827	109634828	rs11966072	Mean corpuscular hemoglobin
chr6	109742014	109742015	rs9487094	Height
chr6	109783940	109783941	rs1046943	Height
chr6	110007646	110007647	rs9400317	Response to hepatitis C treatment
chr6	110090048	110090049	rs4947019	Hematological parameters
chr6	111655529	111655530	rs465969	Psoriasis
chr6	111673713	111673714	rs240993	Psoriasis
chr6	111696090	111696091	rs458017	Psoriasis
chr6	111747082	111747083	rs7760535	Metabolic traits
chr6	111794408	111794409	rs6900341	Metabolite levels
chr6	111848190	111848191	rs3851228	Inflammatory bowel disease
chr6	111913261	111913262	rs33980500	Psoriasis
chr6	111913261	111913262	rs33980500	Psoriatic arthritis
chr6	113479334	113479335	rs2473967	Asthma (childhood onset)
chr6	113665326	113665327	rs7765175	Coronary artery calcification
chr6	114017132	114017133	rs9488238	Disc degeneration (lumbar)
chr6	114547980	114547981	rs9488343	Gray matter volume (schizophrenia interaction)
chr6	114591985	114591986	rs9488363	Optic disc size (rim)
chr6	115069716	115069717	rs6928844	IgG glycosylation
chr6	116310286	116310287	rs1933737	Urate levels
chr6	116312892	116312893	rs9488822	LDL cholesterol
chr6	116312892	116312893	rs9488822	Cholesterol, total
chr6	116387133	116387134	rs1999930	Age-related macular degeneration
chr6	116443734	116443735	rs3812111	Age-related macular degeneration
chr6	116543846	116543847	rs1204798	Dental caries
chr6	117086377	117086378	rs654128	Telomere length
chr6	117114024	117114025	rs6901250	C-reactive protein
chr6	117210051	117210052	rs339331	Prostate cancer
chr6	117522155	117522156	rs961764	Height
chr6	117605990	117605991	rs13201929	Myopia (pathological)
chr6	117730818	117730819	rs2273601	QT interval (interaction)
chr6	117771276	117771277	rs17635492	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
chr6	117786179	117786180	rs9387478	Lung cancer
chr6	117819356	117819357	rs2057314	Colorectal cancer
chr6	117844071	117844072	rs210648	Economic and political preferences
chr6	117871835	117871836	rs9285425	Height
chr6	118130306	118130307	rs2199936	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr6	118130306	118130307	rs2199936	Cardiovascular disease risk factors
chr6	118130306	118130307	rs2199936	Urate levels
chr6	118574060	118574061	rs281868	Resting heart rate
chr6	118578042	118578043	rs89107	Cardiac structure and function
chr6	118618980	118618981	rs166881	Thiazide-induced adverse metabolic effects in hypertensive patients
chr6	118653203	118653204	rs12210810	QT interval
chr6	118667521	118667522	rs11153730	Heart rate
chr6	118667521	118667522	rs11153730	QT interval
chr6	118680373	118680374	rs11970286	Electrocardiographic traits
chr6	118680373	118680374	rs11970286	QT interval
chr6	118788651	118788652	rs11752626	QT interval
chr6	118807846	118807847	rs25422	Renal cell carcinoma
chr6	118962739	118962740	rs6906287	Electrocardiographic conduction measures
chr6	118993631	118993632	rs11756438	QT interval
chr6	119866140	119866141	rs1392089	Immune reponse to smallpox (secreted IL-2)
chr6	121098456	121098457	rs2817937	Primary tooth development (number of teeth)
chr6	121100136	121100137	rs2789066	HIV-1 control
chr6	121339178	121339179	rs1343075	Cognitive performance
chr6	121730721	121730722	rs17083533	Heart rate
chr6	121748541	121748542	rs11154022	Resting heart rate
chr6	121781389	121781390	rs11154027	Heart rate
chr6	121816878	121816879	rs9490306	Migraine without aura
chr6	121816878	121816879	rs9490306	Migraine
chr6	121902868	121902869	rs4541776	Protein quantitative trait loci
chr6	122114450	122114451	rs9320841	Resting heart rate
chr6	122131484	122131485	rs1015451	Heart rate
chr6	122146033	122146034	rs9398652	Resting heart rate
chr6	122158269	122158270	rs12110693	Biomedical quantitative traits
chr6	123282940	123282941	rs13192613	Prostate cancer (gene x gene interaction)
chr6	123989740	123989741	rs9490860	IgG glycosylation
chr6	124326226	124326227	rs117780815	Alzheimer's disease (cognitive decline)
chr6	124405154	124405155	rs13204086	Periodontitis (Mean PAL)
chr6	124559731	124559732	rs77490164	Periodontitis (Mean PAL)
chr6	124691236	124691237	rs9491140	Neuroticism
chr6	124951062	124951063	rs504008	QRS duration
chr6	125156448	125156449	rs11154271	Subcutaneous adipose tissue
chr6	126022601	126022602	rs1777220	Endometrial cancer
chr6	126090376	126090377	rs9388451	Brugada syndrome
chr6	126698718	126698719	rs9388489	Type 1 diabetes
chr6	126767599	126767600	rs1361108	Height
chr6	126767599	126767600	rs1361108	Menarche (age at onset)
chr6	126835654	126835655	rs1490388	Height
chr6	126851159	126851160	rs1490384	Height
chr6	126964509	126964510	rs4273712	Intracranial volume
chr6	126966307	126966308	rs4549631	Height
chr6	127115453	127115454	rs13209747	Blood pressure
chr6	127167071	127167072	rs13204965	Bone mineral density
chr6	127391843	127391844	rs972275	Iron status biomarkers
chr6	127414800	127414801	rs719726	Triglycerides
chr6	127436063	127436064	rs1936800	Triglycerides
chr6	127436063	127436064	rs1936800	HDL cholesterol
chr6	127436063	127436064	rs1936800	Renal function-related traits (BUN)
chr6	127452638	127452639	rs9491696	Waist-hip ratio
chr6	127456121	127456122	rs9491697	Crohn's disease
chr6	127493610	127493611	rs6569474	Metabolite levels
chr6	127509156	127509157	rs7745274	Waist-hip ratio
chr6	127600629	127600630	rs2180341	Breast cancer
chr6	128021802	128021803	rs17299841	Immune response to smallpox vaccine (IL-6)
chr6	128194472	128194473	rs12194062	QRS duration
chr6	128245764	128245765	rs13204742	Crohn's disease
chr6	128278797	128278798	rs802734	Multiple sclerosis
chr6	128278797	128278798	rs802734	Celiac disease
chr6	128492181	128492182	rs10499138	Hearing impairment
chr6	129820037	129820038	rs12193446	Axial length
chr6	129834628	129834629	rs12205363	Refractive error
chr6	129861391	129861392	rs2275215	Body mass index
chr6	130008444	130008445	rs12660691	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
chr6	130031492	130031493	rs17057678	Antineutrophil cytoplasmic antibody-associated vasculitis
chr6	130216509	130216510	rs9375674	Renal sinus fat
chr6	130345834	130345835	rs1415701	Height
chr6	130349118	130349119	rs6569648	Height
chr6	130358427	130358428	rs6899976	Height
chr6	130550062	130550063	rs10447419	PR interval
chr6	130886436	130886437	rs9492645	IgG glycosylation
chr6	131256363	131256364	rs7769153	Response to statin therapy (LDL-C)
chr6	131282209	131282210	rs6941712	Lentiform nucleus volume
chr6	131355863	131355864	rs6908917	IgG glycosylation
chr6	131446790	131446791	rs602848	Migraine with aura
chr6	131446790	131446791	rs602848	Migraine - clinic-based
chr6	131563576	131563577	rs4629710	Multiple myeloma (IgH translocation)
chr6	131809919	131809920	rs2807278	Obesity
chr6	132058946	132058947	rs12199015	Response to fenofibrate (adiponectin levels)
chr6	132228768	132228769	rs6907728	Obesity-related traits
chr6	132643116	132643117	rs589756	Obesity-related traits
chr6	132888938	132888939	rs9399032	Migraine without aura
chr6	133146795	133146796	rs7769051	Type 2 diabetes nephropathy
chr6	133315803	133315804	rs271170	Bone mineral density
chr6	133663588	133663589	rs11753937	Response to angiotensin II receptor blocker therapy
chr6	133860344	133860345	rs9402515	Protein quantitative trait loci
chr6	133867801	133867802	rs9375969	Visceral fat
chr6	134158799	134158800	rs1208285	Infantile hypertrophic pyloric stenosis
chr6	134196673	134196674	rs12524865	Coronary heart disease
chr6	134214524	134214525	rs12190287	Coronary heart disease
chr6	134544732	134544733	rs1763500	Body mass index (interaction)
chr6	134576510	134576511	rs9493873	Immune reponse to smallpox (secreted IFN-alpha)
chr6	134720066	134720067	rs9402592	Dental caries
chr6	134773553	134773554	rs9321453	Urate levels
chr6	134898455	134898456	rs228437	Melanoma
chr6	135094271	135094272	rs11760067	Coronary artery calcification
chr6	135138989	135138990	rs2049953	Non-alcoholic fatty liver disease histology (AST)
chr6	135411227	135411228	rs9376090	Cholesterol, total
chr6	135415003	135415004	rs7745098	Hodgkin's lymphoma
chr6	135418634	135418635	rs7775698	Mean corpuscular volume
chr6	135418634	135418635	rs7775698	Mean corpuscular hemoglobin
chr6	135418634	135418635	rs7775698	Red blood cell traits
chr6	135418634	135418635	rs7775698	mean corpuscular hemoglobin concentration
chr6	135418634	135418635	rs7775698	Red blood cell count
chr6	135418634	135418635	rs7775698	Platelet counts
chr6	135418634	135418635	rs7775698	Hematological and biochemical traits
chr6	135418634	135418635	rs7775698	Hematology traits
chr6	135418915	135418916	rs7776054	Red blood cell traits
chr6	135418915	135418916	rs7776054	Mean corpuscular hemoglobin
chr6	135419017	135419018	rs9399137	Platelet counts
chr6	135419017	135419018	rs9399137	Mean corpuscular volume
chr6	135419017	135419018	rs9399137	Mean corpuscular hemoglobin
chr6	135419017	135419018	rs9399137	Hematology traits
chr6	135419017	135419018	rs9399137	HbA2 levels
chr6	135419017	135419018	rs9399137	F-cell distribution
chr6	135423208	135423209	rs9373124	White blood cell types
chr6	135423208	135423209	rs9373124	Other erythrocyte phenotypes
chr6	135426572	135426573	rs4895441	Red blood cell traits
chr6	135426572	135426573	rs4895441	Mean corpuscular hemoglobin concentration
chr6	135426572	135426573	rs4895441	White blood cell count
chr6	135426572	135426573	rs4895441	Mean corpuscular volume
chr6	135427143	135427144	rs9376092	Beta thalassemia/hemoglobin E disease
chr6	135427158	135427159	rs9389269	Red blood cell traits
chr6	135427816	135427817	rs9402686	Hematological parameters
chr6	135432551	135432552	rs9494145	Mean platelet volume
chr6	135432551	135432552	rs9494145	Red blood cell traits
chr6	135435500	135435501	rs9483788	Other erythrocyte phenotypes
chr6	135435500	135435501	rs9483788	Hematocrit
chr6	135452151	135452152	rs6569992	Red blood cell traits
chr6	135494874	135494875	rs9321490	Multiple sclerosis
chr6	135540379	135540380	rs210937	Obesity-related traits
chr6	135739354	135739355	rs11154801	Multiple sclerosis
chr6	136001002	136001003	rs9389316	Immune reponse to smallpox (secreted IL-2)
chr6	136133658	136133659	rs947583	Phosphorus levels
chr6	136368004	136368005	rs11154851	Alzheimer's disease (cognitive decline)
chr6	136505035	136505036	rs560713	Intraocular pressure
chr6	137452907	137452908	rs17066096	Multiple sclerosis
chr6	137673301	137673302	rs6928289	Thiazide-induced adverse metabolic effects in hypertensive patients
chr6	137967213	137967214	rs13192841	Multiple sclerosis
chr6	137973067	137973068	rs2327832	Celiac disease
chr6	138002636	138002637	rs10499194	Rheumatoid arthritis
chr6	138006503	138006504	rs6920220	Rheumatoid arthritis
chr6	138006503	138006504	rs6920220	Inflammatory bowel disease
chr6	138006503	138006504	rs6920220	Ulcerative colitis
chr6	138132515	138132516	rs10499197	Systemic lupus erythematosus and Systemic sclerosis
chr6	138195722	138195723	rs5029939	Sjogren's syndrome
chr6	138195722	138195723	rs5029939	Systemic lupus erythematosus
chr6	138196065	138196066	rs2230926	Systemic lupus erythematosus
chr6	138196065	138196066	rs2230926	Rheumatoid arthritis
chr6	138199416	138199417	rs610604	Psoriasis
chr6	138266684	138266685	rs9321637	Cardiac Troponin-T levels
chr6	138426031	138426032	rs1556640	Bulimia nervosa
chr6	139660011	139660012	rs11155053	Obesity-related traits
chr6	139829665	139829666	rs605066	HDL cholesterol
chr6	139831179	139831180	rs679582	Blood trace element (Se levels)
chr6	139834011	139834012	rs632057	Mean corpuscular volume
chr6	139834011	139834012	rs632057	Mean corpuscular hemoglobin
chr6	139835688	139835689	rs668459	Mean corpuscular volume
chr6	139835688	139835689	rs668459	Mean corpuscular hemoglobin
chr6	139835688	139835689	rs668459	Adiponectin levels
chr6	139838418	139838419	rs628751	Mean corpuscular hemoglobin
chr6	139839422	139839423	rs643381	Mean corpuscular volume
chr6	139840692	139840693	rs592423	Adiponectin levels
chr6	139844428	139844429	rs590856	Red blood cell traits
chr6	140139814	140139815	rs12664111	IgG glycosylation
chr6	140273646	140273647	rs642858	Type 2 diabetes
chr6	141169824	141169825	rs11155133	Acute lymphoblastic leukemia (childhood)
chr6	141856593	141856594	rs6570465	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr6	141857133	141857134	rs7742587	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr6	142033725	142033726	rs17071124	Sleep quality
chr6	142512135	142512136	rs225675	Thiazide-induced adverse metabolic effects in hypertensive patients
chr6	142527141	142527142	rs225694	Height
chr6	142548098	142548099	rs225717	Retinal vascular caliber
chr6	142655800	142655801	rs7741741	Height
chr6	142679571	142679572	rs6570507	Scoliosis
chr6	142679571	142679572	rs6570507	Height
chr6	142703876	142703877	rs4896582	Height
chr6	142750515	142750516	rs3817928	Pulmonary function (interaction)
chr6	142750515	142750516	rs3817928	Pulmonary function
chr6	142753337	142753338	rs1329705	Airflow obstruction
chr6	142767632	142767633	rs3748069	Height
chr6	142797288	142797289	rs7763064	Height
chr6	142822216	142822217	rs9496398	Neutrophil count
chr6	143119831	143119832	rs12211360	Adiponectin levels
chr6	143898893	143898894	rs12199775	Inflammatory bowel disease
chr6	143943313	143943314	rs9390123	Lung Cancer (DNA repair capacity)
chr6	143994198	143994199	rs9403521	Obesity-related traits
chr6	144079853	144079854	rs6931865	Erectile dysfunction
chr6	146918949	146918950	rs2275606	Leprosy
chr6	147531080	147531081	rs2786189	Bronchopulmonary dysplasia
chr6	147549296	147549297	rs556493	Bronchopulmonary dysplasia
chr6	147680358	147680359	rs9390459	Coagulation factor levels
chr6	147701132	147701133	rs9373523	Tuberculosis
chr6	147759533	147759534	rs9403856	IgG glycosylation
chr6	147934946	147934947	rs9377063	Obesity-related traits
chr6	147971573	147971574	rs1302019	Myopia (pathological)
chr6	148423370	148423371	rs9390537	Alzheimer's disease
chr6	148521291	148521292	rs9497965	Thyroid hormone levels
chr6	148547801	148547802	rs9497975	HIV-1 control
chr6	148704953	148704954	rs6930576	Type 2 diabetes nephropathy
chr6	148788005	148788006	rs6930337	Protein quantitative trait loci
chr6	148923788	148923789	rs13196614	Migraine
chr6	149270828	149270829	rs13219957	Job-related exhaustion
chr6	149329266	149329267	rs2500535	Response to antidepressants
chr6	149435110	149435111	rs7772697	Diabetic retinopathy
chr6	149525605	149525606	rs636864	Hemostatic factors and hematological phenotypes
chr6	149593919	149593920	rs727979	Hemostatic factors and hematological phenotypes
chr6	149608873	149608874	rs9485372	Breast cancer
chr6	149762536	149762537	rs2179367	Dupuytren's disease
chr6	150298841	150298842	rs1853665	Radiation response
chr6	150358011	150358012	rs9479482	Alopecia areata
chr6	150380883	150380884	rs78546022	Metabolite levels (HVA/5-HIAA ratio)
chr6	150570866	150570867	rs3734729	Pulmonary function (interaction)
chr6	150570866	150570867	rs3734729	Pulmonary function
chr6	150651899	150651900	rs1591830	Metabolite levels
chr6	150913960	150913961	rs9372078	Panic disorder
chr6	151004769	151004770	rs17080102	Blood pressure
chr6	151009888	151009889	rs4869931	Systolic blood pressure in sickle cell anemia
chr6	151102829	151102830	rs75253868	Alzheimer's disease (cognitive decline)
chr6	151125250	151125251	rs10046456	Obesity-related traits
chr6	151163114	151163115	rs17427389	Alcohol and nictotine co-dependence
chr6	151207077	151207078	rs11754661	Alzheimer's disease (late onset)
chr6	151252984	151252985	rs6922269	Coronary heart disease
chr6	151895455	151895456	rs6909279	Bone mineral density
chr6	151901408	151901409	rs4870044	Bone mineral density (spine)
chr6	151901408	151901409	rs4870044	Bone mineral density (hip)
chr6	151907747	151907748	rs4869742	Bone mineral density
chr6	151907747	151907748	rs4869742	Chronic myeloid leukemia
chr6	151914112	151914113	rs3757318	Breast cancer
chr6	151933174	151933175	rs1038304	Bone mineral density (hip)
chr6	151933174	151933175	rs1038304	Bone mineral density (spine)
chr6	151936676	151936677	rs6929137	Bone mineral density (spine)
chr6	151939349	151939350	rs3734805	Breast cancer
chr6	151948365	151948366	rs2046210	Breast Cancer in BRCA1 mutation carriers
chr6	151948365	151948366	rs2046210	Breast cancer
chr6	151957713	151957714	rs12173570	Breast size
chr6	151987356	151987357	rs9383938	Breast cancer
chr6	152009637	152009638	rs2941740	Bone mineral density (hip)
chr6	152068363	152068364	rs1999805	Bone mineral density (spine)
chr6	152080831	152080832	rs60945108	Obesity-related traits
chr6	152090706	152090707	rs2504063	Bone mineral density (spine)
chr6	152110942	152110943	rs543650	Height
chr6	152157880	152157881	rs6902771	Alcohol dependence
chr6	152285686	152285687	rs2982694	Sudden cardiac arrest
chr6	152295612	152295613	rs9383951	Breast cancer
chr6	152358178	152358179	rs2982712	Height
chr6	152738753	152738754	rs17082664	Bipolar disorder and major depressive disorder (combined)
chr6	152738753	152738754	rs17082664	Bipolar disorder
chr6	152790572	152790573	rs9371601	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr6	152790572	152790573	rs9371601	Bipolar disorder
chr6	152791473	152791474	rs7747960	Bipolar disorder
chr6	152947952	152947953	rs1322512	Tonometry
chr6	153265209	153265210	rs13218732	Migraine
chr6	153441078	153441079	rs1933488	Prostate cancer
chr6	154004970	154004971	rs2186141	Migraine - clinic-based
chr6	154077192	154077193	rs1937579	Coronary artery calcification
chr6	154234866	154234867	rs6900489	Metabolite levels  (X-11787)
chr6	154414562	154414563	rs675026	Coronary heart disease
chr6	154478439	154478440	rs2236256	Chronic lymphocytic leukemia
chr6	154726987	154726988	rs2275336	Parkinson's disease
chr6	154986663	154986664	rs9397738	Renal function-related traits (eGRFcrea)
chr6	155929800	155929801	rs35229355	Response to treatment for acute lymphoblastic leukemia
chr6	156197501	156197502	rs4269383	Pancreatic cancer
chr6	156657841	156657842	rs12213468	IgG glycosylation
chr6	156913011	156913012	rs2817461	Sensory disturbances after bilateral sagittal split ramus osteotomy
chr6	157009380	157009381	rs9384488	Alzheimer's disease biomarkers
chr6	157128256	157128257	rs11967485	Calcium levels
chr6	157441049	157441050	rs9478751	Uric acid levels
chr6	158041282	158041283	rs2163287	Response to antidepressant treatment
chr6	158389740	158389741	rs9458975	Cannabis use (initiation)
chr6	158435571	158435572	rs9365723	Colorectal cancer
chr6	158929441	158929442	rs9456307	Height
chr6	159465976	159465977	rs1738074	Multiple sclerosis
chr6	159465976	159465977	rs1738074	Celiac disease
chr6	159490435	159490436	rs212388	Crohn's disease
chr6	159490435	159490436	rs212388	Crohn's disease and celiac disease
chr6	159646332	159646333	rs365302	Coronary heart disease
chr6	160071158	160071159	rs2842992	Age-related macular degeneration (GA)
chr6	160137686	160137687	rs4516970	Iron status biomarkers
chr6	160402704	160402705	rs6917747	Brain lesion load
chr6	160459190	160459191	rs78797168	Periodontitis (CDC/AAP)
chr6	160564475	160564476	rs662138	Metabolic traits
chr6	160578859	160578860	rs1564348	LDL cholesterol
chr6	160578859	160578860	rs1564348	Cholesterol, total
chr6	160581373	160581374	rs651164	Prostate cancer
chr6	160668388	160668389	rs2279463	Chronic kidney disease
chr6	160681392	160681393	rs3127573	Creatinine levels
chr6	160741621	160741622	rs3120139	Lp (a) levels
chr6	160789295	160789296	rs402219	Monocyte early outgrowth colony forming units
chr6	160824027	160824028	rs2504916	Response to hepatitis C treatment
chr6	160833663	160833664	rs9364554	Prostate cancer
chr6	160840251	160840252	rs7758229	Colorectal cancer
chr6	160863531	160863532	rs2048327	Coronary heart disease
chr6	160907133	160907134	rs3127599	Coronary heart disease
chr6	160910516	160910517	rs12214416	Lp (a) levels
chr6	160960358	160960359	rs6919346	Lp (a) levels
chr6	160961136	160961137	rs3798220	Coronary heart disease
chr6	160962502	160962503	rs7767084	Coronary heart disease
chr6	160969737	160969738	rs10755578	Coronary heart disease
chr6	161010117	161010118	rs10455872	Aortic-valve calcification
chr6	161010117	161010118	rs10455872	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr6	161010117	161010118	rs10455872	Response to statin therapy
chr6	161010117	161010118	rs10455872	Response to statin therapy (LDL-C)
chr6	161010117	161010118	rs10455872	Lp (a) levels
chr6	161018173	161018174	rs7770628	Protein quantitative trait loci
chr6	161089816	161089817	rs1084651	HDL cholesterol
chr6	161137989	161137990	rs783147	Lp (a) levels
chr6	161333936	161333937	rs1247318	Aging
chr6	161933934	161933935	rs16892673	Aging
chr6	162001435	162001436	rs992037	Metabolite levels
chr6	162161618	162161619	rs926849	Disc degeneration (lumbar)
chr6	162236074	162236075	rs3016539	Pancreatic cancer
chr6	162314920	162314921	rs12207186	IgG glycosylation
chr6	164186676	164186677	rs10945919	Response to TNF antagonist treatment
chr6	164900597	164900598	rs4709845	Major depressive disorder
chr6	165466350	165466351	rs227458	Visceral adipose tissue adjusted for BMI
chr6	165935420	165935421	rs519595	Response to fenofibrate
chr6	166015430	166015431	rs7762160	Conduct disorder (symptom count)
chr6	166046482	166046483	rs753760	Thyroid hormone levels
chr6	166128637	166128638	rs9364813	Economic and political preferences (immigration/crime)
chr6	166155456	166155457	rs1039002	Bipolar disorder
chr6	166534741	166534742	rs6456042	Asthma
chr6	166571442	166571443	rs1056053	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr6	166706168	166706169	rs6915183	Longevity
chr6	167177421	167177422	rs635808	Dental caries
chr6	167336150	167336151	rs9459805	Endometrial cancer
chr6	167360388	167360389	rs2236313	Vitiligo
chr6	167371109	167371110	rs2149085	Crohn's disease
chr6	167373546	167373547	rs1819333	Inflammatory bowel disease
chr6	167383074	167383075	rs9355610	Graves' disease
chr6	167406632	167406633	rs415890	Crohn's disease
chr6	167437987	167437988	rs2301436	Crohn's disease
chr6	167532792	167532793	rs3093024	Rheumatoid arthritis
chr6	167534289	167534290	rs3093023	Rheumatoid arthritis
chr6	167557033	167557034	rs11575088	Social autistic-like traits
chr6	167754974	167754975	rs12528714	IgG glycosylation
chr6	168388927	168388928	rs2843012	Metabolite levels (5-HIAA)
chr6	168484084	168484085	rs4708431	Attention deficit hyperactivity disorder (combined symptoms)
chr6	168490567	168490568	rs9364220	Attention deficit hyperactivity disorder (inattention symptoms)
chr6	168490567	168490568	rs9364220	Attention deficit hyperactivity disorder (combined symptoms)
chr6	168511015	168511016	rs1473500	Immune reponse to smallpox (secreted IL-2)
chr6	168757110	168757111	rs6915443	Sexual dimorphism in anthropometric traits
chr6	168941623	168941624	rs13208776	Vitiligo
chr6	169727600	169727601	rs12190007	Obesity-related traits
chr6	169820380	169820381	rs438465	Corneal astigmatism
chr6	169958981	169958982	rs3734905	HIV-1 control
chr6	170113243	170113244	rs7762018	Thiazide-induced adverse metabolic effects in hypertensive patients
chr6	170379024	170379025	rs924043	Type 1 diabetes
chr6	170425520	170425521	rs10946292	Obesity-related traits
chr7	1022727	1022728	rs12701220	Bronchopulmonary dysplasia
chr7	1039002	1039003	rs10256972	Longevity
chr7	1083776	1083777	rs1997243	Cholesterol, total
chr7	1273844	1273845	rs10275044	Renal function-related traits (BUN)
chr7	1285194	1285195	rs10277115	Renal function-related traits (sCR)
chr7	1285194	1285195	rs10277115	Renal function-related traits (eGRFcrea)
chr7	1288638	1288639	rs13241427	Fat distribution (HIV)
chr7	1886534	1886535	rs6952808	Bipolar disorder and schizophrenia
chr7	1912221	1912222	rs4721135	Longevity
chr7	1920825	1920826	rs10275045	Schizophrenia or bipolar disorder
chr7	1950808	1950809	rs4332037	Bipolar disorder
chr7	1968952	1968953	rs12699477	Testicular germ cell tumor
chr7	2004420	2004421	rs12666575	Schizophrenia
chr7	2017444	2017445	rs6461049	Schizophrenia
chr7	2036668	2036669	rs4721295	Schizophrenia, schizoaffective disorder or bipolar disorder
chr7	2041431	2041432	rs1107592	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr7	2041431	2041432	rs1107592	Bipolar disorder and schizophrenia
chr7	2278225	2278226	rs7799006	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr7	2298226	2298227	rs2398668	Bipolar disorder and schizophrenia
chr7	2448492	2448493	rs6952809	Multiple sclerosis
chr7	2582451	2582452	rs6972204	Obesity-related traits
chr7	2759794	2759795	rs798554	Height
chr7	2763101	2763102	rs798544	Height
chr7	2789879	2789880	rs798502	Ulcerative colitis
chr7	2795956	2795957	rs798497	Height
chr7	2801802	2801803	rs798489	Height
chr7	2869984	2869985	rs1182188	Height
chr7	2915377	2915378	rs6977940	White matter integrity
chr7	3128788	3128789	rs4722404	Atopic dermatitis
chr7	3915563	3915564	rs6462411	Quantitative traits
chr7	4411208	4411209	rs10488360	Factor VII
chr7	4474131	4474132	rs314590	Obesity-related traits
chr7	4723533	4723534	rs9791644	Lung function (forced vital capacity)
chr7	4839264	4839265	rs2306921	Obesity-related traits
chr7	5524804	5524805	rs10216189	Relative hand skill in reading disability
chr7	5880376	5880377	rs308097	IgG glycosylation
chr7	6449271	6449272	rs702485	HDL cholesterol
chr7	7259269	7259270	rs12702595	Serum dimethylarginine levels (symmetric)
chr7	7259269	7259270	rs12702595	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr7	7268430	7268431	rs10259085	Multiple sclerosis (severity)
chr7	7302292	7302293	rs1299548	Visceral adipose tissue adjusted for BMI
chr7	7399403	7399404	rs10486158	Bipolar disorder and schizophrenia
chr7	7571419	7571420	rs17168526	Immune reponse to smallpox (secreted IL-1beta)
chr7	7848911	7848912	rs10259199	Obesity-related traits
chr7	7864750	7864751	rs12702661	Obesity-related traits
chr7	7883322	7883323	rs7780564	Insulin-like growth factors
chr7	7938595	7938596	rs10486201	Obesity-related traits
chr7	8152066	8152067	rs59072263	Intraocular pressure
chr7	8157886	8157887	rs6463768	Metabolite levels (Pyroglutamine)
chr7	8177396	8177397	rs17143586	Obesity-related traits
chr7	8552613	8552614	rs765855	Breast Cancer in BRCA1 mutation carriers
chr7	8642353	8642354	rs10245124	Obesity-related traits
chr7	8718079	8718080	rs2349775	Neuroticism
chr7	8838716	8838717	rs6463843	Brain imaging
chr7	8998975	8998976	rs17157663	Quantitative traits
chr7	9066819	9066820	rs10952132	Response to fenofibrate
chr7	9189540	9189541	rs1371737	Obesity-related traits
chr7	9266387	9266388	rs1285407	Protein quantitative trait loci
chr7	9539278	9539279	rs9918508	Hippocampal atrophy
chr7	10149975	10149976	rs7778619	Select biomarker traits
chr7	10364722	10364723	rs2882834	Capecitabine sensitivity
chr7	11291399	11291400	rs4720952	IgG glycosylation
chr7	12059805	12059806	rs769111	Tourette syndrome
chr7	12094965	12094966	rs1035147	Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
chr7	12193431	12193432	rs114945094	Anorexia nervosa
chr7	12219534	12219535	rs17594709	IgG glycosylation
chr7	12273151	12273152	rs14978	Response to amphetamines
chr7	12391318	12391319	rs6967385	Response to taxane treatment (placlitaxel)
chr7	12713069	12713070	rs10488226	Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)
chr7	12932048	12932049	rs732577	Sudden cardiac arrest
chr7	12937254	12937255	rs17166499	Bipolar disorder and schizophrenia
chr7	13440221	13440222	rs10255329	Metabolite levels  (X-11787)
chr7	13543728	13543729	rs13307587	Reading and spelling
chr7	13554007	13554008	rs13227425	Word reading
chr7	13560220	13560221	rs1357978	Word reading
chr7	14445916	14445917	rs6971925	Response to treatment for acute lymphoblastic leukemia
chr7	15063832	15063833	rs10244051	Metabolic traits
chr7	15064308	15064309	rs2191349	Fasting glucose-related traits (interaction with BMI)
chr7	15064308	15064309	rs2191349	Fasting glucose-related traits
chr7	15064983	15064984	rs6947830	Metabolic syndrome
chr7	15133126	15133127	rs12699683	Paclitaxel-induced neuropathy
chr7	15335935	15335936	rs12531027	Obesity-related traits
chr7	15630870	15630871	rs11763353	Blood trace element (Zn levels)
chr7	15742785	15742786	rs10486776	Stroke
chr7	15757999	15758000	rs2159222	Migraine with aura
chr7	16326645	16326646	rs35681285	Serum tamsulosin hydrochloride concentration
chr7	16500141	16500142	rs10270805	Response to statin therapy
chr7	16707860	16707861	rs58370486	Alzheimer's disease (cognitive decline)
chr7	16837453	16837454	rs2280655	IgG glycosylation
chr7	16861848	16861849	rs10253216	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
chr7	16889811	16889812	rs1525739	Type 2 diabetes (dietary heme iron intake interaction)
chr7	17085320	17085321	rs6961860	Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
chr7	17284576	17284577	rs4410790	Caffeine consumption
chr7	17287268	17287269	rs6968865	Coffee consumption
chr7	17309278	17309279	rs12670403	Metabolic traits
chr7	17318311	17318312	rs13236243	Sensory disturbances after bilateral sagittal split ramus osteotomy
chr7	17561582	17561583	rs10499504	Response to antipsychotic treatment
chr7	17919257	17919258	rs4142995	HDL cholesterol
chr7	17997611	17997612	rs10226084	Fibrinogen
chr7	18375244	18375245	rs12666612	Obesity-related traits
chr7	18428920	18428921	rs12155400	Retinopathy in non-diabetics
chr7	18800412	18800413	rs11764116	Ulcerative colitis
chr7	18877873	18877874	rs2073963	Male-pattern baldness
chr7	18980266	18980267	rs2853552	Obesity-related traits
chr7	19031934	19031935	rs11984041	Stroke
chr7	19049387	19049388	rs2107595	Stroke (ischemic)
chr7	19106538	19106539	rs430	Obesity-related traits
chr7	19248277	19248278	rs17140875	Obesity-related traits
chr7	19616521	19616522	rs4470914	Height
chr7	19805479	19805480	rs6977660	Thyroid stimulating hormone
chr7	20047574	20047575	rs38152	HIV-1 control
chr7	20086981	20086982	rs6954796	Non-word repetition
chr7	20255704	20255705	rs3095008	Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)
chr7	20647014	20647015	rs10950821	Response to statin therapy
chr7	20791997	20791998	rs2108258	Dental caries
chr7	20862301	20862302	rs2709736	Bipolar I disorder
chr7	20885094	20885095	rs13245023	IgG glycosylation
chr7	20994490	20994491	rs12155172	Prostate cancer
chr7	21147677	21147678	rs11974269	Obesity-related traits
chr7	21163354	21163355	rs10950840	Obesity-related traits
chr7	21222789	21222790	rs6971109	Capecitabine sensitivity
chr7	21504426	21504427	rs17144465	Major depressive disorder
chr7	21504426	21504427	rs17144465	Major depressive disorder (broad)
chr7	21584087	21584088	rs2285947	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)
chr7	21607351	21607352	rs12670798	LDL cholesterol
chr7	21607351	21607352	rs12670798	Cholesterol, total
chr7	21742973	21742974	rs368331	Total ventricular volume
chr7	21742973	21742974	rs368331	MRI atrophy measures
chr7	21938239	21938240	rs4487645	Multiple myeloma (hyperdiploidy)
chr7	21938239	21938240	rs4487645	Multiple myeloma
chr7	22024039	22024040	rs1175000	Height
chr7	22109458	22109459	rs10499559	Thyroid stimulating hormone
chr7	22514052	22514053	rs17364464	Dialysis-related mortality
chr7	22732838	22732839	rs2097677	C-reactive protein
chr7	22756462	22756463	rs10155981	Bilirubin levels
chr7	22856605	22856606	rs2286503	Fibrinogen
chr7	22985009	22985010	rs2286492	Bipolar disorder
chr7	22994185	22994186	rs73082373	Periodontitis (Mean PAL)
chr7	23420766	23420767	rs375092	Personality dimensions
chr7	23480466	23480467	rs11763760	IgG glycosylation
chr7	23482684	23482685	rs6957923	Height
chr7	23502973	23502974	rs12534093	Height
chr7	24240164	24240165	rs886448	Asthma (childhood onset)
chr7	24378039	24378040	rs2521634	Periodontitis
chr7	24692551	24692552	rs2721800	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr7	25133848	25133849	rs39453	Colorectal cancer
chr7	25161601	25161602	rs1861525	Alzheimer's disease (cognitive decline)
chr7	25608408	25608409	rs17151904	Carotid atherosclerosis in HIV infection
chr7	25612660	25612661	rs975369	Preeclampsia
chr7	25871108	25871109	rs1055144	Waist-hip ratio
chr7	25901638	25901639	rs12700667	Endometriosis
chr7	25950544	25950545	rs10261878	Body mass index
chr7	25991825	25991826	rs4722551	Triglycerides
chr7	25991825	25991826	rs4722551	LDL cholesterol
chr7	25991825	25991826	rs4722551	Cholesterol, total
chr7	26008051	26008052	rs745580	Obesity-related traits
chr7	26481803	26481804	rs10951138	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr7	26557617	26557618	rs886716	Smoking behavior
chr7	26891664	26891665	rs7804356	Type 1 diabetes
chr7	26892439	26892440	rs10486483	Crohn's disease
chr7	27231761	27231762	rs4722672	Ulcerative colitis
chr7	27330055	27330056	rs13225783	Heart failure
chr7	27335560	27335561	rs11564024	Immune reponse to smallpox (secreted IL-1beta)
chr7	27337866	27337867	rs17428471	Blood pressure
chr7	27976562	27976563	rs10486567	Prostate cancer
chr7	28004197	28004198	rs4722750	Thiazide-induced adverse metabolic effects in hypertensive patients
chr7	28180555	28180556	rs864745	Crohn's disease
chr7	28180555	28180556	rs864745	Type 2 diabetes
chr7	28185090	28185091	rs849141	Height
chr7	28189082	28189083	rs1029534	Height
chr7	28189410	28189411	rs1635852	Systemic lupus erythematosus and Systemic sclerosis
chr7	28189410	28189411	rs1635852	Height
chr7	28189945	28189946	rs1708299	Height
chr7	28196221	28196222	rs849134	Type 2 diabetes
chr7	28229041	28229042	rs550448	Type 1 diabetes
chr7	28391141	28391142	rs11765845	Diabetic retinopathy
chr7	28432475	28432476	rs7799265	Airflow obstruction
chr7	28762962	28762963	rs2237349	Attention deficit hyperactivity disorder
chr7	29014194	29014195	rs2018683	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
chr7	29041189	29041190	rs2252521	Cognitive performance
chr7	29184488	29184489	rs10486607	Diabetes related insulin traits
chr7	29218158	29218159	rs245914	Psychosis (atypical)
chr7	29218158	29218159	rs245914	Obesity-related traits
chr7	29921523	29921524	rs740145	Corneal curvature
chr7	29962523	29962524	rs17158483	Obesity-related traits
chr7	30083020	30083021	rs10488084	Estradiol levels
chr7	30937177	30937178	rs1000597	Nephrolithiasis
chr7	31155346	31155347	rs1558477	Major depressive disorder
chr7	31904026	31904027	rs2270221	Endometriosis
chr7	32189539	32189540	rs11975235	Presence of antiphospholipid antibodies
chr7	32347334	32347335	rs215614	Smoking behavior
chr7	32376747	32376748	rs10237735	Palmitic acid (16:0) plasma levels
chr7	32460723	32460724	rs62458065	Metabolite levels (HVA/MHPG ratio)
chr7	33256038	33256039	rs10262453	Sagittal craniosynostosis
chr7	33673264	33673265	rs17170316	Cytomegalovirus antibody response
chr7	34697059	34697060	rs2530544	IgG glycosylation
chr7	34697139	34697140	rs2530545	IgG glycosylation
chr7	35401446	35401447	rs2392362	Information processing speed
chr7	35554787	35554788	rs343064	Non-alcoholic fatty liver disease histology (other)
chr7	35607232	35607233	rs6973609	Obesity-related traits
chr7	36191698	36191699	rs4302748	Platelet counts
chr7	36211748	36211749	rs9648428	Obesity-related traits
chr7	36546068	36546069	rs7777593	Obesity-related traits
chr7	36610492	36610493	rs6948404	HIV-1 control
chr7	36917994	36917995	rs741301	Type 2 diabetes nephropathy
chr7	36952020	36952021	rs10488023	Breast size
chr7	36961319	36961320	rs13230047	Anticoagulant levels
chr7	37067394	37067395	rs10488029	IgG glycosylation
chr7	37076853	37076854	rs10488031	QT interval
chr7	37266351	37266352	rs4723619	Response to treatment for acute lymphoblastic leukemia
chr7	37365195	37365196	rs2392492	Alzheimer's disease (cognitive decline)
chr7	37374509	37374510	rs6974491	Primary biliary cirrhosis
chr7	37374509	37374510	rs6974491	Celiac disease
chr7	37436853	37436854	rs11984075	Celiac disease and Rheumatoid arthritis
chr7	37562367	37562368	rs1425132	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
chr7	37757555	37757556	rs6951258	Obesity-related traits
chr7	37841533	37841534	rs2718058	Alzheimer's disease (late onset)
chr7	37938421	37938422	rs10226308	Bone mineral density
chr7	37989094	37989095	rs16879765	Dupuytren's disease
chr7	38004405	38004406	rs1668357	Myopia (pathological)
chr7	38128325	38128326	rs6959212	Bone mineral density
chr7	38128325	38128326	rs6959212	Height
chr7	38136276	38136277	rs1524058	Bone mineral density (spine)
chr7	38240907	38240908	rs4723738	Treatment response for severe sepsis
chr7	38835034	38835035	rs11984145	Cognitive performance
chr7	39121499	39121500	rs10464366	IgG glycosylation
chr7	40466199	40466200	rs4379368	Migraine without aura
chr7	40466199	40466200	rs4379368	Migraine - clinic-based
chr7	40466199	40466200	rs4379368	Migraine
chr7	40954480	40954481	rs29880	Iron status biomarkers
chr7	40965126	40965127	rs7789197	Prostate cancer (gene x gene interaction)
chr7	41470092	41470093	rs1079866	Menarche (age at onset)
chr7	41478607	41478608	rs10486715	Quantitative traits
chr7	41622529	41622530	rs4724055	Non-substance related behavioral disinhibition
chr7	41743293	41743294	rs2877098	Migraine without aura
chr7	41811907	41811908	rs10486722	Pit-and-Fissure caries
chr7	42036836	42036837	rs846271	IgG glycosylation
chr7	42176281	42176282	rs2049622	Age-related macular degeneration
chr7	42264678	42264679	rs4724100	Allergic rhinitis
chr7	42325624	42325625	rs12532960	Inflammatory biomarkers
chr7	43158476	43158477	rs2024125	Obesity-related traits
chr7	43286838	43286839	rs17172185	Esophageal adenocarcinoma
chr7	43377275	43377276	rs17172199	Alzheimer's disease (cognitive decline)
chr7	43910881	43910882	rs10232743	Obesity-related traits
chr7	44223720	44223721	rs730497	Glycated hemoglobin levels
chr7	44229067	44229068	rs1799884	Glycemic traits
chr7	44229067	44229068	rs1799884	Metabolite levels
chr7	44229067	44229068	rs1799884	Glycated hemoglobin levels
chr7	44231215	44231216	rs3757840	Metabolic syndrome
chr7	44235667	44235668	rs4607517	Fasting glucose-related traits (interaction with BMI)
chr7	44235667	44235668	rs4607517	Fasting plasma glucose
chr7	44235667	44235668	rs4607517	Fasting glucose-related traits
chr7	44259870	44259871	rs1127065	Metabolic syndrome
chr7	44276650	44276651	rs3757837	Osteoarthritis (hip)
chr7	44579179	44579180	rs2072183	LDL cholesterol
chr7	44579179	44579180	rs2072183	Cholesterol, total
chr7	45982459	45982460	rs2462686	Major depressive disorder
chr7	46008109	46008110	rs11977526	Insulin-like growth factors
chr7	46242582	46242583	rs6964415	Sudden cardiac arrest
chr7	46275727	46275728	rs1486139	Select biomarker traits
chr7	46392566	46392567	rs17513961	Treatment response for severe sepsis
chr7	46620144	46620145	rs7784776	QRS duration
chr7	46753490	46753491	rs700750	Obesity-related traits
chr7	46753552	46753553	rs700752	Insulin-like growth factors
chr7	47779968	47779969	rs7800244	Hepatitis C induced liver fibrosis
chr7	48817964	48817965	rs11767191	Response to amphetamines
chr7	49329679	49329680	rs7801534	Thiazide-induced adverse metabolic effects in hypertensive patients
chr7	49633801	49633802	rs4492324	Obesity-related traits
chr7	50225390	50225391	rs7805803	Total ventricular volume
chr7	50253896	50253897	rs17664743	Self-reported allergy
chr7	50269671	50269672	rs1456893	Crohn's disease
chr7	50304460	50304461	rs1456896	Inflammatory bowel disease
chr7	50304460	50304461	rs1456896	Crohn's disease
chr7	50305862	50305863	rs4917014	HDL cholesterol
chr7	50305862	50305863	rs4917014	Systemic lupus erythematosus
chr7	50313351	50313352	rs10276619	Systemic lupus erythematosus
chr7	50313351	50313352	rs10276619	Hippocampal atrophy
chr7	50335231	50335232	rs4917017	IgG glycosylation
chr7	50346133	50346134	rs7781977	IgG glycosylation
chr7	50350266	50350267	rs6583437	IgG glycosylation
chr7	50355206	50355207	rs6421315	IgG glycosylation
chr7	50428427	50428428	rs12718597	Mean corpuscular volume
chr7	50428444	50428445	rs12718598	Red blood cell traits
chr7	50466303	50466304	rs11978267	Acute lymphoblastic leukemia (childhood)
chr7	50469980	50469981	rs11980379	Acute lymphoblastic leukemia (B-cell precursor)
chr7	50470603	50470604	rs4132601	Acute lymphoblastic leukemia (childhood)
chr7	50473250	50473251	rs6964969	Acute lymphoblastic leukemia (childhood)
chr7	50622711	50622712	rs1451375	Malaria
chr7	50664921	50664922	rs12540874	Systemic sclerosis
chr7	50751089	50751090	rs10248619	Fasting glucose-related traits (interaction with BMI)
chr7	50754678	50754679	rs2282930	Bone mineral density
chr7	51027193	51027194	rs4948088	Type 1 diabetes
chr7	51537886	51537887	rs1949829	Wegener's granulomatosis
chr7	52006414	52006415	rs406001	Post-traumatic stress disorder (asjusted for relatedness)
chr7	52472449	52472450	rs1012036	Emphysema-related traits
chr7	53127558	53127559	rs1174864	IgG glycosylation
chr7	54181931	54181932	rs6593122	Vaccine-related adverse events
chr7	54674872	54674873	rs679830	Obesity-related traits
chr7	54978923	54978924	rs2252586	Glioma
chr7	55159348	55159349	rs11979158	Glioma
chr7	55724444	55724445	rs9656709	Behavioural disinhibition (generation interaction)
chr7	57699150	57699151	rs4870684	Bipolar disorder and schizophrenia
chr7	62577769	62577770	rs6956675	Obesity-related traits
chr7	63346885	63346886	rs13437751	QT interval (interaction)
chr7	63733330	63733331	rs10266483	Response to statin therapy
chr7	65271196	65271197	rs17711722	Calcium levels
chr7	65326820	65326821	rs11763147	Corneal structure
chr7	65617594	65617595	rs875971	Aortic root size
chr7	66030611	66030612	rs801193	Aortic root size
chr7	66096027	66096028	rs10263935	Aortic root size
chr7	66421445	66421446	rs4718428	Corneal structure
chr7	67059266	67059267	rs10263639	Breast cancer
chr7	67188787	67188788	rs7807441	Menarche (age at onset)
chr7	67426322	67426323	rs6961611	Information processing speed
chr7	68050412	68050413	rs1403155	Immune reponse to smallpox (secreted IL-2)
chr7	68611959	68611960	rs6945541	Male-pattern baldness
chr7	69238157	69238158	rs11765886	IgG glycosylation
chr7	69806022	69806023	rs6943555	Alcohol consumption
chr7	69887084	69887085	rs11766624	Obesity-related traits
chr7	70045940	70045941	rs10237317	Bipolar disorder
chr7	70473004	70473005	rs1525293	Major depressive disorder
chr7	71016158	71016159	rs4719147	Response to angiotensin II receptor blocker therapy
chr7	71388849	71388850	rs11766496	Airflow obstruction
chr7	71751315	71751316	rs12699131	Schizophrenia
chr7	72129666	72129667	rs13238203	Triglycerides
chr7	72311816	72311817	rs2058059	Subcutaneous adipose tissue
chr7	72746647	72746648	rs6943090	Immune reponse to smallpox (secreted IL-12p40)
chr7	72856268	72856269	rs2240466	Caffeine consumption
chr7	72856268	72856269	rs2240466	Triglycerides
chr7	72856429	72856430	rs1178979	Triglycerides
chr7	72857048	72857049	rs1178977	Urate levels
chr7	72864868	72864869	rs714052	Hypertriglyceridemia
chr7	72864868	72864869	rs714052	Triglycerides
chr7	72904809	72904810	rs17145713	Protein C levels
chr7	72971230	72971231	rs13233571	C-reactive protein
chr7	72977897	72977898	rs12539316	Gamma glutamyl transpeptidase
chr7	72982873	72982874	rs17145738	Triglycerides
chr7	72982873	72982874	rs17145738	HDL cholesterol
chr7	72987353	72987354	rs2286276	Hypertriglyceridemia
chr7	72987353	72987354	rs2286276	Triglycerides
chr7	72994475	72994476	rs12666883	Obesity-related traits
chr7	73010441	73010442	rs13247874	Lipid metabolism phenotypes
chr7	73017004	73017005	rs13226650	Metabolic syndrome
chr7	73020336	73020337	rs3812316	Triglycerides
chr7	73026377	73026378	rs17145750	Liver enzyme levels (gamma-glutamyl transferase)
chr7	74126033	74126034	rs117026326	Sjogren's syndrome
chr7	75059330	75059331	rs236670	Obesity-related traits
chr7	75173179	75173180	rs1167796	Systemic lupus erythematosus
chr7	75211413	75211414	rs237238	Alcoholism (12-month weekly alcohol consumption)
chr7	75951229	75951230	rs7789940	Multiple sclerosis
chr7	75953296	75953297	rs758944	Multiple sclerosis
chr7	75975585	75975586	rs7779014	Multiple sclerosis
chr7	75978228	75978229	rs17149161	Multiple sclerosis
chr7	76639870	76639871	rs6955651	Body mass index
chr7	76738590	76738591	rs3864639	Obesity-related traits
chr7	76762950	76762951	rs12540771	Response to amphetamines
chr7	77416438	77416439	rs6465825	Chronic kidney disease
chr7	77549905	77549906	rs12234571	Obesity-related traits
chr7	77596811	77596812	rs848452	Dental caries
chr7	77964787	77964788	rs2691543	Height
chr7	78043290	78043291	rs17150687	Response to antidepressant treatment
chr7	78152671	78152672	rs62468577	Bronchopulmonary dysplasia
chr7	78158471	78158472	rs12666870	Obesity-related traits
chr7	78175976	78175977	rs11525066	Hippocampal atrophy
chr7	78331464	78331465	rs1496766	Acute lymphoblastic leukemia (childhood)
chr7	79651452	79651453	rs2199936	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr7	79651452	79651453	rs2199936	Cardiovascular disease risk factors
chr7	79651452	79651453	rs2199936	Urate levels
chr7	80236013	80236014	rs13236689	Mean platelet volume
chr7	80258809	80258810	rs10499859	Left ventricular mass
chr7	80286907	80286908	rs11574703	Response to fenofibrate
chr7	80340621	80340622	rs2366858	HDL cholesterol
chr7	80599356	80599357	rs4236644	Bilirubin levels
chr7	81731445	81731446	rs258671	Response to taxane treatment (docetaxel)
chr7	81768171	81768172	rs117576300	Serum dimethylarginine levels (asymmetric)
chr7	81782513	81782514	rs6942458	Obesity-related traits
chr7	81786219	81786220	rs2367911	Bipolar disorder and schizophrenia
chr7	81839552	81839553	rs11978472	Crohn's disease (need for surgery)
chr7	81847650	81847651	rs10954668	Non-alcoholic fatty liver disease histology (lobular)
chr7	81857892	81857893	rs929351	Ulcerative colitis
chr7	82115239	82115240	rs10262537	Metabolite levels (Dihydroxy docosatrienoic acid)
chr7	82337858	82337859	rs2371208	Aging traits
chr7	82450034	82450035	rs2715148	Major depressive disorder
chr7	83609038	83609039	rs797820	Attention deficit hyperactivity disorder
chr7	83656799	83656800	rs10235789	Iris characteristics
chr7	83772414	83772415	rs447	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr7	83782838	83782839	rs17158675	Obesity-related traits
chr7	83911270	83911271	rs488333	Prion diseases
chr7	86348998	86348999	rs2189812	IgG glycosylation
chr7	86696713	86696714	rs1476587	Brachial circumference
chr7	86821979	86821980	rs11773103	Bipolar disorder and major depressive disorder (combined)
chr7	88481441	88481442	rs10248351	Hypothyroidism
chr7	88560877	88560878	rs1406503	Body mass index
chr7	88596384	88596385	rs6959888	Anorexia nervosa
chr7	88695069	88695070	rs10236237	IgG glycosylation
chr7	89060732	89060733	rs6973392	Dental caries
chr7	89763863	89763864	rs10266254	Coronary artery calcification
chr7	89977759	89977760	rs42648	Homocysteine levels
chr7	90915353	90915354	rs2888830	Dental caries
chr7	91240296	91240297	rs2540552	IgG glycosylation
chr7	91272343	91272344	rs1476442	Obesity-related traits
chr7	92246743	92246744	rs42041	Rheumatoid arthritis
chr7	92248075	92248076	rs42235	Height
chr7	92256904	92256905	rs2040494	Height
chr7	92264409	92264410	rs2282978	Height
chr7	92408369	92408370	rs445	White blood cell count
chr7	92408369	92408370	rs445	White blood cell types
chr7	92764981	92764982	rs1133906	Systemic lupus erythematosus and Systemic sclerosis
chr7	93241639	93241640	rs7780752	Birth weight
chr7	93538294	93538295	rs180273	Pulmonary function decline
chr7	93549595	93549596	rs180242	Heart rate
chr7	93691743	93691744	rs9918668	Aging
chr7	93713520	93713521	rs10487245	Obesity-related traits
chr7	94000472	94000473	rs10262915	Intelligence
chr7	94003259	94003260	rs6465411	Intelligence
chr7	94006993	94006994	rs13221576	Intelligence
chr7	94008534	94008535	rs4729127	Intelligence
chr7	94009633	94009634	rs7792596	Intelligence
chr7	94047265	94047266	rs3736638	Immune reponse to smallpox (secreted IL-12p40)
chr7	94053999	94054000	rs441051	Mean forced vital capacity from 2 exams
chr7	94930390	94930391	rs854555	Response to TNF antagonist treatment
chr7	94938256	94938257	rs2057681	Metabolite levels
chr7	94938256	94938257	rs2057681	Paraoxonase activity
chr7	94954695	94954696	rs854572	Paraoxonase activity
chr7	95600367	95600368	rs13231718	Immune reponse to smallpox (secreted IL-10)
chr7	95631195	95631196	rs1488515	Obesity-related traits
chr7	96117917	96117918	rs4729260	Bone mineral density (spine)
chr7	96120674	96120675	rs4727338	Bone mineral density
chr7	96133530	96133531	rs7781370	Bone mineral density (hip)
chr7	96362343	96362344	rs1464807	Attention deficit hyperactivity disorder
chr7	96415054	96415055	rs12669076	Immunoglobulin A
chr7	96581810	96581811	rs17598306	Radiation response
chr7	97017794	97017795	rs10255878	Adverse response to radiation therapy
chr7	97229777	97229778	rs10486003	Response to platinum-based agents
chr7	97422925	97422926	rs1229542	Myopia (pathological)
chr7	97620690	97620691	rs13438327	Sudden cardiac arrest
chr7	97816326	97816327	rs6465657	Prostate cancer
chr7	97924553	97924554	rs77443149	Obesity-related traits
chr7	97993361	97993362	rs3779195	Sex hormone-binding globulin levels
chr7	98021210	98021211	rs9649213	Prostate cancer (gene x gene interaction)
chr7	98759116	98759117	rs9297145	Inflammatory bowel disease
chr7	98760503	98760504	rs7809799	Ulcerative colitis
chr7	98957879	98957880	rs740160	Dehydroepiandrosterone sulphate levels
chr7	99118800	99118801	rs11761528	Dehydroepiandrosterone sulphate levels
chr7	99207875	99207876	rs7792939	Anthropometric traits
chr7	99489570	99489571	rs17277546	Metabolic traits
chr7	99489570	99489571	rs17277546	Dehydroepiandrosterone sulphate levels
chr7	99593345	99593346	rs4727443	Interstitial lung disease
chr7	99940306	99940307	rs13228694	Obesity-related traits
chr7	100004445	100004446	rs1476679	Alzheimer's disease (late onset)
chr7	100214014	100214015	rs7786877	Mean corpuscular volume
chr7	100235969	100235970	rs7385804	Iron levels
chr7	100235969	100235970	rs7385804	Hematocrit
chr7	100235969	100235970	rs7385804	Hematological parameters
chr7	100240295	100240296	rs2075672	Red blood cell traits
chr7	100315516	100315517	rs1734907	Inflammatory bowel disease
chr7	100345105	100345106	rs2075671	Other erythrocyte phenotypes
chr7	100453207	100453208	rs314370	Resting heart rate
chr7	100458092	100458093	rs7801190	Coronary heart disease
chr7	100486753	100486754	rs12666989	Resting heart rate
chr7	100490076	100490077	rs7636	Type 2 diabetes
chr7	100497130	100497131	rs13245899	Heart rate
chr7	100512118	100512119	rs6976053	Plasminogen activator inhibitor type 1 levels (PAI-1)
chr7	100769537	100769538	rs2227631	Plasminogen activator inhibitor type 1 levels (PAI-1)
chr7	100881402	100881403	rs3757458	QT interval
chr7	101115993	101115994	rs17135437	Response to citalopram treatment
chr7	101809850	101809851	rs365836	Response to antidepressants
chr7	102378436	102378437	rs12540771	Response to amphetamines
chr7	102519030	102519031	rs17135875	Blood pressure measurement (cold pressor test)
chr7	103175443	103175444	rs1008126	Metabolite levels (Pyroglutamine)
chr7	103404814	103404815	rs7341475	Schizophrenia
chr7	103527368	103527369	rs3914132	Otosclerosis
chr7	103625876	103625877	rs4298437	Alzheimer's disease
chr7	103628035	103628036	rs17157903	Multiple sclerosis (age of onset)
chr7	104466963	104466964	rs4073894	Educational attainment
chr7	104503812	104503813	rs10953454	Obesity
chr7	104758249	104758250	rs6968355	Myopia (pathological)
chr7	105273719	105273720	rs10242311	Dental caries
chr7	105281187	105281188	rs11983798	Alzheimer's disease (late onset)
chr7	105542579	105542580	rs13438712	Obesity-related traits
chr7	105671266	105671267	rs10270308	Warfarin maintenance dose
chr7	106359215	106359216	rs342275	Platelet counts
chr7	106372218	106372219	rs342293	Mean platelet volume
chr7	106372902	106372903	rs342296	Mean platelet volume
chr7	106409451	106409452	rs17398575	Carotid intima media thickness
chr7	106411857	106411858	rs17477177	Blood pressure
chr7	106495808	106495809	rs17153527	Menopause (age at onset)
chr7	106594884	106594885	rs7779057	Serum tamsulosin hydrochloride concentration
chr7	106662082	106662083	rs7798500	Adverse response to lamotrigine and phenytoin
chr7	106763217	106763218	rs13224682	Response to antipsychotic treatment
chr7	106938419	106938420	rs3815148	Osteoarthritis
chr7	107207694	107207695	rs4730250	Osteoarthritis
chr7	107244544	107244545	rs10953541	Coronary heart disease
chr7	107336057	107336058	rs2188561	Alcohol consumption
chr7	107443385	107443386	rs4730268	IgG glycosylation
chr7	107453102	107453103	rs2108225	Ulcerative colitis
chr7	107479518	107479519	rs4730273	Ulcerative colitis
chr7	107480314	107480315	rs4380874	Ulcerative colitis
chr7	107484436	107484437	rs4730276	Ulcerative colitis
chr7	107492788	107492789	rs4510766	Ulcerative colitis
chr7	107495433	107495434	rs886774	Ulcerative colitis
chr7	107503440	107503441	rs4598195	Ulcerative colitis
chr7	107580838	107580839	rs2158836	Ulcerative colitis
chr7	107592197	107592198	rs2072209	IgG glycosylation
chr7	107782199	107782200	rs382140	Coffee consumption
chr7	107973296	107973297	rs6975557	Femoral neck bone geometry and menarche (age at onset)
chr7	108544460	108544461	rs1404697	Smoking behavior
chr7	108548659	108548660	rs848353	Smoking behavior
chr7	109003573	109003574	rs10277209	Prostate cancer (gene x gene interaction)
chr7	109152710	109152711	rs10953615	Gallbladder cancer
chr7	110047470	110047471	rs6968385	Attention deficit hyperactivity disorder (time to onset)
chr7	110047963	110047964	rs4730430	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr7	110467220	110467221	rs10279573	Cognitive performance
chr7	111527559	111527560	rs10255299	C-reactive protein and white blood cell count
chr7	111642645	111642646	rs61159171	Breast size
chr7	111677905	111677906	rs10428959	Response to fenofibrate
chr7	112086332	112086333	rs17159640	Mortality among heart failure patients
chr7	112094742	112094743	rs6956741	Amyotrophic lateral sclerosis (age of onset)
chr7	112159177	112159178	rs5009270	Osteoarthritis (hip)
chr7	112628372	112628373	rs10229603	Attention deficit hyperactivity disorder and conduct disorder
chr7	112649413	112649414	rs6969802	IgG glycosylation
chr7	112911409	112911410	rs10953730	Metabolite levels
chr7	113741104	113741105	rs6466479	IgG glycosylation
chr7	114357542	114357543	rs1869839	Crohn's disease
chr7	114629284	114629285	rs7784447	Obesity
chr7	116162728	116162729	rs4236601	Glaucoma (primary open-angle)
chr7	116186240	116186241	rs3807989	Atrial fibrillation
chr7	116186240	116186241	rs3807989	Electrocardiographic traits
chr7	116186240	116186241	rs3807989	PR interval
chr7	116191300	116191301	rs11773845	PR interval
chr7	116346602	116346603	rs10243024	Multiple sclerosis (severity)
chr7	116358043	116358044	rs38855	Triglycerides
chr7	116577123	116577124	rs7782376	Cognitive performance
chr7	116892845	116892846	rs38904	Inflammatory bowel disease
chr7	116917117	116917118	rs4730775	Dupuytren's disease
chr7	117023534	117023535	rs4730779	Waist circumference
chr7	117067821	117067822	rs7808424	Coronary heart disease
chr7	117991894	117991895	rs41997	Response to platinum-based chemotherapy in non-small-cell lung cancer
chr7	118159548	118159549	rs2106595	Smoking behavior
chr7	119606631	119606632	rs17142462	Immune reponse to smallpox (secreted IL-12p40)
chr7	120305148	120305149	rs728115	Alcohol and nictotine co-dependence
chr7	120785063	120785064	rs13245690	Bone mineral density
chr7	120903814	120903815	rs4609139	Bone mineral density
chr7	120969768	120969769	rs2908004	Bone mineral density
chr7	120974764	120974765	rs3801387	Bone mineral density
chr7	120979088	120979089	rs2707466	Cortical thickness
chr7	121018578	121018579	rs917727	Bone mineral density
chr7	121033120	121033121	rs7776725	Biomedical quantitative traits
chr7	121275228	121275229	rs10253361	Alcoholism (alcohol dependence factor score)
chr7	122202592	122202593	rs2429582	Brain structure
chr7	122759979	122759980	rs4727963	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
chr7	123376559	123376560	rs9649465	Migraine
chr7	123411222	123411223	rs4731120	Platelet counts
chr7	124384326	124384327	rs7802263	Reading and spelling
chr7	124462660	124462661	rs17246404	Chronic lymphocytic leukemia
chr7	125391644	125391645	rs1419607	Obesity-related traits
chr7	126324590	126324591	rs17691394	Carotid atherosclerosis in HIV infection
chr7	126437896	126437897	rs11971186	Chemerin levels
chr7	126639603	126639604	rs17864092	Depression (quantitative trait)
chr7	127164957	127164958	rs6467136	Type 2 diabetes
chr7	127246902	127246903	rs10229583	Type 2 diabetes
chr7	127862801	127862802	rs791595	Type 2 diabetes
chr7	128415194	128415195	rs1799922	Primary tooth development (time to first tooth eruption)
chr7	128415194	128415195	rs1799922	Primary tooth development (number of teeth)
chr7	128568959	128568960	rs729302	Systemic lupus erythematosus
chr7	128573966	128573967	rs4728142	Ulcerative colitis
chr7	128573966	128573967	rs4728142	Systemic lupus erythematosus
chr7	128594182	128594183	rs10488631	Systemic sclerosis
chr7	128594182	128594183	rs10488631	Systemic lupus erythematosus
chr7	128594182	128594183	rs10488631	Primary biliary cirrhosis
chr7	128594182	128594183	rs10488631	Rheumatoid arthritis
chr7	128617465	128617466	rs12531711	Systemic lupus erythematosus
chr7	128617465	128617466	rs12531711	Primary biliary cirrhosis
chr7	128695982	128695983	rs13239597	Systemic lupus erythematosus and Systemic sclerosis
chr7	128717905	128717906	rs12537284	Systemic lupus erythematosus
chr7	128993755	128993756	rs11979476	Inflammatory biomarkers
chr7	129004846	129004847	rs11766298	Response to fenofibrate
chr7	129023596	129023597	rs7787531	Tuberculosis
chr7	129356205	129356206	rs9641855	Obesity-related traits
chr7	129663495	129663496	rs11556924	Coronary heart disease
chr7	130433383	130433384	rs4731702	HDL cholesterol
chr7	130466853	130466854	rs972283	Type 2 diabetes
chr7	130653850	130653851	rs2048672	Breast cancer
chr7	130900120	130900121	rs10265216	Major depressive disorder (broad)
chr7	131021098	131021099	rs7807274	Asthma (childhood onset)
chr7	131287989	131287990	rs12534221	AB1-42
chr7	131370038	131370039	rs11761231	Rheumatoid arthritis
chr7	131453524	131453525	rs1106683	Body mass index
chr7	131453664	131453665	rs1106684	Body mass index
chr7	131713359	131713360	rs17166082	Self-employment
chr7	131829127	131829128	rs1399090	Economic and political preferences
chr7	131853600	131853601	rs12386622	Homeostasis model assessment of beta-cell function (interaction)
chr7	132189688	132189689	rs10808265	Pulmonary function decline
chr7	132325308	132325309	rs4731889	Oleic acid (18:1n-9) plasma levels
chr7	133335175	133335176	rs10488172	Tonometry
chr7	133747945	133747946	rs11770757	Alzheimer's disease (cognitive decline)
chr7	134250321	134250322	rs4732038	Longevity
chr7	134785740	134785741	rs17231212	Immune reponse to smallpox (secreted IL-10)
chr7	135293127	135293128	rs4294134	Paget's disease
chr7	135329977	135329978	rs12530845	Red blood cell traits
chr7	135479572	135479573	rs12707249	Obesity-related traits
chr7	135488620	135488621	rs6946494	Visceral adipose tissue adjusted for BMI
chr7	135501468	135501469	rs13237474	Periodontitis (CDC/AAP)
chr7	136146535	136146536	rs10250997	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr7	136584362	136584363	rs1364402	Migraine with aura
chr7	136642633	136642634	rs2350782	Heart rate
chr7	137203818	137203819	rs6467710	AIDS progression
chr7	137858765	137858766	rs10255295	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr7	137858765	137858766	rs10255295	Bipolar disorder (mood-incongruent)
chr7	138049386	138049387	rs357394	Pulmonary function
chr7	138157389	138157390	rs1874326	Quantitative traits
chr7	138411424	138411425	rs3800569	F-cell distribution
chr7	139506579	139506580	rs10277664	Gray matter volume (schizophrenia interaction)
chr7	139557946	139557947	rs194151	Obesity-related traits
chr7	139591859	139591860	rs7810727	Migraine without aura
chr7	139702592	139702593	rs17837497	Acute lymphoblastic leukemia (childhood)
chr7	140231129	140231130	rs10237118	Optic disc size (cup)
chr7	140592226	140592227	rs17623382	Response to Vitamin E supplementation
chr7	141505086	141505087	rs145241704	Anorexia nervosa
chr7	141672603	141672604	rs10246939	Bitter taste perception
chr7	141673344	141673345	rs713598	Bitter taste response
chr7	142104570	142104571	rs361433	Capecitabine sensitivity
chr7	142274853	142274854	rs2854536	Narcolepsy
chr7	142456927	142456928	rs10273639	Pancreatitis
chr7	143109138	143109139	rs11767557	Alzheimer's disease (late onset)
chr7	143110761	143110762	rs11771145	Alzheimer's disease (late onset)
chr7	143741579	143741580	rs11976180	Obesity-related traits
chr7	144074928	144074929	rs720475	Breast cancer
chr7	144841530	144841531	rs10487524	Attention deficit hyperactivity disorder
chr7	144892085	144892086	rs12531488	Brain imaging
chr7	145959242	145959243	rs802568	Bipolar disorder and schizophrenia
chr7	146135937	146135938	rs1358075	Obesity-related traits
chr7	146897402	146897403	rs10273775	Alzheimer's disease
chr7	147226890	147226891	rs6464816	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr7	147577536	147577537	rs2708240	QT interval (interaction)
chr7	147615639	147615640	rs2538958	IgG glycosylation
chr7	147702691	147702692	rs2214681	Bone mineral density
chr7	147901015	147901016	rs4549702	Body mass index (interaction)
chr7	148258047	148258048	rs7807268	Crohn's disease
chr7	148650633	148650634	rs822552	Height
chr7	149203661	149203662	rs855913	Amyotrophic lateral sclerosis
chr7	149289463	149289464	rs354033	Multiple sclerosis
chr7	150512171	150512172	rs10231759	Height
chr7	150517021	150517022	rs2110001	Height
chr7	150529448	150529449	rs17173637	HDL cholesterol
chr7	150622161	150622162	rs2968864	QT interval
chr7	150623136	150623137	rs2968863	QT interval
chr7	150637862	150637863	rs4725982	Electrocardiographic traits
chr7	150637862	150637863	rs4725982	QT interval
chr7	150667209	150667210	rs3807375	Electrocardiographic traits
chr7	150669975	150669976	rs3778872	QT interval
chr7	150915070	150915071	rs1122979	IgG glycosylation
chr7	150919828	150919829	rs7812088	Bone mineral density
chr7	151120947	151120948	rs13232179	Coronary heart disease
chr7	151406004	151406005	rs10480300	Urate levels
chr7	151406004	151406005	rs10480300	Red blood cell traits
chr7	151407800	151407801	rs7805747	Chronic kidney disease
chr7	151415040	151415041	rs10224002	Hemoglobin
chr7	151415040	151415041	rs10224002	Hematocrit
chr7	151546588	151546589	rs7795096	Bipolar disorder (age of onset and psychomotor symptoms)
chr7	152387868	152387869	rs10234749	Palmitic acid (16:0) plasma levels
chr7	152669839	152669840	rs11981919	Obesity-related traits
chr7	152878332	152878333	rs4285401	Nicotine use
chr7	153271876	153271877	rs11771429	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)
chr7	153271876	153271877	rs11771429	Barrett's esophagus
chr7	153535688	153535689	rs2110267	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr7	153535688	153535689	rs2110267	Attention deficit hyperactivity disorder (combined symptoms)
chr7	153549295	153549296	rs2192271	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr7	153553063	153553064	rs6947495	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr7	153558948	153558949	rs12671878	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
chr7	153578415	153578416	rs38989	IgG glycosylation
chr7	153625842	153625843	rs6464375	Pancreatic cancer
chr7	154072019	154072020	rs6977820	Tardive dyskinesia
chr7	154210797	154210798	rs10260404	Amyotrophic lateral sclerosis
chr7	154509323	154509324	rs12666280	QT interval
chr7	154970468	154970469	rs10263087	Formal thought disorder in schizophrenia
chr7	155008712	155008713	rs1561176	Personality dimensions
chr7	155285134	155285135	rs1861960	Migraine
chr7	155762156	155762157	rs6943029	Platelet aggregation
chr7	155768748	155768749	rs10267337	Obesity-related traits
chr7	155837294	155837295	rs10226930	Corneal astigmatism
chr7	156048648	156048649	rs10949808	Bipolar disorder and schizophrenia
chr7	156880397	156880398	rs6966038	Response to citalopram treatment
chr7	157090295	157090296	rs2527866	Quantitative traits
chr7	157294937	157294938	rs10227331	Inattentive symptoms
chr7	157387440	157387441	rs10274279	Myopia (pathological)
chr7	157510194	157510195	rs6459804	Bipolar disorder and schizophrenia
chr7	158136985	158136986	rs4909189	Response to amphetamines
chr7	158223105	158223106	rs7786808	Obesity-related traits
chr7	158724788	158724789	rs2730245	Height
chr7	158846928	158846929	rs2730260	Myopia (pathological)
chr8	240577	240578	rs55680580	Serum dimethylarginine levels (symmetric)
chr8	445600	445601	rs17665859	Bilirubin levels
chr8	516478	516479	rs722782	Age-related macular degeneration (GA)
chr8	566206	566207	rs17666538	IgG glycosylation
chr8	1244223	1244224	rs17669535	Menarche (age at onset)
chr8	1746949	1746950	rs11986414	Gaucher disease severity
chr8	1883351	1883352	rs13279485	Multiple sclerosis
chr8	1951299	1951300	rs13263558	Obesity-related traits
chr8	2040103	2040104	rs2235121	Bipolar disorder and schizophrenia
chr8	2740501	2740502	rs641525	Emphysema-related traits
chr8	2780955	2780956	rs2627282	Blood pressure measurement (high sodium intervention)
chr8	2819808	2819809	rs4875857	IgG glycosylation
chr8	3076958	3076959	rs28455997	Periodontitis (CDC/AAP)
chr8	3088172	3088173	rs73660619	Alzheimer's disease (cognitive decline)
chr8	3088762	3088763	rs1540507	Periodontitis (CDC/AAP)
chr8	3091583	3091584	rs1442407	Systolic blood pressure in sickle cell anemia
chr8	3156219	3156220	rs142816172	Eating disorders (purging via substances)
chr8	3189895	3189896	rs2551043	Obesity-related traits
chr8	3316985	3316986	rs17394429	Obesity-related traits
chr8	3488337	3488338	rs2449215	Obesity-related traits
chr8	3594905	3594906	rs2623702	Pulmonary function decline
chr8	3828137	3828138	rs1529316	Multiple sclerosis
chr8	3978129	3978130	rs4875284	Serum selenium levels
chr8	4078352	4078353	rs2407314	Insulin resistance/response
chr8	4105146	4105147	rs1714746	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
chr8	4110031	4110032	rs13259289	Illicit drug use
chr8	4164012	4164013	rs4875320	Coronary heart disease
chr8	4180843	4180844	rs10503253	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr8	4180843	4180844	rs10503253	Schizophrenia
chr8	4214178	4214179	rs10503256	Schizophrenia
chr8	4238138	4238139	rs6558872	Schizophrenia, schizoaffective disorder or bipolar disorder
chr8	4282617	4282618	rs980238	Disc degeneration (lumbar)
chr8	4284691	4284692	rs4875102	Disc degeneration (lumbar)
chr8	4285389	4285390	rs1154053	Disc degeneration (lumbar)
chr8	4299882	4299883	rs17070309	Immune response to smallpox vaccine (IL-6)
chr8	4483140	4483141	rs2616984	Cognitive performance
chr8	4617809	4617810	rs1379326	Interstitial lung disease
chr8	4875171	4875172	rs10112481	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
chr8	4926464	4926465	rs1454292	Hair morphology
chr8	5071411	5071412	rs7816936	Endometriosis
chr8	5227101	5227102	rs77265424	Metabolite levels (5-HIAA)
chr8	5373539	5373540	rs62494762	Metabolite levels (HVA/MHPG ratio)
chr8	5426530	5426531	rs11777345	Waist-hip ratio
chr8	5461752	5461753	rs4875598	Attention deficit hyperactivity disorder symptoms (interaction)
chr8	5764941	5764942	rs2840445	Dietary macronutrient intake
chr8	6152918	6152919	rs6559140	Metabolite levels (5-HIAA)
chr8	6323277	6323278	rs2916733	Epirubicin-induced leukopenia
chr8	6351251	6351252	rs17077154	Cytomegalovirus antibody response
chr8	6821616	6821617	rs2738058	Periodontitis (PAL4Q3)
chr8	6822784	6822785	rs2738048	IgA nephropathy
chr8	6829084	6829085	rs2738113	Endometriosis
chr8	7189357	7189358	rs9692809	Optic disc size (cup)
chr8	7836059	7836060	rs9692809	Optic disc size (cup)
chr8	8577378	8577379	rs13256369	Obesity-related traits
chr8	8717006	8717007	rs332034	Conduct disorder (interaction)
chr8	8722377	8722378	rs10108954	Prion diseases
chr8	8890097	8890098	rs1045529	Myopia (pathological)
chr8	8990576	8990577	rs189798	Myopia (pathological)
chr8	8999018	8999019	rs3748140	Alzheimer's disease
chr8	9178267	9178268	rs6984305	Liver enzyme levels (alkaline phosphatase)
chr8	9183357	9183358	rs9987289	LDL cholesterol
chr8	9183357	9183358	rs9987289	HDL cholesterol
chr8	9183357	9183358	rs9987289	Cholesterol, total
chr8	9183357	9183358	rs9987289	Metabolic syndrome (bivariate traits)
chr8	9183357	9183358	rs9987289	HDL Cholesterol - Triglycerides (HDLC-TG)
chr8	9183357	9183358	rs9987289	C-reactive protein
chr8	9183595	9183596	rs4841132	Glycemic traits (pregnancy)
chr8	9183595	9183596	rs4841132	Metabolite levels
chr8	9183595	9183596	rs4841132	Fasting insulin-related traits (interaction with BMI)
chr8	9183595	9183596	rs4841132	Fasting glucose-related traits (interaction with BMI)
chr8	9184690	9184691	rs6601299	Coronary heart disease
chr8	9185145	9185146	rs2126259	HDL cholesterol
chr8	9185145	9185146	rs2126259	LDL cholesterol
chr8	9187241	9187242	rs1461729	HDL cholesterol
chr8	9395531	9395532	rs6601327	Multiple myeloma (hyperdiploidy)
chr8	9601698	9601699	rs12545912	Multiple myeloma (hyperdiploidy)
chr8	9745797	9745798	rs17150703	Obesity (early onset extreme)
chr8	9775515	9775516	rs473034	Obesity (early onset extreme)
chr8	9792661	9792662	rs2055729	Multiple myeloma (hyperdiploidy)
chr8	9814410	9814411	rs656319	Myopia (pathological)
chr8	9986654	9986655	rs1484642	Bipolar disorder and schizophrenia
chr8	10022937	10022938	rs7017212	Schizophrenia
chr8	10071619	10071620	rs11775334	Hypertension
chr8	10086410	10086411	rs6999631	Bulimia nervosa
chr8	10334780	10334781	rs11782819	Alzheimer's disease
chr8	10352307	10352308	rs4281086	Obesity-related traits
chr8	10462805	10462806	rs4841398	Obesity-related traits
chr8	10671271	10671272	rs6601530	Carotid intima media thickness
chr8	10683928	10683929	rs11776767	Triglycerides
chr8	11045160	11045161	rs7819412	Triglycerides
chr8	11104110	11104111	rs7824557	Retinal vascular caliber
chr8	11119036	11119037	rs2251301	Response to antipsychotic therapy (extrapyramidal side effects)
chr8	11276541	11276542	rs2002030	Cognitive performance
chr8	11340180	11340181	rs7812879	Systemic lupus erythematosus
chr8	11343679	11343680	rs2254546	Systemic lupus erythematosus
chr8	11343679	11343680	rs2254546	Kawasaki disease
chr8	11343972	11343973	rs2736340	Systemic lupus erythematosus and Systemic sclerosis
chr8	11343972	11343973	rs2736340	Kawasaki disease
chr8	11343972	11343973	rs2736340	Systemic lupus erythematosus
chr8	11343972	11343973	rs2736340	Rheumatoid arthritis
chr8	11349185	11349186	rs13277113	Systemic lupus erythematosus
chr8	11352540	11352541	rs2618476	Systemic lupus erythematosus
chr8	11359637	11359638	rs1600249	Rheumatoid arthritis
chr8	11409991	11409992	rs2255327	Immune response to smallpox vaccine (IL-6)
chr8	11480456	11480457	rs2243407	Periodontitis (CDC/AAP)
chr8	11612697	11612698	rs804280	Myopia (pathological)
chr8	11638243	11638244	rs6601606	Neutrophil count
chr8	11643914	11643915	rs804292	Nicotine use
chr8	11643914	11643915	rs804292	Alcohol dependence
chr8	11684462	11684463	rs2645424	Non-alcoholic fatty liver disease histology (other)
chr8	11684462	11684463	rs2645424	Non-alcoholic fatty liver disease histology (lobular)
chr8	11698746	11698747	rs1296028	Parkinson's disease
chr8	12691870	12691871	rs17120471	IgG glycosylation
chr8	12711862	12711863	rs4831837	Morbidity-free survival
chr8	12811151	12811152	rs2946505	Migraine
chr8	13176406	13176407	rs1671400	Obesity-related traits
chr8	13260535	13260536	rs289585	Bipolar disorder
chr8	14113815	14113816	rs9886428	IgG glycosylation
chr8	14389480	14389481	rs1903595	Platelet aggregation
chr8	14517293	14517294	rs11203649	Obesity-related traits
chr8	14550155	14550156	rs11989868	Obesity-related traits
chr8	14853780	14853781	rs4427170	Methamphetamine dependence
chr8	15197416	15197417	rs12676170	Corneal astigmatism
chr8	15532584	15532585	rs4831760	Pulmonary function decline
chr8	15665611	15665612	rs240657	Intelligence
chr8	16929634	16929635	rs10090288	Depression and alcohol dependence
chr8	17143829	17143830	rs3793427	Tonometry
chr8	17205576	17205577	rs4921542	Creutzfeldt-Jakob disease (variant)
chr8	17282410	17282411	rs13271465	Obesity-related traits
chr8	17329826	17329827	rs2720508	Conduct disorder (case status)
chr8	17800768	17800769	rs2299587	Economic and political preferences
chr8	17977649	17977650	rs17126232	Obesity
chr8	18233581	18233582	rs7006687	QT interval (interaction)
chr8	18272437	18272438	rs4921914	Urinary metabolites
chr8	18272880	18272881	rs1495741	Bladder cancer
chr8	18272880	18272881	rs1495741	Triglycerides
chr8	18272880	18272881	rs1495741	Cholesterol, total
chr8	18273299	18273300	rs1495743	Metabolic traits
chr8	18381234	18381235	rs10090117	Paclitaxel-induced neuropathy
chr8	18673730	18673731	rs2638663	Lung function (forced expiratory volume in 1 second)
chr8	18707870	18707871	rs7833787	Obesity-related traits
chr8	18782046	18782047	rs4921617	Neutrophil count
chr8	19539637	19539638	rs7816924	Response to antidepressant treatment (citalopram)
chr8	19651160	19651161	rs920590	Acute lymphoblastic leukemia (childhood)
chr8	19786890	19786891	rs7816032	Hyperactive-impulsive symptoms
chr8	19813528	19813529	rs268	Metabolic syndrome
chr8	19816237	19816238	rs295	Metabolic syndrome
chr8	19816933	19816934	rs301	Metabolic syndrome (bivariate traits)
chr8	19819327	19819328	rs325	HDL cholesterol
chr8	19819438	19819439	rs326	Triglycerides
chr8	19819438	19819439	rs326	HDL cholesterol
chr8	19819723	19819724	rs328	Triglycerides
chr8	19819723	19819724	rs328	HDL cholesterol
chr8	19820404	19820405	rs331	Lipid metabolism phenotypes
chr8	19824491	19824492	rs13702	HDL Cholesterol - Triglycerides (HDLC-TG)
chr8	19824562	19824563	rs1059611	Lipid metabolism phenotypes
chr8	19824666	19824667	rs15285	Triglycerides-Blood Pressure (TG-BP)
chr8	19826372	19826373	rs2197089	Metabolic syndrome (bivariate traits)
chr8	19827847	19827848	rs10105606	Triglycerides
chr8	19830920	19830921	rs10096633	Triglycerides
chr8	19830920	19830921	rs10096633	Metabolic traits
chr8	19832645	19832646	rs17482753	Lipid traits
chr8	19832645	19832646	rs17482753	HDL cholesterol
chr8	19844221	19844222	rs12678919	Triglycerides
chr8	19844221	19844222	rs12678919	HDL cholesterol
chr8	19844221	19844222	rs12678919	Metabolite levels
chr8	19844221	19844222	rs12678919	Hematological and biochemical traits
chr8	19845375	19845376	rs7841189	Metabolic syndrome
chr8	19847689	19847690	rs10503669	Triglycerides
chr8	19847689	19847690	rs10503669	HDL cholesterol
chr8	19848079	19848080	rs17410962	Triglycerides
chr8	19849756	19849757	rs17091905	Cardiovascular disease risk factors
chr8	19865174	19865175	rs2083637	Metabolic syndrome
chr8	19865174	19865175	rs2083637	HDL cholesterol
chr8	19865174	19865175	rs2083637	Waist circumference and related phenotypes
chr8	19868385	19868386	rs1441756	Metabolic syndrome (bivariate traits)
chr8	19876745	19876746	rs7016880	Hypertriglyceridemia
chr8	19912369	19912370	rs115849089	Lipid metabolism phenotypes
chr8	19928581	19928582	rs9644568	Hypertriglyceridemia
chr8	19987702	19987703	rs10503672	Amyotrophic lateral sclerosis (age of onset)
chr8	20066048	20066049	rs1106634	Bipolar disorder and schizophrenia
chr8	20066048	20066049	rs1106634	Major depressive disorder (broad)
chr8	20081889	20081890	rs1390943	Circulating myeloperoxidase levels (serum)
chr8	20246757	20246758	rs17412740	Preeclampsia
chr8	20301436	20301437	rs4922199	Dental caries
chr8	20336572	20336573	rs10111661	Dental caries
chr8	20626320	20626321	rs2122469	Serum tamsulosin hydrochloride concentration
chr8	20967550	20967551	rs7015657	Migraine with aura
chr8	21662444	21662445	rs17581368	Entorhinal cortical thickness
chr8	21820812	21820813	rs7843479	Mean corpuscular volume
chr8	21884543	21884544	rs11776272	Obesity-related traits
chr8	21978371	21978372	rs76547188	Obesity-related traits
chr8	22088431	22088432	rs12541335	Hypertriglyceridemia
chr8	22400988	22400989	rs4872511	HIV-1 control
chr8	22404839	22404840	rs2280890	HIV-1 control
chr8	22619550	22619551	rs11998649	Visceral fat
chr8	22643706	22643707	rs12155789	Serum dimethylarginine levels (asymmetric)
chr8	23082970	23082971	rs13278062	Age-related macular degeneration
chr8	23101619	23101620	rs7463256	Attention deficit hyperactivity disorder
chr8	23526462	23526463	rs1512268	Prostate cancer
chr8	23534017	23534018	rs10503733	Prostate cancer
chr8	23584225	23584226	rs13273073	Treatment response for severe sepsis
chr8	23636280	23636281	rs218869	Response to mTOR inhibitor (everolimus)
chr8	23751150	23751151	rs10109414	Chronic kidney disease
chr8	23777005	23777006	rs17786744	Urate levels
chr8	23818686	23818687	rs7833268	Subcutaneous adipose tissue
chr8	24044300	24044301	rs11777116	Migraine - clinic-based
chr8	24116303	24116304	rs1013209	Height
chr8	24378740	24378741	rs11781622	White matter integrity
chr8	25892141	25892142	rs11135910	Prostate cancer
chr8	26206076	26206077	rs1594829	Height
chr8	26718879	26718880	rs4732957	Response to amphetamines
chr8	27076597	27076598	rs1446682	Bipolar disorder and schizophrenia
chr8	27195120	27195121	rs28834970	Alzheimer's disease (late onset)
chr8	27416800	27416801	rs17057381	Dental caries
chr8	27452846	27452847	rs17466684	Panic disorder
chr8	27456252	27456253	rs2279590	Alzheimer's disease
chr8	27464518	27464519	rs11136000	Alzheimer's disease
chr8	27466314	27466315	rs1532278	Alzheimer's disease (late onset)
chr8	27467685	27467686	rs9331896	Alzheimer's disease (late onset)
chr8	27468861	27468862	rs9331888	Alzheimer's disease
chr8	27487789	27487790	rs569214	Alzheimer's disease
chr8	27740416	27740417	rs11774576	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
chr8	27905887	27905888	rs6983473	Cardiac Troponin-T levels
chr8	27923387	27923388	rs4732812	Suicidal ideation
chr8	28181754	28181755	rs11779594	IgG glycosylation
chr8	28791158	28791159	rs2221894	Obesity-related traits
chr8	28954891	28954892	rs7844537	Metabolite levels  (X-11787)
chr8	28995021	28995022	rs13251954	Metabolite levels (HVA-5-HIAA Factor score)
chr8	29106058	29106059	rs2954793	Metabolite levels (HVA)
chr8	29344461	29344462	rs12548021	Colorectal cancer
chr8	29360304	29360305	rs10091038	Response to statin therapy
chr8	29509615	29509616	rs9693444	Breast cancer
chr8	29982517	29982518	rs12681963	Migraine
chr8	30262785	30262786	rs2979481	Heart rate variability traits
chr8	30436851	30436852	rs10503871	Metabolite levels  (X-11787)
chr8	30498858	30498859	rs2978263	Cognitive performance
chr8	30936355	30936356	rs2553268	Exercise treadmill test traits
chr8	31034274	31034275	rs11774682	IgG glycosylation
chr8	31174829	31174830	rs2575029	Obesity-related traits
chr8	31633446	31633447	rs10503887	Hip geometry
chr8	31794108	31794109	rs1462872	Coronary artery calcification
chr8	32139651	32139652	rs1487141	Metabolite levels  (X-11787)
chr8	32411215	32411216	rs16879552	Hirschsprung's disease
chr8	32412358	32412359	rs2439312	Dialysis-related mortality
chr8	32416273	32416274	rs7825175	Thyroid hormone levels
chr8	32432368	32432369	rs2439302	Thyroid cancer
chr8	33565377	33565378	rs4469412	Immune response to smallpox vaccine (IL-6)
chr8	33665679	33665680	rs10503951	Immune response to smallpox vaccine (IL-6)
chr8	33673010	33673011	rs11786194	Immune response to smallpox vaccine (IL-6)
chr8	34045260	34045261	rs9297216	Asthma (childhood onset)
chr8	34126947	34126948	rs6990255	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr8	34126947	34126948	rs6990255	Bipolar disorder
chr8	34236991	34236992	rs2609653	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr8	34236991	34236992	rs2609653	Bipolar disorder
chr8	34524002	34524003	rs6987004	Pulmonary function decline
chr8	36459453	36459454	rs7814403	Obesity-related traits
chr8	36846108	36846109	rs7816345	Breast size
chr8	36941541	36941542	rs4739466	Bipolar disorder
chr8	36951913	36951914	rs2407103	Insulin resistance/response
chr8	37096058	37096059	rs1015003	Heart rate
chr8	37681425	37681426	rs12676965	Axial length
chr8	37686748	37686749	rs6468442	Menopause (age at onset)
chr8	37977731	37977732	rs2517388	Menopause (age at onset)
chr8	38004424	38004425	rs16887217	Orthostatic hypotension
chr8	38031344	38031345	rs16887244	Schizophrenia
chr8	38469302	38469303	rs7832232	Pancreatic cancer
chr8	39548377	39548378	rs1349547	HIV-1 susceptibility
chr8	40053604	40053605	rs10958605	Parkinson's disease (motor and cognition)
chr8	40252700	40252701	rs11786458	Inattentive symptoms
chr8	40484238	40484239	rs2722425	Fasting plasma glucose
chr8	40726393	40726394	rs7829127	Refractive error
chr8	41519461	41519462	rs515071	Type 2 diabetes
chr8	41549193	41549194	rs6474359	Glycated hemoglobin levels
chr8	41615137	41615138	rs7006290	Pulmonary function decline
chr8	41630404	41630405	rs4737009	Glycated hemoglobin levels
chr8	42546710	42546711	rs1451240	Nicotine dependence
chr8	42550497	42550498	rs6474412	Smoking behavior
chr8	43695233	43695234	rs58810682	Response to amphetamines
chr8	47947700	47947701	rs2287654	Visceral adipose tissue adjusted for BMI
chr8	49053164	49053165	rs11778329	Attention deficit hyperactivity disorder
chr8	49812200	49812201	rs12155623	Sudden cardiac arrest
chr8	51384986	51384987	rs13272236	IgG glycosylation
chr8	51412590	51412591	rs310558	Pulmonary function
chr8	52216761	52216762	rs7821565	Tuberculosis
chr8	52887540	52887541	rs1015213	Glaucoma (primary open-angle)
chr8	53214264	53214265	rs7009219	Alzheimer's disease (cognitive decline)
chr8	53684860	53684861	rs7822058	Obesity-related traits
chr8	54119213	54119214	rs1425902	IgE levels in asthmatics (D.p. specific)
chr8	54410207	54410208	rs10958369	Response to antineoplastic agents
chr8	54555199	54555200	rs11773966	Bipolar disorder (mood-incongruent)
chr8	55310710	55310711	rs1504749	Intracranial aneurysm
chr8	55327090	55327091	rs10958409	Intracranial aneurysm
chr8	55421613	55421614	rs10102164	LDL cholesterol
chr8	55421613	55421614	rs10102164	Cholesterol, total
chr8	55437523	55437524	rs9298506	Intracranial aneurysm
chr8	55440067	55440068	rs10104997	Dengue shock syndrome
chr8	56168058	56168059	rs12542677	Immune reponse to smallpox (secreted IL-1beta)
chr8	56599547	56599548	rs4737395	Myopia (pathological)
chr8	56599776	56599777	rs4738393	Migraine - clinic-based
chr8	57095807	57095808	rs10958476	Height
chr8	57100148	57100149	rs7833986	Height
chr8	57100790	57100791	rs13273123	Height
chr8	57155597	57155598	rs9650315	Height
chr8	57179019	57179020	rs7815788	Height
chr8	57194162	57194163	rs7460090	Height
chr8	57209245	57209246	rs4075154	Height
chr8	57313905	57313906	rs12545109	Obesity-related traits
chr8	58789080	58789081	rs10504249	Blood pressure measurement (low sodium intervention)
chr8	58840923	58840924	rs1992045	Bipolar disorder and schizophrenia
chr8	59324161	59324162	rs2859998	Narcolepsy with cataplexy
chr8	59388564	59388565	rs2081687	LDL cholesterol
chr8	59388564	59388565	rs2081687	Cholesterol, total
chr8	59508579	59508580	rs11994937	IgG glycosylation
chr8	59708308	59708309	rs960089	Cognitive performance
chr8	60130295	60130296	rs3110127	RR interval (heart rate)
chr8	60178720	60178721	rs10089517	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr8	60179085	60179086	rs7837791	Refractive error
chr8	60545663	60545664	rs4737547	Multiple myeloma (IgH translocation)
chr8	60623347	60623348	rs12541902	Obesity-related traits
chr8	60961820	60961821	rs569688	Myopia (pathological)
chr8	61003896	61003897	rs6995588	Cardiac hypertrophy
chr8	61105198	61105199	rs10098647	Obesity-related traits
chr8	61194169	61194170	rs10957125	Response to amphetamines
chr8	61346196	61346197	rs9650199	Response to amphetamines
chr8	61876043	61876044	rs10104895	Pulmonary function decline
chr8	62054462	62054463	rs12681792	Migraine
chr8	62409427	62409428	rs903027	MRI atrophy measures
chr8	63258916	63258917	rs142014203	Bulimia nervosa
chr8	63621568	63621569	rs2882926	Periodontitis (PAL4Q3)
chr8	63883592	63883593	rs7834588	Response to Vitamin E supplementation
chr8	65640259	65640260	rs10808739	HIV-1 susceptibility
chr8	65730206	65730207	rs6472155	Retinopathy in non-diabetics
chr8	65999962	65999963	rs2980003	Thiazide-induced adverse metabolic effects in hypertensive patients
chr8	66463477	66463478	rs6981992	Obesity-related traits
chr8	66624231	66624232	rs10504390	IgG glycosylation
chr8	66822029	66822030	rs6472235	Myopia (pathological)
chr8	66851730	66851731	rs4601292	HIV-1 viral setpoint
chr8	66974251	66974252	rs13279522	Response to statin therapy
chr8	68799376	68799377	rs6990917	Adverse response to lamotrigine and phenytoin
chr8	69389216	69389217	rs1517114	Response to irinotecan in non-small-cell lung cancer
chr8	69563694	69563695	rs7825271	Obesity-related traits
chr8	69730718	69730719	rs16935110	Obesity-related traits
chr8	69992379	69992380	rs2912522	Dupuytren's disease
chr8	70412449	70412450	rs6982250	Height
chr8	70493973	70493974	rs13273088	Fasting insulin-related traits (interaction with BMI)
chr8	70680982	70680983	rs10090896	Metabolite levels  (X-11787)
chr8	70724753	70724754	rs16936455	HIV-1 control
chr8	70809260	70809261	rs12680109	Attention deficit hyperactivity disorder
chr8	70976504	70976505	rs7010162	Testicular germ cell tumor
chr8	71139329	71139330	rs72663955	Metabolite levels (HVA-5-HIAA Factor score)
chr8	71167993	71167994	rs2926702	Non-small cell lung cancer
chr8	71386903	71386904	rs10091374	Cardiac Troponin-T levels
chr8	71544747	71544748	rs13272623	IgG glycosylation
chr8	71591202	71591203	rs7017914	Bone mineral density
chr8	72263955	72263956	rs2218488	Sleepiness
chr8	72270081	72270082	rs7006821	Chronic obstructive pulmonary disease-related biomarkers
chr8	72447417	72447418	rs13263568	Migraine
chr8	72561741	72561742	rs7834018	Autism
chr8	73070734	73070735	rs11994034	Attention deficit hyperactivity disorder (combined symptoms)
chr8	73106915	73106916	rs1963982	Blood pressure
chr8	73236809	73236810	rs7006742	Pulmonary function decline
chr8	73363988	73363989	rs2116078	Multiple sclerosis (age of onset)
chr8	73633027	73633028	rs2247572	Cognitive performance
chr8	73778641	73778642	rs10504543	Echocardiographic traits
chr8	74007346	74007347	rs12677663	Crohn's disease
chr8	74066178	74066179	rs2383876	Corneal curvature
chr8	74274190	74274191	rs12679254	Inattentive symptoms
chr8	74467503	74467504	rs4342585	Axial length
chr8	75294974	75294975	rs4471028	Waist circumference
chr8	75373947	75373948	rs16938910	Response to tocilizumab in rheumatoid arthritis
chr8	75513133	75513134	rs6472866	Protein quantitative trait loci
chr8	76036443	76036444	rs1531590	IgG glycosylation
chr8	76147953	76147954	rs16939046	Information processing speed
chr8	76230300	76230301	rs6472903	Breast cancer
chr8	76417936	76417937	rs2943559	Breast cancer
chr8	76478767	76478768	rs2941484	Urate levels
chr8	76573710	76573711	rs2922763	Body mass index
chr8	76615662	76615663	rs4735692	Obesity
chr8	77507612	77507613	rs7846606	Orofacial clefts
chr8	77611624	77611625	rs4735738	Menarche (age at onset)
chr8	78093836	78093837	rs7821178	Menarche (age at onset)
chr8	78160178	78160179	rs7846385	Height
chr8	78178484	78178485	rs6473015	Height
chr8	78325884	78325885	rs13259667	Behavioural disinhibition (generation interaction)
chr8	78680348	78680349	rs3864663	Sudden cardiac arrest
chr8	78956657	78956658	rs2219968	Prostate cancer (gene x gene interaction)
chr8	79034458	79034459	rs13272568	Bone mineral density
chr8	79401037	79401038	rs1520333	Multiple sclerosis
chr8	80227447	80227448	rs1460163	Creutzfeldt-Jakob disease
chr8	80985034	80985035	rs181166265	Metabolite levels (HVA/MHPG ratio)
chr8	81031821	81031822	rs10957961	Metabolite levels (Pyroglutamine)
chr8	81228825	81228826	rs11987678	Sleep duration
chr8	81268154	81268155	rs6473223	Self-reported allergy
chr8	81308149	81308150	rs7000782	Atopic dermatitis
chr8	81357701	81357702	rs400824	Migraine - clinic-based
chr8	81438419	81438420	rs1051920	Hypothyroidism
chr8	81461973	81461974	rs440837	Sex hormone-binding globulin levels
chr8	81470119	81470120	rs272594	Neutrophil count
chr8	81986952	81986953	rs5003154	Bladder cancer
chr8	82027671	82027672	rs10097731	Serum total protein level
chr8	82151746	82151747	rs12216812	Myopia (pathological)
chr8	82445223	82445224	rs16909318	Visceral fat
chr8	82653643	82653644	rs11782652	Ovarian cancer
chr8	82928597	82928598	rs7820074	Orofacial clefts
chr8	83073828	83073829	rs13264970	Prostate cancer (gene x gene interaction)
chr8	83669119	83669120	rs6473383	Heart failure
chr8	83903813	83903814	rs7015622	Response to antidepressant treatment
chr8	83991230	83991231	rs1375785	Information processing speed
chr8	84812000	84812001	rs2199936	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr8	84812000	84812001	rs2199936	Cardiovascular disease risk factors
chr8	84812000	84812001	rs2199936	Urate levels
chr8	86268312	86268313	rs1532423	Blood trace element (Zn levels)
chr8	87025012	87025013	rs285406	Adverse response to lamotrigine and phenytoin
chr8	88868339	88868340	rs12543318	Orofacial clefts
chr8	89547931	89547932	rs10504861	Migraine without aura
chr8	89585047	89585048	rs7838490	Body mass index and cholesterol (psychopharmacological treatment)
chr8	89592082	89592083	rs11995572	Schizophrenia
chr8	89760310	89760311	rs7004633	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr8	89760310	89760311	rs7004633	Schizophrenia
chr8	89993487	89993488	rs10429371	Smooth-surface caries
chr8	90211099	90211100	rs2046315	Smooth-surface caries
chr8	90211099	90211100	rs2046315	Pit-and-Fissure caries
chr8	90211099	90211100	rs2046315	Dental caries
chr8	90342185	90342186	rs4397449	Cognitive performance
chr8	90656987	90656988	rs160441	Tuberculosis
chr8	90778512	90778513	rs42490	Leprosy
chr8	90823686	90823687	rs40457	Leprosy
chr8	90875917	90875918	rs7015630	Crohn's disease
chr8	92075642	92075643	rs4493873	Migraine - clinic-based
chr8	92360395	92360396	rs921231	Fat distribution (HIV)
chr8	92418627	92418628	rs10504906	Fat distribution (HIV)
chr8	92559914	92559915	rs2657195	Disc degeneration (lumbar)
chr8	94085538	94085539	rs1027730	Attention deficit hyperactivity disorder
chr8	94169349	94169350	rs278567	Bipolar disorder and schizophrenia
chr8	94222944	94222945	rs278541	IgG glycosylation
chr8	94358097	94358098	rs7387468	Temperament
chr8	94916102	94916103	rs35820208	Response to amphetamines
chr8	95960510	95960511	rs896854	Type 2 diabetes
chr8	96053999	96054000	rs7818382	Alzheimer's disease (late onset)
chr8	96106036	96106037	rs4590408	Metabolite levels (HVA-5-HIAA Factor score)
chr8	96106036	96106037	rs4590408	Metabolite levels (HVA)
chr8	96120071	96120072	rs4392868	Radiation response
chr8	96127029	96127030	rs7000734	Radiation response
chr8	96504471	96504472	rs77742018	Anorexia nervosa
chr8	96515887	96515888	rs1909881	Obesity-related traits
chr8	96595735	96595736	rs3104964	Colorectal cancer
chr8	97263417	97263418	rs7814319	Lung function (forced vital capacity)
chr8	97369633	97369634	rs2640806	Obesity-related traits
chr8	97796730	97796731	rs3763558	DNA methylation (variation)
chr8	98154440	98154441	rs17737465	Sleep duration
chr8	98166912	98166913	rs1835740	Migraine
chr8	98282188	98282189	rs1864729	Estradiol plasma levels (breast cancer)
chr8	98329764	98329765	rs6468544	Antipsychotic-induced QTc interval prolongation
chr8	99022008	99022009	rs2444896	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
chr8	99088580	99088581	rs13278732	Eosinophilic esophagitis (pediatric)
chr8	99113686	99113687	rs10107366	Obesity-related traits
chr8	99129506	99129507	rs2071598	Prion diseases
chr8	99317738	99317739	rs11785622	Thiazide-induced adverse metabolic effects in hypertensive patients
chr8	100835181	100835182	rs959695	Hippocampal atrophy
chr8	101330208	101330209	rs1371867	Atrioventricular conduction
chr8	101807229	101807230	rs36061340	Alcohol consumption
chr8	101813155	101813156	rs3847153	Premature ovarian failure
chr8	101841545	101841546	rs3108919	AIDS
chr8	101919320	101919321	rs931812	Attention deficit hyperactivity disorder and conduct disorder
chr8	102227922	102227923	rs1264202	Response to antipsychotic treatment in schizophrenia (reasoning)
chr8	102596209	102596210	rs6988306	Bronchopulmonary dysplasia
chr8	102944862	102944863	rs517811	Cognitive performance
chr8	103052376	103052377	rs16868941	Coffee consumption
chr8	103578873	103578874	rs2511714	Chronic lymphocytic leukemia
chr8	103639940	103639941	rs6998277	Migraine
chr8	103975988	103975989	rs6468852	Alzheimer's disease (late onset)
chr8	104118565	104118566	rs6983777	Attention deficit hyperactivity disorder (combined symptoms)
chr8	104573788	104573789	rs75686122	Cocaine dependence
chr8	105359431	105359432	rs2458413	Paget's disease
chr8	105700679	105700680	rs4734806	Periodontitis (DPAL)
chr8	105957539	105957540	rs16872085	Sudden cardiac arrest
chr8	105958019	105958020	rs284489	Glaucoma (primary open-angle)
chr8	105992695	105992696	rs977396	Response to antipsychotic treatment
chr8	106142332	106142333	rs9297357	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr8	106509974	106509975	rs2622633	Coronary artery calcification
chr8	106581527	106581528	rs6993770	Platelet counts
chr8	106581527	106581528	rs6993770	Vascular endothelial growth factor levels
chr8	106613320	106613321	rs17217757	Tuberculosis
chr8	107844446	107844447	rs2981205	Intelligence (childhood)
chr8	107909008	107909009	rs4269515	Dental caries
chr8	108040351	108040352	rs7004587	Obesity-related traits
chr8	108281426	108281427	rs6993449	IgG glycosylation
chr8	108789815	108789816	rs4534106	Brain structure
chr8	109228007	109228008	rs611744	Dupuytren's disease
chr8	109629902	109629903	rs2935776	T-tau
chr8	110115675	110115676	rs7832552	Body mass (lean)
chr8	110217265	110217266	rs7823896	Myopia (pathological)
chr8	110229393	110229394	rs2199936	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
chr8	110229393	110229394	rs2199936	Cardiovascular disease risk factors
chr8	110229393	110229394	rs2199936	Urate levels
chr8	110478821	110478822	rs73313124	Obesity-related traits
chr8	112976140	112976141	rs12549576	Bilirubin levels
chr8	113074095	113074096	rs1996720	Temperament
chr8	114873379	114873380	rs1912816	Bronchopulmonary dysplasia
chr8	115121026	115121027	rs9942773	Periodontal microbiota
chr8	115578306	115578307	rs7014900	Post-traumatic stress disorder (asjusted for relatedness)
chr8	116110724	116110725	rs218361	Eating disorders
chr8	116330854	116330855	rs6983039	IgG glycosylation
chr8	116394074	116394075	rs17658378	Attention deficit hyperactivity disorder (time to onset)
chr8	116599198	116599199	rs2293889	HDL cholesterol
chr8	116633698	116633699	rs2721937	Major depressive disorder
chr8	116648564	116648565	rs2737229	Cholesterol, total
chr8	116813904	116813905	rs800586	Response to tocilizumab in rheumatoid arthritis
chr8	117556269	117556270	rs4876662	Aortic root size
chr8	117630682	117630683	rs16892766	Colorectal cancer
chr8	117641609	117641610	rs11987235	Corneal curvature
chr8	118025644	118025645	rs3019885	Asthma
chr8	118089512	118089513	rs7815720	Intraocular pressure
chr8	118150992	118150993	rs11989843	Obesity-related traits
chr8	118184782	118184783	rs13266634	Type 2 diabetes
chr8	118184782	118184783	rs13266634	Type 2 diabetes and other traits
chr8	118184782	118184783	rs13266634	Glycated hemoglobin levels
chr8	118185024	118185025	rs3802177	Type 2 diabetes
chr8	118185732	118185733	rs11558471	Fasting glucose-related traits (interaction with BMI)
chr8	118185732	118185733	rs11558471	Proinsulin levels
chr8	118185732	118185733	rs11558471	Fasting glucose-related traits
chr8	118549375	118549376	rs17667932	Kawasaki disease
chr8	118827838	118827839	rs11989122	Height
chr8	118909259	118909260	rs7459527	Obesity-related traits
chr8	119391408	119391409	rs17749211	Multiple sclerosis
chr8	119766193	119766194	rs11988997	Pancreatitis
chr8	119830679	119830680	rs903614	Chronic obstructive pulmonary disease-related biomarkers
chr8	119923872	119923873	rs4355801	Bone mineral density
chr8	119976541	119976542	rs7839059	Bone mineral density
chr8	119977336	119977337	rs12679857	Type 1 diabetes
chr8	119977791	119977792	rs2062375	Osteoporosis
chr8	120007419	120007420	rs2062377	Bone mineral density
chr8	120007419	120007420	rs2062377	Bone mineral density (spine)
chr8	120012699	120012700	rs11995824	Bone mineral density (hip)
chr8	120044828	120044829	rs6469804	Bone mineral density (spine)
chr8	120052237	120052238	rs6993813	Bone mineral density (hip)
chr8	120224805	120224806	rs1364705	Hippocampal atrophy
chr8	120353266	120353267	rs2469997	Hypertension
chr8	120435811	120435812	rs2071518	Blood pressure
chr8	120647928	120647929	rs7007970	Height
chr8	120953872	120953873	rs7005380	Interstitial lung disease
chr8	121562417	121562418	rs7839488	Myopia (pathological)
chr8	121568920	121568921	rs4395927	Myopia (pathological)
chr8	121583282	121583283	rs4455882	Myopia (pathological)
chr8	121610437	121610438	rs6469937	Myopia (severe)
chr8	121635395	121635396	rs6986718	Bipolar disorder and schizophrenia
chr8	121694649	121694650	rs11989782	Eosinophilic esophagitis (pediatric)
chr8	122182309	122182310	rs1604897	IgG glycosylation
chr8	122210889	122210890	rs7819988	Periodontitis (CDC/AAP)
chr8	122621908	122621909	rs11995252	Obesity-related traits
chr8	122622499	122622500	rs17232789	Dialysis-related mortality
chr8	122706290	122706291	rs279612	Metabolite levels (5-HIAA)
chr8	122908502	122908503	rs7844723	Hemostatic factors and hematological phenotypes
chr8	122909686	122909687	rs956225	Alzheimer's disease
chr8	122963214	122963215	rs907121	Weight
chr8	123408090	123408091	rs11781551	Carotid intima media thickness
chr8	123706154	123706155	rs4871297	Type 1 diabetes nephropathy
chr8	123881217	123881218	rs6470120	Nicotine use
chr8	123973067	123973068	rs10108684	Immune response to smallpox vaccine (IL-6)
chr8	124696866	124696867	rs2294015	Event-related brain oscillations
chr8	124714721	124714722	rs13258681	Prostate cancer (gene x gene interaction)
chr8	124765701	124765702	rs10088262	Pancreatic cancer
chr8	124831833	124831834	rs10481151	Cognitive performance
chr8	125721365	125721366	rs11781525	IgG glycosylation
chr8	126477977	126477978	rs2001945	Triglycerides
chr8	126479314	126479315	rs6982636	Lipid metabolism phenotypes
chr8	126481474	126481475	rs2980879	Adiponectin levels
chr8	126482076	126482077	rs2954021	Liver enzyme levels (alkaline phosphatase)
chr8	126482076	126482077	rs2954021	Liver enzyme levels (alanine transaminase)
chr8	126482076	126482077	rs2954021	LDL cholesterol
chr8	126484525	126484526	rs2954026	HDL Cholesterol - Triglycerides (HDLC-TG)
chr8	126486408	126486409	rs17321515	Triglycerides
chr8	126490971	126490972	rs2954029	Triglycerides
chr8	126490971	126490972	rs2954029	LDL cholesterol
chr8	126490971	126490972	rs2954029	HDL cholesterol
chr8	126490971	126490972	rs2954029	Cholesterol, total
chr8	126493745	126493746	rs2954033	Triglycerides-Blood Pressure (TG-BP)
chr8	126504725	126504726	rs6987702	LDL cholesterol
chr8	126504725	126504726	rs6987702	Cholesterol, total
chr8	126507388	126507389	rs2954038	Response to statin therapy
chr8	126534670	126534671	rs921720	Obesity-related traits
chr8	126534670	126534671	rs921720	Inflammatory bowel disease
chr8	126537569	126537570	rs4871611	Crohn's disease
chr8	126540050	126540051	rs1551398	Crohn's disease
chr8	126867504	126867505	rs4006531	Metabolite levels (Dihydroxy docosatrienoic acid)
chr8	127092881	127092882	rs1906493	Crohn's disease
chr8	127332656	127332657	rs11986011	Age-related macular degeneration
chr8	127902002	127902003	rs4871750	Obesity-related traits
chr8	127911595	127911596	rs2220321	Obesity-related traits
chr8	128093296	128093297	rs1016343	Prostate cancer
chr8	128095155	128095156	rs13252298	Prostate cancer
chr8	128103936	128103937	rs1456315	Prostate cancer
chr8	128104342	128104343	rs13254738	Prostate cancer
chr8	128106879	128106880	rs6983561	Prostate cancer
chr8	128124915	128124916	rs16901979	Prostate cancer
chr8	128125194	128125195	rs10505483	Prostate cancer
chr8	128188018	128188019	rs2466024	Chronic lymphocytic leukemia
chr8	128192980	128192981	rs2456449	Chronic lymphocytic leukemia
chr8	128209819	128209820	rs2466032	Chronic lymphocytic leukemia
chr8	128211228	128211229	rs2466035	Chronic lymphocytic leukemia
chr8	128320345	128320346	rs16902094	Prostate cancer
chr8	128323180	128323181	rs445114	Prostate cancer
chr8	128355617	128355618	rs13281615	Breast cancer
chr8	128387851	128387852	rs1562430	Breast cancer
chr8	128407442	128407443	rs10505477	Colorectal cancer
chr8	128413304	128413305	rs6983267	Colorectal cancer
chr8	128413304	128413305	rs6983267	Prostate cancer
chr8	128424791	128424792	rs7014346	Colorectal cancer
chr8	128485037	128485038	rs1447295	Prostate cancer
chr8	128504496	128504497	rs17766217	Response to antidepressant treatment
chr8	128517572	128517573	rs4242382	Prostate cancer
chr8	128518553	128518554	rs4242384	Prostate cancer
chr8	128532136	128532137	rs10090154	Prostate cancer
chr8	128539359	128539360	rs7837688	Prostate cancer
chr8	128718067	128718068	rs9642880	Bladder cancer
chr8	128718067	128718068	rs9642880	Urinary bladder cancer
chr8	128815028	128815029	rs4410871	Allergic sensitization
chr8	128815028	128815029	rs4410871	Multiple sclerosis
chr8	128920196	128920197	rs16902460	Psychosis (atypical)
chr8	129072160	129072161	rs2648875	End-stage renal disease
chr8	129075831	129075832	rs2608053	Hodgkin's lymphoma
chr8	129192270	129192271	rs2019960	Hodgkin's lymphoma
chr8	129192270	129192271	rs2019960	Multiple sclerosis
chr8	129194640	129194641	rs11780156	Breast cancer
chr8	129220072	129220073	rs11995854	Obesity-related traits
chr8	129246414	129246415	rs10492294	Immunoglobulin A
chr8	129264588	129264589	rs9792269	Celiac disease
chr8	129280948	129280949	rs11775199	Metabolite levels (Dihydroxy docosatrienoic acid)
chr8	129316013	129316014	rs975730	Celiac disease and Rheumatoid arthritis
chr8	129427517	129427518	rs7815944	Atopic dermatitis
chr8	129543948	129543949	rs10088218	Ovarian cancer
chr8	129567180	129567181	rs6651252	Crohn's disease
chr8	129946153	129946154	rs987525	Orofacial clefts
chr8	129946153	129946154	rs987525	Cleft lip
chr8	130491751	130491752	rs891835	Glioma
chr8	130572109	130572110	rs10956483	White blood cell types
chr8	130613613	130613614	rs10098310	White blood cell count
chr8	130624104	130624105	rs1991866	Inflammatory bowel disease
chr8	130676638	130676639	rs9918807	Retinopathy in non-diabetics
chr8	130685456	130685457	rs4295627	Glioma
chr8	130725664	130725665	rs6470764	Height
chr8	130820038	130820039	rs2128382	Colorectal cancer
chr8	130958950	130958951	rs16904179	Post-traumatic stress disorder (asjusted for relatedness)
chr8	130980471	130980472	rs10092658	Protein quantitative trait loci
chr8	131033495	131033496	rs16904191	Migraine
chr8	131092412	131092413	rs6984045	Multiple sclerosis
chr8	131617849	131617850	rs16904316	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr8	131812032	131812033	rs263238	Total ventricular volume
chr8	132330715	132330716	rs10108033	IgG glycosylation
chr8	132353734	132353735	rs4596632	Eye color
chr8	132886442	132886443	rs7832443	Response to cholinesterase inhibitors in Alzheimer's disease
chr8	132999935	132999936	rs2270875	Response to cholinesterase inhibitors in Alzheimer's disease
chr8	133103289	133103290	rs2014357	Common traits (Other)
chr8	133369093	133369094	rs978152	Coronary artery calcification
chr8	133929916	133929917	rs853308	Vitiligo
chr8	134071832	134071833	rs2741200	Temperament
chr8	134145511	134145512	rs2294025	Graves' disease
chr8	134196848	134196849	rs4527850	Type 2 diabetes
chr8	134270547	134270548	rs2272651	Post-traumatic stress disorder (asjusted for relatedness)
chr8	134461850	134461851	rs10106540	Personality dimensions
chr8	134475076	134475077	rs2736871	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia
chr8	134615749	134615750	rs2945733	Intraocular pressure
chr8	134668676	134668677	rs2860223	Schizophrenia (negative symptoms)
chr8	134778341	134778342	rs74566133	Eating disorders (purging via substances)
chr8	135566566	135566567	rs7827545	Hypertension
chr8	135567045	135567046	rs1372662	Hypertension
chr8	135593724	135593725	rs6577655	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr8	135637336	135637337	rs12680655	Height
chr8	135638631	135638632	rs733254	Height
chr8	135869975	135869976	rs12541063	Blood pressure
chr8	135879158	135879159	rs4909801	Response to alcohol consumption (flushing response)
chr8	136713136	136713137	rs4243849	Non-alcoholic fatty liver disease histology (other)
chr8	136871738	136871739	rs12680546	Amyotrophic lateral sclerosis
chr8	136989203	136989204	rs16905439	Insomnia (caffeine-induced)
chr8	137768891	137768892	rs16906293	Bilirubin levels
chr8	137850010	137850011	rs16906415	IgG glycosylation
chr8	138905295	138905296	rs9657451	Cognitive performance
chr8	138909718	138909719	rs62531686	PCA3 expression level
chr8	138918944	138918945	rs2705293	Neuroticism
chr8	139077727	139077728	rs984440	Obesity-related traits
chr8	139255917	139255918	rs4909764	Inflammatory biomarkers
chr8	139301377	139301378	rs10875423	Periodontitis (PAL4Q3)
chr8	139504269	139504270	rs11166827	Cognitive performance
chr8	139884508	139884509	rs6988229	Asthma (bronchodilator response)
chr8	140519516	140519517	rs2468677	Adiponectin levels
chr8	140995242	140995243	rs1870805	Obesity-related traits
chr8	141150168	141150169	rs6992848	Response to amphetamines
chr8	141574193	141574194	rs2944755	Thiazide-induced adverse metabolic effects in hypertensive patients
chr8	142104943	142104944	rs4961252	Response to interferon beta therapy
chr8	142161063	142161064	rs3816063	Obesity-related traits
chr8	142300314	142300315	rs7827290	Bipolar disorder
chr8	142359549	142359550	rs7386474	Bipolar disorder and schizophrenia
chr8	142466820	142466821	rs11777747	Coronary artery calcification
chr8	142540924	142540925	rs7837045	Breast size
chr8	142556804	142556805	rs1566080	Obesity-related traits
chr8	142632314	142632315	rs13263959	Hair color
chr8	142736530	142736531	rs4072286	Obesity-related traits
chr8	143020730	143020731	rs7845056	IgG glycosylation
chr8	143121670	143121671	rs4917300	Amyotrophic lateral sclerosis
chr8	143312932	143312933	rs4129585	Schizophrenia
chr8	143691837	143691838	rs7465272	Bipolar disorder and schizophrenia
chr8	143761930	143761931	rs2294008	Duodenal ulcer
chr8	143761930	143761931	rs2294008	Bladder cancer
chr8	144657599	144657600	rs2290416	Attention deficit hyperactivity disorder
chr8	144693838	144693839	rs2045084	Rhegmatogenous retinal detachment
chr8	144802455	144802456	rs35925379	Obesity-related traits
chr8	145005560	145005561	rs6995402	Platelet counts
chr8	145021166	145021167	rs7464572	Fibrinogen
chr8	145043542	145043543	rs11136341	LDL cholesterol
chr8	145043542	145043543	rs11136341	Cholesterol, total
chr8	145139521	145139522	rs6558295	Metabolic traits
chr9	289060	289061	rs6476030	Obesity-related traits
chr9	331489	331490	rs10813766	Mean platelet volume
chr9	565916	565917	rs7027930	Pulmonary function decline
chr9	678836	678837	rs12352279	Migraine - clinic-based
chr9	841151	841152	rs912062	Obesity-related traits
chr9	845515	845516	rs7040024	Testicular cancer
chr9	863634	863635	rs755383	Testicular germ cell tumor
chr9	863634	863635	rs755383	Testicular cancer
chr9	863634	863635	rs755383	Testicular germ cell cancer
chr9	955793	955794	rs364477	Major depressive disorder
chr9	1056958	1056959	rs17641078	Hyperactive-impulsive symptoms
chr9	1202370	1202371	rs10809650	Dupuytren's disease
chr9	1456796	1456797	rs1412259	Response to taxane treatment (docetaxel)
chr9	2194226	2194227	rs4741652	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr9	2203937	2203938	rs6475600	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
chr9	2548555	2548556	rs10812227	Gambling
chr9	2551653	2551654	rs12237653	Gambling
chr9	2640758	2640759	rs3780181	LDL cholesterol
chr9	2640758	2640759	rs3780181	Cholesterol, total
chr9	2691185	2691186	rs10738760	Vascular endothelial growth factor levels
chr9	2696554	2696555	rs930811	Obesity-related traits
chr9	2742770	2742771	rs2034764	Alzheimer's disease (age of onset)
chr9	2777383	2777384	rs10812641	Blood trace element (Se levels)
chr9	2838469	2838470	rs10968457	Obesity-related traits
chr9	2978376	2978377	rs7045640	Systolic blood pressure in sickle cell anemia
chr9	3929423	3929424	rs514716	Alzheimer's disease biomarkers
chr9	4015369	4015370	rs564816	Methotrexate phramacokinetics (acute lymphoblastic leukemia)
chr9	4267208	4267209	rs1571583	Thyroid hormone levels
chr9	4287465	4287466	rs7041847	Type 2 diabetes
chr9	4289049	4289050	rs7034200	Fasting glucose-related traits (interaction with BMI)
chr9	4289049	4289050	rs7034200	Fasting glucose-related traits
chr9	4291746	4291747	rs7020673	Type 1 diabetes
chr9	4292082	4292083	rs10758593	Type 1 diabetes
chr9	4293149	4293150	rs10814916	Type 2 diabetes
chr9	4426630	4426631	rs10974531	Pancreatic cancer
chr9	4555304	4555305	rs7856675	Coronary artery calcification
chr9	4744742	4744743	rs409801	Platelet counts
chr9	4763175	4763176	rs385893	Platelet counts
chr9	4763175	4763176	rs385893	Hematological parameters
chr9	4774014	4774015	rs296859	Handedness
chr9	4792338	4792339	rs423955	Platelet counts
chr9	4814947	4814948	rs13300663	Platelet counts
chr9	4834393	4834394	rs457287	Platelet counts
chr9	4844264	4844265	rs2236496	Mean corpuscular volume
chr9	4844264	4844265	rs2236496	Red blood cell traits
chr9	4844264	4844265	rs2236496	Mean corpuscular hemoglobin
chr9	4845519	4845520	rs10815094	Mean corpuscular hemoglobin
chr9	4856876	4856877	rs10758658	Mean corpuscular volume
chr9	4856876	4856877	rs10758658	Mean corpuscular hemoglobin
chr9	4981601	4981602	rs10758669	Inflammatory bowel disease
chr9	4981601	4981602	rs10758669	Ulcerative colitis
chr9	4981601	4981602	rs10758669	Crohn's disease
chr9	4985878	4985879	rs2274471	Crohn's disease
chr9	5070830	5070831	rs10974944	Myeloproliferative neoplasms
chr9	5213686	5213687	rs10975003	Ulcerative colitis
chr9	5410722	5410723	rs1535454	Obesity-related traits
chr9	5893860	5893861	rs2150702	Multiple sclerosis
chr9	6172379	6172380	rs7032572	Self-reported allergy
chr9	6190075	6190076	rs1342326	Asthma
chr9	6193454	6193455	rs2381416	Asthma
chr9	6253570	6253571	rs10975519	Endometriosis
chr9	6486307	6486308	rs16924631	Periodontal microbiota
chr9	6784725	6784726	rs10815468	Bipolar disorder and schizophrenia
chr9	6849316	6849317	rs4742269	Radiation response
chr9	7043454	7043455	rs16925187	Response to fenofibrate (adiponectin levels)
chr9	7195407	7195408	rs2820914	Obesity-related traits
chr9	7274695	7274696	rs1887867	Obesity-related traits
chr9	7518655	7518656	rs2381628	IgG glycosylation
chr9	7558260	7558261	rs4400445	Obesity-related traits
chr9	7682600	7682601	rs842304	HIV-1 susceptibility
chr9	7734249	7734250	rs10758892	Myopia (pathological)
chr9	7925380	7925381	rs1535480	Common traits (Other)
chr9	8012417	8012418	rs12682851	Prostate cancer (gene x gene interaction)
chr9	8045605	8045606	rs2146180	Personality dimensions
chr9	8196510	8196511	rs7044355	Platelet aggregation
chr9	8235632	8235633	rs10815798	Attention deficit hyperactivity disorder and conduct disorder
chr9	8846954	8846955	rs1975197	Restless legs syndrome
chr9	8879117	8879118	rs17584499	Type 2 diabetes
chr9	9020222	9020223	rs378363	Migraine - clinic-based
chr9	9261736	9261737	rs4626664	Restless legs syndrome
chr9	9910122	9910123	rs10759102	Airflow obstruction
chr9	9924723	9924724	rs7849581	Myopia (pathological)
chr9	10043013	10043014	rs291272	Temperament
chr9	10139579	10139580	rs294845	Obesity-related traits
chr9	10260262	10260263	rs2475335	Partial epilepsies
chr9	10430601	10430602	rs649891	Type 2 diabetes
chr9	10505223	10505224	rs72700966	Epilepsy (remission after treatment)
chr9	11257447	11257448	rs10959672	Response to amphetamines
chr9	11402318	11402319	rs10809457	Palmitic acid (16:0) plasma levels
chr9	12108915	12108916	rs12351590	Word reading
chr9	12108915	12108916	rs12351590	Reading and spelling
chr9	12396730	12396731	rs13289810	Hair color
chr9	12521825	12521826	rs16929097	Asthma (childhood onset)
chr9	12582564	12582565	rs1325154	Attention deficit hyperactivity disorder (time to onset)
chr9	12672096	12672097	rs1408799	Eye color
chr9	12672096	12672097	rs1408799	Blue vs. green eyes
chr9	12914395	12914396	rs1953021	Periodontitis (CDC/AAP)
chr9	13007128	13007129	rs1360517	AIDS
chr9	13557490	13557491	rs1324183	Corneal structure
chr9	14064740	14064741	rs7039300	Alzheimer's disease biomarkers
chr9	14441676	14441677	rs59677118	Alcohol consumption
chr9	14446000	14446001	rs1556032	AIDS
chr9	14470832	14470833	rs10961534	Hypothyroidism
chr9	14562313	14562314	rs10961577	Visceral adipose tissue adjusted for BMI
chr9	14898160	14898161	rs10961780	Height
chr9	15104560	15104561	rs10756650	Metabolite levels (Pyroglutamine)
chr9	15157976	15157977	rs1780159	Calcium levels
chr9	15283096	15283097	rs12003180	Bipolar disorder and schizophrenia
chr9	15289577	15289578	rs471364	HDL cholesterol
chr9	15296033	15296034	rs643531	HDL cholesterol
chr9	15305377	15305378	rs581080	HDL cholesterol
chr9	15305377	15305378	rs581080	Cholesterol, total
chr9	15309927	15309928	rs2245641	Bipolar disorder
chr9	15335913	15335914	rs16933006	Obesity-related traits
chr9	15986715	15986716	rs1927702	Body mass index
chr9	16000234	16000235	rs79156074	Metabolite levels (5-HIAA/ MHPG Ratio)
chr9	16034537	16034538	rs3008706	Bilirubin levels
chr9	16368731	16368732	rs7864648	Height
chr9	16385131	16385132	rs9406636	Metabolite levels (Dihydroxy docosatrienoic acid)
chr9	16512747	16512748	rs10124550	Metabolite levels (Pyroglutamine)
chr9	16864520	16864521	rs2153271	Freckling
chr9	16915020	16915021	rs3814113	Ovarian cancer in BRCA1 mutation carriers
chr9	16915020	16915021	rs3814113	Ovarian cancer
chr9	16970808	16970809	rs4961511	Corneal astigmatism
chr9	17458871	17458872	rs10810790	Response to amphetamines
chr9	17487944	17487945	rs2383024	Pulmonary function decline
chr9	17731920	17731921	rs1536076	Parkinson's disease
chr9	17895104	17895105	rs10810865	Cognitive performance
chr9	17938350	17938351	rs1755289	Multiple sclerosis
chr9	17979577	17979578	rs1755271	Obesity-related traits
chr9	18109234	18109235	rs2210327	Heart failure
chr9	18215279	18215280	rs1944766	Fat distribution (HIV)
chr9	18444137	18444138	rs6475216	Obesity-related traits
chr9	18458067	18458068	rs1340043	Obesity-related traits
chr9	18761098	18761099	rs1978746	QT interval (interaction)
chr9	18930221	18930222	rs1571228	Non-small cell lung cancer
chr9	19213633	19213634	rs141215807	Metabolite levels (HVA)
chr9	19579426	19579427	rs3780215	Body mass index (asthmatics)
chr9	19664080	19664081	rs4258076	Cognitive performance
chr9	20098710	20098711	rs16937883	Asthma (toluene diisocyanate-induced)
chr9	21035306	21035307	rs7867456	Axial length
chr9	21499623	21499624	rs7849420	Lipid traits
chr9	21747802	21747803	rs4636294	Cutaneous nevi
chr9	21816527	21816528	rs7023329	Melanoma
chr9	21984660	21984661	rs3731217	Acute lymphoblastic leukemia (B-cell precursor)
chr9	21986846	21986847	rs3731211	Platelet counts
chr9	22003366	22003367	rs1063192	Glaucoma (primary open-angle)
chr9	22003366	22003367	rs1063192	Vertical cup-disc ratio
chr9	22019128	22019129	rs523096	Glaucoma
chr9	22026076	22026077	rs615552	Migraine without aura
chr9	22029546	22029547	rs564398	Type 2 diabetes
chr9	22031004	22031005	rs7865618	Glaucoma (primary open-angle)
chr9	22031004	22031005	rs7865618	Coronary heart disease
chr9	22033365	22033366	rs2157719	Glaucoma (primary open-angle)
chr9	22033365	22033366	rs2157719	Glioma
chr9	22043925	22043926	rs1412829	Nasopharyngeal carcinoma
chr9	22043925	22043926	rs1412829	Glioma (high-grade)
chr9	22062133	22062134	rs1011970	Breast cancer
chr9	22068651	22068652	rs4977756	Glioma
chr9	22068651	22068652	rs4977756	Glaucoma
chr9	22072263	22072264	rs10757269	Ankle-brachial index
chr9	22081849	22081850	rs6475606	Intracranial aneurysm
chr9	22083403	22083404	rs1333040	Intracranial aneurysm
chr9	22084309	22084310	rs1537370	Coronary artery calcification
chr9	22088259	22088260	rs10757272	Intracranial aneurysm
chr9	22096054	22096055	rs10757274	Coronary heart disease
chr9	22098573	22098574	rs4977574	Coronary heart disease
chr9	22098573	22098574	rs4977574	Myocardial infarction (early onset)
chr9	22103812	22103813	rs1333042	Coronary heart disease
chr9	22115104	22115105	rs10965235	Endometriosis
chr9	22115285	22115286	rs944797	Coronary heart disease
chr9	22115958	22115959	rs2383207	Abdominal aortic aneurysm
chr9	22124476	22124477	rs10757278	Myocardial infarction
chr9	22125346	22125347	rs1333048	Coronary heart disease
chr9	22125502	22125503	rs1333049	Coronary artery calcification
chr9	22125502	22125503	rs1333049	Coronary heart disease
chr9	22129578	22129579	rs7020996	Type 2 diabetes
chr9	22132075	22132076	rs2383208	Type 2 diabetes
chr9	22133283	22133284	rs10965250	Type 2 diabetes
chr9	22134093	22134094	rs10811661	Type 2 diabetes
chr9	22134093	22134094	rs10811661	Fasting glucose-related traits (interaction with BMI)
chr9	22136488	22136489	rs1333051	Type 2 diabetes
chr9	22137684	22137685	rs7018475	Type 2 diabetes
chr9	22169699	22169700	rs1537377	Endometriosis
chr9	22206986	22206987	rs1679013	Chronic lymphocytic leukemia
chr9	22362103	22362104	rs961831	Personality dimensions
chr9	22488677	22488678	rs586716	Tuberculosis
chr9	22670714	22670715	rs613391	Quantitative traits
chr9	22770885	22770886	rs10811771	Response to antipsychotic therapy (extrapyramidal side effects)
chr9	22819575	22819576	rs7849973	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chr9	22842201	22842202	rs12554707	Response to amphetamines
chr9	23426270	23426271	rs12000445	Response to platinum-based chemotherapy in non-small-cell lung cancer
chr9	24092071	24092072	rs4246856	D-dimer levels
chr9	24111279	24111280	rs2225614	Quantitative traits
chr9	24720231	24720232	rs10491833	Serum dimethylarginine levels (symmetric)
chr9	25414050	25414051	rs7021404	Metabolite levels (Dihydroxy docosatrienoic acid)
chr9	25449121	25449122	rs12552736	RR interval (heart rate)
chr9	25452811	25452812	rs13300284	RR interval (heart rate)
chr9	25501296	25501297	rs2210430	Sleep quality
chr9	25551356	25551357	rs17774966	Entorhinal cortical thickness
chr9	26208856	26208857	rs4978053	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr9	26614846	26614847	rs10812428	Drug-induced liver injury (flucloxacillin)
chr9	26694887	26694888	rs13294589	Gallbladder cancer
chr9	26789939	26789940	rs1889899	Smoking behavior
chr9	26935995	26935996	rs7045881	Schizophrenia
chr9	27075714	27075715	rs1577330	IgG glycosylation
chr9	27126414	27126415	rs1334809	IgG glycosylation
chr9	27309658	27309659	rs10967875	Obesity-related traits
chr9	27488091	27488092	rs17779457	Urinary symptoms in response to radiotherapy in prostate cancer
chr9	27490966	27490967	rs7046653	Response to TNF antagonist treatment
chr9	27533983	27533984	rs10812610	Heart failure
chr9	27536396	27536397	rs2814707	Amyotrophic lateral sclerosis
chr9	27543280	27543281	rs3849942	Amyotrophic lateral sclerosis (sporadic)
chr9	27543280	27543281	rs3849942	Amyotrophic lateral sclerosis
chr9	27556779	27556780	rs10122902	Amyotrophic lateral sclerosis
chr9	27561048	27561049	rs774359	Amyotrophic lateral sclerosis
chr9	27610656	27610657	rs2889829	PCA3 expression level
chr9	27630561	27630562	rs12555345	Total ventricular volume
chr9	27882652	27882653	rs7029145	Immunoglobulin A
chr9	28181084	28181085	rs1319535	IgG glycosylation
chr9	28359781	28359782	rs16912725	Obesity-related traits
chr9	28402042	28402043	rs10968562	Obesity-related traits
chr9	28414338	28414339	rs10968576	Obesity
chr9	28414338	28414339	rs10968576	Body mass index
chr9	28425514	28425515	rs1412239	Obesity
chr9	28587993	28587994	rs2891316	Endometrial cancer
chr9	29545874	29545875	rs13290799	Obesity-related traits
chr9	29783988	29783989	rs10969375	Obesity-related traits
chr9	31419914	31419915	rs10435736	Metabolite levels  (X-11787)
chr9	31450665	31450666	rs148359873	Serum dimethylarginine levels (symmetric)
chr9	31450665	31450666	rs148359873	Serum dimethylarginine levels (asymmetric/symetric ratio)
chr9	31546471	31546472	rs4576506	Alzheimer's disease
chr9	32422689	32422690	rs7032871	IgG glycosylation
chr9	32433525	32433526	rs10970976	Asthma
chr9	32556379	32556380	rs17290760	Immune response to smallpox vaccine (IL-6)
chr9	32755027	32755028	rs10758161	Immune response to anthrax vaccine
chr9	32870067	32870068	rs10971170	IgG glycosylation
chr9	32914588	32914589	rs12377462	Vitamin B12 levels
chr9	33122644	33122645	rs10113903	IgG glycosylation
chr9	33124871	33124872	rs12342831	IgG glycosylation
chr9	33125803	33125804	rs10758189	IgG glycosylation
chr9	33128020	33128021	rs10813951	IgG glycosylation
chr9	33139452	33139453	rs3780486	IgG glycosylation
chr9	33153526	33153527	rs10813957	IgG glycosylation
chr9	33180361	33180362	rs10813960	Urate levels
chr9	33217265	33217266	rs830407	Bipolar disorder and schizophrenia
chr9	33283581	33283582	rs12336160	Erectile dysfunction and prostate cancer treatment
chr9	33799369	33799370	rs216345	Bipolar disorder
chr9	34071540	34071541	rs7871764	Height
chr9	34710259	34710260	rs2812378	Rheumatoid arthritis
chr9	34743680	34743681	rs951005	Rheumatoid arthritis
chr9	35141704	35141705	rs10972341	Weight
chr9	35269818	35269819	rs10121009	Parkinson's disease
chr9	35648949	35648950	rs3138083	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
chr9	35700836	35700837	rs4879926	IgE levels in asthmatics
chr9	36099398	36099399	rs4878639	IgG glycosylation
chr9	36969204	36969205	rs16933812	Obesity and blood pressure
chr9	36997416	36997417	rs3758171	Intelligence
chr9	36998992	36998993	rs1329573	Intelligence
chr9	37000686	37000687	rs3824344	Intelligence
chr9	37002114	37002115	rs7020413	Intelligence
chr9	37037975	37037976	rs1329568	Response to tocilizumab in rheumatoid arthritis
chr9	37916407	37916408	rs3747547	Metabolite levels (Dihydroxy docosatrienoic acid)
chr9	38041141	38041142	rs7873102	Brain structure
chr9	38456364	38456365	rs1110183	Hypertension
chr9	38675464	38675465	rs7039377	Obesity-related traits
chr9	38750578	38750579	rs184891496	Metabolite levels (HVA/MHPG ratio)
chr9	71229178	71229179	rs7864204	Body mass index (interaction)
chr9	71434706	71434707	rs4744712	Chronic kidney disease
chr9	71471911	71471912	rs6560397	Pit-and-Fissure caries
chr9	71766592	71766593	rs11145465	Refractive error
chr9	71865931	71865932	rs2282335	Renal sinus fat
chr9	71943001	71943002	rs3750552	Bipolar disorder
chr9	72998331	72998332	rs11142387	Body mass index
chr9	73094534	73094535	rs963265	Migraine with aura
chr9	73157415	73157416	rs10780944	Pubertal anthropometrics
chr9	73784263	73784264	rs4745062	Longevity
chr9	74887702	74887703	rs11143230	Suicidal ideation
chr9	75764564	75764565	rs3758354	Schizophrenia, bipolar disorder and depression (combined)
chr9	76157699	76157700	rs12555078	Obesity-related traits
chr9	76158681	76158682	rs11143609	HIV-1 control
chr9	77149836	77149837	rs7042950	Refractive error
chr9	77149836	77149837	rs7042950	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr9	77499795	77499796	rs11144134	Magnesium levels
chr9	78028345	78028346	rs489332	Schizophrenia
chr9	78276674	78276675	rs10512049	Total ventricular volume
chr9	78425924	78425925	rs12344488	Non-alcoholic fatty liver disease histology (AST)
chr9	78542285	78542286	rs11144688	Height
chr9	78665775	78665776	rs7047865	Metabolite levels (5-HIAA)
chr9	78665775	78665776	rs7047865	Amyotrophic lateral sclerosis (age of onset)
chr9	78841400	78841401	rs10746997	Response to fenofibrate (adiponectin levels)
chr9	78906149	78906150	rs2842483	Multiple sclerosis (age of onset)
chr9	79038169	79038170	rs6560517	Dialysis-related mortality
chr9	79408143	79408144	rs10781380	Hippocampal atrophy
chr9	79610627	79610628	rs79460104	Response to amphetamines
chr9	80320364	80320365	rs4745661	IgG glycosylation
chr9	80940575	80940576	rs1411916	Visceral fat
chr9	81083896	81083897	rs10125737	Obesity-related traits
chr9	81310679	81310680	rs1757948	vWF and FVIII levels
chr9	81889357	81889358	rs2769967	Inattentive symptoms
chr9	81952127	81952128	rs13292136	Type 2 diabetes
chr9	82039361	82039362	rs2378383	Asthma (childhood onset)
chr9	82310897	82310898	rs914715	Bipolar disorder
chr9	82345880	82345881	rs2151145	Menopause (age at onset)
chr9	82807502	82807503	rs12554086	RR interval (heart rate)
chr9	84015036	84015037	rs10867752	Hippocampal atrophy
chr9	84213159	84213160	rs2777777	Visceral adipose tissue adjusted for BMI
chr9	84222617	84222618	rs815847	Visceral fat
chr9	84372740	84372741	rs11139399	Hippocampal atrophy
chr9	84522748	84522749	rs13295552	IgG glycosylation
chr9	85135914	85135915	rs7043482	Insulin resistance/response
chr9	85311146	85311147	rs668853	Ulcerative colitis
chr9	85414980	85414981	rs1998303	Select biomarker traits
chr9	85609780	85609781	rs10867921	Obesity-related traits
chr9	86552204	86552205	rs7853377	Height
chr9	86741460	86741461	rs13288553	Molar-incisor hypomineralization
chr9	86922035	86922036	rs10123041	Response to statin therapy
chr9	86944424	86944425	rs12000457	Obesity-related traits
chr9	87186404	87186405	rs4877280	Waist-to-hip circumference ratio (interaction)
chr9	87930044	87930045	rs2841498	Partial epilepsies
chr9	89116627	89116628	rs8181166	Height
chr9	89527457	89527458	rs11141597	Asthma (childhood onset)
chr9	89573082	89573083	rs9792548	Insulin resistance/response
chr9	90031668	90031669	rs1806864	Bipolar disorder and schizophrenia
chr9	90209136	90209137	rs3095748	Immune reponse to smallpox (secreted IFN-alpha)
chr9	90235793	90235794	rs11141915	Response to gemcitabine in pancreatic cancer
chr9	90811181	90811182	rs2814828	Height
chr9	90835725	90835726	rs2778031	Height
chr9	91260561	91260562	rs17054265	Obesity-related traits
chr9	91540058	91540059	rs1875620	Response to statin therapy (LDL-C)
chr9	92036426	92036427	rs4132699	Orofacial clefts
chr9	92249583	92249584	rs10908907	Alcoholism (heaviness of drinking)
chr9	92887230	92887231	rs2081670	Protein quantitative trait loci
chr9	93181530	93181531	rs883924	Hepatitis C induced liver fibrosis
chr9	93409356	93409357	rs1831521	Cognitive test performance
chr9	93555738	93555739	rs290258	Prostate cancer (gene x gene interaction)
chr9	93563535	93563536	rs290986	Multiple sclerosis
chr9	93633239	93633240	rs10993738	Type 2 diabetes
chr9	93636663	93636664	rs290227	Vascular dementia
chr9	93928415	93928416	rs4743820	Inflammatory bowel disease
chr9	93975470	93975471	rs773506	Type 2 diabetes nephropathy
chr9	94822539	94822540	rs7872515	Bipolar disorder and schizophrenia
chr9	95429119	95429120	rs9969804	Height
chr9	95559504	95559505	rs10992471	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr9	95887319	95887320	rs2275848	Obesity (early onset extreme)
chr9	96562562	96562563	rs7027203	DNA methylation (variation)
chr9	96631133	96631134	rs10114408	Colorectal cancer
chr9	96716027	96716028	rs11789015	Esophageal adenocarcinoma
chr9	96716027	96716028	rs11789015	Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)
chr9	96716027	96716028	rs11789015	Barrett's esophagus
chr9	96858410	96858411	rs6479527	Esophageal adenocarcinoma
chr9	96893944	96893945	rs1257763	Height
chr9	97068925	97068926	rs10993160	Body mass index
chr9	97314740	97314741	rs16910061	Height
chr9	97444037	97444038	rs10125337	Obesity-related traits
chr9	97713458	97713459	rs10821415	Atrial fibrillation
chr9	97741273	97741274	rs3802458	Erectile dysfunction and prostate cancer treatment
chr9	97741335	97741336	rs3802457	Polycystic ovary syndrome
chr9	98231007	98231008	rs16909898	Pulmonary function (interaction)
chr9	98231007	98231008	rs16909898	Pulmonary function
chr9	98256234	98256235	rs473902	Height
chr9	98259702	98259703	rs10512248	Height
chr9	98376698	98376699	rs10988802	Chemerin levels
chr9	98429265	98429266	rs11790994	Inattentive symptoms
chr9	98816483	98816484	rs1547201	IgG glycosylation
chr9	99097526	99097527	rs6479272	Non-small cell lung cancer
chr9	99132043	99132044	rs10820447	Migraine with aura
chr9	99161511	99161512	rs2025151	Height
chr9	99539137	99539138	rs10816533	Height
chr9	100316229	100316230	rs1475545	Obesity-related traits
chr9	100546599	100546600	rs925489	Hypothyroidism
chr9	100549012	100549013	rs7850258	Hypothyroidism
chr9	100550027	100550028	rs1443438	Obesity-related traits
chr9	100556108	100556109	rs965513	Thyroid cancer
chr9	100556108	100556109	rs965513	Thyroid cancer (Papillary, radiation-related)
chr9	100591462	100591463	rs7045138	Thyroid hormone levels
chr9	100696202	100696203	rs755109	Quantitative traits
chr9	100740123	100740124	rs4743150	Coronary heart disease
chr9	101123335	101123336	rs10986018	Folate pathway vitamin levels
chr9	101253225	101253226	rs2779551	Post-traumatic stress disorder (asjusted for relatedness)
chr9	101908364	101908365	rs334353	Age-related macular degeneration
chr9	102037969	102037970	rs10819643	Lung function (forced expiratory flow between 25% and 75% of forced vital capacity)
chr9	102119089	102119090	rs12551906	Callous-unemotional behaviour
chr9	102234322	102234323	rs649057	Smooth-surface caries
chr9	102234322	102234323	rs649057	Dental caries
chr9	102723691	102723692	rs10760706	Alopecia areata
chr9	102808684	102808685	rs7028939	Preeclampsia
chr9	102976540	102976541	rs10989019	Preeclampsia
chr9	104223232	104223233	rs10819937	Liver enzyme levels (alkaline phosphatase)
chr9	104537609	104537610	rs4523321	Obesity-related traits
chr9	104622867	104622868	rs10989661	Smoking behavior
chr9	104867837	104867838	rs10989824	Thiazide-induced adverse metabolic effects in hypertensive patients
chr9	104944754	104944755	rs320209	Response to antipsychotic treatment
chr9	105442116	105442117	rs2210533	Obesity-related traits
chr9	105502497	105502498	rs10990268	Tourette syndrome
chr9	105735194	105735195	rs1342899	Response to antineoplastic agents
chr9	106024219	106024220	rs16922670	Alzheimer's disease
chr9	106369943	106369944	rs144649413	Metabolite levels (MHPG)
chr9	106793725	106793726	rs1536895	Orofacial clefts (interaction)
chr9	107324199	107324200	rs13287980	Gout
chr9	107531955	107531956	rs2472476	Obesity-related traits
chr9	107588776	107588777	rs4149311	Myopia (pathological)
chr9	107589133	107589134	rs4149310	Metabolite levels
chr9	107594363	107594364	rs2515629	Coronary heart disease
chr9	107620834	107620835	rs9282541	HDL cholesterol
chr9	107647219	107647220	rs4149268	HDL cholesterol
chr9	107647654	107647655	rs3890182	HDL cholesterol
chr9	107653425	107653426	rs12686004	HDL cholesterol
chr9	107657069	107657070	rs3905000	MRI atrophy measures
chr9	107657069	107657070	rs3905000	HDL cholesterol
chr9	107664300	107664301	rs1883025	HDL cholesterol
chr9	107664300	107664301	rs1883025	Cholesterol, total
chr9	107664300	107664301	rs1883025	Metabolic syndrome
chr9	107665738	107665739	rs2575876	Lipid metabolism phenotypes
chr9	107677288	107677289	rs4149263	Periodontitis (Mean PAL)
chr9	108427061	108427062	rs1463984	Cognitive performance
chr9	108440541	108440542	rs10120372	Visceral adipose tissue/subcutaneous adipose tissue ratio
chr9	108631949	108631950	rs9969729	Alzheimer's disease (late onset)
chr9	108655095	108655096	rs4742971	Protein quantitative trait loci
chr9	108936673	108936674	rs7861820	Menarche and menopause (age at onset)
chr9	108967087	108967088	rs2090409	Pubertal anthropometrics
chr9	108967087	108967088	rs2090409	Menarche (age at onset)
chr9	109599045	109599046	rs7027110	Height
chr9	109632352	109632353	rs4743034	Height
chr9	109676892	109676893	rs1858231	Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
chr9	110125810	110125811	rs817858	Body mass index
chr9	110156299	110156300	rs817826	Prostate cancer
chr9	110306114	110306115	rs10759243	Breast cancer
chr9	110872306	110872307	rs7042864	Tonometry
chr9	110888477	110888478	rs865686	Breast cancer
chr9	111455574	111455575	rs10512385	Paclitaxel-induced neuropathy
chr9	111799562	111799563	rs643410	Schizophrenia (negative symptoms)
chr9	111854245	111854246	rs523340	Information processing speed
chr9	112526288	112526289	rs1327796	Type 2 diabetes
chr9	112596910	112596911	rs2025875	Obesity-related traits
chr9	112945404	112945405	rs7032940	Height
chr9	113131162	113131163	rs1327533	Longevity
chr9	113197262	113197263	rs7042161	Bipolar disorder
chr9	113300834	113300835	rs1889321	Pulmonary function decline
chr9	113419758	113419759	rs10980508	Type 2 diabetes (dietary heme iron intake interaction)
chr9	113662680	113662681	rs1007000	Corneal structure
chr9	113807081	113807082	rs1468758	Height
chr9	113915904	113915905	rs10980800	White blood cell count
chr9	114293633	114293634	rs10980926	Pubertal anthropometrics
chr9	114293633	114293634	rs10980926	Menarche (age at onset)
chr9	114301584	114301585	rs10441737	Menarche (age at onset)
chr9	114303678	114303679	rs7873730	Menarche (age at onset)
chr9	114348616	114348617	rs2273788	Monocyte count
chr9	114798036	114798037	rs10125054	Obesity-related traits
chr9	114823120	114823121	rs4979078	Venous thromboembolism
chr9	114850189	114850190	rs2782931	Amyotrophic lateral sclerosis
chr9	115687734	115687735	rs10817408	IgG glycosylation
chr9	115997248	115997249	rs6477998	Hematology traits
chr9	116991070	116991071	rs7868992	Tourette syndrome
chr9	117049890	117049891	rs946053	Height
chr9	117088063	117088064	rs10982156	End-stage coagulation
chr9	117240905	117240906	rs79509430	Obesity-related traits
chr9	117260833	117260834	rs10982256	Bipolar disorder
chr9	117545665	117545666	rs6478106	Crohn's disease
chr9	117552884	117552885	rs3810936	Crohn's disease
chr9	117553248	117553249	rs4246905	Inflammatory bowel disease
chr9	117553248	117553249	rs4246905	Ulcerative colitis
chr9	117558702	117558703	rs6478108	Leprosy
chr9	117566439	117566440	rs4263839	Crohn's disease
chr9	117567012	117567013	rs4979462	Primary biliary cirrhosis
chr9	117568765	117568766	rs6478109	Inflammatory bowel disease
chr9	117592637	117592638	rs2006996	Inflammatory bowel disease
chr9	117605069	117605070	rs11554257	Ulcerative colitis
chr9	117830811	117830812	rs7847271	Prostate cancer (gene x gene interaction)
chr9	118050413	118050414	rs7853844	Pancreatic cancer
chr9	118202715	118202716	rs9409154	Visceral adipose tissue adjusted for BMI
chr9	118424986	118424987	rs12006166	Migraine
chr9	119122341	119122342	rs751543	Height
chr9	119134795	119134796	rs7869550	Height
chr9	119181793	119181794	rs17303101	Migraine
chr9	119249338	119249339	rs7852872	Hippocampal volume
chr9	119252628	119252629	rs6478241	Migraine without aura
chr9	119252628	119252629	rs6478241	Migraine - clinic-based
chr9	119252628	119252629	rs6478241	Migraine
chr9	119314216	119314217	rs13290997	Pulmonary function (interaction)
chr9	119333682	119333683	rs10983238	Attention deficit hyperactivity disorder
chr9	119839327	119839328	rs16934284	Obesity-related traits
chr9	119925094	119925095	rs6478282	Immune response to anthrax vaccine
chr9	119926425	119926426	rs4838255	Response to antipsychotic treatment
chr9	120137757	120137758	rs2226006	Economic and political preferences (fairness)
chr9	120559010	120559011	rs10115586	IgG glycosylation
chr9	120795989	120795990	rs2416604	Obesity-related traits
chr9	121031028	121031029	rs876347	Response to antipsychotic therapy (extrapyramidal side effects)
chr9	121346416	121346417	rs1572299	Schizophrenia
chr9	121359285	121359286	rs11789399	Bipolar disorder and schizophrenia
chr9	121984552	121984553	rs10984447	Multiple sclerosis
chr9	122059708	122059709	rs4837628	Parkinson's disease
chr9	122258576	122258577	rs10984561	Pulmonary function decline
chr9	122861296	122861297	rs16909449	Response to statin therapy
chr9	123056636	123056637	rs4837752	Response to antipsychotic therapy (extrapyramidal side effects)
chr9	123640499	123640500	rs1953126	Celiac disease and Rheumatoid arthritis
chr9	123652897	123652898	rs881375	Rheumatoid arthritis
chr9	123690238	123690239	rs3761847	Rheumatoid arthritis
chr9	123914873	123914874	rs9408926	Immune reponse to smallpox (secreted IFN-alpha)
chr9	123951916	123951917	rs9408928	Immune reponse to smallpox (secreted IFN-alpha)
chr9	124098534	124098535	rs767770	Bipolar disorder and schizophrenia
chr9	124422402	124422403	rs7025486	Abdominal aortic aneurysm
chr9	124476012	124476013	rs35061590	Heart rate
chr9	124521259	124521260	rs3747851	Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
chr9	124549641	124549642	rs10985375	Thiazide-induced adverse metabolic effects in hypertensive patients
chr9	124560852	124560853	rs10818593	Metabolite levels  (X-11787)
chr9	124565819	124565820	rs10760187	Periodontal microbiota
chr9	124906722	124906723	rs3818638	Obesity-related traits
chr9	125573029	125573030	rs16912238	Obesity-related traits
chr9	126154353	126154354	rs872863	Myopia (pathological)
chr9	126352217	126352218	rs7852296	Personality dimensions
chr9	126446777	126446778	rs10818854	Body mass index (non-asthmatics)
chr9	126446777	126446778	rs10818854	Polycystic ovary syndrome
chr9	126525211	126525212	rs2479106	Polycystic ovary syndrome
chr9	126695769	126695770	rs10818894	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
chr9	126783846	126783847	rs2075064	Waist circumference
chr9	126926106	126926107	rs2807580	Cognitive performance
chr9	127327762	127327763	rs10114038	Follicule stimulating hormone
chr9	128831096	128831097	rs4838320	Economic and political preferences (immigration/crime)
chr9	128857850	128857851	rs10987149	Response to mTOR inhibitor (everolimus)
chr9	128929022	128929023	rs888219	Response to antipsychotic treatment
chr9	129194772	129194773	rs758970	Obesity-related traits
chr9	129465324	129465325	rs867559	Body mass index
chr9	130107963	130107964	rs4130590	Bipolar disorder
chr9	130110410	130110411	rs7029536	Metabolite levels (HVA)
chr9	130504069	130504070	rs514024	Eating disorders (purging via substances)
chr9	130619636	130619637	rs7865146	Metabolic syndrome
chr9	130976556	130976557	rs2502731	Attention deficit hyperactivity disorder
chr9	131084627	131084628	rs11539570	Obesity-related traits
chr9	131403220	131403221	rs12380424	Axial length
chr9	131475582	131475583	rs72758841	Obesity-related traits
chr9	131888115	131888116	rs10988217	Hypersomnia (HLA-DQB1*06:02 negative)
chr9	132339069	132339070	rs10988428	Metabolite levels (Pyroglutamine)
chr9	132349596	132349597	rs73628692	Metabolite levels (HVA/5-HIAA ratio)
chr9	132370359	132370360	rs10988449	Response to antidepressant treatment
chr9	132444098	132444099	rs7866070	Common traits (Other)
chr9	132939791	132939792	rs4836694	Alzheimer's disease (cognitive decline)
chr9	133464083	133464084	rs7466269	Height
chr9	133478826	133478827	rs7851693	Bone mineral density
chr9	133748082	133748083	rs2070997	Response to amphetamines
chr9	133765655	133765656	rs10901296	Bilirubin levels
chr9	134450072	134450073	rs11243437	Response to amphetamines
chr9	135096766	135096767	rs11243676	Systemic lupus erythematosus
chr9	135344406	135344407	rs569434	Obesity-related traits
chr9	135618282	135618283	rs11243897	Attention deficit hyperactivity disorder
chr9	135632492	135632493	rs12552369	Major depressive disorder
chr9	135647020	135647021	rs10901212	Obesity-related traits
chr9	135776033	135776034	rs1076160	Psoriasis
chr9	135845034	135845035	rs2905072	Bipolar disorder
chr9	136131187	136131188	rs8176749	Tumor biomarkers
chr9	136131187	136131188	rs8176749	Coagulation factor levels
chr9	136131321	136131322	rs8176746	mean corpuscular hemoglobin concentration
chr9	136131414	136131415	rs8176743	End-stage coagulation
chr9	136132753	136132754	rs8176722	Malaria
chr9	136132872	136132873	rs8176720	Serum alkaline phosphatase levels
chr9	136132908	136132909	rs8176719	Malaria
chr9	136132908	136132909	rs8176719	Venous thromboembolism
chr9	136135551	136135552	rs8176704	Coagulation factor levels
chr9	136137064	136137065	rs687621	Venous thromboembolism
chr9	136137064	136137065	rs687621	Activated partial thromboplastin time
chr9	136137064	136137065	rs687621	D-dimer levels
chr9	136137105	136137106	rs687289	Coagulation factor levels
chr9	136139264	136139265	rs657152	Serum alkaline phosphatase levels
chr9	136139264	136139265	rs657152	Thyroid hormone levels
chr9	136139264	136139265	rs657152	Obesity-related traits
chr9	136139264	136139265	rs657152	Phytosterol levels
chr9	136139264	136139265	rs657152	Liver enzyme levels
chr9	136141869	136141870	rs2519093	Venous thromboembolism
chr9	136142202	136142203	rs514659	Coronary heart disease
chr9	136142216	136142217	rs644234	Protein biomarker
chr9	136142354	136142355	rs643434	End-stage coagulation
chr9	136142354	136142355	rs643434	Inflammatory biomarkers
chr9	136143441	136143442	rs612169	Metabolic traits
chr9	136149228	136149229	rs505922	Graves' disease
chr9	136149228	136149229	rs505922	End-stage coagulation
chr9	136149228	136149229	rs505922	Duodenal ulcer
chr9	136149228	136149229	rs505922	Venous thromboembolism
chr9	136149228	136149229	rs505922	Pancreatic cancer
chr9	136149228	136149229	rs505922	Protein quantitative trait loci
chr9	136149398	136149399	rs507666	Soluble ICAM-1
chr9	136153874	136153875	rs651007	Serum alkaline phosphatase levels
chr9	136153874	136153875	rs651007	End-stage coagulation
chr9	136153874	136153875	rs651007	Metabolite levels
chr9	136153874	136153875	rs651007	E-selectin levels
chr9	136154167	136154168	rs579459	Red blood cell traits
chr9	136154167	136154168	rs579459	Liver enzyme levels (alkaline phosphatase)
chr9	136154167	136154168	rs579459	Coronary heart disease
chr9	136154167	136154168	rs579459	Soluble levels of adhesion molecules
chr9	136154167	136154168	rs579459	Soluble E-selectin levels
chr9	136154303	136154304	rs649129	Soluble levels of adhesion molecules
chr9	136154866	136154867	rs495828	Venous thromboembolism
chr9	136154866	136154867	rs495828	Red blood cell count
chr9	136154866	136154867	rs495828	Hematological and biochemical traits
chr9	136154866	136154867	rs495828	Angiotensin-converting enzyme activity
chr9	136154999	136155000	rs635634	LDL cholesterol
chr9	136154999	136155000	rs635634	Cholesterol, total
chr9	136166345	136166346	rs7025162	Serum alkaline phosphatase levels
chr9	136323753	136323754	rs4962153	Liver enzyme levels
chr9	136478354	136478355	rs3025343	Smoking behavior
chr9	136676013	136676014	rs7021663	IgG glycosylation
chr9	136679079	136679080	rs756777	IgG glycosylation
chr9	136723519	136723520	rs12344583	vWF and FVIII levels
chr9	136835342	136835343	rs3780792	Multiple sclerosis
chr9	136925662	136925663	rs11789898	Platelet counts
chr9	137125500	137125501	rs10785877	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
chr9	137269455	137269456	rs34312136	Intelligence
chr9	137280938	137280939	rs35079168	Intelligence
chr9	137284922	137284923	rs4501664	Intelligence
chr9	137285502	137285503	rs11102986	Intelligence
chr9	137436313	137436314	rs3118515	Central corneal thickness
chr9	137440211	137440212	rs3132306	Central corneal thickness
chr9	137440527	137440528	rs1536482	Central corneal thickness
chr9	137440527	137440528	rs1536482	Corneal structure
chr9	137506577	137506578	rs11103429	Crohn's disease (need for surgery)
chr9	137568050	137568051	rs7044529	Corneal structure
chr9	137568050	137568051	rs7044529	Central corneal thickness
chr9	137704781	137704782	rs7874142	Longevity
chr9	137816458	137816459	rs2094962	IgG glycosylation
chr9	138028676	138028677	rs3849221	Obesity-related traits
chr9	138029700	138029701	rs10776934	Response to hepatitis C treatment
chr9	138275775	138275776	rs10858396	Attention deficit hyperactivity disorder
chr9	138529721	138529722	rs1537415	Periodontitis
chr9	139089678	139089679	rs7860634	Thyroid hormone levels
chr9	139111869	139111870	rs7849585	Height
chr9	139121739	139121740	rs12338076	Height
chr9	139252147	139252148	rs11787792	Type 2 diabetes
chr9	139265595	139265596	rs34971035	Obesity-related traits
chr9	139265595	139265596	rs34971035	Monocyte chemoattractant protein-1
chr9	139266404	139266405	rs10781499	Inflammatory bowel disease
chr9	139266404	139266405	rs10781499	Ulcerative colitis
chr9	139266495	139266496	rs4077515	Crohn's disease
chr9	139266495	139266496	rs4077515	Ulcerative colitis
chr9	139269337	139269338	rs10781500	Ankylosing spondylitis
chr9	139269337	139269338	rs10781500	Ulcerative colitis
chr9	139860263	139860264	rs11145951	Corneal structure
chr9	139862632	139862633	rs57024841	Beta-trace protein levels
chr9	140088629	140088630	rs28417902	Obesity-related traits
chrX	990179	990180	rs4129148	Schizophrenia
chrX	2885722	2885723	rs12393627	Height
chrX	3410668	3410669	rs7059886	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	4596137	4596138	rs5916687	Amyotrophic lateral sclerosis
chrX	5184701	5184702	rs6638512	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	6220473	6220474	rs7885458	Biochemical measures
chrX	8394252	8394253	rs7892812	Cognitive performance
chrX	8913825	8913826	rs5934505	Androgen levels
chrX	9751473	9751474	rs5934683	Colorectal cancer
chrX	9814134	9814135	rs2405942	Prostate cancer
chrX	10231690	10231691	rs12388359	Alcohol dependence
chrX	11048691	11048692	rs5934953	Cognitive performance
chrX	12971523	12971524	rs5979785	Celiac disease
chrX	13615117	13615118	rs5978649	Multiple sclerosis
chrX	14950530	14950531	rs5980075	Waist-to-hip circumference ratio (interaction)
chrX	17698396	17698397	rs5955543	Wilms tumor
chrX	22134657	22134658	rs5951698	Tourette syndrome
chrX	22148050	22148051	rs1540283	Immune reponse to smallpox (secreted IFN-alpha)
chrX	22160991	22160992	rs12559632	F-cell distribution
chrX	22892076	22892077	rs5925696	Erectile dysfunction and prostate cancer treatment
chrX	23383443	23383444	rs5925760	Immune reponse to smallpox (secreted IFN-alpha)
chrX	25853613	25853614	rs5944185	Erectile dysfunction and prostate cancer treatment
chrX	26369898	26369899	rs6526555	Metabolite levels (HVA/MHPG ratio)
chrX	26369898	26369899	rs6526555	Metabolite levels (5-HIAA/ MHPG Ratio)
chrX	28233052	28233053	rs5971305	Erectile dysfunction and prostate cancer treatment
chrX	29640817	29640818	rs7890572	Cardiovascular disease risk factors
chrX	30119776	30119777	rs6628506	Metabolite levels (HVA/MHPG ratio)
chrX	32015375	32015376	rs16990008	Response to antidepressant treatment
chrX	32225254	32225255	rs1456737	Bipolar disorder and schizophrenia
chrX	33784062	33784063	rs5928363	Tuberculosis
chrX	33811840	33811841	rs113065570	Periodontitis (Mean PAL)
chrX	34892502	34892503	rs4271113	Multiple sclerosis
chrX	37854726	37854727	rs872690	Erectile dysfunction and prostate cancer treatment
chrX	37999651	37999652	rs56156506	Anorexia nervosa
chrX	39885629	39885630	rs17145638	Pit-and-Fissure caries
chrX	43607032	43607033	rs3027409	Smoking behavior
chrX	44400185	44400186	rs6610953	Personality dimensions
chrX	47174275	47174276	rs6611365	Optic disc size (disc)
chrX	47906479	47906480	rs142513793	Tuberculosis
chrX	50182183	50182184	rs1934179	Hypospadias
chrX	51210056	51210057	rs1327301	Prostate cancer
chrX	51229682	51229683	rs5945572	Prostate cancer
chrX	51241671	51241672	rs5945619	Prostate cancer
chrX	53974053	53974054	rs7065696	Bipolar disorder and schizophrenia
chrX	56811694	56811695	rs4826508	Blood trace element (Zn levels)
chrX	62625198	62625199	rs10127000	Periodontitis (Mean PAL)
chrX	64367018	64367019	rs7064929	Erectile dysfunction and prostate cancer treatment
chrX	65606692	65606693	rs5965182	Erectile dysfunction and prostate cancer treatment
chrX	66510983	66510984	rs6625163	Male-pattern baldness
chrX	66563017	66563018	rs2497938	Male-pattern baldness
chrX	66942624	66942625	rs5031002	LDL cholesterol
chrX	67021549	67021550	rs5919432	Prostate cancer
chrX	68798702	68798703	rs11796357	Primary tooth development (time to first tooth eruption)
chrX	68798702	68798703	rs11796357	Primary tooth development (number of teeth)
chrX	68805317	68805318	rs4844096	Primary tooth development (number of teeth)
chrX	68892915	68892916	rs5936487	Primary tooth development (time to first tooth eruption)
chrX	75347433	75347434	rs5937496	Amyotrophic lateral sclerosis
chrX	78497117	78497118	rs5912838	Graves' disease
chrX	78649192	78649193	rs1474563	Height
chrX	82535168	82535169	rs1410530	Bipolar disorder and schizophrenia
chrX	82711941	82711942	rs213443	Bipolar disorder and schizophrenia
chrX	82871194	82871195	rs5922838	Depression and alcohol dependence
chrX	82954489	82954490	rs5968205	Depression and alcohol dependence
chrX	86192002	86192003	rs2710057	Bone mineral density (hip)
chrX	87190348	87190349	rs12012519	HIV-1 control
chrX	88530064	88530065	rs5941160	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	89288226	89288227	rs5941436	Cognitive performance
chrX	89804126	89804127	rs2755459	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	90812717	90812718	rs6618677	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	91402219	91402220	rs2573905	Alzheimer's disease
chrX	95079869	95079870	rs5990417	Major depressive disorder (broad)
chrX	97864353	97864354	rs4827947	Immune reponse to smallpox (secreted IL-1beta)
chrX	105493918	105493919	rs379742	Pancreatitis
chrX	106244766	106244767	rs12688220	Pancreatitis
chrX	109820067	109820068	rs1573036	Sex hormone-binding globulin levels
chrX	109939204	109939205	rs5943057	Coronary heart disease
chrX	111155232	111155233	rs7050529	Smoking behavior
chrX	111646463	111646464	rs5982533	Biochemical measures
chrX	115302191	115302192	rs1403543	Cystic fibrosis severity
chrX	116222262	116222263	rs6646773	Response to citalopram treatment
chrX	116869913	116869914	rs5910235	Metabolite levels (5-HIAA/ MHPG Ratio)
chrX	117088055	117088056	rs2430212	Iron status biomarkers
chrX	118567701	118567702	rs5910578	Paget's disease
chrX	118716986	118716987	rs7879933	Brain connectivity
chrX	119867474	119867475	rs1972809	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	121967358	121967359	rs4559365	Metabolite levels (MHPG)
chrX	124073661	124073662	rs7060947	Immune reponse to smallpox (secreted IFN-alpha)
chrX	129104733	129104734	rs2361405	Periodontitis (Mean PAL)
chrX	129199811	129199812	rs3788848	Dental caries
chrX	130518918	130518919	rs1715	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
chrX	132024503	132024504	rs7892161	Periodontitis (Mean PAL)
chrX	132137155	132137156	rs17324272	HIV-1 control
chrX	133125790	133125791	rs7883190	Relative hand skill
chrX	133322603	133322604	rs765132	Response to anti-TNF alpha therapy in inflammatory bowel disease
chrX	136055294	136055295	rs1190739	Coronary heart disease
chrX	138117408	138117409	rs10521792	Response to taxane treatment (placlitaxel)
chrX	139166682	139166683	rs5907577	Bipolar disorder and schizophrenia
chrX	139314055	139314056	rs5955415	Bipolar disorder and schizophrenia
chrX	141360570	141360571	rs5954596	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	142842118	142842119	rs139956886	Tuberculosis
chrX	143254696	143254697	rs9636470	Alcohol and nictotine co-dependence
chrX	144141318	144141319	rs6627057	Bipolar disorder and schizophrenia
chrX	145748907	145748908	rs381365	Immune reponse to smallpox (secreted IFN-alpha)
chrX	146322622	146322623	rs5904726	Coronary heart disease
chrX	147042773	147042774	rs5904818	Antineutrophil cytoplasmic antibody-associated vasculitis
chrX	147324255	147324256	rs5936441	Response to acetaminophen (hepatotoxicity)
chrX	147381020	147381021	rs2159767	Schizophrenia
chrX	148567450	148567451	rs530501	Cognitive performance
chrX	149635294	149635295	rs17252936	Immune reponse to smallpox (secreted IFN-alpha)
chrX	151655561	151655562	rs10856240	Cognitive performance
chrX	152862637	152862638	rs12010175	Type 2 diabetes
chrX	152899921	152899922	rs5945326	Type 2 diabetes
chrX	153006494	153006495	rs11156606	Bipolar disorder and schizophrenia
chrX	153207544	153207545	rs2269372	Schizophrenia
chrX	153554403	153554404	rs766420	Bilirubin levels
chrX	153764216	153764217	rs1050828	Red blood cell traits
chrX	153764662	153764663	rs762516	Red blood cell traits
chrX	153945601	153945602	rs2664170	Type 1 diabetes
chrX	154014106	154014107	rs5987027	Mean corpuscular volume
chrX	154014106	154014107	rs5987027	Hematology traits
chrX	154233773	154233774	rs17281398	Antineutrophil cytoplasmic antibody-associated vasculitis
chrY	940179	940180	rs4129148	Schizophrenia
chrY	6477299	6477300	rs5941160	Antineutrophil cytoplasmic antibody-associated vasculitis
